Citrus Sinensis ID: 010676

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500----
Protein Sequence
MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNPFV
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccHHHHHHHHHcccccccccccccccccccHHHHccccccccccccccccccccccccccccccccccccHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHcccccccccccccccccccccccccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccEEEccEEccccccEEEEEEcccccEEEEEEEEEccccccHHHHHHHHHHHHHHHHcccccccEEEEEEEEEccEEEEEEEEcccccHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEEEcccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccHHHccccccccccccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccEEEcccccHHHHHHHHcccccccHccccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcccccccEccccccccccccccccccccccccHHHHHHHcccccccccccccccccccccccHHHcccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHccccHcccEEEccccEEEEEEEEEccEEEEEEEEEcccccccccHHHHHHHHHHHHHHHHcHHHHHHHccccccccEEEEEEEcccccHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccHHHHccccccccccHHHHccccc
Coil and Loop (DISEMBL)
mhhlprflspreksagkaamdprkmrqkprlERRNAAKHIEydvastssslddsssssslitrsldlsdrtsfriegvEGEFERICRSlglsgpedfaiPAAAWEARknrsasdllprsrlKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELScrasgagnndALAVMettelppsglaessaccvssnyvkgikgvrppllkpppgmrqpvidnacsTWDIlrdfapkdgitpssvmndralssssddednekegeEADRAIVKeeeddmvlsescsftteheddssstttepmsnispngrfKRIITYWQkgdllgrgsfgsvyegisddgfFFAVKEVslldqgsqAKQSISQLEQEIALLSRFEHEnivqyygtdkdesKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKylhdqdvvhrdIKCANILvdangsvkladfglakatklndvkscrgtafwmapevcsnpfv
Flexible Loop (DISEMBL)
mhhlprflspreksagkaamdprkmrqkprlerrnaakhieydvastssslddsssssslitrsldlsdrtsfriegvegeFERICRSLGLSGPEDFAIPAAAWEARKnrsasdllprsrlKQLDTLKETverqsdaagavvgelcdRVSDIvrirneteltrtkltqvaelscrasgagnnDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFApkdgitpssvmndralssssddednekegeeadraivkeeeddmvLSESCSFTteheddssstttepmsnispngrFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAfwmapevcsnpfv
Low Complexity Region (SEG)
MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVAstssslddsssssslitrsldlsdrTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALssssddednekegeeadRAIVKEEEDDMVLSESCSFtteheddssstttePMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNPFV
Disordered region (IsUnstruct)
************************************************************************FRIEGVEGEFERICRSLGLSGPEDFAIPAAAW*********************************AGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCR**************************SACCVSSNYVKGIKGVRPPL*********PVIDNACSTWDILRDFA***************************************************************************RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLD***********LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC*****
Disordered Region (DISOPRED)
****PR************************************************************************************************************************************************************************************************************************************************************************************************************************************WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS****************QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL***KSCRGTAFWMAPEVCSNP**
Disordered Region (DISEMBL)
MHHLPRFLSPR********************ERRNAAKHIEYDV******************RSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMN*******************ADRAIVKEEEDDMVLSES********************NISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL**********SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNPFV
Disordered Region (DISPRO)
*****************************RLERRN*AKHIEYD**********************DLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNR***************************************************************************************LAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPK*****************************************************************MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNPFV
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNPFV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	504	2.2.26 [Sep-21-2011]
Q39008	608	Mitogen-activated protein	yes	no	0.952	0.789	0.512	1e-116
Q9SZ67	1895	Probable WRKY transcripti	no	no	0.517	0.137	0.542	7e-71
O22040	666	Mitogen-activated protein	no	no	0.333	0.252	0.457	2e-38
Q9FZ36	651	Mitogen-activated protein	no	no	0.333	0.258	0.451	2e-38
O22042	651	Mitogen-activated protein	no	no	0.331	0.256	0.438	4e-36
Q54R82	942	Mitogen-activated protein	no	no	0.333	0.178	0.448	5e-36
E9Q3S4	1311	Mitogen-activated protein	yes	no	0.335	0.128	0.435	6e-35
Q61083	619	Mitogen-activated protein	no	no	0.394	0.321	0.411	8e-35
Q9Y2U5	619	Mitogen-activated protein	yes	no	0.398	0.324	0.420	5e-34
P28829	659	Protein kinase byr2 OS=Sc	yes	no	0.333	0.254	0.437	2e-33

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  419 bits (1078), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 264/515 (51%), Positives = 334/515 (64%), Gaps = 35/515 (6%)

Query: 6   RFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSL--DDSSSSSSLITR 63
           R L+  +KS G+   D + +    RLERR+AA++I YD AS SSS   D S S+SSL+TR
Sbjct: 3   RILARMKKSTGRRGGD-KNITPVRRLERRDAARNINYDAASCSSSSAEDLSVSTSSLMTR 61

Query: 64  SLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQ 123
           SL+  + TSFRI G  GE +RI RSLG+SGP+D AI   AWEA K RS+SD++ R +   
Sbjct: 62  SLEFPEPTSFRIGGGVGEMDRIYRSLGVSGPDDLAISFDAWEACKKRSSSDVVNRFKSFD 121

Query: 124 LDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETEL-----TRTKLTQVAELSC---R 175
           LD +++    +   +G VVG   D ++  V+ ++ +E        T+L+++  L     R
Sbjct: 122 LDKVRDQDLSEEGPSGVVVGS--DSMNHKVQGQDLSEAGPSGGIVTELSEIGNLITPVDR 179

Query: 176 ASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKG-------IKGVRPPLLKPPPGM 228
               G  +   VME T      + +S    V +N V         IKG+RPP+LKPPP M
Sbjct: 180 LVADGVVENRRVMERTPT----IVKSKGYLVPNNVVAVGVGVGGGIKGLRPPVLKPPPAM 235

Query: 229 RQPVIDNACSTWDILRDFAPKDGI---TPSSVMNDRALSSSSDDEDNEKEGEEADRAIVK 285
           ++P ID+  S+WD L  FAP + +   + SS  ++         E+  +  E   R I  
Sbjct: 236 KRPPIDHRGSSWDFLTHFAPSETVKRPSSSSSSSEDGCDEEEGKEEEAEAEEMGARFIQL 295

Query: 286 EEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSV 345
            +  D    E+CSFTT +E DSSST +   S I P+G    IIT WQKG LLGRGSFGSV
Sbjct: 296 GDTAD----ETCSFTT-NEGDSSSTVSN-TSPIYPDG--GAIITSWQKGQLLGRGSFGSV 347

Query: 346 YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405
           YEGIS DG FFAVKEVSLLDQGSQA++ I QLE EI LLS+ +H+NIV+Y GT KD S L
Sbjct: 348 YEGISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNL 407

Query: 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465
           YIFLELVT+GSLL LYQRY LRDS VS YTRQIL GLKYLHD+  +HRDIKCANILVDAN
Sbjct: 408 YIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKGFIHRDIKCANILVDAN 467

Query: 466 GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCS 500
           G+VKLADFGLAK +K ND+KSC+GT FWMAPEV +
Sbjct: 468 GAVKLADFGLAKVSKFNDIKSCKGTPFWMAPEVIN 502

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1

 Score =  268 bits (685), Expect = 7e-71,   Method: Compositional matrix adjust.
 Identities = 160/295 (54%), Positives = 188/295 (63%), Gaps = 34/295 (11%)

Query: 214  IKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNE 273
            IKG+RPP+L+  P M+   I    STWD +  FAP + + P S  ++        +E   
Sbjct: 1527 IKGLRPPVLQLQPAMKLSHIPRG-STWDFVTHFAPPETVAPPSSSSEAREEEVETEETGA 1585

Query: 274  KEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISP----NGRFKRIIT 329
                  D+             E+CSFT  ++ DSS T    +SN SP     G F   IT
Sbjct: 1586 MFIPLGDK-------------ETCSFTV-NKGDSSRT----ISNTSPIYASEGSF---IT 1624

Query: 330  YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             WQKG LLGRGS GSVYEGIS DG FFA KEVSLLDQGSQA + I Q+E  IALLS+ +H
Sbjct: 1625 CWQKGQLLGRGSLGSVYEGISADGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQH 1684

Query: 390  ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
            +NIV+Y GT KDES LYIFLELVT+GSL  LYQR  L DS VS YTRQIL GLKYLHD+ 
Sbjct: 1685 QNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHDKG 1744

Query: 450  VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--WMAPEVCSNP 502
             +HR+IKCAN+LVDANG+VKLADFGLAK      V S   T +  WMAPEV  NP
Sbjct: 1745 FIHRNIKCANVLVDANGTVKLADFGLAK------VMSLWRTPYWNWMAPEVILNP 1793

Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  160 bits (406), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 81/177 (45%), Positives = 115/177 (64%), Gaps = 9/177 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL---LDQGSQAKQSISQLEQEIALLSR 386
           W+KG L+GRG+FG+VY G++ D G   AVK+V +        + +  I +LE+E+ LL  
Sbjct: 69  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 445
             H NIV+Y GT +++  L I LE V  GS+ +L +++    +S V  YTRQ+LLGL+YL
Sbjct: 129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYL 188

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEV 498
           H+  ++HRDIK ANILVD  G +KLADFG    +A+   +   KS +GT +WMAPEV
Sbjct: 189 HNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEV 245

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  160 bits (405), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 80/177 (45%), Positives = 117/177 (66%), Gaps = 9/177 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS---ISQLEQEIALLSR 386
           W+KG L+GRG+FG+VY G++ D G   AVK+V +    +  +++   I +LE+E+ LL  
Sbjct: 68  WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKN 127

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYL 445
             H NIV+Y GT +++  L I LE V  GS+ +L +++    +S V  YT Q+LLGL+YL
Sbjct: 128 LSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEYL 187

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEV 498
           H+  ++HRDIK ANILVD  G +KLADFG    +A+   ++  KS +GT +WMAPEV
Sbjct: 188 HNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEV 244

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  152 bits (385), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 78/178 (43%), Positives = 115/178 (64%), Gaps = 11/178 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 385
           W+KG+L+G G+FG VY G++ D G   A+K+V L+   S +K+     I +LE+E+ LL 
Sbjct: 68  WRKGELIGCGAFGRVYMGMNLDSGELLAIKQV-LIAPSSASKEKTQGHIRELEEEVQLLK 126

Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
              H NIV+Y GT ++   L I +E V  GS+ +L +++    +  +  YT+Q+LLGL+Y
Sbjct: 127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEY 186

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCRGTAFWMAPEV 498
           LH+  ++HRDIK ANILVD  G ++LADFG +K       +N  KS +GT +WMAPEV
Sbjct: 187 LHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEV 244

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  152 bits (384), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 78/174 (44%), Positives = 114/174 (65%), Gaps = 6/174 (3%)

Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRF 387
           WQKG +LGRG +GSVY G++ D G  FAVK++ ++D  S  + K  I    +EI ++   
Sbjct: 170 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 229

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
            H+NIV+Y GT  D+S L +FLE +  GS+ +L  ++    ++ +  YT+QIL GL +LH
Sbjct: 230 RHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLH 289

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRGTAFWMAPEV 498
              ++HRDIK ANIL+D  G VKL+DFG +K+    ++  KS +GT +WMAPEV
Sbjct: 290 ANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEV 343

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1

 Score =  149 bits (375), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 78/179 (43%), Positives = 111/179 (62%), Gaps = 10/179 (5%)

Query: 330  YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE 388
            +W KG++LGRG++G+VY G++  G   AVK+V+L      A ++   +L++E+ LL   +
Sbjct: 1043 FWTKGEILGRGAYGTVYCGLTSLGQLIAVKQVALDTSDKLATEKEYRKLQEEVDLLKALK 1102

Query: 389  HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD 447
            H NIV Y GT  +E+ L IF+E V  GS+ ++  R+  L +     YTRQIL G+ YLHD
Sbjct: 1103 HVNIVAYLGTCLEENTLSIFMEFVPGGSISSIINRFGPLPEMVFCKYTRQILQGVAYLHD 1162

Query: 448  QDVVHRDIKCANILVDANGSVKLADFGLAK--------ATKLNDVKSCRGTAFWMAPEV 498
              VVHRDIK  N+++   G +KL DFG AK         T  + +KS RGT +WMAPEV
Sbjct: 1163 NCVVHRDIKGNNVMLMPTGIIKLIDFGCAKRLAWAGLNGTHSDMLKSMRGTPYWMAPEV 1221

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q61083|M3K2_MOUSE Mitogen-activated protein kinase kinase kinase 2 OS=Mus musculus GN=Map3k2 PE=1 SV=2

 Score =  148 bits (374), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 91/221 (41%), Positives = 123/221 (55%), Gaps = 22/221 (9%)

Query: 299 FTTEHED----------DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEG 348
           FT E++D          D+ + T   +++ISP  R  R  T W+ G LLG+G+FG VY  
Sbjct: 317 FTPEYDDSRIRRRGSDIDNPTLT---VTDISPPSRSPRAPTNWRLGKLLGQGAFGRVYLC 373

Query: 349 IS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT--DKDESKL 405
              D G   AVK+V    +  +  + ++ LE EI LL    HE IVQYYG   D  E  L
Sbjct: 374 YDVDTGRELAVKQVQFNPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPQEKTL 433

Query: 406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA 464
            IF+EL   GS+ +  + Y  L ++    YTRQIL G+ YLH   +VHRDIK ANIL D+
Sbjct: 434 SIFMELSPGGSIKDQLKAYGALTENVTRKYTRQILEGVHYLHSNMIVHRDIKGANILRDS 493

Query: 465 NGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVCS 500
            G++KL DFG +K  +        +KS  GT +WM+PEV S
Sbjct: 494 TGNIKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 534

Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7. Plays a role in caveolae kiss-and-run dynamics.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2

 Score =  145 bits (367), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 92/219 (42%), Positives = 120/219 (54%), Gaps = 18/219 (8%)

Query: 299 FTTEHED--------DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS 350
           FT E++D        D  + T   M +ISP  R  R  T W+ G LLG+G+FG VY    
Sbjct: 317 FTPEYDDSRIRRRGSDIDNPTLTVM-DISPPSRSPRAPTNWRLGKLLGQGAFGRVYLCYD 375

Query: 351 -DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT--DKDESKLYI 407
            D G   AVK+V       +  + ++ LE EI LL    HE IVQYYG   D  E  L I
Sbjct: 376 VDTGRELAVKQVQFDPDSPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPQEKTLSI 435

Query: 408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG 466
           F+E +  GS+ +  + Y  L ++    YTRQIL G+ YLH   +VHRDIK ANIL D+ G
Sbjct: 436 FMEYMPGGSIKDQLKAYGALTENVTRKYTRQILEGVHYLHSNMIVHRDIKGANILRDSTG 495

Query: 467 SVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVCS 500
           +VKL DFG +K  +        +KS  GT +WM+PEV S
Sbjct: 496 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 534

Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1

 Score =  144 bits (363), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 80/183 (43%), Positives = 111/183 (60%), Gaps = 15/183 (8%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAK----QSISQLEQEIALLS 385
           W +G L+G GSFG VY G+ +  G   AVK+V +LD  S++K    + +  L  EIALL 
Sbjct: 394 WIRGALIGSGSFGQVYLGMNASSGELMAVKQV-ILDSVSESKDRHAKLLDALAGEIALLQ 452

Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
              HE+IVQY G++ +   L IFLE V  GS+  L   Y    ++ V  + +Q L GL+Y
Sbjct: 453 ELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGSFEETLVKNFIKQTLKGLEY 512

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--------SCRGTAFWMAP 496
           LH + +VHRDIK ANILVD  G +K++DFG++K  +LN           S +G++FWMAP
Sbjct: 513 LHSRGIVHRDIKGANILVDNKGKIKISDFGISKKLELNSTSTKTGGARPSFQGSSFWMAP 572

Query: 497 EVC 499
           EV 
Sbjct: 573 EVV 575

Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	504
255545546	555	Mitogen-activated protein kinase kinase	0.863	0.783	0.646	1e-162
356509460	566	PREDICTED: mitogen-activated protein kin	0.878	0.782	0.584	1e-150
224082218	548	predicted protein [Populus trichocarpa]	0.871	0.801	0.639	1e-144
356552843	590	PREDICTED: mitogen-activated protein kin	0.890	0.761	0.561	1e-141
357489127	593	Mitogen-activated protein kinase kinase	0.954	0.811	0.588	1e-140
32400274	592	putative mitogen-activated protein kinas	0.952	0.810	0.580	1e-137
356518515	555	PREDICTED: mitogen-activated protein kin	0.871	0.790	0.600	1e-136
224066881	558	predicted protein [Populus trichocarpa]	0.875	0.790	0.635	1e-135
449445122	565	PREDICTED: mitogen-activated protein kin	0.890	0.794	0.565	1e-134
225459451	567	PREDICTED: mitogen-activated protein kin	0.902	0.802	0.568	1e-134

>gi|255545546|ref|XP_002513833.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223546919|gb|EEF48416.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis]

 Score =  578 bits (1491), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 322/498 (64%), Positives = 366/498 (73%), Gaps = 63/498 (12%)

Query: 20  MDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVE 79
           MDP+  R +PRLERRNAAKHIEYD  S+ SSLD SS SSSL+TRSLDL + TSFRIEG +
Sbjct: 1   MDPKNGRSRPRLERRNAAKHIEYDATSSFSSLDASSCSSSLVTRSLDLPEGTSFRIEGTD 60

Query: 80  GEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDT--LKETVERQSDA 137
           GEF+RICRS+GL+GPEDF IP AAWEA K RSASDLLPRSRL   D+  + E   ++ + 
Sbjct: 61  GEFDRICRSIGLTGPEDFEIPTAAWEAMKVRSASDLLPRSRLYVSDSPRIAEAKHKEQEQ 120

Query: 138 AGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSG 197
             +   ELC RV D VR  + TELT+ K  QV  +    SG G                 
Sbjct: 121 EKS---ELCARVLDTVRTDDSTELTQEK--QVQPVKLNVSGGG----------------- 158

Query: 198 LAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSV 257
                           IKGVRPPLLKPPP M  PVID  CSTWDILRDFAP++    S +
Sbjct: 159 ----------------IKGVRPPLLKPPPSMTLPVIDKCCSTWDILRDFAPENDRRSSML 202

Query: 258 MNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDM---------------VLSESCSFTTE 302
           + +  LSS  DDE      EE   AI K EE++                VLSESCSFTT 
Sbjct: 203 IAEGGLSS--DDE------EEVAAAINKGEEEEEEEDDDDNLSRIREIGVLSESCSFTTS 254

Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS 362
           ++DDSSSTTTE MSNISP+ RF+R+I+ W+KGDLLGRGSFGSVYEGI+ DGFFFA+KEVS
Sbjct: 255 NDDDSSSTTTELMSNISPHERFRRMISDWEKGDLLGRGSFGSVYEGIAHDGFFFAIKEVS 314

Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ 422
           LLDQGSQ KQSI QLEQEIALLS+FEHENIV+YYGTDKD+S LYIFLELVT+GSL+NLYQ
Sbjct: 315 LLDQGSQGKQSIYQLEQEIALLSQFEHENIVRYYGTDKDDSNLYIFLELVTQGSLMNLYQ 374

Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
           RYHLRDSQVSAYTRQIL GLKYLHD++VVHRDIKCANILVDA+GSVKLADFGLAKATKLN
Sbjct: 375 RYHLRDSQVSAYTRQILHGLKYLHDRNVVHRDIKCANILVDASGSVKLADFGLAKATKLN 434

Query: 483 DVKSCRGTAFWMAPEVCS 500
           DVKSC+GTAFWMAPEV +
Sbjct: 435 DVKSCKGTAFWMAPEVVN 452

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356509460|ref|XP_003523467.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  538 bits (1386), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 302/517 (58%), Positives = 359/517 (69%), Gaps = 74/517 (14%)

Query: 1   MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHI--EYDVASTSSSLDDSSSSS 58
           MH+L R   PR+++     MD +  R+KP+LERRNA K+   EYDV S       S S  
Sbjct: 1   MHYLSRIFEPRKQTK---TMDRKNPRRKPKLERRNALKYSSSEYDVVS-------SPSDD 50

Query: 59  SLITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPR 118
           +L TRS++  DRTSFRIEGVEGEF+RICRSLGLSGPEDFAIPAAAWEA K RS+SD+LPR
Sbjct: 51  TLYTRSMEFYDRTSFRIEGVEGEFDRICRSLGLSGPEDFAIPAAAWEAMKFRSSSDILPR 110

Query: 119 SRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASG 178
            +L  LD  +E VE                         E+++   ++ + AE    +  
Sbjct: 111 LKLDNLDIPEEDVE------------------------EESKVNEVRMFKSAEEGELSEN 146

Query: 179 AGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDN-AC 237
            G +D++ V E  E              SSN   GIKG+RPP+LKPPPG R  V+D+ AC
Sbjct: 147 HGVSDSVRVREIDE--------------SSN---GIKGIRPPMLKPPPGTRVQVVDDSAC 189

Query: 238 STWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMV----- 292
           S+WD+LRD AP+ G      +N    S+   +   ++EGE   +   K EE+  V     
Sbjct: 190 SSWDLLRDLAPQGG--EGLPLNH---SNEEREVAEKEEGEVGTKESPKREEEQNVDNAAR 244

Query: 293 -------LSESCSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIITY--WQKGDLLGRGSF 342
                  LSESCSF+T +EDDSSS+TT+P SN ISP GR KRIIT   WQKG+ LG GSF
Sbjct: 245 IAEIVAGLSESCSFSTSNEDDSSSSTTDPRSNNISPQGRIKRIITAGSWQKGEFLGGGSF 304

Query: 343 GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402
           GSVYEGISDDGFFFAVKEVSLLDQG+Q KQS+ QLEQEIALLS+FEH+NIVQYYGT+ D+
Sbjct: 305 GSVYEGISDDGFFFAVKEVSLLDQGTQGKQSVYQLEQEIALLSQFEHDNIVQYYGTEMDQ 364

Query: 403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV 462
           SKLYIFLELVTKGSL +LYQ+Y LRDSQVSAYTRQIL GLKYLHD++VVHRDIKCANILV
Sbjct: 365 SKLYIFLELVTKGSLRSLYQKYTLRDSQVSAYTRQILHGLKYLHDRNVVHRDIKCANILV 424

Query: 463 DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC 499
           DA+GSVKLADFGLAKATKLNDVKS +GTAFWMAPEV 
Sbjct: 425 DASGSVKLADFGLAKATKLNDVKSMKGTAFWMAPEVV 461

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224082218|ref|XP_002306607.1| predicted protein [Populus trichocarpa] gi|222856056|gb|EEE93603.1| predicted protein [Populus trichocarpa]

 Score =  518 bits (1333), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 325/508 (63%), Positives = 364/508 (71%), Gaps = 69/508 (13%)

Query: 1   MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSL 60
           MHHLP+FL+ ++K++   +MDP+  R+  RLERRNA KHI+YD A+ S S  D SSSSSL
Sbjct: 1   MHHLPQFLTRKKKTS---SMDPKNRRRP-RLERRNALKHIDYD-ATPSFSSLDDSSSSSL 55

Query: 61  ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSR 120
            TRSLDL DRTSFRIEG EGE +RICRSLGLSGPEDFAIPAAAWEA K RSASDLL RSR
Sbjct: 56  FTRSLDLPDRTSFRIEGTEGELDRICRSLGLSGPEDFAIPAAAWEAMKARSASDLLRRSR 115

Query: 121 L------KQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSC 174
           L      K  +  K  VE  +        ELC  V   VR+R+ +    T+L    ++  
Sbjct: 116 LLGPDSPKAAEEFKAIVEMTNQQEER---ELCAGVLKSVRVRDSS----TELNTCHDIDN 168

Query: 175 RASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVID 234
           R    G                                 IKG RPPLLKPPP M  PVID
Sbjct: 169 RGVSVG---------------------------------IKGPRPPLLKPPPSMTLPVID 195

Query: 235 NACSTWDILRDFAPK-DGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVL 293
             CSTWD+ RDFAP+ DG+    V N++  SS  DD+  E+  +  D A           
Sbjct: 196 KECSTWDLFRDFAPENDGV----VNNNKEFSSGDDDDGRERRPQVIDAA----------- 240

Query: 294 SESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDG 353
             SCSFTT ++DDSSS+TTEPMSNISPN RF+R IT W+KG+LLGRGSFGSVYEGISDDG
Sbjct: 241 --SCSFTTSNDDDSSSSTTEPMSNISPNLRFRRSITDWEKGELLGRGSFGSVYEGISDDG 298

Query: 354 FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
           FFFAVKEVSLLDQGSQ KQSI QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT
Sbjct: 299 FFFAVKEVSLLDQGSQGKQSIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 358

Query: 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
           KGSLL LYQRY+LRDSQVSAYTRQIL GLKYLHDQ+VVHRDIKCAN+LVDANGSVKLADF
Sbjct: 359 KGSLLKLYQRYNLRDSQVSAYTRQILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLADF 418

Query: 474 GLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           GLAKATK NDVKSC+GTAFWMAPEV +N
Sbjct: 419 GLAKATKFNDVKSCKGTAFWMAPEVVNN 446

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356552843|ref|XP_003544772.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  509 bits (1310), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 300/534 (56%), Positives = 358/534 (67%), Gaps = 85/534 (15%)

Query: 1   MHHLPRFLSPREKSAGKAAMDP--------RKMRQKPRLERRNAAKHIEYDVASTSSSLD 52
           M+HLPR    R+K A  + MDP         K  Q+P+LERRNAAKH EYD  S  SS D
Sbjct: 1   MNHLPRIFGNRKKQA--SDMDPTKKKKKSKGKKHQQPKLERRNAAKHFEYDAGSLCSSRD 58

Query: 53  DSSSSSSL-----ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEAR 107
           +  +S+S       TRS++L DR SFRIEGVEGEF++ICRSLGLSGPEDF+IPAAAWEA 
Sbjct: 59  EYDASTSSSSSLHCTRSMELFDRKSFRIEGVEGEFDQICRSLGLSGPEDFSIPAAAWEAM 118

Query: 108 KNRSASDLLPRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLT 167
           K R +SDLLP               R+    G                  E +    +  
Sbjct: 119 KLRCSSDLLP---------------RRPKHGGEEE-----------EFDEEPKEKEKEEV 152

Query: 168 QVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPG 227
           ++A L        + D   V++   +P    AESS CC       GIKG RPP+LKPPPG
Sbjct: 153 EIAVLE-------SEDRARVLDECVVP----AESSGCC------GGIKGFRPPMLKPPPG 195

Query: 228 MRQPVIDNA-CSTWDILRDFAPK-DGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVK 285
           +R  V+D+A CSTWD++RDFAPK +G    S +      +SSDDED+ +  E+ +    +
Sbjct: 196 VRVSVVDDATCSTWDLMRDFAPKGEGGGKDSYVE----LNSSDDEDDHEREEKEEEEEEE 251

Query: 286 EEEDDMV------------------LSESCSFTTEHEDDSSSTTTEPMSN-ISPNGRFKR 326
           EEE ++                   + +   F+T +EDDSSST+T P SN ISPNGR KR
Sbjct: 252 EEEGEVGGVRVESVEEENAAAIAEIVGDFSGFSTSNEDDSSSTSTGPRSNNISPNGRIKR 311

Query: 327 IITY--WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           +IT   WQKG+LLGRGSFGSVYEGIS+DGFFFAVKEVSLLDQG+Q +QS+ QLEQEIALL
Sbjct: 312 VITAGNWQKGELLGRGSFGSVYEGISEDGFFFAVKEVSLLDQGNQGRQSVYQLEQEIALL 371

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           S+FEHENIVQY GT+ D S LYIF+ELVTKGSL NLYQRY+LRDSQVSAYTRQIL GLKY
Sbjct: 372 SQFEHENIVQYIGTEMDASNLYIFIELVTKGSLRNLYQRYNLRDSQVSAYTRQILHGLKY 431

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           LHD+++VHRDIKCANILVDANGSVKLADFGLAKATK NDVKSC+GTAFWMAPEV
Sbjct: 432 LHDRNIVHRDIKCANILVDANGSVKLADFGLAKATKFNDVKSCKGTAFWMAPEV 485

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357489127|ref|XP_003614851.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355516186|gb|AES97809.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula]

 Score =  503 bits (1295), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 297/505 (58%), Positives = 358/505 (70%), Gaps = 24/505 (4%)

Query: 1   MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSS- 59
           M+HLPR    R KS     M+ +K +Q P+L+RRNA K+  YD   +SSS + S S SS 
Sbjct: 1   MNHLPRIFGYRNKST--TEMNSKKKKQ-PKLQRRNAVKNFNYDAQPSSSSPESSESVSSS 57

Query: 60  -LITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPR 118
            L TRS+D  DR SFR+EGV+GEF+ ICRSLGL+GPEDF+IPAAAWEA K RS+SD+LPR
Sbjct: 58  ILCTRSMDFYDRKSFRVEGVDGEFDIICRSLGLNGPEDFSIPAAAWEAMKVRSSSDVLPR 117

Query: 119 SRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASG 178
             + + D  K  V  + D  G V  E  DRV  +VR  +  E +         +S R S 
Sbjct: 118 LNVTEFDETK--VSDEIDEVGVV--ECDDRV--LVR-DSPAESSVGDSGGEVNVSIRDSP 170

Query: 179 AGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACS 238
           A ++      E   +   G  E+S+C   S    GIKG+RPP+LKPPPG+R  V+D+ CS
Sbjct: 171 AESSGCCTGGEI-RVSVRGFDETSSCSTGSG---GIKGIRPPMLKPPPGVRVSVVDDTCS 226

Query: 239 TWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMV--LSES 296
           TWDILRDFAP+          +       D+ + + E +E    I +EE  D++   S S
Sbjct: 227 TWDILRDFAPE---GEGKEREEEEEEEKVDEVEEKGEADEVGLKIEEEENGDIIGEFSRS 283

Query: 297 CSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIIT--YWQKGDLLGRGSFGSVYEGISDDG 353
           CSFTT  EDDSSSTTT+  SN ISPN R K +IT   WQKG+LLGRGSFG+VYEGIS+DG
Sbjct: 284 CSFTTSQEDDSSSTTTDTRSNSISPNVRLKPVITPGSWQKGELLGRGSFGTVYEGISEDG 343

Query: 354 FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
           FFFAVK+VSLLDQGSQ KQS+ QLE EIALLS+FEHENIV+Y GT+ DES LYIF+E VT
Sbjct: 344 FFFAVKQVSLLDQGSQGKQSVVQLEHEIALLSQFEHENIVRYIGTEMDESNLYIFIEFVT 403

Query: 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
           KGSLL+LY+RY LRDSQVSAYTRQIL GLKYLHD+++VHRDIKCANILVDANGSVK+ADF
Sbjct: 404 KGSLLSLYRRYKLRDSQVSAYTRQILHGLKYLHDRNIVHRDIKCANILVDANGSVKVADF 463

Query: 474 GLAKATKLNDVKSCRGTAFWMAPEV 498
           GLAKA KLNDVKSC+GTAFWMAPEV
Sbjct: 464 GLAKAIKLNDVKSCQGTAFWMAPEV 488

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|32400274|emb|CAE00640.1| putative mitogen-activated protein kinase 1 [Medicago sativa]

 Score =  493 bits (1270), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 293/505 (58%), Positives = 349/505 (69%), Gaps = 25/505 (4%)

Query: 1   MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSS- 59
           M+HLPR    R KS     M+ +K +Q P+L+RRNA K+  YD   +SSS + S S+SS 
Sbjct: 1   MNHLPRIFGYRNKST--TEMNSKKKKQ-PKLQRRNAVKNFNYDAQPSSSSPESSESASSS 57

Query: 60  ---LITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLL 116
              L TRS+D  DR SFR+EGV+GEF+ ICRSLGL+GPEDF+IPAAAWEA K RS+SD+L
Sbjct: 58  ASILCTRSMDFHDRKSFRVEGVDGEFDIICRSLGLNGPEDFSIPAAAWEAMKFRSSSDVL 117

Query: 117 PRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRA 176
           PR  + + D  K + E   D  G V    CD   D V +R+    +      V   S R 
Sbjct: 118 PRLNVSEFDETKTSGE--IDQVGVVD---CD---DRVLVRDSPAESSGGEVNV---SIRD 166

Query: 177 SGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNA 236
           S A ++      E   +P  G  E+S C   S    GIKG+RPP+LKPPPG+R  V+D+ 
Sbjct: 167 SPAKSSGCCTGGEI-RVPVRGFDETSNCSTGSG---GIKGIRPPMLKPPPGVRVSVVDDT 222

Query: 237 CSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSES 296
           CSTWDILRDFAP+          +        +E  E    E      +  +     S S
Sbjct: 223 CSTWDILRDFAPEGEGKEREEQEEEEEKVDEVEEKEEVGELELKVEEEENGDIIGEFSRS 282

Query: 297 CSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIIT--YWQKGDLLGRGSFGSVYEGISDDG 353
           CSFTT  EDDSSSTTT+  SN ISPN R K +IT   WQKG+LLGRGSFG+VYEGIS+DG
Sbjct: 283 CSFTTSQEDDSSSTTTDTRSNSISPNVRLKPVITPGSWQKGELLGRGSFGTVYEGISEDG 342

Query: 354 FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
           FFFAVK+VSLLDQGSQ KQS+ QLE EIALLS+FEHENIV+Y GT+ DES LYIF+E VT
Sbjct: 343 FFFAVKQVSLLDQGSQGKQSVVQLEHEIALLSQFEHENIVRYIGTEMDESNLYIFIEFVT 402

Query: 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
           KGSLL+LY+RY LRDSQVSAYTRQIL GLKYLHD+++VHRDIKCANILVDANGSVK+ADF
Sbjct: 403 KGSLLSLYRRYKLRDSQVSAYTRQILHGLKYLHDRNIVHRDIKCANILVDANGSVKVADF 462

Query: 474 GLAKATKLNDVKSCRGTAFWMAPEV 498
           GLAKA KLNDVKSC+GTAFWMAPEV
Sbjct: 463 GLAKAIKLNDVKSCQGTAFWMAPEV 487

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356518515|ref|XP_003527924.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  492 bits (1266), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 295/491 (60%), Positives = 350/491 (71%), Gaps = 52/491 (10%)

Query: 20  MDPRKMRQKPRLERRNAAKHI--EYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEG 77
           MD +  R+KP+LERRNA K+   EYD  S       S S  +L TRS++  DRTSFRIEG
Sbjct: 1   MDRKNPRRKPKLERRNALKYSSSEYDAGS-------SPSDDTLYTRSMEFYDRTSFRIEG 53

Query: 78  VEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDA 137
           VEGEF+RICRSLGLSGPEDFAIPAAAWEA K R +SD+LPR +   LD L        D 
Sbjct: 54  VEGEFDRICRSLGLSGPEDFAIPAAAWEAIKFRYSSDILPRLK---LDNL--------DI 102

Query: 138 AGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSG 197
                GE   +V++ + I N  E    KL++            + D+ +V     +    
Sbjct: 103 PEEEEGEEELKVNEDI-IVNSVE--EGKLSE-----------KHGDSSSVRVRVRVRVRE 148

Query: 198 LAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNA-CSTWDILRDFAPK--DGITP 254
           + ESS          GIKG RPP+LKPPPG R  V+D++ CSTWD+LRD AP+  +G+  
Sbjct: 149 IDESST---------GIKGTRPPMLKPPPGARVQVVDDSTCSTWDLLRDLAPQGEEGLPL 199

Query: 255 SSVMNDRALSSSSDDEDNEKE-GEEADRAIVKEEEDDMV--LSESCSFTTEHEDDSSSTT 311
           +   N+  ++   +    EKE GE   R   K EE++ V  LSESCSF+T +EDDSSS+T
Sbjct: 200 NRSENESEVAREVERGAVEKEEGEVGTRESPKREEEENVAGLSESCSFSTSNEDDSSSST 259

Query: 312 TEPM-SNISPNGRFKRIITY--WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS 368
           T+P  +NISP GR KRIIT   WQKG+ LG GSFGSVYEGISDDGFFFAVKEVSLLDQG+
Sbjct: 260 TDPTSNNISPQGRIKRIITAESWQKGEFLGGGSFGSVYEGISDDGFFFAVKEVSLLDQGT 319

Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
           Q KQS+ QLEQEIALLS+FEHENIVQYYGT+ D+SKLYIFLELVTKGSL +LYQ+Y LRD
Sbjct: 320 QGKQSVYQLEQEIALLSQFEHENIVQYYGTEMDQSKLYIFLELVTKGSLRSLYQKYTLRD 379

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
           SQVS+YTRQIL GLKYLHD++VVHRDIKCANILVDA+GSVKLADFGLAKATKLNDVKS +
Sbjct: 380 SQVSSYTRQILHGLKYLHDRNVVHRDIKCANILVDASGSVKLADFGLAKATKLNDVKSMK 439

Query: 489 GTAFWMAPEVC 499
           GTAFWMAPEV 
Sbjct: 440 GTAFWMAPEVV 450

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224066881|ref|XP_002302260.1| predicted protein [Populus trichocarpa] gi|222843986|gb|EEE81533.1| predicted protein [Populus trichocarpa]

 Score =  487 bits (1254), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 316/497 (63%), Positives = 363/497 (73%), Gaps = 56/497 (11%)

Query: 20  MDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVE 79
           MDP+  R+  RLERRNA +H+ YD  +TSSS     SSSSL+++SLDL DRTSFRIEG E
Sbjct: 1   MDPKNRRRP-RLERRNALRHVAYD--ATSSSSSLDDSSSSLLSQSLDLPDRTSFRIEGTE 57

Query: 80  GEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAG 139
           GEF+RI RSLGLSGPEDF+IP AAWEA K RSASD+LPRSRL   D+ K   E +    G
Sbjct: 58  GEFDRIFRSLGLSGPEDFSIPEAAWEAMKVRSASDILPRSRLFGSDSPKAAEEAKVVVEG 117

Query: 140 AVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLA 199
               EL  RV + VR+R+ +  T++   + AEL+       +N  L V            
Sbjct: 118 TK-SELHARVLNSVRVRDSS--TQSTQNEPAELN--KFRDADNRCLPV------------ 160

Query: 200 ESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMN 259
                        GIKG+RPPLLKPPP M  PVID  CSTWD+ RDFAP++      V+N
Sbjct: 161 -------------GIKGLRPPLLKPPPSMTLPVIDKECSTWDLFRDFAPEN----DRVVN 203

Query: 260 DRALSSSSD---------------DEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHE 304
           +   S+  D               D DN++E EE    I     + +VLSESCSF+T ++
Sbjct: 204 NNIESTYDDGEEEKEERREQVINADADNKREEEENLLRI----GETVVLSESCSFSTSND 259

Query: 305 DDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL 364
           DDSSS+TTEPMSNISPN RF+R ITYW+KG+LLGRGSFGSVYEGISDDGFFFAVKEVSLL
Sbjct: 260 DDSSSSTTEPMSNISPNVRFRRAITYWEKGELLGRGSFGSVYEGISDDGFFFAVKEVSLL 319

Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY 424
           DQGS+ KQSI QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL  LYQRY
Sbjct: 320 DQGSKGKQSIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLQKLYQRY 379

Query: 425 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484
           +LRDSQVS+YTRQIL GLKYLHDQ+VVHRDIKCAN+LVDANGSVKLADFGLAKATKLNDV
Sbjct: 380 NLRDSQVSSYTRQILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLADFGLAKATKLNDV 439

Query: 485 KSCRGTAFWMAPEVCSN 501
           KSC+GTAFWMAPEV +N
Sbjct: 440 KSCKGTAFWMAPEVVNN 456

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449445122|ref|XP_004140322.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Cucumis sativus] gi|449519384|ref|XP_004166715.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Cucumis sativus]

 Score =  484 bits (1247), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 289/511 (56%), Positives = 348/511 (68%), Gaps = 62/511 (12%)

Query: 1   MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSL 60
           M+ LP+F SPR K   +  MDPRK+  KP+L R NAAK+I+YD  S+SSS     SS SL
Sbjct: 1   MNRLPQFFSPRNK---RKPMDPRKIPGKPKLGRLNAAKNIDYDAPSSSSS--LEDSSGSL 55

Query: 61  ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSR 120
            TRS++  D +SFRI+G++GE + ICR+LGL+GP+DFAIP  AWEARK RS+S+LLPRSR
Sbjct: 56  YTRSMENPDPSSFRIKGLDGEVDLICRTLGLAGPDDFAIPMEAWEARKVRSSSELLPRSR 115

Query: 121 LKQLDTLKETVERQSDAAGA-VVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGA 179
           L  +DT  +T E   D     +  ELC RV D VRI    +L++TK T+ AEL+ R    
Sbjct: 116 LYPMDTSPKTEEISEDKEDKEIQDELCRRVKDSVRI--SVDLSKTK-TEFAELNERR--- 169

Query: 180 GNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACST 239
                             +A ++ C   S    GI G RPPLLKPPP MR P  DNA ST
Sbjct: 170 ------------------MATATGCSSRS----GINGARPPLLKPPPSMRLPNFDNAYST 207

Query: 240 WDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGE----------EADRAIVKEEED 289
           WDIL+ FAP                   +DE  E+ GE          E +   V+  E+
Sbjct: 208 WDILKGFAPL-----------------VEDEHQEEVGERVEPLVEVEGEGEGNTVRPVEN 250

Query: 290 DMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI 349
             ++    SFTT ++DDSSS+TTEP +NISPN R   IIT W  G LLGRGSFGSVYE I
Sbjct: 251 ASLIGSWGSFTTSNDDDSSSSTTEP-ANISPNMRVNPIITSWVLGRLLGRGSFGSVYEAI 309

Query: 350 SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409
           S+DG FFA+KEVSLLD+ SQ +QSI QL+QEIALLS FEHENIVQYYGT  D SKLYIFL
Sbjct: 310 SEDGTFFALKEVSLLDEDSQGRQSIYQLQQEIALLSEFEHENIVQYYGTHSDGSKLYIFL 369

Query: 410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469
           ELV++GSL++LYQR  L DS VSAYTRQIL GLKYLH+++V+HRDIKCANILVD NGSVK
Sbjct: 370 ELVSQGSLMSLYQRTSLMDSIVSAYTRQILSGLKYLHERNVIHRDIKCANILVDVNGSVK 429

Query: 470 LADFGLAKATKLNDVKSCRGTAFWMAPEVCS 500
           LADFGLAKATKLNDVKSC+GTA+WMAPEV +
Sbjct: 430 LADFGLAKATKLNDVKSCKGTAYWMAPEVVN 460

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225459451|ref|XP_002284356.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera]

 Score =  484 bits (1246), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 289/508 (56%), Positives = 345/508 (67%), Gaps = 53/508 (10%)

Query: 1   MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSL 60
           MHHLPR     ++S G   M P++  +KP+LERRNA +HI+YD +++SSS      S +L
Sbjct: 1   MHHLPRLFDYSKRSKG---MFPKQKPRKPKLERRNALRHIDYDASASSSS-SSFDDSLAL 56

Query: 61  ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSR 120
            T+SLDLSDR+SFRI G EGE + ICRSLGLSGP++ +IP AAWEA K RS SD+LPR+R
Sbjct: 57  HTQSLDLSDRSSFRIHGTEGEVDEICRSLGLSGPDELSIPEAAWEAWKVRSNSDVLPRTR 116

Query: 121 LKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAG 180
             +L + K   E +      VV +L D   D V                   SC      
Sbjct: 117 FNRLHSSKRK-ESEVKVDDGVVDDLADGFEDSV-------------------SC------ 150

Query: 181 NNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTW 240
            +DA+     T    S L+ S           GIKGVRPP L PPP M  PVI + CSTW
Sbjct: 151 -SDAIGRRRET----SELSSSRIVGGVGGCGGGIKGVRPPFLSPPPLMSLPVISDGCSTW 205

Query: 241 DILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEE------DDM-VL 293
           DIL+ F P D    SSV+ +   SSS DDE         D A+VK E+      D++ +L
Sbjct: 206 DILKSFGP-DADGGSSVVVEGG-SSSEDDE--------FDAALVKGEDVNGLRNDEIALL 255

Query: 294 SESCSFTT-EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD 352
           SES SFTT  ++DDSSSTTTEPMSNISPNG  +   T W KG  LG GSFG+VYEG+S+D
Sbjct: 256 SESYSFTTTSNDDDSSSTTTEPMSNISPNGSLRPSFTNWMKGAFLGSGSFGTVYEGMSED 315

Query: 353 GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412
           G FFAVKEVSLLDQGSQ KQS+ QLEQEI LLS+F+HENIVQY+GT KDESKLYIFLELV
Sbjct: 316 GIFFAVKEVSLLDQGSQGKQSLYQLEQEIDLLSQFQHENIVQYHGTAKDESKLYIFLELV 375

Query: 413 TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472
           TKGSL +LYQRY+L DSQ SAYTRQIL GL YLH+++V+HRDIKCANILV ANGSVKL+D
Sbjct: 376 TKGSLASLYQRYNLGDSQASAYTRQILHGLNYLHERNVIHRDIKCANILVGANGSVKLSD 435

Query: 473 FGLAKATKLNDVKSCRGTAFWMAPEVCS 500
           FGLAKAT+LND KSC+GT FWMAPEV +
Sbjct: 436 FGLAKATQLNDAKSCKGTPFWMAPEVVN 463

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	504
TAIR|locus:2133559	608	MEKK1 "MAPK/ERK kinase kinase	0.960	0.796	0.469	3.8e-101
TAIR|locus:2133539	773	MAPKKK9 "mitogen-activated pro	0.541	0.353	0.560	9e-90
TAIR|locus:2133529	560	MEKK3 "MAPK/ERK kinase kinase	0.353	0.317	0.702	4.2e-65
TAIR|locus:2118116	1895	WRKY19 [Arabidopsis thaliana (	0.384	0.102	0.626	2.7e-62
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.339	0.193	0.517	8.6e-40
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.331	0.233	0.508	1.8e-38
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.333	0.275	0.491	4.2e-38
DICTYBASE|DDB_G0283265	1267	mkkA "octicosapeptide/Phox/Bem	0.333	0.132	0.448	8e-36
TAIR|locus:2080394	651	NP3 "NPK1-related protein kina	0.331	0.256	0.438	1.2e-35
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.333	0.252	0.468	1.8e-35

TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1003 (358.1 bits), Expect = 3.8e-101, P = 3.8e-101
 Identities = 240/511 (46%), Positives = 302/511 (59%)

Query:     4 LPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVAXXXXXXXXXXXXXXXXXX 63
             + R L+  +KS G+   D + +    RLERR+AA++I YD A                  
Sbjct:     1 MDRILARMKKSTGRRGGD-KNITPVRRLERRDAARNINYDAASCSSSSAEDLSVSTSSLM 59

Query:    64 XXXXXXX--TSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRL 121
                      TSFRI G  GE +RI RSLG+SGP+D AI   AWEA K RS+SD++ R + 
Sbjct:    60 TRSLEFPEPTSFRIGGGVGEMDRIYRSLGVSGPDDLAISFDAWEACKKRSSSDVVNRFKS 119

Query:   122 KQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTR-----TKLTQVAELSC-- 174
               LD +++    +   +G VVG   D ++  V+ ++ +E        T+L+++  L    
Sbjct:   120 FDLDKVRDQDLSEEGPSGVVVGS--DSMNHKVQGQDLSEAGPSGGIVTELSEIGNLITPV 177

Query:   175 -RASGAGNNDALAVMETTE--LPPSG-LAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQ 230
              R    G  +   VME T   +   G L  ++   V      GIKG+RPP+LKPPP M++
Sbjct:   178 DRLVADGVVENRRVMERTPTIVKSKGYLVPNNVVAVGVGVGGGIKGLRPPVLKPPPAMKR 237

Query:   231 PVIDNACSTWDILRDFAPKDGI---TPSSVMNDRALXXXXXXXXXXXXXXXXXRAIVKEE 287
             P ID+  S+WD L  FAP + +   + SS  ++                    R I   +
Sbjct:   238 PPIDHRGSSWDFLTHFAPSETVKRPSSSSSSSEDGCDEEEGKEEEAEAEEMGARFIQLGD 297

Query:   288 EDDMVLSESCSFXXXXXXXXXXXXXXPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYE 347
               D    E+CSF                S I P+G    IIT WQKG LLGRGSFGSVYE
Sbjct:   298 TAD----ETCSFTTNEGDSSSTVSNT--SPIYPDGG--AIITSWQKGQLLGRGSFGSVYE 349

Query:   348 GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407
             GIS DG FFAVKEVSLLDQGSQA++ I QLE EI LLS+ +H+NIV+Y GT KD S LYI
Sbjct:   350 GISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNLYI 409

Query:   408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467
             FLELVT+GSLL LYQRY LRDS VS YTRQIL GLKYLHD+  +HRDIKCANILVDANG+
Sbjct:   410 FLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKGFIHRDIKCANILVDANGA 469

Query:   468 VKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
             VKLADFGLAK +K ND+KSC+GT FWMAPEV
Sbjct:   470 VKLADFGLAKVSKFNDIKSCKGTPFWMAPEV 500

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IGI

GO:0006970 "response to osmotic stress" evidence=IGI;IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009611 "response to wounding" evidence=RCA;IDA

GO:0003677 "DNA binding" evidence=IDA

GO:0019900 "kinase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IMP;RCA;IPI

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2133539 MAPKKK9 "mitogen-activated protein kinase kinase kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 749 (268.7 bits), Expect = 9.0e-90, Sum P(2) = 9.0e-90
 Identities = 166/296 (56%), Positives = 195/296 (65%)

Query:   212 KGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALXXXXXXXX 271
             +GIKGVRP +LKPPP M+ P +D   S+WDIL  FAP   I        R          
Sbjct:   387 RGIKGVRPSVLKPPPVMKLPPVDLPGSSWDILTHFAPDSEIV-------RRPSSSSSSEN 439

Query:   272 XXXXXXXXXRAIVKEEEDDMVLS------ESCSFXXXXXXXXXXXXXXPMSNISP---NG 322
                        + KEE  DM +       E+CSF               +SN SP   +G
Sbjct:   440 GCDEEEAEDDKVEKEETGDMFIQLEDTTDEACSFTTNEGDSSST-----VSNTSPICVSG 494

Query:   323 RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
                 I T WQKG LL +GSFGSVYE IS+DG FFAVKEVSLLDQGSQA++ I QLE EIA
Sbjct:   495 G--SINTSWQKGQLLRQGSFGSVYEAISEDGDFFAVKEVSLLDQGSQAQECIQQLEGEIA 552

Query:   383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
             LLS+ EH+NI++Y GTDKD S LYIFLELVT+GSLL LY+RY +RDS +S YT+QIL GL
Sbjct:   553 LLSQLEHQNILRYRGTDKDGSNLYIFLELVTQGSLLELYRRYQIRDSLISLYTKQILDGL 612

Query:   443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
             KYLH +  +HRDIKCA ILVDANG+VKLADFGLAK +KLND+KS + T FWMAPEV
Sbjct:   613 KYLHHKGFIHRDIKCATILVDANGTVKLADFGLAKVSKLNDIKSRKETLFWMAPEV 668

GO:0005737 "cytoplasm" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0031347 "regulation of defense response" evidence=IMP

TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 633 (227.9 bits), Expect = 4.2e-65, Sum P(2) = 4.2e-65
 Identities = 125/178 (70%), Positives = 145/178 (81%)

Query:   321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
             N R    IT W KG LLGRGS+ SVYE IS+DG FFAVKEVSLLD+G QA++ I QLE E
Sbjct:   293 NFRKPEDITSWLKGQLLGRGSYASVYEAISEDGDFFAVKEVSLLDKGIQAQECIQQLEGE 352

Query:   381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL 440
             IALLS+ +H+NIV+Y GT KD SKLYIFLELVT+GS+  LY+RY L  + VS YTRQIL 
Sbjct:   353 IALLSQLQHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERYQLSYTVVSLYTRQILA 412

Query:   441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
             GL YLHD+  VHRDIKCAN+LVDANG+VKLADFGLA+A+K ND+ SC+GT FWMAPEV
Sbjct:   413 GLNYLHDKGFVHRDIKCANMLVDANGTVKLADFGLAEASKFNDIMSCKGTLFWMAPEV 470

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2118116 WRKY19 [Arabidopsis thaliana (taxid:3702)]

 Score = 587 (211.7 bits), Expect = 2.7e-62, Sum P(2) = 2.7e-62
 Identities = 134/214 (62%), Positives = 149/214 (69%)

Query:   295 ESCSFXXXXXXXXXXXXXXPMSNISP----NGRFKRIITYWQKGDLLGRGSFGSVYEGIS 350
             E+CSF               +SN SP     G F   IT WQKG LLGRGS GSVYEGIS
Sbjct:  1594 ETCSFTVNKGDSSRT-----ISNTSPIYASEGSF---ITCWQKGQLLGRGSLGSVYEGIS 1645

Query:   351 DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410
              DG FFA KEVSLLDQGSQA + I Q+E  IALLS+ +H+NIV+Y GT KDES LYIFLE
Sbjct:  1646 ADGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLE 1705

Query:   411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470
             LVT+GSL  LYQR  L DS VS YTRQIL GLKYLHD+  +HR+IKCAN+LVDANG+VKL
Sbjct:  1706 LVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKL 1765

Query:   471 ADFGLAKATKLNDVKSCRGTAFW--MAPEVCSNP 502
             ADFGLAK      V S   T +W  MAPEV  NP
Sbjct:  1766 ADFGLAK------VMSLWRTPYWNWMAPEVILNP 1793

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003700 "sequence-specific DNA binding transcription factor activity" evidence=IEA;ISS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005622 "intracellular" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006952 "defense response" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017111 "nucleoside-triphosphatase activity" evidence=IEA

GO:0043531 "ADP binding" evidence=IEA

GO:0043565 "sequence-specific DNA binding" evidence=IEA

GO:0009941 "chloroplast envelope" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 433 (157.5 bits), Expect = 8.6e-40, P = 8.6e-40
 Identities = 90/174 (51%), Positives = 120/174 (68%)

Query:   331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             W+KG LLG GSFG VY G  S+ G   A+KEV+L     ++++S  QL QEI++LSR  H
Sbjct:   400 WKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCSDDPKSRESAQQLGQEISVLSRLRH 459

Query:   390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
             +NIVQYYG++  + KLYI+LE V+ GS+  L Q Y    ++ +  YT+QIL GL YLH +
Sbjct:   460 QNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYGQFGENAIRNYTQQILSGLAYLHAK 519

Query:   449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVCSN 501
             + VHRDIK ANILVD +G VK+ADFG+AK  T  +   S +G+ +WMAPEV  N
Sbjct:   520 NTVHRDIKGANILVDPHGRVKVADFGMAKHITAQSGPLSFKGSPYWMAPEVIKN 573

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 404 (147.3 bits), Expect = 1.8e-38, Sum P(2) = 1.8e-38
 Identities = 88/173 (50%), Positives = 116/173 (67%)

Query:   331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             W+KG L+GRG+FGSVY    S+ G   A+KEV L     ++ + I QLEQEI LLS  +H
Sbjct:   346 WKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNLQH 405

Query:   390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
              NIVQY+G++  E + +I+LE V  GS+ N Y R H   + +S V  +TR IL GL YLH
Sbjct:   406 PNIVQYFGSETVEDRFFIYLEYVHPGSI-NKYIRDHCGTMTESVVRNFTRHILSGLAYLH 464

Query:   447 DQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEV 498
             ++  VHRDIK AN+LVDA+G VKLADFG+AK  T      S +G+ +WMAPE+
Sbjct:   465 NKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPYWMAPEL 517

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 410 (149.4 bits), Expect = 4.2e-38, P = 4.2e-38
 Identities = 84/171 (49%), Positives = 113/171 (66%)

Query:   331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             W+KG  LG G+FG VY G  S+ G   A+KEV ++     +K+ + QL QEI LL++  H
Sbjct:   214 WKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQLCH 273

Query:   390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
              NIVQYYG++  E  L ++LE V+ GS+  L + Y    +  +  YTRQIL GL YLH +
Sbjct:   274 PNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDYGSFTEPVIQNYTRQILAGLAYLHGR 333

Query:   449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEV 498
             + VHRDIK ANILVD NG +KLADFG+AK  T  + + S +G+ +WMAPEV
Sbjct:   334 NTVHRDIKGANILVDPNGEIKLADFGMAKHVTAFSTMLSFKGSPYWMAPEV 384

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)]

 Score = 387 (141.3 bits), Expect = 8.0e-36, Sum P(2) = 8.0e-36
 Identities = 78/174 (44%), Positives = 114/174 (65%)

Query:   331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRF 387
             WQKG +LGRG +GSVY G++ D G  FAVK++ ++D  S  + K  I    +EI ++   
Sbjct:   495 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 554

Query:   388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLH 446
              H+NIV+Y GT  D+S L +FLE +  GS+ +L  ++    ++ +  YT+QIL GL +LH
Sbjct:   555 RHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLH 614

Query:   447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRGTAFWMAPEV 498
                ++HRDIK ANIL+D  G VKL+DFG +K+    ++  KS +GT +WMAPEV
Sbjct:   615 ANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEV 668

GO:0030587 "sorocarp development" evidence=IMP

GO:0009653 "anatomical structure morphogenesis" evidence=IMP

GO:0005938 "cell cortex" evidence=IDA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA;ISS

GO:0000186 "activation of MAPKK activity" evidence=IEA;ISS

GO:0000165 "MAPK cascade" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2080394 NP3 "NPK1-related protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 373 (136.4 bits), Expect = 1.2e-35, Sum P(2) = 1.2e-35
 Identities = 78/178 (43%), Positives = 115/178 (64%)

Query:   331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 385
             W+KG+L+G G+FG VY G++ D G   A+K+V L+   S +K+     I +LE+E+ LL 
Sbjct:    68 WRKGELIGCGAFGRVYMGMNLDSGELLAIKQV-LIAPSSASKEKTQGHIRELEEEVQLLK 126

Query:   386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
                H NIV+Y GT ++   L I +E V  GS+ +L +++    +  +  YT+Q+LLGL+Y
Sbjct:   127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEY 186

Query:   445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCRGTAFWMAPEV 498
             LH+  ++HRDIK ANILVD  G ++LADFG +K       +N  KS +GT +WMAPEV
Sbjct:   187 LHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEV 244

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048046 "apoplast" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006270 "DNA replication initiation" evidence=RCA

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0016572 "histone phosphorylation" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

GO:0051726 "regulation of cell cycle" evidence=RCA

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 389 (142.0 bits), Expect = 1.8e-35, P = 1.8e-35
 Identities = 83/177 (46%), Positives = 116/177 (65%)

Query:   331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQ-GSQAKQS--ISQLEQEIALLSR 386
             W+KG L+GRG+FG+VY G++ D G   AVK+V +     S+ K    I +LE+E+ LL  
Sbjct:    69 WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128

Query:   387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 445
               H NIV+Y GT +++  L I LE V  GS+ +L +++    +S V  YTRQ+LLGL+YL
Sbjct:   129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYL 188

Query:   446 HDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEV 498
             H+  ++HRDIK ANILVD  G +KLADFG    +A+   +   KS +GT +WMAPEV
Sbjct:   189 HNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEV 245

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39008	M3K1_ARATH	2, ., 7, ., 1, 1, ., 2, 5	0.5126	0.9523	0.7894	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	504
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-93
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-73
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-65
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-58
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-51
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-50
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-48
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-48
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-47
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-46
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-44
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-44
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-43
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-42
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-40
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-40
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-39
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-38
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-38
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-37
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-37
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-37
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-36
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-35
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-35
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-35
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-33
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-32
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-31
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-31
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-31
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-31
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-31
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-30
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-30
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-30
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-30
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-30
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-29
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-28
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-28
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-27
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-27
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-27
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-26
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-25
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-25
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-24
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-24
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-24
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-23
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-22
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-22
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-22
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-22
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-22
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-22
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-21
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-21
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-21
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-21
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-21
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-20
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-20
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-20
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-20
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-20
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-20
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-20
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-19
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-19
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-19
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-18
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-18
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-18
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-18
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-18
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-18
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-17
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-17
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-17
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-17
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-16
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-16
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-16
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-16
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-15
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-15
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-14
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-14
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-13
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-13
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-13
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-13
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-12
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-12
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-12
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-12
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	6e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	0.003

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  283 bits (727), Expect = 2e-93
 Identities = 106/172 (61%), Positives = 132/172 (76%), Gaps = 3/172 (1%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W+KG+LLG GSFGSVYEG++ DDG FFAVKEVSL D G   ++++ QLEQEIALLS+ +H
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
            NIVQY GT+++E  LYIFLELV  GSL  L ++Y    +  +  YTRQILLGL+YLHD+
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVC 499
           + VHRDIK ANILVD NG VKLADFG+AK   + +  KS +G+ +WMAPEV 
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVI 173

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  232 bits (595), Expect = 2e-73
 Identities = 92/181 (50%), Positives = 119/181 (65%), Gaps = 15/181 (8%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W +G+LLGRGSFGSVY  +  D G   AVK V L      +++ +  LE+EI +LS  +H
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSVEL---SGDSEEELEALEREIRILSSLQH 58

Query: 390 ENIVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
            NIV+YYG+++DE K  L IFLE V+ GSL +L +++  L +  +  YTRQIL GL YLH
Sbjct: 59  PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV------KSCRGTAFWMAPEVCS 500
              +VHRDIK ANILVD++G VKLADFG AK  +L D+       S RGT +WMAPEV  
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAK--RLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 501 N 501
            
Sbjct: 177 G 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  212 bits (542), Expect = 1e-65
 Identities = 85/173 (49%), Positives = 112/173 (64%), Gaps = 11/173 (6%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           Q GDL+GRG+FG VY+G++ + G F A+K++SL     +A +SI Q   EI LL   +H 
Sbjct: 3   QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQ---EIDLLKNLKHP 59

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 449
           NIV+Y G+ +    LYI LE    GSL  + +++    +S V+ Y  Q+L GL YLH+Q 
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEV 498
           V+HRDIK ANIL   +G VKLADFG+  ATKLNDV     S  GT +WMAPEV
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGV--ATKLNDVSKDDASVVGTPYWMAPEV 170

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  193 bits (494), Expect = 1e-58
 Identities = 65/174 (37%), Positives = 97/174 (55%), Gaps = 7/174 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++  + LG GSFG VY       G   A+K +       + K+   ++ +EI +L + +H
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKK----KKIKKDRERILREIKILKKLKH 56

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
            NIV+ Y   +DE KLY+ +E    G L +L ++   L + +   Y RQIL  L+YLH +
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVCSN 501
            +VHRD+K  NIL+D +G VKLADFGLA+     +   +  GT  +MAPEV   
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG 170

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  174 bits (443), Expect = 4e-51
 Identities = 64/173 (36%), Positives = 90/173 (52%), Gaps = 7/173 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++    LG GSFG+VY+      G   AVK +    + S+  Q      +EI +L R  H
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQ---TARREIRILRRLSH 57

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
            NIV+     +D+  LY+ +E    G L +   R   L + +      QIL GL+YLH  
Sbjct: 58  PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC--RGTAFWMAPEVC 499
            ++HRD+K  NIL+D NG VK+ADFGLAK    +        GT ++MAPEV 
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL 170

Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  173 bits (440), Expect = 1e-50
 Identities = 80/179 (44%), Positives = 109/179 (60%), Gaps = 7/179 (3%)

Query: 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           T W++G LLG+G+FG VY     D G   AVK+V       + K+ ++ LE EI LL   
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
           +HE IVQYYG  +D+  L IF+E +  GS+ +  + Y  L ++    YTRQIL G++YLH
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVCS 500
              +VHRDIK ANIL D+ G+VKL DFG +K      +    +KS  GT +WM+PEV S
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  166 bits (424), Expect = 2e-48
 Identities = 61/173 (35%), Positives = 103/173 (59%), Gaps = 9/173 (5%)

Query: 330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
            ++  + +G+G FG VY+      G   A+K + L     ++K+   ++  EI +L + +
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIINEIQILKKCK 55

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLH 446
           H NIV+YYG+   + +L+I +E  + GSL +L +  +    +SQ++   +++L GL+YLH
Sbjct: 56  HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEV 498
              ++HRDIK ANIL+ ++G VKL DFGL+   +      +  GT +WMAPEV
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEV 168

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  164 bits (417), Expect = 8e-48
 Identities = 65/171 (38%), Positives = 96/171 (56%), Gaps = 10/171 (5%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G FG+VY       G   A+K +        +   + +L +EI +L +  H NIV+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           YG  +DE+ LY+ +E    GSL +L +     L + ++     QIL GL+YLH   ++HR
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 454 DIKCANILVDA-NGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVCSN 501
           D+K  NIL+D+ NG VKLADFGL+K   +  + +K+  GT  +MAPEV   
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG 167

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  164 bits (417), Expect = 3e-47
 Identities = 82/182 (45%), Positives = 109/182 (59%), Gaps = 14/182 (7%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 385
           W KG L+G GSFGSVY G+ +  G   AVK+V L    + +K      +  L +EIALL 
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
             +HENIVQY G+  D   L IFLE V  GS+  L   Y    ++ V  + RQIL GL Y
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--------SCRGTAFWMAP 496
           LH++ ++HRDIK ANILVD  G +K++DFG++K  + N +         S +G+ FWMAP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 497 EV 498
           EV
Sbjct: 182 EV 183

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  161 bits (410), Expect = 3e-46
 Identities = 74/179 (41%), Positives = 106/179 (59%), Gaps = 11/179 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           WQ+G+ +G G+FG VY  ++ D G   AVKE+ +  Q +  K +I ++  E+ +L   +H
Sbjct: 2   WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRI--QDNDPK-TIKEIADEMKVLELLKH 58

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHDQ 448
            N+V+YYG +    K+YIF+E  + G+L  L +   + D  V   YT Q+L GL YLH  
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLN------DVKSCRGTAFWMAPEVCSN 501
            +VHRDIK ANI +D NG +KL DFG A   K N      +V+S  GT  +MAPEV + 
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  157 bits (399), Expect = 1e-44
 Identities = 76/179 (42%), Positives = 113/179 (63%), Gaps = 12/179 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ--AKQSISQLEQEIALLSRFE 388
           W KG++LG+G++G+VY G+++ G   AVK+V L D  +   A++   +L++E+ LL   +
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVEL-DTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD 447
           H NIVQY GT  D++ + IF+E V  GS+ ++  R+  L +     YT+QIL G+ YLH+
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK--------ATKLNDVKSCRGTAFWMAPEV 498
             VVHRDIK  N+++  NG +KL DFG A+         T  N +KS  GT +WMAPEV
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  157 bits (399), Expect = 2e-44
 Identities = 69/175 (39%), Positives = 100/175 (57%), Gaps = 11/175 (6%)

Query: 332 QKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
              + +G+GSFG VY+ I        A+K + L     +A+  I  ++QEI  LS+    
Sbjct: 4   TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL----EEAEDEIEDIQQEIQFLSQCRSP 59

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
            I +YYG+    SKL+I +E    GS L+L +   L ++ ++   R++LLGL+YLH++  
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK 119

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVCSN 501
           +HRDIK ANIL+   G VKLADFG+  + +L    S R    GT FWMAPEV   
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGV--SGQLTSTMSKRNTFVGTPFWMAPEVIKQ 172

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  154 bits (391), Expect = 2e-43
 Identities = 72/182 (39%), Positives = 106/182 (58%), Gaps = 11/182 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL----LDQGSQAKQSI-SQLEQEIALL 384
           W KG+L+G+G++G VY  ++   G   AVK+V L      +    ++ +   L  EI  L
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-VSAYTRQILLGLK 443
              +H NIVQY G +  E  L IFLE V  GS+ +  + Y   + Q V  +T Q+L GL 
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK---LNDVK-SCRGTAFWMAPEVC 499
           YLH + ++HRD+K  N+LVDA+G  K++DFG++K +     ND   S +G+ FWMAPEV 
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 500 SN 501
            +
Sbjct: 183 HS 184

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  151 bits (384), Expect = 2e-42
 Identities = 57/177 (32%), Positives = 96/177 (54%), Gaps = 15/177 (8%)

Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
             +G+GSFG VY      DG  + +KE+ L +   + ++       E+ +L +  H NI+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE---DALNEVKILKKLNHPNII 62

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ 448
           +YY + +++ KL I +E    G L    ++         + Q+  +  Q+ L LKYLH +
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVCSN 501
            ++HRDIK  NI + +NG VKL DFG++K   L+      K+  GT ++++PE+C N
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELCQN 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  146 bits (371), Expect = 1e-40
 Identities = 61/171 (35%), Positives = 98/171 (57%), Gaps = 16/171 (9%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           + LG GS+GSVY+ I  + G   A+K V +       ++ + ++ +EI++L + +   IV
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVVPV-------EEDLQEIIKEISILKQCDSPYIV 61

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           +YYG+    + L+I +E    GS+ ++ +     L + +++A   Q L GL+YLH    +
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEV 498
           HRDIK  NIL++  G  KLADFG+  + +L D      +  GT FWMAPEV
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPEV 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  146 bits (371), Expect = 1e-40
 Identities = 67/168 (39%), Positives = 95/168 (56%), Gaps = 12/168 (7%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+      G   A+K + L             ++QEI++L    H NIV Y
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAY 65

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           +G+     KL+I +E    GSL ++YQ  R  L + Q++   R+ L GL YLH+   +HR
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125

Query: 454 DIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEV 498
           DIK ANIL+  +G VKLADFG++    AT +   KS  GT +WMAPEV
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTAT-IAKRKSFIGTPYWMAPEV 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  141 bits (359), Expect = 7e-39
 Identities = 54/177 (30%), Positives = 86/177 (48%), Gaps = 14/177 (7%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFF-----AVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
             G  LG G+FG VY+G             AVK    L + +  +Q I +  +E  ++ +
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQ-IEEFLREARIMRK 57

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKY 444
            +H N+V+  G   +E  LYI +E +  G LL+     R  L  S + ++  QI  G++Y
Sbjct: 58  LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMAPEV 498
           L  ++ +HRD+   N LV  N  VK++DFGL++          +  +    WMAPE 
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES 174

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  141 bits (356), Expect = 1e-38
 Identities = 80/179 (44%), Positives = 106/179 (59%), Gaps = 9/179 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W+ G LLGRG+FG VY    +D G   AVK+V       +  + ++ LE EI LL    H
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
           + IVQYYG   D +E KL IF+E +  GS+ +  + Y  L ++    YTRQIL G+ YLH
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVCS 500
              +VHRDIK ANIL D+ G+VKL DFG +K  +        +KS  GT +WM+PEV S
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  140 bits (354), Expect = 6e-38
 Identities = 66/175 (37%), Positives = 100/175 (57%), Gaps = 18/175 (10%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
            +K   +G G+ G VY+      G   A+K++ L       KQ+   +  EI ++   +H
Sbjct: 24  LEK---IGEGASGEVYKATDRATGKEVAIKKMRL------RKQNKELIINEILIMKDCKH 74

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 447
            NIV YY +     +L++ +E +  GSL ++  +  +R  + Q++   R++L GL+YLH 
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEV 498
           Q+V+HRDIK  NIL+  +GSVKLADFG   A +L   KS R    GT +WMAPEV
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGF--AAQLTKEKSKRNSVVGTPYWMAPEV 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  138 bits (350), Expect = 1e-37
 Identities = 56/178 (31%), Positives = 88/178 (49%), Gaps = 17/178 (9%)

Query: 333 KGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
            G  LG G+FG VY+G             AVK +    +   ++Q I +  +E  ++ + 
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL----KEDASEQQIEEFLREARIMRKL 58

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLK 443
           +H NIV+  G   +E  L I +E +  G LL+ Y R +    L  S + ++  QI  G++
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLD-YLRKNRPKELSLSDLLSFALQIARGME 117

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMAPEV 498
           YL  ++ +HRD+   N LV  N  VK++DFGL++         VK  +    WMAPE 
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  138 bits (349), Expect = 1e-37
 Identities = 80/181 (44%), Positives = 107/181 (59%), Gaps = 9/181 (4%)

Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           T W+ G LLG+G+FG VY    +D G   AVK+V    +  +  + ++ LE EI LL   
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 388 EHENIVQYYGTDKD--ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
            HE IVQYYG  +D  E  L IF+E +  GS+ +  + Y  L ++    YTRQIL G+ Y
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVC 499
           LH   +VHRDIK ANIL D+ G+VKL DFG +K  +        +KS  GT +WM+PEV 
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 500 S 500
           S
Sbjct: 182 S 182

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  137 bits (345), Expect = 5e-37
 Identities = 79/179 (44%), Positives = 106/179 (59%), Gaps = 9/179 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W++G LLG+G+FG VY     D G   A K+V    +  +  + +S LE EI LL   +H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
           E IVQYYG   D+ E  L IF+E +  GS+ +  + Y  L +S    YTRQIL G+ YLH
Sbjct: 64  ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVCS 500
              +VHRDIK ANIL D+ G+VKL DFG +K  +        ++S  GT +WM+PEV S
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  136 bits (344), Expect = 1e-36
 Identities = 55/178 (30%), Positives = 84/178 (47%), Gaps = 15/178 (8%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFF-----AVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           + G  LG G+FG VY+G             AVK    L +G+  ++      +E +++ +
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK---TLKEGASEEEREE-FLEEASIMKK 57

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 444
             H NIV+  G       LYI  E +  G LL+  +++   L    +     QI  G++Y
Sbjct: 58  LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEV 498
           L  ++ VHRD+   N LV  N  VK++DFGL++    +D    RG       WMAPE 
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175

Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  131 bits (333), Expect = 3e-35
 Identities = 56/173 (32%), Positives = 94/173 (54%), Gaps = 13/173 (7%)

Query: 332 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           ++  +LG+GS G VY+      G  +A+K++ +            QL +E+  L   E  
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF----RKQLLRELKTLRSCESP 59

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH-DQ 448
            +V+ YG    E ++ I LE +  GSL +L ++   + +  ++   RQIL GL YLH  +
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPE 497
            ++HRDIK +N+L+++ G VK+ADFG++K   L +         GT  +M+PE
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPE 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  131 bits (332), Expect = 5e-35
 Identities = 63/182 (34%), Positives = 94/182 (51%), Gaps = 18/182 (9%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           + +G+GSFG+V +     DG     KE   +D G+  ++   QL  E+ +L   +H NIV
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKE---IDYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 394 QYYGTDKDESK--LYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLH 446
           +YY    D S   LYI +E    G L  L Q+      ++ +  +     Q+LL L   H
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 447 -----DQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVC 499
                   V+HRD+K ANI +DAN +VKL DFGLAK      +  K+  GT ++M+PE  
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182

Query: 500 SN 501
           ++
Sbjct: 183 NH 184

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  131 bits (331), Expect = 5e-35
 Identities = 63/179 (35%), Positives = 103/179 (57%), Gaps = 12/179 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSRF 387
           W KG  LG G+F S Y    D   G   AVK+V+ +   S  ++ + + L +EI L++R 
Sbjct: 2   WLKGQQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
            H +I++  G   ++S   +F+E +  GS+ +L  +Y   +++ +  YT Q+L GL YLH
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 447 DQDVVHRDIKCANILVDANGS-VKLADFGLA-----KATKLNDVK-SCRGTAFWMAPEV 498
           +  ++HRD+K AN+L+D+ G  +++ADFG A     K T   + +    GT  +MAPEV
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  125 bits (317), Expect = 6e-33
 Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 22/182 (12%)

Query: 335 DLLGRGSFGSVYEGISDDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
             LG G+FG VY+G            AVK +    +   +++      +E  ++ +  H 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL----KEDASEEERKDFLKEARVMKKLGHP 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLL----------NLYQRYHLRDSQVSAYTRQILL 440
           N+V+  G   +E  LY+ LE +  G LL             ++  L    + ++  QI  
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAF---WMAP 496
           G++YL  +  VHRD+   N LV  +  VK++DFGL++    +D  +   G      WMAP
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 497 EV 498
           E 
Sbjct: 177 ES 178

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  125 bits (315), Expect = 2e-32
 Identities = 68/178 (38%), Positives = 103/178 (57%), Gaps = 14/178 (7%)

Query: 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           + +Q+ +L+GRG++G+VY G     G   A+K ++L          +S +++E+ALLS+ 
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINL----DTPDDDVSDIQREVALLSQL 56

Query: 388 EH---ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
                 NI +YYG+     +L+I +E    GS+  L +   + +  +S   R++L+ LKY
Sbjct: 57  RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKY 116

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEV 498
           +H   V+HRDIK ANILV   G+VKL DFG+  A  LN   S R    GT +WMAPEV
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGV--AALLNQNSSKRSTFVGTPYWMAPEV 172

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  122 bits (308), Expect = 1e-31
 Identities = 69/173 (39%), Positives = 96/173 (55%), Gaps = 17/173 (9%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G++G VY           A+KE+   D      + +  L +EIAL S  +H NIVQ
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-----RYVQPLHEEIALHSYLKHRNIVQ 69

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Y G+D +     IF+E V  GSL  L +         +  +  YT+QIL GLKYLHD  +
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 451 VHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSC----RGTAFWMAPEV 498
           VHRDIK  N+LV+  +G VK++DFG +K  +L  +  C     GT  +MAPEV
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTLQYMAPEV 180

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 3e-31
 Identities = 62/176 (35%), Positives = 93/176 (52%), Gaps = 10/176 (5%)

Query: 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
              W+    LG G+FG VY+    + G F A K + +     ++++ +     EI +LS 
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSE 58

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKY 444
            +H NIV  Y     E+KL+I +E    G+L ++       L + Q+    RQ+L  L +
Sbjct: 59  CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEV 498
           LH   V+HRD+K  NIL+  +G VKLADFG++   K    K  +  GT +WMAPEV
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV 174

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  121 bits (304), Expect = 4e-31
 Identities = 70/173 (40%), Positives = 105/173 (60%), Gaps = 11/173 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           + K + +G+GSFG VY+GI +      A+K + L     +A+  I  ++QEI +LS+ + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
             I +YYG+    +KL+I +E +  GS L+L +   L ++ ++   R+IL GL YLH + 
Sbjct: 62  PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEV 498
            +HRDIK AN+L+   G VKLADFG+A   +L D +  R    GT FWMAPEV
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEV 172

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  120 bits (303), Expect = 5e-31
 Identities = 69/172 (40%), Positives = 108/172 (62%), Gaps = 9/172 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           + K + +G+GSFG V++GI  D     V  + ++D   +A+  I  ++QEI +LS+ +  
Sbjct: 6   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 62

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
            + +YYG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEV 498
           +HRDIK AN+L+  +G VKLADFG+A   +L D +  R    GT FWMAPEV
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEV 172

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  120 bits (301), Expect = 7e-31
 Identities = 60/175 (34%), Positives = 102/175 (58%), Gaps = 16/175 (9%)

Query: 337 LGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +G GSFG +Y  +  SD      +KE+ L     + K++    ++E+ LL++ +H NIV 
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHC-VIKEIDLTKMPVKEKEAS---KKEVILLAKMKHPNIVT 63

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVV 451
           ++ + ++  +L+I +E    G L+    R       + Q+ ++  QI LGLK++HD+ ++
Sbjct: 64  FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123

Query: 452 HRDIKCANILVDANGSV-KLADFGLAKATKLND----VKSCRGTAFWMAPEVCSN 501
           HRDIK  NI +  NG V KL DFG+A+  +LND      +C GT ++++PE+C N
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEICQN 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 2e-30
 Identities = 59/173 (34%), Positives = 90/173 (52%), Gaps = 20/173 (11%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEH 389
           LG+GSFG V      D G  +A+K +         K+ I + ++      E  +LSR  H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK--------KKKIIKRKEVEHTLTERNILSRINH 52

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             IV+ +   + E KLY+ LE    G L + L +     + +   Y  +I+L L+YLH  
Sbjct: 53  PFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL 112

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
            +++RD+K  NIL+DA+G +KL DFGLAK    ++        GT  ++APEV
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEV 164

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  119 bits (298), Expect = 2e-30
 Identities = 67/173 (38%), Positives = 104/173 (60%), Gaps = 11/173 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           + K + +G+GSFG V++GI +      A+K + L     +A+  I  ++QEI +LS+ + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
             + +YYG+    +KL+I +E +  GS L+L +     + Q++   ++IL GL YLH + 
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEV 498
            +HRDIK AN+L+   G VKLADFG+A   +L D +  R    GT FWMAPEV
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEV 172

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  119 bits (300), Expect = 2e-30
 Identities = 59/175 (33%), Positives = 92/175 (52%), Gaps = 17/175 (9%)

Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRF 387
             LG GSFG V        G ++A+K +S        K  I +L+Q      E  +L   
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILS--------KAKIVKLKQVEHVLNEKRILQSI 58

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLH 446
            H  +V  YG+ +D+S LY+ +E V  G L +  ++       V+  Y  Q++L L+YLH
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
             D+V+RD+K  N+L+D++G +K+ DFG AK  K      C GT  ++APE+  +
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-GTPEYLAPEIILS 172

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  118 bits (299), Expect = 3e-30
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 31/195 (15%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--LLDQGSQAKQSISQLEQEI-ALLSRFEH 389
           G ++G GSF +V      +    +A+K +    L +  + K    ++E+E+   L+   H
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--EKKVKYVKIEKEVLTRLNG--H 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 448
             I++ Y T +DE  LY  LE    G LL   ++Y   D + +  Y  +ILL L+YLH +
Sbjct: 62  PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK---------ATKLNDVKSCR----------- 488
            ++HRD+K  NIL+D +  +K+ DFG AK         + K +                 
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181

Query: 489 --GTAFWMAPEVCSN 501
             GTA +++PE+ + 
Sbjct: 182 FVGTAEYVSPELLNE 196

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  117 bits (295), Expect = 5e-30
 Identities = 66/179 (36%), Positives = 96/179 (53%), Gaps = 21/179 (11%)

Query: 335 DLLGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSRF 387
             LG+GS+GSVY  + +SD   F+A+KEV L         S+SQ E+     EI +L+  
Sbjct: 6   KKLGKGSYGSVYKVKRLSD-NQFYALKEVDL--------GSMSQKEREDAVNEIRILASV 56

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGL 442
            H NI+ Y     D +KL I +E    G L     +       + + ++     Q+L GL
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           + LH+Q ++HRD+K ANIL+ AN  VK+ D G++K  K N  K+  GT  +MAPEV   
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKG 175

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 6e-30
 Identities = 55/183 (30%), Positives = 97/183 (53%), Gaps = 21/183 (11%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           ++  +++G G++G VY+      G   A+K + ++      +    ++++E  +L ++  
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------EDEEEEIKEEYNILRKYSN 61

Query: 389 HENIVQYYGT------DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS----AYT-RQ 437
           H NI  +YG         ++ +L++ +EL   GS+ +L +    +  ++     AY  R+
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMA 495
            L GL YLH+  V+HRDIK  NIL+  N  VKL DFG++    + L    +  GT +WMA
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181

Query: 496 PEV 498
           PEV
Sbjct: 182 PEV 184

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  114 bits (287), Expect = 5e-29
 Identities = 56/174 (32%), Positives = 96/174 (55%), Gaps = 19/174 (10%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-----LSRFEHE 390
           +G+GSFG V++ +   D   +A+K++ L          +++ E+E A+     L++ +  
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDL--------SKMNRREREEAIDEARVLAKLDSS 59

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHD 447
            I++YY +  D+ KL I +E    G L  L +      L + QV  +  QILLGL +LH 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVC 499
           + ++HRDIK  N+ +DA  +VK+ D G+AK    N     +  GT ++++PE+C
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC 173

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  113 bits (285), Expect = 2e-28
 Identities = 58/177 (32%), Positives = 84/177 (47%), Gaps = 23/177 (12%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEH 389
           LG G FG V           FA+K V         K+ I +  Q      E  +L    H
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVK--------KRHIVETGQQEHIFSEKEILEECNH 52

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             IV+ Y T KD+  +Y+ +E    G L   L  R    +     Y   ++L  +YLH++
Sbjct: 53  PFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS----CRGTAFWMAPEVCSN 501
            +++RD+K  N+L+D+NG VKL DFG AK  KL   +     C GT  ++APE+  N
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFC-GTPEYVAPEIILN 166

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 2e-28
 Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 11/152 (7%)

Query: 332 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFE 388
           +K + LG G++G VY+      G   A+K++ L       ++ I    L +EI+LL   +
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL----DNEEEGIPSTAL-REISLLKELK 56

Query: 389 HENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           H NIV+       E KLY+  E         L+      L  + + +   Q+L GL Y H
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPG-PLSPNLIKSIMYQLLRGLAYCH 115

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
              ++HRD+K  NIL++ +G +KLADFGLA+A
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARA 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  112 bits (281), Expect = 5e-28
 Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 11/171 (6%)

Query: 337 LGRGSFGS--VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG+G+FG   +Y    DD      KEV+L     + ++       EI +LS  +H NI+ 
Sbjct: 8   LGKGAFGEATLYRRTEDDSLV-VWKEVNLTRLSEKERRDA---LNEIVILSLLQHPNIIA 63

Query: 395 YYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           YY    D++ L I +E    G+L   +   +     +  V  Y  QI+  + Y+H   ++
Sbjct: 64  YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123

Query: 452 HRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVCS 500
           HRDIK  NI +   G +KL DFG++K   ++ +  ++  GT ++M+PE+C 
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQ 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (284), Expect = 1e-27
 Identities = 63/182 (34%), Positives = 92/182 (50%), Gaps = 18/182 (9%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EH 389
           ++    LG GSFG VY     D    A+K ++   +     + + +  +EI +L+     
Sbjct: 2   YRILRKLGEGSFGEVYLAR--DRKLVALKVLAK--KLESKSKEVERFLREIQILASLNHP 57

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYL 445
            NIV+ Y   +DE  LY+ +E V  GSL +L ++      L +S+      QIL  L+YL
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 446 HDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLNDV--------KSCRGTAFWMAP 496
           H + ++HRDIK  NIL+D +G  VKL DFGLAK                +  GT  +MAP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 497 EV 498
           EV
Sbjct: 178 EV 179

Length = 384

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 1e-27
 Identities = 51/150 (34%), Positives = 83/150 (55%), Gaps = 15/150 (10%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQ--SISQLEQEIALLSRFEHENIV 393
           +G G++G VY+  +   G   A+K++ +       K+   I+ +  EI LL +  H NIV
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM----ENEKEGFPITAIR-EIKLLQKLRHPNIV 61

Query: 394 QYYG--TDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           +     T K +  +Y+  E +     G L +        +SQ+  Y +Q+L GL+YLH  
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA 478
            ++HRDIK +NIL++ +G +KLADFGLA+ 
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARP 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  110 bits (276), Expect = 2e-27
 Identities = 64/168 (38%), Positives = 99/168 (58%), Gaps = 9/168 (5%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+  + + G   A+K + L     +  +  + ++QEI ++   +H NIV Y
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKL-----EPGEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           +G+     KL+I +E    GSL ++Y     L +SQ++  +R+ L GL YLH +  +HRD
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131

Query: 455 IKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVCS 500
           IK ANIL+  NG VKLADFG++      +   KS  GT +WMAPEV +
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  110 bits (275), Expect = 3e-27
 Identities = 67/168 (39%), Positives = 96/168 (57%), Gaps = 9/168 (5%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+  +   G   AVK + L + G       S ++QEI ++   +H NIV Y
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKL-EPGD----DFSLIQQEIFMVKECKHCNIVAY 71

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           +G+     KL+I +E    GSL ++Y     L + Q++   R+ L GL YLH +  +HRD
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131

Query: 455 IKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVCS 500
           IK ANIL+  NG VKLADFG+A      +   KS  GT +WMAPEV +
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAA 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  110 bits (276), Expect = 3e-27
 Identities = 55/173 (31%), Positives = 97/173 (56%), Gaps = 15/173 (8%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G+   VY  I   +    A+K + L     + + S+ +L +E+  +S+  H N+V+Y
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 396 YGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           Y +     +L++ +  ++ GSLL++    Y R  L ++ ++   +++L GL+YLH    +
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GTAFWMAPEV 498
           HRDIK  NIL+  +GSVK+ADFG++ +      ++ +      GT  WMAPEV
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  109 bits (275), Expect = 6e-27
 Identities = 61/185 (32%), Positives = 89/185 (48%), Gaps = 17/185 (9%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           KR + + ++   LG G FG V         D     V   SL    S  +Q  S  E+EI
Sbjct: 3   KRHLKFIKQ---LGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREI 57

Query: 382 ALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQ 437
            +L   +HENIV+Y G         L + +E +  GSL +  QR+   +   ++  ++ Q
Sbjct: 58  EILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ 117

Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT-AF 492
           I  G+ YL  Q  +HRD+   NILV++   VK++DFGLAK    +     VK    +  F
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 493 WMAPE 497
           W APE
Sbjct: 178 WYAPE 182

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 1e-26
 Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 15/155 (9%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
           +QK   +G G++G VY+      G   A+K++ L  +     K ++    +EI LL    
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELN 56

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLK 443
           H NI++     + +  LY+  E +      +LY+     +  L +S + +Y  Q+L GL 
Sbjct: 57  HPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           + H   ++HRD+K  N+L++  G +KLADFGLA++
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLARS 147

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  106 bits (266), Expect = 6e-26
 Identities = 52/167 (31%), Positives = 87/167 (52%), Gaps = 12/167 (7%)

Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G+ G V +      G   AVK + L       +    Q+ +E+ +L +     IV +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRL----EINEAIQKQILRELDILHKCNSPYIVGF 64

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQ-DVVH 452
           YG   +   + I +E +  GSL  + +    R  +  +      +L GL YLH++  ++H
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKL-NDV-KSCRGTAFWMAPE 497
           RD+K +NILV++ G +KL DFG+  + +L N + K+  GT+ +MAPE
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGV--SGQLVNSLAKTFVGTSSYMAPE 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  106 bits (266), Expect = 7e-26
 Identities = 55/170 (32%), Positives = 92/170 (54%), Gaps = 10/170 (5%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+G F  VY+ I   DG   A+K+V + +    AK     L +EI LL + +H N+++Y
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCL-KEIDLLKQLDHPNVIKY 67

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
             +  + ++L I LEL   G L  +      Q+  + +  +  Y  Q+   L+++H + +
Sbjct: 68  LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127

Query: 451 VHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEV 498
           +HRDIK AN+ + A G VKL D GL +  ++K     S  GT ++M+PE 
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  105 bits (264), Expect = 9e-26
 Identities = 56/176 (31%), Positives = 104/176 (59%), Gaps = 19/176 (10%)

Query: 337 LGRGSFG-SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG ++     +DG  + +KE+++     + ++   +  +E+A+LS  +H NIVQY
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQY 64

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLR------DSQVSAYTRQILLGLKYLHDQD 449
             + ++   LYI ++    G   +LY++ + +      + Q+  +  QI L LK++HD+ 
Sbjct: 65  QESFEENGNLYIVMDYCEGG---DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVCSN 501
           ++HRDIK  NI +  +G++KL DFG+A+   LN      ++C GT ++++PE+C N
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICEN 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  105 bits (265), Expect = 1e-25
 Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 12/169 (7%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G+ GSV +  + + G  FA+K ++        KQ    + +E+ +    +   IV+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ----ILRELEINKSCKSPYIVKY 64

Query: 396 YGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYLHDQ 448
           YG   D+  S + I +E    GSL ++Y++   R  ++           +L GL YLH +
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
            ++HRDIK +NIL+   G VKL DFG++     +   +  GT+F+MAPE
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPE 173

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  104 bits (262), Expect = 2e-25
 Identities = 57/171 (33%), Positives = 86/171 (50%), Gaps = 19/171 (11%)

Query: 338 GRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           G+G+FG V      D    FA+K ++   Q    K S+  +  E  +L    H  +V  +
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMN--KQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHL------RDSQVSAYTRQILLGLKYLHDQDV 450
            + +DE  +Y+ ++L+  G L     RYHL       + QV  +  +I+L L+YLH + +
Sbjct: 67  YSFQDEENMYLVVDLLLGGDL-----RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 451 VHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEV 498
           +HRDIK  NIL+D  G V + DF +A       L    S  GT  +MAPEV
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEV 170

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  104 bits (262), Expect = 2e-25
 Identities = 54/174 (31%), Positives = 92/174 (52%), Gaps = 14/174 (8%)

Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           + +G++G V+       G  +A+K +   D     K  + Q+  E  +LS+ +   +V+ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
           Y + + +  LY+ +E +  G L +L +     D  V+  Y  +I+L L+YLH   ++HRD
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118

Query: 455 IKCANILVDANGSVKLADFGLAKA-------TKLNDVKSCR---GTAFWMAPEV 498
           +K  NIL+D+NG +KL DFGL+K           +D K  +   GT  ++APEV
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 3e-25
 Identities = 56/167 (33%), Positives = 85/167 (50%), Gaps = 12/167 (7%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L  G+ + ++     QE  ++ +  H+ +VQ Y
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKT---LKPGTMSPEA---FLQEAQIMKKLRHDKLVQLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +      LR  Q+     QI  G+ YL  ++ +HR
Sbjct: 68  AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHR 127

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D+   NILV  N   K+ADFGLA+  + ++  +  G  F   W APE
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 2e-24
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 37/181 (20%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EI-ALLSRFEH 389
           LG G+FGSVY   + + G   A+K         + K+     E+     E+ +L    EH
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIK---------KMKKKFYSWEECMNLREVKSLRKLNEH 57

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------SQVSAYTRQILLGLK 443
            NIV+     ++  +LY   E +      NLYQ    R       S + +   QIL GL 
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GTAFWMAPE 497
           ++H     HRD+K  N+LV     VK+ADFGLA+     +++S         T ++ APE
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVSTRWYRAPE 168

Query: 498 V 498
           +
Sbjct: 169 I 169

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  102 bits (255), Expect = 4e-24
 Identities = 56/165 (33%), Positives = 91/165 (55%), Gaps = 8/165 (4%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG+VY           A+K++S    G Q+ +    + +E+  L +  H N ++Y
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            G    E   ++ +E  L +   +L ++++  L++ +++A     L GL YLH  + +HR
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHR 139

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           DIK  NIL+   G+VKLADFG   A+ ++   S  GT +WMAPEV
Sbjct: 140 DIKAGNILLTEPGTVKLADFG--SASLVSPANSFVGTPYWMAPEV 182

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  101 bits (253), Expect = 5e-24
 Identities = 52/148 (35%), Positives = 85/148 (57%), Gaps = 11/148 (7%)

Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
           AVK++ L  Q     Q    L  E+ ++  ++H NIV+ Y +     +L++ +E +  G+
Sbjct: 48  AVKKMDLRKQ-----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102

Query: 417 LLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL- 475
           L ++     + + Q++     +L  L +LH Q V+HRDIK  +IL+ ++G VKL+DFG  
Sbjct: 103 LTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC 162

Query: 476 AKATKLNDV---KSCRGTAFWMAPEVCS 500
           A+ +K  +V   KS  GT +WMAPEV S
Sbjct: 163 AQVSK--EVPRRKSLVGTPYWMAPEVIS 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 8e-24
 Identities = 55/167 (32%), Positives = 80/167 (47%), Gaps = 12/167 (7%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+EG+ ++    AVK    L  G+           E  ++ +  H  ++Q Y
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKT---LKPGTM---DPKDFLAEAQIMKKLRHPKLIQLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  EL+  GSLL   Q      L+  Q+     Q+  G+ YL  Q+ +HR
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR 127

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D+   N+LV  N   K+ADFGLA+  K +  ++  G  F   W APE
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 54/154 (35%), Positives = 81/154 (52%), Gaps = 19/154 (12%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ- 394
           LG G+FG VY+      G   A+K++ + ++       I+ L +EI +L + +H N+V  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITAL-REIKILKKLKHPNVVPL 72

Query: 395 ----YYGTDKDESKLYIFLELVT-------KGSLLNLYQRYHLRDSQVSAYTRQILLGLK 443
                   DK + K      +VT        G L N      L +SQ+  Y  Q+L G+ 
Sbjct: 73  IDMAVERPDKSKRKRGSVY-MVTPYMDHDLSGLLEN--PSVKLTESQIKCYMLQLLEGIN 129

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           YLH+  ++HRDIK ANIL+D  G +K+ADFGLA+
Sbjct: 130 YLHENHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 97.7 bits (243), Expect = 1e-22
 Identities = 60/171 (35%), Positives = 96/171 (56%), Gaps = 8/171 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           + + + +G+G+ G+VY  I    G   A+K+++L  Q    K+ I     EI ++   +H
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIIN---EILVMRENKH 75

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
            NIV Y  +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 450 VVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEV 498
           V+HRDIK  NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 98.2 bits (244), Expect = 1e-22
 Identities = 61/165 (36%), Positives = 93/165 (56%), Gaps = 8/165 (4%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG+VY    S      AVK++S    G Q  +    + +E+  L + +H N ++Y
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSY--SGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++HR
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHR 145

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           DIK  NIL+   G VKLADFG   A+K +   S  GT +WMAPEV
Sbjct: 146 DIKAGNILLTEPGQVKLADFG--SASKSSPANSFVGTPYWMAPEV 188

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 60/180 (33%), Positives = 92/180 (51%), Gaps = 16/180 (8%)

Query: 330 YWQKGDLLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           Y +K  +LG G FG V    Y+  +D  G   AVK +    +    +Q+ S  ++EI +L
Sbjct: 5   YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL----KRECGQQNTSGWKKEINIL 60

Query: 385 SRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
               HENIV+Y G  +++    L + +E V  GSL +   ++ L  +Q+  + +QI  G+
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGM 120

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPE 497
            YLH Q  +HRD+   N+L+D +  VK+ DFGLAKA           +      FW A E
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 97.3 bits (242), Expect = 2e-22
 Identities = 57/171 (33%), Positives = 97/171 (56%), Gaps = 13/171 (7%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V+   +     FFA+K    +V L+D   +     + +E+ +  L+ +EH 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLA-WEHP 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
            +   Y T + +  L+  +E +  G L+   Q  H  D  + + Y  +I+ GL++LH + 
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEV 498
           +V+RD+K  NIL+D +G +K+ADFG+ K   L D K+C   GT  ++APE+
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 5e-22
 Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 11/169 (6%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           + G  +G+G FG V  G    G   AVK   L D  + A+  ++    E ++++   H N
Sbjct: 9   KLGATIGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLA----EASVMTTLRHPN 61

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQ 448
           +VQ  G     + LYI  E + KGSL++  +   R  +  +Q   +   +  G++YL ++
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           + VHRD+   N+LV  +   K++DFGLAK        S +    W APE
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-QDSGKLPVKWTAPE 169

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 62/182 (34%), Positives = 93/182 (51%), Gaps = 19/182 (10%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL---SR 386
           +++   +G G++G+VY+    + G F A+K+V +    S+    +S L +EIALL     
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRV--PLSEEGIPLSTL-REIALLKQLES 57

Query: 387 FEHENIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQ 437
           FEH NIV+            E KL +  E V +   L  Y        L    +    RQ
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD--LATYLSKCPKPGLPPETIKDLMRQ 115

Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAP 496
           +L G+ +LH   +VHRD+K  NILV ++G VK+ADFGLA+       + S   T ++ AP
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAP 175

Query: 497 EV 498
           EV
Sbjct: 176 EV 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 95.1 bits (236), Expect = 7e-22
 Identities = 58/173 (33%), Positives = 95/173 (54%), Gaps = 8/173 (4%)

Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +W+    LG G+FG VY+  + +    A  +V  +D  +++++ +     EI +L+  +H
Sbjct: 6   FWEIIGELGDGAFGKVYKAQNKETGVLAAAKV--ID--TKSEEELEDYMVEIDILASCDH 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+ L+I +E    G++  + L     L + Q+    +Q L  L YLH+
Sbjct: 62  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEV 498
             ++HRD+K  NIL   +G +KLADFG+ AK T+ +    S  GT +WMAPEV
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 174

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 95.3 bits (238), Expect = 7e-22
 Identities = 52/159 (32%), Positives = 88/159 (55%), Gaps = 20/159 (12%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI--SQLEQEIALLSRF 387
           ++KG  LG G++  VY+    + G   A+K++ L  +  +AK  I  + L +EI LL   
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKL-GERKEAKDGINFTAL-REIKLLQEL 59

Query: 388 EHENI---VQYYGTDKDESKLYIF----LELVTK-GSLLNLYQRYHLRDSQVSAYTRQIL 439
           +H NI   +  +G   + + ++ F    LE V K  S++       L  + + +Y    L
Sbjct: 60  KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV-------LTPADIKSYMLMTL 112

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            GL+YLH   ++HRD+K  N+L+ ++G +KLADFGLA++
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 96.1 bits (240), Expect = 8e-22
 Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 15/152 (9%)

Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIV 393
            +G G++G V   +    G   A+K++S +      AK+ +    +EI LL    HENI+
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL----REIKLLRHLRHENII 62

Query: 394 Q----YYGTDKDE-SKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLH 446
                      ++ + +YI  EL    + L+  +     L D  +  +  QIL GLKYLH
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTEL--METDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
             +V+HRD+K +NILV++N  +K+ DFGLA+ 
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARG 152

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 57/170 (33%), Positives = 92/170 (54%), Gaps = 12/170 (7%)

Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRG F  VY      DG   A+K+V + D   ++A+    +   EI LL +  H N+++
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLNHPNVIK 66

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           YY +  ++++L I LEL   G L  +      Q+  + +  V  Y  Q+   L+++H + 
Sbjct: 67  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPE 497
           V+HRDIK AN+ + A G VKL D GL +  ++K     S  GT ++M+PE
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 94.4 bits (234), Expect = 2e-21
 Identities = 60/167 (35%), Positives = 94/167 (56%), Gaps = 12/167 (7%)

Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G GSFG+VY   + D       A+K++S    G Q+ +    + +E+  L R +H N +
Sbjct: 33  IGHGSFGAVY--FARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVKFLQRIKHPNSI 88

Query: 394 QYYGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           +Y G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++
Sbjct: 89  EYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMI 147

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           HRDIK  NIL+   G VKLADFG   A+  +   S  GT +WMAPEV
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFG--SASIASPANSFVGTPYWMAPEV 192

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 61/184 (33%), Positives = 99/184 (53%), Gaps = 20/184 (10%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
            +RI T       +G G+FG V+   + IS    ++A+K +++ +   + KQ    +  E
Sbjct: 3   LERIKT-------VGTGTFGRVHLVRDRIS--EHYYALKVMAIPEV-IRLKQ-EQHVHNE 51

Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQI 438
             +L    H  I++ + T+ D+  LY+ +E V  G L + Y R   R S  +   Y  +I
Sbjct: 52  KRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFS-YLRNSGRFSNSTGLFYASEI 110

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPE 497
           +  L+YLH +++V+RD+K  NIL+D  G +KL DFG AK  KL D   +  GT  ++APE
Sbjct: 111 VCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWTLCGTPEYLAPE 168

Query: 498 VCSN 501
           V  +
Sbjct: 169 VIQS 172

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 69/185 (37%), Positives = 100/185 (54%), Gaps = 26/185 (14%)

Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           W+  + +G+G++G VY+  +  DG   AVK   +LD  S   + I   E E  +L     
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVK---ILDPISDVDEEI---EAEYNILQSLPN 77

Query: 389 HENIVQYYG----TDK-DESKLYIFLELVTKGS-------LLNLYQRYHLRDSQVSAYTR 436
           H N+V++YG     DK    +L++ LEL   GS       LL   QR  L ++ +S    
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYILY 135

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFW 493
             LLGL++LH+  ++HRD+K  NIL+   G VKL DFG++    +T+L    S  GT FW
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFW 194

Query: 494 MAPEV 498
           MAPEV
Sbjct: 195 MAPEV 199

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 93.2 bits (231), Expect = 4e-21
 Identities = 59/173 (34%), Positives = 93/173 (53%), Gaps = 10/173 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W+    LG G+FG VY+  + + G   A K +      +++++ +     EI +L+   H
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYMVEIEILATCNH 68

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
             IV+  G    + KL+I +E    G++  + L     L + Q+    RQ+L  L+YLH 
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEV 498
             ++HRD+K  N+L+  +G +KLADFG+ AK  K L    S  GT +WMAPEV
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEV 181

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 92.2 bits (229), Expect = 5e-21
 Identities = 48/162 (29%), Positives = 88/162 (54%), Gaps = 5/162 (3%)

Query: 339 RGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG 397
           +G+FGSVY       G +FA+K +   D  ++ + +  + E+ I ++ + E   + + Y 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAKLYY 64

Query: 398 TDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
           + + +  LY+ +E +  G   +L +    L +     Y  +++LG++ LH + ++HRDIK
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124

Query: 457 CANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
             N+L+D  G +KL DFGL++    N  K   GT  ++APE 
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPET 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 93.2 bits (231), Expect = 5e-21
 Identities = 57/167 (34%), Positives = 92/167 (55%), Gaps = 8/167 (4%)

Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 82

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142

Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVCS 500
           K  +IL+  +G VKL+DFG  A+ +K +   KS  GT +WMAPE+ S
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS 189

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 93.6 bits (233), Expect = 5e-21
 Identities = 54/177 (30%), Positives = 96/177 (54%), Gaps = 21/177 (11%)

Query: 336 LLGRGSFGSV----YEGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 387
           +LG+GSFG V     +G  +    +AVK    +V L D   +     +  E+ +  L+  
Sbjct: 2   VLGKGSFGKVLLAELKGTDE---LYAVKVLKKDVILQDDDVEC----TMTEKRVLALAG- 53

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLH 446
           +H  + Q +   + + +L+  +E V  G L+   QR     + +   Y  +I+LGL++LH
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVCS 500
           ++ +++RD+K  N+L+D+ G +K+ADFG+ K   L  V +   C GT  ++APE+ S
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILS 169

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 93.2 bits (231), Expect = 6e-21
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 8/165 (4%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG+VY      +    A+K++S    G Q+ +    + +E+  L +  H N +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++HR
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           D+K  NIL+   G VKL DFG   A+ +       GT +WMAPEV
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEV 182

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 92.2 bits (229), Expect = 7e-21
 Identities = 60/188 (31%), Positives = 82/188 (43%), Gaps = 32/188 (17%)

Query: 336 LLGRGSFGSVYEGISDDGFFFAVKE----VSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
            LG G+FG VYEG + D            V  L +G+   Q   +  +E  L+S F H N
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPN 60

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL----------- 440
           IV+  G        YI +EL+  G LL+     +LRD++V  +   +L            
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLS-----YLRDARVERFGPPLLTLKELLDICLDV 115

Query: 441 --GLKYLHDQDVVHRDIKCANILV-----DANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
             G  YL     +HRD+   N LV     DA+  VK+ DFGLA+    +D     G    
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 493 ---WMAPE 497
              WMAPE
Sbjct: 176 PVRWMAPE 183

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 92.1 bits (229), Expect = 7e-21
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 7/146 (4%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+G +   G   A+K++ L    S+ +   S   +EI+LL   +H NIV  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRL---ESEEEGVPSTAIREISLLKELQHPNIVCL 64

Query: 396 YGTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                 ES+LY+  E ++   K  L +L +  ++    V +Y  QIL G+ + H + V+H
Sbjct: 65  QDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH 124

Query: 453 RDIKCANILVDANGSVKLADFGLAKA 478
           RD+K  N+L+D  G +KLADFGLA+A
Sbjct: 125 RDLKPQNLLIDNKGVIKLADFGLARA 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 51/144 (35%), Positives = 86/144 (59%), Gaps = 8/144 (5%)

Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
           V ++D   Q ++ +  L  E+ ++  ++H+N+V+ Y +     +L++ +E +  G+L ++
Sbjct: 51  VKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108

Query: 421 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKAT 479
             +  L + Q++     +L  L YLH Q V+HRDIK  +IL+  +G VKL+DFG  A+ +
Sbjct: 109 VSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168

Query: 480 KLNDV---KSCRGTAFWMAPEVCS 500
           K  DV   KS  GT +WMAPEV S
Sbjct: 169 K--DVPKRKSLVGTPYWMAPEVIS 190

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 48/182 (26%), Positives = 91/182 (50%), Gaps = 15/182 (8%)

Query: 335 DLLGRGSFGSVY--EGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLS----R 386
           + LG G+FG VY     ++     A+KE+++     G   ++    +   ++ ++    +
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLG 441
             H NIV+YY T  +  +LYI ++L+    L   +     ++    + ++     Q++L 
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 442 LKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVC 499
           L+YLH ++ +VHRD+   NI++  +  V + DFGLAK  +    + S  GT  +  PE+ 
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV 185

Query: 500 SN 501
            N
Sbjct: 186 KN 187

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 60/181 (33%), Positives = 101/181 (55%), Gaps = 24/181 (13%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
           +++ + LG G++ +VY+G +   G   A+KE+ L  ++G+      S   +EI+L+   +
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP-----STAIREISLMKELK 56

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLK 443
           HENIV+ +     E+KL +  E + K   L  Y   H     L  + V ++T Q+L G+ 
Sbjct: 57  HENIVRLHDVIHTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFWMAPE 497
           + H+  V+HRD+K  N+L++  G +KLADFGLA+A      T  N+V     T ++ AP+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----TLWYRAPD 170

Query: 498 V 498
           V
Sbjct: 171 V 171

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 50/182 (27%), Positives = 75/182 (41%), Gaps = 31/182 (17%)

Query: 335 DLLGRGSFGSVYEGISDDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
             LG GSFG V  G            AVK +       +    +    +E A++   +HE
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK----SDKLSDIMDDFLKEAAIMHSLDHE 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--------YTRQILLGL 442
           N+++ YG       + +  EL   GSLL+      LR   +          Y  QI  G+
Sbjct: 57  NLIRLYGVVLTHPLMMVT-ELAPLGSLLD-----RLRKDALGHFLISTLCDYAVQIANGM 110

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WMA 495
           +YL  +  +HRD+   NIL+ ++  VK+ DFGL +A   N+                W A
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCA 168

Query: 496 PE 497
           PE
Sbjct: 169 PE 170

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 20/173 (11%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G+ G V++    + G   A+K+V+L  L+ G       +Q  +EI  L   +H  +V
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-----NQALREIKALQACQHPYVV 62

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQ 448
           +        S   + +E +       L +        L ++QV +Y R +L G+ Y+H  
Sbjct: 63  KLLDVFPHGSGFVLVMEYMPSD----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
            ++HRD+K AN+L+ A+G +K+ADFGLA+     + +       T ++ APE+
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 48/144 (33%), Positives = 84/144 (58%), Gaps = 2/144 (1%)

Query: 359 KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           K+V++     + +Q    L  E+ ++  + HEN+V  Y +     +L++ +E +  G+L 
Sbjct: 48  KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107

Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AK 477
           ++     + + Q++     +L  L YLH+Q V+HRDIK  +IL+ ++G +KL+DFG  A+
Sbjct: 108 DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167

Query: 478 ATK-LNDVKSCRGTAFWMAPEVCS 500
            +K +   KS  GT +WMAPEV S
Sbjct: 168 VSKEVPKRKSLVGTPYWMAPEVIS 191

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 12/170 (7%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+EG+  +    A+K   +L      KQ     ++E+  L R  H++++  +
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIK---ILKSDDLLKQQ--DFQKEVQALKRLRHKHLISLF 68

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA---YTRQILLGLKYLHDQDVVHR 453
                   +YI  EL+ KGSLL   +    +   V++      Q+  G+ YL +Q+ +HR
Sbjct: 69  AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D+   NILV  +   K+ADFGLA+  K  DV           W APE  S
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAAS 177

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 90.2 bits (223), Expect = 3e-20
 Identities = 63/186 (33%), Positives = 101/186 (54%), Gaps = 26/186 (13%)

Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
           +L+G G++G VY+G     G   A+K   ++D     ++ I   +QEI +L ++  H NI
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEI---KQEINMLKKYSHHRNI 65

Query: 393 VQYYGT--DKD----ESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
             YYG    K+    + +L++ +E    GS+ +L +      L++  ++   R+IL GL 
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVC 499
           +LH   V+HRDIK  N+L+  N  VKL DFG+  + +L+     R    GT +WMAPEV 
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 500 S---NP 502
           +   NP
Sbjct: 184 ACDENP 189

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 49/151 (32%), Positives = 84/151 (55%), Gaps = 6/151 (3%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L D  ++   S +   +EI+LL    H
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELNH 58

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA 478
             V+HRD+K  N+L++  G++KLADFGLA+A
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARA 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 14/173 (8%)

Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG VY+G+     ++    AVK        S  ++ +    QE  ++ +F+H
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFL----QEAYIMRQFDH 66

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G   +   ++I +EL   G L +  Q  +Y L  + +  Y+ Q+   L YL  
Sbjct: 67  PHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGT--AFWMAPE 497
           +  VHRDI   N+LV +   VKL DFGL++  +     K+ +G     WMAPE
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 91.4 bits (227), Expect = 4e-20
 Identities = 55/194 (28%), Positives = 103/194 (53%), Gaps = 10/194 (5%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLD 365
           SSS+++   S         + ++  ++ + +G G+ G+VY+ I    G  +A+K +    
Sbjct: 52  SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI---- 107

Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH 425
            G+       Q+ +EI +L    H N+V+ +       ++ + LE +  GSL      + 
Sbjct: 108 YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---THI 164

Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLND 483
             +  ++   RQIL G+ YLH + +VHRDIK +N+L+++  +VK+ADFG+++  A  ++ 
Sbjct: 165 ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224

Query: 484 VKSCRGTAFWMAPE 497
             S  GT  +M+PE
Sbjct: 225 CNSSVGTIAYMSPE 238

Length = 353

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 89.3 bits (221), Expect = 5e-20
 Identities = 59/168 (35%), Positives = 89/168 (52%), Gaps = 15/168 (8%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++     QE  ++ +  HE +VQ Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
               +E  +YI  E ++KGSLL+       +Y LR  Q+     QI  G+ Y+   + VH
Sbjct: 68  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 125

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           RD++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 6e-20
 Identities = 54/160 (33%), Positives = 88/160 (55%), Gaps = 14/160 (8%)

Query: 332 QKGDLLGRGSFGSVY---EGISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSR 386
           +   ++GRG+FG V+   +   D G  +A+K +  S + + +Q    I+ +  E  +L+ 
Sbjct: 4   EVIKVIGRGAFGEVWLVRD--KDTGQVYAMKVLRKSDMIKRNQ----IAHVRAERDILAD 57

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 445
            +   IV+ Y + +DE  LY+ +E +  G L+NL  R     +     Y  +++L L  +
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
           H    +HRDIK  NIL+DA+G +KLADFGL K  K+N  K
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCK--KMNKAK 155

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 90.3 bits (224), Expect = 6e-20
 Identities = 57/172 (33%), Positives = 88/172 (51%), Gaps = 15/172 (8%)

Query: 334 GDLLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G+ LG GSFG V        G ++A+K   L  +     + +  + QE ++L    H  I
Sbjct: 23  GETLGTGSFGRVRIAKHKGTGEYYAIK--CLKKREILKMKQVQHVAQEKSILMELSHPFI 80

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS-----QVSA-YTRQILLGLKYLH 446
           V    + +DE+++Y  LE V  G L       HLR +      V+  Y  +++L  +YLH
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFT-----HLRKAGRFPNDVAKFYHAELVLAFEYLH 135

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
            +D+++RD+K  N+L+D  G VK+ DFG AK         C GT  ++APEV
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-GTPEYLAPEV 186

Length = 329

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 88.9 bits (220), Expect = 6e-20
 Identities = 57/174 (32%), Positives = 90/174 (51%), Gaps = 14/174 (8%)

Query: 336 LLGRGSFGS---VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           ++G GSFG    V    SD    +A+KE+ L    S  + S     +E  LL++ +H NI
Sbjct: 7   VVGEGSFGRALLVQHVNSDQ--KYAMKEIRLPKSSSAVEDS----RKEAVLLAKMKHPNI 60

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQ-VSAYTRQILLGLKYLHDQD 449
           V +  + + +  LYI +E    G L+     QR  L     +  +  Q+ LG++++H++ 
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVCSN 501
           V+HRDIK  NI +  NG VKL DFG A+        +C   GT +++ PE+  N
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 7e-20
 Identities = 53/152 (34%), Positives = 84/152 (55%), Gaps = 8/152 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+      G   A+K++ L +   +   S +   +EI+LL    H
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL-ETEDEGVPSTAI--REISLLKELNH 57

Query: 390 ENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
            NIV+       E+KLY+   FL+L  K  + +      L    + +Y  Q+L G+ Y H
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCH 116

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
              V+HRD+K  N+L+D  G++KLADFGLA+A
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 89.3 bits (221), Expect = 8e-20
 Identities = 62/183 (33%), Positives = 101/183 (55%), Gaps = 22/183 (12%)

Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           W+  + +G+G++G V++ ++  +G   AVK   +LD      + I   E E  +L    +
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVK---ILDPIHDIDEEI---EAEYNILKALSD 73

Query: 389 HENIVQYYGT-----DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS----AYT-RQI 438
           H N+V++YG       K+  +L++ LEL   GS+ +L + +  R  ++     AY   + 
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMA 495
           L+GL++LH    +HRD+K  NIL+   G VKL DFG++    +T+L    S  GT FWMA
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 192

Query: 496 PEV 498
           PEV
Sbjct: 193 PEV 195

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 89.3 bits (221), Expect = 9e-20
 Identities = 59/186 (31%), Positives = 99/186 (53%), Gaps = 26/186 (13%)

Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
           +++G G++G VY+G     G   A+K + + +   +      +++ EI +L ++  H NI
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE------EIKLEINMLKKYSHHRNI 75

Query: 393 VQYYGTDKDES------KLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
             YYG    +S      +L++ +E    GS+ +L +      L++  ++   R+IL GL 
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVC 499
           +LH   V+HRDIK  N+L+  N  VKL DFG+  + +L+     R    GT +WMAPEV 
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 500 S---NP 502
           +   NP
Sbjct: 194 ACDENP 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 60/175 (34%), Positives = 86/175 (49%), Gaps = 18/175 (10%)

Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG G FG V    Y+   D+ G   AVK +     G+     I+ L++EI +L    HEN
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHEN 67

Query: 392 IVQYYG--TDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD 447
           IV+Y G  T+   + + + +E +  GSL     R    +   Q   Y  QI  G+ YL  
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT-AFWMAPE 497
           +  VHRD+   N+LV++   VK+ DFGL KA + +     VK    +  FW APE
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 89.0 bits (220), Expect = 1e-19
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 9/196 (4%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ 366
           S     E + +I   G  K+  T ++K   +G+G+ G+VY  +         +EV++   
Sbjct: 1   SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMD----VATGQEVAIRQM 53

Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL 426
             Q +     +  EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     +
Sbjct: 54  NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM 113

Query: 427 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS 486
            + Q++A  R+ L  L++LH   V+HRDIK  NIL+  +GSVKL DFG          K 
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173

Query: 487 CR--GTAFWMAPEVCS 500
               GT +WMAPEV +
Sbjct: 174 STMVGTPYWMAPEVVT 189

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 51/171 (29%), Positives = 89/171 (52%), Gaps = 17/171 (9%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
           F   ++ ++K   +G+G+FG V++          A+K+V L++   +    I+ L +EI 
Sbjct: 7   FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGF-PITAL-REIK 63

Query: 383 LLSRFEHENIVQYY--------GTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQV 431
           +L   +HEN+V             ++ +   Y+  E       G L N   ++ L  S++
Sbjct: 64  ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL--SEI 121

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
               + +L GL Y+H   ++HRD+K ANIL+  +G +KLADFGLA+A  L+
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 89.0 bits (220), Expect = 1e-19
 Identities = 63/191 (32%), Positives = 103/191 (53%), Gaps = 11/191 (5%)

Query: 313 EPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 371
           E + +I   G  K+  T ++K   +G+G+ G+VY  I    G   A+K+++L  Q  +  
Sbjct: 6   EKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK-- 60

Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
                +  EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     + + Q+
Sbjct: 61  ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-G 489
           +A  R+ L  L +LH   V+HRDIK  NIL+  +GSVKL DFG  A+ T     +S   G
Sbjct: 118 AAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 490 TAFWMAPEVCS 500
           T +WMAPEV +
Sbjct: 178 TPYWMAPEVVT 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 46/146 (31%), Positives = 77/146 (52%), Gaps = 7/146 (4%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G++G V +  +   G   A+K+    +     K++  +   E+ +L +  HENIV 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVN 64

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
                + + +LY+  E V + +LL L +     L    V +Y  Q+L  + Y H  +++H
Sbjct: 65  LKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123

Query: 453 RDIKCANILVDANGSVKLADFGLAKA 478
           RDIK  NILV  +G +KL DFG A+A
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARA 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 60/176 (34%), Positives = 91/176 (51%), Gaps = 19/176 (10%)

Query: 336 LLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
            LG+G+FGSV    Y+ + D+ G   AVK++    Q S A+  +   E+EI +L   +H+
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKL----QHSTAEH-LRDFEREIEILKSLQHD 65

Query: 391 NIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLH 446
           NIV+Y G         L + +E +  GSL +  Q++  R    ++  Y  QI  G++YL 
Sbjct: 66  NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKS-CRGTAFWMAPE 497
            +  VHRD+   NILV++   VK+ DFGL K    +     V+       FW APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 56/180 (31%), Positives = 80/180 (44%), Gaps = 21/180 (11%)

Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG       D     V   +L +  S+  +S      E  ++S+F H+NI
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDES--DFLMEALIMSKFNHQNI 71

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKY 444
           V+  G   +    +I LEL+  G L +  +    R  + S+ T + LL        G KY
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ADFG+A+           G A     WM PE
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 58/177 (32%), Positives = 96/177 (54%), Gaps = 14/177 (7%)

Query: 337 LGRGSFGSVY----EGISDDGFFFAVK---EVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG G++G V+     G  D G  +A+K   + +++ +   A+ + ++  Q +  + R   
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTE-RQVLEAVRRCPF 66

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             +V  +   + ++KL++ L+ V  G L  +LYQR H  +S+V  Y  +I+L L +LH  
Sbjct: 67  --LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK---ATKLNDVKSCRGTAFWMAPEVCSNP 502
            +++RDIK  NIL+D+ G V L DFGL+K   A +     S  GT  +MAPEV    
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 56/187 (29%), Positives = 81/187 (43%), Gaps = 31/187 (16%)

Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+ G        +D    AVK +    + + +  +    E+E  LL+ F+HE
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL----KETASNDARKDFEREAELLTNFQHE 68

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAY 434
           NIV++YG   +     +  E +  G L N + R H  D                SQ+   
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-- 492
             QI  G+ YL  Q  VHRD+   N LV  +  VK+ DFG+++     D     G     
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 493 --WMAPE 497
             WM PE
Sbjct: 188 IRWMPPE 194

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 87.1 bits (215), Expect = 5e-19
 Identities = 60/191 (31%), Positives = 104/191 (54%), Gaps = 11/191 (5%)

Query: 313 EPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAK 371
           E +  I   G  K+  T ++K   +G+G+ G+V+  I    G   A+K+++L     Q +
Sbjct: 6   EKLRTIVSIGDPKKKYTRYEK---IGQGASGTVFTAIDVATGQEVAIKQINL-----QKQ 57

Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
                +  EI ++   ++ NIV +  +     +L++ +E +  GSL ++     + ++Q+
Sbjct: 58  PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI 117

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-G 489
           +A  R+ L  L++LH   V+HRDIK  N+L+  +GSVKL DFG  A+ T     +S   G
Sbjct: 118 AAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 490 TAFWMAPEVCS 500
           T +WMAPEV +
Sbjct: 178 TPYWMAPEVVT 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 86.3 bits (214), Expect = 7e-19
 Identities = 48/155 (30%), Positives = 83/155 (53%), Gaps = 15/155 (9%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K + +G G++G+V++  + +     A+K V L D     +   S   +EI LL   +H
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKH 58

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY------HLRDSQVSAYTRQILLGLK 443
           +NIV+ Y     + KL +  E   +       ++Y       +    V ++  Q+L GL 
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           + H  +V+HRD+K  N+L++ NG +KLADFGLA+A
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 85.7 bits (212), Expect = 7e-19
 Identities = 51/167 (30%), Positives = 84/167 (50%), Gaps = 11/167 (6%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++ +  HE +VQ Y
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLY 65

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  +YI  E ++ G LLN  +      + SQ+    + +  G+ YL  +  +HRD
Sbjct: 66  GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRD 125

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           +   N LVD  G VK++DFGL++    ++  S  G+ F   W  PEV
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 86.4 bits (214), Expect = 7e-19
 Identities = 56/170 (32%), Positives = 93/170 (54%), Gaps = 12/170 (7%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENI 392
           D LG+G++GSVY+ +    G   A+KE+ L LD+        +Q+  E+ +L +     I
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-----FNQIIMELDILHKAVSPYI 61

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           V +YG    E  +Y+ +E +  GSL  LY        + +  +   T  ++ GLK+L ++
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
            +++HRD+K  N+LV+ NG VKL DFG++     +  K+  G   +MAPE
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPE 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 8e-19
 Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 20/174 (11%)

Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           + +G+G+FG VY+G+       AVK           ++ +    QE  +L +++H NIV+
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFL----QEAEILKQYDHPNIVK 56

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL-------LGLKYLHD 447
             G    +  +YI +ELV  GSLL       LR  +     +++L        G++YL  
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLT-----FLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPE 497
           ++ +HRD+   N LV  N  +K++DFG+++  +        G       W APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE 165

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 54/170 (31%), Positives = 91/170 (53%), Gaps = 12/170 (7%)

Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQ-GSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRG F  VY      D    A+K+V + +   ++A+Q   +   EI LL +  H N+++
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQLNHPNVIK 66

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           Y  +  ++++L I LEL   G L  +      Q+  + +  V  Y  Q+   ++++H + 
Sbjct: 67  YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPE 497
           V+HRDIK AN+ + A G VKL D GL +  ++K     S  GT ++M+PE
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 60/183 (32%), Positives = 94/183 (51%), Gaps = 17/183 (9%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R +T ++K + +G G++G VY    +  G   A+K+V + D   +    IS L +EI LL
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM-DN-ERDGIPISSL-REITLL 60

Query: 385 SRFEHENIVQYYGTDKDESKLYIFL-------ELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
               H NIV+       +    IFL       +L    SLL+        +SQV     Q
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDL---ASLLDNMPT-PFSESQVKCLMLQ 116

Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGTAFWMA 495
           +L GL+YLH+  ++HRD+K +N+L+   G +K+ADFGLA+   L    +     T ++ A
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRA 176

Query: 496 PEV 498
           PE+
Sbjct: 177 PEL 179

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 26/159 (16%)

Query: 338 GRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFEHENIV 393
           GRG++G VY+    +G     +A+K+        +    ISQ   +EIALL   +HEN+V
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENVV 65

Query: 394 QYYGT--DKDESKLYIFLELVTKGSLLNLYQ--RYH-------LRDSQVSAYTRQILLGL 442
                  +  +  +Y+  +        +L+Q  ++H       +  S V +   QIL G+
Sbjct: 66  SLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 443 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAK 477
            YLH   V+HRD+K ANILV       G VK+ D GLA+
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 56/167 (33%), Positives = 82/167 (49%), Gaps = 4/167 (2%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQ-SISQLEQEIALLSRFEHENIVQY 395
           LG GSFG V      +  F  V  +   ++    KQ  +  +  E  +L+   H   V  
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVA-IKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL 96

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
           YG+ KDES LY+ LE V  G      +R     + V   Y  QI+L  +YL   ++V+RD
Sbjct: 97  YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRD 156

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +K  N+L+D +G +K+ DFG AK         C GT  ++APE+  N
Sbjct: 157 LKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-GTPEYIAPEILLN 202

Length = 340

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 53/175 (30%), Positives = 97/175 (55%), Gaps = 16/175 (9%)

Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GS+G V       DG  + +K+++L +   + +++    EQE  LLS+ +H NIV Y
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA---EQEAQLLSQLKHPNIVAY 64

Query: 396 YGT-DKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQ 448
             + + ++  LYI +     G   +LY +        L ++QV  +  QI + L+YLH++
Sbjct: 65  RESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATK-LNDVKSCR-GTAFWMAPEVCSN 501
            ++HRD+K  N+ +     +K+ D G+A+  +   D+ S   GT ++M+PE+ SN
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 11/167 (6%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G        A+K   ++ +G+ ++       +E  ++ +  H N+VQ Y
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSED---DFIEEAKVMMKLSHPNLVQLY 65

Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN L +R   L    +      +   ++YL     +HRD
Sbjct: 66  GVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRD 125

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           +   N LV  +  VK++DFGLA+    +   S +GT F   W  PEV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEV 172

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 51/172 (29%), Positives = 93/172 (54%), Gaps = 15/172 (8%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V    +     FFA+K    +V L D   +     + +E+ +  L+ +EH 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVEC----TMVERRVLALA-WEHP 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
            +   + T + +  L+  +E +  G L+   Q     D ++   Y  +I+ GL++LH + 
Sbjct: 57  FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
           +++RD+K  N+L+D +G +K+ADFG+ K     + K+   C GT  ++APE+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEI 167

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 54/167 (32%), Positives = 86/167 (51%), Gaps = 13/167 (7%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+   ++     QE  ++ +  H+ +V  Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKT---LKPGTMMPEA---FLQEAQIMKKLRHDKLVPLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E + KGSLL+  +     +L+  Q+     QI  G+ Y+   + +HR
Sbjct: 68  AVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 54/168 (32%), Positives = 86/168 (51%), Gaps = 15/168 (8%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L  G+ + +S     +E  ++ +  H+ +VQ Y
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKT---LKPGTMSPES---FLEEAQIMKKLRHDKLVQLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
               +E  +YI  E ++KGSLL+  +    R  L+   +     Q+  G+ Y+   + +H
Sbjct: 68  AVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERMNYIH 125

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           RD++ ANILV      K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 55/159 (34%), Positives = 81/159 (50%), Gaps = 11/159 (6%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
           F ++ TY +K D LG GS+ +VY+G S   G   A+KE+ L  +      +I    +E +
Sbjct: 1   FGKLETY-KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI----REAS 55

Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQIL 439
           LL   +H NIV  +     +  L +  E +     L  Y       L    V  +  Q+L
Sbjct: 56  LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTD--LKQYMDDCGGGLSMHNVRLFLFQLL 113

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            GL Y H + V+HRD+K  N+L+   G +KLADFGLA+A
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA 152

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 54/188 (28%), Positives = 99/188 (52%), Gaps = 27/188 (14%)

Query: 330 YWQKGDLLGRGSFG---SVYEGISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLS 385
            ++    LG+G++G   S     + +    A+K+++ +  +   AK+++    +E+ LL 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLR 56

Query: 386 RF-EHENIVQYYGTD----KDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTR 436
            F  H+NI   Y  D     + ++LY++ EL+      +L+Q       L D+   ++  
Sbjct: 57  HFRGHKNITCLYDMDIVFPGNFNELYLYEELME----ADLHQIIRSGQPLTDAHFQSFIY 112

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GT 490
           QIL GLKY+H  +V+HRD+K  N+LV+A+  +K+ DFGLA+    N  ++         T
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 491 AFWMAPEV 498
            ++ APE+
Sbjct: 173 RWYRAPEI 180

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 83.4 bits (206), Expect = 5e-18
 Identities = 52/167 (31%), Positives = 81/167 (48%), Gaps = 13/167 (7%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     A+K    L QGS    S      E  L+ + +H  +V+ Y
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKS---LKQGSM---SPEAFLAEANLMKQLQHPRLVRLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++  ++ +HR
Sbjct: 68  AVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV      K+ADFGLA+  + N+  +  G  F   W APE
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 83.7 bits (207), Expect = 7e-18
 Identities = 54/166 (32%), Positives = 87/166 (52%), Gaps = 17/166 (10%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           KR +  +     +G G++G VY+    D G   A+K+V L     +    I+ + +EI +
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAI-REIKI 59

Query: 384 LSRFEHENIVQYYG--TD--------KDESKLYIFLELVTKGSLLNLYQR--YHLRDSQV 431
           L +  H NIV      TD        KD+   Y+  E +    L+ L +    H  +  +
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            ++ +Q+L GL Y H ++ +HRDIKC+NIL++  G +KLADFGLA+
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.1 bits (205), Expect = 8e-18
 Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 12/167 (7%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  ++    AVK    L  G+    S+    +E  L+   +H+ +V+ Y
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTM---SVQAFLEEANLMKTLQHDKLVRLY 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +      +   ++  ++ QI  G+ Y+  ++ +HR
Sbjct: 68  AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 127

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ AN+LV  +   K+ADFGLA+  + N+  +  G  F   W APE
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 59/172 (34%), Positives = 86/172 (50%), Gaps = 14/172 (8%)

Query: 336 LLGRGSFGSVY---EGISDDGFFFAV-KEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           L+GRG FG V    E  + D +   V K+  LL     A++++S  E+E  +LS      
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPW 62

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQD 449
           I Q     +D+  LY+ +E    G LL+L  RY     +     Y  +++L +  +H   
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEV 498
            VHRDIK  N+L+D  G +KLADFG A     N +   K   GT  ++APEV
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 53/175 (30%), Positives = 91/175 (52%), Gaps = 16/175 (9%)

Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
             +G G++G V        G   A+K++S  +  +  ++++    +EI +L RF+HENI+
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILRRFKHENII 66

Query: 394 QYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                 +  S      +YI  EL+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA 125

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM-APEV 498
           +V+HRD+K +N+L++ N  +K+ DFGLA+        +   T +    W  APE+
Sbjct: 126 NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 54/171 (31%), Positives = 93/171 (54%), Gaps = 13/171 (7%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G+++G G FG+V +G    G   AVK +   D  +QA        +E A++++  H+N+V
Sbjct: 11  GEIIGEGEFGAVLQG-EYTGQKVAVKNIKC-DVTAQA------FLEETAVMTKLHHKNLV 62

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           +  G       LYI +EL++KG+L+N  +   R  +   Q+  ++  +  G++YL  + +
Sbjct: 63  RLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           VHRD+   NILV  +G  K++DFGLA+   +  V + +    W APE   +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTAPEALKH 171

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 53/157 (33%), Positives = 83/157 (52%), Gaps = 22/157 (14%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG GS G V+  + SD     AVK++ L D      QS+    +EI ++ R +H+NIV+ 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKV 67

Query: 396 Y------GTDKDES--------KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 441
           Y      G+D  E          +YI  E + +  L N+ ++  L +     +  Q+L G
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLLRG 126

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
           LKY+H  +V+HRD+K AN+ ++    V K+ DFGLA+
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 11/169 (6%)

Query: 337 LGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG G+FGSV +G+     G    V  V  L Q   A     +  +E +++++ +H  IV+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVA-VKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVR 60

Query: 395 YYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
             G  K E  L + +EL   G LL  L +R  +  S +     Q+ +G+ YL  +  VHR
Sbjct: 61  LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPE 497
           D+   N+L+      K++DFG+++A        ++     +   W APE
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE 168

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 50/181 (27%), Positives = 93/181 (51%), Gaps = 12/181 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K  ++GRG+FG V+      D     +K++ +       + +    + E  +L    H
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLLSH 58

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLH 446
            NI++YY    ++  L I +E    G+L    Q      L +  +  +  QILL L ++H
Sbjct: 59  PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 447 DQDVVHRDIKCANILVDANGSV-KLADFGLAK--ATKLNDVKSCRGTAFWMAPEVC-SNP 502
            + ++HRD+K  NIL+D +  V K+ DFG++K  ++K +   +  GT  +++PE+C   P
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYTVVGTPCYISPELCEGKP 177

Query: 503 F 503
           +
Sbjct: 178 Y 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 55/172 (31%), Positives = 95/172 (55%), Gaps = 10/172 (5%)

Query: 336 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAK-QSISQLEQEIALLSRFEHE 390
           +LG G++G V+        D G  +A+K +       +AK    ++ E+ +    R +  
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-QSP 65

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
            +V  +   + E+KL++ L+ V+ G +  +LYQR +  + +V  Y+ +I+L L++LH   
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG 125

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK---ATKLNDVKSCRGTAFWMAPEV 498
           +V+RDIK  NIL+D+ G V L DFGL+K   + +     S  GT  +MAPE+
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 14/176 (7%)

Query: 332 QKGDLLGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
           +K  +LG G+FG+VY+G+     +     V    L ++ S   ++  ++  E  +++  +
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP--KANKEILDEAYVMASVD 67

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYL 445
           H ++V+  G         I  +L+  G LL+ Y R H   +    +  +  QI  G+ YL
Sbjct: 68  HPHVVRLLGICLSSQVQLI-TQLMPLGCLLD-YVRNHKDNIGSQYLLNWCVQIAKGMSYL 125

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTA--FWMAPE 497
            ++ +VHRD+   N+LV     VK+ DFGLAK       +  +  G     WMA E
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 50/145 (34%), Positives = 83/145 (57%), Gaps = 7/145 (4%)

Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           L+G GS+G V +    + G   A+K+  L  +  +  + I+   +EI +L +  HEN+V 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAM--REIRMLKQLRHENLVN 64

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
                + + +LY+  E V   ++L+  ++Y   L +S+V  Y  QIL G+++ H  +++H
Sbjct: 65  LIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123

Query: 453 RDIKCANILVDANGSVKLADFGLAK 477
           RDIK  NILV  +G VKL DFG A+
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 80.6 bits (199), Expect = 9e-17
 Identities = 56/171 (32%), Positives = 91/171 (53%), Gaps = 12/171 (7%)

Query: 336 LLGRGSFGSVY-----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V+      G  D G  +A+K   +L + +   +   + + E  +L+   H 
Sbjct: 3   VLGQGSFGKVFLVRKITG-PDAGQLYAMK---VLKKATLKVRDRVRTKMERDILAEVNHP 58

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
            IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ L L +LH   
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEV 498
           +++RD+K  NIL+D  G +KL DFGL+K +  ++ K  S  GT  +MAPEV
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 46/178 (25%), Positives = 92/178 (51%), Gaps = 24/178 (13%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +G G++G V   I +  G   A+K++    D  + AK+++    +E+ +L  F+H+NI+ 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----RELKILRHFKHDNIIA 68

Query: 395 ----YYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLH 446
                     D   +Y+ ++L+      +L+   H    L +  +  +  Q+L GLKY+H
Sbjct: 69  IRDILRPPGADFKDVYVVMDLMES----DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GTAFWMAPEV 498
             +V+HRD+K +N+LV+ +  +++ DFG+A+    +  +          T ++ APE+
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 21/175 (12%)

Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
            +GRG+FG+V + +    G   AVK +       + K+ +  L+    ++   +   IV+
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD---VVMRSSDCPYIVK 67

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------VSAYTRQILLGLKYL-HD 447
           +YG    E   +I +EL+   SL   Y+  +           +       +  L YL  +
Sbjct: 68  FYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLA-----KATKLNDVKSCRGTAFWMAPE 497
             ++HRD+K +NIL+D NG++KL DFG++        K  D   CR    +MAPE
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA-GCRP---YMAPE 177

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 11/167 (6%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G        A+K +   ++G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIE---EAKVMMKLSHPKLVQLY 65

Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  LYI  E +  G LLN L QR   L    + +  + +  G++YL     +HRD
Sbjct: 66  GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           +   N LV + G VK++DFG+ +    ++  S  G  F   W  PEV
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEV 172

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 23/173 (13%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G +G VYEG+        AVK +       +    + +  +E A++   +H N+VQ 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYLHD 447
            G    E   YI  E +T G+LL+     +LR+    +V+A        QI   ++YL  
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVNAVVLLYMATQISSAMEYLEK 122

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 54/170 (31%), Positives = 89/170 (52%), Gaps = 27/170 (15%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           F ++ TY  K D LG G++ +VY+G   ++D+    A+KE+ L  +      +I    +E
Sbjct: 2   FGKLETY-IKLDKLGEGTYATVYKGRSKLTDN--LVALKEIRLEHEEGAPCTAI----RE 54

Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTK---------GSLLNLYQRYHLRDSQV 431
           ++LL   +H NIV  +     E  L +  E + K         G+ +N++         V
Sbjct: 55  VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--------V 106

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
             +  Q+L GL Y H + V+HRD+K  N+L++  G +KLADFGLA+A  +
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 9/166 (5%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+G +G V+     D G   A+K +            +  +  E  +L+  + E +V+ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMK--KSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66

Query: 396 YGTDKDESKLYIFLELVTKG---SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
               +D+  LY+ +E V  G   +LLN      L +     Y  ++   +  LH+   +H
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELGYIH 124

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RD+K  N L+DA+G +KL DFGL+K   +    S  G+  +MAPEV
Sbjct: 125 RDLKPENFLIDASGHIKLTDFGLSKGI-VTYANSVVGSPDYMAPEV 169

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 39/169 (23%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSRFE-H 389
           +G G+F  V +  S   G ++A+K           K+    LEQ     EI  L R   H
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK---------CMKKHFKSLEQVNNLREIQALRRLSPH 57

Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGL 442
            NI++      D+   +L +  EL+     +NLY     ++  L + +V +Y  Q+L  L
Sbjct: 58  PNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            ++H   + HRDIK  NIL+  +  +KLADFG           SCRG  
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFG-----------SCRGIY 150

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 50/176 (28%), Positives = 97/176 (55%), Gaps = 23/176 (13%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V    +   G +FAVK    +V L+D   +     + +E+ +  L+ +E+ 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVEC----TMVEKRVLALA-WENP 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS------QVSAYTRQILLGLKY 444
            +   Y T + +  L+  +E +  G L+     +H++D       + + Y  +I+ GL++
Sbjct: 57  FLTHLYCTFQTKEHLFFVMEFLNGGDLM-----FHIQDKGRFDLYRATFYAAEIVCGLQF 111

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEV 498
           LH + +++RD+K  N+++D +G +K+ADFG+ K     D ++    GT  ++APE+
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 53/171 (30%), Positives = 95/171 (55%), Gaps = 8/171 (4%)

Query: 336 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +LG G++G V+    +S  D G  +A+K +       +AK +     +   L    +   
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           +V  +   + ++KL++ L+ +  G L  +L QR   ++ +V  Y+ +I+L L++LH   +
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEV 498
           ++RDIK  NIL+D+NG V L DFGL+K    ++V+   S  GT  +MAP++
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 78.3 bits (193), Expect = 7e-16
 Identities = 56/167 (33%), Positives = 84/167 (50%), Gaps = 7/167 (4%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V       DG F+AVK +       + +Q     E+ + LL   +H  +V  
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGL 61

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + + +   KLY  L+ V  G L    QR     + +   Y  +I   L YLH  ++++RD
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121

Query: 455 IKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEV 498
           +K  NIL+D+ G V L DFGL K   + +   S  C GT  ++APEV
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEV 167

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 77.7 bits (191), Expect = 8e-16
 Identities = 63/181 (34%), Positives = 95/181 (52%), Gaps = 29/181 (16%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
           +G G++G+VY+      G F A+K V +  Q ++    +S + +E+ALL R   F+H NI
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTV-REVALLKRLEAFDHPNI 64

Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+         TD+ E+K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 65  VRLMDVCATSRTDR-ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG-------TAFWMAPE 497
           LH   +VHRD+K  NILV + G VKLADFGLA+      + SC+        T ++ APE
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAPE 177

Query: 498 V 498
           V
Sbjct: 178 V 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 56/174 (32%), Positives = 92/174 (52%), Gaps = 16/174 (9%)

Query: 336 LLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEH 389
           +LG+G +G V++      +D G  FA+K   +L + +  + ++  +  + E  +L   +H
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMK---VLKKATIVRNQKDTAHTKAERNILEAVKH 59

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD 447
             IV      +   KLY+ LE ++ G L    +R    + D+    Y  +I L L++LH 
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT-ACFYLSEISLALEHLHQ 118

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
           Q +++RD+K  NIL+DA G VKL DFGL K +      +   C GT  +MAPE+
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEI 171

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 77.3 bits (190), Expect = 9e-16
 Identities = 54/165 (32%), Positives = 81/165 (49%), Gaps = 11/165 (6%)

Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG GS+ +VY+GIS  +G   A+K +S+  +      +I    +E +LL   +H NIV  
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI----REASLLKGLKHANIVLL 68

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVH 452
           +     +  L    E +     L  Y   H   L    V  +  Q+L GL Y+H Q ++H
Sbjct: 69  HDIIHTKETLTFVFEYMHTD--LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAP 496
           RD+K  N+L+   G +KLADFGLA+A  + +   S      W  P
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRP 171

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 77.0 bits (190), Expect = 9e-16
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 27/183 (14%)

Query: 337 LGRGSFGSVYEGI-----SDDGFF-FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG+GSFG VYEG+       +     A+K V+     + + +   +   E +++  F   
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN----ENASMRERIEFLNEASVMKEFNCH 69

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ----VSAYTRQILL------ 440
           ++V+  G         + +EL+ KG L + Y R    +++    +   T Q  +      
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKS-YLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGT--AFWM 494
             G+ YL  +  VHRD+   N +V  + +VK+ DFG+ +     D   K  +G     WM
Sbjct: 129 ADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 495 APE 497
           APE
Sbjct: 189 APE 191

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 54/171 (31%), Positives = 87/171 (50%), Gaps = 13/171 (7%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V    + + G  +AVK    +V L D   +   +    E+ I  L+R  H 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMT----EKRILSLAR-NHP 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
            + Q Y   +   +L+  +E V  G L+   Q+    D ++   Y  +I   L +LHD+ 
Sbjct: 57  FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEV 498
           +++RD+K  N+L+D  G  KLADFG+ K    N   +    GT  ++APE+
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI 167

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 11/169 (6%)

Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LLG+G+FG V++G   D    AVK     D   + K    +   E  +L +++H NIV+
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKE-DLPQELK---IKFLSEARILKQYDHPNIVK 56

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
             G       +YI +ELV  G  L+  ++    L+  Q+  +      G+ YL  ++ +H
Sbjct: 57  LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPE 497
           RD+   N LV  N  +K++DFG+++    + + S  G       W APE
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPE 164

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 57/172 (33%), Positives = 87/172 (50%), Gaps = 15/172 (8%)

Query: 336 LLGRGSFGSVYEGI---SDDGFFFAV--KEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V       +D+ +   V  K+V L D         +  E+ I  L+  +H 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDC----TMTEKRILALAA-KHP 56

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQD 449
            +   +   + + +L+  +E V  G L+   QR    D   S  Y  ++ L L +LH   
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
           V++RD+K  NIL+DA G  KLADFG+ K   LN V +   C GT  ++APE+
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEI 167

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 57/176 (32%), Positives = 91/176 (51%), Gaps = 18/176 (10%)

Query: 337 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHEN 391
           +G G++G V++   + + G F A+K V +  Q  +    +S + +E+A+L     FEH N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTI-REVAVLRHLETFEHPN 65

Query: 392 IVQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLK 443
           +V+ +       TD+ E+KL +  E V +   + L+      +    +     Q+L GL 
Sbjct: 66  VVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEV 498
           +LH   VVHRD+K  NILV ++G +KLADFGLA+        +      W  APEV
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 13/167 (7%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+    +     AVK +           S+     E  ++   +H+ +V+ +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK------PGSMSVEAFLAEANVMKTLQHDKLVKLH 67

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA---YTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +        +     ++ QI  G+ ++  ++ +HR
Sbjct: 68  AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV A+   K+ADFGLA+  + N+  +  G  F   W APE
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 16/172 (9%)

Query: 337 LGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           +G G FG V  G            A+K    L  GS  KQ +  L  E +++ +F+H NI
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKT---LKAGSSDKQRLDFL-TEASIMGQFDHPNI 67

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD 449
           ++  G       + I  E +  GSL + + R +       Q+    R I  G+KYL + +
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPE 497
            VHRD+   NILV++N   K++DFGL++  + ++     K  +    W APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 39/112 (34%), Positives = 60/112 (53%), Gaps = 26/112 (23%)

Query: 380 EIALLSRF-EHENIVQYYGT-----DKDESKLYIFLEL--------VTKGSLLNLYQRYH 425
           EI  L    +H NIV+         DKD   +Y+  E         +    L ++++RY 
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKD---IYLVFEYMETDLHAVIRANILEDVHKRYI 112

Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +       Y  Q+L  LKY+H  +V+HRD+K +NIL++++  VKLADFGLA+
Sbjct: 113 M-------Y--QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 58/170 (34%), Positives = 93/170 (54%), Gaps = 11/170 (6%)

Query: 336 LLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGS-QAKQSISQLEQE---IALLSRFEH 389
           ++GRG FG VY G   +D G  +A+K    LD+   + KQ  +    E   ++L+S  + 
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             IV          KL   L+L+  G L  +L Q     ++++  Y  +I+LGL+++H++
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
            VV+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 54/168 (32%), Positives = 86/168 (51%), Gaps = 7/168 (4%)

Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G+GSFG V       DG F+AVK +       + +Q+    E+ + LL   +H  +V 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            + + +   KLY  L+ V  G L    QR     + +   Y  ++   + YLH  ++++R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 454 DIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEV 498
           D+K  NIL+D+ G V L DFGL K   +  +  S  C GT  ++APEV
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEV 167

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 75.7 bits (186), Expect = 5e-15
 Identities = 54/169 (31%), Positives = 91/169 (53%), Gaps = 9/169 (5%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
           +G+G+FG VY+    D    +A+K +S   +   AK+ ++    E  +L R    E   I
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLS--KKEIVAKKEVAHTIGERNILVRTLLDESPFI 58

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           V    + + +S LY+  + ++ G L  +L +     + +   Y  +++L L++LH  D+V
Sbjct: 59  VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118

Query: 452 HRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
           +RD+K  NIL+DA G + L DFGL+KA  T      +  GT  ++APEV
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 16/172 (9%)

Query: 337 LGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQL--EQEIALL-SRFEH 389
           LGRG FG V    Y+   +    +A+K  +L      A+  +  L  E+ I    +   H
Sbjct: 7   LGRGHFGKVLLAEYKKTGE---LYAIK--ALKKGDIIARDEVESLMCEKRIFETANSERH 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
             +V  +   + E  +   +E    G L+         + +   Y   ++LGL+YLH+  
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK 121

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
           +V+RD+K  N+L+D  G VK+ADFGL K       ++   C GT  ++APEV
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEV 172

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 54/171 (31%), Positives = 85/171 (49%), Gaps = 11/171 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K + LG GS+ +VY+G S  +G   A+K + L ++      +I    +E +LL   +H
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI----REASLLKGLKH 62

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
            NIV  +     +  L +  E V     L  Y   H   L    V  +  Q+L GL Y+H
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTD--LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAP 496
            + ++HRD+K  N+L+   G +KLADFGLA+A  + +   S      W  P
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP 171

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 52/167 (31%), Positives = 89/167 (53%), Gaps = 8/167 (4%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           Q  ++LG G+ G+VY+          AVK + L       KQ +S+LE    +L + +  
Sbjct: 4   QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE----ILYKCDSP 59

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
            I+ +YG    E+++ I  E +  GSL ++Y++  + +  +      ++ GL YL    +
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSL-DVYRK--IPEHVLGRIAVAVVKGLTYLWSLKI 116

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +HRD+K +N+LV+  G VKL DFG++     +  K+  GT  +MAPE
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPE 163

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 51/159 (32%), Positives = 87/159 (54%), Gaps = 11/159 (6%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
           F ++ TY  K D LG G++ +V++G S       A+KE+ L  +      +I    +E++
Sbjct: 1   FGKLETY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVS 55

Query: 383 LLSRFEHENIVQYYG---TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
           LL   +H NIV  +    T++  + ++ +L+   K  L N      + +  V  +  Q+L
Sbjct: 56  LLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN--VKIFMFQLL 113

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            GL Y H + ++HRD+K  N+L++  G +KLADFGLA+A
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA 152

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 53/165 (32%), Positives = 90/165 (54%), Gaps = 23/165 (13%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
           F ++ TY  K + LG G++ +V++G S       A+KE+ L  +      +I    +E++
Sbjct: 2   FGKMETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVS 56

Query: 383 LLSRFEHENIVQYYG---TDKDESKLYIFLELVTK------GSLLNLYQRYHLRDSQVSA 433
           LL   +H NIV  +    TDK  + ++ +L+   K      G++++++         V  
Sbjct: 57  LLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN--------VKI 108

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           +  QIL GL Y H + V+HRD+K  N+L++  G +KLADFGLA+A
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA 153

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 56/183 (30%), Positives = 95/183 (51%), Gaps = 28/183 (15%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRG++G V     S+     A+K+++   D    AK+++    +EI LL   +HEN++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLRHLDHENVIA 68

Query: 395 YYGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLGLK 443
                    +     +YI  EL+      +L+Q   +R SQ  +      +  Q+L GLK
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELMDT----DLHQI--IRSSQTLSDDHCQYFLYQLLRGLK 122

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEV--- 498
           Y+H  +V+HRD+K +N+L++AN  +K+ DFGLA+ T      +     T ++ APE+   
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN 182

Query: 499 CSN 501
           CS 
Sbjct: 183 CSE 185

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 6/167 (3%)

Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 394
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 50  VIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 167

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 51/160 (31%), Positives = 86/160 (53%), Gaps = 23/160 (14%)

Query: 331 WQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           ++K + +G G++G VY+    ++++    A+K++ L +Q  +   S +   +EI+LL   
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNE--TIALKKIRL-EQEDEGVPSTAI--REISLLKEM 58

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--------VSAYTRQIL 439
           +H NIV+       E +LY+  E       L+L  + H+  S         +  Y  QIL
Sbjct: 59  QHGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112

Query: 440 LGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKA 478
            G+ Y H   V+HRD+K  N+L+D    ++KLADFGLA+A
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152

Length = 294

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 57/186 (30%), Positives = 80/186 (43%), Gaps = 31/186 (16%)

Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+           D    AVK  +L D    A++      +E  LL+  +HE
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKD---FHREAELLTNLQHE 67

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------LRDSQVSAYT 435
           +IV++YG   +   L +  E +  G L N + R H               L  SQ+    
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
           +QI  G+ YL  Q  VHRD+   N LV  N  VK+ DFG+++     D     G      
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 493 -WMAPE 497
            WM PE
Sbjct: 187 RWMPPE 192

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 36/105 (34%), Positives = 61/105 (58%), Gaps = 11/105 (10%)

Query: 380 EIALLSRFEHENIVQY----YGTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVS 432
           EI +L + +H NIV       G++ D  K+Y+ +E V    K  +  + Q +    S+V 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQ--SEVK 109

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
               Q+L G+ +LHD  ++HRD+K +N+L++  G +K+ DFGLA+
Sbjct: 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)

Query: 332 QKGDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSR 386
             G  LG G+FG V E    G+S      AV +V++      A  S  + L  E+ ++S 
Sbjct: 38  SFGKTLGAGAFGKVVEATAYGLSKSD---AVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 387 F-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILL 440
              HENIV   G       + +  E    G LLN  +R   R+S ++     +++ Q+  
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAK 152

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAP 496
           G+ +L  ++ +HRD+   N+L+     VK+ DFGLA+    +     +G A     WMAP
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212

Query: 497 E 497
           E
Sbjct: 213 E 213

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 47/174 (27%), Positives = 89/174 (51%), Gaps = 19/174 (10%)

Query: 336 LLGRGSFGSVY---EGISDDGFFFAV--KEVSLLDQGSQAKQSISQLEQEI-ALLSR--F 387
           +LG+GSFG V       +D+ +   +  K+V + D   +     + +E+ + AL  +  F
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVEC----TMVEKRVLALPGKPPF 62

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
               + Q +   +   +LY  +E V  G L+ ++ Q    ++     Y  +I +GL +LH
Sbjct: 63  ----LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEV 498
            + +++RD+K  N+++DA G +K+ADFG+ K        +    GT  ++APE+
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEI 172

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 51/174 (29%), Positives = 88/174 (50%), Gaps = 21/174 (12%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL--SRFEHENIV 393
           LG+G FG V    +   G  +A K++       +  + ++  E++I     SRF    IV
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF----IV 56

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL--------RDSQVSAYTRQILLGLKYL 445
                 + +  L + + L+  G L     +YH+         +++   Y  QI+ GL++L
Sbjct: 57  SLAYAFETKDDLCLVMTLMNGGDL-----KYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEV 498
           H + +V+RD+K  N+L+D +G+V+++D GLA   K    +K   GT  +MAPEV
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 50/167 (29%), Positives = 84/167 (50%), Gaps = 6/167 (3%)

Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 394
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 50  VIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H   ++HRD
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 167

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV
Sbjct: 168 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 12/161 (7%)

Query: 330 YWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ--------- 379
           Y QKG  LG G++G V +   +  G   A+K+V +++  +   +    +           
Sbjct: 10  YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQI 438
           E+ +++  +HENI+       +   + + ++++    L  +   +  L +SQV     QI
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L GL  LH    +HRD+  ANI +++ G  K+ADFGLA+  
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169

Length = 335

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 13/159 (8%)

Query: 323 RFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
            FK+I        LLG+G  G V+   +   G  FA+K +   +   + K      EQEI
Sbjct: 2   HFKKI-------KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI 54

Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQI 438
             L+  +H  +   Y + + E+ L + ++    G L  L QR     L +     Y  ++
Sbjct: 55  --LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV 112

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           LL L+YLH   +V+RD+K  NIL+  +G + L+DF L+K
Sbjct: 113 LLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK 151

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 59/189 (31%), Positives = 82/189 (43%), Gaps = 34/189 (17%)

Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+         + D    AVK  +L D    A++     ++E  LL+  +HE
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHE 67

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------------SQVS 432
           +IV++YG   D   L +  E +  G L N + R H  D                  SQ+ 
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
               QI  G+ YL  Q  VHRD+   N LV AN  VK+ DFG+++     D     G   
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 493 ----WMAPE 497
               WM PE
Sbjct: 187 LPIRWMPPE 195

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 51/169 (30%), Positives = 88/169 (52%), Gaps = 10/169 (5%)

Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           ++GRG+FG V       S     +A+K +S  +   ++  +    E++I  ++    E I
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQ--VYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWI 105

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           VQ +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH 165

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           RD+K  N+L+D +G +KLADFG       N +  C    GT  +++PEV
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV 214

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 56/174 (32%), Positives = 89/174 (51%), Gaps = 16/174 (9%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI---SQLEQEIALLSRFEHENI 392
           +G G++GSV     +  G   AVK++S      +  QSI    +  +E+ LL   +HEN+
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKHMKHENV 78

Query: 393 VQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
           +           L  F  + LVT      L N+ +   L D  V     QIL GLKY+H 
Sbjct: 79  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 138

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
            D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 191

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 4e-14
 Identities = 43/143 (30%), Positives = 77/143 (53%), Gaps = 4/143 (2%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G+G+FG V      D G  +A+K  +LL      K  ++ ++ E  +L+  +   +V 
Sbjct: 8   VIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHR 453
            Y + +D   LY+ +E +  G L+ +  +Y      V+  Y  + +L ++ +H    +HR
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125

Query: 454 DIKCANILVDANGSVKLADFGLA 476
           DIK  NIL+D  G +KL+DFGL+
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 56/176 (31%), Positives = 93/176 (52%), Gaps = 22/176 (12%)

Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--- 391
           +G G+FG V+  ++D  DG   A+K+   +    Q   S  ++ +E+ +L  F+H+N   
Sbjct: 8   IGYGAFGVVW-SVTDPRDGKRVALKK---MPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63

Query: 392 ---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD 447
              I+Q    D  E ++Y+  EL+ +  L  +      L    V  +  QIL GLKYLH 
Sbjct: 64  ALDILQPPHIDPFE-EIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA-----FWMAPEV 498
             ++HRDIK  N+LV++N  +K+ DFGLA+  + ++  S   T      ++ APE+
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVVTQYYRAPEI 175

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 23/175 (13%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G FG V+ G   +    A+K +       +   S     +E  ++ +  H  +VQ Y
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKYLHDQ 448
           G   + S + +  E +  G L +     +LR +Q   ++++ LL        G+ YL   
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSD-----YLR-AQRGKFSQETLLGMCLDVCEGMAYLESS 119

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           +V+HRD+   N LV  N  VK++DFG+ +    +   S  GT F   W +PEV S
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFS 174

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 52/169 (30%), Positives = 86/169 (50%), Gaps = 8/169 (4%)

Query: 337 LGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V +    D    +A+K  ++      ++  ++    E  +L++     IV  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALK--TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQDVVHRD 454
             + +   KLY+ L  +  G L +  QR    D S+   YT ++L  L+ LH  +V++RD
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVCS 500
           +K  NIL+D  G + L DFGL K    +D K+   C GT  ++APE+  
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLL 166

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 73.5 bits (180), Expect = 6e-14
 Identities = 60/190 (31%), Positives = 94/190 (49%), Gaps = 34/190 (17%)

Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS 362
           ED+      +   N SPN  +K        G+++G GSFG VYE I  D     A+K+V 
Sbjct: 48  EDEDEEKMIDNDINRSPNKSYKL-------GNIIGNGSFGVVYEAICIDTSEKVAIKKVL 100

Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHENIV---QYYGTD---KDESKLYIFLELVTK-- 414
              Q  Q K       +E+ ++    H NI+    YY T+   K+E    IFL +V +  
Sbjct: 101 ---QDPQYKN------RELLIMKNLNHINIIFLKDYYYTECFKKNEKN--IFLNVVMEFI 149

Query: 415 GSLLNLYQRYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-S 467
              ++ Y +++ R++       V  Y+ Q+   L Y+H + + HRD+K  N+L+D N  +
Sbjct: 150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT 209

Query: 468 VKLADFGLAK 477
           +KL DFG AK
Sbjct: 210 LKLCDFGSAK 219

Length = 440

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 57/169 (33%), Positives = 91/169 (53%), Gaps = 9/169 (5%)

Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGS-QAKQSISQLEQE---IALLSRFEHE 390
           ++GRG FG VY    +D G  +A+K    LD+   + KQ  +    E   ++L+S  +  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
            IV          KL   L+L+  G L  +L Q     + ++  Y  +I+LGL+++H++ 
Sbjct: 58  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF 117

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           VV+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 17/173 (9%)

Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQE------IALLSRFE 388
           ++G+GSFG V       DG  +AVK +       Q K  +++ EQ+        LL   +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVL-------QKKIVLNRKEQKHIMAERNVLLKNVK 54

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
           H  +V  + + +   KLY  L+ V  G L  +L +     + +   Y  +I   L YLH 
Sbjct: 55  HPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
            ++V+RD+K  NIL+D+ G V L DFGL K    + +   +  GT  ++APEV
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 34/120 (28%), Positives = 66/120 (55%), Gaps = 6/120 (5%)

Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
           AVK+++L    S +K+ +  L+QEI    + +H NI+ Y  +   +S+LY+   L+  GS
Sbjct: 29  AVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85

Query: 417 LLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
             +L + +    L +  ++   + +L  L Y+H +  +HR +K ++IL+  +G V L+  
Sbjct: 86  CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 11/170 (6%)

Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEHENI 392
           ++G+GSFG V       +  F+AVK   +L + +  + K+    + +   LL   +H  +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVK---VLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V  + + +   KLY  L+ +  G L    QR     + +   Y  +I   L YLH  ++V
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 118

Query: 452 HRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKS--CRGTAFWMAPEV 498
           +RD+K  NIL+D+ G + L DFGL K   + N   S  C GT  ++APEV
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEV 167

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 23/180 (12%)

Query: 337 LGRGSFGSVY---EGISDDGFFFAV-KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG+GSFG+VY   +  +       V KE+ +   G        Q  QE  LLS+ +H  I
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPV---GELNPNETVQANQEAQLLSKLDHPAI 64

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHD 447
           V+++ +  +     I  E      L    +        L ++QV  +  Q+LLG+ Y+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC------RGTAFWMAPEVCSN 501
           + ++HRD+K  NI +  N  +K+ DFG+++      + SC       GT ++M+PE   +
Sbjct: 125 RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL----MGSCDLATTFTGTPYYMSPEALKH 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 44/123 (35%), Positives = 63/123 (51%), Gaps = 7/123 (5%)

Query: 379 QEIALLSRFEHENIVQYYGTDKDESKL---YIFLELVTKGSLLNLYQRYHLRDSQVSAYT 435
           +E+ LL    HENI+    +D   S L   Y   EL+    L  L     L    +  + 
Sbjct: 58  RELKLLKHLRHENIISL--SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFL 114

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            QIL GLKY+H   VVHRD+K +NIL++ N  +K+ DFGLA+      +     T ++ A
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD-PQMTGYVSTRYYRA 173

Query: 496 PEV 498
           PE+
Sbjct: 174 PEI 176

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 57/180 (31%), Positives = 86/180 (47%), Gaps = 17/180 (9%)

Query: 333 KGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           K  ++G G FG V+ GI    G       +  L  G   KQ    L  E +++ +F H N
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFL-SEASIMGQFSHHN 67

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-----RQILLGLKYLH 446
           I++  G         I  E +  G+L + Y R H  D + S+Y      R I  G+KYL 
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA------FWMAPEVCS 500
           D + VHRD+   NILV++N   K++DFGL++  + +D +    T+       W APE  +
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIA 183

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 28/178 (15%)

Query: 336 LLGRGSFGSVY---EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFE 388
           LLG+G+FG V    E  +  G ++A+K    EV +      AK  ++    E  +L    
Sbjct: 2   LLGKGTFGKVILVREKAT--GKYYAMKILKKEVII------AKDEVAHTLTESRVLQNTR 53

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLGL 442
           H  +     + +   +L   +E    G L      +HL   +V +      Y  +I+  L
Sbjct: 54  HPFLTALKYSFQTHDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSAL 108

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
            YLH  DVV+RD+K  N+++D +G +K+ DFGL K   +    +K+  GT  ++APEV
Sbjct: 109 GYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 5/143 (3%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS+G V++  + + G   A+K+    +     K+ I+   +EI +L + +H N+V  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKK-IAL--REIRMLKQLKHPNLVNL 65

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
               + + KL++  E      L  L +    + +  +     Q L  + + H  + +HRD
Sbjct: 66  IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRD 125

Query: 455 IKCANILVDANGSVKLADFGLAK 477
           +K  NIL+   G +KL DFG A+
Sbjct: 126 VKPENILITKQGQIKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 58/191 (30%), Positives = 92/191 (48%), Gaps = 36/191 (18%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           +++G+GS+G V   I +  G   A+K++  + +  S A    +++ +EI LL    H +I
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA----TRILREIKLLRLLRHPDI 61

Query: 393 VQ----YYGTDKDESK-LYIFLELVTKGSLLNLYQRYHLRDS------QVSAYTRQILLG 441
           V+         + E K +Y+  EL+      +L+Q     D       Q   Y  Q+L  
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHHQFFLY--QLLRA 115

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM------- 494
           LKY+H  +V HRD+K  NIL +A+  +K+ DFGLA+    ND        FW        
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTP---TAIFWTDYVATRW 171

Query: 495 --APEVCSNPF 503
             APE+C + F
Sbjct: 172 YRAPELCGSFF 182

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 48/165 (29%), Positives = 88/165 (53%), Gaps = 9/165 (5%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 395
           LG G+ GSV +           K+V  +     AK S+  Q+ +E+ ++       IV +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIG----AKSSVRKQILRELQIMHECRSPYIVSF 68

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD-QDVVHR 453
           YG   +E+ + + +E +  GSL  +Y++   +    +      ++ GL YL++   ++HR
Sbjct: 69  YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR 128

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPE 497
           DIK +NILV++ G +KL DFG++    +N +  +  GT+ +M+PE
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS-GELINSIADTFVGTSTYMSPE 172

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 43/147 (29%), Positives = 76/147 (51%), Gaps = 4/147 (2%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V      D G  +A+K +   D     K+ ++ +  E  +L   +   +V+
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVK 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            + + +D+  LY+ +E +  G ++ L  +   L +     Y  + +L +  +H    +HR
Sbjct: 66  MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR 125

Query: 454 DIKCANILVDANGSVKLADFGLAKATK 480
           DIK  N+L+DA G VKL+DFGL    K
Sbjct: 126 DIKPDNLLLDAKGHVKLSDFGLCTGLK 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 70.3 bits (172), Expect = 9e-13
 Identities = 46/143 (32%), Positives = 77/143 (53%), Gaps = 4/143 (2%)

Query: 339 RGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG 397
           RG+FG VY G   ++   +AVK V   D  +  K  + Q++ E   L+  +   IV  Y 
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMIN--KNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 398 TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRDIK 456
           + +  + +Y+ +E +  G + +L   Y   D +++  Y  ++ L L YLH   ++HRD+K
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131

Query: 457 CANILVDANGSVKLADFGLAKAT 479
             N+L+   G +KL DFGL+K T
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 9/165 (5%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQ 394
           LG G+ G V + +    G   A K + L     + K +I +Q+ +E+ +L       IV 
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHL-----EIKPAIRNQIIRELKVLHECNSPYIVG 63

Query: 395 YYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVH 452
           +YG    + ++ I +E +  GSL   L +   + ++ +   +  +L GL YL ++  ++H
Sbjct: 64  FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           RD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 168

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 48/174 (27%), Positives = 91/174 (52%), Gaps = 19/174 (10%)

Query: 336 LLGRGSFGSVY----EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 387
           +LG+GSFG V     +G  +    +A+K    +V + D   +     + +E+ +  LS  
Sbjct: 7   VLGKGSFGKVMLAERKGTDE---LYAIKILKKDVVIQDDDVEC----TMVEKRVLALSG- 58

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +   + Q +   +   +LY  +E V  G L+  + Q    ++     Y  +I +GL +LH
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEV 498
            + +++RD+K  N+++D+ G +K+ADFG+ K    + V  K+  GT  ++APE+
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 52/169 (30%), Positives = 87/169 (51%), Gaps = 11/169 (6%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG+G FG V    + + G  +A K++       ++ + ++ LE+EI  L +     IV  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQDV 450
               + ++ L + + L+  G L   Y  Y+     L   +V  Y+ QI  G+ +LH  D+
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEV 498
           V+RD+K  N+L+D  G+ +L+D GLA   K     + R GT  +MAPE+
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEI 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 53/189 (28%), Positives = 84/189 (44%), Gaps = 52/189 (27%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-------------EIAL 383
           +G G++G V                S  D  +  K +I +L +             E+ L
Sbjct: 23  VGSGAYGQV---------------CSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67

Query: 384 LSRFEHENIVQYYGTDKDESKLYIF-----LE------LVTK--GSLLNLYQRYH-LRDS 429
           L   +HEN++           L +F     LE      LVT   G+ LN   +   L D 
Sbjct: 68  LKHMDHENVI---------GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD 118

Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
            +     QIL GLKY+H   ++HRD+K +NI V+ +  +K+ DFGLA+ T  +++     
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD-DEMTGYVA 177

Query: 490 TAFWMAPEV 498
           T ++ APE+
Sbjct: 178 TRWYRAPEI 186

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 15/170 (8%)

Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRG+FG V+ G +  D    AVK     L    +AK       QE  +L ++ H NIV+
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
             G    +  +YI +ELV  G  L   +     L+  ++         G++YL  +  +H
Sbjct: 58  LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG-----TAFWMAPE 497
           RD+   N LV     +K++DFG+++  + + V +  G        W APE
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPE 166

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 10/169 (5%)

Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 2   LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117

Query: 452 HRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
           +RDIK  N+++D +G +K+ DFGL K   +    +K+  GT  ++APEV
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 43/147 (29%), Positives = 79/147 (53%), Gaps = 4/147 (2%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V      D G  +A+K+  L       K+ ++ +  E  +L+  ++  +V+
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKK--LRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            Y + +DE+ LY+ +E +  G ++ L  +     + +   Y  + +L +  +H    +HR
Sbjct: 66  LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR 125

Query: 454 DIKCANILVDANGSVKLADFGLAKATK 480
           DIK  N+L+DA G +KL+DFGL    K
Sbjct: 126 DIKPDNLLLDAKGHIKLSDFGLCTGLK 152

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 30/192 (15%)

Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVS---- 432
           H+NI+   G    +  LY+ +E  +KG+L               Y    + D Q++    
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 433 -AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTT 197

Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 198 NGRLPVKWMAPE 209

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 21/177 (11%)

Query: 336 LLGRGSFGSVYEG--ISDDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G+G FG VY G  I  DG     AVK ++ +       + + Q  +E  ++  F H N
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD----LEEVEQFLKEGIIMKDFSHPN 57

Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYLH 446
           ++   G     + S L + L  +  G L N + R    +  V     +  Q+  G++YL 
Sbjct: 58  VLSLLGICLPSEGSPL-VVLPYMKHGDLRN-FIRSETHNPTVKDLIGFGLQVAKGMEYLA 115

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPE 497
            +  VHRD+   N ++D + +VK+ADFGLA+         +++    +    WMA E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 49/192 (25%), Positives = 79/192 (41%), Gaps = 33/192 (17%)

Query: 337 LGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           +G+G+FG V++    G+     F  V  V +L + + A    +  ++E AL++ F+H NI
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVA-VKMLKEEASA-DMQADFQREAALMAEFDHPNI 70

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR------------------YHLRDSQVS-- 432
           V+  G       + +  E +  G L    +                     L    +S  
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 433 ---AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
                 +Q+  G+ YL ++  VHRD+   N LV  N  VK+ADFGL++     D      
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190

Query: 490 TAF----WMAPE 497
                  WM PE
Sbjct: 191 NDAIPIRWMPPE 202

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 39/114 (34%), Positives = 65/114 (57%), Gaps = 5/114 (4%)

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEV 498
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S  C GT  ++APE+
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEI 167

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 42/147 (28%), Positives = 76/147 (51%), Gaps = 4/147 (2%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V      D G  +A+K +   D     K+ +  +  E  +L   +   +V+
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--LEKEQVGHIRAERDILVEADSLWVVK 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            + + +D+  LY+ +E +  G ++ L  +   L + +   Y  + +L +  +H    +HR
Sbjct: 66  MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125

Query: 454 DIKCANILVDANGSVKLADFGLAKATK 480
           DIK  N+L+D+ G VKL+DFGL    K
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGLCTGLK 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 39/141 (27%), Positives = 75/141 (53%), Gaps = 4/141 (2%)

Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G+FG V      D    +A+K  +L  +    +  ++ ++ E  +L+  ++E +V+ 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMK--TLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           Y + +D+  LY  ++ +  G +++L  R  +  +     Y  ++   ++ +H    +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126

Query: 455 IKCANILVDANGSVKLADFGL 475
           IK  NIL+D +G +KL DFGL
Sbjct: 127 IKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 56/198 (28%), Positives = 82/198 (41%), Gaps = 37/198 (18%)

Query: 327 IITYWQKGDLLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           I+  W+    LG G+FG V+           D    AVK  +L +    A+Q     ++E
Sbjct: 7   IVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQRE 57

Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------ 428
             LL+  +H++IV++YG   +   L +  E +  G L N + R H  D            
Sbjct: 58  AELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAP 116

Query: 429 -----SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
                 Q+ A   QI  G+ YL     VHRD+   N LV     VK+ DFG+++     D
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176

Query: 484 VKSCRGTAF----WMAPE 497
                G       WM PE
Sbjct: 177 YYRVGGRTMLPIRWMPPE 194

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 67.0 bits (163), Expect = 6e-12
 Identities = 40/141 (28%), Positives = 77/141 (54%), Gaps = 4/141 (2%)

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G+FG V      D    +A+K  +L  +    +  ++ ++ E  +L+  ++E +V+ 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMK--TLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
           Y + +D+  LY  ++ +  G +++L  R  +    ++  Y  ++ L ++ +H    +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 455 IKCANILVDANGSVKLADFGL 475
           IK  NIL+D +G +KL DFGL
Sbjct: 127 IKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 35/193 (18%)

Query: 337 LGRGSFGSVY----EGISD----DGFFFAVKEVSLL--------DQGSQAKQSISQLEQE 380
           LG G FG V+    +G+ D            +  +L        D    A++      +E
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED---FLKE 69

Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR---- 436
           + +LSR    NI +  G    +  L + +E +  G L    Q++    S ++  ++    
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 437 --------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
                   QI  G++YL   + VHRD+   N LV  N ++K+ADFG+++    +D    +
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189

Query: 489 GTAF----WMAPE 497
           G A     WMA E
Sbjct: 190 GRAPLPIRWMAWE 202

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 20/175 (11%)

Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG+G FG V    +   G  +A K+++      +     + +E+ I  L++     IV  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRI--LAKVHSRFIVSL 58

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH----------LRDSQVSAYTRQILLGLKYL 445
               + ++ L + + ++  G L     RYH            + +   YT QI+ GL++L
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDL-----RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEV 498
           H + +++RD+K  N+L+D +G+V+++D GLA       +  K   GT  +MAPE+
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL 168

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 66.4 bits (162), Expect = 7e-12
 Identities = 37/101 (36%), Positives = 61/101 (60%), Gaps = 5/101 (4%)

Query: 402 ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460
           ES+L+  +E V+ G L+   QR   L +     Y+ +I L L +LH++ +++RD+K  N+
Sbjct: 68  ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV 127

Query: 461 LVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEV 498
           L+DA G +KL D+G+ K   +  D  S  C GT  ++APE+
Sbjct: 128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEI 167

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 46/171 (26%), Positives = 90/171 (52%), Gaps = 13/171 (7%)

Query: 336 LLGRGSFGSVY-EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V           +A+K    +V + D   +     + +E+ + L  + +  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC----TMVEKRV-LALQDKPP 61

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 449
            + Q +   +   +LY  +E V  G L+   Q+    ++ Q   Y  +I +GL +LH + 
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEV 498
           +++RD+K  N+++D+ G +K+ADFG+ K   ++ V  ++  GT  ++APE+
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 26/176 (14%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LGRG++G V +      G   AVK +       + K+ +  L+  I++ S  +    V +
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD--ISMRSV-DCPYTVTF 65

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-----SAYTRQILLGLKYLHDQ-D 449
           YG    E  ++I +E V   SL   Y++ + +   +           I+  L+YLH +  
Sbjct: 66  YGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 450 VVHRDIKCANILVDANGSVKLADFG--------LAKATKLNDVKSCRGTAFWMAPE 497
           V+HRD+K +N+L++ NG VKL DFG        +AK           G   +MAPE
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA-------GCKPYMAPE 173

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.9 bits (160), Expect = 1e-11
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 10/169 (5%)

Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  S  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 2   LLGKGTFGKVILVREKAS--GKYYAMK--ILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                + + + +L   +E V  G L  +L +     + +   Y  +I+  L YLH   +V
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117

Query: 452 HRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
           +RD+K  N+++D +G +K+ DFGL K   T    +K+  GT  ++APEV
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV 166

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 22/183 (12%)

Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
           D++G G+FG V +  I  DG         + +  S+          E+ +L +   H NI
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNI 70

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYT 435
           +   G  +    LY+ +E    G+LL+  ++                   L   Q+  + 
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWM 494
             +  G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K+  R    WM
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 190

Query: 495 APE 497
           A E
Sbjct: 191 AIE 193

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 38/128 (29%), Positives = 67/128 (52%), Gaps = 21/128 (16%)

Query: 379 QEIALLSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQ 430
           +E+ L+    H+NI+          + ++   +Y+ +EL+      NL Q     L   +
Sbjct: 64  RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMDLDHER 119

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +S    Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GT 170

Query: 491 AFWMAPEV 498
           +F M P V
Sbjct: 171 SFMMTPYV 178

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 54/175 (30%), Positives = 78/175 (44%), Gaps = 19/175 (10%)

Query: 336 LLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G            A+K    L  G   KQ    L  E +++ +F+H N
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKT---LKAGYTEKQRRDFL-SEASIMGQFDHPN 66

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 449
           I+   G       + I  E +  GSL    +++       Q+    R I  G+KYL D  
Sbjct: 67  IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPE 497
            VHRD+   NILV++N   K++DFGL++   L D      + RG      W APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAPE 179

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 51/192 (26%), Positives = 83/192 (43%), Gaps = 32/192 (16%)

Query: 334 GDLLGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+ +      V  V +L +    ++ +S L  E+ ++    +
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVA-VKML-KDDATEKDLSDLVSEMEMMKMIGK 74

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-------------------LNLYQRYHLRDS 429
           H+NI+   G    E  LY+ +E    G+L                       +    +D 
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSC 487
              AY  Q+  G+++L  +  +HRD+   N+LV  +  +K+ADFGLA+     D   K+ 
Sbjct: 135 VSFAY--QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 488 RG--TAFWMAPE 497
            G     WMAPE
Sbjct: 193 NGRLPVKWMAPE 204

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 46/171 (26%), Positives = 88/171 (51%), Gaps = 12/171 (7%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V    +      +A+K ++  +   +A+ +  + E+ +  L   + + I  
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV--LVNGDCQWITT 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
            +   +DE+ LY+ ++    G LL L  ++   L +     Y  +++L +  +H    VH
Sbjct: 66  LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEV 498
           RDIK  N+L+D NG ++LADFG     K+N   + +     GT  +++PE+
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEI 174

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 39/128 (30%), Positives = 68/128 (53%), Gaps = 9/128 (7%)

Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL-----LNLYQRYHLRDSQVSAY 434
           E+  L+  +H  IV+++   K + KL + +E  + G L       L +    ++ +V   
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLNDVKSCRGT 490
             QI+L L  +H + ++HRD+K ANI +   G +KL DFG +K    +  L+   S  GT
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234

Query: 491 AFWMAPEV 498
            +++APE+
Sbjct: 235 PYYLAPEL 242

Length = 478

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 38/141 (26%), Positives = 75/141 (53%), Gaps = 4/141 (2%)

Query: 337 LGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G+FG V      D    +A+K +   D     +   + ++ E  +L+  ++E +V+ 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKAD--VLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
           Y + +D+  LY  ++ +  G +++L  R  + +  ++  Y  ++   ++ +H    +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126

Query: 455 IKCANILVDANGSVKLADFGL 475
           IK  NIL+D +G +KL DFGL
Sbjct: 127 IKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 46/173 (26%), Positives = 85/173 (49%), Gaps = 11/173 (6%)

Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G FG V    +   G  +A K++       +  ++++  E++I  L +     +V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVVS 64

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-----RDSQVSAYTRQILLGLKYLHDQD 449
                + +  L + L L+  G L   +  Y++      + +   Y  +I  GL+ LH + 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLK--FHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVCSN 501
           +V+RD+K  NIL+D  G ++++D GLA      + ++   GT  +MAPEV  N
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN 175

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 52/179 (29%), Positives = 80/179 (44%), Gaps = 23/179 (12%)

Query: 335 DLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +++G G FG V  G          F A+K    L  G   KQ    L  E +++ +F+H 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKT---LKSGYTEKQRRDFL-SEASIMGQFDHP 65

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILLGLKYL 445
           NI+   G       + I  E +  G+L +  +     D Q +        R I  G+KYL
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYL 122

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPE 497
            + + VHRD+   NILV++N   K++DFGL++  + +       S  G      W APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 46/171 (26%), Positives = 89/171 (52%), Gaps = 12/171 (7%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V    + + G  +A+K ++  +   +A+ +  + E+++  L   +   I  
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV--LVNGDRRWITN 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            +   +DE+ LY+ ++    G LL L  ++   L +     Y  +++L +  +H    VH
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH 125

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEV 498
           RDIK  N+L+D NG ++LADFG     +L    + +     GT  +++PE+
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEI 174

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 35/103 (33%), Positives = 60/103 (58%), Gaps = 5/103 (4%)

Query: 400 KDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 458
           +  S+L++ +E V  G L+   QR   L +     Y  +I + L +LH++ +++RD+K  
Sbjct: 66  QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD 125

Query: 459 NILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEV 498
           N+L+DA+G +KL D+G+ K      D  S  C GT  ++APE+
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEI 167

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 48/171 (28%), Positives = 88/171 (51%), Gaps = 7/171 (4%)

Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G FG V    +   G  +A K +       +  +S++  E++I  L +   + +V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVNSQFVVN 64

Query: 395 YYGTDKDESKLYIFLELVTKGSL-LNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVV 451
                + +  L + L ++  G L  ++Y   +    + +   Y  +IL GL+ LH ++ V
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124

Query: 452 HRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVCSN 501
           +RD+K  NIL+D  G ++++D GLA K  +   ++   GT  +MAPEV +N
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN 175

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.6 bits (154), Expect = 3e-11
 Identities = 50/184 (27%), Positives = 80/184 (43%), Gaps = 24/184 (13%)

Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           D++G G+FG V +  I  DG         + +  S+        E E+ L     H NI+
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNII 59

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAYTRQILL- 440
              G  +    LY+ +E    G+LL+             +   +   S +S  ++Q+L  
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS--SQQLLHF 117

Query: 441 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 493
                 G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K+  R    W
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177

Query: 494 MAPE 497
           MA E
Sbjct: 178 MAIE 181

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 20/182 (10%)

Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           D++G G+FG V    I  DG         L +  S+        E E+ L     H NI+
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV-LCKLGHHPNII 66

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ---------VSAYTRQILL---- 440
              G  ++   LYI +E    G+LL+  ++  + ++           S  T Q LL    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 441 ----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMA 495
               G++YL ++  +HRD+   N+LV  N + K+ADFGL++  ++   K+  R    WMA
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMA 186

Query: 496 PE 497
            E
Sbjct: 187 IE 188

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 52/187 (27%), Positives = 92/187 (49%), Gaps = 22/187 (11%)

Query: 330 YWQKGDLLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
           YW    +LG G+ G+V       DG  FAVK   ++D    ++   ++ + E+  L   +
Sbjct: 34  YWIS-RVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCD 89

Query: 389 HENIVQ-----YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR------- 436
             +IV+          ++   + +   ++   +  +L Q    R      +         
Sbjct: 90  FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149

Query: 437 -QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK---ATKLNDV-KSCRGTA 491
            Q+LL + ++H + ++HRDIK ANIL+ +NG VKL DFG +K   AT  +DV ++  GT 
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 492 FWMAPEV 498
           +++APE+
Sbjct: 210 YYVAPEI 216

Length = 496

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 40/206 (19%)

Query: 325 KRIITYWQKGDLLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQA---------- 370
           ++ +T+ +K   LG G FG V+    EG+      F  K+ SL   G+Q           
Sbjct: 4   RKRLTFKEK---LGEGQFGEVHLCEAEGMEK----FMDKDFSLDVSGNQPVLVAVKMLRE 56

Query: 371 ---KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR 427
              K + +   +EI ++SR +  NI++          L +  E +  G L     R+  +
Sbjct: 57  DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQ 116

Query: 428 DSQVSAYTR------------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
           ++   A               QI  G+KYL   + VHRD+   N LV  N ++K+ADFG+
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Query: 476 AKATKLNDVKSCRGTAF----WMAPE 497
           ++     D    +G A     WM+ E
Sbjct: 177 SRNLYSGDYYRIQGRAVLPIRWMSWE 202

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 11/173 (6%)

Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G FG V    +   G  +A K++       +  +S++  E++I  L +     +V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVNSRFVVS 64

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS-----QVSAYTRQILLGLKYLHDQD 449
                + +  L + L L+  G L   +  YH+ ++     +   Y  +I  GL+ LH + 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 450 VVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVCSN 501
           +V+RD+K  NIL+D +G ++++D GLA    +   +K   GT  +MAPEV  N
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 175

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 21/169 (12%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 14  IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 65

Query: 397 GTD-KDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           G   +++  LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVH 125

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPE 497
           RD+   N+LV  +   K++DFGL K     +  S + T      W APE
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPE 169

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 48/169 (28%), Positives = 91/169 (53%), Gaps = 8/169 (4%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V    + +    FA+K ++  +   +A+ +  + E+++  L   +++ I  
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDNQWITT 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQDVVH 452
            +   +DE+ LY+ ++    G LL L  ++  R  +     Y  ++++ +  +H    VH
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125

Query: 453 RDIKCANILVDANGSVKLADFG-LAKATKLNDVKS--CRGTAFWMAPEV 498
           RDIK  NIL+D NG ++LADFG   K  +   V+S    GT  +++PE+
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 53/208 (25%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVK--------EVSLLDQGSQAKQSISQLEQEIAL 383
             G  LG G FG V +        F +K         V +L + + + + +  L  E  L
Sbjct: 3   VLGKTLGEGEFGKVVKA-----TAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNL 56

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------------- 430
           L +  H ++++ YG    +  L + +E    GSL     R  LR+S+             
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL-----RSFLRESRKVGPSYLGSDGNR 111

Query: 431 -----------------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
                            + ++  QI  G++YL +  +VHRD+   N+LV     +K++DF
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDF 171

Query: 474 GLAKATKLND--VKSCRG--TAFWMAPE 497
           GL++     D  VK  +G     WMA E
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIE 199

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 46/171 (26%), Positives = 82/171 (47%), Gaps = 8/171 (4%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G+           V +L   +       +L +E  ++ + ++  IV+  
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES   + +EL   G L    Q+  H+ +  ++    Q+ +G+KYL + + VHRD+
Sbjct: 63  GICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121

Query: 456 KCANILVDANGSVKLADFGLAKATKLND-VKSCRGTA----FWMAPEVCSN 501
              N+L+      K++DFGL+KA   ++     +        W APE C N
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE-CMN 171

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 53/183 (28%), Positives = 95/183 (51%), Gaps = 19/183 (10%)

Query: 327 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQG-SQAKQSISQLEQEIALL 384
           ++  +Q+   +G G+ G V        G   AVK++S   Q  + AK++     +E+ LL
Sbjct: 19  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY----RELVLL 74

Query: 385 SRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTR 436
               H+NI+          + ++   +Y+ +EL+      NL Q  H  L   ++S    
Sbjct: 75  KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIHMELDHERMSYLLY 130

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMA 495
           Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+    N + +    T ++ A
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRA 190

Query: 496 PEV 498
           PEV
Sbjct: 191 PEV 193

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 44/181 (24%), Positives = 70/181 (38%), Gaps = 23/181 (12%)

Query: 336 LLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
            LGRG FG V+                 VK +         +   S+  +E+ +  +  H
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD----ENLQSEFRRELDMFRKLSH 67

Query: 390 ENIVQYYGTDKDESKLYIFLE----------LVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
           +N+V+  G  ++    Y+ LE          L    S     +   L   Q  A   QI 
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAP 496
           LG+ +L +   VHRD+   N LV +   VK++   L+K    ++    R       W+AP
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 497 E 497
           E
Sbjct: 188 E 188

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 41/145 (28%), Positives = 76/145 (52%), Gaps = 7/145 (4%)

Query: 336 LLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G++G V +    +     A+K+    ++  + K++  +   E+ +L   + ENIV+
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR---ELKMLRTLKQENIVE 64

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                +   KLY+  E V K ++L L +     +   +V +Y  Q++  + + H  D+VH
Sbjct: 65  LKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123

Query: 453 RDIKCANILVDANGSVKLADFGLAK 477
           RDIK  N+L+  N  +KL DFG A+
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 8/170 (4%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G++GSV      D        V  L +  Q+     +  +E+ LL   +HEN++   
Sbjct: 23  VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 397 GTDKDESKLYIFLE--LVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                 + +  F E  LVT      L N+ +   L D  V     Q+L GLKY+H   ++
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGII 140

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           HRD+K +N+ V+ +  +++ DFGLA+    +++     T ++ APE+  N
Sbjct: 141 HRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTGYVATRWYRAPEIMLN 189

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 21/130 (16%)

Query: 379 QEIALLSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQ 430
           +E+ L+    H+NI+        +  L      YI +EL+      NL Q  +  L   +
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQMELDHER 127

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +S    Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GT 178

Query: 491 AFWMAPEVCS 500
           +F M P V +
Sbjct: 179 SFMMTPYVVT 188

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 49/185 (26%), Positives = 93/185 (50%), Gaps = 29/185 (15%)

Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 69

Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+          + ++   +Y+ +EL+      NL Q  +  L   ++S   
Sbjct: 70  MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 125

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMT 176

Query: 496 PEVCS 500
           P V +
Sbjct: 177 PYVVT 181

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 18/160 (11%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G +LG+G FGSV E    S+DG F  V  V +L     +   I +  +E A +  F+H N
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVA-VKMLKADIFSSSDIEEFLREAACMKEFDHPN 62

Query: 392 IVQYYGTD---KDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL----- 440
           +++  G     + + +L I    L  +  G L        + +   +    Q L+     
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL-PLQTLVRFMID 121

Query: 441 ---GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
              G++YL  ++ +HRD+   N +++ N +V +ADFGL+K
Sbjct: 122 IASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 51/192 (26%), Positives = 84/192 (43%), Gaps = 30/192 (15%)

Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      G+  +      K    + +    ++ +S L  E+ ++    +
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVS---- 432
           H+NI+   G    +  LY+ +E  +KG+L               Y    + + Q+S    
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 433 ---AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VK 485
              AY  Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      
Sbjct: 143 VSCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 486 SCRGTAFWMAPE 497
           + R    WMAPE
Sbjct: 201 NGRLPVKWMAPE 212

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 52/175 (29%), Positives = 86/175 (49%), Gaps = 12/175 (6%)

Query: 332 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +K  LLG G FG+V++GI   +G    +       Q    +Q+  ++   +  +   +H 
Sbjct: 10  RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS----QVSAYTRQILLGLKYLH 446
            IV+  G     S L +  +L   GSLL+ + R H RDS    ++  +  QI  G+ YL 
Sbjct: 70  YIVRLLGICPGAS-LQLVTQLSPLGSLLD-HVRQH-RDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----SCRGTAFWMAPE 497
           +  +VHR++   NIL+ ++  V++ADFG+A     +D K      +    WMA E
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 60/201 (29%), Positives = 86/201 (42%), Gaps = 48/201 (23%)

Query: 334 GDLLGRGSFGSVYE----GIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           G  LG G FG V      GI     D     AVK   L D  +   + ++ L  E+ L+ 
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK--MLKDNATD--KDLADLISEMELMK 72

Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR----------------- 427
              +H+NI+   G    E  LY+ +E   KG+L     R  LR                 
Sbjct: 73  LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL-----REFLRARRPPGPDYTFDITKVP 127

Query: 428 DSQVS-------AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
           + Q+S       AY  Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+   
Sbjct: 128 EEQLSFKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 481 LND----VKSCRGTAFWMAPE 497
             D      + R    WMAPE
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPE 206

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 50/199 (25%)

Query: 331 WQKGDLLGRGSFGSVY----------------------EGISDDGFFFAVKEVSLLDQGS 368
           ++K + +G G++G VY                      EGI       A++E+SLL    
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPT----ALREISLL---- 54

Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYH- 425
              Q +S+    + LL        V++      +  LY+  E +       ++   R   
Sbjct: 55  ---QMLSESIYIVRLLD-------VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG 104

Query: 426 --LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKLN 482
             L    + ++  Q+L G+ + H   V+HRD+K  N+LVD   G +K+AD GL +A  + 
Sbjct: 105 RPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI- 163

Query: 483 DVKSCRG---TAFWMAPEV 498
            VKS      T ++ APEV
Sbjct: 164 PVKSYTHEIVTLWYRAPEV 182

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 55/176 (31%), Positives = 87/176 (49%), Gaps = 27/176 (15%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
            +G G+ G VY+      G   AVK++       + K+ +  L+  + L S  +   IV+
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD--VVLKS-HDCPYIVK 78

Query: 395 YYGTDKDESKLYIFLELVTK--GSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYL 445
            YG    +S ++I +EL++     LL   Q          +  + V A        L YL
Sbjct: 79  CYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA--------LHYL 130

Query: 446 HD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPE 497
            +   V+HRD+K +NIL+DA+G+VKL DFG++   +L D K+     G A +MAPE
Sbjct: 131 KEKHGVIHRDVKPSNILLDASGNVKLCDFGISG--RLVDSKAKTRSAGCAAYMAPE 184

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 60.3 bits (146), Expect = 6e-10
 Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 9/171 (5%)

Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
            +G G++GSV   I    G   A+K++S   +  Q++    +  +E+ LL   +HEN++ 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLS---RPFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 395 YYGTDKDESKLYIFLE--LVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                        F +  LV      +L +   + L + +V     Q+L GLKY+H   +
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +HRD+K  N+ V+ +  +K+ DFGLA+     ++     T ++ APEV  N
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVVTRWYRAPEVILN 188

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 49/193 (25%), Positives = 79/193 (40%), Gaps = 36/193 (18%)

Query: 337 LGRGSFGSVY----EGI-----------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           LG G FG V+    EG+                  AVK +    +    K + +   +EI
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML----RADVTKTARNDFLKEI 68

Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-------- 433
            ++SR ++ NI++  G    +  L +  E +  G L     +  +  +   A        
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 434 -----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
                   QI  G+KYL   + VHRD+   N LV  + ++K+ADFG+++     D    +
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 489 GTAF----WMAPE 497
           G A     WMA E
Sbjct: 189 GRAVLPIRWMAWE 201

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 37/188 (19%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEGI+       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 14  LGQGSFGMVYEGIAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 68

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSA 433
            ++V+  G         + +EL+T+G L     + +LR                  ++  
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
              +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G    
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 493 ---WMAPE 497
              WM+PE
Sbjct: 184 PVRWMSPE 191

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 57/190 (30%), Positives = 89/190 (46%), Gaps = 32/190 (16%)

Query: 333 KGDLLGRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +G  +GRG++G VY+    DG     +A+K++    +G+    S  +   EIALL   +H
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACR---EIALLRELKH 57

Query: 390 ENIV--QYYGTDKDESKLYIFLELVT----------KGSLLNLYQRYHLRDSQVSAYTRQ 437
            N++  Q       + K+++  +             + S  N  +   L  S V +   Q
Sbjct: 58  PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQ 116

Query: 438 ILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAK-----ATKLNDVKSCR 488
           IL G+ YLH   V+HRD+K ANILV       G VK+AD G A+        L D+    
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 489 GTAFWMAPEV 498
            T ++ APE+
Sbjct: 177 VTFWYRAPEL 186

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 52/192 (27%), Positives = 81/192 (42%), Gaps = 30/192 (15%)

Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      GI  D     V     + +     + +S L  E+ ++    +
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-------------------QRYHLRDS 429
           H+NI+   G    +  LY+ +E  +KG+L                       ++   +D 
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VK 485
              AY  Q+  G++YL  Q  +HRD+   N+LV  +  +K+ADFGLA+     D      
Sbjct: 137 VSCAY--QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 486 SCRGTAFWMAPE 497
           + R    WMAPE
Sbjct: 195 NGRLPVKWMAPE 206

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 23/183 (12%)

Query: 336 LLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           L+  G++G+VY     +    FA+K+++   Q    +  I Q+  E  +L+  E+  +V 
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKIN--KQNLILRNQIQQVFVERDILTFAENPFVVS 65

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            + + + +  L + +E V  G    L +    L       Y  + +L L+YLH+  +VHR
Sbjct: 66  MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHR 125

Query: 454 DIKCANILVDANGSVKLADFGLAKATKLN------------------DVKSCRGTAFWMA 495
           D+K  N+L+ + G +KL DFGL+K   ++                  D + C GT  ++A
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIA 184

Query: 496 PEV 498
           PEV
Sbjct: 185 PEV 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 49/169 (28%), Positives = 85/169 (50%), Gaps = 9/169 (5%)

Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEV 498
           RD+K  N+++D +G +K+ DFGL K   + D   +K+  GT  ++APEV
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEV 167

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 38/125 (30%), Positives = 69/125 (55%), Gaps = 2/125 (1%)

Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 433
           +Q+ +E+ +L       IV +YG    + ++ I +E +  GSL   L +   + +  +  
Sbjct: 48  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 107

Query: 434 YTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
            +  +L GL YL ++  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 167

Query: 493 WMAPE 497
           +M+PE
Sbjct: 168 YMSPE 172

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 45/172 (26%), Positives = 85/172 (49%), Gaps = 17/172 (9%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEV----SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG V +G+    +    K++     +L   ++ K    ++ +E  ++ + ++  I
Sbjct: 3   LGSGNFGCVKKGV----YKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYI 57

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           V+  G  + E+ L + +E+ + G L      ++  +  S V     Q+ +G+KYL  ++ 
Sbjct: 58  VRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA-----FWMAPE 497
           VHRD+   N+L+      K++DFGL+KA   +D      +A      W APE
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 50/190 (26%), Positives = 75/190 (39%), Gaps = 35/190 (18%)

Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VY+G     ++     +V   +L +      Q   +  QE  L+S  +H NI
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ--EFRQEAELMSDLQHPNI 70

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR---------------- 436
           V   G    E    +  E +  G L      + +R+S  S                    
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDL----HEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 437 -----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
                QI  G++YL     VHRD+   N LV    +VK++DFGL++     D    +  +
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 492 F----WMAPE 497
                WM PE
Sbjct: 187 LLPVRWMPPE 196

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 39/153 (25%), Positives = 85/153 (55%), Gaps = 6/153 (3%)

Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIALLSR 386
           T  ++  +LG G+FG+VY+GI   +G    +   + +L++ +  K ++  +++ + +++ 
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL-IMAS 65

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 444
            +H ++V+  G     + + +  +L+  G LL+    +  ++    +  +  QI  G+ Y
Sbjct: 66  MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           L ++ +VHRD+   N+LV +   VK+ DFGLA+
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 13/111 (11%)

Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDS 429
            QLE EI  L R  HENI++     + E+  Y    ++T+    +LY     + +  +D 
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTY----MITQKYDFDLYSFMYDEAFDWKDR 263

Query: 430 ----QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
               Q  A  +Q+L  ++Y+HD+ ++HRDIK  NI ++ +G + L DFG A
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314

Length = 501

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 33/186 (17%)

Query: 337 LGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG+GSFG VYEG + D          AVK V   ++ +  ++ I  L  E +++  F   
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV---NESASLRERIEFL-NEASVMKGFTCH 69

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---------------QVSAYT 435
           ++V+  G         + +EL+  G L + Y R    ++               Q++A  
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKS-YLRSLRPEAENNPGRPPPTLQEMIQMAA-- 126

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
            +I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G      
Sbjct: 127 -EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 493 -WMAPE 497
            WMAPE
Sbjct: 186 RWMAPE 191

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 49/171 (28%), Positives = 89/171 (52%), Gaps = 9/171 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL-----EIKPAIRNQIIRELQVLHECN 61

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121

Query: 448 Q-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 172

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 16/159 (10%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G +LG G FGSV EG    DDG    V  V  +         I +   E A +  F+H N
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVA-VKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 392 IVQYYG---TDKDESKL---YIFLELVTKGSLLN--LYQR-----YHLRDSQVSAYTRQI 438
           +++  G         K+    + L  +  G L +  LY R       L    +  +   I
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            LG++YL +++ +HRD+   N ++  + +V +ADFGL+K
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 13/171 (7%)

Query: 336 LLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +LG G FG +  G     S      A+     L  G   KQ    L  E   L +F+H N
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIH---TLRAGCSDKQRRGFL-AEALTLGQFDHSN 67

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 449
           IV+  G     + + I  E ++ G+L +  +++   L   Q+      +  G+KYL +  
Sbjct: 68  IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC---RGTAFWMAPE 497
            VH+ +    +LV+++   K++ F   +  K   + +    +    W APE
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPE 178

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 56/190 (29%), Positives = 88/190 (46%), Gaps = 32/190 (16%)

Query: 333 KGDLLGRGSFGSVYEGISDDGFF---FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +G  +GRG++G VY+    DG     +A+K++    +G+    S  +   EIALL   +H
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACR---EIALLRELKH 57

Query: 390 ENIV--QYYGTDKDESKLYIFLELVT----------KGSLLNLYQRYHLRDSQVSAYTRQ 437
            N++  Q       + K+++  +             + S  N  +   L    V +   Q
Sbjct: 58  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQ 116

Query: 438 ILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAK-----ATKLNDVKSCR 488
           IL G+ YLH   V+HRD+K ANILV       G VK+AD G A+        L D+    
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 489 GTAFWMAPEV 498
            T ++ APE+
Sbjct: 177 VTFWYRAPEL 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 47/170 (27%), Positives = 87/170 (51%), Gaps = 8/170 (4%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI---V 393
           +G G++G+V   +  D    A   +  L +  Q++    +  +E+ LL   +HEN+   +
Sbjct: 23  VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 394 QYYGTDKDESKLYIF-LELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
             +  D    + + F L +   G+ L  L +   L + ++     Q+L GLKY+H   ++
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGII 140

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           HRD+K  N+ V+ +  +K+ DFGLA+ T  +++     T ++ APEV  N
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYVVTRWYRAPEVILN 189

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 39/199 (19%)

Query: 337 LGRGSFGSVY-------EGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIA 382
           LG G FG V+       + +    F F V++       V +L +    K + +   +E+ 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLKEVK 71

Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------------ 430
           +LSR +  NI++  G   DE  L +  E +  G L      +HL D +            
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 431 --VSAYTR------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
               +Y+       QI  G+KYL   + VHRD+   N LV  N ++K+ADFG+++     
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG 191

Query: 483 DVKSCRGTAF----WMAPE 497
           D    +G A     WMA E
Sbjct: 192 DYYRIQGRAVLPIRWMAWE 210

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 58.6 bits (141), Expect = 5e-09
 Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 36/195 (18%)

Query: 337 LGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G FG V+         FF  K +S   +G + ++  SQL  E+ ++   +H+NIV+Y
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISY--RGLKEREK-SQLVIEVNVMRELKHKNIVRY 77

Query: 396 YGT--DKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHD- 447
                +K   KLYI +E    G L    Q+ +     + +  +   TRQ+L  L Y H+ 
Sbjct: 78  IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137

Query: 448 ------QDVVHRDIKCANILV---------------DANGS--VKLADFGLAKATKLNDV 484
                 + V+HRD+K  NI +               + NG    K+ DFGL+K   +  +
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM 197

Query: 485 -KSCRGTAFWMAPEV 498
             SC GT ++ +PE+
Sbjct: 198 AHSCVGTPYYWSPEL 212

Length = 1021

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 50/158 (31%), Positives = 85/158 (53%), Gaps = 16/158 (10%)

Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDG----FFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           T ++K  +LG G+FG+VY+G+   +G       A+KE   L + +  K +   L+ E  +
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILD-EAYV 62

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----QIL 439
           ++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  S Y      QI 
Sbjct: 63  MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLD-YVREH-KDNIGSQYLLNWCVQIA 119

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            G+ YL ++ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)

Query: 334 GDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G  LG G FGSV EG ++ D     V  V  +      +  +     E   +  F+H N+
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVA-VKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 393 VQYYGT--DKDESKLY----IFLELVTKGSLLN--LYQRY-----HLRDSQVSAYTRQIL 439
           ++  G      ES+ Y    + L  +  G L +  LY R      +L    +  +   I 
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            G++YL  +  +HRD+   N +++ N +V +ADFGL+K
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 50/177 (28%), Positives = 73/177 (41%), Gaps = 17/177 (9%)

Query: 335 DLLGRGSFGSVYEGISDDGFFFA---VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           D +G G FG V  G +  G   A   VKE+    + S          QE+       H N
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKEL----RASATPDEQLLFLQEVQPYRELNHPN 56

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLR-DSQVSAYTR---QILLGLKYL 445
           ++Q  G   +     + LE    G L N  +  R  +   +Q     R   ++  GL +L
Sbjct: 57  VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAF-WMAPEV 498
           H  D +H D+   N  + A+ SVK+ D+GLA      D    K C      W+APE+
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 51/185 (27%), Positives = 75/185 (40%), Gaps = 27/185 (14%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEV---SLLDQGSQAKQSISQLEQEIALLSRFEHE 390
            DLL  G+FG ++ GI  D      +EV   ++ D  S+ +  ++ L QE  LL    H+
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ--VTLLLQESCLLYGLSHQ 68

Query: 391 NI-----VQYYGTDKDE--------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           NI     V     +             L +FL    +  L        L   Q+     Q
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT-----AF 492
           I  G+ YLH + V+H+DI   N ++D    VK+ D  L++     D   C G        
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-HCLGDNENRPVK 184

Query: 493 WMAPE 497
           WMA E
Sbjct: 185 WMALE 189

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 46/178 (25%), Positives = 88/178 (49%), Gaps = 21/178 (11%)

Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G FG V    +   G  +A K++       +  ++++  E+ I  L +     +V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI--LEKVNSRFVVS 64

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR-------DSQVSA-YTRQILLGLKYLH 446
                + +  L + L ++  G L     ++H+        D Q +  Y  ++  GL+ L 
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDL-----KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVCSN 501
            + +V+RD+K  NIL+D  G ++++D GL  A ++ + ++ R   GT  +MAPEV +N
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGL--AVQIPEGETVRGRVGTVGYMAPEVINN 175

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 21/109 (19%)

Query: 380 EIALLSRFEHENIVQYYGT-----------DKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
           E  LL    H ++++   T               S LY +L   TK S     +   +  
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYL---TKRS-----RPLPIDQ 158

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           + +    +QIL GL+YLH Q ++HRD+K  NI ++    V + D G A+
Sbjct: 159 ALI--IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 49/188 (26%), Positives = 76/188 (40%), Gaps = 31/188 (16%)

Query: 337 LGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG  +FG +Y+G       D     A+K  +L D  +   Q   + +QE +L++   H N
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIK--TLKDINN--PQQWGEFQQEASLMAELHHPN 68

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA----------------- 433
           IV   G    E  + +  E + +G L   L  R    D   S+                 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
              QI  G++YL     VH+D+   NIL+     VK++D GL++     D    +  +  
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 493 ---WMAPE 497
              WM PE
Sbjct: 189 PIRWMPPE 196

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 25/184 (13%)

Query: 337 LGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHEN 391
           LG+G+F ++Y+G+    SD       +EVS++ +   +    S    E A L+S+  H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 392 IVQYYG-TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
           +V+ YG   +DE+   +  E V  G L +++   H   + VS +      +Q+   L YL
Sbjct: 63  LVKLYGVCVRDENI--MVEEYVKFGPL-DVF--LHREKNNVSLHWKLDVAKQLASALHYL 117

Query: 446 HDQDVVHRDIKCANILV---DANGS----VKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
            D+ +VH ++   NILV     N      +KL+D G+     +   +       W+APE 
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI--PITVLSREERVERIPWIAPEC 175

Query: 499 CSNP 502
             N 
Sbjct: 176 IRNG 179

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 27/62 (43%), Positives = 34/62 (54%), Gaps = 7/62 (11%)

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +    RQ+L GL+ LH   +VHRDIK  N+LV  +G VK+ DFG A       V  C G 
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA-------VDMCTGI 363

Query: 491 AF 492
            F
Sbjct: 364 NF 365

Length = 507

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 8/154 (5%)

Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIALLSR 386
           T  +K  +LG G+FG+VY+GI   DG    +   + +L + +  K +   L+ E  +++ 
Sbjct: 7   TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAG 65

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
                + +  G     S + +  +L+  G LL+ Y R +   +    +  +  QI  G+ 
Sbjct: 66  VGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLD-YVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           YL +  +VHRD+   N+LV +   VK+ DFGLA+
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 9e-07
 Identities = 28/82 (34%), Positives = 40/82 (48%), Gaps = 14/82 (17%)

Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
           L  +QV+A  RQ+L  + Y+H + ++HRDIK  N+LV+    + L DFG A        +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF-----AR 311

Query: 486 SCRGTAFWM---------APEV 498
               T F           APEV
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEV 333

Length = 461

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 29/97 (29%), Positives = 45/97 (46%)

Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
           E  +L    H +I+Q  GT        + L          L  + ++    + A  R +L
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
             ++YLH+  ++HRDIK  NI ++  G V L DFG A
Sbjct: 193 RAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 24/69 (34%), Positives = 40/69 (57%), Gaps = 4/69 (5%)

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
           ++T Q+  G+++L  ++ VHRD+   N+L+     VK+ DFGLA+    +     +G+ F
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300

Query: 493 ----WMAPE 497
               WMAPE
Sbjct: 301 LPVKWMAPE 309

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 21/177 (11%)

Query: 337 LGRGSFGSVYEGISDDGFFFA---VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G FG V  G  + G+  A   VKE+    + S + Q   +  +E       +H N++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKEL----RVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--------QVSAYTRQILLGLKYL 445
           Q  G   + +   + +E    G L    +     +         Q  A   +I LGL +L
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHL 116

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAPEV 498
           H  + +H D+   N L+ A+ +VK+ D+GL+      D        +    W+APE+
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 5/115 (4%)

Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
           V + D  +  ++ +  L+ E+ L   F H NI+  +      S L++    +  GS  +L
Sbjct: 30  VRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSL 89

Query: 421 YQRYHLRDSQVSAYTRQILLG----LKYLHDQDVVHRDIKCANILVDANGSVKLA 471
            + Y   +    A    IL G    L YLH    +HR+IK ++IL+  +G V L+
Sbjct: 90  LKTYF-PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS 143

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 48/193 (24%), Positives = 79/193 (40%), Gaps = 41/193 (21%)

Query: 337 LGRGSFGSVYEGISDDGFFFA------VKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEH 389
           LG   FG VY+G       F        + V++     +A+  +  + + E  + SR +H
Sbjct: 13  LGEDRFGKVYKG-----HLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67

Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLR-----------DSQVSA---- 433
            NIV   G   K++    IF    +  S  +L++   +R           D  V +    
Sbjct: 68  PNIVCLLGVVTKEQPLSMIF----SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123

Query: 434 -----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
                   QI  G+++L    VVH+D+   N+LV    +VK++D GL +     D     
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183

Query: 489 GTAF----WMAPE 497
           G +     WM+PE
Sbjct: 184 GNSLLPIRWMSPE 196

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 16/161 (9%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFF---AVKEVSLLDQGSQAKQSI---SQLEQE-IAL 383
           W+   L+G G FG VYE            AV ++  L+  +   +++   +  + + IAL
Sbjct: 14  WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73

Query: 384 LSRF---EHENIVQYYGTDK-DESKLY---IFLELVTKGSLLNLYQRYHLRDSQ-VSAYT 435
                  +H  I +YYG       ++Y   I LE + + +   +++R   ++ + +    
Sbjct: 74  WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIM 132

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
           + +L  L+Y+H+  + H DIK  NI+VD N    + D+G+A
Sbjct: 133 KDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 25/68 (36%), Positives = 39/68 (57%), Gaps = 4/68 (5%)

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
           Y+ Q+  G+++L  +  +HRD+   NIL+  N  VK+ DFGLA+    +     +G+A  
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 493 ---WMAPE 497
              WMAPE
Sbjct: 239 PLKWMAPE 246

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 23/68 (33%), Positives = 39/68 (57%), Gaps = 4/68 (5%)

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
           ++ Q+  G+++L  ++ VHRD+   N+L+     VK+ DFGLA+    +     +G+ F 
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 493 ---WMAPE 497
              WMAPE
Sbjct: 304 PLKWMAPE 311

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.8 bits (112), Expect = 1e-05
 Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 6/86 (6%)

Query: 415 GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLAD 472
           G L +L ++   L +++V    RQ++  L  LH  +++H DIK  N+L D A   + L D
Sbjct: 94  GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCD 153

Query: 473 FGLAKATKLNDVKSC-RGTAFWMAPE 497
           +GL K        SC  GT  + +PE
Sbjct: 154 YGLCKII---GTPSCYDGTLDYFSPE 176

Length = 267

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 25/69 (36%), Positives = 39/69 (56%), Gaps = 4/69 (5%)

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
           +Y+ Q+  G+++L  +  +HRD+   NIL+  N  VK+ DFGLA+    +     +G A 
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 493 ----WMAPE 497
               WMAPE
Sbjct: 237 LPLKWMAPE 245

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 25/68 (36%), Positives = 38/68 (55%), Gaps = 4/68 (5%)

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
           Y+ Q+  G+++L  +  +HRD+   NIL+  N  VK+ DFGLA+    +     +G A  
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 493 ---WMAPE 497
              WMAPE
Sbjct: 244 PLKWMAPE 251

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 27/102 (26%), Positives = 53/102 (51%), Gaps = 10/102 (9%)

Query: 402 ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460
           E  +++ L+    G L +   ++ ++ +  V  +  ++++ L  LH + +V RD+   NI
Sbjct: 57  EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116

Query: 461 LVDANGSVKLADFGLAKATKLNDVK-SCRGTA---FWMAPEV 498
           L+D  G ++L  F      + ++V+ SC G A    + APEV
Sbjct: 117 LLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEV 153

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 22/55 (40%), Positives = 30/55 (54%), Gaps = 1/55 (1%)

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRG 489
           R++L  L YLH + ++HRD+K  NI +D   +  L DFG A K     D   C G
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246

Length = 392

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 38/137 (27%), Positives = 56/137 (40%), Gaps = 14/137 (10%)

Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDE-SKLYIFLELVTKGSLLNLYQRYH-LRDSQVS 432
           ++  +E AL +R  H NIV    + +     L+   E V   +L  +      L   +  
Sbjct: 23  ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETG 82

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGL---------AKATK 480
               Q+L  L   H+Q +VHRD+K  NI+V   G     K+ DFG+         A    
Sbjct: 83  RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVAT 142

Query: 481 LNDVKSCRGTAFWMAPE 497
           L       GT  + APE
Sbjct: 143 LTRTTEVLGTPTYCAPE 159

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 5/99 (5%)

Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR 436
           L+ E+ +   F H NIV Y  T   +++L++    +  GS  +L    H  D        
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMSELAIA 104

Query: 437 QILLG----LKYLHDQDVVHRDIKCANILVDANGSVKLA 471
            IL G    L Y+H    VHR +K ++IL+  +G V L+
Sbjct: 105 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 143

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 24/69 (34%), Positives = 39/69 (56%), Gaps = 6/69 (8%)

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VK-SCR 488
           ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+   +ND    VK + R
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYVVKGNAR 275

Query: 489 GTAFWMAPE 497
               WMAPE
Sbjct: 276 LPVKWMAPE 284

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 22/69 (31%), Positives = 38/69 (55%), Gaps = 4/69 (5%)

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
           +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  + +     +G A 
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277

Query: 493 ----WMAPE 497
               WMAPE
Sbjct: 278 LPVKWMAPE 286

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 44/184 (23%), Positives = 81/184 (44%), Gaps = 25/184 (13%)

Query: 337 LGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+G+F  +++GI     D       EV L       +       +  +++S+  H+++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 394 QYYGTD--KDESKLYIFLELVTKGSL-LNLYQRYHLRDS----QVSAYTRQILLGLKYLH 446
             YG     DES +    E V  GSL   L +  +L +     +V+   +Q+   L +L 
Sbjct: 63  LNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVA---KQLAWALHFLE 117

Query: 447 DQDVVHRDIKCANILV-----DANGS---VKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           D+ + H ++   N+L+        G+   +KL+D G++      ++   R    W+ PE 
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP--WVPPEC 175

Query: 499 CSNP 502
             NP
Sbjct: 176 IENP 179

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 20/42 (47%), Positives = 25/42 (59%), Gaps = 1/42 (2%)

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLA 476
           RQIL  L  LH   +VHRD+K  NI+    +GS K+ D G A
Sbjct: 262 RQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 25/81 (30%), Positives = 38/81 (46%), Gaps = 20/81 (24%)

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL----------NDVKS 486
           +I   ++Y+H + V+HRD+K  NIL+   G V + D+G A   KL          ++   
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 487 CR----------GTAFWMAPE 497
           C           GT  +MAPE
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPE 201

Length = 932

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	504
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	99.98
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.98
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.97
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
KOG0578	550	consensus p21-activated serine/threonine protein k	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.97
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.96
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.96
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.96
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.96
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.96
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.96
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.96
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.96
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.96
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.96
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.96
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.96
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.96
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.96
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.96
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.96
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.96
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.96
KOG0589	426	consensus Serine/threonine protein kinase [General	99.96
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.96
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.96
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.96
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.96
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.96
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.96
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.96
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.96
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.96
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.96
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.96
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.96
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.96
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.96
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.96
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.95
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.95
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.95
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.95
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.95
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.95
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.95
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.95
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.95
PTZ00267	478	NIMA-related protein kinase; Provisional	99.95
PHA03212	391	serine/threonine kinase US3; Provisional	99.95
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.95
KOG0610	459	consensus Putative serine/threonine protein kinase	99.95
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.95
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.95
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.95
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.95
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.95
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.95
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.95
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.95
KOG0584	632	consensus Serine/threonine protein kinase [General	99.95
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.95
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.95
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.95
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.95
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.95
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.95
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.95
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.95
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.95
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.95
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.95
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.95
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.95
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.95
PTZ00036	440	glycogen synthase kinase; Provisional	99.95
KOG0586	596	consensus Serine/threonine protein kinase [General	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.95
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.95
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.95
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.95
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.95
PTZ00283	496	serine/threonine protein kinase; Provisional	99.95
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.95
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.95
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.95
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.95
PHA03209	357	serine/threonine kinase US3; Provisional	99.95
PHA03207	392	serine/threonine kinase US3; Provisional	99.94
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.94
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.94
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.94
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.94
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.94
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.94
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.94
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.94
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.94
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.94
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.94
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.94
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.94
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.94
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.94
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.94
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.94
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.94
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.94
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.94
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.94
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.94
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.94
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.94
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.94
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.94
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.94
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.94
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.94
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.94
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.94
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.94
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.94
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.94
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.94
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.94
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.94
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.94
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.94
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.94
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.94
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.94
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.94
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.94
PTZ00284	467	protein kinase; Provisional	99.94
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.94
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.94
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.94
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.94
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.94
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.94
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.94
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.94
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.94
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.94
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.94
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.94
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.94
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.94
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.94
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.94
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.94
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.94
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.94
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.94
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.94
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.94
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.94
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.94
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.94
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.93
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.93
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.93
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.93
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.93
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.93
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.93
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.93
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.93
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.93
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.93
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.93
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.93
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.93
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.93
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.93
PHA02988	283	hypothetical protein; Provisional	99.93
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.93
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.93
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.93
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.93
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.93
PHA03210	501	serine/threonine kinase US3; Provisional	99.93
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.93
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.93
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.93
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.93
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.93
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.93
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.93
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.93
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.93
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.93
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.93
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.93
KOG3653	534	consensus Transforming growth factor beta/activin	99.93
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.93
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.93
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.93
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.93
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.93
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.93
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.93
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.93
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.93
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.93
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.93
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.93
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.93
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.93
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.93
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.93
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.93
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.93
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.93
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.93
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.93
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.93
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.93
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.93
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.93
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.93
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.93
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.93
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.93
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.93
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.93
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.93
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.93
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.93
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.93
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.93
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.93
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.93
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.93
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.93
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.93
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.93
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.93
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.93
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.93
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.93
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.93
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.93
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.93
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.93
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.93
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.93
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.93
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.93
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.93
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.93
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.93
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.93
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.93
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.93
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.93
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.93
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.92
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.92
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.92
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.92
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.92
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.92
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.92
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.92
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.92
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.92
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.92
PLN00009	294	cyclin-dependent kinase A; Provisional	99.92
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.92
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.92
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.92
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.92
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.92
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.92
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.92
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.92
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.92
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.92
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.92
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.92
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.92
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.92
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.92
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.92
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.92
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.92
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.92
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.92
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.92
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.92
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.92
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.92
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.91
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.91
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.91
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.91
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.91
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.91
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.91
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.91
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.91
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.91
PHA02882	294	putative serine/threonine kinase; Provisional	99.91
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.91
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.91
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.91
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.91
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.91
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.91
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.91
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.91
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.91
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.91
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.91
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.91
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.91
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.91
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.91
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.91
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.9
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.9
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.9
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.9
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.9
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.89
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.89
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.89
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.88
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.88
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.88
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.88
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.88
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.88
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.87
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.87
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.86
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.86
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.86
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.85
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.85
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.85
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.85
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.83
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.83
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.82
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.82
PRK10345	210	hypothetical protein; Provisional	99.82
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.81
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.81
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.81
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.8
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.8
smart00090	237	RIO RIO-like kinase.	99.79
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.64
PLN00181	793	protein SPA1-RELATED; Provisional	99.63
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.62
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.51
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.47
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.38
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.36
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.2
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.13
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.09
KOG3087	229	consensus Serine/threonine protein kinase [General	99.06
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.05
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.0
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.96
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.9
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.87
KOG1243	690	consensus Protein kinase [General function predict	98.82
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.81
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.8
PRK09902	216	hypothetical protein; Provisional	98.62
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.61
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.61
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.53
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.44
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.39
PF01636	239	APH: Phosphotransferase enzyme family This family	98.37
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.37
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.29
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.28
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.21
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.12
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.96
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.95
PLN02876	822	acyl-CoA dehydrogenase	97.93
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.93
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.92
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.89
KOG2270	520	consensus Serine/threonine protein kinase involved	97.84
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.69
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.58
PRK10593	297	hypothetical protein; Provisional	97.49
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.48
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.39
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.36
PRK05231	319	homoserine kinase; Provisional	97.21
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.18
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.14
COG4248	637	Uncharacterized protein with protein kinase and he	96.95
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.89
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.54
KOG2137	700	consensus Protein kinase [Signal transduction mech	96.52
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.46
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.42
PLN02756	418	S-methyl-5-thioribose kinase	96.28
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.19
PLN02236	344	choline kinase	96.17
PRK12396	409	5-methylribose kinase; Reviewed	95.88
PRK06148	1013	hypothetical protein; Provisional	95.74
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.72
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.56
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.47
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.35
PRK11768	325	serine/threonine protein kinase; Provisional	95.17
PTZ00384	383	choline kinase; Provisional	94.44
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.19
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	94.1
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.58
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	93.25
KOG1236	565	consensus Predicted unusual protein kinase [Genera	91.34
PHA00451	362	protein kinase	91.09
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	91.07

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=315.63  Aligned_cols=172  Identities=29%  Similarity=0.534  Sum_probs=154.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ....+|.+.+.||+|+|++||+|+. .++..||||.+.....   .+...+.+..||.+|+.++|||||.+++++..++.
T Consensus         7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen    7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            4567899999999999999999998 6789999999865432   23445678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC------CcEEEEecCccc
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN------GSVKLADFGLAK  477 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~------g~VKL~DFGLA~  477 (504)
                      +|||||||.||+|..+++.. .+++..++.++.||+.||++||+++||||||||+||||+..      -.+||+|||||+
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999999876 69999999999999999999999999999999999999865      358999999999


Q ss_pred             ccccCC-cccccCCCccccccccc
Q 010676          478 ATKLND-VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       478 ~~~~~~-~~s~~GT~~YmAPEVL~  500 (504)
                      ....+. ..+.||++.||||||++
T Consensus       164 ~L~~~~~a~tlcGSplYMAPEV~~  187 (429)
T KOG0595|consen  164 FLQPGSMAETLCGSPLYMAPEVIM  187 (429)
T ss_pred             hCCchhHHHHhhCCccccCHHHHH
Confidence            887665 45678999999999994

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-36  Score=303.71  Aligned_cols=174  Identities=31%  Similarity=0.502  Sum_probs=155.4

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      -.+.|+++++||+|+||.||+++. .+++.||+|++++...  .......+...|..+|..++||+||+++..|++...+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~i--v~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKI--VEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHh--hhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            357899999999999999999988 6899999998865433  2334567889999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc-cC-
Q 010676          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-LN-  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~-~~-  482 (504)
                      |||+||+.||.|..++++ ..+++..++.|+.+|+.||.|||++|||||||||+||||+.+|+++|+|||||+..- .+ 
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999999999998875 569999999999999999999999999999999999999999999999999998533 32 


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...+.|||+.|||||++.++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~  200 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGK  200 (357)
T ss_pred             ccccccCCccccChHHHhcC
Confidence            35567999999999999865

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-36  Score=305.91  Aligned_cols=178  Identities=30%  Similarity=0.427  Sum_probs=154.4

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhh--HHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA--KQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .+.+.|.+.+.||+|+||.|-+|.. .+|+.||||++.........  ......+.+|+++|++|+|||||+++++|...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            4667899999999999999999998 79999999999764433322  12223467999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHH-hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEecCcccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKA  478 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~-~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~---g~VKL~DFGLA~~  478 (504)
                      +..||||||+.||+|.+.+- +..+.+..-+.|++||+.||.|||++||+||||||+|||+..+   ..+||+|||+|+.
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            99999999999999998664 4558888889999999999999999999999999999999866   6799999999998


Q ss_pred             cccC-CcccccCCCcccccccccCCC
Q 010676          479 TKLN-DVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       479 ~~~~-~~~s~~GT~~YmAPEVL~g~~  503 (504)
                      .... -+.+.||||.|.|||||.++-
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg  354 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKG  354 (475)
T ss_pred             cccceehhhhcCCccccChhheecCC
Confidence            7543 367889999999999998763

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-34  Score=308.51  Aligned_cols=172  Identities=36%  Similarity=0.606  Sum_probs=155.0

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      .+|..+++||+|||+.||++++ .+|..||+|++.......  ....+++.+||+|.+.|+|||||+++++|++.+++||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k--~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK--PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC--cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            5699999999999999999999 899999999997533322  2334678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Cc
Q 010676          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~  484 (504)
                      |+|+|..++|..++++ +.+++.++++|++||+.||.|||+++|||||||..||||+++.+|||+|||||......  ..
T Consensus        96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence            9999999999999875 45999999999999999999999999999999999999999999999999999876643  35


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      .+.||||.|.||||+...
T Consensus       176 ~TlCGTPNYIAPEVl~k~  193 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKS  193 (592)
T ss_pred             ceecCCCcccChhHhccC
Confidence            678899999999999853

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=285.06  Aligned_cols=172  Identities=31%  Similarity=0.536  Sum_probs=156.4

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++++.||.|+||.|.+++. .+|..||+|++.+.+  ......+++..+|..+|+.+.||+++++++.|.+.+.+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~--vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK--VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH--HHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            56899999999999999999998 689999999886433  233445678889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc
Q 010676          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~  485 (504)
                      |||||++||.|..++++. +|++..++.|+.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+..... .-
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T~  199 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-TW  199 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-EE
Confidence            999999999999999874 5999999999999999999999999999999999999999999999999999987766 55


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      +.||||.|+|||++..+
T Consensus       200 TlCGTPeYLAPEii~sk  216 (355)
T KOG0616|consen  200 TLCGTPEYLAPEIIQSK  216 (355)
T ss_pred             EecCCccccChHHhhcC
Confidence            67899999999999865

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=287.59  Aligned_cols=173  Identities=29%  Similarity=0.476  Sum_probs=154.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ....+.+.++.||+|..|+||++.+ .++..+|+|.+....    .....+++.+|+++|+.++|||||.+|++|..+..
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~----~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI----DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC----CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence            3445677789999999999999998 689999999985422    23445778999999999999999999999999994


Q ss_pred             -EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          405 -LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       405 -lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                       ++|+||||++|+|..++.. +.+++..+..++.++++||.|||+ ++||||||||+||||+.+|.|||||||.++.+..
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence             9999999999999999876 569999999999999999999995 9999999999999999999999999999988776


Q ss_pred             CCcccccCCCcccccccccCC
Q 010676          482 NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....+++||..|||||-+.|.
T Consensus       232 S~a~tfvGT~~YMsPERi~g~  252 (364)
T KOG0581|consen  232 SIANTFVGTSAYMSPERISGE  252 (364)
T ss_pred             hhcccccccccccChhhhcCC
Confidence            667788999999999999885

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-33  Score=296.59  Aligned_cols=177  Identities=31%  Similarity=0.509  Sum_probs=154.2

Q ss_pred             ccccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec
Q 010676          322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  400 (504)
Q Consensus       322 ~~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~  400 (504)
                      +.+.+..+.|+.+++||+|+||.||+|++ .+|+.||+|.+......   .....-..+||.||++|+||||++|.+...
T Consensus       110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~---~~~~~t~~REI~ILr~l~HpNIikL~eivt  186 (560)
T KOG0600|consen  110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK---EGFPITAIREIKILRRLDHPNIIKLEEIVT  186 (560)
T ss_pred             cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC---CcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence            45566778899999999999999999998 79999999998764422   223345679999999999999999999876


Q ss_pred             CC--CeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          401 DE--SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       401 ~~--~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                      ..  ..+|||+|||+. +|.-++...  +|++.++++|++||+.||+|||++||+|||||.+|||||.+|.+||+|||||
T Consensus       187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             ecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence            65  689999999987 788887765  5999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCC---cccccCCCcccccccccCC
Q 010676          477 KATKLND---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       477 ~~~~~~~---~~s~~GT~~YmAPEVL~g~  502 (504)
                      +++....   .+..+-|.||+|||+|.|.
T Consensus       266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~  294 (560)
T KOG0600|consen  266 RFYTPSGSAPYTSRVVTLWYRPPELLLGA  294 (560)
T ss_pred             eeccCCCCcccccceEEeeccChHHhcCC
Confidence            9766543   5667789999999999874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=288.34  Aligned_cols=178  Identities=31%  Similarity=0.490  Sum_probs=155.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~  403 (504)
                      ...+.|.+++.||+|+||.||+|.+ .++..||+|++...............+.+|+.+++.++ ||||++++.++.+..
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567899999999999999999987 68899999976543211111123456678999999999 999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEecCcccccc-
Q 010676          404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATK-  480 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~-g~VKL~DFGLA~~~~-  480 (504)
                      .+|+||||+.||+|.+++.. ..+.+..+..+|+||+.||+|||++||+||||||+|||++.+ +++||+|||++.... 
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            99999999999999998877 669999999999999999999999999999999999999999 999999999998773 


Q ss_pred             -cCCcccccCCCcccccccccCCC
Q 010676          481 -LNDVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       481 -~~~~~s~~GT~~YmAPEVL~g~~  503 (504)
                       .......|||+.|+|||+|.++.
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~  197 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKG  197 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCC
Confidence             34467889999999999999853

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-34  Score=284.96  Aligned_cols=174  Identities=35%  Similarity=0.557  Sum_probs=151.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEee-eecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG-TDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~-~~~~~~  403 (504)
                      .....|++++.||+|+||.||++.. .+|..+|.|.+..   +.......+.+..|+.+|++|+|||||++++ .|..++
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f---~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF---GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch---hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            4456899999999999999999998 7999999998763   2233444567889999999999999999998 566666


Q ss_pred             e-EEEEEEeccCCCHHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCcEEEcCCCcEEEEec
Q 010676          404 K-LYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHD--QD--VVHRDIKCANILVDANGSVKLADF  473 (504)
Q Consensus       404 ~-lyLVmEy~~ggsL~~ll~~~-----~l~e~~v~~i~~QIl~gL~yLHs--~g--IIHRDLKP~NILLd~~g~VKL~DF  473 (504)
                      . ++||||||.+|+|.++++..     .+++..++.++.|++.||.++|.  ..  |+||||||.||+|+.+|.|||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            6 99999999999999988654     39999999999999999999998  44  999999999999999999999999


Q ss_pred             CcccccccCC--cccccCCCcccccccccCC
Q 010676          474 GLAKATKLND--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       474 GLA~~~~~~~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||++.+....  ..+.+|||+||+||++.+.
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~  203 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHES  203 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcC
Confidence            9999876544  4678899999999998754

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1e-32  Score=291.21  Aligned_cols=150  Identities=27%  Similarity=0.506  Sum_probs=137.5

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .-+++|+++++||+|+||.||+|+. .+|.+||+|++++...  .....+.++..|-.+|....+++||+||..|++..+
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M--~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM--LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH--HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence            3467999999999999999999997 6899999999875443  334557889999999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      +||||||++||++..++.+. .|++..++.|+.+++.||..||++|+|||||||+|+|||..|++||+|||||.
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence            99999999999999988765 49999999999999999999999999999999999999999999999999984

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-33  Score=279.83  Aligned_cols=170  Identities=28%  Similarity=0.441  Sum_probs=148.0

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      +.|+.+.++|+|+||+||++++ .+|+.||||.+.-.....   ...+-.++||++|++++|+|+|.++.+|.....+++
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~---~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP---VVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH---HHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence            5688889999999999999999 689999999886433322   222345799999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHH-hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc-c-CCc
Q 010676          408 FLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-L-NDV  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~-~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~-~-~~~  484 (504)
                      |+|||+..-|..+-. ..+++...++.|++|++.|+.|+|++++|||||||+||||+.+|.+||||||||+.+. . ...
T Consensus        79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            999999866655543 2469999999999999999999999999999999999999999999999999999765 3 346


Q ss_pred             ccccCCCcccccccccC
Q 010676          485 KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g  501 (504)
                      +.++.|.||+|||++-|
T Consensus       159 TDYVATRWYRaPELLvG  175 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVG  175 (396)
T ss_pred             hhhhhhhhccChhhhcc
Confidence            77889999999999876

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.8e-32  Score=277.62  Aligned_cols=170  Identities=53%  Similarity=0.810  Sum_probs=148.5

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC--e
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--K  404 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~--~  404 (504)
                      ...|..++.||+|+||.||++.+ .+|...|||.+......     ..+.+++|+.+|.+++|||||++++......  .
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~-----~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP-----TSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch-----hHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            45788999999999999999998 45999999998754211     1567899999999999999999999754444  6


Q ss_pred             EEEEEEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEecCccccccc
Q 010676          405 LYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKL  481 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~-~g~VKL~DFGLA~~~~~  481 (504)
                      ++|+|||+++|+|.+++.+.+  +++..++.|++||+.||.|||++|||||||||+||||+. ++.+||+|||+++....
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999999998875  899999999999999999999999999999999999999 79999999999886552


Q ss_pred             -----CCcccccCCCcccccccccCC
Q 010676          482 -----NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 -----~~~~s~~GT~~YmAPEVL~g~  502 (504)
                           .......||+.|||||++.++
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g  196 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNG  196 (313)
T ss_pred             ccccccccccccCCccccCchhhcCC
Confidence                 224467899999999999853

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.98  E-value=5e-32  Score=282.62  Aligned_cols=171  Identities=37%  Similarity=0.568  Sum_probs=149.8

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-eEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-KLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-~ly  406 (504)
                      .....+.+.||+|+||+||+|.+.....||+|.+.........   ...|.+|+.+|.+++|||||++++++.... .++
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            3455666779999999999999976666999988754433322   678999999999999999999999999887 799


Q ss_pred             EEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCcEEEcCCC-cEEEEecCccccccc
Q 010676          407 IFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANG-SVKLADFGLAKATKL  481 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~g-IIHRDLKP~NILLd~~g-~VKL~DFGLA~~~~~  481 (504)
                      |||||+++|+|..++..   ..++...+..|+.||+.||.|||+++ |||||||++||||+.++ ++||+|||+++....
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            99999999999999966   56999999999999999999999999 99999999999999998 999999999987654


Q ss_pred             --CCcccccCCCcccccccccC
Q 010676          482 --NDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       482 --~~~~s~~GT~~YmAPEVL~g  501 (504)
                        ...+...||+.|||||++.+
T Consensus       197 ~~~~~~~~~GT~~wMAPEv~~~  218 (362)
T KOG0192|consen  197 SKTSMTSVAGTYRWMAPEVLRG  218 (362)
T ss_pred             ccccccCCCCCccccChhhhcC
Confidence              34455689999999999985

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.97  E-value=3.6e-32  Score=267.12  Aligned_cols=170  Identities=28%  Similarity=0.448  Sum_probs=148.9

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      .+|...+.||+|.||+||+|++ .+|+.||||.+++.......   .....+||++|+.++|+||+.++++|...+.+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi---~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI---NRTALREIKLLQELKHPNIIELIDVFPHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc---cHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence            4688889999999999999998 79999999999875433211   1345699999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          408 FLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |+||++. +|..+++...  +....++.|+.+++.||+|||.+.|+||||||.|+||+.+|.+||+|||+|+.+....  
T Consensus        79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9999986 8999887654  8889999999999999999999999999999999999999999999999999876444  


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....+-|.+|+|||+|.|.
T Consensus       158 ~~~~V~TRWYRAPELLfGs  176 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGS  176 (318)
T ss_pred             cccceeeeeccChHHhccc
Confidence            3334789999999998763

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-32  Score=287.90  Aligned_cols=178  Identities=31%  Similarity=0.517  Sum_probs=154.2

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE  402 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~  402 (504)
                      ++-..+|..++.||.|+|++||+|+. .+++.||||++.+..  ........-+..|-..|.+| .||.|++||..|+++
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~--Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY--IIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHH--HHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence            45567999999999999999999998 689999999875422  22223334566788888888 799999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      ..+|+|+||+++|+|.+++++.+ |++..+++|+.||+.||+|||++|||||||||+||||+.+|++||+|||.|+.+..
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            99999999999999999998865 99999999999999999999999999999999999999999999999999986532


Q ss_pred             CC---------------cccccCCCcccccccccCCCC
Q 010676          482 ND---------------VKSCRGTAFWMAPEVCSNPFV  504 (504)
Q Consensus       482 ~~---------------~~s~~GT~~YmAPEVL~g~~v  504 (504)
                      ..               ..+++||..|.+||+|..+++
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~  264 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA  264 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCCC
Confidence            11               145789999999999998764

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-32  Score=292.08  Aligned_cols=177  Identities=27%  Similarity=0.463  Sum_probs=155.6

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE  402 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~  402 (504)
                      +.-+++|.++++||+|+||+|+++.. .+++.||||.+++...  .....++.++.|-+|+.... ||++++++.+|++.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I--l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI--LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce--eccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            44567999999999999999999998 5788999999875433  33444677788888887775 99999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc--
Q 010676          403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--  480 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~--  480 (504)
                      +++|+||||+.||++..+.+...|++..+..|+..|+.||+|||++||||||||.+|||+|.+|++||+|||+|+...  
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            999999999999996666666789999999999999999999999999999999999999999999999999999743  


Q ss_pred             cCCcccccCCCcccccccccCCC
Q 010676          481 LNDVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       481 ~~~~~s~~GT~~YmAPEVL~g~~  503 (504)
                      .+...++||||.|||||+|.++-
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~  544 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQS  544 (694)
T ss_pred             CCccccccCChhhcChhhhccCc
Confidence            34467789999999999998763

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=286.57  Aligned_cols=171  Identities=29%  Similarity=0.450  Sum_probs=148.6

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~  403 (504)
                      .++++|.+++.||.|+||.||+|+. .++..||||.++..-..   .+..-. .+|+.-|++|+ |||||+|.+.+.+.+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~ee~~n-LREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---WEECMN-LREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---HHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            4567899999999999999999998 68999999987643221   111222 48999999999 999999999998888


Q ss_pred             -eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          404 -KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       404 -~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                       .+|+|||||+. +|.++++..  .|++..+..|++||++||+|+|++|++||||||+||||..+..|||+|||||+.+.
T Consensus        83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence             99999999986 899998754  49999999999999999999999999999999999999989999999999999876


Q ss_pred             cC-CcccccCCCcccccccccC
Q 010676          481 LN-DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~-~~~s~~GT~~YmAPEVL~g  501 (504)
                      .. ..+.++.|.||+|||+|..
T Consensus       162 SkpPYTeYVSTRWYRAPEvLLr  183 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAPEVLLR  183 (538)
T ss_pred             cCCCcchhhhcccccchHHhhh
Confidence            54 4678899999999998864

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=6.5e-32  Score=272.06  Aligned_cols=177  Identities=28%  Similarity=0.389  Sum_probs=151.6

Q ss_pred             ccccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee-
Q 010676          322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-  399 (504)
Q Consensus       322 ~~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~-  399 (504)
                      ....+-++.|+.++.|++|+||.||+|++ +++..||+|.++......-  .- -...+||.+|.+++|||||.+..+. 
T Consensus        69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G--FP-ItsLREIniLl~~~H~NIV~vkEVVv  145 (419)
T KOG0663|consen   69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG--FP-ITSLREINILLKARHPNIVEVKEVVV  145 (419)
T ss_pred             ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC--Cc-chhHHHHHHHHhcCCCCeeeeEEEEe
Confidence            44456678999999999999999999999 6899999999876543221  11 2345999999999999999997764 


Q ss_pred             -cCCCeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          400 -KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       400 -~~~~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                       .+-+.+|||||||+. +|..++...  .|...+++.++.|++.||+|||.+.|+|||||++|+|+++.|.+||+|||||
T Consensus       146 G~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLA  224 (419)
T KOG0663|consen  146 GSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLA  224 (419)
T ss_pred             ccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchh
Confidence             445679999999987 899988764  4899999999999999999999999999999999999999999999999999


Q ss_pred             cccccC--CcccccCCCcccccccccCC
Q 010676          477 KATKLN--DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       477 ~~~~~~--~~~s~~GT~~YmAPEVL~g~  502 (504)
                      +.+...  ..+..+-|.+|+|||+|.|.
T Consensus       225 R~ygsp~k~~T~lVVTLWYRaPELLLG~  252 (419)
T KOG0663|consen  225 REYGSPLKPYTPLVVTLWYRAPELLLGA  252 (419)
T ss_pred             hhhcCCcccCcceEEEeeecCHHHhcCC
Confidence            987654  35667799999999999874

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=7.6e-32  Score=285.20  Aligned_cols=171  Identities=31%  Similarity=0.546  Sum_probs=154.0

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|.+.+.||+|+||+||+|+. .+.+.||+|.+.+..   ..+..+..+.+|++|++.++|||||.++++|++...+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g---r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG---RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC---CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence            5788999999999999999998 588999999886433   234456789999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--c
Q 010676          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~  484 (504)
                      |+||+.| +|+.++.. +.++++.+..++.+++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+....+.  .
T Consensus        79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence            9999998 99998875 469999999999999999999999999999999999999999999999999999866554  4


Q ss_pred             ccccCCCcccccccccCCC
Q 010676          485 KSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~~  503 (504)
                      ++..|||.|||||++.++.
T Consensus       158 tsikGtPlYmAPElv~e~p  176 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQP  176 (808)
T ss_pred             eeccCcccccCHHHHcCCC
Confidence            6678999999999998764

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.1e-31  Score=275.13  Aligned_cols=182  Identities=26%  Similarity=0.480  Sum_probs=163.2

Q ss_pred             CCccccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeee
Q 010676          320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT  398 (504)
Q Consensus       320 p~~~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~  398 (504)
                      ....-+....+|++.+.||+|+||.|-+|.. ..|+.||||.+...  ....++.+-++.+||+|+..|+||||+.+|.+
T Consensus        44 rhhhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKd--kIkdeqDlvhIRREIeIMSsLNHPhII~IyEV  121 (668)
T KOG0611|consen   44 RHHHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKD--KIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV  121 (668)
T ss_pred             ccCcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhh--hcccHHHHHHHHHHHHHHhhcCCCceeehhhh
Confidence            3333445566899999999999999999998 78999999987643  34557778899999999999999999999999


Q ss_pred             ecCCCeEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          399 DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       399 ~~~~~~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      |+..+.+.|||||..+|.|.+|+.+. .+++.++..+|+||++|+.|+|+++++|||||.+|||+|.|+++||+||||+.
T Consensus       122 FENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSN  201 (668)
T KOG0611|consen  122 FENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSN  201 (668)
T ss_pred             hcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhh
Confidence            99999999999999999999999765 59999999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC-cccccCCCcccccccccCCC
Q 010676          478 ATKLND-VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       478 ~~~~~~-~~s~~GT~~YmAPEVL~g~~  503 (504)
                      .+.... ..++||++.|.+||+++|.-
T Consensus       202 ly~~~kfLqTFCGSPLYASPEIvNG~P  228 (668)
T KOG0611|consen  202 LYADKKFLQTFCGSPLYASPEIVNGTP  228 (668)
T ss_pred             hhccccHHHHhcCCcccCCccccCCCC
Confidence            766554 57889999999999999864

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=2.6e-30  Score=266.97  Aligned_cols=172  Identities=28%  Similarity=0.492  Sum_probs=147.6

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||+||+|.+ .++..||+|++.....  ........+.+|+.++..++|+||+++++.+.+...+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence            3689999999999999999987 5789999998864321  123334678889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC---
Q 010676          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~---  483 (504)
                      ||||+++|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......   
T Consensus        79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            9999999999998865 458999999999999999999999999999999999999999999999999987532110   


Q ss_pred             ----------------------------------cccccCCCcccccccccCC
Q 010676          484 ----------------------------------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ----------------------------------~~s~~GT~~YmAPEVL~g~  502 (504)
                                                        ....+||+.|||||++.++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~  211 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT  211 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC
Confidence                                              1234799999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-30  Score=266.50  Aligned_cols=147  Identities=27%  Similarity=0.518  Sum_probs=131.5

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++++.||+|+||.||++.+ .++..||||++.....  ........+.+|+.++..++||||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            3689999999999999999987 6889999998864221  123345678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      ||||+++|+|.+++... .+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999999988654 58889999999999999999999999999999999999999999999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=4.2e-30  Score=267.60  Aligned_cols=173  Identities=26%  Similarity=0.436  Sum_probs=150.5

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..++|++.+.||+|+||.||++.+ .++..||+|++......  .......+.+|+.+++.++||||+++++++.+++.+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            346899999999999999999998 57889999988642211  122234577899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |+||||+++|+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            999999999999999988889999999999999999999999999999999999999999999999999998654322  


Q ss_pred             -cccccCCCcccccccccC
Q 010676          484 -VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g  501 (504)
                       ....+||+.|||||++.+
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~  217 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKS  217 (370)
T ss_pred             ecccCCCCcccCCHHHHhc
Confidence             234569999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-30  Score=264.34  Aligned_cols=149  Identities=28%  Similarity=0.534  Sum_probs=132.6

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++++.||+|+||.||+|.+ .++..||||++.....  ........+.+|+.++..++|+||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM--LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence            3689999999999999999998 5789999999864321  112334567889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ||||+.+|+|.+++... .+++..+..|+.||+.||.|||++||+||||||+||||+.+|.++|+|||++...
T Consensus        79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            99999999999988654 5899999999999999999999999999999999999999999999999998653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=7.6e-30  Score=265.46  Aligned_cols=147  Identities=28%  Similarity=0.518  Sum_probs=131.3

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .|++++.||+|+||+||+|.+ .++..||+|++.....  ........+.+|+.+++.++|+||+++++++.+.+.+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV--LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence            588999999999999999988 6789999998864322  1233456788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      |||+++|+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            9999999999988654 588899999999999999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=6.6e-30  Score=260.61  Aligned_cols=173  Identities=29%  Similarity=0.526  Sum_probs=150.4

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..++|++.+.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++++...+.+
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI--LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            357899999999999999999998 5789999998864321  1223346788999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      |+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... 
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            9999999999999888654 58889999999999999999999999999999999999999999999999998654332 


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ...+||+.|||||++.++
T Consensus       173 ~~~~gt~~y~aPE~~~~~  190 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSK  190 (329)
T ss_pred             ceecCChhhcCHHHHcCC
Confidence            345799999999998765

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=9.5e-30  Score=264.29  Aligned_cols=146  Identities=27%  Similarity=0.506  Sum_probs=130.8

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .|.+++.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.++++++|+||+++++.+.+.+.+|+|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV--LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence            588999999999999999998 5788999998864221  1233456788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      |||+++|+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~  149 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence            9999999999988664 48889999999999999999999999999999999999999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2e-30  Score=278.81  Aligned_cols=176  Identities=30%  Similarity=0.518  Sum_probs=156.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ..++-|++++.||.|+.|.|-+|++ .+|+..|||++.......  ......+++||.||+.+.|||++++|+.|++..+
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s--~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS--SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccc--cccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            3466799999999999999999998 799999999997653222  2234568899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHH-hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-
Q 010676          405 LYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~-~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-  482 (504)
                      +|+|+||++||.|++++- ++.+.+.++.++|+||+.|+.|+|..+|+||||||+|+||+.++++||+|||+|..-..+ 
T Consensus        87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            999999999999998774 566999999999999999999999999999999999999999999999999999765444 


Q ss_pred             CcccccCCCcccccccccCCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~~  503 (504)
                      ...+.||+|.|.|||++.|.-
T Consensus       167 lLeTSCGSPHYA~PEIV~G~p  187 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRP  187 (786)
T ss_pred             cccccCCCcccCCchhhcCCC
Confidence            467889999999999999864

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=1e-29  Score=263.20  Aligned_cols=146  Identities=27%  Similarity=0.498  Sum_probs=130.2

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++++.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.+|..++|+||+++++.+.+++.+|+|
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV--LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH--HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence            689999999999999999998 5789999998854221  1123346678999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      |||+++|+|.+++... .+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|.
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~  149 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence            9999999999988765 47888899999999999999999999999999999999999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=276.77  Aligned_cols=170  Identities=32%  Similarity=0.562  Sum_probs=153.6

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ..+|.....||+|..|.||.|.. .++..||||.+.+..+...     +-+.+|+.+|+.++|+|||++++.|...+.+|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k-----eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK-----ELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch-----hhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            44688888999999999999987 6889999999987655432     34779999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--c
Q 010676          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~  484 (504)
                      +||||++||+|.+++....+++.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||||..+....  .
T Consensus       347 VVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             EEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998765443  4


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      .+.+|||+|||||++..+
T Consensus       427 ~TmVGTPYWMAPEVvtrk  444 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRK  444 (550)
T ss_pred             ccccCCCCccchhhhhhc
Confidence            567899999999998763

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-29  Score=257.99  Aligned_cols=171  Identities=27%  Similarity=0.422  Sum_probs=149.0

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++++.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.++..++||||+++++++...+.+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL   78 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence            3689999999999999999998 4689999999864321  112334668899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCccc
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s  486 (504)
                      ||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus        79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~~  157 (333)
T cd05600          79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANS  157 (333)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccCC
Confidence            99999999999998754 588999999999999999999999999999999999999999999999999876543 3345


Q ss_pred             ccCCCcccccccccCC
Q 010676          487 CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       487 ~~GT~~YmAPEVL~g~  502 (504)
                      ..||+.|+|||++.+.
T Consensus       158 ~~gt~~y~aPE~~~~~  173 (333)
T cd05600         158 VVGSPDYMAPEVLRGK  173 (333)
T ss_pred             cccCccccChhHhcCC
Confidence            5699999999998764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.9e-30  Score=255.29  Aligned_cols=171  Identities=28%  Similarity=0.470  Sum_probs=148.2

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV--IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence            3689999999999999999998 4789999998864321  112234568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCccc
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s  486 (504)
                      ||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~~~  157 (291)
T cd05612          79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWT  157 (291)
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-ccc
Confidence            99999999999988654 5889999999999999999999999999999999999999999999999998765433 234


Q ss_pred             ccCCCcccccccccCC
Q 010676          487 CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       487 ~~GT~~YmAPEVL~g~  502 (504)
                      .+||+.|+|||++.+.
T Consensus       158 ~~gt~~y~aPE~~~~~  173 (291)
T cd05612         158 LCGTPEYLAPEVIQSK  173 (291)
T ss_pred             ccCChhhcCHHHHcCC
Confidence            5699999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-30  Score=268.28  Aligned_cols=175  Identities=32%  Similarity=0.483  Sum_probs=149.9

Q ss_pred             cccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          323 RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       323 ~~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .+...++.|...++||+|+||.||+|...+|..||||.+.......     ..+|.+|+.+|.+++|||+|+|+|||.+.
T Consensus        69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~  143 (361)
T KOG1187|consen   69 ELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-----EREFLNEVEILSRLRHPNLVKLLGYCLEG  143 (361)
T ss_pred             HHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-----hhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence            3455667899999999999999999999999999999665322211     34599999999999999999999999999


Q ss_pred             C-eEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCcEEEcCCCcEEEEecCc
Q 010676          403 S-KLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQD---VVHRDIKCANILVDANGSVKLADFGL  475 (504)
Q Consensus       403 ~-~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~g---IIHRDLKP~NILLd~~g~VKL~DFGL  475 (504)
                      + ..+||+||+++|+|.+++...   .++|.+..+|+.+++.||+|||...   |||||||++|||+|.+...||+|||+
T Consensus       144 ~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGL  223 (361)
T KOG1187|consen  144 GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGL  223 (361)
T ss_pred             CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccC
Confidence            8 599999999999999988654   6799999999999999999999853   99999999999999999999999999


Q ss_pred             cccccc-CCccc-c-cCCCcccccccccCC
Q 010676          476 AKATKL-NDVKS-C-RGTAFWMAPEVCSNP  502 (504)
Q Consensus       476 A~~~~~-~~~~s-~-~GT~~YmAPEVL~g~  502 (504)
                      |+.... ..... . .||.+|+|||++..+
T Consensus       224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~g  253 (361)
T KOG1187|consen  224 AKLGPEGDTSVSTTVMGTFGYLAPEYASTG  253 (361)
T ss_pred             cccCCccccceeeecCCCCccCChhhhccC
Confidence            976554 33222 2 799999999998754

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.97  E-value=2.3e-30  Score=262.76  Aligned_cols=171  Identities=33%  Similarity=0.545  Sum_probs=147.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc-eeEEeeeecCCC--
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES--  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~~~~~~--  403 (504)
                      ...|+.++.||+|+||+||+|+. .+|+.||+|++.+.....-   ......+|+.+|+.++|+| ||++++++.+.+  
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG---~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG---VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC---CCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence            45678888899999999999998 6889999999986543210   1234569999999999999 999999998877  


Q ss_pred             ----eEEEEEEeccCCCHHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecC
Q 010676          404 ----KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (504)
Q Consensus       404 ----~lyLVmEy~~ggsL~~ll~~~-----~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFG  474 (504)
                          .+|+||||+.. +|..++...     +++...++.+++||+.||.|||+++|+||||||+||||+.+|.+||+|||
T Consensus        87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence                89999999976 899988763     47778899999999999999999999999999999999999999999999


Q ss_pred             cccccc--cCCcccccCCCcccccccccCC
Q 010676          475 LAKATK--LNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       475 LA~~~~--~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      +|+...  .......++|.+|.|||+|.|.
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs  195 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGS  195 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCC
Confidence            998654  3346677899999999999875

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=1.7e-29  Score=260.48  Aligned_cols=172  Identities=29%  Similarity=0.503  Sum_probs=147.3

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||++.. .++..||+|++.....  ........+.+|+.++..++|+||+++++.+.+.+.+|+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3689999999999999999998 5789999998864321  123345678889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC---
Q 010676          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~---  483 (504)
                      ||||+++|+|.+++.+ ..+++..+..|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++.......   
T Consensus        79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            9999999999998865 458999999999999999999999999999999999999999999999999986432110   


Q ss_pred             ----------------------------------cccccCCCcccccccccCC
Q 010676          484 ----------------------------------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ----------------------------------~~s~~GT~~YmAPEVL~g~  502 (504)
                                                        ....+||+.|||||++.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~  211 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT  211 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC
Confidence                                              1134699999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.96  E-value=1.6e-29  Score=256.92  Aligned_cols=166  Identities=29%  Similarity=0.445  Sum_probs=142.6

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEecc
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~  413 (504)
                      +.||+|+||.||+|.+ .+|..||+|++.....  ........+.+|+.+++.++||||+++++++...+.+|+||||+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence            4699999999999988 5889999998864221  122334567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCcccccCC
Q 010676          414 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGT  490 (504)
Q Consensus       414 ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~~s~~GT  490 (504)
                      +++|..++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....  ......+||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence            9999988765 4589999999999999999999999999999999999999999999999999875322  223445799


Q ss_pred             CcccccccccCC
Q 010676          491 AFWMAPEVCSNP  502 (504)
Q Consensus       491 ~~YmAPEVL~g~  502 (504)
                      +.|||||++.+.
T Consensus       159 ~~y~aPE~~~~~  170 (323)
T cd05571         159 PEYLAPEVLEDN  170 (323)
T ss_pred             ccccChhhhcCC
Confidence            999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-30  Score=269.48  Aligned_cols=177  Identities=31%  Similarity=0.553  Sum_probs=148.0

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccch---------hhHHHHHHHHHHHHHHhhCCCCceeE
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS---------QAKQSISQLEQEIALLSRFEHENIVQ  394 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~---------~~~~~~~~~~~Ei~iL~~L~HpnIV~  394 (504)
                      +..++.|++++.||+|.||.|-+|.+ .+++.||||++.......         ....-++++.+||.+|+++.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            35678999999999999999999998 689999999986533221         11112357889999999999999999


Q ss_pred             EeeeecC--CCeEEEEEEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEE
Q 010676          395 YYGTDKD--ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  471 (504)
Q Consensus       395 l~~~~~~--~~~lyLVmEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~  471 (504)
                      |+.+..+  .+.+|||+|||..|.+...-.... +.+.+++.|++.++.||+|||.+|||||||||+|+||+.+|+|||+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence            9998765  467999999999988765444444 8899999999999999999999999999999999999999999999


Q ss_pred             ecCcccccccCC-------cccccCCCcccccccccC
Q 010676          472 DFGLAKATKLND-------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       472 DFGLA~~~~~~~-------~~s~~GT~~YmAPEVL~g  501 (504)
                      |||.+.......       ....+|||.|||||++.+
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~  289 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG  289 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcC
Confidence            999987552221       234679999999999887

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=8.3e-31  Score=254.41  Aligned_cols=174  Identities=31%  Similarity=0.511  Sum_probs=157.1

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      .+++|++++.||+|-||.||+|+. .++..+|+|++.+..  ....+...++.+|+++...|+||||+++|++|.+...+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            467899999999999999999997 688999999886533  33344456788999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          406 YIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      |+++||...|.|...++.   ..+++.....|+.|++.||.|+|.+++|||||||+|+|++.+|.+||+|||++.....+
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN  177 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence            999999999999998873   34899999999999999999999999999999999999999999999999999877777


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....|||..|.+||+..+.
T Consensus       178 kR~tlcgt~dyl~pEmv~~~  197 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGR  197 (281)
T ss_pred             CceeeecccccCCHhhcCCC
Confidence            77888999999999999875

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.96  E-value=2e-29  Score=262.09  Aligned_cols=173  Identities=28%  Similarity=0.440  Sum_probs=150.0

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..++|++.+.||+|+||.||++.+ .++..||+|++......  .......+.+|+.+++.++||||+++++++.+.+.+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356899999999999999999998 57889999988642211  122234577899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |+||||+++|+|.+++....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......  
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            999999999999999988889999999999999999999999999999999999999999999999999987654322  


Q ss_pred             -cccccCCCcccccccccC
Q 010676          484 -VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g  501 (504)
                       ....+||+.|||||++.+
T Consensus       199 ~~~~~~gt~~y~aPE~~~~  217 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKS  217 (370)
T ss_pred             cCCCCCCCcCeECHHHhcc
Confidence             234569999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.96  E-value=2.7e-29  Score=258.54  Aligned_cols=175  Identities=31%  Similarity=0.440  Sum_probs=149.7

Q ss_pred             cccccceeeeeeecccCceeEEEEEcc--CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~~--~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      ....++|++.+.||+|+||.||+|.+.  ++..||+|.+.....  ........+.+|+.++..++||||+++++++.+.
T Consensus        26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            345678999999999999999999863  346899998864321  1223345678999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      +.+|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            9999999999999999988654 588999999999999999999999999999999999999999999999999976543


Q ss_pred             CCcccccCCCcccccccccCC
Q 010676          482 NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      . ....+||+.|||||++.+.
T Consensus       184 ~-~~~~~gt~~y~aPE~~~~~  203 (340)
T PTZ00426        184 R-TYTLCGTPEYIAPEILLNV  203 (340)
T ss_pred             C-cceecCChhhcCHHHHhCC
Confidence            2 3345799999999998754

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.96  E-value=2.8e-29  Score=261.32  Aligned_cols=174  Identities=26%  Similarity=0.430  Sum_probs=150.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...++|++.+.||+|+||.||++.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++++.+...
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3457899999999999999999998 5788999998864221  112223457789999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      +|+||||+++|+|.+++....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... 
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999997654322 


Q ss_pred             --cccccCCCcccccccccC
Q 010676          484 --VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 --~~s~~GT~~YmAPEVL~g  501 (504)
                        ....+||+.|||||++.+
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~  217 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKS  217 (371)
T ss_pred             ccccCcccCccccCHHHHhc
Confidence              234569999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2e-29  Score=256.99  Aligned_cols=172  Identities=33%  Similarity=0.537  Sum_probs=149.1

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|.+.+.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.++..++|+||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence            3689999999999999999998 4799999999864321  112334568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC---
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~---  483 (504)
                      ||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......   
T Consensus        79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            99999999999988765 68999999999999999999999999999999999999999999999999987644322   


Q ss_pred             ----------------------------cccccCCCcccccccccCC
Q 010676          484 ----------------------------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ----------------------------~~s~~GT~~YmAPEVL~g~  502 (504)
                                                  .....||+.|+|||++.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  205 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT  205 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence                                        2334699999999998765

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.96  E-value=7.4e-29  Score=246.81  Aligned_cols=171  Identities=25%  Similarity=0.372  Sum_probs=145.8

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .|++.+.||+|+||.||+|.+ .++..||+|.+......  .......+.+|+.++..++|+||+++++++.+.+.+|+|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence            378889999999999999998 68999999988643221  122234577899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-Cc
Q 010676          409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DV  484 (504)
Q Consensus       409 mEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-~~  484 (504)
                      |||+.+|+|..++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ..
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV  158 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence            999999999877643   24888999999999999999999999999999999999999999999999998765432 23


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....||+.|||||++.+.
T Consensus       159 ~~~~g~~~y~aPE~~~~~  176 (285)
T cd05631         159 RGRVGTVGYMAPEVINNE  176 (285)
T ss_pred             cCCCCCCCccCHhhhcCC
Confidence            445699999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.9e-29  Score=258.68  Aligned_cols=176  Identities=30%  Similarity=0.521  Sum_probs=153.2

Q ss_pred             ccccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec
Q 010676          322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  400 (504)
Q Consensus       322 ~~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~  400 (504)
                      ..+....+.|++...||.|..++||+|+. ..+..||||++.+.+..    ..+..+.+|+..+..++||||++++..|.
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~----~~ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN----NDLDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh----hhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            34455567899999999999999999998 67899999999764432    23677899999999999999999999999


Q ss_pred             CCCeEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          401 DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       401 ~~~~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      .+..+|+||.||.+|++.++++.   .++.+..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||...
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence            99999999999999999999875   469999999999999999999999999999999999999999999999999865


Q ss_pred             ccccCC------cccccCCCcccccccccC
Q 010676          478 ATKLND------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       478 ~~~~~~------~~s~~GT~~YmAPEVL~g  501 (504)
                      .+....      ....+||++||||||+..
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q  204 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ  204 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhh
Confidence            432221      145679999999999653

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.96  E-value=5.8e-29  Score=252.81  Aligned_cols=172  Identities=29%  Similarity=0.444  Sum_probs=145.6

Q ss_pred             ceeeeeeecccCceeEEEEEc----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCe
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK  404 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~  404 (504)
                      +|++++.||+|+||.||++..    .++..||+|++...... ........+.+|+.++..++ |+||+++++++...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence            488999999999999999886    36889999988642211 12233456778999999995 9999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            9999999999999988754 458999999999999999999999999999999999999999999999999987543222


Q ss_pred             ---cccccCCCcccccccccCC
Q 010676          484 ---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ---~~s~~GT~~YmAPEVL~g~  502 (504)
                         ....+||+.|||||++.+.
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~  181 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGK  181 (332)
T ss_pred             CCccccccCCccccCHHHhcCC
Confidence               2345699999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.8e-30  Score=257.69  Aligned_cols=177  Identities=27%  Similarity=0.422  Sum_probs=156.2

Q ss_pred             cccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       323 ~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      +-+..+++|..+++||+|+||.|-+++. .+++.||+|++++.  ....+..+.+...|-++|+..+||++..+...|++
T Consensus       162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKe--viiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt  239 (516)
T KOG0690|consen  162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKE--VIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT  239 (516)
T ss_pred             cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhh--heeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence            3445678999999999999999999987 68999999988642  23345556777889999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc-c
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-T  479 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~-~  479 (504)
                      ++.+|+||||..||.|..++.+. .+++.....|-.+|+.||.|||+++||+||||.+|+|+|.+|++||+|||||+. +
T Consensus       240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999999999998877654 599999999999999999999999999999999999999999999999999986 3


Q ss_pred             c-cCCcccccCCCcccccccccC
Q 010676          480 K-LNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       480 ~-~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      . ......+||||.|+|||||..
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleD  342 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLED  342 (516)
T ss_pred             cccceeccccCChhhcCchhhcc
Confidence            3 334678899999999999974

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.96  E-value=5.5e-29  Score=253.23  Aligned_cols=166  Identities=30%  Similarity=0.462  Sum_probs=142.3

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEecc
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~  413 (504)
                      +.||+|+||.||++.+ .+|..||+|++.....  ........+.+|+.+++.++||||++++++|...+.+|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence            4699999999999998 5789999998864221  122344567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--CcccccCC
Q 010676          414 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGT  490 (504)
Q Consensus       414 ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~s~~GT  490 (504)
                      +++|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ......||
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence            99999887654 5899999999999999999999999999999999999999999999999998753222  23345699


Q ss_pred             CcccccccccCC
Q 010676          491 AFWMAPEVCSNP  502 (504)
Q Consensus       491 ~~YmAPEVL~g~  502 (504)
                      +.|||||++.++
T Consensus       159 ~~y~aPE~~~~~  170 (323)
T cd05595         159 PEYLAPEVLEDN  170 (323)
T ss_pred             cCcCCcccccCC
Confidence            999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.96  E-value=7.7e-29  Score=252.97  Aligned_cols=171  Identities=25%  Similarity=0.406  Sum_probs=146.9

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||++.+ .++..||+|++.....  ........+.+|+.++..++|+||+++++++.+.+.+|+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM--LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4689999999999999999998 5788999998864221  122334557789999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc-
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~-  484 (504)
                      ||||+.+|+|.+++..  ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            9999999999999875  4588999999999999999999999999999999999999999999999999876543322 


Q ss_pred             --ccccCCCcccccccccC
Q 010676          485 --KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       485 --~s~~GT~~YmAPEVL~g  501 (504)
                        ...+||+.|||||++.+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~  177 (331)
T cd05624         159 QSSVAVGTPDYISPEILQA  177 (331)
T ss_pred             eeccccCCcccCCHHHHhc
Confidence              23469999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.96  E-value=4.8e-29  Score=253.20  Aligned_cols=170  Identities=29%  Similarity=0.474  Sum_probs=143.9

Q ss_pred             eeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHH---hhCCCCceeEEeeeecCCCeEE
Q 010676          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL---SRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL---~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      |++.+.||+|+||.||+|.+ .++..||||++.....  ........+.+|+.++   ..++||||+++++++...+.+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            67899999999999999987 5789999999864321  1122334566666554   5677999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCc
Q 010676          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDV  484 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~  484 (504)
                      +||||+.+++|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ...
T Consensus        79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999875322  223


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ...+||+.|||||++.+.
T Consensus       159 ~~~~g~~~y~aPE~~~~~  176 (324)
T cd05589         159 STFCGTPEFLAPEVLTET  176 (324)
T ss_pred             cccccCccccCHhHhcCC
Confidence            446799999999998764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5.8e-29  Score=253.89  Aligned_cols=170  Identities=26%  Similarity=0.426  Sum_probs=146.4

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++++.||+|+||.||++.. .++..||+|++.....  ........+.+|+.++..++|+||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM--LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence            3689999999999999999997 5789999998864221  122234567889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc-
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~-  484 (504)
                      ||||+.+++|.+++.+  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            9999999999999875  3589999999999999999999999999999999999999999999999999876443221 


Q ss_pred             --ccccCCCccccccccc
Q 010676          485 --KSCRGTAFWMAPEVCS  500 (504)
Q Consensus       485 --~s~~GT~~YmAPEVL~  500 (504)
                        ...+||+.|||||++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~  176 (331)
T cd05597         159 QSNVAVGTPDYISPEILQ  176 (331)
T ss_pred             cccceeccccccCHHHHh
Confidence              2246999999999986

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.96  E-value=6.7e-29  Score=253.38  Aligned_cols=166  Identities=28%  Similarity=0.451  Sum_probs=142.6

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEecc
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~  413 (504)
                      +.||+|+||.||++.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++++...+.+|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence            4699999999999998 5789999998864221  123345677889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCcccccCC
Q 010676          414 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGT  490 (504)
Q Consensus       414 ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~~s~~GT  490 (504)
                      +++|..++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....  ......+||
T Consensus        79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence            99998887654 589999999999999999999999999999999999999999999999999875322  223445799


Q ss_pred             CcccccccccCC
Q 010676          491 AFWMAPEVCSNP  502 (504)
Q Consensus       491 ~~YmAPEVL~g~  502 (504)
                      +.|||||++.+.
T Consensus       159 ~~y~aPE~~~~~  170 (328)
T cd05593         159 PEYLAPEVLEDN  170 (328)
T ss_pred             cCccChhhhcCC
Confidence            999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=7.6e-29  Score=260.48  Aligned_cols=175  Identities=35%  Similarity=0.537  Sum_probs=153.5

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE  402 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~  402 (504)
                      ..+...|++++.||+|.||.||+++. .+|..+|+|.+.......  ......+.+|+.+|+++. |||||.++++|++.
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~--~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG--KEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc--cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            34566899999999999999999998 469999999987544332  224567889999999999 99999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC----CcEEEEecCcccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLADFGLAKA  478 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~----g~VKL~DFGLA~~  478 (504)
                      +.+|+|||++.||.|.+.+....+++..+..++.||+.++.|||+.||+||||||+|||+...    +.+|++|||++..
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            999999999999999997766569999999999999999999999999999999999999633    5799999999988


Q ss_pred             cccC-CcccccCCCcccccccccC
Q 010676          479 TKLN-DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       479 ~~~~-~~~s~~GT~~YmAPEVL~g  501 (504)
                      .... .....+||+.|+|||++.+
T Consensus       189 ~~~~~~~~~~~Gtp~y~APEvl~~  212 (382)
T KOG0032|consen  189 IKPGERLHTIVGTPEYVAPEVLGG  212 (382)
T ss_pred             ccCCceEeeecCCccccCchhhcC
Confidence            7653 3567789999999999984

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.96  E-value=1.1e-28  Score=250.72  Aligned_cols=166  Identities=28%  Similarity=0.448  Sum_probs=141.7

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEecc
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~  413 (504)
                      +.||+|+||.||++.+ .++..||+|++.....  ........+.+|+.++..++||||+++++++...+.+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            4699999999999997 6889999999864321  122334567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCcccccC
Q 010676          414 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (504)
Q Consensus       414 ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~~s~~G  489 (504)
                      +++|..++... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence            99999887654 58999999999999999999997 7999999999999999999999999999875332  22334569


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|||||++.++
T Consensus       159 t~~y~aPE~~~~~  171 (325)
T cd05594         159 TPEYLAPEVLEDN  171 (325)
T ss_pred             CcccCCHHHHccC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=9.3e-29  Score=249.82  Aligned_cols=164  Identities=29%  Similarity=0.455  Sum_probs=141.0

Q ss_pred             ecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccCC
Q 010676          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (504)
Q Consensus       337 LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~gg  415 (504)
                      ||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.++..++||||+++++++...+.+|+||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI--VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence            79999999999998 5788999998864221  12334566788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--CcccccCCCc
Q 010676          416 SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF  492 (504)
Q Consensus       416 sL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~s~~GT~~  492 (504)
                      +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .....+||+.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence            999888654 5899999999999999999999999999999999999999999999999998753222  2334569999


Q ss_pred             ccccccccCC
Q 010676          493 WMAPEVCSNP  502 (504)
Q Consensus       493 YmAPEVL~g~  502 (504)
                      |||||++.+.
T Consensus       159 y~aPE~~~~~  168 (312)
T cd05585         159 YLAPELLLGH  168 (312)
T ss_pred             cCCHHHHcCC
Confidence            9999998764

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.96  E-value=9.5e-29  Score=251.02  Aligned_cols=170  Identities=33%  Similarity=0.474  Sum_probs=147.7

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|.+.+.||+|+||.||++.+ .++..||+|++.....  ........+.+|+.+++.++|+||+++++++...+.+|+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL--LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence            3689999999999999999998 5789999998874322  122344668889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      ||||+++++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999999999998764  58999999999999999999999999999999999999999999999999997654332  


Q ss_pred             -cccccCCCccccccccc
Q 010676          484 -VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~  500 (504)
                       .....||+.|+|||++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~  176 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLT  176 (330)
T ss_pred             eeecccCCccccCHHHhc
Confidence             12346999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.96  E-value=1.2e-28  Score=245.57  Aligned_cols=169  Identities=29%  Similarity=0.465  Sum_probs=143.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++.+.||.|+||.||+|.+ .++..||+|.+.......    ....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKNLKHANIVTLHDIIHTERCLT   79 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC----cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            45799999999999999999998 578999999886432211    1235678999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--
Q 010676          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--  482 (504)
                      +||||+.+ +|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            99999986 888877654  3788899999999999999999999999999999999999999999999998764322  


Q ss_pred             CcccccCCCcccccccccC
Q 010676          483 DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g  501 (504)
                      ......+|+.|||||++.+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~  177 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLG  177 (288)
T ss_pred             cccCceecccccChHHhcC
Confidence            2234568999999998865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.5e-29  Score=265.86  Aligned_cols=172  Identities=33%  Similarity=0.578  Sum_probs=153.5

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe-E
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-L  405 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~-l  405 (504)
                      .+.|..++++|+|+||.+++++. .++..|++|++.+........   ...++|+.++++++|||||.+++.|..++. +
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r---~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER---RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh---HHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence            46789999999999999999987 577899999998765544332   356799999999999999999999999998 9


Q ss_pred             EEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          406 YIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      ||||+||+||+|.+.+.+.+   |.++.+..|+.||+.||.|||+++|+|||||+.|||++.++.|+|+|||+|+.....
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999999886543   899999999999999999999999999999999999999999999999999987766


Q ss_pred             C--cccccCCCcccccccccCC
Q 010676          483 D--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      .  ..+..||+.||+||++.+.
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~  181 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDI  181 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCC
Confidence            4  4567899999999999875

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.96  E-value=1.6e-28  Score=249.27  Aligned_cols=171  Identities=25%  Similarity=0.402  Sum_probs=144.3

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-CceeEEeeeecCCCeEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~~~~~~~lyL  407 (504)
                      +|++++.||+|+||.||+|.+ .++..||+|++.....  ........+..|+.++..+.| ++|+++++++...+.+|+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            488999999999999999998 4678999998864221  112334567789999999876 568889999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc--cCCc
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDV  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~--~~~~  484 (504)
                      ||||+++|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....  ....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence            99999999999888654 58999999999999999999999999999999999999999999999999987532  2223


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ...+||+.|+|||++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~  176 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQ  176 (324)
T ss_pred             eeecCCccccChhhhcCC
Confidence            445799999999998764

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.96  E-value=1.3e-29  Score=257.95  Aligned_cols=164  Identities=29%  Similarity=0.459  Sum_probs=138.8

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC-----
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-----  402 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-----  402 (504)
                      -.|.-.+++|.|+||.||+|+. .++..||||.+.......         .+|+.+|+.++|||||+++.+|...     
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---------NRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            3688899999999999999998 578999999886433322         2789999999999999998877432     


Q ss_pred             CeEEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEecCcc
Q 010676          403 SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLA  476 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~-g~VKL~DFGLA  476 (504)
                      -++.+||||++. +|.++++.     ..++.-.++.|++||+.||.|||+.||+||||||.|||+|.+ |.+||||||.|
T Consensus        95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            256799999987 78888873     468888999999999999999999999999999999999965 99999999999


Q ss_pred             cccccCC-cccccCCCcccccccccCC
Q 010676          477 KATKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       477 ~~~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      +.+..+. ..++..|.+|+|||++.|.
T Consensus       174 K~L~~~epniSYicSRyYRaPELifga  200 (364)
T KOG0658|consen  174 KVLVKGEPNISYICSRYYRAPELIFGA  200 (364)
T ss_pred             eeeccCCCceeEEEeccccCHHHHcCc
Confidence            9865544 4556689999999999874

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.96  E-value=1.4e-28  Score=250.31  Aligned_cols=171  Identities=29%  Similarity=0.438  Sum_probs=139.8

Q ss_pred             ccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeec
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  400 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~  400 (504)
                      .++|++.+.||+|+||.||+|.+      .++..||+|++....    .......+.+|+.+|..+ +||||+++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            35799999999999999999974      345789999875321    122345688999999999 8999999999877


Q ss_pred             CC-CeEEEEEEeccCCCHHHHHHhc-------------------------------------------------------
Q 010676          401 DE-SKLYIFLELVTKGSLLNLYQRY-------------------------------------------------------  424 (504)
Q Consensus       401 ~~-~~lyLVmEy~~ggsL~~ll~~~-------------------------------------------------------  424 (504)
                      .. ..+|+||||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            64 4689999999999999988642                                                       


Q ss_pred             --------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC----cccccCCCc
Q 010676          425 --------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF  492 (504)
Q Consensus       425 --------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~  492 (504)
                              .+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......    .....+++.
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                    26677888999999999999999999999999999999999999999999997643221    122346788


Q ss_pred             ccccccccCC
Q 010676          493 WMAPEVCSNP  502 (504)
Q Consensus       493 YmAPEVL~g~  502 (504)
                      |||||++.++
T Consensus       242 y~aPE~~~~~  251 (338)
T cd05102         242 WMAPESIFDK  251 (338)
T ss_pred             ccCcHHhhcC
Confidence            9999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.96  E-value=1.6e-28  Score=249.49  Aligned_cols=167  Identities=32%  Similarity=0.490  Sum_probs=141.0

Q ss_pred             eeecccCceeEEEEEc----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEE
Q 010676          335 DLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       335 k~LG~G~FG~VYka~~----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmE  410 (504)
                      +.||+|+||.||++..    .++..||+|++....... .......+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh-hhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            6799999999999986    367899999886432211 12233567789999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Ccccc
Q 010676          411 LVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSC  487 (504)
Q Consensus       411 y~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~s~  487 (504)
                      |+.+++|.+++...+ +.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....  .....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            999999999886554 788889999999999999999999999999999999999999999999998753322  23345


Q ss_pred             cCCCcccccccccCC
Q 010676          488 RGTAFWMAPEVCSNP  502 (504)
Q Consensus       488 ~GT~~YmAPEVL~g~  502 (504)
                      +||+.|+|||++.+.
T Consensus       161 ~gt~~y~aPE~~~~~  175 (323)
T cd05584         161 CGTIEYMAPEILMRS  175 (323)
T ss_pred             CCCccccChhhccCC
Confidence            699999999998754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=2.4e-28  Score=262.59  Aligned_cols=163  Identities=27%  Similarity=0.286  Sum_probs=140.0

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ...|.+.+.||+|+||.||+|.+ .++..||||....           ..+.+|+.+|++++|+|||++++++...+..|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            34799999999999999999998 5678899995321           23468999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      +||+++. ++|..++...  .+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++...... 
T Consensus       237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            9999996 5787777543  58999999999999999999999999999999999999999999999999987654322 


Q ss_pred             ---cccccCCCcccccccccCC
Q 010676          484 ---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ---~~s~~GT~~YmAPEVL~g~  502 (504)
                         .....||+.|||||++.+.
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~  337 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGD  337 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCC
Confidence               1234699999999998765

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.96  E-value=2.9e-28  Score=248.60  Aligned_cols=170  Identities=26%  Similarity=0.410  Sum_probs=145.3

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||++.. .++..||+|++.....  ........+.+|+.++..++|+||+++++++.+.+.+|+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence            3689999999999999999997 5678899998854221  122233457789999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      ||||+.+|+|.+++.+  ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            9999999999999976  458899999999999999999999999999999999999999999999999987543222  


Q ss_pred             -cccccCCCccccccccc
Q 010676          484 -VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~  500 (504)
                       ....+||+.|||||++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~  176 (332)
T cd05623         159 QSSVAVGTPDYISPEILQ  176 (332)
T ss_pred             eecccccCccccCHHHHh
Confidence             12346999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.96  E-value=2.3e-28  Score=245.00  Aligned_cols=169  Identities=30%  Similarity=0.482  Sum_probs=142.7

Q ss_pred             ccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++.......    ....+.+|+.+++.++||||+++++++.+...+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG----TPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc----cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence            357999999999999999999984 78999999886432211    1234668999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--
Q 010676          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--  482 (504)
                      +||||+.+ +|.+++..  ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        80 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          80 LVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             EEEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence            99999964 67776654  34889999999999999999999999999999999999999999999999998754322  


Q ss_pred             CcccccCCCcccccccccC
Q 010676          483 DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g  501 (504)
                      ......||+.|||||++.+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~  177 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLG  177 (303)
T ss_pred             cCCCCcccCCCCChHHHcC
Confidence            2334568999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=2.8e-28  Score=244.18  Aligned_cols=170  Identities=29%  Similarity=0.368  Sum_probs=141.8

Q ss_pred             cceeeeeeecccCceeEEEEEcc-----------------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN  391 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-----------------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn  391 (504)
                      ++|++.+.||+|+||.||+|.+.                 ++..||+|.+....    .......+.+|+.++..++|||
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----CHHHHHHHHHHHHHHhhcCCCC
Confidence            57899999999999999999753                 23479999875422    1233467889999999999999


Q ss_pred             eeEEeeeecCCCeEEEEEEeccCCCHHHHHHhcC--------------------CChHHHHHHHHHHHHHHHHHHHCCce
Q 010676          392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--------------------LRDSQVSAYTRQILLGLKYLHDQDVV  451 (504)
Q Consensus       392 IV~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~--------------------l~e~~v~~i~~QIl~gL~yLHs~gII  451 (504)
                      |+++++++...+.+|+||||+.+++|.+++....                    +++..+..++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999886532                    46677889999999999999999999


Q ss_pred             ecCCCCCcEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          452 HRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       452 HRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||||||+|||++.++.+||+|||+++......    .....++..|||||++.++
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  215 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG  215 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC
Confidence            99999999999999999999999987654332    1233467889999987654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.96  E-value=2.6e-28  Score=241.38  Aligned_cols=171  Identities=25%  Similarity=0.417  Sum_probs=145.6

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||+|++ .++..||+|++......   ......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN---EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence            3689999999999999999998 47889999988653322   2233567789999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC---
Q 010676          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~---  483 (504)
                      ||||+.++.|..+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            9999999877665543 458999999999999999999999999999999999999999999999999987654322   


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....||+.|+|||++.+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~  176 (287)
T cd07848         158 YTEYVATRWYRSPELLLGA  176 (287)
T ss_pred             ccccccccccCCcHHHcCC
Confidence            2345689999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.96  E-value=3.6e-28  Score=246.67  Aligned_cols=171  Identities=25%  Similarity=0.410  Sum_probs=143.7

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~lyL  407 (504)
                      +|++.+.||+|+||.||+|.+ .++..||+|++.....  ........+..|..++..+ +|++|+++++++...+.+|+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence            488899999999999999988 4778999998864321  1122334566777887776 58999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Cc
Q 010676          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~  484 (504)
                      ||||+++|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence            9999999999988765 45899999999999999999999999999999999999999999999999998754322  23


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ...+||+.|||||++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~  176 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQ  176 (323)
T ss_pred             ccCCCChhhcCHHHhcCC
Confidence            445799999999998765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.96  E-value=2.7e-28  Score=248.81  Aligned_cols=166  Identities=27%  Similarity=0.459  Sum_probs=141.7

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      ++||+|+||.||+|.+ .++..||+|++.....  ........+..|+.++..+ +||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV--NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            4699999999999998 5789999999874321  1223345678899999888 6999999999999999999999999


Q ss_pred             cCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc--cCCcccccC
Q 010676          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~--~~~~~s~~G  489 (504)
                      ++++|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...  .......+|
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence            99999987754 469999999999999999999999999999999999999999999999999987522  222344579


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|||||++.+.
T Consensus       159 t~~y~aPE~~~~~  171 (329)
T cd05588         159 TPNYIAPEILRGE  171 (329)
T ss_pred             CccccCHHHHcCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.96  E-value=5.1e-28  Score=246.68  Aligned_cols=171  Identities=27%  Similarity=0.406  Sum_probs=149.8

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .++|++.+.||+|+||.||++.+ .++..+|+|.+....    .......+.+|+.+|+.++||||+++++++..++.+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            36899999999999999999998 578899999886421    1223467889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      +||||+++++|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  159 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence            999999999999988764 588999999999999999999986 699999999999999999999999999876654445


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....||+.|+|||++.+.
T Consensus       160 ~~~~g~~~y~aPE~~~~~  177 (331)
T cd06649         160 NSFVGTRSYMSPERLQGT  177 (331)
T ss_pred             ccCCCCcCcCCHhHhcCC
Confidence            556799999999998764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.96  E-value=3.1e-28  Score=250.39  Aligned_cols=167  Identities=29%  Similarity=0.466  Sum_probs=142.5

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ...+|++++.||+|+||.||+|++ .+++.||||++....    .......+.+|+.+++.++|+||+++++++...+.+
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            356788899999999999999998 578999999885322    123345688999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |+||||+.+++|...   ....+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......  
T Consensus       148 ~lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        148 QVLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             EEEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            999999999988643   235677788999999999999999999999999999999999999999999987654322  


Q ss_pred             cccccCCCccccccccc
Q 010676          484 VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~  500 (504)
                      .....||..|+|||++.
T Consensus       225 ~~~~~gt~~y~aPE~~~  241 (353)
T PLN00034        225 CNSSVGTIAYMSPERIN  241 (353)
T ss_pred             ccccccCccccCccccc
Confidence            23457999999999884

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.96  E-value=3.3e-28  Score=247.14  Aligned_cols=166  Identities=31%  Similarity=0.461  Sum_probs=136.9

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHH-HHHhhCCCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI-ALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei-~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      +.||+|+||+||+|.+ .++..||+|++......  .......+..|. .+++.++|+||+++++++...+.+|+||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH--hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence            4699999999999998 57789999988642211  112223344444 4567899999999999999999999999999


Q ss_pred             cCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCcccccC
Q 010676          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~~s~~G  489 (504)
                      .+++|..++... .+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ......+|
T Consensus        79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence            999999988654 488889999999999999999999999999999999999999999999999875322  22345579


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|||||++.+.
T Consensus       159 t~~y~aPE~~~~~  171 (325)
T cd05602         159 TPEYLAPEVLHKQ  171 (325)
T ss_pred             CccccCHHHHcCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.96  E-value=3e-28  Score=246.40  Aligned_cols=165  Identities=32%  Similarity=0.491  Sum_probs=141.3

Q ss_pred             eeecccCceeEEEEEc----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEE
Q 010676          335 DLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       335 k~LG~G~FG~VYka~~----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmE  410 (504)
                      +.||+|+||.||++.+    .+|..||+|++......   ......+.+|+.+|.+++||||+++++++.+.+.+|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            5799999999999875    46889999998643221   1223456789999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Ccccc
Q 010676          411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSC  487 (504)
Q Consensus       411 y~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~s~  487 (504)
                      |+.+++|.+++... .+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence            99999999988654 5899999999999999999999999999999999999999999999999998764433  23345


Q ss_pred             cCCCcccccccccCC
Q 010676          488 RGTAFWMAPEVCSNP  502 (504)
Q Consensus       488 ~GT~~YmAPEVL~g~  502 (504)
                      .||+.|||||++.+.
T Consensus       159 ~g~~~y~aPE~~~~~  173 (318)
T cd05582         159 CGTVEYMAPEVVNRR  173 (318)
T ss_pred             cCChhhcCHHHHcCC
Confidence            799999999998754

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.96  E-value=4.4e-28  Score=246.25  Aligned_cols=166  Identities=32%  Similarity=0.462  Sum_probs=138.1

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHH-HHhhCCCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      ++||+|+||.||+|.+ .+|..||+|++......  .......+..|.. +++.++||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL--NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence            4699999999999998 57899999988643211  1122344555554 567799999999999999999999999999


Q ss_pred             cCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc--cCCcccccC
Q 010676          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~--~~~~~s~~G  489 (504)
                      .+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...  .......+|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence            99999887765 458999999999999999999999999999999999999999999999999987532  222345579


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|||||++.++
T Consensus       159 t~~y~aPE~~~~~  171 (325)
T cd05604         159 TPEYLAPEVIRKQ  171 (325)
T ss_pred             ChhhCCHHHHcCC
Confidence            9999999998765

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.96  E-value=4.2e-28  Score=246.18  Aligned_cols=166  Identities=33%  Similarity=0.482  Sum_probs=137.7

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHH-HHhhCCCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      +.||+|+||+||+|.+ .+|..||+|++......  .......+..|.. +++.++||||+++++++...+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL--KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence            4699999999999998 57999999988643211  1122334455544 567899999999999999999999999999


Q ss_pred             cCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCcccccC
Q 010676          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~~s~~G  489 (504)
                      .+++|..++... .+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....  ......+|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence            999999888654 588999999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|||||++.++
T Consensus       159 t~~y~aPE~~~~~  171 (323)
T cd05575         159 TPEYLAPEVLRKQ  171 (323)
T ss_pred             ChhhcChhhhcCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.96  E-value=5e-28  Score=245.14  Aligned_cols=166  Identities=31%  Similarity=0.484  Sum_probs=137.5

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHH-HHhhCCCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      ++||+|+||.||+|.+ .++..||+|++......  .......+..|+. +++.++||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL--KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4699999999999998 57889999988642211  1222344555554 678899999999999999999999999999


Q ss_pred             cCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCcccccC
Q 010676          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~~s~~G  489 (504)
                      ++++|..++.. ..+.+..+..|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....  ......+|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence            99999887765 4588999999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|+|||++.+.
T Consensus       159 t~~y~aPE~~~~~  171 (321)
T cd05603         159 TPEYLAPEVLRKE  171 (321)
T ss_pred             CcccCCHHHhcCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.96  E-value=5.2e-28  Score=246.97  Aligned_cols=166  Identities=28%  Similarity=0.464  Sum_probs=140.8

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      +.||+|+||.||+|.+ .++..||+|++......  .......+.+|+.++.++ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc--chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence            4699999999999998 57889999998753221  123345677888888776 7999999999999999999999999


Q ss_pred             cCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCcccccC
Q 010676          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~~s~~G  489 (504)
                      ++++|..++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....  ......+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence            99999887765 4599999999999999999999999999999999999999999999999999875322  22334579


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|+|||++.++
T Consensus       159 t~~y~aPE~~~~~  171 (329)
T cd05618         159 TPNYIAPEILRGE  171 (329)
T ss_pred             CccccCHHHHcCC
Confidence            9999999998765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=4.7e-28  Score=245.00  Aligned_cols=168  Identities=28%  Similarity=0.486  Sum_probs=140.0

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC-----C
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-----S  403 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-----~  403 (504)
                      +|++.+.||+|+||.||+|++ .++..||||.+......   ......+.+|+.+++.++||||+++++++...     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   77 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH---VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK   77 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc---chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence            589999999999999999997 57899999987632211   12235678999999999999999999887533     3


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .+|+||||+. ++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          78 DIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             eEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            5899999996 5788877654 5899999999999999999999999999999999999999999999999998754322


Q ss_pred             C-----cccccCCCcccccccccC
Q 010676          483 D-----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~-----~~s~~GT~~YmAPEVL~g  501 (504)
                      .     .....||+.|+|||++.+
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~  180 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGS  180 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhc
Confidence            1     234569999999999865

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.95  E-value=5.1e-28  Score=245.43  Aligned_cols=166  Identities=27%  Similarity=0.483  Sum_probs=137.5

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhh-CCCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      ++||+|+||.||+|.+ .++..||+|.+......  .......+..|..++.. ++||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL--EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4699999999999998 57889999988643211  11223344556666654 47999999999999999999999999


Q ss_pred             cCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCcccccC
Q 010676          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~~s~~G  489 (504)
                      ++|+|..++... .+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ......+|
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence            999999888654 589999999999999999999999999999999999999999999999999875432  22344579


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|||||++.+.
T Consensus       159 t~~y~aPE~~~~~  171 (316)
T cd05592         159 TPDYIAPEILKGQ  171 (316)
T ss_pred             CccccCHHHHcCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.95  E-value=5.8e-28  Score=245.70  Aligned_cols=171  Identities=25%  Similarity=0.413  Sum_probs=144.2

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCeEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~lyL  407 (504)
                      .|+..+.||+|+||.||+|.+ .++..||+|++.....  ........+..|+.++..+. |++|+++++++.+.+.+|+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            377889999999999999997 5789999998864221  11233456778888888876 5788889999999999999


Q ss_pred             EEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Cc
Q 010676          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~  484 (504)
                      ||||+++|+|..++.. ..+++.++..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence            9999999999998866 45899999999999999999999999999999999999999999999999998754322  23


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....||+.|||||++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~  176 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQ  176 (323)
T ss_pred             cCccCCccccCHHHHcCC
Confidence            345699999999998765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.95  E-value=4.9e-28  Score=245.93  Aligned_cols=166  Identities=29%  Similarity=0.473  Sum_probs=139.5

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      ++||+|+||.||+|.+ .++..||+|++.....  ........+..|+.++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence            4699999999999998 5788999998864221  1122345566788888776 6999999999999999999999999


Q ss_pred             cCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCcccccC
Q 010676          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~~s~~G  489 (504)
                      ++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence            99999988765 4589999999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|||||++.+.
T Consensus       159 t~~y~aPE~~~~~  171 (320)
T cd05590         159 TPDYIAPEILQEM  171 (320)
T ss_pred             CccccCHHHHcCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.95  E-value=8.1e-28  Score=245.92  Aligned_cols=171  Identities=27%  Similarity=0.427  Sum_probs=148.3

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .++|++.+.||+|+||.||++.+ .++..+|+|.+.....    ......+.+|+.+++.++|+||++++++|..++.+|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC----HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            35799999999999999999998 4788999998764321    223456889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      +||||+.+++|.+++... .+++..+..++.|++.||.|||++ +|+|+||||+|||++.++.+||+|||++........
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~  159 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc
Confidence            999999999999988764 478888999999999999999975 799999999999999999999999999876544444


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....||..|+|||++.+.
T Consensus       160 ~~~~~~~~y~aPE~~~~~  177 (333)
T cd06650         160 NSFVGTRSYMSPERLQGT  177 (333)
T ss_pred             ccCCCCccccCHHHhcCC
Confidence            456799999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-27  Score=238.44  Aligned_cols=171  Identities=26%  Similarity=0.391  Sum_probs=145.3

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .|++.+.||+|+||.||++.+ .++..||+|++......  .......+.+|+.+++.++|+||+++++++.+++.+|+|
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh--hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            378899999999999999998 57899999988642221  122234567899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-c
Q 010676          409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-V  484 (504)
Q Consensus       409 mEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-~  484 (504)
                      |||+.+++|..++..   ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....... .
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            999999999987743   248899999999999999999999999999999999999999999999999987654332 2


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....||+.|||||++.+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~  176 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNE  176 (285)
T ss_pred             ccccCCCCccCcHHhcCC
Confidence            345689999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.95  E-value=6e-28  Score=244.84  Aligned_cols=166  Identities=29%  Similarity=0.441  Sum_probs=139.1

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      ++||+|+||.||+|.+ .++..||+|++.....  ........+..|+.++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence            4699999999999998 5688999998864221  1123345566788888765 7999999999999999999999999


Q ss_pred             cCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--CcccccC
Q 010676          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~s~~G  489 (504)
                      ++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  .....+|
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence            99999987754 45889999999999999999999999999999999999999999999999998753322  2334569


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|||||++.+.
T Consensus       159 t~~y~aPE~~~~~  171 (321)
T cd05591         159 TPDYIAPEILQEL  171 (321)
T ss_pred             CccccCHHHHcCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.95  E-value=9.2e-28  Score=238.36  Aligned_cols=164  Identities=27%  Similarity=0.423  Sum_probs=139.6

Q ss_pred             ecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccCC
Q 010676          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (504)
Q Consensus       337 LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~gg  415 (504)
                      ||+|+||+||++.+ .++..||+|.+.....  ........+..|+.+++.++|+||+++++++.....+|+||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL--KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHH--hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence            79999999999998 5789999998864221  12233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--ccccc
Q 010676          416 SLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCR  488 (504)
Q Consensus       416 sL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~~s~~  488 (504)
                      +|..++..     ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......  .....
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence            99877632     348899999999999999999999999999999999999999999999999987654332  23456


Q ss_pred             CCCcccccccccCC
Q 010676          489 GTAFWMAPEVCSNP  502 (504)
Q Consensus       489 GT~~YmAPEVL~g~  502 (504)
                      ||+.|||||++.++
T Consensus       159 g~~~y~aPE~~~~~  172 (280)
T cd05608         159 GTPGFMAPELLQGE  172 (280)
T ss_pred             CCcCccCHHHhcCC
Confidence            99999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1e-28  Score=251.05  Aligned_cols=172  Identities=29%  Similarity=0.475  Sum_probs=149.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC---
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---  401 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~---  401 (504)
                      .+..+|..++.||+|.||.|+.+.+ .+|..||||.+...   .......++..+|+++|+.++|+||+.+++.+..   
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~---F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP---FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh---hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            3455677789999999999999998 68999999977521   2334455778899999999999999999998865   


Q ss_pred             --CCeEEEEEEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          402 --ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       402 --~~~lyLVmEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                        -+.+|+|+|+|+ .+|.++++... +++..+..+++||+.||+|+|+.||+||||||.|+|++.+..+||+|||||+.
T Consensus        96 ~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   96 DKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             cccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence              356999999995 58999999887 99999999999999999999999999999999999999999999999999998


Q ss_pred             cc----cCCcccccCCCcccccccccC
Q 010676          479 TK----LNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       479 ~~----~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      ..    ...++.++.|.+|.|||++..
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~  201 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLN  201 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhc
Confidence            74    444677889999999998854

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=1.1e-27  Score=257.74  Aligned_cols=169  Identities=27%  Similarity=0.408  Sum_probs=143.9

Q ss_pred             cceeeeeeecccCceeEEEEEcc-C-CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-D-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-~-g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ..|.+.+.||+|+||.||+|... + +..|++|.+....     ......+.+|+.+|+.++|||||++++++...+.+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-----ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            35999999999999999999873 4 6788888664322     222345678999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      |||||+++|+|.+++..     ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999999987753     2488899999999999999999999999999999999999999999999999986543


Q ss_pred             CC----cccccCCCcccccccccCC
Q 010676          482 ND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..    ....+||+.|||||++.++
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~  246 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERK  246 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCC
Confidence            22    3345699999999998765

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=6.1e-28  Score=253.63  Aligned_cols=163  Identities=24%  Similarity=0.296  Sum_probs=140.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ...|++++.||+|+||.||+|.+ .+++.||+|...           ...+.+|+.+|+.++||||++++++|......|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            35799999999999999999998 678999999542           134578999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc---C
Q 010676          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL---N  482 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~---~  482 (504)
                      +|||++. ++|..++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++....   .
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            9999996 577776644 4689999999999999999999999999999999999999999999999999865322   2


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....+||+.|+|||++.+.
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~  258 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARD  258 (391)
T ss_pred             ccccccCccCCCChhhhcCC
Confidence            23345799999999998764

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.95  E-value=1e-27  Score=244.24  Aligned_cols=166  Identities=26%  Similarity=0.451  Sum_probs=141.6

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      ++||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.++.++ +|+||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV--HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence            4699999999999998 5788999999864321  2233456678899999887 5999999999999999999999999


Q ss_pred             cCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc--cCCcccccC
Q 010676          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~--~~~~~s~~G  489 (504)
                      ++++|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...  .......+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence            99999988765 469999999999999999999999999999999999999999999999999987532  222344679


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|||||++.+.
T Consensus       159 t~~y~aPE~~~~~  171 (327)
T cd05617         159 TPNYIAPEILRGE  171 (327)
T ss_pred             CcccCCHHHHCCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=3.4e-28  Score=250.71  Aligned_cols=148  Identities=27%  Similarity=0.438  Sum_probs=133.3

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .+.|++++.||.|.-|+||++.. .++..+|+|++......  ....+.+.+.|-+||..++||+++.||..|+++..+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~--~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA--SRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh--hhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            45789999999999999999998 46699999998654332  2445677788999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      ++||||+||+|..+.++.   .|++..++.|+.+++.||+|||..|||+|||||+||||.++|+|.|+||.|+.
T Consensus       154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccc
Confidence            999999999999998764   39999999999999999999999999999999999999999999999999863

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.95  E-value=1.9e-27  Score=244.85  Aligned_cols=172  Identities=28%  Similarity=0.423  Sum_probs=142.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-  403 (504)
                      .+.++|++.+.||+|+||.||++.+ .+|..||+|++.....   .......+.+|+.+++.++||||+++++++.... 
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   94 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ---NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS   94 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc---chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence            4567899999999999999999998 5789999998864321   1223456778999999999999999999886543 


Q ss_pred             -----eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          404 -----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       404 -----~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                           .+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876          95 LEEFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             ccccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence                 57999999986 4655553 3588899999999999999999999999999999999999999999999999876


Q ss_pred             cccCC-cccccCCCcccccccccCC
Q 010676          479 TKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..... .....||+.|+|||++.+.
T Consensus       173 ~~~~~~~~~~~~t~~y~aPE~~~~~  197 (359)
T cd07876         173 ACTNFMMTPYVVTRYYRAPEVILGM  197 (359)
T ss_pred             cccCccCCCCcccCCCCCchhccCC
Confidence            43322 3445689999999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.8e-27  Score=229.91  Aligned_cols=174  Identities=46%  Similarity=0.764  Sum_probs=149.8

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      +.|++.+.||+|+||.||+|.+ .++..|++|.+...............+.+|+.+++.++||||+++++++.....+|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4689999999999999999997 578999999887544333334445678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC---
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~---  483 (504)
                      ||||+++++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++......   
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            99999999999988654 47888999999999999999999999999999999999999999999999987543221   


Q ss_pred             --cccccCCCcccccccccCC
Q 010676          484 --VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 --~~s~~GT~~YmAPEVL~g~  502 (504)
                        .....|+..|+|||++.+.
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~  182 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGE  182 (263)
T ss_pred             ccccCCCcCccccCcceeccC
Confidence              1334588999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.95  E-value=1.3e-27  Score=236.72  Aligned_cols=170  Identities=31%  Similarity=0.491  Sum_probs=136.6

Q ss_pred             cceeeeeeecccCceeEEEEEc--cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC---CCCceeEEeeeec---
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDK---  400 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~--~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~---  400 (504)
                      ++|++.+.||+|+||.||+|.+  .++..||+|.+.........   ...+.+|+.+++.+   +||||+++++++.   
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~   77 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   77 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc---hHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence            3689999999999999999987  35788999988653322211   12344566666554   6999999999874   


Q ss_pred             --CCCeEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCc
Q 010676          401 --DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (504)
Q Consensus       401 --~~~~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGL  475 (504)
                        ....+|+||||+. ++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence              3456999999997 488888764   3488899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC-cccccCCCcccccccccCC
Q 010676          476 AKATKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       476 A~~~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ++...... .....||+.|+|||++.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~  184 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQS  184 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCC
Confidence            87654332 3345689999999998653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1e-27  Score=243.83  Aligned_cols=163  Identities=33%  Similarity=0.502  Sum_probs=135.7

Q ss_pred             ecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC---CCCceeEEeeeecCCCeEEEEEEec
Q 010676          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       337 LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      ||+|+||+||+|.+ .++..||+|++.....  ........+..|..++..+   .||||+++++++.+.+.+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHH--hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            79999999999998 5789999998864221  1122234455666666654   6999999999999999999999999


Q ss_pred             cCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCcccccC
Q 010676          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~~s~~G  489 (504)
                      .+++|..++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....  ......+|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence            999999887654 589999999999999999999999999999999999999999999999999875322  22345679


Q ss_pred             CCcccccccccC
Q 010676          490 TAFWMAPEVCSN  501 (504)
Q Consensus       490 T~~YmAPEVL~g  501 (504)
                      |+.|||||++.+
T Consensus       159 t~~y~aPE~~~~  170 (330)
T cd05586         159 TTEYLAPEVLLD  170 (330)
T ss_pred             CccccCHHHHcC
Confidence            999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.95  E-value=9.9e-28  Score=231.91  Aligned_cols=167  Identities=37%  Similarity=0.546  Sum_probs=145.2

Q ss_pred             eeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      |++++.||+|+||+||++.+ .++..||+|.+.......   .......+|+.+++.++|+||+++++++.....+|+||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE---EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH---HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc---cccchhhhhhhccccccccccccccccccccccccccc
Confidence            78999999999999999998 567799999987543322   22223446999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHH-hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc--ccCCccc
Q 010676          410 ELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT--KLNDVKS  486 (504)
Q Consensus       410 Ey~~ggsL~~ll~-~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~--~~~~~~s  486 (504)
                      ||+.+++|.+++. ...++...+..++.||+.||.+||++||+|+||||+|||++.++.++|+|||++...  .......
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999997 677999999999999999999999999999999999999999999999999998753  2223445


Q ss_pred             ccCCCccccccccc
Q 010676          487 CRGTAFWMAPEVCS  500 (504)
Q Consensus       487 ~~GT~~YmAPEVL~  500 (504)
                      ..+|..|+|||++.
T Consensus       158 ~~~~~~y~aPE~~~  171 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQ  171 (260)
T ss_dssp             SSSSGGGSCHHHHT
T ss_pred             cccccccccccccc
Confidence            67899999999987

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.95  E-value=1.1e-27  Score=242.85  Aligned_cols=166  Identities=28%  Similarity=0.470  Sum_probs=138.7

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhh-CCCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      ++||+|+||.||+|.+ .+|..||+|.+......  .......+..|..++.. ++||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence            4699999999999998 57889999988642211  11223445667777765 48999999999999999999999999


Q ss_pred             cCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc--cCCcccccC
Q 010676          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~--~~~~~s~~G  489 (504)
                      .+++|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...  .......+|
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence            999999888654 58999999999999999999999999999999999999999999999999987532  222345679


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|+|||++.+.
T Consensus       159 t~~y~aPE~~~~~  171 (316)
T cd05620         159 TPDYIAPEILQGL  171 (316)
T ss_pred             CcCccCHHHHcCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3e-29  Score=259.92  Aligned_cols=168  Identities=41%  Similarity=0.708  Sum_probs=151.6

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .|...++||+|.||.||+|.+ .+++.||+|++.+..    .+..+..+++|+.+|.+++++||.++|+.+..+..+|++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~----~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE----AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhh----cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            567779999999999999998 789999999997633    344567788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--cc
Q 010676          409 LELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~l-~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~~  485 (504)
                      ||||.||++.++++.+.+ .+..+..++++++.||.|||.++.+|||||+.|||+..+|.|||+|||.+.......  ..
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~  169 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK  169 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence            999999999999998876 888899999999999999999999999999999999999999999999987655433  35


Q ss_pred             cccCCCcccccccccC
Q 010676          486 SCRGTAFWMAPEVCSN  501 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g  501 (504)
                      .++||++||||||+.+
T Consensus       170 tfvGTPfwMAPEVI~~  185 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQ  185 (467)
T ss_pred             cccccccccchhhhcc
Confidence            6789999999999986

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.95  E-value=4.8e-28  Score=254.51  Aligned_cols=170  Identities=32%  Similarity=0.479  Sum_probs=146.8

Q ss_pred             eee--eeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          331 WQK--GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       331 y~i--~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      |++  .++||.|.||+||-|+. ++|+.||||++.+.......   ...+.+|+.||+++.||.||.+-..|++.+.+|.
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq---esqlR~EVaILq~l~HPGiV~le~M~ET~ervFV  640 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ---ESQLRNEVAILQNLHHPGIVNLECMFETPERVFV  640 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch---HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence            554  47899999999999998 79999999998765433322   2678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEecCcccccccC
Q 010676          408 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATKLN  482 (504)
Q Consensus       408 VmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~---g~VKL~DFGLA~~~~~~  482 (504)
                      |||-+.|.-|.-++.  .+++++...+.++.||+.||.|||-+||+|+||||+|||+...   -.+||||||+|+.+...
T Consensus       641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            999998866665553  4569999999999999999999999999999999999999754   47999999999998766


Q ss_pred             C-cccccCCCcccccccccCCC
Q 010676          483 D-VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       483 ~-~~s~~GT~~YmAPEVL~g~~  503 (504)
                      . ..+.+|||.|+|||||.++-
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkG  742 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKG  742 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhcc
Confidence            5 45678999999999998763

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=1.2e-28  Score=264.17  Aligned_cols=179  Identities=35%  Similarity=0.661  Sum_probs=152.4

Q ss_pred             CCCCccccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEe
Q 010676          318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY  396 (504)
Q Consensus       318 ~sp~~~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~  396 (504)
                      .++.++|.++      ...||+|.|-+||+|.+ .+|..||--.++..+. .+....+++|..|+.+|+.|+|+||+++|
T Consensus        35 ~~p~gRy~k~------~evLGrGafKtVYka~De~~giEVAWnqvk~~d~-~q~~~~leR~~~Ev~lLKsL~H~NIirfy  107 (632)
T KOG0584|consen   35 KDPTGRYLKF------DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV-TQSPEELERLYSEVHLLKSLKHPNIIRFY  107 (632)
T ss_pred             cCCCCceeeh------hhhcccccceeeeeccccccchhhHHHHHhHHHh-hcChHHHHHHHHHHHHHccCCCCceeeee
Confidence            3455655443      46799999999999999 5788888665554333 23345568899999999999999999999


Q ss_pred             eeecCCCe--EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEc-CCCcEEE
Q 010676          397 GTDKDESK--LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKL  470 (504)
Q Consensus       397 ~~~~~~~~--lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILLd-~~g~VKL  470 (504)
                      ++|.+...  +.+|+|++..|+|..|.++. .++...++.|++||+.||.|||++.  |||||||++||||+ ..|.|||
T Consensus       108 ~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKI  187 (632)
T KOG0584|consen  108 DSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKI  187 (632)
T ss_pred             eheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceee
Confidence            99987665  88999999999999999775 5899999999999999999999985  99999999999997 4589999


Q ss_pred             EecCcccccccCCcccccCCCcccccccccCCC
Q 010676          471 ADFGLAKATKLNDVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       471 ~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~~  503 (504)
                      +|+|||.........++.|||.|||||+....|
T Consensus       188 GDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~Y  220 (632)
T KOG0584|consen  188 GDLGLATLLRKSHAKSVIGTPEFMAPEMYEENY  220 (632)
T ss_pred             cchhHHHHhhccccceeccCccccChHHHhhhc
Confidence            999999988877777889999999999987655

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.95  E-value=1.5e-28  Score=242.53  Aligned_cols=177  Identities=27%  Similarity=0.470  Sum_probs=153.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccch---hhHHHHHHHHHHHHHHhhCC-CCceeEEeeeec
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFE-HENIVQYYGTDK  400 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~---~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~  400 (504)
                      .+...|...+.||+|..++|-++.. .+|..+|+|++.......   ......+...+|+.||+++. ||+|+++.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            3445677788899999999998877 688999999886543332   33444556678999999985 999999999999


Q ss_pred             CCCeEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          401 DESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       401 ~~~~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ++..+++|+|+|+.|.|++++... .++++....|++|++.|++|||.++||||||||+|||++.+.++||+|||+++.+
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence            999999999999999999999765 5999999999999999999999999999999999999999999999999999887


Q ss_pred             ccCC-cccccCCCcccccccccCC
Q 010676          480 KLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..+. ....||||+|+|||.+.-.
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~  197 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCS  197 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeee
Confidence            6654 6778999999999998643

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.95  E-value=1.7e-27  Score=241.79  Aligned_cols=166  Identities=30%  Similarity=0.503  Sum_probs=138.5

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhh-CCCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      +.||+|+||.||+|.+ .++..||+|++......  .......+..|..++.. ++||||+++++++.+.+.+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            4699999999999998 56889999988643211  11223445567777765 58999999999999999999999999


Q ss_pred             cCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCcccccC
Q 010676          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~~s~~G  489 (504)
                      ++|+|..++... .+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  .......|
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence            999999988764 588999999999999999999999999999999999999999999999999875322  22344569


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|||||++.+.
T Consensus       159 t~~y~aPE~~~~~  171 (316)
T cd05619         159 TPDYIAPEILLGQ  171 (316)
T ss_pred             CccccCHHHHcCC
Confidence            9999999998765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-29  Score=246.12  Aligned_cols=173  Identities=31%  Similarity=0.510  Sum_probs=150.6

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.+.|++.+.||+|.|+.||++.. .+|+.+|+|++........   ..+.+.+|+.|-+.|+|||||++.+...+...
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~---~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~   84 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQEESF   84 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc---cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence            4557899999999999999999987 7899999998865443322   45788999999999999999999999999999


Q ss_pred             EEEEEEeccCCCHH-HHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~-~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~---g~VKL~DFGLA~~~~  480 (504)
                      .|||+|++.|++|. ++.++.-+++..+..+++||+.+|.|+|.+||||||+||.|+|+...   .-+||+|||+|....
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            99999999999986 46677779999999999999999999999999999999999999643   359999999998776


Q ss_pred             cCC-cccccCCCcccccccccC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g  501 (504)
                      .+. ....+|||.||||||+..
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrk  186 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKK  186 (355)
T ss_pred             CccccccccCCCcccCHHHhhc
Confidence            332 455679999999999874

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=5.4e-28  Score=255.53  Aligned_cols=173  Identities=30%  Similarity=0.466  Sum_probs=148.7

Q ss_pred             cccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          323 RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       323 ~~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .+..-...+++++.||+|-||.||+|.+.....||+|.++....      ....|.+|+.+|++|+|+|||+++++|..+
T Consensus       200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m------~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM------SPEAFLREAQIMKKLRHEKLVKLYGVCTKQ  273 (468)
T ss_pred             CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc------ChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence            33344456778899999999999999998888999998875322      125677999999999999999999999998


Q ss_pred             CeEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ..+||||||+..|+|.++++.   ..+...+.+.++.||+.|++||+++++|||||...||||++++.+||+|||||+..
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence            899999999999999999986   34888999999999999999999999999999999999999999999999999966


Q ss_pred             ccCCcccccC---CCcccccccccC
Q 010676          480 KLNDVKSCRG---TAFWMAPEVCSN  501 (504)
Q Consensus       480 ~~~~~~s~~G---T~~YmAPEVL~g  501 (504)
                      ..+......|   ...|.|||.|.-
T Consensus       354 ~d~~Y~~~~~~kfPIkWtAPEa~~~  378 (468)
T KOG0197|consen  354 GDDEYTASEGGKFPIKWTAPEALNY  378 (468)
T ss_pred             CCCceeecCCCCCCceecCHHHHhh
Confidence            5555443333   345999998874

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.4e-27  Score=243.79  Aligned_cols=171  Identities=27%  Similarity=0.432  Sum_probs=145.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--  402 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|.+....   ........+.+|+.+|+.++|+||+++++++...  
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            4557899999999999999999997 578899999875322   1122345577899999999999999999887543  


Q ss_pred             ----CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       403 ----~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                          ..+|++|+++ +++|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence                4579999988 67899988888899999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCcccccCCCcccccccccC
Q 010676          479 TKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       479 ~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      .... .....||+.|+|||++.+
T Consensus       168 ~~~~-~~~~~~t~~y~aPE~~~~  189 (343)
T cd07878         168 ADDE-MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             cCCC-cCCccccccccCchHhcC
Confidence            5433 344569999999999876

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.95  E-value=1.4e-27  Score=257.33  Aligned_cols=165  Identities=29%  Similarity=0.422  Sum_probs=144.4

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-C-----CceeEEeeeecCC
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-H-----ENIVQYYGTDKDE  402 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H-----pnIV~l~~~~~~~  402 (504)
                      +|.++++||+|+||.|-+|++ .+++.||||+++..      +....+-..|+.+|..|+ |     -|||+++++|...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK------KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC------hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            799999999999999999999 68999999999743      334455668999999987 4     3899999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--CcEEEEecCccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAK  477 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~--g~VKL~DFGLA~  477 (504)
                      +++|||+|++.. +|.++++.++   ++...++.++.||+.||.+||++||||+||||+||||..-  ..|||+|||.+.
T Consensus       261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            999999999965 8999998764   7889999999999999999999999999999999999743  379999999998


Q ss_pred             ccccCCcccccCCCcccccccccCC
Q 010676          478 ATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       478 ~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....... .+..+..|+|||||.|.
T Consensus       340 ~~~q~vy-tYiQSRfYRAPEVILGl  363 (586)
T KOG0667|consen  340 FESQRVY-TYIQSRFYRAPEVILGL  363 (586)
T ss_pred             ccCCcce-eeeeccccccchhhccC
Confidence            7665544 67789999999999875

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.95  E-value=2.4e-27  Score=240.38  Aligned_cols=166  Identities=29%  Similarity=0.478  Sum_probs=140.5

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      ++||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.++..+ +||||+++++++...+.+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence            4699999999999988 4688999998864321  1122345567888888877 6999999999999999999999999


Q ss_pred             cCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CCcccccC
Q 010676          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG  489 (504)
Q Consensus       413 ~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~~~s~~G  489 (504)
                      .+++|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ......+|
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence            999999888765 699999999999999999999999999999999999999999999999999875322  22334569


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|||||++.+.
T Consensus       159 ~~~y~aPE~~~~~  171 (318)
T cd05570         159 TPDYIAPEILSYQ  171 (318)
T ss_pred             CccccCHHHhcCC
Confidence            9999999998764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-28  Score=253.60  Aligned_cols=175  Identities=26%  Similarity=0.388  Sum_probs=150.9

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..+.|..-++||+||||.||-+.. .+|+.||+|.+.....  ..+....-.++|-.+|.+++.++||.+-.+|++.+.+
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi--Kkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI--KKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH--HHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            345788889999999999999887 6899999997643222  2233334567899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHH-Hhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          406 YIFLELVTKGSLLNLY-QRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll-~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      |+||.+|.||+|.-++ +.+  +|++..+..|+.+|+.||++||..+||+|||||+|||+|+.|+|.|+|+|||..+..+
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            9999999999998654 333  6999999999999999999999999999999999999999999999999999987766


Q ss_pred             C-cccccCCCcccccccccCCC
Q 010676          483 D-VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       483 ~-~~s~~GT~~YmAPEVL~g~~  503 (504)
                      . ...-+||.+||||||++++.
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~  362 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEV  362 (591)
T ss_pred             CccccccCcccccCHHHHcCCc
Confidence            5 44448999999999999863

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.95  E-value=5e-27  Score=232.31  Aligned_cols=166  Identities=30%  Similarity=0.431  Sum_probs=144.9

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.++||+|+||.||+|.+ .++..||+|.+....    .......+.+|+.++++++||||+++++++...+.+++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            678899999999999999997 688999999886432    122335688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCccccc
Q 010676          409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR  488 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~~  488 (504)
                      |||+++++|..+   ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++............
T Consensus        78 ~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~  154 (279)
T cd06619          78 TEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV  154 (279)
T ss_pred             EecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence            999999998654   34788889999999999999999999999999999999999999999999999866555455567


Q ss_pred             CCCcccccccccCC
Q 010676          489 GTAFWMAPEVCSNP  502 (504)
Q Consensus       489 GT~~YmAPEVL~g~  502 (504)
                      ||..|+|||++.++
T Consensus       155 ~~~~y~aPE~~~~~  168 (279)
T cd06619         155 GTNAYMAPERISGE  168 (279)
T ss_pred             CChhhcCceeecCC
Confidence            99999999998754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.95  E-value=4.5e-27  Score=236.32  Aligned_cols=169  Identities=30%  Similarity=0.467  Sum_probs=142.5

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ++.|.+.+.||+|+||.||+|.+ .++..||+|.+........    ...+.+|+.+++.++|+||+++++++..++.+|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA----PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc----chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            35799999999999999999998 4788999998865332211    234668999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      +||||+.+ +|.+++...  .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            99999986 777776543  37888999999999999999999999999999999999999999999999987543222 


Q ss_pred             -cccccCCCcccccccccC
Q 010676          484 -VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g  501 (504)
                       .....+|+.|+|||++.+
T Consensus       160 ~~~~~~~~~~y~aPE~~~~  178 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLG  178 (309)
T ss_pred             ccccccccccccCCHHHhC
Confidence             233468999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.95  E-value=8.9e-27  Score=231.87  Aligned_cols=170  Identities=26%  Similarity=0.414  Sum_probs=144.4

Q ss_pred             eeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      |+..+.||+|+||+||+|.+ .+++.||+|.+.....  ........+.+|+.+++.++|+||+.+++++..++.+|++|
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence            67889999999999999988 5789999998864321  11223345678999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-Ccc
Q 010676          410 ELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVK  485 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-~~~  485 (504)
                      ||+.+++|..++...   .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR  159 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence            999999998877542   4899999999999999999999999999999999999999999999999998654322 223


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...|+..|+|||++.+.
T Consensus       160 ~~~g~~~~~aPE~~~~~  176 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQ  176 (285)
T ss_pred             CCCCCcCccChHHhcCC
Confidence            45689999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.95  E-value=9.8e-27  Score=231.88  Aligned_cols=170  Identities=27%  Similarity=0.413  Sum_probs=144.5

Q ss_pred             eeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      |++.+.||+|+||.||++.+ .+++.||+|.+......  .......+.+|+.+++.++|+||+.+++.+.+.+.+|+||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc--chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence            67889999999999999998 57899999987643221  1222345678999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-cc
Q 010676          410 ELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VK  485 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-~~  485 (504)
                      ||+.+++|.+++...   .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  159 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence            999999999887542   48889999999999999999999999999999999999999999999999987543322 23


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...||..|||||++.++
T Consensus       160 ~~~g~~~y~aPE~~~~~  176 (285)
T cd05630         160 GRVGTVGYMAPEVVKNE  176 (285)
T ss_pred             CCCCCccccChHHHcCC
Confidence            44699999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.95  E-value=2.4e-27  Score=245.44  Aligned_cols=168  Identities=30%  Similarity=0.477  Sum_probs=141.5

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-----
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-----  403 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----  403 (504)
                      +|++++.||+|+||.||++.+ .++..||+|.+.....   ......++.+|+.+++.++|+||+++++++...+     
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   77 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ---NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE   77 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc---chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence            478899999999999999998 5889999998753211   1223456889999999999999999999998776     


Q ss_pred             eEEEEEEeccCCCHHHHHH-hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~-~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .+|+||||+.+ +|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          78 EIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             eEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            79999999975 6776664 456899999999999999999999999999999999999999999999999998764332


Q ss_pred             C---cccccCCCcccccccccC
Q 010676          483 D---VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~---~~s~~GT~~YmAPEVL~g  501 (504)
                      .   .....+|+.|+|||++.+
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~  178 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMG  178 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcC
Confidence            2   233458999999999876

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=1.2e-26  Score=227.00  Aligned_cols=174  Identities=45%  Similarity=0.739  Sum_probs=146.7

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--CeE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKL  405 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--~~l  405 (504)
                      .+|++++.||+|+||.||++.+ .++..|++|.+...............+.+|+.+++.++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4789999999999999999998 5789999998864332222334457788999999999999999999988763  568


Q ss_pred             EEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc---
Q 010676          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL---  481 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~---  481 (504)
                      |++|||+++++|.+++... .+++..+..++.|++.+|.|||+++|+|+||||.|||++.++.++|+|||++.....   
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            9999999999999988664 578889999999999999999999999999999999999999999999999875432   


Q ss_pred             --CCcccccCCCcccccccccCC
Q 010676          482 --NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 --~~~~s~~GT~~YmAPEVL~g~  502 (504)
                        .......||..|+|||++.+.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~  184 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGE  184 (265)
T ss_pred             cccccccCCCCccccChhhhcCC
Confidence              123344689999999998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=276.32  Aligned_cols=173  Identities=29%  Similarity=0.427  Sum_probs=151.0

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..++|.++++||+|+||.|.+++. .+++.||+|++.+...-..  ....-|..|-.+|...+.+-|++++.+|++++++
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr--~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR--AETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc--hhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            346899999999999999999998 6899999998865222111  1224577888999998999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          406 YIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      |+||||++||+|..++.++. +++.++++|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.|-.+..++ 
T Consensus       151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence            99999999999999999887 9999999999999999999999999999999999999999999999999987665443 


Q ss_pred             c--ccccCCCcccccccccC
Q 010676          484 V--KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ~--~s~~GT~~YmAPEVL~g  501 (504)
                      .  ...+|||.|.+||||..
T Consensus       231 V~s~~aVGTPDYISPEvLqs  250 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQS  250 (1317)
T ss_pred             EEeccccCCCCccCHHHHHh
Confidence            2  34579999999999863

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.95  E-value=4.3e-27  Score=245.02  Aligned_cols=173  Identities=29%  Similarity=0.426  Sum_probs=142.7

Q ss_pred             ccccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeee
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT  398 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~  398 (504)
                      ...++|++++.||+|+||.||+|+.      .++..||+|++.....    ......+.+|+.+|..+ +||||++++++
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC----cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            3345799999999999999999973      3566899998753221    12235678999999999 79999999999


Q ss_pred             ecCCCeEEEEEEeccCCCHHHHHHhc------------------------------------------------------
Q 010676          399 DKDESKLYIFLELVTKGSLLNLYQRY------------------------------------------------------  424 (504)
Q Consensus       399 ~~~~~~lyLVmEy~~ggsL~~ll~~~------------------------------------------------------  424 (504)
                      +...+..|+||||+++|+|.+++...                                                      
T Consensus       108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            99999999999999999999888542                                                      


Q ss_pred             ----------------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          425 ----------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       425 ----------------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                                            .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                                  2567788899999999999999999999999999999999999999999998765432


Q ss_pred             Cc----ccccCCCcccccccccCC
Q 010676          483 DV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      ..    ....++..|||||++.+.
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~  291 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNC  291 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCC
Confidence            21    122356679999998764

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.95  E-value=6e-27  Score=249.69  Aligned_cols=164  Identities=29%  Similarity=0.424  Sum_probs=134.5

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-----  401 (504)
                      ...|++++.||+|+||.||+|.+ .++..||||.+....         ....+|+.+|+.++|+||+++++++..     
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK  135 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence            35799999999999999999998 578899999874321         123479999999999999999887633     


Q ss_pred             ---CCeEEEEEEeccCCCHHHHHH-----hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEe
Q 010676          402 ---ESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLAD  472 (504)
Q Consensus       402 ---~~~lyLVmEy~~ggsL~~ll~-----~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-~VKL~D  472 (504)
                         ...+|+||||+++ +|.+++.     ...+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|
T Consensus       136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence               2357899999986 5666553     23588899999999999999999999999999999999998665 799999


Q ss_pred             cCcccccccC-CcccccCCCcccccccccC
Q 010676          473 FGLAKATKLN-DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       473 FGLA~~~~~~-~~~s~~GT~~YmAPEVL~g  501 (504)
                      ||+++..... ......||+.|||||++.+
T Consensus       215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~  244 (440)
T PTZ00036        215 FGSAKNLLAGQRSVSYICSRFYRAPELMLG  244 (440)
T ss_pred             cccchhccCCCCcccCCCCcCccCHHHhcC
Confidence            9999865433 2344578999999999865

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=3e-27  Score=253.11  Aligned_cols=174  Identities=25%  Similarity=0.462  Sum_probs=155.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .....|.+.+.||+|.|+.|.+|++ .++..||||++.......   ...+.+.+|+.+++.++|||||+++.+..+...
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~---~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP---SKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh---HHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            4467899999999999999999998 689999999887544332   334558899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +|+||||+.+|.+++++.+. .+.+..+..+|.|++++++|||+++|||||||.+||||+.+.++||+||||+..+..+.
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence            99999999999999988765 47888999999999999999999999999999999999999999999999998876554


Q ss_pred             -cccccCCCcccccccccCC
Q 010676          484 -VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g~  502 (504)
                       ..+.||++.|.|||+++|.
T Consensus       210 ~lqt~cgsppyAaPEl~~g~  229 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGK  229 (596)
T ss_pred             cccccCCCCCccChHhhcCc
Confidence             5778999999999999986

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=1.1e-26  Score=231.23  Aligned_cols=171  Identities=31%  Similarity=0.518  Sum_probs=148.2

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||++.+ .++..+|+|.+.....  ........+.+|+.++++++||||+++++++...+.+|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI--VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence            3689999999999999999998 5789999998864221  112334668899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCccc
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s  486 (504)
                      ||||+.+++|.+++... .+++..+..++.||+.||.|||++||+|+||+|.||||+.++.+||+|||++...... ...
T Consensus        79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~~~  157 (290)
T cd05580          79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYT  157 (290)
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-CCC
Confidence            99999999999988654 5899999999999999999999999999999999999999999999999998875544 334


Q ss_pred             ccCCCcccccccccCC
Q 010676          487 CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       487 ~~GT~~YmAPEVL~g~  502 (504)
                      ..|++.|+|||.+.++
T Consensus       158 ~~~~~~y~aPE~~~~~  173 (290)
T cd05580         158 LCGTPEYLAPEIILSK  173 (290)
T ss_pred             CCCCccccChhhhcCC
Confidence            5689999999988654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.95  E-value=5e-27  Score=244.66  Aligned_cols=176  Identities=27%  Similarity=0.450  Sum_probs=143.8

Q ss_pred             cccccccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEE
Q 010676          323 RFKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY  395 (504)
Q Consensus       323 ~~~~~~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l  395 (504)
                      .+....++|++++.||+|+||.||+|++      .++..||+|.+.....    ......+.+|+.+++.+ +|+|||++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~~h~nIv~~  107 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH----TDEREALMSELKILSHLGQHKNIVNL  107 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC----HHHHHHHHHHHHHHHhhccCCceeeE
Confidence            3344456899999999999999999885      2345799998864322    12245688999999999 89999999


Q ss_pred             eeeecCCCeEEEEEEeccCCCHHHHHHhc---------------------------------------------------
Q 010676          396 YGTDKDESKLYIFLELVTKGSLLNLYQRY---------------------------------------------------  424 (504)
Q Consensus       396 ~~~~~~~~~lyLVmEy~~ggsL~~ll~~~---------------------------------------------------  424 (504)
                      ++++...+.+|+||||+.+|+|.+++...                                                   
T Consensus       108 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (374)
T cd05106         108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV  187 (374)
T ss_pred             eeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence            99999999999999999999999887532                                                   


Q ss_pred             --------------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          425 --------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       425 --------------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                                          .+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                                256778899999999999999999999999999999999999999999999876543221


Q ss_pred             ----ccccCCCcccccccccCC
Q 010676          485 ----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ----~s~~GT~~YmAPEVL~g~  502 (504)
                          ....++..|||||++.+.
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~  289 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDC  289 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCC
Confidence                122356679999988654

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.95  E-value=8.8e-27  Score=230.18  Aligned_cols=169  Identities=34%  Similarity=0.525  Sum_probs=135.9

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhh---CCCCceeEEeeeecC----
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENIVQYYGTDKD----  401 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~---L~HpnIV~l~~~~~~----  401 (504)
                      +|++.+.||+|+||.||+|.+ .++..||+|.+..........   ..+.+|+.+++.   ++||||+++++++..    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~   77 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP---LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD   77 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc---hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence            488999999999999999998 578999999886532221111   223456655554   479999999998754    


Q ss_pred             -CCeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          402 -ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       402 -~~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                       ...++++|||+.+ +|..++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        78 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          78 RETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             CCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence             3458999999985 788877653   48899999999999999999999999999999999999999999999999987


Q ss_pred             ccccCC-cccccCCCcccccccccCC
Q 010676          478 ATKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       478 ~~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...... .....||..|+|||++.+.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~  182 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS  182 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC
Confidence            654332 2345689999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.95  E-value=6.8e-27  Score=229.80  Aligned_cols=170  Identities=22%  Similarity=0.365  Sum_probs=142.7

Q ss_pred             cceeeeeeecccCceeEEEEEc----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ..|++.+.||+|+||.||+|++    ..+..||+|.+.....    ......+.+|+.++.+++||||+++++++...+.
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS----DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC----HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            4689999999999999999975    3466899998764321    2223568899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +|+||||+++++|.+++...  .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999988753  5889999999999999999999999999999999999999999999999987653322


Q ss_pred             Cc---ccccCCCcccccccccCC
Q 010676          483 DV---KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~---~s~~GT~~YmAPEVL~g~  502 (504)
                      ..   ....++..|+|||++.++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~  183 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYH  183 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhC
Confidence            11   122356789999988654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.95  E-value=8.9e-27  Score=230.94  Aligned_cols=164  Identities=29%  Similarity=0.401  Sum_probs=137.7

Q ss_pred             ecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccCC
Q 010676          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (504)
Q Consensus       337 LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~gg  415 (504)
                      ||+|+||.||++.. .+|..||+|.+.......  ......+..|+.+++.++||||+++++++..+..+|+||||+.++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence            79999999999987 579999999886422211  112234557999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-cccccCCC
Q 010676          416 SLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTA  491 (504)
Q Consensus       416 sL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-~~s~~GT~  491 (504)
                      +|..++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .....||.
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence            998877543   47888889999999999999999999999999999999999999999999987654332 23456899


Q ss_pred             cccccccccCC
Q 010676          492 FWMAPEVCSNP  502 (504)
Q Consensus       492 ~YmAPEVL~g~  502 (504)
                      .|+|||++.++
T Consensus       159 ~y~aPE~~~~~  169 (277)
T cd05607         159 GYMAPEILKEE  169 (277)
T ss_pred             CccCHHHHccC
Confidence            99999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=254.66  Aligned_cols=171  Identities=29%  Similarity=0.493  Sum_probs=146.4

Q ss_pred             ccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +....+++.++..||+|.||+||+|.+..  .||||++.......   +.++.|++|+.+|++-+|.||+-+.||+....
T Consensus       387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~---~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTP---EQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCH---HHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            33445567789999999999999999843  69999987655443   36788999999999999999999999998877


Q ss_pred             eEEEEEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc-
Q 010676          404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-  480 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~-  480 (504)
                      . .||+.+|+|.+|+.++.  +.+|...+...|++||++|+.|||.++|||||||..||||+++++|||+||||+.... 
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence            6 99999999999999875  4568888999999999999999999999999999999999999999999999986422 


Q ss_pred             ---cCCcccccCCCccccccccc
Q 010676          481 ---LNDVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       481 ---~~~~~s~~GT~~YmAPEVL~  500 (504)
                         ........|...||||||+.
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIR  563 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIR  563 (678)
T ss_pred             eccccccCCCccchhhhcHHHHh
Confidence               22344556889999999986

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=9.7e-27  Score=252.08  Aligned_cols=173  Identities=27%  Similarity=0.403  Sum_probs=145.4

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC--
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  403 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~--  403 (504)
                      ..++|++.+.||+|+||+||+|.+ .++..||||.+......   ......+.+|+.++..++|+||++++..+...+  
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS---EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC---HHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            346899999999999999999987 68999999988653322   233456789999999999999999987764332  


Q ss_pred             ------eEEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 010676          404 ------KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       404 ------~lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                            .+++||||+.+|+|.+++..     ..+++..+..++.|++.||.|||+++|+||||||+||||+.++.+||+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence                  37899999999999998864     2488899999999999999999999999999999999999999999999


Q ss_pred             cCcccccccC----CcccccCCCcccccccccCC
Q 010676          473 FGLAKATKLN----DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       473 FGLA~~~~~~----~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||+++.....    .....+||+.|||||++.++
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~  220 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK  220 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCC
Confidence            9998764322    22345799999999999765

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.95  E-value=9.6e-27  Score=224.76  Aligned_cols=173  Identities=61%  Similarity=0.999  Sum_probs=150.9

Q ss_pred             ceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|+..+.||+|+||.||+|.+. ++..|++|.+...............+.+|+.+++.++|+||+++++++.....+|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999985 899999999876544444455567889999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-ccc
Q 010676          409 LELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKS  486 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-~~s  486 (504)
                      |||+++++|.+++.... +++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            99999999999987655 8899999999999999999999999999999999999999999999999987654332 344


Q ss_pred             ccCCCcccccccccCC
Q 010676          487 CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       487 ~~GT~~YmAPEVL~g~  502 (504)
                      ..|+..|+|||.+.++
T Consensus       161 ~~~~~~y~~pe~~~~~  176 (258)
T cd06632         161 FKGSPYWMAPEVIAQQ  176 (258)
T ss_pred             cCCCcceeCHHHhcCC
Confidence            5689999999987653

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.95  E-value=1.2e-26  Score=233.78  Aligned_cols=170  Identities=28%  Similarity=0.435  Sum_probs=147.5

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||++.+ .++..+++|.+.....    .....++.+|+.++..++||||+++++++..++.+|+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK----PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence            3689999999999999999987 5788899998754221    2234567889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~  485 (504)
                      ||||+++++|.+++... .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.........
T Consensus        77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (308)
T cd06615          77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  156 (308)
T ss_pred             EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence            99999999999998654 58899999999999999999997 69999999999999999999999999998765544445


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...|+..|+|||++.+.
T Consensus       157 ~~~~~~~~~aPE~~~~~  173 (308)
T cd06615         157 SFVGTRSYMSPERLQGT  173 (308)
T ss_pred             cCCCCcCccChhHhcCC
Confidence            56789999999998764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.95  E-value=4.8e-27  Score=241.16  Aligned_cols=172  Identities=26%  Similarity=0.393  Sum_probs=142.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--  402 (504)
                      .+.++|++.+.||+|+||.||++.+ .++..||+|.+.....   .......+.+|+.+++.++||||+++++++...  
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   90 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS   90 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc---ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence            4567999999999999999999998 5788999998754322   122345677899999999999999999987543  


Q ss_pred             ----CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       403 ----~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                          ..+|+||||+.+ +|...+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        91 ~~~~~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          91 LEEFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             ccccceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence                357999999986 56665543 588889999999999999999999999999999999999999999999999976


Q ss_pred             cccCC-cccccCCCcccccccccCC
Q 010676          479 TKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..... .....||+.|+|||++.+.
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~~~~~  193 (355)
T cd07874         169 AGTSFMMTPYVVTRYYRAPEVILGM  193 (355)
T ss_pred             CCCccccCCccccCCccCHHHHcCC
Confidence            54332 3345699999999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3e-28  Score=258.70  Aligned_cols=166  Identities=34%  Similarity=0.568  Sum_probs=144.9

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .|.-++.||.|+||.||.|.+ .+...||||.+...  +.+....-+.+..|+..|++++|||++.|.++|..+...|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsyS--GKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS--GKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeecccc--ccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            466678899999999999998 68899999987543  334445567788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHH--HhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCccc
Q 010676          409 LELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (504)
Q Consensus       409 mEy~~ggsL~~ll--~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s  486 (504)
                      ||||-| +-.+++  .+.++.+.++..|+.+.+.||.|||+++.||||||..|||++..|.|||+|||.|.....  ..+
T Consensus       105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--Ans  181 (948)
T KOG0577|consen  105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--ANS  181 (948)
T ss_pred             HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc--hhc
Confidence            999976 666666  356799999999999999999999999999999999999999999999999999865433  356


Q ss_pred             ccCCCccccccccc
Q 010676          487 CRGTAFWMAPEVCS  500 (504)
Q Consensus       487 ~~GT~~YmAPEVL~  500 (504)
                      ++|||+||||||+.
T Consensus       182 FvGTPywMAPEVIL  195 (948)
T KOG0577|consen  182 FVGTPYWMAPEVIL  195 (948)
T ss_pred             ccCCccccchhHhe
Confidence            78999999999985

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=5.2e-27  Score=242.42  Aligned_cols=162  Identities=25%  Similarity=0.276  Sum_probs=138.0

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ..|++++.||+|+||.||+|.+ .++..||+|+...           .....|+.+++.++|+||+++++++......|+
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            3699999999999999999998 4678899996431           112468999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-Cc
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DV  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-~~  484 (504)
                      ||||+.+ +|.+++..  ..+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++..... ..
T Consensus       135 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        135 VLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             EEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            9999965 77777654  35889999999999999999999999999999999999999999999999998753322 23


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....||+.|+|||++.+.
T Consensus       214 ~~~~gt~~y~aPE~~~~~  231 (357)
T PHA03209        214 LGLAGTVETNAPEVLARD  231 (357)
T ss_pred             ccccccccccCCeecCCC
Confidence            345699999999998764

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=1.6e-26  Score=241.83  Aligned_cols=165  Identities=24%  Similarity=0.288  Sum_probs=139.9

Q ss_pred             cccceeeeeeecccCceeEEEEEc---cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~---~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +..+|.+++.||+|+||.||++..   ..+..|++|.+...          ..+.+|+.+|+.++||||+++++++....
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~  159 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKS  159 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence            345799999999999999999975   34678899876421          12458999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .+|+|||++.+ +|..++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.++|+|||++......
T Consensus       160 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        160 TVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEEEEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            99999999974 77777654 45899999999999999999999999999999999999999999999999998754432


Q ss_pred             C----cccccCCCcccccccccCC
Q 010676          483 D----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      .    .....||+.|+|||++.+.
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~  262 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALD  262 (392)
T ss_pred             cccccccccccccCccCHhHhcCC
Confidence            2    2235699999999998754

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.94  E-value=1.2e-26  Score=239.16  Aligned_cols=172  Identities=27%  Similarity=0.392  Sum_probs=142.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--  402 (504)
                      .+.++|++.+.||+|+||.||++.+ .++..||||++.....   .......+.+|+.+++.++||||+++++++...  
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~   97 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS   97 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc---CchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence            4567899999999999999999998 5788999998864221   122335677899999999999999999887543  


Q ss_pred             ----CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       403 ----~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                          ..+|+||||+.+ +|..++. ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        98 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875          98 LEEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             ccccCeEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence                357999999976 6666664 3588889999999999999999999999999999999999999999999999976


Q ss_pred             cccCC-cccccCCCcccccccccCC
Q 010676          479 TKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..... .....||+.|+|||++.+.
T Consensus       176 ~~~~~~~~~~~~t~~y~aPE~~~~~  200 (364)
T cd07875         176 AGTSFMMTPYVVTRYYRAPEVILGM  200 (364)
T ss_pred             cCCCCcccCCcccCCcCCHHHHhCC
Confidence            54332 2345689999999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.94  E-value=1.4e-26  Score=244.41  Aligned_cols=177  Identities=28%  Similarity=0.434  Sum_probs=145.2

Q ss_pred             ccccccccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeE
Q 010676          322 GRFKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQ  394 (504)
Q Consensus       322 ~~~~~~~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~  394 (504)
                      +++....+.|+++++||+|+||.||+|++.      .+..||||.+.....    ....+.+.+|+.+|..+. ||||++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~~l~~l~~HpnIv~  105 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR----SSEKQALMSELKIMTHLGPHLNIVN  105 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCCCeee
Confidence            455555678999999999999999999862      235799998754221    223457889999999996 999999


Q ss_pred             EeeeecCCCeEEEEEEeccCCCHHHHHHhc--------------------------------------------------
Q 010676          395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--------------------------------------------------  424 (504)
Q Consensus       395 l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~--------------------------------------------------  424 (504)
                      +++++.....+||||||+++|+|.+++...                                                  
T Consensus       106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (400)
T cd05105         106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT  185 (400)
T ss_pred             EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence            999999999999999999999999887542                                                  


Q ss_pred             -----------------------------------------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 010676          425 -----------------------------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  457 (504)
Q Consensus       425 -----------------------------------------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP  457 (504)
                                                                     .+++..+..++.||+.||.|||+++|+||||||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp  265 (400)
T cd05105         186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA  265 (400)
T ss_pred             cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence                                                           256677889999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          458 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       458 ~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      +|||++.++.+||+|||+++......    .....++..|||||++.+.
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  314 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN  314 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC
Confidence            99999999999999999987643322    1223467889999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=7.2e-27  Score=230.96  Aligned_cols=170  Identities=32%  Similarity=0.509  Sum_probs=147.7

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++++.||+|+||.||++.+ .++..||+|.+....    .......+.+|+.++++++|+||+++++++...+.+|+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence            3688999999999999999998 488999999876421    12234568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc----CCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          408 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~----~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      ||||+++++|..++...    .+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999999988764    68999999999999999999997 59999999999999999999999999998765544


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ......+++.|+|||++.+.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~  176 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSG  176 (286)
T ss_pred             ccccCCCccCccCcchhcCC
Confidence            44555689999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.94  E-value=1.4e-26  Score=225.88  Aligned_cols=172  Identities=30%  Similarity=0.480  Sum_probs=146.7

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||+|++ .++..||+|.+.......  ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD--AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC--HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence            5799999999999999999998 588999999876433222  2334567889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      ||||+++++|.+++..     ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999999987742     23788899999999999999999999999999999999999999999999998765432


Q ss_pred             C--cccccCCCcccccccccCC
Q 010676          483 D--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      .  .....|++.|+|||++.+.
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~  181 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHEN  181 (267)
T ss_pred             hHHHhcCCCCccccChhhhccC
Confidence            2  2234688999999988653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.94  E-value=2.1e-26  Score=224.84  Aligned_cols=173  Identities=43%  Similarity=0.749  Sum_probs=148.2

Q ss_pred             ceeeeeeecccCceeEEEEEccCCceEEEEEEeccccc-hhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++++.||+|+||.||+|...++..+|+|.+...... .........+.+|+.+|+.++|+||+++++++...+.+|++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            48889999999999999999888999999988653322 22233456788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc------
Q 010676          409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------  481 (504)
Q Consensus       409 mEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~------  481 (504)
                      |||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++.....      
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (265)
T cd06631          81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT  160 (265)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence            999999999998876 4588999999999999999999999999999999999999999999999999875321      


Q ss_pred             --CCcccccCCCcccccccccCC
Q 010676          482 --NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 --~~~~s~~GT~~YmAPEVL~g~  502 (504)
                        .......|+..|+|||++.+.
T Consensus       161 ~~~~~~~~~~~~~~~~pe~~~~~  183 (265)
T cd06631         161 HSNMLKSMHGTPYWMAPEVINES  183 (265)
T ss_pred             ccccccccCCCccccChhhhcCC
Confidence              112234589999999998754

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.8e-26  Score=225.21  Aligned_cols=169  Identities=32%  Similarity=0.460  Sum_probs=144.7

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      .++|++.+.||+|+||.||+|.+.++..||+|.+.....      ....+.+|+.++++++|+||+++++++...+.+|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc------cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            357999999999999999999987788899998764321      13457889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      +|||+.+++|.+++...   .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999999998654   488999999999999999999999999999999999999999999999999886653332


Q ss_pred             ccccC---CCcccccccccCC
Q 010676          485 KSCRG---TAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~G---T~~YmAPEVL~g~  502 (504)
                      ....|   +..|+|||++.+.
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~  179 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYN  179 (261)
T ss_pred             cccCCCcCceeccCccccccC
Confidence            22223   4579999988653

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.94  E-value=1.3e-26  Score=226.53  Aligned_cols=168  Identities=39%  Similarity=0.612  Sum_probs=145.1

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .++|++.+.||+|+||.||+|.+ .++..||+|++.....     .....+.+|+.++..++||||+++++++.....+|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            35799999999999999999997 6788999998864321     12345778999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      +||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||.||+++.++.++|+|||++.......  
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence            99999999999998864 458999999999999999999999999999999999999999999999999987654222  


Q ss_pred             cccccCCCccccccccc
Q 010676          484 VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~  500 (504)
                      .....|++.|+|||++.
T Consensus       163 ~~~~~~~~~y~~PE~~~  179 (267)
T cd06646         163 RKSFIGTPYWMAPEVAA  179 (267)
T ss_pred             cCccccCccccCHhHcc
Confidence            23446899999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.94  E-value=3.4e-26  Score=221.10  Aligned_cols=170  Identities=32%  Similarity=0.571  Sum_probs=147.1

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|.+.+.||+|+||.||+|.+ .++..|++|.+......   ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN---RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC---HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            478889999999999999998 57899999988643322   23346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |||+.+++|.+++...   .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++......  
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999988663   48888999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....|++.|+|||++.++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~  176 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDK  176 (256)
T ss_pred             hhccccCccccCHHHhcCC
Confidence            2334689999999998765

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.94  E-value=1.9e-26  Score=224.42  Aligned_cols=168  Identities=26%  Similarity=0.433  Sum_probs=142.9

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      ++|++.+.||+|+||.||++...++..+|+|.+.....      ....+.+|+.+|+.++||||+++++++...+.+|+|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc------cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            46889999999999999999988888899997653221      124578899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc--
Q 010676          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--  484 (504)
Q Consensus       409 mEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~--  484 (504)
                      |||+++++|.+++..  ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++.......  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999999998864  3488899999999999999999999999999999999999999999999999875433222  


Q ss_pred             -ccccCCCcccccccccCC
Q 010676          485 -KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 -~s~~GT~~YmAPEVL~g~  502 (504)
                       ....++..|+|||++.++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~  176 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFS  176 (256)
T ss_pred             cCCCCCchhhCChhhcccC
Confidence             122356689999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.94  E-value=2.4e-26  Score=223.95  Aligned_cols=169  Identities=28%  Similarity=0.473  Sum_probs=144.9

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      .++|++.+.||+|+||.||+|...++..|++|.+....      .....+.+|+.+++.++|+||+++++++...+.+|+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            45899999999999999999998888889999765321      123568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      +|||+.+++|.+++..   ..++...+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            9999999999998864   3478888999999999999999999999999999999999999999999999976543321


Q ss_pred             ---ccccCCCcccccccccCC
Q 010676          485 ---KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ---~s~~GT~~YmAPEVL~g~  502 (504)
                         ....++..|+|||++.++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~  179 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFG  179 (261)
T ss_pred             eccCCCccceecCCHHHhccC
Confidence               223356789999998754

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.1e-26  Score=224.41  Aligned_cols=168  Identities=26%  Similarity=0.387  Sum_probs=142.2

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+......      ...+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            368899999999999999999877788999987532211      23567899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCccc
Q 010676          409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s  486 (504)
                      |||+++++|.+++...  .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999988653  47889999999999999999999999999999999999999999999999987654332222


Q ss_pred             cc---CCCcccccccccCC
Q 010676          487 CR---GTAFWMAPEVCSNP  502 (504)
Q Consensus       487 ~~---GT~~YmAPEVL~g~  502 (504)
                      ..   ++..|+|||++.+.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~  176 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYS  176 (256)
T ss_pred             cCCCCCCccccCHHHhccC
Confidence            22   34579999998754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.94  E-value=2.6e-26  Score=226.99  Aligned_cols=170  Identities=26%  Similarity=0.414  Sum_probs=142.7

Q ss_pred             cceeeeeeecccCceeEEEEEc-----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      ..|++.+.||+|+||.||+|..     .++..+++|.+....    .......+.+|+.+++.++||||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN----NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            5789999999999999999984     356789999875322    1233467889999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHh------------------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 010676          404 KLYIFLELVTKGSLLNLYQR------------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  465 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~------------------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~  465 (504)
                      ..|+||||+.+++|.+++..                  ..+++..+..++.||+.||.|||++||+|+||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            99999999999999998842                  236778889999999999999999999999999999999999


Q ss_pred             CcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          466 GSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       466 g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      +.+||+|||+++......    .....++..|+|||++.++
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  201 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG  201 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccC
Confidence            999999999987653322    2233467789999998654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.94  E-value=1.3e-26  Score=226.61  Aligned_cols=167  Identities=38%  Similarity=0.654  Sum_probs=144.8

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||+|.+ .++..||+|.+.....     .....+.+|+.+++.++||||+++++.+...+.+|+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-----EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-----hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence            4789999999999999999987 5789999998864321     223457789999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Cc
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~  484 (504)
                      ||||+++++|.+++... .+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......  ..
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence            99999999999988654 5899999999999999999999999999999999999999999999999998654322  12


Q ss_pred             ccccCCCccccccccc
Q 010676          485 KSCRGTAFWMAPEVCS  500 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~  500 (504)
                      ....||..|+|||++.
T Consensus       164 ~~~~~~~~y~aPE~~~  179 (267)
T cd06645         164 KSFIGTPYWMAPEVAA  179 (267)
T ss_pred             ccccCcccccChhhhc
Confidence            3446899999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.94  E-value=2.8e-26  Score=225.93  Aligned_cols=168  Identities=33%  Similarity=0.512  Sum_probs=141.7

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|.+.+.||+|+||.||+|.+ .++..||+|.+.......   .....+.+|+.+++.++||||+++++++..++.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE---GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC---CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence            488899999999999999998 578999999886432211   1224567899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          409 LELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      |||+. ++|.+++..    ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... 
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            99998 578877754    348899999999999999999999999999999999999999999999999987543221 


Q ss_pred             -cccccCCCcccccccccC
Q 010676          484 -VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g  501 (504)
                       .....+++.|+|||++.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~  175 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLG  175 (285)
T ss_pred             cccCCcccccccChHHhcC
Confidence             233457899999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.94  E-value=3.7e-26  Score=228.93  Aligned_cols=172  Identities=30%  Similarity=0.539  Sum_probs=149.6

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ....+|++.+.||+|+||.||+|.+ .++..|++|.+......     ....+.+|+.+++.+.|+||+++++.+.....
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~   91 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence            3456899999999999999999997 57889999988653322     13557789999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      +|+||||+.+++|.+++....+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++....... 
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             EEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            9999999999999999988788999999999999999999999999999999999999999999999999987543322 


Q ss_pred             -cccccCCCcccccccccCC
Q 010676          484 -VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g~  502 (504)
                       .....|++.|+|||++.++
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~  191 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRK  191 (296)
T ss_pred             ccCcccCCccccCHHHHcCC
Confidence             2334689999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.94  E-value=3.5e-26  Score=229.21  Aligned_cols=172  Identities=31%  Similarity=0.542  Sum_probs=150.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ....+|++.+.||+|+||.||++.+ .++..||+|.+......     ....+.+|+.+++.++|+||+++++++...+.
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDE   90 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence            3456899999999999999999997 68999999988643321     12457789999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      +|+||||+++++|.+++.+..+++..+..++.|++.+|.|||+.||+|+||||+|||++.++.++|+|||++....... 
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             EEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999987654332 


Q ss_pred             -cccccCCCcccccccccCC
Q 010676          484 -VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g~  502 (504)
                       .....+++.|+|||++.++
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~  190 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRK  190 (297)
T ss_pred             CcCcccCCccccCHHHHcCC
Confidence             2234689999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.94  E-value=5.3e-26  Score=220.75  Aligned_cols=169  Identities=28%  Similarity=0.498  Sum_probs=145.2

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||+|+||.||++.+ .++..|++|.+.....    ......+.+|+.+++.++|+||+++++.+.+.+.+|++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS----SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV   76 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            488999999999999999998 5789999998864322    12345677899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |||+++++|.+++..   ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......  
T Consensus        77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            999999999988754   237888999999999999999999999999999999999999999999999987553322  


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....|++.|+|||++.+.
T Consensus       157 ~~~~~~~~~~~aPE~~~~~  175 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENM  175 (255)
T ss_pred             cccccCCccccCHHHHccC
Confidence            2345689999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.94  E-value=2e-26  Score=229.04  Aligned_cols=171  Identities=28%  Similarity=0.475  Sum_probs=145.7

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||+|+||.||+|.+ .++..|++|.+...............+.+|+.+++.++|+||+++++++.+.+.+|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            478889999999999999997 5789999999875443322222335567899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--c
Q 010676          409 LELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~  484 (504)
                      |||+ +++|.+++....  +++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......  .
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 889999987754  8999999999999999999999999999999999999999999999999987654332  2


Q ss_pred             ccccCCCcccccccccC
Q 010676          485 KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g  501 (504)
                      ....+++.|+|||++.+
T Consensus       160 ~~~~~~~~y~aPE~~~~  176 (298)
T cd07841         160 THQVVTRWYRAPELLFG  176 (298)
T ss_pred             cccccceeeeCHHHHhC
Confidence            33357889999998854

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.94  E-value=3.2e-26  Score=260.60  Aligned_cols=173  Identities=24%  Similarity=0.311  Sum_probs=145.1

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++.++||+|+||.||+|.+ .++..||+|++.....  .......++.+|+.+++.++||||+++++++.+.+..|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly   78 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY   78 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence            36899999999999999999998 5789999998864221  12233457889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecC
Q 010676          407 IFLELVTKGSLLNLYQRY------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFG  474 (504)
                      +||||++|++|.+++...            .++...+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999999988631            24456678899999999999999999999999999999999999999999


Q ss_pred             cccccccCC--------------------cccccCCCcccccccccCC
Q 010676          475 LAKATKLND--------------------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       475 LA~~~~~~~--------------------~~s~~GT~~YmAPEVL~g~  502 (504)
                      +++......                    ....+||+.|||||++.+.
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~  206 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV  206 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC
Confidence            997652110                    1124699999999998764

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-27  Score=256.46  Aligned_cols=169  Identities=29%  Similarity=0.522  Sum_probs=145.3

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC----
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----  403 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----  403 (504)
                      .-|...+.||+|+||.||++++ .+|..||||.+.....    ........+|+++|++++|+|||++++.-++..    
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~----~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS----LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcc----cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            3577788999999999999997 7999999998865432    222456789999999999999999999866544    


Q ss_pred             --eEEEEEEeccCCCHHHHHHh----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--CCC--cEEEEec
Q 010676          404 --KLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANG--SVKLADF  473 (504)
Q Consensus       404 --~lyLVmEy~~ggsL~~ll~~----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd--~~g--~VKL~DF  473 (504)
                        ...+|||||.||+|..+++.    +++++.+++.++..++.||.|||++||+||||||.||++-  .+|  .-||+||
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence              46899999999999999964    6799999999999999999999999999999999999995  334  3699999


Q ss_pred             CcccccccCC-cccccCCCcccccccccC
Q 010676          474 GLAKATKLND-VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       474 GLA~~~~~~~-~~s~~GT~~YmAPEVL~g  501 (504)
                      |.|+.+..+. ..+.+||..|++||++..
T Consensus       169 G~Arel~d~s~~~S~vGT~~YLhPel~E~  197 (732)
T KOG4250|consen  169 GAARELDDNSLFTSLVGTEEYLHPELYER  197 (732)
T ss_pred             cccccCCCCCeeeeecCchhhcChHHHhh
Confidence            9999876654 677889999999999983

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=4.6e-26  Score=222.26  Aligned_cols=173  Identities=47%  Similarity=0.822  Sum_probs=147.1

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccch----hhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS----QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      +|.++..||+|+||.||+|.+ .++..|++|.+.......    ........+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            478889999999999999988 568899999886543322    223345678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +|+||||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++....+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999998764 57888999999999999999999999999999999999999999999999987654221


Q ss_pred             --------cccccCCCcccccccccCC
Q 010676          484 --------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 --------~~s~~GT~~YmAPEVL~g~  502 (504)
                              .....|+..|+|||++.++
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~  187 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQT  187 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccC
Confidence                    1123588999999988754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.7e-26  Score=222.34  Aligned_cols=174  Identities=45%  Similarity=0.732  Sum_probs=146.5

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--CeE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKL  405 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--~~l  405 (504)
                      ..|++.+.||+|+||.||+|.+ .++..|++|.+...............+.+|+.+++.++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3689999999999999999998 5789999998754332222344556788999999999999999999988654  568


Q ss_pred             EEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--
Q 010676          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--  482 (504)
                      +++|||+++++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            999999999999998865 45888999999999999999999999999999999999999999999999998754321  


Q ss_pred             ---CcccccCCCcccccccccCC
Q 010676          483 ---DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ---~~~s~~GT~~YmAPEVL~g~  502 (504)
                         ......++..|+|||++.+.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~  184 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGE  184 (264)
T ss_pred             cCccccccCCcccccCHhhhcCC
Confidence               12234589999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.94  E-value=2.7e-26  Score=230.88  Aligned_cols=160  Identities=31%  Similarity=0.476  Sum_probs=130.7

Q ss_pred             eeeecccCceeEEEEEcc---CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC--CCeEEEE
Q 010676          334 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLYIF  408 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~---~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--~~~lyLV  408 (504)
                      ++.||+|+||+||+|...   ++..||+|.+.....       ...+.+|+.+|+.++||||+++++++..  +..+|++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            467999999999999863   568899998753221       1235689999999999999999998843  5678999


Q ss_pred             EEeccCCCHHHHHHhc----------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----cCCCcEEEEecC
Q 010676          409 LELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFG  474 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~----------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL----d~~g~VKL~DFG  474 (504)
                      |||+.+ +|..++...          .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            999875 777766421          37888899999999999999999999999999999999    456789999999


Q ss_pred             cccccccC-----CcccccCCCcccccccccC
Q 010676          475 LAKATKLN-----DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       475 LA~~~~~~-----~~~s~~GT~~YmAPEVL~g  501 (504)
                      +++.....     ......||+.|||||++.+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  189 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG  189 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcC
Confidence            99765422     1234568999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.94  E-value=4.4e-26  Score=220.96  Aligned_cols=164  Identities=27%  Similarity=0.476  Sum_probs=137.6

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEecc
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~  413 (504)
                      +.||+|+||.||+|++ .++..||+|.+....    .......+.+|+.+++.++||||+++++++.....+|+||||+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL----PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            3699999999999998 578899999764221    12334568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcccc----
Q 010676          414 KGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC----  487 (504)
Q Consensus       414 ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~----  487 (504)
                      +++|.+++...  .+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++...........    
T Consensus        77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99999998653  378899999999999999999999999999999999999999999999999875443221111    


Q ss_pred             cCCCcccccccccCC
Q 010676          488 RGTAFWMAPEVCSNP  502 (504)
Q Consensus       488 ~GT~~YmAPEVL~g~  502 (504)
                      ..+..|+|||++.++
T Consensus       157 ~~~~~y~aPE~~~~~  171 (252)
T cd05084         157 QIPVKWTAPEALNYG  171 (252)
T ss_pred             CCceeecCchhhcCC
Confidence            124569999998765

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.94  E-value=2.3e-26  Score=224.42  Aligned_cols=172  Identities=31%  Similarity=0.530  Sum_probs=147.4

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||++.+ .++..++||.+.....  ........+.+|+.+++.++|+||+++++++...+.+|+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh--hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence            5788999999999999999997 6889999998764332  223334678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +|||+++++|.+++..     ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999999998763     34788999999999999999999999999999999999999999999999998765433


Q ss_pred             C--cccccCCCcccccccccCC
Q 010676          483 D--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      .  .....|+..|+|||++.+.
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~  181 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHEN  181 (267)
T ss_pred             CcccccccCCcCccCHHHhcCC
Confidence            2  2344689999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.94  E-value=6.7e-26  Score=222.10  Aligned_cols=173  Identities=46%  Similarity=0.765  Sum_probs=146.1

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC--CCeEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLY  406 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--~~~ly  406 (504)
                      .|+..+.||+|+||.||+|.+ .++..|++|.+...............+.+|+.+++.++||||+++++++..  ...+|
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            688999999999999999988 578999999886544333333445678899999999999999999998765  46789


Q ss_pred             EEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC---
Q 010676          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---  482 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~---  482 (504)
                      ++|||+++++|.+++... .+++..++.++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++......   
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            999999999999988654 5888899999999999999999999999999999999999999999999998754321   


Q ss_pred             --CcccccCCCcccccccccCC
Q 010676          483 --DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 --~~~s~~GT~~YmAPEVL~g~  502 (504)
                        ......++..|+|||++.+.
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~  184 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVISGE  184 (266)
T ss_pred             CCccccCCccccccCHHHhCCC
Confidence              12334588999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.94  E-value=4e-28  Score=241.83  Aligned_cols=165  Identities=37%  Similarity=0.657  Sum_probs=147.7

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      .-|.++..||+|+||.||+|+. .+|..+|||.+..       ...++++..||.++++++.|++|++|+.+.....+||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence            4578889999999999999998 6899999998864       2345778899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          408 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |||||..|++.++++  +..+.+.++..+++..+.||+|||...-||||||..|||++.+|..||+|||.|..+....  
T Consensus       106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            999999999999885  4569999999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccccCCCccccccccc
Q 010676          484 VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~  500 (504)
                      .....|||.||||||+.
T Consensus       186 RNTVIGTPFWMAPEVI~  202 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIE  202 (502)
T ss_pred             hCccccCcccccHHHHH
Confidence            34567999999999986

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.94  E-value=8.2e-26  Score=219.76  Aligned_cols=172  Identities=29%  Similarity=0.507  Sum_probs=147.5

Q ss_pred             cceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||+|... ++..|++|.+.......  ......+.+|+.++++++|+||+++++++...+.+++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD--AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            57999999999999999999985 89999999886433221  2234568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      ||||+++++|..++..     ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999999998854     23788999999999999999999999999999999999999999999999998764432


Q ss_pred             C--cccccCCCcccccccccCC
Q 010676          483 D--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      .  .....++..|+|||++.+.
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~  181 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHEN  181 (267)
T ss_pred             CcccceecCCccccCHHHhccC
Confidence            2  2334589999999988654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.94  E-value=5.6e-26  Score=223.50  Aligned_cols=168  Identities=28%  Similarity=0.446  Sum_probs=145.6

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||+|+||.||+|.+ .++..|++|++......   ......+.+|+.+++.++|+||+++++++.....+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence            488999999999999999998 57899999988654321   12235688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC---
Q 010676          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~---  483 (504)
                      |||+ +++|.+++..  ..+++..+..++.||+.+|.|||++||+|+||||+||+++.++.++|+|||++.......   
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9999 9999998864  348999999999999999999999999999999999999999999999999987654432   


Q ss_pred             cccccCCCcccccccccC
Q 010676          484 VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g  501 (504)
                      .....|+..|+|||++.+
T Consensus       157 ~~~~~~~~~y~aPE~~~~  174 (286)
T cd07832         157 YSHQVATRWYRAPELLYG  174 (286)
T ss_pred             cccccCcccccCceeeec
Confidence            334568999999998854

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.94  E-value=4.4e-26  Score=226.09  Aligned_cols=171  Identities=27%  Similarity=0.357  Sum_probs=143.7

Q ss_pred             ccceeeeeeecccCceeEEEEEccC-----------------CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDD-----------------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE  390 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~-----------------g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp  390 (504)
                      .++|++.+.||+|+||.||+|.+..                 +..||+|.+.....    ......+.+|+.++.+++|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS----DNAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC----HHHHHHHHHHHHHHHhcCCC
Confidence            3578999999999999999988632                 24578887753221    23456788999999999999


Q ss_pred             ceeEEeeeecCCCeEEEEEEeccCCCHHHHHHhcC------------CChHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 010676          391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA  458 (504)
Q Consensus       391 nIV~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~------------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~  458 (504)
                      ||+++++++..++.++++|||+.+++|..++....            +++..+..++.|++.||.|||++||+|+||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            99999999999999999999999999999886643            788899999999999999999999999999999


Q ss_pred             cEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          459 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       459 NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||+++.++.++|+|||+++......    .....+++.|||||++.++
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  207 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG  207 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC
Confidence            9999999999999999987644332    2233467889999988653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.9e-27  Score=244.57  Aligned_cols=174  Identities=30%  Similarity=0.425  Sum_probs=154.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ++.+-|.+.+.||+|.|.+|-+|+. -+|..||||++.+.+....   ...++.+|++.++.++|||||+||.+..++..
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~---st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK   91 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL---STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK   91 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh---hhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence            4567899999999999999999988 6899999999976655433   33578899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEEEEecCccccccc
Q 010676          405 LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKL  481 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd-~~g~VKL~DFGLA~~~~~  481 (504)
                      +|||+|+-++|+|++|+-  ..++.+..+++||.||+.||.|+|+..+|||||||+|+++- +-|-|||+||||+..+..
T Consensus        92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999999999884  35799999999999999999999999999999999998875 568999999999877655


Q ss_pred             C-CcccccCCCcccccccccCC
Q 010676          482 N-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      + .....||+..|-|||+|.|-
T Consensus       172 G~kL~TsCGSLAYSAPEILLGD  193 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGD  193 (864)
T ss_pred             cchhhcccchhhccCchhhhcC
Confidence            4 46778999999999999874

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.94  E-value=9.3e-26  Score=218.82  Aligned_cols=170  Identities=31%  Similarity=0.504  Sum_probs=147.0

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++++.||.|+||.||.+.. .++..+++|.+.......   .....+.+|+.++++++|+||+++++++.+.+.++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch---hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence            488999999999999999987 678899999886543222   2345678999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |||+++++|.+++...   .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++.......  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence            9999999999988764   48889999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....|++.|+|||++.+.
T Consensus       158 ~~~~~~~~~y~ape~~~~~  176 (256)
T cd08221         158 AETVVGTPYYMSPELCQGV  176 (256)
T ss_pred             ccccCCCccccCHhhcCCC
Confidence            2345689999999988653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.94  E-value=4.8e-26  Score=227.71  Aligned_cols=169  Identities=30%  Similarity=0.480  Sum_probs=142.9

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++.+.||.|+||.||+|.+ .++..||+|.+........    ...+.+|+.+++.++|+||+++++++...+.+|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~   80 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   80 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc----hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence            46799999999999999999988 4788999998865432221    234668999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--
Q 010676          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--  482 (504)
                      +||||+.+ +|..++..  ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......  
T Consensus        81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            99999985 88887764  34888999999999999999999999999999999999999999999999998754322  


Q ss_pred             CcccccCCCcccccccccC
Q 010676          483 DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g  501 (504)
                      ......+++.|+|||++.+
T Consensus       160 ~~~~~~~~~~y~~PE~~~~  178 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLG  178 (301)
T ss_pred             cccccceeecccCcHHHhC
Confidence            2233457899999998865

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=8.1e-26  Score=219.19  Aligned_cols=169  Identities=38%  Similarity=0.632  Sum_probs=147.4

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||.|+||.||+|.+ .++..+++|.+.....     .....+.+|+.+++.++||||+++++++...+.+|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-----hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            5799999999999999999998 5678899998864322     134678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--C
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~  483 (504)
                      +|||+.+++|.+++..  ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......  .
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            9999999999998865  46899999999999999999999999999999999999999999999999998764432  2


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....++..|+|||++.+.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~  176 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVE  176 (262)
T ss_pred             cccccCCccccCchhhccc
Confidence            2344688999999998654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.94  E-value=5.6e-26  Score=223.93  Aligned_cols=172  Identities=25%  Similarity=0.393  Sum_probs=141.6

Q ss_pred             cccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  400 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~  400 (504)
                      ..++|++.+.||+|+||.||+|.+.      .+..||+|.+.....    ......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS----MRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            4567999999999999999998752      356799997643211    122356789999999999999999999999


Q ss_pred             CCCeEEEEEEeccCCCHHHHHHhc-----------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEE
Q 010676          401 DESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK  469 (504)
Q Consensus       401 ~~~~lyLVmEy~~ggsL~~ll~~~-----------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VK  469 (504)
                      ....+|+||||+++++|.+++...           .++...+..++.|++.||.|||++|++|+||||+|||++.++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            999999999999999999988652           245678889999999999999999999999999999999999999


Q ss_pred             EEecCcccccccCCc----ccccCCCcccccccccCC
Q 010676          470 LADFGLAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       470 L~DFGLA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      |+|||+++.......    ....+++.|||||++.++
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG  196 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC
Confidence            999999875432221    123457789999998764

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.94  E-value=3.9e-26  Score=225.02  Aligned_cols=171  Identities=29%  Similarity=0.413  Sum_probs=142.5

Q ss_pred             ccceeeeeeecccCceeEEEEEccC------CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~------g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      ..+|++.+.||+|+||.||+|....      ...|++|.+....    .......+.+|+.++..++||||+++++++..
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA----EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC----CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            3578999999999999999998632      2578889775322    12334568899999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA  464 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~  464 (504)
                      ....|++|||+++++|.+++...                 .+++..+..++.||+.||.|||++||+|+||||+|||++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            99999999999999999988652                 3677889999999999999999999999999999999999


Q ss_pred             CCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          465 NGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       465 ~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ++.++|+|||+++......    .....+++.|||||++.++
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  201 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG  201 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC
Confidence            9999999999987543222    2233468889999988654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.94  E-value=4.3e-26  Score=230.19  Aligned_cols=169  Identities=26%  Similarity=0.446  Sum_probs=139.1

Q ss_pred             cceeeeeeecccCceeEEEEEcc-CCc----eEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-DGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-~g~----~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .+|++.+.||+|+||.||+|.+. ++.    .||+|.+....    .......+.+|+.+++.++||||+++++++... 
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            47999999999999999999863 333    48888775321    122345688899999999999999999998765 


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      ..+++++|+.+|+|.+++...  .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            578999999999999988764  478888999999999999999999999999999999999999999999999986543


Q ss_pred             CCc----ccccCCCcccccccccCC
Q 010676          482 NDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      ...    ....++..|||||++.+.
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~  186 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHR  186 (316)
T ss_pred             CCcceeccCCccceeecChHHhccC
Confidence            221    122346789999988654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.94  E-value=5.3e-26  Score=221.58  Aligned_cols=173  Identities=35%  Similarity=0.667  Sum_probs=146.3

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchh-hHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      .|+.++.||+|+||.||++.+ .++..||+|.+........ .......+.+|+.+++.++|+||+++++++...+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999997 6889999998864332221 22345778899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEecCcccccccCC--
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLND--  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-~VKL~DFGLA~~~~~~~--  483 (504)
                      ||||+.+++|.+++... .+++..+..++.||+.||.|||++|++|+||+|.||+++.++ .++|+|||++.......  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            99999999999988654 588899999999999999999999999999999999998776 59999999987654321  


Q ss_pred             ----cccccCCCcccccccccCC
Q 010676          484 ----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ----~~s~~GT~~YmAPEVL~g~  502 (504)
                          .....||..|+|||++.++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~  183 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGE  183 (268)
T ss_pred             CCccccccccccceeCHhHhccC
Confidence                1234588999999998654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=8.7e-28  Score=272.50  Aligned_cols=176  Identities=40%  Similarity=0.729  Sum_probs=154.3

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      +..+.-+|+.+..||.|.||.||.|.+ .+|...|+|.++.....   ......+.+|..+|..|+|||+|++|++-.+.
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecH
Confidence            445666899999999999999999998 78999999998765543   34456788999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      +.+||+||||.+|+|.++++.++ .++.....|..|++.||.|||++|||||||||.||+++.+|.+|++|||.|..+..
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999999999999999877 44555667889999999999999999999999999999999999999999987654


Q ss_pred             CC------cccccCCCcccccccccCC
Q 010676          482 ND------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~------~~s~~GT~~YmAPEVL~g~  502 (504)
                      +.      .....||+-|||||++.|-
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t 1413 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGT 1413 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhccc
Confidence            42      3456799999999999863

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.94  E-value=5.3e-26  Score=222.25  Aligned_cols=168  Identities=29%  Similarity=0.457  Sum_probs=143.3

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      ++|++++.||+|+||.||++...++..+|+|.+.....      ....+.+|+.++..++||||+++++++...+.+|++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            46899999999999999999887777899998753221      124578899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCccc
Q 010676          409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s  486 (504)
                      |||+.+++|.+++...  .+++..+..++.||+.||.|||++||+|+||||.|||++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999988753  48899999999999999999999999999999999999999999999999987654332222


Q ss_pred             ---ccCCCcccccccccCC
Q 010676          487 ---CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       487 ---~~GT~~YmAPEVL~g~  502 (504)
                         ..++..|+|||++.++
T Consensus       158 ~~~~~~~~~y~~pe~~~~~  176 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYS  176 (256)
T ss_pred             cCCCccChhhCCHHHHhcC
Confidence               2356779999998753

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.94  E-value=1.1e-25  Score=225.85  Aligned_cols=171  Identities=30%  Similarity=0.548  Sum_probs=149.5

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ....|++.+.||.|+||.||+|.+ .++..|++|.+......     ....+.+|+.+++.++|+||+++++++...+.+
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-----KKELIINEILVMKELKNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-----hHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence            345799999999999999999997 68899999988643221     234578899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |+||||+.+++|..++....+++.++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......  
T Consensus        92 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            999999999999999988889999999999999999999999999999999999999999999999999987644332  


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....++..|+|||++.++
T Consensus       172 ~~~~~~~~~y~aPE~~~~~  190 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRK  190 (296)
T ss_pred             CCCcCCCccccCcchhcCC
Confidence            2234689999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.94  E-value=5.5e-26  Score=225.87  Aligned_cols=169  Identities=30%  Similarity=0.451  Sum_probs=142.7

Q ss_pred             cceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .+|.+.+.||+|+||.||++..      .++..+++|.+....     ......+.+|+.++++++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-----DNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-----HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            4789999999999999999974      245678888775321     22345688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc--------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcE
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY--------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV  468 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~--------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~V  468 (504)
                      +.+|+||||+.+++|.+++...              .+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            9999999999999999988643              27889999999999999999999999999999999999999999


Q ss_pred             EEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          469 KLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       469 KL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      +|+|||+++......    .....++..|+|||++.++
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  197 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR  197 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccC
Confidence            999999987543322    1223457789999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.94  E-value=3.7e-26  Score=222.24  Aligned_cols=171  Identities=30%  Similarity=0.478  Sum_probs=148.9

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .|++.+.||.|+||.||+|.+ .++..|++|++......  .......+.+|+.++++++||||+++++++.....+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV--EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc--chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            488999999999999999998 47899999988643221  123456788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-Cccc
Q 010676          409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKS  486 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-~~~s  486 (504)
                      |||+.+++|..++... .+.+..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus        79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence            9999999999998766 7999999999999999999999999999999999999999999999999998765433 2334


Q ss_pred             ccCCCcccccccccCC
Q 010676          487 CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       487 ~~GT~~YmAPEVL~g~  502 (504)
                      ..|+..|+|||++.+.
T Consensus       159 ~~~~~~y~~PE~~~~~  174 (258)
T cd05578         159 TSGTPGYMAPEVLCRQ  174 (258)
T ss_pred             cCCChhhcCHHHHccc
Confidence            5688999999998653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.94  E-value=6e-26  Score=218.45  Aligned_cols=164  Identities=30%  Similarity=0.490  Sum_probs=142.0

Q ss_pred             eeecccCceeEEEEEccC----CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEE
Q 010676          335 DLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~----g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmE  410 (504)
                      +.||+|+||.||+|.+..    +..|++|.+.......    ....+.+|+.++..++|+||+++++++.....+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   76 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE   76 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence            469999999999999853    8899999886433221    35678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHh----------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          411 LVTKGSLLNLYQR----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       411 y~~ggsL~~ll~~----------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      |+++++|.+++..          ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            9999999999876          458999999999999999999999999999999999999999999999999998655


Q ss_pred             cCC----cccccCCCcccccccccCC
Q 010676          481 LND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...    .....++..|+|||++.+.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~  182 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDG  182 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccC
Confidence            432    3344578899999988753

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PTZ00284 protein kinase; Provisional

Probab=99.94  E-value=1.5e-25  Score=239.90  Aligned_cols=167  Identities=21%  Similarity=0.310  Sum_probs=131.9

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC------CCceeEEeeeec
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE------HENIVQYYGTDK  400 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~------HpnIV~l~~~~~  400 (504)
                      .++|+++++||+|+||+||+|++ .++..||||++.....      ....+..|+.++..++      |.+|++++++|.
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK------YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh------hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            46899999999999999999998 5788999998863221      1123345555555554      556899998887


Q ss_pred             CC-CeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCC-----------
Q 010676          401 DE-SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANG-----------  466 (504)
Q Consensus       401 ~~-~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g-----------  466 (504)
                      .. ..+|+||+++ +++|.+++.. ..+++..+..|+.||+.||.|||. .|||||||||+|||++.++           
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            64 5789999988 5577776644 569999999999999999999997 5999999999999998765           


Q ss_pred             -----cEEEEecCcccccccCCcccccCCCcccccccccCC
Q 010676          467 -----SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       467 -----~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                           .+||+|||++.... ......+||+.|||||++.+.
T Consensus       281 ~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~~~~  320 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVVLGL  320 (467)
T ss_pred             CCCCceEEECCCCccccCc-cccccccCCccccCcHHhhcC
Confidence                 49999999876432 223456799999999998765

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.94  E-value=3.3e-26  Score=224.83  Aligned_cols=170  Identities=31%  Similarity=0.437  Sum_probs=143.3

Q ss_pred             cceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      +.|.+.+.||+|+||.||+|...      ++..||+|.+.....    ......+.+|+.+|+.++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS----NDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC----HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            46888999999999999999863      357899998753221    22346788999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc---------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY---------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS  467 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~---------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~  467 (504)
                      ..+|+||||+++++|.+++...               .+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            9999999999999999998653               2677888999999999999999999999999999999999999


Q ss_pred             EEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          468 VKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       468 VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ++|+|||++.......    .....+++.|+|||++.++
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  199 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR  199 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccC
Confidence            9999999987543222    1233467889999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.94  E-value=7e-26  Score=222.80  Aligned_cols=170  Identities=24%  Similarity=0.393  Sum_probs=144.8

Q ss_pred             cceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||+|.+. ++..||+|++.......   ...+.+.+|+.+++.++|+||+++++++.....+|+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP---VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc---cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            36899999999999999999984 78999999886432211   112456789999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--c
Q 010676          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~  484 (504)
                      ||||++++.|..++.. ..+++..+..++.||+.+|.|||++||+|+||||.||+++.++.++|+|||++.......  .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence            9999999888887754 358999999999999999999999999999999999999999999999999987654332  2


Q ss_pred             ccccCCCcccccccccC
Q 010676          485 KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g  501 (504)
                      ....++..|+|||++.+
T Consensus       158 ~~~~~~~~~~aPE~~~~  174 (286)
T cd07847         158 TDYVATRWYRAPELLVG  174 (286)
T ss_pred             cCcccccccCCHHHHhC
Confidence            33458899999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=7.6e-26  Score=223.67  Aligned_cols=169  Identities=34%  Similarity=0.506  Sum_probs=140.8

Q ss_pred             ceeeeeeecccCceeEEEEEc-----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC--C
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--E  402 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--~  402 (504)
                      +|++.+.||+|+||+||++..     .++..||+|.+.....    ......+.+|+.+|+.++||||+++++++..  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG----QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            458999999999999988652     4678999998764321    1233567789999999999999999998755  3


Q ss_pred             CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      ..+|++|||+.+++|.+++....+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+++.....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            46899999999999999998888999999999999999999999999999999999999999999999999998765432


Q ss_pred             Cc-----ccccCCCcccccccccCC
Q 010676          483 DV-----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~-----~s~~GT~~YmAPEVL~g~  502 (504)
                      ..     ....++..|+|||++.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~  185 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKEN  185 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhccc
Confidence            21     122356779999988654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.94  E-value=7.5e-26  Score=224.23  Aligned_cols=169  Identities=28%  Similarity=0.446  Sum_probs=138.0

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCc----eEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~----~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      ++|++++.||+|+||.||+|.+ .++.    .+++|.+..    .........+..|+.++..+.||||+++++++.. .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD----RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc----ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            5788999999999999999987 3454    356665532    1223344667888989999999999999998764 5


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+++++||+++|+|.+++...  .+++..+..|+.||+.||.|||+++++||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            678999999999999998653  488999999999999999999999999999999999999999999999999876432


Q ss_pred             CC----cccccCCCcccccccccCC
Q 010676          482 ND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..    .....++..|+|||++.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~  186 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFG  186 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccC
Confidence            22    1233467889999998754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.94  E-value=2.5e-26  Score=223.40  Aligned_cols=171  Identities=29%  Similarity=0.444  Sum_probs=146.3

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      -..+|++++.||.|+||.||+|.+.++..+++|.+....     ......+.+|+.+++.++|+||+++++++.....+|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence            345799999999999999999999889999999875422     122346788999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          407 IFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +||||+++++|.+++..   ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999999999999865   347889999999999999999999999999999999999999999999999987654322


Q ss_pred             --cccccCCCcccccccccCC
Q 010676          484 --VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 --~~s~~GT~~YmAPEVL~g~  502 (504)
                        .....++..|+|||++.++
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~  179 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHG  179 (261)
T ss_pred             ccccCCCCceEecCHHHHccC
Confidence              1223467789999988654

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.94  E-value=7.6e-26  Score=227.21  Aligned_cols=176  Identities=28%  Similarity=0.445  Sum_probs=143.7

Q ss_pred             cccccccceeeeeeecccCceeEEEEEcc--------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCcee
Q 010676          323 RFKRIITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIV  393 (504)
Q Consensus       323 ~~~~~~~~y~i~k~LG~G~FG~VYka~~~--------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV  393 (504)
                      ++....++|.+++.||+|+||.||++.+.        +...+|+|.+....    .......+.+|+.++..+ +|+||+
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~~i~   87 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNII   87 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----ChHHHHHHHHHHHHHHHhcCCCCEe
Confidence            34444578999999999999999999752        23569999775321    122345678899999999 799999


Q ss_pred             EEeeeecCCCeEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 010676          394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK  456 (504)
Q Consensus       394 ~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLK  456 (504)
                      ++++++...+.+|+||||+.+++|.+++...                 .+++.+++.++.||+.||.|||++|++|||||
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk  167 (307)
T cd05098          88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA  167 (307)
T ss_pred             eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence            9999999999999999999999999998653                 37788899999999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          457 CANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       457 P~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |+|||++.++.+||+|||++.......    .....+++.|||||++.++
T Consensus       168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  217 (307)
T cd05098         168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR  217 (307)
T ss_pred             HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC
Confidence            999999999999999999987543221    1112245689999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3e-26  Score=244.63  Aligned_cols=175  Identities=30%  Similarity=0.498  Sum_probs=146.3

Q ss_pred             cccceeeeeeecccCceeEEEEEcc--CC--ce-EEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISD--DG--FF-FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~--~g--~~-vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      ...+..+.++||+|.||.||+|...  ++  .. ||+|..+..  .......+.++++|.+++++++|||||++||++..
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~--~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS--SELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc--ccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            3445566799999999999999873  22  23 899977641  22345667889999999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ...+|||||+|.||+|.+++++++  ++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+||||++..
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            999999999999999999998875  999999999999999999999999999999999999999999999999998764


Q ss_pred             ccCC-cc-cccCCCcccccccccCCC
Q 010676          480 KLND-VK-SCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       480 ~~~~-~~-s~~GT~~YmAPEVL~g~~  503 (504)
                      ..-. .. ...-...|+|||.+..+.
T Consensus       313 ~~~~~~~~~~klPirWLAPEtl~~~~  338 (474)
T KOG0194|consen  313 SQYVMKKFLKKLPIRWLAPETLNTGI  338 (474)
T ss_pred             cceeeccccccCcceecChhhhccCc
Confidence            3111 11 223456799999998653

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1e-25  Score=218.91  Aligned_cols=167  Identities=29%  Similarity=0.443  Sum_probs=144.5

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      .++|++.+.||.|+||.||+|... +..|++|.+.....      ...++.+|+.+++.++|+||+++++++...+..|+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            357899999999999999999875 78899998863221      34678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      ||||+++++|.+++...   .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            99999999999998764   489999999999999999999999999999999999999999999999999876533222


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                       ....+..|+|||++.++
T Consensus       158 -~~~~~~~~~ape~~~~~  174 (256)
T cd05039         158 -SGKLPVKWTAPEALREK  174 (256)
T ss_pred             -cCCCcccccCchhhcCC
Confidence             33456779999988654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.4e-26  Score=227.33  Aligned_cols=170  Identities=26%  Similarity=0.357  Sum_probs=140.7

Q ss_pred             cceeeeeeecccCceeEEEEEccC---------------CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCcee
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDD---------------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV  393 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~---------------g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV  393 (504)
                      ++|++.+.||+|+||.||++.+..               ...||+|.+....    .......+.+|+.++++++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            479999999999999999987632               2358899775321    122345688999999999999999


Q ss_pred             EEeeeecCCCeEEEEEEeccCCCHHHHHHhc-------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 010676          394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRY-------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  460 (504)
Q Consensus       394 ~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~-------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NI  460 (504)
                      ++++++...+.+|+||||+.+++|.+++...             .+.+..+..++.|++.||.|||++|++|+||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            9999999999999999999999999988543             257788899999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCcccccccCCc----ccccCCCcccccccccCC
Q 010676          461 LVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       461 LLd~~g~VKL~DFGLA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      |++.++.+||+|||++........    ....++..|+|||++.++
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  206 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG  206 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC
Confidence            999999999999999875433221    222356789999988654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.94  E-value=5.2e-26  Score=222.88  Aligned_cols=161  Identities=25%  Similarity=0.374  Sum_probs=130.9

Q ss_pred             eecccCceeEEEEEccC---CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEec
Q 010676          336 LLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       336 ~LG~G~FG~VYka~~~~---g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      .||+|+||.||+|...+   ...+++|.+....    .......+.+|+.+++.++|+||+++++.+.....+|+||||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA----TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC----ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            58999999999997533   3466777554221    2233456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC---
Q 010676          413 TKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (504)
Q Consensus       413 ~ggsL~~ll~~~~------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~---  483 (504)
                      .+|+|.+++....      +.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999999886542      3567788999999999999999999999999999999999999999999986533221   


Q ss_pred             -cccccCCCccccccccc
Q 010676          484 -VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~  500 (504)
                       .....++..|+|||++.
T Consensus       158 ~~~~~~~~~~y~aPE~~~  175 (269)
T cd05042         158 TKDCHAVPLRWLAPELVE  175 (269)
T ss_pred             ccCCCCCcccccCHHHHh
Confidence             12234577899999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=6.2e-27  Score=219.76  Aligned_cols=171  Identities=30%  Similarity=0.479  Sum_probs=147.3

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ..|...+.||+|+||+||+|++ .++..||+|.+.+.+...-.   .....+||-+|+.++|.|||++++....+..+.+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv---pssalreicllkelkhknivrl~dvlhsdkkltl   78 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV---PSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC---cHHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence            3567778899999999999998 68899999999875543322   2345699999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--C
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~  483 (504)
                      |+|||.. +|..++..  +.++.+.++.++.|++.||.|+|+++++||||||.|+||+.+|.+||+|||+++.....  .
T Consensus        79 vfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   79 VFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             eHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            9999976 78887765  34888899999999999999999999999999999999999999999999999876544  3


Q ss_pred             cccccCCCcccccccccCCC
Q 010676          484 VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~~  503 (504)
                      ....+-|.+|.+|.|+.|..
T Consensus       158 ysaevvtlwyrppdvlfgak  177 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAK  177 (292)
T ss_pred             eeceeeeeeccCcceeeeee
Confidence            44556899999999998753

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.94  E-value=7.6e-26  Score=224.97  Aligned_cols=167  Identities=32%  Similarity=0.581  Sum_probs=144.5

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      +.|++++.||+|+||.||+|.+ .++..+++|.+...     .......+.+|+.+++.++|+||+++++++..+..+|+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            5689999999999999999998 56889999987642     22335668889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--C
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~  483 (504)
                      ||||+++++|..++.+  ..+++..+..++.||+.+|.|||++||+|+||||+||+++.++.++|+|||++......  .
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            9999999999887754  45899999999999999999999999999999999999999999999999998653322  2


Q ss_pred             cccccCCCccccccccc
Q 010676          484 VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~  500 (504)
                      .....+++.|+|||++.
T Consensus       167 ~~~~~~~~~y~aPE~~~  183 (292)
T cd06644         167 RDSFIGTPYWMAPEVVM  183 (292)
T ss_pred             cceecCCccccCceeec
Confidence            23446899999999985

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.2e-25  Score=226.12  Aligned_cols=172  Identities=30%  Similarity=0.485  Sum_probs=146.6

Q ss_pred             cceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||+|... ++..||+|.+.......  ......+.+|+.+++.++|+||+++++.+.....+|+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   78 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK--RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL   78 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch--HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence            36899999999999999999984 68999999886533221  2345678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      ||||+.+++|.+++..   ..+++..+..++.||+.||.|||+.|++|+||||+||||+.++.++|+|||++....... 
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            9999999999998875   358899999999999999999999999999999999999999999999999986532211 


Q ss_pred             ------------------------------cccccCCCcccccccccCC
Q 010676          484 ------------------------------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ------------------------------~~s~~GT~~YmAPEVL~g~  502 (504)
                                                    .....||..|+|||++.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  207 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD  207 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC
Confidence                                          1123588999999998764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=255.48  Aligned_cols=168  Identities=32%  Similarity=0.572  Sum_probs=145.1

Q ss_pred             cceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      +.|.|+..||.|.||.||+|.++ ++...|-|.+..     .....+..++-||.||..++||+||+|++.|..++.+||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence            46888889999999999999985 555666676643     335567889999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc--cCC
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LND  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~--~~~  483 (504)
                      ++|||.||-+..++-.  ..+.+.++..+++|+|.||.|||+++|||||||..|||++-+|.++|+|||.+....  ...
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            9999999999887754  459999999999999999999999999999999999999999999999999864322  223


Q ss_pred             cccccCCCcccccccccC
Q 010676          484 VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g  501 (504)
                      ..++.|||+||||||+..
T Consensus       187 RDsFIGTPYWMAPEVvmC  204 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMC  204 (1187)
T ss_pred             hccccCCcccccchheee
Confidence            467789999999999863

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.94  E-value=1e-25  Score=222.51  Aligned_cols=169  Identities=32%  Similarity=0.521  Sum_probs=140.0

Q ss_pred             cceeeeeeecccCceeEEEEEc-----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC--
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--  401 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--  401 (504)
                      ..|++.+.||+|+||.||++..     .++..|++|.+....     ......+.+|+.++..++||||+++++++..  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-----AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-----HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            3688999999999999999873     468899999875322     2334678899999999999999999987643  


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ...+|+||||+++++|.+++...  .+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++...
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            45689999999999999998653  4889999999999999999999999999999999999999999999999998865


Q ss_pred             ccCCc-----ccccCCCcccccccccCC
Q 010676          480 KLNDV-----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~~-----~s~~GT~~YmAPEVL~g~  502 (504)
                      .....     ....++..|+|||++.++
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~  186 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTES  186 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccC
Confidence            43221     111234569999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.94  E-value=8.8e-26  Score=223.75  Aligned_cols=169  Identities=31%  Similarity=0.480  Sum_probs=142.4

Q ss_pred             ccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .+.|++.+.||+|+||.||+|.+. ++..||+|.+........    ...+.+|+.+++.++|+||+++++++.+.+.+|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA----PFTAIREASLLKDLKHANIVTLHDIIHTKKTLT   79 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC----chhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence            468999999999999999999984 789999998864322111    123568999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--
Q 010676          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--  482 (504)
                      +||||+.+ +|.+++...  .+.+..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.....  
T Consensus        80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            99999985 898887653  4788999999999999999999999999999999999999999999999998754322  


Q ss_pred             CcccccCCCcccccccccC
Q 010676          483 DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g  501 (504)
                      ......++..|+|||++.+
T Consensus       159 ~~~~~~~~~~~~aPE~~~~  177 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLG  177 (291)
T ss_pred             cccccccccccCCcHHhhc
Confidence            1222347889999998865

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.94  E-value=1e-25  Score=222.31  Aligned_cols=172  Identities=31%  Similarity=0.588  Sum_probs=143.0

Q ss_pred             cccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeec
Q 010676          323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  400 (504)
Q Consensus       323 ~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~  400 (504)
                      .+....++|++.+.||+|+||.||++.+ .++..+++|++.....      ....+.+|+.++..+ +|+||+++++++.
T Consensus        12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638          12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD------IDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc------hHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            3445678999999999999999999988 5788999997653211      124567899999998 6999999999873


Q ss_pred             -----CCCeEEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEE
Q 010676          401 -----DESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  470 (504)
Q Consensus       401 -----~~~~lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL  470 (504)
                           ....+|+||||+++++|.+++..     ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEE
Confidence                 45679999999999999987642     34788889999999999999999999999999999999999999999


Q ss_pred             EecCcccccccCC--cccccCCCccccccccc
Q 010676          471 ADFGLAKATKLND--VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       471 ~DFGLA~~~~~~~--~~s~~GT~~YmAPEVL~  500 (504)
                      +|||++.......  .....|++.|+|||++.
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (286)
T cd06638         166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA  197 (286)
T ss_pred             ccCCceeecccCCCccccccCCCcccChhhhc
Confidence            9999987654322  23346999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.94  E-value=1.8e-25  Score=216.61  Aligned_cols=170  Identities=29%  Similarity=0.517  Sum_probs=143.3

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-CCeEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLYI  407 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-~~~lyL  407 (504)
                      .|++++.||+|+||.||++.+ .++..|++|.+......   ......+.+|+.+++.++|+|++++++.+.. +..+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS---RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC---HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            488999999999999999998 46789999988643222   2234567889999999999999999998764 456899


Q ss_pred             EEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--
Q 010676          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--  482 (504)
                      +|||+++++|.+++...   .+++.++..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......  
T Consensus        78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999999988652   3889999999999999999999999999999999999999999999999998765322  


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ......+++.|+|||++.++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~  177 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNK  177 (257)
T ss_pred             ccccccCCcCccChhHhcCC
Confidence            22344689999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.7e-26  Score=224.46  Aligned_cols=167  Identities=37%  Similarity=0.632  Sum_probs=145.5

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||.|+||.||++.+ .++..+++|.+....     ......+.+|+.+++.++|+||+++++++..+..+|+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-----EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-----HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            5689999999999999999998 578999999886432     2334668899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      ||||+++++|..++..  ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......  
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            9999999999998865  358999999999999999999999999999999999999999999999999876543221  


Q ss_pred             cccccCCCccccccccc
Q 010676          484 VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~  500 (504)
                      .....+|+.|+|||++.
T Consensus       160 ~~~~~~~~~y~~PE~~~  176 (280)
T cd06611         160 RDTFIGTPYWMAPEVVA  176 (280)
T ss_pred             cceeecchhhcCHHHHh
Confidence            23346899999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.94  E-value=9.2e-26  Score=222.96  Aligned_cols=166  Identities=33%  Similarity=0.601  Sum_probs=142.8

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .|++.+.||+|+||.||++.+ .++..+++|.+....     ......+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-----HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            478889999999999999998 467888998875322     23346678899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Cc
Q 010676          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  484 (504)
Q Consensus       409 mEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~  484 (504)
                      |||+.+++|..++..  ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......  ..
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            999999999887754  45899999999999999999999999999999999999999999999999998654322  12


Q ss_pred             ccccCCCccccccccc
Q 010676          485 KSCRGTAFWMAPEVCS  500 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~  500 (504)
                      ....+|+.|+|||++.
T Consensus       161 ~~~~~~~~y~aPE~~~  176 (282)
T cd06643         161 DSFIGTPYWMAPEVVM  176 (282)
T ss_pred             ccccccccccCHhhcc
Confidence            3456899999999984

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.94  E-value=9.3e-26  Score=220.72  Aligned_cols=169  Identities=29%  Similarity=0.451  Sum_probs=143.8

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ...|.+.+.||+|+||.||+|.+ .++..+++|.+...      ......+.+|+.+++.++|+||+++++++..++.++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            34688999999999999999998 56889999987532      122356789999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      ++|||+++++|.+++...   .+++..+..++.|++.||.|||++|++|+||||+|||++.++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999999988653   47888899999999999999999999999999999999999999999999987654433


Q ss_pred             ccc---ccCCCcccccccccCC
Q 010676          484 VKS---CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s---~~GT~~YmAPEVL~g~  502 (504)
                      ...   ..++..|+|||++.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~  180 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYN  180 (263)
T ss_pred             eeccCCCCCccccCCHHHhccC
Confidence            221   2246679999988654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=1.3e-25  Score=220.18  Aligned_cols=172  Identities=41%  Similarity=0.692  Sum_probs=145.5

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccc-----hhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG-----SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~-----~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +|.+.+.||.|+||.||+|.+ .++..+|+|.+......     .......+.+.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            588899999999999999987 57899999988542211     112223456788999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .+++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999998876 45888899999999999999999999999999999999999999999999998754321


Q ss_pred             C----cccccCCCcccccccccC
Q 010676          483 D----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~----~~s~~GT~~YmAPEVL~g  501 (504)
                      .    .....|+..|+|||++.+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~  184 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHS  184 (272)
T ss_pred             ccccccccccCCccccCHHHhcc
Confidence            1    223458899999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.94  E-value=4.1e-26  Score=224.95  Aligned_cols=168  Identities=30%  Similarity=0.506  Sum_probs=141.7

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||+|+||.||+|.+ .+|..|++|.+.......   .....+.+|+.+++.++|+||+++++++.+...+|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE---GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc---cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence            488899999999999999998 578999999886432211   1224567899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Cc
Q 010676          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  484 (504)
Q Consensus       409 mEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~  484 (504)
                      +||+.+ +|.+++..  ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.....  ..
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence            999985 67776653  45899999999999999999999999999999999999999999999999998754432  22


Q ss_pred             ccccCCCcccccccccC
Q 010676          485 KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g  501 (504)
                      ....+++.|+|||++.+
T Consensus       157 ~~~~~~~~y~aPE~~~~  173 (284)
T cd07839         157 SAEVVTLWYRPPDVLFG  173 (284)
T ss_pred             CCCccccCCcChHHHhC
Confidence            33457899999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.94  E-value=6e-27  Score=264.63  Aligned_cols=175  Identities=39%  Similarity=0.634  Sum_probs=147.5

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  401 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-  401 (504)
                      +.++..+|+.+++||+||||.||++++ -+|+.||||.+.+..    ......++.+|+.+|.+|+|||||+||..|.+ 
T Consensus       474 ~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs  549 (1351)
T KOG1035|consen  474 FSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVES  549 (1351)
T ss_pred             hhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence            356788999999999999999999999 599999999887543    23445778899999999999999999842100 


Q ss_pred             --------------------------------------------------------------------------------
Q 010676          402 --------------------------------------------------------------------------------  401 (504)
Q Consensus       402 --------------------------------------------------------------------------------  401 (504)
                                                                                                      
T Consensus       550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~  629 (1351)
T KOG1035|consen  550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN  629 (1351)
T ss_pred             CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------------C--------CeEEEEEEeccCCCHHHHHHhcCCC--hHHHHHHHHHHHHH
Q 010676          402 ------------------------------E--------SKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLG  441 (504)
Q Consensus       402 ------------------------------~--------~~lyLVmEy~~ggsL~~ll~~~~l~--e~~v~~i~~QIl~g  441 (504)
                                                    +        ..+||.||||+..+|.+++..+.+.  ...++++|+||+.|
T Consensus       630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEG  709 (1351)
T ss_pred             cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHH
Confidence                                          0        2379999999999999999988875  77899999999999


Q ss_pred             HHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc--------------------cCCcccccCCCcccccccccC
Q 010676          442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--------------------LNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       442 L~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~--------------------~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      |.|+|++|||||||||.||+++.++.|||+|||+|....                    ....+..+||.-|+|||++.+
T Consensus       710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            999999999999999999999999999999999997621                    011234579999999999976


Q ss_pred             C
Q 010676          502 P  502 (504)
Q Consensus       502 ~  502 (504)
                      -
T Consensus       790 ~  790 (1351)
T KOG1035|consen  790 T  790 (1351)
T ss_pred             c
Confidence            3

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=9.5e-26  Score=223.43  Aligned_cols=169  Identities=32%  Similarity=0.517  Sum_probs=142.4

Q ss_pred             ceeeeeeecccCceeEEEEEc-----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--  402 (504)
                      .|++.+.||+|+||.||++..     .++..||+|.+.....    ......+.+|+.+++.++|+||+++++++...  
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG----GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc----HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            578899999999999999973     4678999998753321    22345688999999999999999999988765  


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      ..+|+||||+++++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            5789999999999999998654  47889999999999999999999999999999999999999999999999987654


Q ss_pred             cCC-----cccccCCCcccccccccCC
Q 010676          481 LND-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...     .....++..|+|||++.++
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~  187 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQS  187 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccC
Confidence            322     1234577789999988754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=2.2e-26  Score=245.96  Aligned_cols=146  Identities=27%  Similarity=0.506  Sum_probs=130.9

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      -|..++.||-|.||.|.++.. .+...||+|.+.+.+.  .....+.++..|-.||...+++-||+||..|.+.+.+|+|
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV--l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV--LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH--HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            488899999999999999976 5678999998764433  3345567788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          409 LELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      |+|++||++-.+|-+.+ |.+..+.+|+.++.+|+++.|+.|+|||||||+|||||.+|++||+|||||.
T Consensus       708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc
Confidence            99999999998876655 7778888999999999999999999999999999999999999999999985

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.94  E-value=1.1e-25  Score=226.29  Aligned_cols=171  Identities=27%  Similarity=0.482  Sum_probs=138.9

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCc--eEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~--~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~  403 (504)
                      .++|++.+.||+|+||.||+|.+ .++.  .+++|.+...    ........+.+|+.++.++ +|+||+++++++...+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc----CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            35789999999999999999987 3454  3466654321    1223346778899999999 8999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  466 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g  466 (504)
                      .+|+||||+++++|.+++...                 .+++.+++.++.||+.||.|||++||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            999999999999999988643                 367889999999999999999999999999999999999999


Q ss_pred             cEEEEecCcccccccCCc-ccccCCCcccccccccCC
Q 010676          467 SVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       467 ~VKL~DFGLA~~~~~~~~-~s~~GT~~YmAPEVL~g~  502 (504)
                      .+||+|||++........ ....++..|+|||++.+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  198 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS  198 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc
Confidence            999999999864321111 112246679999988654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.2e-25  Score=218.55  Aligned_cols=170  Identities=31%  Similarity=0.467  Sum_probs=145.4

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ..++|.+.+.||+|+||.||+|.+.++..+++|.+.....      ....+.+|+.+++.++|+||+++++++.....+|
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            3468999999999999999999988788899998764222      1245788999999999999999999999989999


Q ss_pred             EEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +||||+.+++|.+++...   .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999999999988653   48899999999999999999999999999999999999999999999999987654322


Q ss_pred             cc---cccCCCcccccccccCC
Q 010676          484 VK---SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~---s~~GT~~YmAPEVL~g~  502 (504)
                      ..   ...++..|+|||++.++
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~  179 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYG  179 (261)
T ss_pred             hhhhhccCCCccccCHHHhccC
Confidence            11   22245689999998764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.2e-25  Score=220.40  Aligned_cols=171  Identities=25%  Similarity=0.368  Sum_probs=142.5

Q ss_pred             ccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      .++|++.+.||+|+||.||+|...      ++..|++|.+....    .......+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            468999999999999999999863      34689999874322    12223567789999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhc-----------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEE
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  470 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~-----------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL  470 (504)
                      ...+|+||||+++++|.+++...           .+.+..+..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            99999999999999999988642           2567788999999999999999999999999999999999999999


Q ss_pred             EecCcccccccCC----cccccCCCcccccccccCC
Q 010676          471 ADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       471 ~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      +|||+++......    .....+|..|+|||++.++
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG  196 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcC
Confidence            9999987654332    1223467889999988654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.93  E-value=1.8e-25  Score=216.95  Aligned_cols=170  Identities=42%  Similarity=0.750  Sum_probs=147.8

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||+|+||.||+|.+ .++..|++|.+......   ......+.+|+.+++.++|+||+++++.+...+.+++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence            588999999999999999987 57899999998754332   34557789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc---
Q 010676          409 LELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---  484 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~---  484 (504)
                      +||+++++|.+++.... +++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++........   
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            99999999999987653 78888999999999999999999999999999999999999999999999876543221   


Q ss_pred             ---ccccCCCcccccccccCC
Q 010676          485 ---KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ---~s~~GT~~YmAPEVL~g~  502 (504)
                         ....++..|+|||++.+.
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~  178 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGG  178 (264)
T ss_pred             ccccCCcCCcCccChhhccCC
Confidence               124578999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.93  E-value=1.4e-25  Score=219.54  Aligned_cols=170  Identities=26%  Similarity=0.436  Sum_probs=142.8

Q ss_pred             cceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ++|.+.+.||+|+||.||+|.+.    +...|++|.+....    .......+.+|+.+++.++|+||+++++++...+.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            46899999999999999999873    34578999775322    22334568889999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +|++|||+.+++|.+++...  .+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+++.....
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999988653  5889999999999999999999999999999999999999999999999998865421


Q ss_pred             --Ccc--cccCCCcccccccccCC
Q 010676          483 --DVK--SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 --~~~--s~~GT~~YmAPEVL~g~  502 (504)
                        ...  ...++..|+|||.+.+.
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~  183 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYR  183 (266)
T ss_pred             ccceeccCCCCCccccChhhhccC
Confidence              111  12356789999988753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.93  E-value=1.3e-25  Score=224.90  Aligned_cols=175  Identities=29%  Similarity=0.471  Sum_probs=143.6

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc--------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeE
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ  394 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~--------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~  394 (504)
                      +.....+|.+++.||+|+||.||+|..        .++..|++|.+...    ........+.+|+.++..+ +||||++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~   85 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIIN   85 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCchh
Confidence            334466899999999999999999963        23457899976521    1123346788999999999 7999999


Q ss_pred             EeeeecCCCeEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 010676          395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  457 (504)
Q Consensus       395 l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP  457 (504)
                      +++++.....+|+||||+.+++|.+++...                 .++...+..++.||+.||.|||++||+||||||
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp  165 (304)
T cd05101          86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA  165 (304)
T ss_pred             eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence            999999999999999999999999988653                 356778899999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          458 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       458 ~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      +|||++.++.+||+|||+++......    .....+++.|+|||++.++
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  214 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR  214 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC
Confidence            99999999999999999987654322    1122356789999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.93  E-value=1.1e-25  Score=220.63  Aligned_cols=170  Identities=26%  Similarity=0.424  Sum_probs=141.8

Q ss_pred             cceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+|++.+.||+|+||.||+|.+.    .+..+|+|.+....    .......+.+|+.+++.++||||+++++++..++.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            47899999999999999999863    23478888764321    12234678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +|+||||+++++|.+++...  .+++.++..++.|++.||.|||++|++|+||||+|||++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999998764  4788899999999999999999999999999999999999999999999998765432


Q ss_pred             Cc-----ccccCCCcccccccccCC
Q 010676          483 DV-----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~-----~s~~GT~~YmAPEVL~g~  502 (504)
                      ..     ....++..|+|||++.++
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~  184 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYR  184 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccC
Confidence            21     111235679999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.93  E-value=1.4e-25  Score=218.78  Aligned_cols=169  Identities=27%  Similarity=0.434  Sum_probs=142.7

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ..+.|++++.||+|+||.||+|...++..||+|.+.....      ....+.+|+.+++.++|+||+++++++. .+.+|
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            3468999999999999999999998899999998763222      1246788999999999999999999874 56799


Q ss_pred             EEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          407 IFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      ++|||+.+++|.+++..   ..+++.++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            99999999999998764   347888999999999999999999999999999999999999999999999987654222


Q ss_pred             c---ccccCCCcccccccccCC
Q 010676          484 V---KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~---~s~~GT~~YmAPEVL~g~  502 (504)
                      .   ....++..|+|||++.+.
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~  178 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYG  178 (260)
T ss_pred             cccccCCcccccccCHHHhccC
Confidence            1   223456789999988654

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.93  E-value=1.5e-25  Score=250.87  Aligned_cols=171  Identities=28%  Similarity=0.454  Sum_probs=147.9

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ++.|++++.||+|+||.||+|.+ .++..||||++.....  ........+.+|+.++..++|+||+++++++...+.+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   80 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM--INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY   80 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc--cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence            46899999999999999999998 4789999999864332  12334467889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |||||+.+++|.+++... .+.+..++.|+.||+.||.|||.++||||||||+||||+.++.+||+|||+++......  
T Consensus        81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~  160 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELN  160 (669)
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCccc
Confidence            999999999999988754 47888999999999999999999999999999999999999999999999998754332  


Q ss_pred             cccccCCCccccccccc
Q 010676          484 VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~  500 (504)
                      .....+|+.|++||...
T Consensus       161 ~~~~~~t~~~~~pe~~~  177 (669)
T cd05610         161 MMDILTTPSMAKPKNDY  177 (669)
T ss_pred             ccccccCccccCccccc
Confidence            33456899999998643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=1.3e-25  Score=257.00  Aligned_cols=174  Identities=30%  Similarity=0.511  Sum_probs=144.6

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC--
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--  401 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--  401 (504)
                      ...+.+|++++.||+|+||+||+|.+ .++..||+|++......   ......+.+|+.+|..|+|||||+++++|..  
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~---e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK---EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC---HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            34567899999999999999999998 57789999988643322   2234668899999999999999999998844  


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCcEEEcC-----
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-------DVVHRDIKCANILVDA-----  464 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~-------gIIHRDLKP~NILLd~-----  464 (504)
                      ...+||||||+.+++|.+++..     ..+++..++.|+.||+.||.|||..       +||||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            4679999999999999998865     3589999999999999999999984       4999999999999964     


Q ss_pred             ------------CCcEEEEecCcccccccCC-cccccCCCcccccccccC
Q 010676          465 ------------NGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       465 ------------~g~VKL~DFGLA~~~~~~~-~~s~~GT~~YmAPEVL~g  501 (504)
                                  .+.+||+|||++....... ...+.||+.|||||++.+
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g  215 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH  215 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhc
Confidence                        2358999999998654332 344579999999999853

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.93  E-value=1.9e-25  Score=221.62  Aligned_cols=169  Identities=31%  Similarity=0.452  Sum_probs=140.3

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .+.|++.+.||+|+||.||+|.+ .++..|++|.+.......    ....+.+|+.+++.++|+||+++++++......|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   79 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence            36899999999999999999987 578899999886432211    1134568999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--
Q 010676          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--  482 (504)
                      +||||+. ++|.+++..  ..+.+..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++.....  
T Consensus        80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9999996 566665543  34788889999999999999999999999999999999999999999999998754322  


Q ss_pred             CcccccCCCcccccccccC
Q 010676          483 DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g  501 (504)
                      ......+++.|+|||++.+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~  177 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLG  177 (291)
T ss_pred             CCCCccccccccCCceeec
Confidence            1233457899999999865

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.93  E-value=1.5e-25  Score=219.81  Aligned_cols=168  Identities=33%  Similarity=0.469  Sum_probs=140.9

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ..+|++.+.||+|+||.||+|.+.+...||+|.+.....      ....+.+|+.+++.++|+||+++++.+. ....|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence            357999999999999999999987667799998764221      1245788999999999999999999875 456899


Q ss_pred             EEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      ||||+++++|.+++..   ..+++..+..++.|++.||.|||+++|+|+||||.||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999999999875   3478889999999999999999999999999999999999999999999999876543322


Q ss_pred             ---ccccCCCcccccccccCC
Q 010676          485 ---KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ---~s~~GT~~YmAPEVL~g~  502 (504)
                         ....++..|+|||++.++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~  178 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYG  178 (262)
T ss_pred             ccccCCcccceecCHhHhccC
Confidence               123466789999987653

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=2e-26  Score=244.74  Aligned_cols=181  Identities=29%  Similarity=0.440  Sum_probs=151.5

Q ss_pred             CccccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhH---HHHHHHHHHHHHHhhCC---CCcee
Q 010676          321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK---QSISQLEQEIALLSRFE---HENIV  393 (504)
Q Consensus       321 ~~~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~---~~~~~~~~Ei~iL~~L~---HpnIV  393 (504)
                      .+.++. ...|..++.||.|.||.|++|++ .+...|+||.+.+...-...-   ..+-.+-.||.||..++   |+||+
T Consensus       554 e~~~~k-~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl  632 (772)
T KOG1152|consen  554 EKEYKK-FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENIL  632 (772)
T ss_pred             eeeecc-cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchh
Confidence            334433 35699999999999999999998 567788888775321110000   00112346999999997   99999


Q ss_pred             EEeeeecCCCeEEEEEEec-cCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEE
Q 010676          394 QYYGTDKDESKLYIFLELV-TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  471 (504)
Q Consensus       394 ~l~~~~~~~~~lyLVmEy~-~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~  471 (504)
                      +++++|++++++||+||-- +|-+|++++... .+++.+++.||+|++.|+++||+.||||||||-+|+.++.+|.+||+
T Consensus       633 KlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  633 KLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             hhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEe
Confidence            9999999999999999976 456899999765 59999999999999999999999999999999999999999999999


Q ss_pred             ecCcccccccCCcccccCCCcccccccccCC
Q 010676          472 DFGLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       472 DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      |||.+..++.+....++||..|.|||+|.|.
T Consensus       713 dfgsaa~~ksgpfd~f~gtv~~aapevl~g~  743 (772)
T KOG1152|consen  713 DFGSAAYTKSGPFDVFVGTVDYAAPEVLGGE  743 (772)
T ss_pred             eccchhhhcCCCcceeeeeccccchhhhCCC
Confidence            9999998998889999999999999999875

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.93  E-value=3.1e-25  Score=222.57  Aligned_cols=171  Identities=28%  Similarity=0.428  Sum_probs=144.0

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||+|+||.||++.+ .++..|++|.+.....  ........+.+|+.+++.++||||+++++.+..++.+|+|
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL--ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            688999999999999999998 5788999998764321  1223345678999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC----
Q 010676          409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~----  483 (504)
                      |||+.+++|.+++... .+++..+..++.|++.||.|||++||+|+||||.|||++.++.++|+|||+++......    
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            9999999999998664 47888999999999999999999999999999999999999999999999986421110    


Q ss_pred             -------------cccccCCCcccccccccCC
Q 010676          484 -------------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -------------~~s~~GT~~YmAPEVL~g~  502 (504)
                                   .....++..|+|||.+.++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  191 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ  191 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCC
Confidence                         0123578899999988654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.93  E-value=2e-25  Score=221.39  Aligned_cols=167  Identities=30%  Similarity=0.411  Sum_probs=134.9

Q ss_pred             eecccCceeEEEEEc-cCCceEEEEEEeccccchhhH-HHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEecc
Q 010676          336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK-QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (504)
Q Consensus       336 ~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~  413 (504)
                      +||+|+||.||+|.+ .+++.||+|.+.......... .........+.++....||||+.+++++...+.+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999988 578999999886432221111 111111223345555689999999999999999999999999


Q ss_pred             CCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcccccCCCc
Q 010676          414 KGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF  492 (504)
Q Consensus       414 ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~~GT~~  492 (504)
                      +++|..++... .+++..+..|+.|++.||.|||+++|+|+||||+||+++.++.++|+|||++............||..
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  160 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG  160 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence            99999888654 48999999999999999999999999999999999999999999999999987654444445579999


Q ss_pred             ccccccccCC
Q 010676          493 WMAPEVCSNP  502 (504)
Q Consensus       493 YmAPEVL~g~  502 (504)
                      |+|||++.++
T Consensus       161 y~aPE~~~~~  170 (278)
T cd05606         161 YMAPEVLQKG  170 (278)
T ss_pred             CcCcHHhcCC
Confidence            9999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.93  E-value=1.3e-25  Score=219.00  Aligned_cols=169  Identities=29%  Similarity=0.447  Sum_probs=142.0

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ..++|++.+.||+|+||.||+|...++..+|+|.+......      ...+.+|+.++++++|+||+++++++. ....|
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~------~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS------PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC------HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            34679999999999999999999888888999988643221      245789999999999999999999875 45689


Q ss_pred             EEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      ++|||+.+++|.+++...   .+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999988653   38889999999999999999999999999999999999999999999999987654332


Q ss_pred             c---ccccCCCcccccccccCC
Q 010676          484 V---KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~---~s~~GT~~YmAPEVL~g~  502 (504)
                      .   ....++..|+|||++.++
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~  178 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYG  178 (260)
T ss_pred             cccccCCCCCccccChHHHhcC
Confidence            2   122356679999987643

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.93  E-value=1.7e-25  Score=222.41  Aligned_cols=171  Identities=25%  Similarity=0.362  Sum_probs=139.8

Q ss_pred             ccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      .++|++.+.||+|+||.||+|...      .+..||+|.+.....    ......+.+|+.+++.++|+||+++++++..
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS----LRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            468999999999999999998652      355899997653221    1223457789999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEE
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRYH-----------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  470 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~~-----------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL  470 (504)
                      .+..|+||||+.+|+|.+++....           +....+..++.||+.||.|||+++|+||||||+|||++.++.++|
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999999986532           345678889999999999999999999999999999999999999


Q ss_pred             EecCcccccccCCc----ccccCCCcccccccccCC
Q 010676          471 ADFGLAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       471 ~DFGLA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      +|||+++.......    ....++..|+|||.+.++
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~  196 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG  196 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccC
Confidence            99999875432221    122356789999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.93  E-value=2.2e-25  Score=221.09  Aligned_cols=174  Identities=27%  Similarity=0.461  Sum_probs=143.5

Q ss_pred             cccccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEee
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG  397 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~  397 (504)
                      ....++|++.+.||+|+||.||++...      ....+|+|.+....    .......+.+|+.++..+ +|+||+++++
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC----CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            334568999999999999999999863      33688999775321    122345688999999999 7999999999


Q ss_pred             eecCCCeEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 010676          398 TDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  460 (504)
Q Consensus       398 ~~~~~~~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NI  460 (504)
                      ++.....+|++|||+.+++|..++...                 .+++..+..++.||+.||.|||++||+|+||||+||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni  163 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV  163 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence            999999999999999999999988642                 378888999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCcccccccCCc----ccccCCCcccccccccCC
Q 010676          461 LVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       461 LLd~~g~VKL~DFGLA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      |++.++.+||+|||+++.......    ....++..|+|||++.+.
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  209 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR  209 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC
Confidence            999999999999999886543321    122356789999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.93  E-value=5.9e-26  Score=224.12  Aligned_cols=170  Identities=25%  Similarity=0.347  Sum_probs=141.3

Q ss_pred             cceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      ..|++.+.||+|+||.||+|.+.      .+..||+|.+.....    ......+.+|+.++..++||||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE----GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC----HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            46888899999999999999863      357899998763221    22345688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHh-----------------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 010676          403 SKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  465 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~-----------------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~  465 (504)
                      ..+++++||+.+++|.+++..                 ..+++..+..++.|++.||.|||++||+||||||.|||++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            999999999999999998742                 236778889999999999999999999999999999999999


Q ss_pred             CcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          466 GSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       466 g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      +.+||+|||+++......    .....+++.|||||++.++
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  201 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG  201 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcC
Confidence            999999999987643322    1233467889999988643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.93  E-value=2e-25  Score=225.09  Aligned_cols=173  Identities=29%  Similarity=0.464  Sum_probs=141.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc--------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  396 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~--------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~  396 (504)
                      ....+|.+++.||+|+||.||+|..        .....+|+|.+....    .......+.+|+.+++.+ +||||++++
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----TDKDLADLISEMELMKLIGKHKNIINLL   84 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC----ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence            3346899999999999999999974        234578999765321    123345688899999999 599999999


Q ss_pred             eeecCCCeEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 010676          397 GTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (504)
Q Consensus       397 ~~~~~~~~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~N  459 (504)
                      +++...+.+|++|||+.+++|.+++...                 .+++.++..++.||+.||.|||++||+|+||||+|
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  164 (314)
T cd05099          85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN  164 (314)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence            9999999999999999999999988652                 37788899999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          460 ILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       460 ILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||++.++.+||+|||+++......    .....++..|||||++.++
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  211 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR  211 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC
Confidence            999999999999999997654221    1112245679999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.4e-25  Score=220.49  Aligned_cols=170  Identities=38%  Similarity=0.663  Sum_probs=148.9

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||.|+||.||+|.+ .++..|++|.+.....    ......+.+|+.+++.++|+||+++++++..+..+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI   76 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc----chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence            3688899999999999999998 5789999998864321    2233567899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Ccc
Q 010676          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  485 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~  485 (504)
                      |+||+.+++|.+++....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++.....  ...
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          77 IMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             EEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence            999999999999998888999999999999999999999999999999999999999999999999998765433  223


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...+++.|+|||++.+.
T Consensus       157 ~~~~~~~y~~PE~~~~~  173 (274)
T cd06609         157 TFVGTPFWMAPEVIKQS  173 (274)
T ss_pred             cccCCccccChhhhccC
Confidence            45688999999998764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA02988 hypothetical protein; Provisional

Probab=99.93  E-value=1.4e-25  Score=224.12  Aligned_cols=163  Identities=21%  Similarity=0.249  Sum_probs=138.5

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC----CCeEEEEEE
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKLYIFLE  410 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~----~~~lyLVmE  410 (504)
                      ..||+|+++.||+|.. +|..||+|.+.....  ........+.+|+.+|.+++||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK--GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEecccccc--ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            5699999999999988 688999998864322  223335678899999999999999999998866    457899999


Q ss_pred             eccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCcccccccCCccccc
Q 010676          411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR  488 (504)
Q Consensus       411 y~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~~  488 (504)
                      |+.+|+|.+++... .+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...... ....
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-~~~~  181 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-FKNV  181 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-cccc
Confidence            99999999998654 58888999999999999999998 499999999999999999999999999987654332 2345


Q ss_pred             CCCcccccccccC
Q 010676          489 GTAFWMAPEVCSN  501 (504)
Q Consensus       489 GT~~YmAPEVL~g  501 (504)
                      ||..|+|||++.+
T Consensus       182 ~~~~y~aPE~~~~  194 (283)
T PHA02988        182 NFMVYFSYKMLND  194 (283)
T ss_pred             CcccccCHHHhhh
Confidence            8999999999875

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.93  E-value=2.6e-25  Score=220.96  Aligned_cols=164  Identities=31%  Similarity=0.422  Sum_probs=133.6

Q ss_pred             eecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHH---HHhhCCCCceeEEeeeecCCCeEEEEEEe
Q 010676          336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA---LLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (504)
Q Consensus       336 ~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~---iL~~L~HpnIV~l~~~~~~~~~lyLVmEy  411 (504)
                      +||+|+||.||++.+ .++..+|+|.+..........  ...+.+|..   ++....|+||+.+++++...+.+|+||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH--HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence            489999999999998 578999999886433222111  122233333   34445799999999999999999999999


Q ss_pred             ccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcccccCC
Q 010676          412 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT  490 (504)
Q Consensus       412 ~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~~GT  490 (504)
                      +.+++|..++.. ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++............||
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT  158 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence            999999988765 4589999999999999999999999999999999999999999999999999875544444445699


Q ss_pred             CcccccccccC
Q 010676          491 AFWMAPEVCSN  501 (504)
Q Consensus       491 ~~YmAPEVL~g  501 (504)
                      ..|||||++.+
T Consensus       159 ~~y~aPE~~~~  169 (279)
T cd05633         159 HGYMAPEVLQK  169 (279)
T ss_pred             cCccCHHHhcC
Confidence            99999998863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.93  E-value=1.2e-25  Score=230.54  Aligned_cols=171  Identities=29%  Similarity=0.420  Sum_probs=138.3

Q ss_pred             ccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeec
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  400 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~  400 (504)
                      .++|++++.||+|+||.||+|.+      .+++.||||.+.....    ......+.+|+.+|..+ +|+||+++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----HSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC----hHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            35799999999999999999974      3578999998863221    22345678999999999 6899999999775


Q ss_pred             C-CCeEEEEEEeccCCCHHHHHHhc-------------------------------------------------------
Q 010676          401 D-ESKLYIFLELVTKGSLLNLYQRY-------------------------------------------------------  424 (504)
Q Consensus       401 ~-~~~lyLVmEy~~ggsL~~ll~~~-------------------------------------------------------  424 (504)
                      . ...+|+||||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            4 45689999999999999987542                                                       


Q ss_pred             -------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC----cccc
Q 010676          425 -------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC  487 (504)
Q Consensus       425 -------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~  487 (504)
                                   .+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++.......    ....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                         25667788899999999999999999999999999999999999999999987643221    1123


Q ss_pred             cCCCcccccccccCC
Q 010676          488 RGTAFWMAPEVCSNP  502 (504)
Q Consensus       488 ~GT~~YmAPEVL~g~  502 (504)
                      .++..|+|||++.++
T Consensus       242 ~~~~~y~aPE~~~~~  256 (343)
T cd05103         242 RLPLKWMAPETIFDR  256 (343)
T ss_pred             CCCcceECcHHhcCC
Confidence            356789999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.93  E-value=2.2e-25  Score=220.09  Aligned_cols=169  Identities=38%  Similarity=0.688  Sum_probs=146.8

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      -|++.+.||.|+||.||+|.+ .++..||+|.+.....    ......+.+|+.++..++|+||+++++++..+..+|+|
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            477888999999999999987 5788999998753221    22345788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--ccc
Q 010676          409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKS  486 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~~s  486 (504)
                      |||+.+++|..++....+++..+..++.|++.+|.|||++|++|+||||.||+++.++.++|+|||++.......  ...
T Consensus        81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06641          81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence            999999999999988889999999999999999999999999999999999999999999999999987654332  223


Q ss_pred             ccCCCcccccccccCC
Q 010676          487 CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       487 ~~GT~~YmAPEVL~g~  502 (504)
                      ..++..|+|||++.+.
T Consensus       161 ~~~~~~y~~PE~~~~~  176 (277)
T cd06641         161 FVGTPFWMAPEVIKQS  176 (277)
T ss_pred             ccCCccccChhhhccC
Confidence            4588999999998654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.93  E-value=6.5e-26  Score=223.48  Aligned_cols=170  Identities=39%  Similarity=0.673  Sum_probs=147.3

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      +.|++.+.||+|+||.||+|.+ .++..||+|.+.....    ......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc----hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            3577788999999999999987 5688999998753321    2234678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--cc
Q 010676          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~~  485 (504)
                      ||||+++++|.+++....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          80 IMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence            9999999999999988889999999999999999999999999999999999999999999999999987654332  22


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...|+..|+|||++.+.
T Consensus       160 ~~~~~~~y~aPE~~~~~  176 (277)
T cd06642         160 TFVGTPFWMAPEVIKQS  176 (277)
T ss_pred             cccCcccccCHHHhCcC
Confidence            34588999999998764

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=9.5e-26  Score=223.43  Aligned_cols=170  Identities=27%  Similarity=0.406  Sum_probs=146.6

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||+||++.+ .++..||+|++.....    ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK----SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc----chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            5788999999999999999998 5788999998764321    2234568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~  485 (504)
                      ||||+++++|..++... .+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~  160 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD  160 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence            99999999999988764 48899999999999999999997 68999999999999999999999999998755433334


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...||..|+|||++.++
T Consensus       161 ~~~~~~~~~aPE~~~~~  177 (284)
T cd06620         161 TFVGTSTYMSPERIQGG  177 (284)
T ss_pred             ccccCcccCCHHHHccC
Confidence            55799999999988653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=8.9e-26  Score=244.68  Aligned_cols=176  Identities=26%  Similarity=0.349  Sum_probs=135.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc--CCceEEEEEEec------------cccchhhHHHHHHHHHHHHHHhhCCCCc
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSL------------LDQGSQAKQSISQLEQEIALLSRFEHEN  391 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~--~g~~vAVK~v~~------------~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn  391 (504)
                      .+.++|++++.||+|+||+||++...  ++...++|.+..            .............+++|+.+|..++|+|
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            45678999999999999999998652  222222221100            0000111223456789999999999999


Q ss_pred             eeEEeeeecCCCeEEEEEEeccCCCHHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 010676          392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  465 (504)
Q Consensus       392 IV~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~  465 (504)
                      ||++++++...+..|+||+++.+ +|..++....      .....+..|+.||+.||.|||++|||||||||+||||+.+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            99999999999999999999965 6666554332      2345678899999999999999999999999999999999


Q ss_pred             CcEEEEecCcccccccCC---cccccCCCcccccccccCC
Q 010676          466 GSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       466 g~VKL~DFGLA~~~~~~~---~~s~~GT~~YmAPEVL~g~  502 (504)
                      +.+||+|||+++.+....   .....||+.|+|||++.+.
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  343 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD  343 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC
Confidence            999999999998654332   2235699999999998764

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.93  E-value=1.9e-25  Score=220.45  Aligned_cols=170  Identities=37%  Similarity=0.663  Sum_probs=148.2

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ..|+..+.||.|+||.||+|.+ .++..||+|.+.....    ......+.+|+.+++.+.|+||+++++++.....+|+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA----EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            4578889999999999999998 5688999998864321    2334678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--cc
Q 010676          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~~  485 (504)
                      ||||+++++|.+++....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        80 v~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          80 IMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999987654332  22


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...++..|+|||++.++
T Consensus       160 ~~~~~~~y~apE~~~~~  176 (277)
T cd06640         160 TFVGTPFWMAPEVIQQS  176 (277)
T ss_pred             cccCcccccCHhHhccC
Confidence            34588899999998664

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.93  E-value=1.5e-25  Score=224.64  Aligned_cols=160  Identities=31%  Similarity=0.464  Sum_probs=130.0

Q ss_pred             eeeecccCceeEEEEEcc---CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec--CCCeEEEE
Q 010676          334 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--DESKLYIF  408 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~---~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~--~~~~lyLV  408 (504)
                      +..||+|+||.||+|...   ++..||+|.+.....       ...+.+|+.+++.++||||+++++++.  .+..+|+|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            467999999999999863   567899998753211       134678999999999999999999874  45678999


Q ss_pred             EEeccCCCHHHHHHh----------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----cCCCcEEEEecC
Q 010676          409 LELVTKGSLLNLYQR----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFG  474 (504)
Q Consensus       409 mEy~~ggsL~~ll~~----------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL----d~~g~VKL~DFG  474 (504)
                      |||+.+ +|.+++..          ..+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            999976 67666532          137788899999999999999999999999999999999    566799999999


Q ss_pred             cccccccCC-----cccccCCCcccccccccC
Q 010676          475 LAKATKLND-----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       475 LA~~~~~~~-----~~s~~GT~~YmAPEVL~g  501 (504)
                      +++......     .....||+.|+|||++.+
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  189 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG  189 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcC
Confidence            997654321     234568999999999865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.93  E-value=1.5e-25  Score=219.36  Aligned_cols=167  Identities=34%  Similarity=0.641  Sum_probs=140.8

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecC----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD----  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~----  401 (504)
                      .+.|++.+.||+|+||.||+|.. .++..||+|.+.....      ....+.+|+.++..+ +|+||+++++++..    
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            35688889999999999999987 5788999998864321      124567899999988 69999999998864    


Q ss_pred             --CCeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          402 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       402 --~~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                        ...+|++|||+.+++|.+++...   .+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence              34689999999999999988753   4788999999999999999999999999999999999999999999999998


Q ss_pred             cccccC--CcccccCCCccccccccc
Q 010676          477 KATKLN--DVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       477 ~~~~~~--~~~s~~GT~~YmAPEVL~  500 (504)
                      ......  ......|++.|+|||++.
T Consensus       159 ~~~~~~~~~~~~~~g~~~y~aPE~~~  184 (272)
T cd06637         159 AQLDRTVGRRNTFIGTPYWMAPEVIA  184 (272)
T ss_pred             eecccccccCCcccccccccCHhHhc
Confidence            754322  233456899999999985

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.93  E-value=2.4e-25  Score=221.66  Aligned_cols=169  Identities=31%  Similarity=0.435  Sum_probs=141.9

Q ss_pred             cceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .+|.+.+.||+|+||.||+|..      .++..+++|.+....     ......+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-----LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-----HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            4689999999999999999974      245568888764321     22335688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  465 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~  465 (504)
                      +.+++||||+++++|.+++...                 .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            9999999999999999998653                 26888999999999999999999999999999999999999


Q ss_pred             CcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          466 GSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       466 g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      +.++|+|||++.......    .....++..|||||++.+.
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  200 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR  200 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC
Confidence            999999999987543322    1234467889999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.93  E-value=1.8e-25  Score=222.17  Aligned_cols=169  Identities=27%  Similarity=0.430  Sum_probs=139.2

Q ss_pred             ceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +|++.+.||+|+||.||+|.+.      ....+++|.+....    .......+.+|+.+++.++||||+++++.+...+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            4788899999999999999862      23467888764321    1223467889999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-------------------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA  458 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-------------------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~  458 (504)
                      ..|++|||+.+++|.+++...                         .+++..+..++.|++.||.|||+++|+||||||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~  156 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR  156 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence            999999999999999987642                         3677888999999999999999999999999999


Q ss_pred             cEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          459 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       459 NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |||++.++.+||+|||+++......    .....++..|+|||++.+.
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~  204 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH  204 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC
Confidence            9999999999999999987543221    1223457789999987654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=1.2e-25  Score=217.75  Aligned_cols=159  Identities=25%  Similarity=0.356  Sum_probs=132.4

Q ss_pred             eeecccCceeEEEEEccCCc-----------eEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          335 DLLGRGSFGSVYEGISDDGF-----------FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~-----------~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +.||+|+||.||+|.+....           .+++|.+.....      ....+.+|+.+++.++|+||+++++++.. .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR------DSLAFFETASLMSQLSHKHLVKLYGVCVR-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh------hHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence            46999999999999985322           466665542211      14677899999999999999999999887 7


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-------cEEEEecC
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------SVKLADFG  474 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-------~VKL~DFG  474 (504)
                      ..|+||||+.+++|.+++...  .++...+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            789999999999999998754  488899999999999999999999999999999999999887       79999999


Q ss_pred             cccccccCCcccccCCCcccccccccCC
Q 010676          475 LAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       475 LA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ++.....  .....++..|+|||++.+.
T Consensus       154 ~a~~~~~--~~~~~~~~~y~aPE~~~~~  179 (259)
T cd05037         154 IPITVLS--REERVERIPWIAPECIRNG  179 (259)
T ss_pred             ccccccc--ccccccCCCccChhhhcCC
Confidence            9876543  2234577889999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.93  E-value=3e-25  Score=216.77  Aligned_cols=170  Identities=26%  Similarity=0.419  Sum_probs=143.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ...++|++.+.||+|+||.||++....+..+++|.+...      ......+.+|+.+++.++|+||+++++.+.. ...
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   75 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI   75 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence            345789999999999999999999877788999977532      1224568889999999999999999999887 788


Q ss_pred             EEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          406 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      |++|||+++++|.+++...   .++...+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999999998653   3677888999999999999999999999999999999999999999999998765432


Q ss_pred             Ccc---cccCCCcccccccccCC
Q 010676          483 DVK---SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~---s~~GT~~YmAPEVL~g~  502 (504)
                      ...   ...++..|+|||++.++
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~  178 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFG  178 (260)
T ss_pred             CcccccCCcccccccCHhHhccC
Confidence            211   22356779999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-25  Score=248.16  Aligned_cols=168  Identities=24%  Similarity=0.412  Sum_probs=140.1

Q ss_pred             ccceeeeeeecccCceeEEEEEccCC-ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeee-c---C
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTD-K---D  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g-~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~-~---~  401 (504)
                      ..++++.++|.+|||+.||+|.+..+ ..||+|++...     .+..+..+.+||.++++|+ |+|||.|++.. .   .
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            34688999999999999999999655 99999987643     3566788999999999998 99999999932 1   1


Q ss_pred             C---CeEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCcEEEEec
Q 010676          402 E---SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADF  473 (504)
Q Consensus       402 ~---~~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILLd~~g~VKL~DF  473 (504)
                      +   -.++|.||||.||.|.++|+.   .+|++.++++||++++.||.+||.+.  |||||||-+||||+.+|+.|||||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence            1   247899999999999999874   35999999999999999999999988  999999999999999999999999


Q ss_pred             CcccccccCC-cc----------cccCCCccccccccc
Q 010676          474 GLAKATKLND-VK----------SCRGTAFWMAPEVCS  500 (504)
Q Consensus       474 GLA~~~~~~~-~~----------s~~GT~~YmAPEVL~  500 (504)
                      |.|....... ..          ...-|+.|+|||++.
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID  228 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID  228 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHh
Confidence            9986432211 00          012589999999985

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.93  E-value=2.1e-25  Score=218.96  Aligned_cols=163  Identities=24%  Similarity=0.379  Sum_probs=133.5

Q ss_pred             eeecccCceeEEEEEcc---CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEe
Q 010676          335 DLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~---~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy  411 (504)
                      +.||+|+||.||+|...   ++..+++|.+.....    ......+.+|+.+++.++||||+++++++.+...+|+||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS----VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            35899999999999763   446788887654321    12234678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          412 VTKGSLLNLYQRY------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       412 ~~ggsL~~ll~~~------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      +++++|.+++...      ..++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||+++......  
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            9999999988643      24556778899999999999999999999999999999999999999999986543222  


Q ss_pred             --cccccCCCcccccccccC
Q 010676          484 --VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 --~~s~~GT~~YmAPEVL~g  501 (504)
                        .....++..|+|||++.+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~  176 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDE  176 (269)
T ss_pred             ecCCCcCCcccccCHhHhcc
Confidence              122347888999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.93  E-value=2.5e-25  Score=220.74  Aligned_cols=171  Identities=28%  Similarity=0.472  Sum_probs=144.1

Q ss_pred             ceeeeeeecccCceeEEEEEc----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCe
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~  404 (504)
                      .|++.+.||.|+||.||+|.+    .+|..||+|.+..... ........++.+|+.++..+ +|+||+++++++..+..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            478899999999999999987    3788999998864221 11122345677899999999 59999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +|+||||+++++|.+++... .+.+..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            99999999999999988654 48889999999999999999999999999999999999999999999999987654322


Q ss_pred             ---cccccCCCcccccccccC
Q 010676          484 ---VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ---~~s~~GT~~YmAPEVL~g  501 (504)
                         .....|+..|+|||++.+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~  180 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRG  180 (290)
T ss_pred             ccccccccCCcccCChhhccC
Confidence               223568999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.93  E-value=1.7e-25  Score=227.29  Aligned_cols=166  Identities=23%  Similarity=0.359  Sum_probs=138.3

Q ss_pred             eeeeeccc--CceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          333 KGDLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       333 i~k~LG~G--~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      ++++||+|  +|++||++.+ .+|..||+|.+......   ......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT---NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc---HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            56789999  7899999988 68999999988643221   223456778999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC----
Q 010676          410 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----  482 (504)
Q Consensus       410 Ey~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~----  482 (504)
                      ||+++++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||+.+......    
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999999998864   34889999999999999999999999999999999999999999999999865432111    


Q ss_pred             -----CcccccCCCcccccccccC
Q 010676          483 -----DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 -----~~~s~~GT~~YmAPEVL~g  501 (504)
                           ......++..|||||++.+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~  182 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQ  182 (327)
T ss_pred             cccccccccccceecccChHHhhc
Confidence                 0122347788999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.93  E-value=1.3e-25  Score=223.00  Aligned_cols=170  Identities=27%  Similarity=0.432  Sum_probs=143.5

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--Ce
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK  404 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--~~  404 (504)
                      .+.|++.+.||.|+||.||+|.+ .++..+++|.+......   ......+.+|+.++.+++||||+++++++...  +.
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK   80 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence            46799999999999999999998 47889999988654322   11223466899999999999999999988777  88


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +|+||||+.+ +|.+++...  .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus        81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            9999999985 888887653  3899999999999999999999999999999999999999999999999998765443


Q ss_pred             --CcccccCCCcccccccccC
Q 010676          483 --DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 --~~~s~~GT~~YmAPEVL~g  501 (504)
                        ......+++.|+|||++.+
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~  180 (293)
T cd07843         160 LKPYTQLVVTLWYRAPELLLG  180 (293)
T ss_pred             ccccccccccccccCchhhcC
Confidence              2233457899999998865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-26  Score=240.15  Aligned_cols=165  Identities=32%  Similarity=0.486  Sum_probs=141.4

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhh--CCCCceeEEeeeecCCC---
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDES---  403 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~~~~~~~~---  403 (504)
                      ...++.++||+|.||.||+|...+ +.||||++..        +..+.+.+|-+|...  ++|+||++++++-....   
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CchhhHHHhhcCccceeehhhccC-ceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            345677899999999999998754 8999998863        233556677777665  57999999999876555   


Q ss_pred             -eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCcEEEcCCCcEEEEec
Q 010676          404 -KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---------DVVHRDIKCANILVDANGSVKLADF  473 (504)
Q Consensus       404 -~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~---------gIIHRDLKP~NILLd~~g~VKL~DF  473 (504)
                       .++||++|.+.|+|.+++..+.+++....+++..|++||+|||+-         .|+|||||..||||..+++..|+||
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence             799999999999999999999999999999999999999999962         5999999999999999999999999


Q ss_pred             CcccccccC----CcccccCCCcccccccccCC
Q 010676          474 GLAKATKLN----DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       474 GLA~~~~~~----~~~s~~GT~~YmAPEVL~g~  502 (504)
                      |||..+...    +....+||..|||||||.|.
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga  393 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA  393 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence            999875533    23446799999999999875

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.93  E-value=1.9e-25  Score=219.98  Aligned_cols=171  Identities=28%  Similarity=0.462  Sum_probs=145.4

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||+|.+ .++..|++|.+.....   .......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence            3689999999999999999998 4688999998754322   12233568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC---
Q 010676          408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~---  483 (504)
                      ||||++++.+..+... ..+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.+||+|||++.......   
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            9999998777766654 458999999999999999999999999999999999999999999999999987654332   


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....++..|+|||++.+.
T Consensus       158 ~~~~~~~~~~~~PE~~~~~  176 (288)
T cd07833         158 LTDYVATRWYRAPELLVGD  176 (288)
T ss_pred             ccCcccccCCcCCchhcCC
Confidence            2345688999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.93  E-value=4.3e-25  Score=214.15  Aligned_cols=170  Identities=32%  Similarity=0.606  Sum_probs=146.1

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||+|+||.||++.. .++..|++|.+......   ......+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence            488999999999999999998 57889999988643222   22235678999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |||+.+++|.+++...   .+++..+..++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++.......  
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            9999999999988653   47888999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....|++.|+|||++.++
T Consensus       158 ~~~~~~~~~~~~pe~~~~~  176 (256)
T cd08218         158 ARTCIGTPYYLSPEICENR  176 (256)
T ss_pred             hhhccCCccccCHHHhCCC
Confidence            2234588999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.93  E-value=3.6e-25  Score=213.82  Aligned_cols=170  Identities=35%  Similarity=0.538  Sum_probs=144.2

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec--CCCeEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--DESKLY  406 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~--~~~~ly  406 (504)
                      +|++.+.||.|+||.||++.+ .++..+++|.+......   ......+.+|+.+++.++|+||+++++++.  ....+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT---EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC---HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence            488899999999999999987 57889999988643221   233466888999999999999999999775  345689


Q ss_pred             EEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLH-----DQDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLH-----s~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                      ++|||+++++|.+++..     ..+++..+..++.||+.||.|||     +.+|+|+||||+||+++.++.+||+|||++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            99999999999998864     35888999999999999999999     899999999999999999999999999998


Q ss_pred             cccccCC--cccccCCCcccccccccCC
Q 010676          477 KATKLND--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       477 ~~~~~~~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      .......  .....+++.|+|||++.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~  185 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNHM  185 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcCC
Confidence            8765433  3345689999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.93  E-value=3.6e-25  Score=214.82  Aligned_cols=170  Identities=32%  Similarity=0.562  Sum_probs=146.1

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++++.||.|+||+||+|.. .++..+++|++......    .....+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   76 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ----TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL   76 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc----hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence            3689999999999999999997 57889999987532221    145678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          408 FLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      ||||+.+++|.+++..    ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            9999999999999865    247889999999999999999999999999999999999999999999999987544322


Q ss_pred             c------ccccCCCcccccccccCC
Q 010676          484 V------KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~------~s~~GT~~YmAPEVL~g~  502 (504)
                      .      ....|+..|+|||++..+
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~  181 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQV  181 (267)
T ss_pred             cccccccccccCChhhcChHHHccc
Confidence            1      234589999999988654

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.93  E-value=2.6e-25  Score=216.37  Aligned_cols=166  Identities=27%  Similarity=0.449  Sum_probs=139.5

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee-cCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~-~~~~~ly  406 (504)
                      ..+|++.+.||+|+||.||++... +..+++|.+....       ....+.+|+.+++.++|+|++++++++ ...+.+|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            357899999999999999999765 7788999774311       134678999999999999999999875 4567799


Q ss_pred             EEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          407 IFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      ++|||+++++|.+++....   +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9999999999999887543   7788999999999999999999999999999999999999999999999987543322


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                       ....++..|||||++.+.
T Consensus       157 -~~~~~~~~y~aPE~~~~~  174 (256)
T cd05082         157 -DTGKLPVKWTAPEALREK  174 (256)
T ss_pred             -CCCccceeecCHHHHccC
Confidence             233456789999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.8e-25  Score=219.67  Aligned_cols=168  Identities=39%  Similarity=0.696  Sum_probs=145.9

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC---CCceeEEeeeecCCCeE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKL  405 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~~~~~~~l  405 (504)
                      .|++.+.||+|+||.||+|.+ .++..|++|.+.....    ......+.+|+.+++.++   |||++++++++.....+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~   77 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL   77 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence            578889999999999999997 6889999998764322    222356778999998886   99999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |+||||+.+++|.+++....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......  
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            999999999999999988889999999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccccCCCcccccccccC
Q 010676          484 VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g  501 (504)
                      .....|+..|+|||++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~  175 (277)
T cd06917         158 RSTFVGTPYWMAPEVITE  175 (277)
T ss_pred             cccccCCcceeCHHHhcc
Confidence            233468999999998864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.93  E-value=1.3e-25  Score=221.21  Aligned_cols=170  Identities=31%  Similarity=0.485  Sum_probs=144.7

Q ss_pred             cceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||+|.+. ++..||+|.+.......   .....+.+|+.+++.++|+||+++++++..+..+|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK---MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc---hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence            36899999999999999999984 68999999875422211   223457789999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--c
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~  484 (504)
                      ||||+.+++|..+.... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......  .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence            99999999888876543 58999999999999999999999999999999999999999999999999987644322  2


Q ss_pred             ccccCCCcccccccccC
Q 010676          485 KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g  501 (504)
                      ....++..|+|||++.+
T Consensus       158 ~~~~~~~~y~aPE~~~~  174 (286)
T cd07846         158 TDYVATRWYRAPELLVG  174 (286)
T ss_pred             CcccceeeccCcHHhcc
Confidence            33458899999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.93  E-value=3.1e-25  Score=216.35  Aligned_cols=169  Identities=27%  Similarity=0.449  Sum_probs=138.2

Q ss_pred             eeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe--
Q 010676          331 WQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK--  404 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~--  404 (504)
                      |++++.||+|+||.||+|...    .+..||+|.+.....   .......+.+|+.+++.++|+||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH---TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            578899999999999999863    347899998764222   23334678899999999999999999998765544  


Q ss_pred             ----EEEEEEeccCCCHHHHHHh-------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEec
Q 010676          405 ----LYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (504)
Q Consensus       405 ----lyLVmEy~~ggsL~~ll~~-------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DF  473 (504)
                          .+++|||+.+++|..++..       ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence                7999999999999988743       24788899999999999999999999999999999999999999999999


Q ss_pred             CcccccccCCc----ccccCCCcccccccccCC
Q 010676          474 GLAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       474 GLA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      |+++.......    ....++..|+|||++.+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  190 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR  190 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccC
Confidence            99886543321    122356789999988654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.93  E-value=1.4e-25  Score=230.31  Aligned_cols=170  Identities=28%  Similarity=0.426  Sum_probs=138.9

Q ss_pred             cceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD  401 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~  401 (504)
                      ++|++.+.||+|+||.||+|..      .+++.||+|++....    .......+.+|+.++..+ +|+||+++++++..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----TASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            5799999999999999999964      245789999875321    122345677899999999 79999999998754


Q ss_pred             -CCeEEEEEEeccCCCHHHHHHh---------------------------------------------------------
Q 010676          402 -ESKLYIFLELVTKGSLLNLYQR---------------------------------------------------------  423 (504)
Q Consensus       402 -~~~lyLVmEy~~ggsL~~ll~~---------------------------------------------------------  423 (504)
                       +..+|++|||+++++|.+++..                                                         
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             4678999999999999988753                                                         


Q ss_pred             -----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC----cccccCCCccc
Q 010676          424 -----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWM  494 (504)
Q Consensus       424 -----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~Ym  494 (504)
                           ..+++..+..++.||+.||.|||++||+||||||.|||++.++.++|+|||++..+....    .....++..||
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence                 146788899999999999999999999999999999999999999999999997653222    12234677899


Q ss_pred             ccccccCC
Q 010676          495 APEVCSNP  502 (504)
Q Consensus       495 APEVL~g~  502 (504)
                      |||++.+.
T Consensus       243 aPE~~~~~  250 (337)
T cd05054         243 APESIFDK  250 (337)
T ss_pred             CcHHhcCC
Confidence            99987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.93  E-value=2.8e-25  Score=214.71  Aligned_cols=164  Identities=28%  Similarity=0.494  Sum_probs=137.8

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccC
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK  414 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~g  414 (504)
                      ++||+|+||.||+|...++..+|+|.+.....    ......+.+|+.+++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP----QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC----HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence            36999999999999988889999997753221    22234678999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc---ccccC
Q 010676          415 GSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRG  489 (504)
Q Consensus       415 gsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~---~s~~G  489 (504)
                      ++|.+++...  .+.+..+..++.|++.+|.|||++|++|+||||+||+++.++.+||+|||++........   ....+
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            9999988653  478899999999999999999999999999999999999999999999999875432221   12234


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      +..|+|||++.++
T Consensus       157 ~~~y~aPE~~~~~  169 (250)
T cd05085         157 PIKWTAPEALNYG  169 (250)
T ss_pred             cccccCHHHhccC
Confidence            6679999998754

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=3.8e-26  Score=241.89  Aligned_cols=174  Identities=30%  Similarity=0.479  Sum_probs=149.4

Q ss_pred             ccccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeec
Q 010676          322 GRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDK  400 (504)
Q Consensus       322 ~~~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~  400 (504)
                      ..+......|+++++||+||-+.||++...+...||+|.+....   ...+.+.-|.+||.+|.+|+ |.+||+||+|-.
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~---~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv  430 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE---ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV  430 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh---cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence            34555566899999999999999999999888888888775433   33556778999999999997 999999999999


Q ss_pred             CCCeEEEEEEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          401 DESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       401 ~~~~lyLVmEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      +++.+||||||=+ .+|..+++++.  +....++.|+.||+.++.++|.+||||.||||.|+|+ -.|.+||+|||+|..
T Consensus       431 ~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  431 TDGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANA  508 (677)
T ss_pred             cCceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcc
Confidence            9999999999754 58999998776  3334889999999999999999999999999999999 689999999999998


Q ss_pred             cccCCc----ccccCCCccccccccc
Q 010676          479 TKLNDV----KSCRGTAFWMAPEVCS  500 (504)
Q Consensus       479 ~~~~~~----~s~~GT~~YmAPEVL~  500 (504)
                      +..+..    .+.+||+.||+||.|.
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~  534 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALT  534 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHh
Confidence            776543    3557999999999875

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.93  E-value=3.2e-25  Score=225.85  Aligned_cols=172  Identities=29%  Similarity=0.461  Sum_probs=140.6

Q ss_pred             cccceeeeeeecccCceeEEEEEcc--------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEee
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG  397 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~--------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~  397 (504)
                      ...+|++++.||+|+||.||+|.+.        .+..||+|.+...    ........+.+|+.+++++ +|+||+++++
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            3457999999999999999999752        2236899976532    1123356788999999999 7999999999


Q ss_pred             eecCCCeEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 010676          398 TDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  460 (504)
Q Consensus       398 ~~~~~~~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NI  460 (504)
                      ++...+.+|++|||+++++|.+++...                 .++...+..++.||+.||.|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  165 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV  165 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence            999999999999999999999988643                 266778889999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          461 LVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       461 LLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |++.++.+||+|||+++......    .....++..|||||++.+.
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  211 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR  211 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC
Confidence            99999999999999987644321    1112245679999998664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.93  E-value=4e-25  Score=214.39  Aligned_cols=168  Identities=23%  Similarity=0.391  Sum_probs=142.9

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .+|++.+.||+|+||.||++.+.++..+++|.+......      ...+.+|+.+++.++||||+++++++.....+|+|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS------EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC------HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            478899999999999999999877889999987532221      23577899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc-
Q 010676          409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-  485 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~-  485 (504)
                      |||+.+++|.+++...  .+++..+..++.|++.+|.|||+++++|+||||+||+++.++.++|+|||++......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999988653  4788999999999999999999999999999999999999999999999998765433222 


Q ss_pred             --cccCCCcccccccccCC
Q 010676          486 --SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 --s~~GT~~YmAPEVL~g~  502 (504)
                        ...++..|+|||++.++
T Consensus       158 ~~~~~~~~~~~aPe~~~~~  176 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFS  176 (256)
T ss_pred             cCCCccchhhcCHhHhccC
Confidence              22345789999998754

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.93  E-value=3.9e-25  Score=216.00  Aligned_cols=167  Identities=30%  Similarity=0.458  Sum_probs=139.8

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +.|++.+.||+|+||.||+|.+..+..+++|.+.....      ....+.+|+.+++.++|+||+++++++. .+..|++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM------MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc------cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence            57899999999999999999987777899997653221      1245778999999999999999999875 4568999


Q ss_pred             EEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc-
Q 010676          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-  484 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~-  484 (504)
                      |||+.+++|.+++...   .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999999988653   378888999999999999999999999999999999999999999999999876543322 


Q ss_pred             --ccccCCCcccccccccCC
Q 010676          485 --KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 --~s~~GT~~YmAPEVL~g~  502 (504)
                        ....++..|+|||++.++
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~  178 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYG  178 (260)
T ss_pred             ccCCCccchhhCCHHHhccC
Confidence              123366789999987653

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.93  E-value=2.5e-25  Score=218.98  Aligned_cols=161  Identities=19%  Similarity=0.281  Sum_probs=130.2

Q ss_pred             eecccCceeEEEEEccCCc---eEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEec
Q 010676          336 LLGRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       336 ~LG~G~FG~VYka~~~~g~---~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      .||+|+||.||++...++.   .+++|.+....    .......+.+|+.+++.++||||+++++.+.....+|+||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA----SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC----ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            5999999999999764433   34455443221    1223467889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC----C
Q 010676          413 TKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----D  483 (504)
Q Consensus       413 ~ggsL~~ll~~~-----~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~----~  483 (504)
                      .+++|.+++.+.     .+....+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++......    .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999999988653     2455677889999999999999999999999999999999999999999997643221    1


Q ss_pred             cccccCCCccccccccc
Q 010676          484 VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~  500 (504)
                      .....++..|+|||++.
T Consensus       158 ~~~~~~~~~y~aPE~~~  174 (268)
T cd05086         158 EDDKCVPLRWLAPELVG  174 (268)
T ss_pred             ccCCcCcccccCchhcc
Confidence            22345889999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.93  E-value=5.1e-25  Score=212.85  Aligned_cols=170  Identities=29%  Similarity=0.491  Sum_probs=145.2

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||+|+||.||++.+ .++..+++|.+......   ......+.+|+.+|+.++|+||+++++.+...+.+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT---KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc---cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence            488999999999999999988 57889999988643222   23346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEecCcccccccCC-
Q 010676          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLND-  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~-g~VKL~DFGLA~~~~~~~-  483 (504)
                      |||+++++|.+++...   .+++..+..++.|++.+|.|||++||+|+||||.||+++.+ +.++|+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999998753   37889999999999999999999999999999999999855 468999999987654332 


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....++..|+|||++.+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~  176 (256)
T cd08220         158 AYTVVGTPCYISPELCEGK  176 (256)
T ss_pred             ccccccCCcccCchhccCC
Confidence            2335689999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.93  E-value=9.2e-26  Score=225.93  Aligned_cols=170  Identities=32%  Similarity=0.541  Sum_probs=145.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .+.|.....||+|+||.||++.+ .++..||||.+....     ......+.+|+.+++.++|+||+++++.+...+.+|
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW   95 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence            34566667799999999999987 578899999875322     223456789999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--c
Q 010676          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~  484 (504)
                      +||||+++++|.+++....+++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......  .
T Consensus        96 lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658          96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             EEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence            99999999999999887789999999999999999999999999999999999999999999999999987543222  2


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....|+..|+|||++.+.
T Consensus       176 ~~~~~~~~y~aPE~~~~~  193 (292)
T cd06658         176 KSLVGTPYWMAPEVISRL  193 (292)
T ss_pred             ceeecCccccCHHHHccC
Confidence            334689999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.3e-26  Score=246.35  Aligned_cols=162  Identities=41%  Similarity=0.659  Sum_probs=141.8

Q ss_pred             eecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccC
Q 010676          336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK  414 (504)
Q Consensus       336 ~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~g  414 (504)
                      +||+|+||+||-|++ .+...+|||.+....     ....+-+..||.+-+.|+|.|||+++|.+..++.+-|+||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-----SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc-----chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            599999999999999 577899999886432     23346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc--CC--ChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEEEEecCccccccc--CCcccc
Q 010676          415 GSLLNLYQRY--HL--RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKL--NDVKSC  487 (504)
Q Consensus       415 gsL~~ll~~~--~l--~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd-~~g~VKL~DFGLA~~~~~--~~~~s~  487 (504)
                      |+|.++++..  .+  ++.++..|.+||+.||.|||++.|||||||-+|+||+ ..|.+||.|||-++.+..  ....++
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            9999999753  35  7788999999999999999999999999999999997 679999999999886542  235567


Q ss_pred             cCCCcccccccccCC
Q 010676          488 RGTAFWMAPEVCSNP  502 (504)
Q Consensus       488 ~GT~~YmAPEVL~g~  502 (504)
                      .||..||||||+..|
T Consensus       737 TGTLQYMAPEvIDqG  751 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQG  751 (1226)
T ss_pred             ccchhhhChHhhccC
Confidence            799999999999865

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.93  E-value=2.7e-25  Score=221.73  Aligned_cols=170  Identities=26%  Similarity=0.353  Sum_probs=139.7

Q ss_pred             cceeeeeeecccCceeEEEEEcc-----------------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN  391 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-----------------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn  391 (504)
                      ++|++.+.||+|+||.||++...                 +...+|+|.+....    .......+.+|+.+++.++|+|
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA----NKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCC
Confidence            46899999999999999998532                 34568888775321    1233457889999999999999


Q ss_pred             eeEEeeeecCCCeEEEEEEeccCCCHHHHHHhcC------------CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 010676          392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (504)
Q Consensus       392 IV~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~------------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~N  459 (504)
                      |+++++++...+.+|+||||+.+++|.+++....            +++..+..++.||+.||.|||++||+|+||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999886532            5567899999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCcccccccCCc----ccccCCCcccccccccCC
Q 010676          460 ILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       460 ILLd~~g~VKL~DFGLA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      ||++.++.++|+|||+++.......    ....++..|+|||++.++
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  207 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG  207 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC
Confidence            9999999999999999876433321    122346789999976543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.93  E-value=4.1e-25  Score=217.40  Aligned_cols=168  Identities=27%  Similarity=0.441  Sum_probs=137.5

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHH-HhhCCCCceeEEeeeecCCCeEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ++|++.+.||+|+||.||++.+ .+|..||+|.+.......    ....+..|+.+ ++.++||||+++++++..++.+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ----EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH----HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence            3689999999999999999998 579999999886432211    12334455554 56678999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      ++|||++ ++|.+++..     ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9999997 578777654     2488999999999999999999997 99999999999999999999999999987654


Q ss_pred             cCCc-ccccCCCcccccccccC
Q 010676          481 LNDV-KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~~~-~s~~GT~~YmAPEVL~g  501 (504)
                      .... ....|+..|+|||++.+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~  177 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINP  177 (283)
T ss_pred             cccccccccCCccccChhhcCC
Confidence            3322 22458999999998864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=7.6e-26  Score=234.92  Aligned_cols=170  Identities=32%  Similarity=0.457  Sum_probs=142.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC--
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~--  403 (504)
                      -+.++.++.+.||+|.||.||+|.++ |..||||++...+...+..      +.||.....|+|+||+.+++....++  
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~SWfr------EtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERSWFR------ETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEecccchhhhhh------HHHHHHHHHhccchhhhhhhccccCCCc
Confidence            34567889999999999999999886 7899999997655433221      24555556689999999998865543  


Q ss_pred             --eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEEcCCCcEEEEec
Q 010676          404 --KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLADF  473 (504)
Q Consensus       404 --~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~--------gIIHRDLKP~NILLd~~g~VKL~DF  473 (504)
                        ++|||++|.+.|+|++++.++.++.+..++++..++.||+|||..        .|.|||||..||||.++|.+.|+|+
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence              599999999999999999999999999999999999999999952        4999999999999999999999999


Q ss_pred             CcccccccCC------cccccCCCcccccccccCC
Q 010676          474 GLAKATKLND------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       474 GLA~~~~~~~------~~s~~GT~~YmAPEVL~g~  502 (504)
                      |||.......      ....+||..|||||||...
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdet  395 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDET  395 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhh
Confidence            9997654331      2345799999999999753

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.93  E-value=3.2e-25  Score=221.68  Aligned_cols=170  Identities=28%  Similarity=0.507  Sum_probs=138.1

Q ss_pred             cceeeeeeecccCceeEEEEEcc-CCc--eEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCe
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-DGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-~g~--~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~  404 (504)
                      ++|++.+.||+|+||.||+|+.. ++.  .+++|.++...    .....+.+.+|+.++.++ +||||+++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA----SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC----CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            57899999999999999999874 333  46777665221    122345688999999999 69999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc
Q 010676          405 LYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS  467 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~  467 (504)
                      +|+||||+++++|.+++...                 .+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence            99999999999999998653                 3778889999999999999999999999999999999999999


Q ss_pred             EEEEecCcccccccCCcc-cccCCCcccccccccCC
Q 010676          468 VKLADFGLAKATKLNDVK-SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       468 VKL~DFGLA~~~~~~~~~-s~~GT~~YmAPEVL~g~  502 (504)
                      +||+|||++......... ....+..|+|||++.++
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  193 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS  193 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhccC
Confidence            999999998643221111 12235579999988654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.93  E-value=5.1e-25  Score=213.42  Aligned_cols=169  Identities=33%  Similarity=0.526  Sum_probs=148.2

Q ss_pred             ceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||+|+||.||+|.+. ++..|++|++......    .....+.+|+.++..++|+||+++++++.....+|+|
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            6889999999999999999985 6999999988643321    3346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc-
Q 010676          409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-  485 (504)
Q Consensus       409 mEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~-  485 (504)
                      |||+++++|.+++.. ..+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++......... 
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            999999999999875 568999999999999999999999 99999999999999999999999999998765443322 


Q ss_pred             -cccCCCcccccccccCC
Q 010676          486 -SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 -s~~GT~~YmAPEVL~g~  502 (504)
                       ...++..|+|||++.++
T Consensus       158 ~~~~~~~~y~~pE~~~~~  175 (264)
T cd06623         158 NTFVGTVTYMSPERIQGE  175 (264)
T ss_pred             cceeecccccCHhhhCCC
Confidence             45688999999988764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.93  E-value=3.6e-25  Score=213.38  Aligned_cols=168  Identities=32%  Similarity=0.515  Sum_probs=142.0

Q ss_pred             eeeeeeecccCceeEEEEEcc-C----CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          331 WQKGDLLGRGSFGSVYEGISD-D----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~-~----g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      +++.+.||.|+||.||++.+. .    +..+|+|.+.....    ......+.+|+.++..++|+||+++++++.+.+..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   76 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD----EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL   76 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC----hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence            356788999999999999984 3    48899998754321    11346788999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          406 YIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      |++|||+++++|.+++....   +++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++......
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999999886543   899999999999999999999999999999999999999999999999998765433


Q ss_pred             Ccc---cccCCCcccccccccCC
Q 010676          483 DVK---SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~---s~~GT~~YmAPEVL~g~  502 (504)
                      ...   ...+++.|+|||.+.+.
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~  179 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDG  179 (258)
T ss_pred             cccccccCCCcccccChHHhccC
Confidence            211   12367899999988543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.93  E-value=4.3e-25  Score=222.09  Aligned_cols=175  Identities=29%  Similarity=0.442  Sum_probs=145.2

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEe
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  396 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~  396 (504)
                      +.-..++|.+.+.||+|+||.||++..      .++..+|+|.+.....    ......+.+|+.+++++ +|+||++++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~iv~~~  105 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH----SSEREALMSELKIMSHLGNHENIVNLL  105 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC----hHHHHHHHHHHHHHHhccCCCCcceEE
Confidence            334456899999999999999999974      2456899997753321    22345688999999999 799999999


Q ss_pred             eeecCCCeEEEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEec
Q 010676          397 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (504)
Q Consensus       397 ~~~~~~~~lyLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DF  473 (504)
                      +++...+.+|++|||+.+++|.+++....   +++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+||
T Consensus       106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCC
Confidence            99999999999999999999999987532   789999999999999999999999999999999999999999999999


Q ss_pred             CcccccccCC----cccccCCCcccccccccCC
Q 010676          474 GLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       474 GLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |+++......    .....++..|+|||++.++
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  218 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNC  218 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccC
Confidence            9987544322    1123467789999988654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.93  E-value=3.7e-25  Score=220.15  Aligned_cols=175  Identities=28%  Similarity=0.473  Sum_probs=142.4

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      +...+++|++.+.||+|+||.||+|.+ .++..||+|.+.......   .....+.+|+.+++.++||||+++++++...
T Consensus         7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865           7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC---CchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            345567899999999999999999998 578999999886432211   1123456899999999999999999987654


Q ss_pred             C--------eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 010676          403 S--------KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       403 ~--------~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                      .        ..|+||||+.+ +|.+++...  .+++.++..++.||+.||.|||++|++|+||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence            3        46999999975 787777654  589999999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCC------cccccCCCcccccccccCC
Q 010676          473 FGLAKATKLND------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       473 FGLA~~~~~~~------~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||++.......      .....++..|+|||++.+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  198 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE  198 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCC
Confidence            99987543222      1233578899999987653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.93  E-value=1.1e-26  Score=232.63  Aligned_cols=171  Identities=30%  Similarity=0.460  Sum_probs=141.0

Q ss_pred             ccceeeeeeecccCceeEEEEEcc---C--CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD---D--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~---~--g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-  401 (504)
                      ...|++...||+|+||.||+|...   +  .+.||+|.++..+...-.   -....+|+.+++.++||||+.+..+|.+ 
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi---S~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI---SMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc---CHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            457999999999999999999652   2  337899987654332111   1234589999999999999999998877 


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC----CcEEEE
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLA  471 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~----g~VKL~  471 (504)
                      +..+|+++||.+. +|..+++-      ..++...++.|++||+.|+.|||++.|+||||||.||||..+    |.|||+
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence            7889999999987 78887753      238889999999999999999999999999999999999877    899999


Q ss_pred             ecCcccccccC-----CcccccCCCcccccccccCC
Q 010676          472 DFGLAKATKLN-----DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       472 DFGLA~~~~~~-----~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||||++.+...     .....+-|.+|+|||+|.|.
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa  214 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA  214 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhccc
Confidence            99999976533     23445689999999999874

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.93  E-value=4.1e-25  Score=233.45  Aligned_cols=175  Identities=28%  Similarity=0.426  Sum_probs=143.2

Q ss_pred             ccccccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEe
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYY  396 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~  396 (504)
                      +....++|.+++.||+|+||.||+|++.      .+..||+|++.....    ......+.+|+.+|..+. |||||+++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~~H~niv~~~  107 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR----SSEKQALMSELKIMSHLGPHLNIVNLL  107 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC----hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            3344567899999999999999999852      456899998864321    122346889999999997 99999999


Q ss_pred             eeecCCCeEEEEEEeccCCCHHHHHHhc----------------------------------------------------
Q 010676          397 GTDKDESKLYIFLELVTKGSLLNLYQRY----------------------------------------------------  424 (504)
Q Consensus       397 ~~~~~~~~lyLVmEy~~ggsL~~ll~~~----------------------------------------------------  424 (504)
                      +++.....+|+||||+.+|+|.+++...                                                    
T Consensus       108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            9999999999999999999999988643                                                    


Q ss_pred             -----------------------------------------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 010676          425 -----------------------------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  457 (504)
Q Consensus       425 -----------------------------------------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP  457 (504)
                                                                     .+++..+..|+.||+.||.|||+++|+||||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp  267 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA  267 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence                                                           145566788999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          458 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       458 ~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      +|||++.++.+||+|||+++......    .....+++.|||||++.+.
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  316 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN  316 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC
Confidence            99999999999999999987543221    1233477889999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.9e-25  Score=215.13  Aligned_cols=169  Identities=31%  Similarity=0.614  Sum_probs=143.1

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC-
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES-  403 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~-  403 (504)
                      ..++|++.+.||+|+||.||+|.+ .++..+++|.+.....      ....+.+|+.+++++ .|+||+++++++.... 
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP   77 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch------hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence            457899999999999999999998 4778999998764321      235678999999998 6999999999986544 


Q ss_pred             -----eEEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEec
Q 010676          404 -----KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (504)
Q Consensus       404 -----~lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DF  473 (504)
                           .+|+||||+.+++|.+++..     ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence                 58999999999999988754     35889999999999999999999999999999999999999999999999


Q ss_pred             CcccccccCC--cccccCCCcccccccccC
Q 010676          474 GLAKATKLND--VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       474 GLA~~~~~~~--~~s~~GT~~YmAPEVL~g  501 (504)
                      |++.......  .....|+..|+|||++.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  187 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIAC  187 (275)
T ss_pred             ccceecccchhhhcCccccccccCHhHhcc
Confidence            9987543222  234568999999998753

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.93  E-value=2.7e-25  Score=218.13  Aligned_cols=170  Identities=26%  Similarity=0.428  Sum_probs=142.6

Q ss_pred             cceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      ++|++.+.||+|+||.||+|+..      +...+++|.+....    .......+.+|+.++++++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK----DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc----chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            57889999999999999999863      34678888764322    122346688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhcC----------CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 010676          403 SKLYIFLELVTKGSLLNLYQRYH----------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~~----------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                      +..|+||||+++++|.+++....          +++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999999986543          88999999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCC---cccccCCCcccccccccCC
Q 010676          473 FGLAKATKLND---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       473 FGLA~~~~~~~---~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||++.......   .....++..|+|||.+.++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  193 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED  193 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccC
Confidence            99986533221   2233467789999987654

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.93  E-value=4.9e-25  Score=216.98  Aligned_cols=167  Identities=32%  Similarity=0.532  Sum_probs=141.7

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||.|+||.||+|++ .+|..||+|++.......    ....+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   76 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG----TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV   76 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc----chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence            488999999999999999998 578999999886533211    124466899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--
Q 010676          409 LELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~----~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--  482 (504)
                      |||+.+ +|.+++...    .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......  
T Consensus        77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            999986 788877643    4899999999999999999999999999999999999999999999999998754322  


Q ss_pred             CcccccCCCcccccccccC
Q 010676          483 DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g  501 (504)
                      ......+|..|++||++.+
T Consensus       156 ~~~~~~~~~~y~~PE~~~~  174 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLG  174 (284)
T ss_pred             ccccccccccccChHHhcC
Confidence            1233457899999998865

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=3.2e-25  Score=231.73  Aligned_cols=170  Identities=19%  Similarity=0.159  Sum_probs=132.1

Q ss_pred             ccccccccceeeeeeecccCceeEEEEEcc--CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeE-Eeee
Q 010676          322 GRFKRIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ-YYGT  398 (504)
Q Consensus       322 ~~~~~~~~~y~i~k~LG~G~FG~VYka~~~--~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~-l~~~  398 (504)
                      .....+...|.+.+.||+|+||+||+|.+.  ++..+|||++...............+.+|+.+|+.++|+|++. ++++
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~   90 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT   90 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence            344567788999999999999999999873  6778899976422110011233456889999999999999985 5543


Q ss_pred             ecCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCC-CCCcEEEcCCCcEEEEecCccc
Q 010676          399 DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI-KCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       399 ~~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDL-KP~NILLd~~g~VKL~DFGLA~  477 (504)
                          +..||||||++|++|... ..  ..   ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+
T Consensus        91 ----~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             ----CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence                357999999999999632 11  11   2468899999999999999999999 9999999999999999999998


Q ss_pred             ccccCC----------cccccCCCcccccccccC
Q 010676          478 ATKLND----------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       478 ~~~~~~----------~~s~~GT~~YmAPEVL~g  501 (504)
                      ......          .....+|+.|+|||++..
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            654322          234568999999999863

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.93  E-value=1.2e-25  Score=225.53  Aligned_cols=168  Identities=33%  Similarity=0.541  Sum_probs=144.8

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .|.....||+|+||.||++.+ .++..|++|.+.....     .....+.+|+.++..++||||+++++++...+.+|++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            444556799999999999998 5789999998864322     1234577899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--ccc
Q 010676          409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKS  486 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~~s  486 (504)
                      |||+++++|..++....+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.......  ...
T Consensus        97 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659          97 MEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             EecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999987543322  234


Q ss_pred             ccCCCcccccccccCC
Q 010676          487 CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       487 ~~GT~~YmAPEVL~g~  502 (504)
                      ..|+..|+|||++.+.
T Consensus       177 ~~~~~~y~aPE~~~~~  192 (297)
T cd06659         177 LVGTPYWMAPEVISRT  192 (297)
T ss_pred             eecCccccCHHHHccC
Confidence            5689999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.93  E-value=2.3e-25  Score=227.11  Aligned_cols=170  Identities=31%  Similarity=0.557  Sum_probs=142.4

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC---
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---  402 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~---  402 (504)
                      +.++|++.+.||+|+||.||+|.+ .+|..||+|.+.....    ......+.+|+.+++.++|+||+++++++...   
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH----QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE   78 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence            346899999999999999999987 5789999998853221    22345577899999999999999999876543   


Q ss_pred             --CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          403 --SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       403 --~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                        ..+|++|||+.+ +|..++....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        79 ~~~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          79 SFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             ccceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence              458999999975 88888888889999999999999999999999999999999999999999999999999987543


Q ss_pred             cCC-----cccccCCCcccccccccC
Q 010676          481 LND-----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~~-----~~s~~GT~~YmAPEVL~g  501 (504)
                      ...     .....||+.|||||++.+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~  183 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLN  183 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhC
Confidence            221     123468999999998653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.93  E-value=4.5e-25  Score=213.27  Aligned_cols=167  Identities=35%  Similarity=0.619  Sum_probs=146.3

Q ss_pred             cceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      +.|.+.+.||.|+||.||+|... ++..|++|.+.....       ...+.+|+.+++.++|+||+++++++.....+|+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            57889999999999999999985 588999998753211       4678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      +|||+.+++|.+++..  ..+++..+..++.|++.||.|||+.+|+|+||+|.||+++.++.++|+|||++.......  
T Consensus        76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            9999999999999864  348899999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....++..|+|||++.+.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~  174 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEI  174 (256)
T ss_pred             cccccCCccccCHHHHhcC
Confidence            2334588999999998764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.93  E-value=1.6e-25  Score=217.95  Aligned_cols=169  Identities=29%  Similarity=0.452  Sum_probs=146.7

Q ss_pred             ceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||.|+||.||++.+. ++..+++|.+.....    ......+.+|+.+++.++||||+++++.+...+.+|++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            5788899999999999999984 789999998864322    13346688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc
Q 010676          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (504)
Q Consensus       409 mEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~  485 (504)
                      |||+.+++|.+++..  ..+++..+..++.|++.+|.|||+ .|++|+||||+||+++.++.++|+|||++.........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            999999999999875  458889999999999999999999 99999999999999999999999999998765433333


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...++..|+|||++.+.
T Consensus       158 ~~~~~~~y~~PE~~~~~  174 (265)
T cd06605         158 TFVGTSSYMAPERIQGN  174 (265)
T ss_pred             cccCChhccCHHHHcCC
Confidence            36789999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.93  E-value=3.9e-25  Score=221.23  Aligned_cols=170  Identities=32%  Similarity=0.567  Sum_probs=147.4

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .++|.+.+.||+|+||.||++.+ .++..|++|.+.....     .....+.+|+.+++.++||||+++++.+...+.+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-----hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            46899999999999999999987 5788999998753221     12356788999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--c
Q 010676          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~  484 (504)
                      +|+||+++++|.+++.+..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......  .
T Consensus        93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             EEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999886543322  2


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....+++.|+|||++.++
T Consensus       173 ~~~~~~~~y~~PE~~~~~  190 (293)
T cd06647         173 STMVGTPYWMAPEVVTRK  190 (293)
T ss_pred             ccccCChhhcCchhhccC
Confidence            334588999999988654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.93  E-value=4.4e-25  Score=226.72  Aligned_cols=172  Identities=27%  Similarity=0.399  Sum_probs=142.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--  402 (504)
                      .+.++|++.+.||+|+||.||+|.+ .++..||+|.+.....   .......+.+|+.+++.++|+||++++++|...  
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS   89 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc---ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence            3567899999999999999999998 5889999998753221   122335567899999999999999999987644  


Q ss_pred             ----CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       403 ----~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                          ..+|+||||+.+ +|.+++... ++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  167 (353)
T cd07850          90 LEEFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  167 (353)
T ss_pred             ccccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence                357999999975 787777654 89999999999999999999999999999999999999999999999999976


Q ss_pred             cccCC-cccccCCCcccccccccCC
Q 010676          479 TKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..... .....+|..|+|||++.+.
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~  192 (353)
T cd07850         168 AGTSFMMTPYVVTRYYRAPEVILGM  192 (353)
T ss_pred             CCCCCCCCCCcccccccCHHHHhCC
Confidence            54332 2334589999999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.93  E-value=4.5e-25  Score=215.88  Aligned_cols=169  Identities=25%  Similarity=0.415  Sum_probs=135.4

Q ss_pred             eeeeeeecccCceeEEEEEccC-Cc--eEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC------
Q 010676          331 WQKGDLLGRGSFGSVYEGISDD-GF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD------  401 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~~-g~--~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~------  401 (504)
                      |.+++.||+|+||.||+|.+.. +.  .+|+|.+....   ........+.+|+.+++.++|+||+++++++..      
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   77 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG   77 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence            3567889999999999998743 32  58899775432   123335678899999999999999999987632      


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh-------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecC
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~-------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFG  474 (504)
                      ....+++|||+.+++|..++..       ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence            2357899999999999987632       237888999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCc----ccccCCCcccccccccCC
Q 010676          475 LAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       475 LA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      +++.......    ....+++.|+|||++.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  189 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADR  189 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCC
Confidence            9886543321    122367789999998754

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.93  E-value=5.5e-25  Score=215.65  Aligned_cols=170  Identities=27%  Similarity=0.457  Sum_probs=141.0

Q ss_pred             cceeeeeeecccCceeEEEEEcc-CC---ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-DG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-~g---~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ..|++.+.||+|+||.||+|... ++   ..|++|.+....    .......+..|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            46899999999999999999873 33   369999775321    12334678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +|+||||+.+++|.+++...  .++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999999988753  4788999999999999999999999999999999999999999999999998754332


Q ss_pred             Cc----c-ccc--CCCcccccccccCC
Q 010676          483 DV----K-SCR--GTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~----~-s~~--GT~~YmAPEVL~g~  502 (504)
                      ..    . ...  .+..|+|||++.++
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~  186 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYR  186 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccC
Confidence            21    1 111  24579999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.93  E-value=8.3e-25  Score=208.56  Aligned_cols=168  Identities=36%  Similarity=0.666  Sum_probs=148.0

Q ss_pred             ceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|.+.+.||+|+||.||++.+. ++..+++|++.....     .....+.+|+.+++.++|+||+++++++......|++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            4788899999999999999984 788999998864322     2346788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-cc
Q 010676          409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VK  485 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-~~  485 (504)
                      +||+++++|.+++...  .+++..+..++.|++.+|.|||.+|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence            9999999999998775  68999999999999999999999999999999999999999999999999987765443 34


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...++..|++||++.+.
T Consensus       156 ~~~~~~~~~~PE~~~~~  172 (253)
T cd05122         156 TMVGTPYWMAPEVINGK  172 (253)
T ss_pred             ceecCCcccCHHHHcCC
Confidence            55689999999998754

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.93  E-value=5.1e-25  Score=217.35  Aligned_cols=170  Identities=26%  Similarity=0.430  Sum_probs=139.6

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCc----eEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~----~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      ..+|++.+.||+|+||+||+|.+ .++.    .||+|.+.....    ......+.+|+.++..++|+||+++++++.. 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS----PKANKEILDEAYVMAGVGSPYVCRLLGICLT-   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC----HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence            35799999999999999999986 3444    478887753221    2234567889999999999999999999875 


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      ...+++|+|+++|+|.+++...  .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            4578999999999999988653  48999999999999999999999999999999999999999999999999988654


Q ss_pred             cCCc----ccccCCCcccccccccCC
Q 010676          481 LNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      ....    ....+++.|||||++.+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~  186 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHR  186 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccC
Confidence            3221    112346789999998654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=1e-24  Score=216.60  Aligned_cols=170  Identities=31%  Similarity=0.479  Sum_probs=143.9

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC--CCeE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKL  405 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--~~~l  405 (504)
                      +.|...+.||.|+||.||++.+ .++..+|+|.+.....    ......+.+|+.+++.++||||+++++++..  .+.+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   76 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN----PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI   76 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc----hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence            3688999999999999999998 5788999998864322    1334567899999999999999999998754  4479


Q ss_pred             EEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          406 YIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      |+||||+++++|.+++..     ..+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999999999887653     347888999999999999999999999999999999999999999999999987655


Q ss_pred             cCCcccccCCCcccccccccCC
Q 010676          481 LNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ........++..|+|||++.+.
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~  178 (287)
T cd06621         157 NSLAGTFTGTSFYMAPERIQGK  178 (287)
T ss_pred             ccccccccCCccccCHHHhcCC
Confidence            4444445688999999988654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.93  E-value=1.1e-24  Score=208.63  Aligned_cols=170  Identities=52%  Similarity=0.871  Sum_probs=149.1

Q ss_pred             ceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--CeEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKLY  406 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--~~ly  406 (504)
                      +|++.+.||+|+||.||+|.+. ++..+++|++......   ......+.+|+.++++++|+||+++++.+...  ..++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            4788899999999999999985 7999999988654322   33456788999999999999999999999888  8999


Q ss_pred             EEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      ++|||+.+++|.+++... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            999999999999998765 68999999999999999999999999999999999999999999999999988765443  


Q ss_pred             --cccccCCCcccccccccCC
Q 010676          484 --VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 --~~s~~GT~~YmAPEVL~g~  502 (504)
                        .....++..|+|||++.+.
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~  178 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGE  178 (260)
T ss_pred             ccccCCCCCccccCHhhhcCC
Confidence              3345689999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=5.6e-25  Score=215.77  Aligned_cols=170  Identities=33%  Similarity=0.499  Sum_probs=142.7

Q ss_pred             cceeeeeeecccCceeEEEEEc-----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC--
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--  401 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--  401 (504)
                      +.|++.+.||+|+||.||+|..     .++..+|+|.+......    .....+.+|+.+++.++|+||+++++++..  
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            4678889999999999999985     24789999988643322    345678899999999999999999998877  


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ...+|++|||+++++|.+++....  +++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            567999999999999999997655  899999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCc-----ccccCCCcccccccccCC
Q 010676          480 KLNDV-----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~~-----~s~~GT~~YmAPEVL~g~  502 (504)
                      .....     ....++..|+|||++.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~  187 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTS  187 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccC
Confidence            52211     122356679999987643

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1e-24  Score=209.76  Aligned_cols=170  Identities=45%  Similarity=0.751  Sum_probs=147.8

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|.+.+.||+|+||.||++.+ .++..|++|.+......   ......+.+|++++..++|+|++++++++...+.+|++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC---HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence            478899999999999999987 47889999988654322   23456788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc--c
Q 010676          409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--K  485 (504)
Q Consensus       409 mEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~--~  485 (504)
                      |||+.+++|.+++.. ..+++..+..++.|++.+|.|||++||+|+||||+||+++.++.++|+|||++........  .
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA  157 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence            999999999998866 4589999999999999999999999999999999999999999999999999886554432  3


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...++..|+|||++.+.
T Consensus       158 ~~~~~~~y~~pe~~~~~  174 (254)
T cd06627         158 SVVGTPYWMAPEVIEMS  174 (254)
T ss_pred             ccccchhhcCHhhhcCC
Confidence            44689999999987654

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.93  E-value=5e-25  Score=217.49  Aligned_cols=170  Identities=30%  Similarity=0.461  Sum_probs=140.0

Q ss_pred             cceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      +.|++.+.||+|+||.||+|.+.      .+..|++|.+.....    ......+.+|+.+++.++|+||+++++++.+.
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS----EQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            57899999999999999999884      467888887643221    22235678899999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc--------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEEE
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLA  471 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~--------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g---~VKL~  471 (504)
                      ...|+||||+.+++|.+++...        .+++..+..++.||+.||.|||+++++|+||||+|||++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            9999999999999999998764        378889999999999999999999999999999999998665   59999


Q ss_pred             ecCcccccccCCc----ccccCCCcccccccccCC
Q 010676          472 DFGLAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       472 DFGLA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      |||+++.......    .....+..|||||++.++
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG  196 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcC
Confidence            9999876532221    112235679999998654

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.93  E-value=4.3e-25  Score=214.30  Aligned_cols=163  Identities=32%  Similarity=0.511  Sum_probs=137.1

Q ss_pred             eeecccCceeEEEEEccC--C--ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEE
Q 010676          335 DLLGRGSFGSVYEGISDD--G--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~--g--~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmE  410 (504)
                      ++||+|+||.||+|.+.+  +  ..||+|.+......    .....+.+|+.++++++|+||+++++.+.. ..+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e   75 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE   75 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence            468999999999998732  3  36899977543221    445778899999999999999999999988 89999999


Q ss_pred             eccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC----
Q 010676          411 LVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  483 (504)
Q Consensus       411 y~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~----  483 (504)
                      |+++++|.+++...   .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            99999999988764   37889999999999999999999999999999999999999999999999987654321    


Q ss_pred             -cccccCCCcccccccccCC
Q 010676          484 -VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g~  502 (504)
                       .....++..|+|||++.+.
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~  175 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTR  175 (257)
T ss_pred             cccCCCCCceecCHHHhccc
Confidence             1223477889999988653

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.93  E-value=3.3e-25  Score=221.48  Aligned_cols=169  Identities=30%  Similarity=0.449  Sum_probs=138.7

Q ss_pred             ceeeeeeecccCceeEEEEEcc---CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--Ce
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK  404 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~---~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--~~  404 (504)
                      .|++.+.||+|+||.||+|.+.   ++..||+|.+......  .......+.+|+.++..++||||+++++++...  ..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQ--YTGISQSACREIALLRELKHENVVSLVEVFLEHADKS   78 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccc--ccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence            4788999999999999999983   5899999988753211  111224567899999999999999999999888  88


Q ss_pred             EEEEEEeccCCCHHHHHHh------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC----CCcEEEEecC
Q 010676          405 LYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA----NGSVKLADFG  474 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~----~g~VKL~DFG  474 (504)
                      +|+||||+++ +|.+++..      ..+++..++.++.||+.||.|||+++|+||||||+|||++.    ++.+||+|||
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999999986 56665532      24788899999999999999999999999999999999999    8999999999


Q ss_pred             cccccccCC-----cccccCCCcccccccccC
Q 010676          475 LAKATKLND-----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       475 LA~~~~~~~-----~~s~~GT~~YmAPEVL~g  501 (504)
                      ++.......     .....+|..|+|||++.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  189 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLG  189 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhC
Confidence            987643221     223468899999998765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.93  E-value=5.2e-25  Score=217.11  Aligned_cols=168  Identities=32%  Similarity=0.496  Sum_probs=141.7

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||.|+||.||+|.+ .++..|+||.+.......   .....+.+|+.++++++||||+++++++...+.+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc---ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            488899999999999999998 578999999876432211   1224677899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |||+. ++|..++..   ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.......  
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            99996 578887754   358889999999999999999999999999999999999999999999999987544322  


Q ss_pred             cccccCCCcccccccccC
Q 010676          484 VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g  501 (504)
                      .....++..|+|||++.+
T Consensus       157 ~~~~~~~~~y~aPE~~~~  174 (284)
T cd07860         157 YTHEVVTLWYRAPEILLG  174 (284)
T ss_pred             cccccccccccCCeEEec
Confidence            233457889999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.93  E-value=6.4e-25  Score=216.74  Aligned_cols=164  Identities=28%  Similarity=0.420  Sum_probs=138.6

Q ss_pred             ecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccCC
Q 010676          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (504)
Q Consensus       337 LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~gg  415 (504)
                      ||+|+||+||+|.+ .+|..|++|.+......  .......+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK--KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh--hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence            69999999999987 57899999988643211  1222345678999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-CcccccCCC
Q 010676          416 SLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTA  491 (504)
Q Consensus       416 sL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-~~~s~~GT~  491 (504)
                      +|.+++...   .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ......++.
T Consensus        79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence            999888653   4889999999999999999999999999999999999999999999999998754422 223445788


Q ss_pred             cccccccccCC
Q 010676          492 FWMAPEVCSNP  502 (504)
Q Consensus       492 ~YmAPEVL~g~  502 (504)
                      .|+|||++.++
T Consensus       159 ~y~~PE~~~~~  169 (277)
T cd05577         159 GYMAPEVLQGE  169 (277)
T ss_pred             CcCCHHHhcCC
Confidence            99999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.93  E-value=5.1e-25  Score=218.08  Aligned_cols=169  Identities=28%  Similarity=0.418  Sum_probs=141.2

Q ss_pred             cceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .+|++.++||+|+||.||++..      .++..+++|.+....     ......+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-----ESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-----HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            4678899999999999999963      346688888764321     23345788999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  466 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g  466 (504)
                      +.+|++|||+.+++|.+++...                .+++..+..++.||+.||.|||++||+|+||||+|||++.++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            9999999999999999988653                377889999999999999999999999999999999999999


Q ss_pred             cEEEEecCcccccccCCc----ccccCCCcccccccccCC
Q 010676          467 SVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       467 ~VKL~DFGLA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      .+||+|||++........    ....+++.|+|||++.+.
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  199 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR  199 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC
Confidence            999999999875433221    122356789999988764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.93  E-value=7.7e-25  Score=213.53  Aligned_cols=163  Identities=26%  Similarity=0.454  Sum_probs=135.1

Q ss_pred             eecccCceeEEEEEc---cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEec
Q 010676          336 LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       336 ~LG~G~FG~VYka~~---~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      .||+|+||.||+|.+   .++..+|+|++.....   .......+.+|+.+++.++|+||+++++++. ...+++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN---DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC---cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence            589999999999965   4678999998753322   2334567889999999999999999999875 45679999999


Q ss_pred             cCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc-----cc
Q 010676          413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KS  486 (504)
Q Consensus       413 ~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~-----~s  486 (504)
                      ++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||++........     ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            99999998865 4589999999999999999999999999999999999999999999999999876543321     12


Q ss_pred             ccCCCcccccccccCC
Q 010676          487 CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       487 ~~GT~~YmAPEVL~g~  502 (504)
                      ..++..|||||++.+.
T Consensus       158 ~~~~~~y~aPE~~~~~  173 (257)
T cd05116         158 GKWPVKWYAPECMNYY  173 (257)
T ss_pred             CCCCccccCHhHhccC
Confidence            2345789999988653

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.93  E-value=6.8e-25  Score=225.00  Aligned_cols=170  Identities=26%  Similarity=0.447  Sum_probs=144.6

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC--
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  403 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~--  403 (504)
                      +.++|++.+.||+|+||.||++.+ .++..||+|++....   ........+.+|+.+++.++|+||+++++++....  
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            566899999999999999999987 589999999875322   11223356779999999999999999999887654  


Q ss_pred             ----eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       404 ----~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                          .+|+||+|+ +++|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence                468999999 679999988888999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCcccccCCCcccccccccC
Q 010676          480 KLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       480 ~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      ... .....+++.|+|||++.+
T Consensus       169 ~~~-~~~~~~~~~y~aPE~~~~  189 (343)
T cd07880         169 DSE-MTGYVVTRWYRAPEVILN  189 (343)
T ss_pred             ccC-ccccccCCcccCHHHHhC
Confidence            432 234468999999998865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.93  E-value=7.6e-25  Score=214.52  Aligned_cols=161  Identities=27%  Similarity=0.460  Sum_probs=132.9

Q ss_pred             ecccCceeEEEEEcc---CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEecc
Q 010676          337 LGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT  413 (504)
Q Consensus       337 LG~G~FG~VYka~~~---~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~  413 (504)
                      ||+|+||.||+|.+.   .+..||+|++....    .......+.+|+.+++.++|+||+++++++. ...+|+||||++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~   77 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN----EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS   77 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEccccc----ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence            899999999999763   45679999775321    1333466889999999999999999999886 457899999999


Q ss_pred             CCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc-----cc
Q 010676          414 KGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KS  486 (504)
Q Consensus       414 ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~-----~s  486 (504)
                      +++|.+++..  ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++........     ..
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999998864  4589999999999999999999999999999999999999999999999999875433221     11


Q ss_pred             ccCCCcccccccccCC
Q 010676          487 CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       487 ~~GT~~YmAPEVL~g~  502 (504)
                      ..++..|+|||++.++
T Consensus       158 ~~~~~~y~aPE~~~~~  173 (257)
T cd05115         158 GKWPLKWYAPECINFR  173 (257)
T ss_pred             CCCCcccCCHHHHccC
Confidence            2235789999988654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.93  E-value=3.6e-26  Score=242.22  Aligned_cols=159  Identities=31%  Similarity=0.499  Sum_probs=139.8

Q ss_pred             eeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEec
Q 010676          333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       333 i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      -++-||.|..|.||+|+.. +..||||.++.            .-+.+|+-|++|+|+||+.|.++|....++|||||||
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC  194 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC  194 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence            3566999999999999886 56899996642            1236788999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-CcccccCC
Q 010676          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGT  490 (504)
Q Consensus       413 ~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-~~~s~~GT  490 (504)
                      ..|-|..+++.. .+....+..|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++..... ...+++||
T Consensus       195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGT  274 (904)
T KOG4721|consen  195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGT  274 (904)
T ss_pred             ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhh
Confidence            999999999765 4888899999999999999999999999999999999999999999999998865433 34567899


Q ss_pred             CcccccccccCCCC
Q 010676          491 AFWMAPEVCSNPFV  504 (504)
Q Consensus       491 ~~YmAPEVL~g~~v  504 (504)
                      ..||||||+.+.-|
T Consensus       275 VaWMAPEvIrnePc  288 (904)
T KOG4721|consen  275 VAWMAPEVIRNEPC  288 (904)
T ss_pred             HhhhCHHHhhcCCc
Confidence            99999999987643

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.93  E-value=7.7e-25  Score=211.23  Aligned_cols=170  Identities=36%  Similarity=0.520  Sum_probs=147.4

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|++.+.||+|+||.||++.+ .++..+++|.+......   ......+.+|+.+++.++|+||+++++++.....+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS---QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc---HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence            488899999999999999987 57889999988643322   22345677899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          409 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      |||+++++|..++..     ..+++..+..++.|++.||.|||++|++|+||+|.||+++.++.+||+|||++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            999999999998866     458888999999999999999999999999999999999999999999999998765554


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....+++.|++||.+.+.
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~  176 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGR  176 (256)
T ss_pred             cccccCCccccCHHHHCCC
Confidence            4445689999999998764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.93  E-value=8.9e-25  Score=211.34  Aligned_cols=164  Identities=28%  Similarity=0.481  Sum_probs=138.6

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccC
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK  414 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~g  414 (504)
                      ++||+|+||.||++.+.++..|++|.+......    .....+.+|+.++++++|+||+++++++......|+||||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            469999999999999866999999987643322    2345788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc----ccc
Q 010676          415 GSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----SCR  488 (504)
Q Consensus       415 gsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~----s~~  488 (504)
                      ++|.+++...  .++...+..++.|++.+|.|||+++++||||||+|||++.++.++|+|||++.........    ...
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            9999988653  4788889999999999999999999999999999999999999999999998754422211    122


Q ss_pred             CCCcccccccccCC
Q 010676          489 GTAFWMAPEVCSNP  502 (504)
Q Consensus       489 GT~~YmAPEVL~g~  502 (504)
                      ++..|+|||++.++
T Consensus       157 ~~~~y~~PE~~~~~  170 (251)
T cd05041         157 IPIKWTAPEALNYG  170 (251)
T ss_pred             ceeccCChHhhccC
Confidence            35679999998764

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.93  E-value=6.6e-25  Score=220.29  Aligned_cols=171  Identities=30%  Similarity=0.492  Sum_probs=141.8

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--C
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--S  403 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--~  403 (504)
                      ..++|++.+.||+|+||.||+|.+ .+|..||+|.+........   ....+.+|+.++++++|+||+++++++...  +
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG---IPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC---CcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            456899999999999999999998 5789999998864332211   112356799999999999999999988654  5


Q ss_pred             eEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+.+ +|.+++..  ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            68999999975 78887765  4588999999999999999999999999999999999999999999999999876543


Q ss_pred             C--CcccccCCCcccccccccC
Q 010676          482 N--DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       482 ~--~~~s~~GT~~YmAPEVL~g  501 (504)
                      .  ......+++.|+|||++.+
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~  182 (309)
T cd07845         161 PAKPMTPKVVTLWYRAPELLLG  182 (309)
T ss_pred             ccCCCCcccccccccChhhhcC
Confidence            3  2233346888999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.93  E-value=1.1e-24  Score=209.26  Aligned_cols=170  Identities=33%  Similarity=0.615  Sum_probs=146.9

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|.+.+.||.|+||.||++.+ .++..|++|++......   ......+.+|+.+++.++|+|++++++.+.....+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS---EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC---hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence            488899999999999999998 47899999988653322   23345678999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          409 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      |||+++++|.+++..     ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999998865     458999999999999999999999999999999999999999999999999987654332


Q ss_pred             --cccccCCCcccccccccCC
Q 010676          484 --VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 --~~s~~GT~~YmAPEVL~g~  502 (504)
                        .....|++.|+|||++.+.
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~  178 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNK  178 (258)
T ss_pred             ceecceeeeecccChhHhccC
Confidence              2334689999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.93  E-value=9.5e-25  Score=212.79  Aligned_cols=164  Identities=31%  Similarity=0.456  Sum_probs=141.1

Q ss_pred             ecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccCC
Q 010676          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (504)
Q Consensus       337 LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~gg  415 (504)
                      ||.|+||.||+|.+ .++..+++|++......  .......+.+|+.+++.++|+||+++++.+..+..+|++|||++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV--ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcch--hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence            69999999999998 46899999988643321  1223467889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-cccccCCCcc
Q 010676          416 SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFW  493 (504)
Q Consensus       416 sL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-~~s~~GT~~Y  493 (504)
                      +|.+++.+. .++...+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... .....++..|
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCc
Confidence            999988764 47889999999999999999999999999999999999999999999999988655432 2334689999


Q ss_pred             cccccccCC
Q 010676          494 MAPEVCSNP  502 (504)
Q Consensus       494 mAPEVL~g~  502 (504)
                      ++||++.+.
T Consensus       159 ~~PE~~~~~  167 (262)
T cd05572         159 VAPEIILNK  167 (262)
T ss_pred             cChhHhcCC
Confidence            999998654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.93  E-value=1.3e-24  Score=215.63  Aligned_cols=171  Identities=33%  Similarity=0.597  Sum_probs=142.7

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE  402 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~  402 (504)
                      ....++|.+.+.||+|+||.||++.. .++..+|+|.+....      .....+.+|+.++.++ +||||+++++++...
T Consensus        18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34567899999999999999999998 578899999875321      1124567889999988 799999999988643


Q ss_pred             -----CeEEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 010676          403 -----SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       403 -----~~lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                           ..+|+||||+++++|.++++.     ..+.+..+..++.|++.||.|||+++|+|+||||+||+++.++.+||+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence                 468999999999999988752     3588899999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCC--cccccCCCcccccccccC
Q 010676          473 FGLAKATKLND--VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       473 FGLA~~~~~~~--~~s~~GT~~YmAPEVL~g  501 (504)
                      ||++.......  .....|+..|+|||++.+
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  202 (291)
T cd06639         172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC  202 (291)
T ss_pred             cccchhcccccccccCccCCccccChhhhcC
Confidence            99987644322  223468999999998753

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=9.5e-25  Score=215.39  Aligned_cols=169  Identities=27%  Similarity=0.456  Sum_probs=140.0

Q ss_pred             cceeeeeeecccCceeEEEEEcc-CCc----eEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-DGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-~g~----~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .+|++.+.||+|+||.||+|.+. +|.    .+++|.+.....    ......+.+|+.++..++|+||+++++++.. .
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS----PKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            57899999999999999999863 333    578886643221    3344678899999999999999999999887 7


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      ..++||||+.+++|.+++...  .+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            899999999999999988764  488999999999999999999999999999999999999999999999999876543


Q ss_pred             CCc----ccccCCCcccccccccCC
Q 010676          482 NDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      ...    ....++..|+|||.+.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~  186 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHR  186 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcC
Confidence            221    112245679999988653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.93  E-value=1.4e-24  Score=212.75  Aligned_cols=163  Identities=42%  Similarity=0.657  Sum_probs=137.6

Q ss_pred             eeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEec
Q 010676          334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      ...||+|+||.||+|.+ .++..|++|.+....     ....+.+.+|+.+++.++|+||+++++++..++.+|+||||+
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            35799999999999997 577889999875422     223457889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHHhc--CC--ChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEecCcccccccCC--cc
Q 010676          413 TKGSLLNLYQRY--HL--RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLND--VK  485 (504)
Q Consensus       413 ~ggsL~~ll~~~--~l--~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~-~g~VKL~DFGLA~~~~~~~--~~  485 (504)
                      ++++|.+++...  .+  .+..+..++.||+.||.|||++||+|+||||+|||++. ++.++|+|||++.......  ..
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence            999999988753  34  77888899999999999999999999999999999976 6799999999987543222  22


Q ss_pred             cccCCCcccccccccC
Q 010676          486 SCRGTAFWMAPEVCSN  501 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g  501 (504)
                      ...|++.|+|||++.+
T Consensus       168 ~~~~~~~~~aPE~~~~  183 (268)
T cd06624         168 TFTGTLQYMAPEVIDK  183 (268)
T ss_pred             cCCCCccccChhhhcc
Confidence            3458999999999854

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.92  E-value=5e-25  Score=215.29  Aligned_cols=172  Identities=32%  Similarity=0.544  Sum_probs=146.8

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCeEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLY  406 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~ly  406 (504)
                      ++|++.+.||+|+||.||+|.+ .++..|++|++......  .......+.+|+.++++++ |+||+++++++...+.+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI--KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc--chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence            3689999999999999999998 58999999987643221  1222356778999999998 999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      +||||+.+++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            999999999999988776 68999999999999999999999999999999999999999999999999987543322  


Q ss_pred             --------------------cccccCCCcccccccccCC
Q 010676          484 --------------------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 --------------------~~s~~GT~~YmAPEVL~g~  502 (504)
                                          .....++..|+|||++.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~  197 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK  197 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCC
Confidence                                1233578999999987654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.92  E-value=7.2e-25  Score=214.96  Aligned_cols=167  Identities=31%  Similarity=0.549  Sum_probs=141.9

Q ss_pred             eeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--CeEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKLYI  407 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--~~lyL  407 (504)
                      |++.+.||.|+||.||+|.+. ++..+++|.+.....   .......+.+|+.+++.++|+|++++++++...  ..+|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc---cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            678899999999999999984 689999999875431   112234577899999999999999999999888  89999


Q ss_pred             EEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      ||||+++ +|..++...  .+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.......  
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             Eeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9999985 888887654  68999999999999999999999999999999999999999999999999987654432  


Q ss_pred             -cccccCCCcccccccccC
Q 010676          484 -VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g  501 (504)
                       .....++..|+|||++.+
T Consensus       157 ~~~~~~~~~~y~~PE~~~~  175 (287)
T cd07840         157 DYTNRVITLWYRPPELLLG  175 (287)
T ss_pred             cccccccccccCCceeeEc
Confidence             233457889999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.92  E-value=3.6e-25  Score=217.63  Aligned_cols=167  Identities=31%  Similarity=0.468  Sum_probs=137.0

Q ss_pred             eeeeeecccCceeEEEEEcc-----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          332 QKGDLLGRGSFGSVYEGISD-----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       332 ~i~k~LG~G~FG~VYka~~~-----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .+.+.||.|.||.||+|...     .+..|+||.+...    ........+.+|+.++++++||||+++++++.....++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS----SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT----SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc----cccccceeeeeccccccccccccccccccccccccccc
Confidence            46788999999999999875     4678899988431    22233577889999999999999999999999888899


Q ss_pred             EEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +||||+++|+|.+++...   .+++..+..|+.||+.||.|||+++|+|++|+++|||++.++.+||+|||++.......
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999876   68999999999999999999999999999999999999999999999999987652221


Q ss_pred             ----cccccCCCcccccccccCC
Q 010676          484 ----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ----~~s~~GT~~YmAPEVL~g~  502 (504)
                          .........|+|||++.+.
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~  180 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDG  180 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHS
T ss_pred             ccccccccccccccccccccccc
Confidence                1233467789999998643

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.92  E-value=5.1e-25  Score=212.75  Aligned_cols=164  Identities=32%  Similarity=0.557  Sum_probs=140.4

Q ss_pred             ecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccCC
Q 010676          337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (504)
Q Consensus       337 LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~gg  415 (504)
                      ||.|+||.||++.+. ++..+++|.+.....  ........+.+|+.+++.++|+||+++++.+.....+|++|||+.++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhh--hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence            689999999999985 699999998854322  22344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC----------Cc
Q 010676          416 SLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----------DV  484 (504)
Q Consensus       416 sL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~----------~~  484 (504)
                      +|.+++.. ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++......          ..
T Consensus        79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence            99998876 45899999999999999999999999999999999999999999999999998754332          12


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....++..|+|||++.+.
T Consensus       159 ~~~~~~~~~~~Pe~~~~~  176 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQ  176 (265)
T ss_pred             cCcccCccccCHHHhcCC
Confidence            334588899999987653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.92  E-value=8.5e-25  Score=215.53  Aligned_cols=171  Identities=27%  Similarity=0.349  Sum_probs=142.4

Q ss_pred             ccceeeeeeecccCceeEEEEEccC-----CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDD-----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~-----g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-  401 (504)
                      .++|++.+.||+|+||.||+|.+..     +..|++|.+...    ........+.+|+.+++.++|+||+++++++.. 
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            3579999999999999999999854     788899876522    123335668899999999999999999998665 


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh---------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~---------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                      ....+++++|+.+++|.+++..         ..+++..+..++.||+.||.|||+++++|+||||+|||++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            5678999999999999998865         3478899999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCCc----ccccCCCcccccccccCC
Q 010676          473 FGLAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       473 FGLA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      ||+++.+.....    ....++..|+|||++.+.
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~  194 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK  194 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcC
Confidence            999976543321    123467789999988654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=6.5e-26  Score=227.69  Aligned_cols=168  Identities=32%  Similarity=0.525  Sum_probs=143.0

Q ss_pred             ccceee-eeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCe
Q 010676          328 ITYWQK-GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK  404 (504)
Q Consensus       328 ~~~y~i-~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~  404 (504)
                      .+.|++ .+.||+|.|+.|--+++ .+|..||||++.+.     ......++.+|++++.+++ |+||++|+++|+++..
T Consensus        76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~  150 (463)
T KOG0607|consen   76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR  150 (463)
T ss_pred             HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence            344554 47899999999999987 79999999998653     2344567889999999997 9999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHH-hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc---EEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~-~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~---VKL~DFGLA~~~~  480 (504)
                      +|||||-|.||.|...++ +..|++.++.++.+.|+.||.|||.+||.||||||+|||......   ||||||.|..-+.
T Consensus       151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence            999999999999988765 456999999999999999999999999999999999999976544   8999999976544


Q ss_pred             cCC---------cccccCCCccccccccc
Q 010676          481 LND---------VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       481 ~~~---------~~s~~GT~~YmAPEVL~  500 (504)
                      .+.         ..+.+|+..||||||+.
T Consensus       231 ~~~~~spastP~L~tPvGSAEfMAPEVVd  259 (463)
T KOG0607|consen  231 LNNDCSPASTPELLTPVGSAEFMAPEVVD  259 (463)
T ss_pred             cCCCCCCCCCccccCcccchhhcchhHHh
Confidence            332         23457899999999864

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.92  E-value=1.1e-24  Score=214.99  Aligned_cols=167  Identities=32%  Similarity=0.628  Sum_probs=140.8

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeec-----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK-----  400 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~-----  400 (504)
                      .+.|++.+.||.|+||.||+|.+ .++..+|+|++....      .....+..|+.++..+ +|+||+++++++.     
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE------DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            35788899999999999999998 678899999875421      2234577899999888 6999999999885     


Q ss_pred             -CCCeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          401 -DESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       401 -~~~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                       ..+.+|++|||+.+++|.+++...   .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~  168 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS  168 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence             356799999999999999988653   3788889999999999999999999999999999999999999999999998


Q ss_pred             ccccc--CCcccccCCCccccccccc
Q 010676          477 KATKL--NDVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       477 ~~~~~--~~~~s~~GT~~YmAPEVL~  500 (504)
                      .....  .......|++.|+|||++.
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~l~  194 (282)
T cd06636         169 AQLDRTVGRRNTFIGTPYWMAPEVIA  194 (282)
T ss_pred             hhhhccccCCCcccccccccCHhhcC
Confidence            75432  2233456899999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.92  E-value=9.3e-25  Score=214.81  Aligned_cols=159  Identities=25%  Similarity=0.393  Sum_probs=131.0

Q ss_pred             eeecccCceeEEEEEccC-------------CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          335 DLLGRGSFGSVYEGISDD-------------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~-------------g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      +.||+|+||.||+|+...             ...+++|.+...     .......+.+|+.++..++||||+++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-----HRDISLAFFETASMMRQVSHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            368999999999998521             235777765431     12233567788999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc-------EEEEe
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-------VKLAD  472 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~-------VKL~D  472 (504)
                      ....++||||+++++|..++..  ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.       ++|+|
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999999999988864  34899999999999999999999999999999999999987664       89999


Q ss_pred             cCcccccccCCcccccCCCccccccccc
Q 010676          473 FGLAKATKLNDVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       473 FGLA~~~~~~~~~s~~GT~~YmAPEVL~  500 (504)
                      ||++......  ....++..|||||++.
T Consensus       156 ~g~~~~~~~~--~~~~~~~~y~aPE~~~  181 (262)
T cd05077         156 PGIPITVLSR--QECVERIPWIAPECVE  181 (262)
T ss_pred             CCCCccccCc--ccccccccccChhhhc
Confidence            9998654322  2345888999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.92  E-value=7.6e-25  Score=212.87  Aligned_cols=165  Identities=30%  Similarity=0.564  Sum_probs=138.6

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      .+.|++.+.||+|+||.||++.. ++..||+|.+....       ....+.+|+.++..++||||+++++++..+ .+|+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            36799999999999999999874 67789999875321       124678899999999999999999998654 5799


Q ss_pred             EEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      +|||+.+++|.+++...   .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-~  154 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-V  154 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-C
Confidence            99999999999988754   3788889999999999999999999999999999999999999999999998754322 2


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      .....+..|+|||++.++
T Consensus       155 ~~~~~~~~y~~pe~~~~~  172 (254)
T cd05083         155 DNSKLPVKWTAPEALKHK  172 (254)
T ss_pred             CCCCCCceecCHHHhccC
Confidence            223346779999988754

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.92  E-value=1.3e-24  Score=213.10  Aligned_cols=169  Identities=30%  Similarity=0.454  Sum_probs=138.9

Q ss_pred             cceeeeeeecccCceeEEEEEccC----CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~----g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+|.+.+.||+|+||.||+|.+.+    ...+++|.+.....    ....+.+.+|+.+++.++|+||+++++++.. ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS----PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC----HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            468899999999999999998633    34688887753221    2334578899999999999999999998875 56


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .|+||||+++++|.+++...  .+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            78999999999999998764  3789999999999999999999999999999999999999999999999998765433


Q ss_pred             Cc---ccccCCCcccccccccCC
Q 010676          483 DV---KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~---~s~~GT~~YmAPEVL~g~  502 (504)
                      ..   ....++..|+|||++.++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~  183 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFR  183 (270)
T ss_pred             cceecCCCCccccccChhhhccC
Confidence            21   112245679999988654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.92  E-value=6.9e-25  Score=217.36  Aligned_cols=170  Identities=26%  Similarity=0.405  Sum_probs=141.4

Q ss_pred             cceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      ++|++.+.||+|+||.||+|...      ++..||+|.+....    .......+.+|+.+++.++||||+++++++..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            57899999999999999999863      56789999775321    123345688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc-----------------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY-----------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~-----------------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~N  459 (504)
                      +.+|+||||+++++|.+++...                       .+++..+..++.||+.||.|||.++++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            9999999999999999988642                       25677889999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          460 ILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       460 ILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||++.++.++|+|||++.......    ......+..|+|||++.++
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  207 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN  207 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC
Confidence            999999999999999987543221    1122356679999987653

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.92  E-value=1.3e-24  Score=212.45  Aligned_cols=170  Identities=28%  Similarity=0.445  Sum_probs=140.5

Q ss_pred             cceeeeeeecccCceeEEEEEcc-CC---ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD-DG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~-~g---~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ..|...+.||+|+||.||+|... ++   ..+++|.+.....    ......+.+|+.++..++|+||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT----EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC----HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            46888899999999999999873 33   3688887753211    2224568899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +|+||||+.+++|.+++...  .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999988653  4888999999999999999999999999999999999999999999999998754322


Q ss_pred             Ccc-----cccCCCcccccccccCC
Q 010676          483 DVK-----SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~-----s~~GT~~YmAPEVL~g~  502 (504)
                      ...     ....+..|+|||++.++
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~  185 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYR  185 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcC
Confidence            211     11234579999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.92  E-value=1.3e-24  Score=215.95  Aligned_cols=169  Identities=30%  Similarity=0.473  Sum_probs=139.4

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++.+.||+|+||.||+|.+ .++..|++|.+......   ......+.+|+.+++.++|+||+++++++.....+|+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc---ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence            5799999999999999999998 47889999987543221   1223457789999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEecCcccccccC-
Q 010676          408 FLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLN-  482 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~-~g~VKL~DFGLA~~~~~~-  482 (504)
                      ||||+++ +|.+++....   +++..+..++.||+.||.|||+++|+|+||+|+||+++. ++.+||+|||++...... 
T Consensus        79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9999975 7777665432   577888899999999999999999999999999999985 567999999998754322 


Q ss_pred             -CcccccCCCcccccccccC
Q 010676          483 -DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 -~~~s~~GT~~YmAPEVL~g  501 (504)
                       ......+++.|+|||++.+
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~  177 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLG  177 (294)
T ss_pred             cccccCceeecccCHHHHhC
Confidence             2233457899999998865

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.8e-24  Score=210.55  Aligned_cols=163  Identities=27%  Similarity=0.453  Sum_probs=134.4

Q ss_pred             eeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEE
Q 010676          335 DLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmE  410 (504)
                      +.||+|+||.||+|...    .+..+|+|.+......    .....+.+|+.+++.+.|+||+++++++. .+.+++|||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   75 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME   75 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence            46999999999999762    2368999987643221    23456889999999999999999999876 456899999


Q ss_pred             eccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc----
Q 010676          411 LVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----  485 (504)
Q Consensus       411 y~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~----  485 (504)
                      |+.+++|.+++.... +++..+..++.|++.+|.|||.++++|+||||+|||++.++.+||+|||+++........    
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            999999999987655 899999999999999999999999999999999999999999999999998765433211    


Q ss_pred             -cccCCCcccccccccCC
Q 010676          486 -SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 -s~~GT~~YmAPEVL~g~  502 (504)
                       ...++..|+|||.+.+.
T Consensus       156 ~~~~~~~~y~aPE~~~~~  173 (257)
T cd05060         156 TAGRWPLKWYAPECINYG  173 (257)
T ss_pred             cCccccccccCHHHhcCC
Confidence             11135679999988764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.92  E-value=1.4e-24  Score=215.30  Aligned_cols=169  Identities=28%  Similarity=0.449  Sum_probs=138.4

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCe--
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK--  404 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~--  404 (504)
                      ++|++.+.||+|+||.||+|.+ .++..||+|.+......   ......+.+|+.+++.+. |+||+++++++...+.  
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE---EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc---cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            3689999999999999999998 57899999987543211   112245778999999995 6999999998877665  


Q ss_pred             ---EEEEEEeccCCCHHHHHHh------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEecC
Q 010676          405 ---LYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFG  474 (504)
Q Consensus       405 ---lyLVmEy~~ggsL~~ll~~------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~-~g~VKL~DFG  474 (504)
                         +|+||||+++ +|.+++..      ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus        78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence               8999999986 78777643      23788999999999999999999999999999999999998 8999999999


Q ss_pred             cccccccC--CcccccCCCcccccccccC
Q 010676          475 LAKATKLN--DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       475 LA~~~~~~--~~~s~~GT~~YmAPEVL~g  501 (504)
                      ++......  ......+++.|+|||++.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  185 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLG  185 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhC
Confidence            98754322  2233357889999998764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=1.1e-24  Score=215.86  Aligned_cols=159  Identities=21%  Similarity=0.295  Sum_probs=129.5

Q ss_pred             eecccCceeEEEEEcc-------------------------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC
Q 010676          336 LLGRGSFGSVYEGISD-------------------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE  390 (504)
Q Consensus       336 ~LG~G~FG~VYka~~~-------------------------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp  390 (504)
                      .||+|+||.||+|...                         ....+++|.+...     .......+.+|+.+++.++||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~~~~~~~~l~h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-----HRDIALAFFETASLMSQVSHI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-----HHHHHHHHHHHHHHHhcCCCC
Confidence            5999999999998741                         1134777766421     122335677889999999999


Q ss_pred             ceeEEeeeecCCCeEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC--
Q 010676          391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG--  466 (504)
Q Consensus       391 nIV~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g--  466 (504)
                      ||+++++++......|+||||+++++|..++..  ..+++..+..++.||+.||.|||++||+||||||+|||++..+  
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999999988864  4588999999999999999999999999999999999997654  


Q ss_pred             -----cEEEEecCcccccccCCcccccCCCcccccccccC
Q 010676          467 -----SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       467 -----~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                           .+||+|||++......  ....++..|+|||++.+
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~  194 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPG  194 (274)
T ss_pred             cCccceeeecCCccccccccc--cccccCCcccCchhhcC
Confidence                 3899999987543222  22357888999998865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.92  E-value=7.2e-25  Score=223.21  Aligned_cols=172  Identities=29%  Similarity=0.466  Sum_probs=143.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCC-
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE-  402 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~-  402 (504)
                      .+.++|++.+.||+|+||.||+|.+. ++..+++|.+......   ......+.+|+.+++++ +|+||+++++++... 
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~   80 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN---ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN   80 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc---chhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence            45678999999999999999999984 7889999987532111   12234567899999999 999999999987654 


Q ss_pred             -CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          403 -SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       403 -~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                       ..+|+||||+.+ +|..++....+.+..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus        81 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          81 DKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             CceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence             468999999985 899988877888899999999999999999999999999999999999999999999999875433


Q ss_pred             CC-------cccccCCCcccccccccC
Q 010676          482 ND-------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       482 ~~-------~~s~~GT~~YmAPEVL~g  501 (504)
                      ..       .....||..|+|||++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~  186 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLG  186 (337)
T ss_pred             ccccccCcchhcccccccccCceeeec
Confidence            22       223458999999998754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.92  E-value=3.8e-25  Score=216.13  Aligned_cols=160  Identities=21%  Similarity=0.332  Sum_probs=132.4

Q ss_pred             eeecccCceeEEEEEcc-C-------CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          335 DLLGRGSFGSVYEGISD-D-------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~-~-------g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +.||+|+||.||+|... .       ...+++|.+..     ........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence            36999999999999863 2       23467776532     12333456788999999999999999999999989999


Q ss_pred             EEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc--------EEEEecCcc
Q 010676          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--------VKLADFGLA  476 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~--------VKL~DFGLA  476 (504)
                      +||||+.+|+|..++...  .+++..++.++.||+.||.|||++||+||||||+|||++.++.        ++|+|||++
T Consensus        76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999999998754  3788899999999999999999999999999999999987764        699999987


Q ss_pred             cccccCCcccccCCCcccccccccC
Q 010676          477 KATKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       477 ~~~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      ......  ....++..|||||++.+
T Consensus       156 ~~~~~~--~~~~~~~~y~aPE~~~~  178 (258)
T cd05078         156 ITVLPK--EILLERIPWVPPECIEN  178 (258)
T ss_pred             cccCCc--hhccccCCccCchhccC
Confidence            654322  33468899999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=8.1e-26  Score=232.67  Aligned_cols=173  Identities=26%  Similarity=0.392  Sum_probs=145.8

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCe
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~  404 (504)
                      ...+|..+.+||+|+||.|.+|.. .+...||||+++....-  ....++--+.|-++|... +-|++++++.+|++-+.
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDVii--QdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVII--QDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceee--ecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            356899999999999999999987 57789999988642211  111223345677777765 47899999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc--cc
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT--KL  481 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~--~~  481 (504)
                      +|+||||+.||+|-..+++. ++.+..+..|+.+|+-||-|||++|||+||||.+|||++.+|++||+|||+++..  ..
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            99999999999998888774 5999999999999999999999999999999999999999999999999999863  33


Q ss_pred             CCcccccCCCcccccccccC
Q 010676          482 NDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       482 ~~~~s~~GT~~YmAPEVL~g  501 (504)
                      ....+.||||.|+|||++.-
T Consensus       505 ~TTkTFCGTPdYiAPEIi~Y  524 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAY  524 (683)
T ss_pred             cceeeecCCCcccccceEEe
Confidence            34667899999999999863

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.92  E-value=1.2e-24  Score=218.40  Aligned_cols=169  Identities=26%  Similarity=0.463  Sum_probs=137.6

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCc----eEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~----~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      ++|++.+.||+|+||.||+|.+ .++.    .+|+|.+....    .......+.+|+.+++.++||||+++++++... 
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT----GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            4788999999999999999987 3444    46777664321    122234678899999999999999999988754 


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      ..++++||+++|+|.+++...  .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            578999999999999988654  478889999999999999999999999999999999999999999999999976543


Q ss_pred             CC----cccccCCCcccccccccCC
Q 010676          482 ND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..    .....++..|||||++.+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~  186 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYR  186 (303)
T ss_pred             cccccccCCCccccccCCHHHhccC
Confidence            22    1123357789999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.92  E-value=1.5e-24  Score=215.79  Aligned_cols=172  Identities=30%  Similarity=0.557  Sum_probs=141.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-  403 (504)
                      ...++|++.+.||+|+||.||+|.+ .++..|++|.+.......   .....+.+|+.+++.++||||+++++++.+.. 
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE---GFPITAIREIKILRQLNHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc---CchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence            4567899999999999999999998 468899999886533211   12245678999999999999999999887655 


Q ss_pred             ---------eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 010676          404 ---------KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       404 ---------~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                               .+|+||||+++ +|..++...  .+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                     79999999987 666666543  589999999999999999999999999999999999999999999999


Q ss_pred             cCcccccccCCc---ccccCCCcccccccccC
Q 010676          473 FGLAKATKLNDV---KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       473 FGLA~~~~~~~~---~s~~GT~~YmAPEVL~g  501 (504)
                      ||++........   ....++..|+|||++.+
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  191 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLG  191 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcC
Confidence            999876543321   22346788999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.92  E-value=2.8e-24  Score=215.88  Aligned_cols=167  Identities=32%  Similarity=0.544  Sum_probs=141.6

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      +.|++.+.||+|+||.||+|.. .++..|++|++......  .......+.+|+.+++.++||||+++++++...+..|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            4688899999999999999998 57899999988643222  22334568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc
Q 010676          408 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (504)
Q Consensus       408 VmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~  485 (504)
                      ||||+.+ +|.+++.  ...+++..+..++.||+.||.|||+.||+|+||+|.||+++.++.++|+|||++......  .
T Consensus        93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--~  169 (307)
T cd06607          93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--N  169 (307)
T ss_pred             EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--C
Confidence            9999985 6666654  345899999999999999999999999999999999999999999999999998754322  2


Q ss_pred             cccCCCccccccccc
Q 010676          486 SCRGTAFWMAPEVCS  500 (504)
Q Consensus       486 s~~GT~~YmAPEVL~  500 (504)
                      ...+++.|+|||++.
T Consensus       170 ~~~~~~~y~aPE~~~  184 (307)
T cd06607         170 SFVGTPYWMAPEVIL  184 (307)
T ss_pred             CccCCccccCceeee
Confidence            346889999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.92  E-value=1.8e-24  Score=209.24  Aligned_cols=170  Identities=32%  Similarity=0.621  Sum_probs=143.6

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|.+.+.||+|+||.||++.+ .+|..+++|.+.......   .....+.+|+.+++.++|+||+++++.+.....+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV---KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc---hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            488999999999999999998 568899999886532211   1234677899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEecCcccccccCC-
Q 010676          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLND-  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-~VKL~DFGLA~~~~~~~-  483 (504)
                      +||+.+++|.+++...   .+++..+..++.|++.||.|||+++|+|+||||.||+++.++ .++|+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            9999999999988653   378899999999999999999999999999999999999886 46999999987654332 


Q ss_pred             -cccccCCCcccccccccCC
Q 010676          484 -VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g~  502 (504)
                       .....|++.|+|||++.+.
T Consensus       158 ~~~~~~~~~~~~ape~~~~~  177 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNR  177 (257)
T ss_pred             cccccCCCccccCHHHHcCC
Confidence             2234589999999988653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.92  E-value=1.9e-24  Score=213.00  Aligned_cols=167  Identities=33%  Similarity=0.518  Sum_probs=141.0

Q ss_pred             eeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      |++.+.||.|++|.||+|.+ .+|..|++|++.......   .....+.+|+.+++.++|+||+++++++.+.+..|++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE---GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc---cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            67788999999999999997 589999999886432211   12245678999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--c
Q 010676          410 ELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~  484 (504)
                      ||+. ++|.+++...   .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            9996 5898888664   48999999999999999999999999999999999999999999999999987543222  2


Q ss_pred             ccccCCCcccccccccC
Q 010676          485 KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g  501 (504)
                      ....++..|+|||++.+
T Consensus       157 ~~~~~~~~~~aPE~~~~  173 (283)
T cd07835         157 THEVVTLWYRAPEILLG  173 (283)
T ss_pred             CccccccCCCCCceeec
Confidence            23357889999998764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.92  E-value=2.1e-24  Score=221.49  Aligned_cols=172  Identities=30%  Similarity=0.476  Sum_probs=143.9

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC-
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-  402 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-  402 (504)
                      ..+.++|++.+.||+|+||.||+|.+ .++..||+|++.....   .......+.+|+.++..++|+||+++++++... 
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            34567899999999999999999987 6789999998754221   122235677899999999999999999887532 


Q ss_pred             -----CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          403 -----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       403 -----~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                           ..+|++++++ +++|.+++....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence                 4478888887 6789998888789999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCcccccCCCcccccccccC
Q 010676          478 ATKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       478 ~~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      .... ......+|..|+|||++.+
T Consensus       169 ~~~~-~~~~~~~~~~y~aPE~~~~  191 (345)
T cd07877         169 HTDD-EMTGYVATRWYRAPEIMLN  191 (345)
T ss_pred             cccc-cccccccCCCccCHHHHhC
Confidence            6432 2334568999999998755

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.92  E-value=2.8e-24  Score=213.90  Aligned_cols=167  Identities=33%  Similarity=0.534  Sum_probs=143.7

Q ss_pred             eeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      |...+.||+|+||.||++.+ .++..+++|.+.....     .....+.+|+.+++.++|+||+++++++...+..|+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-----hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            44457899999999999987 5788999998754221     22345789999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--cccc
Q 010676          410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSC  487 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~~s~  487 (504)
                      ||+.+++|.+++....+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.......  ....
T Consensus        96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999876543221  2334


Q ss_pred             cCCCcccccccccCC
Q 010676          488 RGTAFWMAPEVCSNP  502 (504)
Q Consensus       488 ~GT~~YmAPEVL~g~  502 (504)
                      .|++.|+|||++.++
T Consensus       176 ~~~~~y~aPE~~~~~  190 (285)
T cd06648         176 VGTPYWMAPEVISRL  190 (285)
T ss_pred             cCCccccCHHHhcCC
Confidence            589999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.92  E-value=2.9e-24  Score=211.30  Aligned_cols=164  Identities=29%  Similarity=0.520  Sum_probs=132.3

Q ss_pred             eeecccCceeEEEEEcc-CCc--eEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeEEEEEE
Q 010676          335 DLLGRGSFGSVYEGISD-DGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~-~g~--~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~lyLVmE  410 (504)
                      +.||+|+||.||+|.+. ++.  .+++|.+....    .......+.+|+.++.++ +||||+++++++...+.+|+|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC----CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            36899999999999974 443  45777664211    122345678899999999 79999999999999999999999


Q ss_pred             eccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEec
Q 010676          411 LVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (504)
Q Consensus       411 y~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DF  473 (504)
                      |+++++|.+++...                 .+++.++..++.|++.||+|||++|++|+||||+|||++.++.+||+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence            99999999988653                 2678899999999999999999999999999999999999999999999


Q ss_pred             CcccccccCCc-ccccCCCcccccccccCC
Q 010676          474 GLAKATKLNDV-KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       474 GLA~~~~~~~~-~s~~GT~~YmAPEVL~g~  502 (504)
                      |++........ .....+..|+|||++.+.
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~  186 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYS  186 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHccC
Confidence            99863221111 112245679999988654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=1.5e-24  Score=239.30  Aligned_cols=169  Identities=31%  Similarity=0.598  Sum_probs=144.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeec---
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDK---  400 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~---  400 (504)
                      -..+-|.+.+.||.|.+|.||+++. .+++..|+|+........      .+++.|.++|+.+. |||++.+|++|.   
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d------eEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE------EEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc------HHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            3345789999999999999999998 688999999876533322      45678889998875 999999999874   


Q ss_pred             --CCCeEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCc
Q 010676          401 --DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (504)
Q Consensus       401 --~~~~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGL  475 (504)
                        .++++|||||||.+|+..+++++   ..+.+..+.+|++.++.||.|||.+.+||||||-.|||++.+|.|||+|||.
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence              46789999999999999998875   3589999999999999999999999999999999999999999999999999


Q ss_pred             cccccc--CCcccccCCCccccccccc
Q 010676          476 AKATKL--NDVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       476 A~~~~~--~~~~s~~GT~~YmAPEVL~  500 (504)
                      +.....  ....++.|||+||||||+.
T Consensus       170 SaQldsT~grRnT~iGtP~WMAPEVia  196 (953)
T KOG0587|consen  170 SAQLDSTVGRRNTFIGTPYWMAPEVIA  196 (953)
T ss_pred             eeeeecccccccCcCCCcccccceeee
Confidence            765443  2345677999999999985

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.92  E-value=2.2e-24  Score=210.97  Aligned_cols=173  Identities=29%  Similarity=0.559  Sum_probs=144.0

Q ss_pred             ceeeeeeecccCceeEEEEEcc--CCceEEEEEEeccccc-----hhhHHHHHHHHHHHHHHhh-CCCCceeEEeeeecC
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQG-----SQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKD  401 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~--~g~~vAVK~v~~~~~~-----~~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~~~~  401 (504)
                      .|++.+.||+|+||.||+|.+.  .+..+|+|.+......     .........+.+|+.++.+ ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4788899999999999999984  4789999987543221     1223445667788888865 789999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGL  475 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGL  475 (504)
                      ++.+|++|||+.+++|.+++..     ..+++..++.++.|++.+|.|||+ .+|+|+||+|.|||++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999887742     348889999999999999999996 7899999999999999999999999999


Q ss_pred             ccccccC-CcccccCCCcccccccccCC
Q 010676          476 AKATKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       476 A~~~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      +...... ......|+..|+|||++.++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~  188 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNE  188 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCC
Confidence            8765443 23445689999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=3.1e-24  Score=209.00  Aligned_cols=164  Identities=30%  Similarity=0.509  Sum_probs=135.0

Q ss_pred             eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHH-HhhCCCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      +.||.|+||.||+|.+ .++..||+|.+......  .......+..|..+ ...++|+||+++++++...+.+|+||||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI--AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh--HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence            5699999999999998 57889999987543221  11222334445444 44568999999999999999999999999


Q ss_pred             cCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcccccCCC
Q 010676          413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA  491 (504)
Q Consensus       413 ~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~~GT~  491 (504)
                      .+++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.++|+|||++.....  .....++.
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~  157 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--NKKFVGTP  157 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc--cccCCCCc
Confidence            999999998764 589999999999999999999999999999999999999999999999999875433  22345889


Q ss_pred             cccccccccCC
Q 010676          492 FWMAPEVCSNP  502 (504)
Q Consensus       492 ~YmAPEVL~g~  502 (504)
                      .|+|||++.++
T Consensus       158 ~y~~pe~~~~~  168 (260)
T cd05611         158 DYLAPETILGV  168 (260)
T ss_pred             CccChhhhcCC
Confidence            99999998765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.92  E-value=3.2e-24  Score=212.43  Aligned_cols=170  Identities=35%  Similarity=0.610  Sum_probs=147.6

Q ss_pred             cccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..+.|++.+.||+|+||.||+|.+. ++..|++|.+.....      ....+.+|+.+++.++|+||+++++.+...+.+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence            3456888899999999999999985 788999998864332      345678999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      |++|||+++++|.+++...  .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999999999999876  69999999999999999999999999999999999999999999999999876543221


Q ss_pred             --cccccCCCcccccccccCC
Q 010676          484 --VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 --~~s~~GT~~YmAPEVL~g~  502 (504)
                        .....++..|++||++.++
T Consensus       171 ~~~~~~~~~~~y~~PE~~~~~  191 (286)
T cd06614         171 SKRNSVVGTPYWMAPEVIKRK  191 (286)
T ss_pred             hhhccccCCcccCCHhHhcCC
Confidence              2334588999999988754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.7e-26  Score=240.90  Aligned_cols=173  Identities=26%  Similarity=0.387  Sum_probs=151.0

Q ss_pred             ccceeeeeeecccCceeEEEEEccC-CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~-g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +.+++++..||-|+||.|-++.... ...+|+|++++.....  ....+++..|-++|..++.|+||++|-.|.+..++|
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd--tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD--TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc--hhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            4566777889999999999988743 3358999886544333  334577889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-c
Q 010676          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-V  484 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-~  484 (504)
                      |+||-|-||.|+.+++.. .|.+.+++.|+..++.|++|||.+|||+|||||+|+|++.+|.+||.|||+|+.+..+. .
T Consensus       497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence            999999999999988754 59999999999999999999999999999999999999999999999999999877654 4


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      -++||||.|.|||++.++
T Consensus       577 wTFcGTpEYVAPEIILnK  594 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILNK  594 (732)
T ss_pred             eeecCCcccccchhhhcc
Confidence            568899999999998875

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.92  E-value=4.2e-24  Score=218.07  Aligned_cols=171  Identities=29%  Similarity=0.422  Sum_probs=144.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-CC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-~~  403 (504)
                      .+.++|++.+.||.|+||.||+|.+ .++..||+|++......   ......+.+|+.+++.++||||++++++|.. ..
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST---PVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc---cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            4567899999999999999999987 58999999987532211   1223557789999999999999999998865 56


Q ss_pred             eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      .+|++|||+. ++|..++....+.+..+..++.||+.||.|||++||+|+||+|.|||++.++.++|+|||++...... 
T Consensus        84 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-  161 (328)
T cd07856          84 DIYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-  161 (328)
T ss_pred             cEEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence            7899999984 58999988888898999999999999999999999999999999999999999999999998754332 


Q ss_pred             cccccCCCcccccccccC
Q 010676          484 VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g  501 (504)
                      .....++..|+|||++.+
T Consensus       162 ~~~~~~~~~y~aPE~~~~  179 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLT  179 (328)
T ss_pred             cCCCcccccccCceeeec
Confidence            234467889999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-25  Score=224.97  Aligned_cols=173  Identities=27%  Similarity=0.441  Sum_probs=149.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL  405 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~l  405 (504)
                      +++|.++++||+|+|..|.++.. .+.+.||+|++++.-.  +..+.+..++.|-.+..+. +||++|.++.+|+++..+
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~--nddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc--CCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            56899999999999999999988 6889999998864322  2234456667777777765 599999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc-cccCC
Q 010676          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-TKLND  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~-~~~~~  483 (504)
                      ++|.||++||+|--.+++ .+++++.+..|..+|+.||.|||++|||+||||.+|+||+..|++||+|+|+++. +..++
T Consensus       327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence            999999999999776654 5699999999999999999999999999999999999999999999999999986 33333


Q ss_pred             -cccccCCCcccccccccCC
Q 010676          484 -VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g~  502 (504)
                       ..++||||.|.|||+|.|.
T Consensus       407 ~tstfcgtpnyiapeilrge  426 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGE  426 (593)
T ss_pred             ccccccCCCcccchhhhccc
Confidence             5678999999999999874

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.92  E-value=2.2e-24  Score=219.24  Aligned_cols=172  Identities=28%  Similarity=0.464  Sum_probs=139.7

Q ss_pred             ce-eeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHH---------HHHHHHHHHHHHhhCCCCceeEEeee
Q 010676          330 YW-QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQ---------SISQLEQEIALLSRFEHENIVQYYGT  398 (504)
Q Consensus       330 ~y-~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~---------~~~~~~~Ei~iL~~L~HpnIV~l~~~  398 (504)
                      +| .+.+.||.|+||+||+|.+ .++..||+|.+...........         ....+.+|+.+++.++|+||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            44 4567899999999999997 5789999998864332211000         01246789999999999999999999


Q ss_pred             ecCCCeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          399 DKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       399 ~~~~~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      +...+.+|+||||+.+ +|.+++.. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.
T Consensus        89 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~  167 (335)
T PTZ00024         89 YVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR  167 (335)
T ss_pred             EecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcccee
Confidence            9999999999999974 78887765 458999999999999999999999999999999999999999999999999987


Q ss_pred             cccc----------------CCcccccCCCcccccccccCC
Q 010676          478 ATKL----------------NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       478 ~~~~----------------~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....                .......++..|+|||++.+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  208 (335)
T PTZ00024        168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA  208 (335)
T ss_pred             ecccccccccccccccccccccccccccccCCCCChhcccC
Confidence            5441                111223468899999998653

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.92  E-value=3.6e-24  Score=212.21  Aligned_cols=172  Identities=30%  Similarity=0.445  Sum_probs=143.8

Q ss_pred             ceeeeeeecccCceeEEEEEc----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCe
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~  404 (504)
                      .|++.+.||+|+||.||++..    .++..||+|.+..... .........+.+|+.++.++ +|+||+++++.+..+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            478899999999999999985    3678899998864322 11223345678899999999 59999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +|+||||+.+++|..++.. ..+++..+..++.|++.+|.|||+.+++|+||||.||+++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            9999999999999988765 458899999999999999999999999999999999999999999999999987643322


Q ss_pred             ---cccccCCCcccccccccCC
Q 010676          484 ---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ---~~s~~GT~~YmAPEVL~g~  502 (504)
                         .....|+..|+|||++.+.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~  181 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGG  181 (288)
T ss_pred             ccccccccCCccccCHHHhcCC
Confidence               1234589999999988653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.92  E-value=1.7e-24  Score=219.03  Aligned_cols=169  Identities=31%  Similarity=0.511  Sum_probs=143.7

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-----
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-----  403 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----  403 (504)
                      +|++.+.||.|+||.||+|.+ .++..|++|.+.....   .....+.+.+|+.+++.++|+||+++++++....     
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            588999999999999999998 4689999998864321   1223456888999999999999999999987775     


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .+|++|+|+.+ +|.+++... .+++..+..++.||+.||.|||++||+|+||||.|||++.++.++|+|||++......
T Consensus        78 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          78 DVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             ceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            79999999985 788877654 6899999999999999999999999999999999999999999999999998865443


Q ss_pred             C-----cccccCCCcccccccccCC
Q 010676          483 D-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      .     .....+|..|+|||++.+.
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~  181 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSS  181 (330)
T ss_pred             ccccccccccccccCcCCceeeecc
Confidence            2     3345689999999998765

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.92  E-value=3.5e-24  Score=227.93  Aligned_cols=171  Identities=27%  Similarity=0.390  Sum_probs=145.8

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +...+.+.||+|-||.|.++....+..||+|.++....    +.....|.+||++|.+|+|||||.+++.|..++.+++|
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~----~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT----KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccc----hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            35678899999999999999998889999998864332    33357799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc
Q 010676          409 LELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~  485 (504)
                      |||+++|+|.+++....   +.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++-+-.++..
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            99999999999997663   234556679999999999999999999999999999999999999999999865555443


Q ss_pred             ccc----CCCcccccc-cccCCC
Q 010676          486 SCR----GTAFWMAPE-VCSNPF  503 (504)
Q Consensus       486 s~~----GT~~YmAPE-VL~g~~  503 (504)
                      ...    -...|||+| ++.|+|
T Consensus       694 ~vqgr~vlpiRwmawEsillgkF  716 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKF  716 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccc
Confidence            333    457899999 555665

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.91  E-value=4.7e-24  Score=207.55  Aligned_cols=164  Identities=26%  Similarity=0.446  Sum_probs=132.2

Q ss_pred             eeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec-CCCeEEEEE
Q 010676          335 DLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-DESKLYIFL  409 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~-~~~~lyLVm  409 (504)
                      +.||+|+||.||+|.+.    ++..+|+|.+....    .......+.+|+.+++.++||||+++++++. .++..|++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT----DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC----CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence            46899999999999863    34578999764321    1233467788999999999999999999765 456689999


Q ss_pred             EeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC----
Q 010676          410 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  483 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~----  483 (504)
                      ||+.+++|.+++...  .+....+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......    
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999998754  35667788899999999999999999999999999999999999999999987543221    


Q ss_pred             --cccccCCCcccccccccCC
Q 010676          484 --VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 --~~s~~GT~~YmAPEVL~g~  502 (504)
                        .....++..|+|||++.+.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~  177 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQ  177 (262)
T ss_pred             cccccCcCCccccChhHhccC
Confidence              1233467789999987643

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.5e-25  Score=229.46  Aligned_cols=176  Identities=24%  Similarity=0.373  Sum_probs=147.1

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhh--HHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA--KQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      +.+.++|.++.+||+|||+.||+|.+ ...++||||+-.+.+.....  ....++..+|..|-+.|+||.||++|++|.-
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            34567899999999999999999998 67889999987654433222  2335667899999999999999999999864


Q ss_pred             -CCeEEEEEEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHC--CceecCCCCCcEEEcC---CCcEEEEecC
Q 010676          402 -ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQ--DVVHRDIKCANILVDA---NGSVKLADFG  474 (504)
Q Consensus       402 -~~~lyLVmEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~--gIIHRDLKP~NILLd~---~g~VKL~DFG  474 (504)
                       .+.+|-|+|||+|.+|..|++..+ +++.++..|+.||+.||.||.+.  .|||-||||.|||+-.   -|.+||+|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence             567999999999999999987655 89999999999999999999976  4999999999999953   4789999999


Q ss_pred             cccccccCCc---------ccccCCCccccccccc
Q 010676          475 LAKATKLNDV---------KSCRGTAFWMAPEVCS  500 (504)
Q Consensus       475 LA~~~~~~~~---------~s~~GT~~YmAPEVL~  500 (504)
                      |++.......         ....||.||++||.|-
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv  653 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV  653 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceee
Confidence            9987654332         2346999999999774

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.91  E-value=2.7e-24  Score=214.08  Aligned_cols=170  Identities=29%  Similarity=0.511  Sum_probs=138.0

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-----  401 (504)
                      +++|++.+.||+|+||.||+|.+ .++..+++|++........   ....+.+|+.+++.++|+||+++++++..     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            57899999999999999999998 5789999998864332211   11345689999999999999999987643     


Q ss_pred             ---CCeEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          402 ---ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       402 ---~~~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                         ...+|+||+|+.+ +|...+..  ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence               3357999999976 56665543  35999999999999999999999999999999999999999999999999998


Q ss_pred             cccccCC-------------cccccCCCcccccccccC
Q 010676          477 KATKLND-------------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       477 ~~~~~~~-------------~~s~~GT~~YmAPEVL~g  501 (504)
                      .......             .....+++.|+|||++.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  200 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG  200 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhC
Confidence            7543221             122357889999998754

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.91  E-value=5.3e-24  Score=209.00  Aligned_cols=164  Identities=28%  Similarity=0.420  Sum_probs=135.0

Q ss_pred             eeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCC--CeEE
Q 010676          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE--SKLY  406 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~--~~ly  406 (504)
                      |++.+.||+|+||.||+|.+ .++..||+|.+........   . ....+|+.++.++. |+||+++++++.+.  +.+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~---~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE---Q-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch---h-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            67889999999999999997 5789999998764322111   1 22346888888885 99999999999887  8899


Q ss_pred             EEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      +||||+.+ +|.+++..  ..+++..+..++.||+.||.|||++||+|+||||+||+++. +.+||+|||++....... 
T Consensus        77 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          77 LVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             EEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            99999985 67776654  35899999999999999999999999999999999999999 999999999987654322 


Q ss_pred             cccccCCCccccccccc
Q 010676          484 VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~  500 (504)
                      .....++..|+|||++.
T Consensus       155 ~~~~~~~~~y~aPE~~~  171 (282)
T cd07831         155 YTEYISTRWYRAPECLL  171 (282)
T ss_pred             cCCCCCCcccCChhHhh
Confidence            23445899999999764

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.91  E-value=5.2e-24  Score=209.53  Aligned_cols=166  Identities=30%  Similarity=0.455  Sum_probs=139.5

Q ss_pred             eeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCeEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~lyLV  408 (504)
                      |++.+.||+|+||.||+|+.. ++..|++|.+.......    ......+|+..+..++ |+||+++++++..++..|+|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW----EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch----hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            678899999999999999984 68899999875322211    1123446889999999 99999999999999999999


Q ss_pred             EEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-c
Q 010676          409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-V  484 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-~  484 (504)
                      |||+ +++|.+++...   .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence            9999 77888877653   58999999999999999999999999999999999999999999999999987654332 3


Q ss_pred             ccccCCCcccccccccC
Q 010676          485 KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g  501 (504)
                      ....++..|+|||++.+
T Consensus       156 ~~~~~~~~~~aPE~~~~  172 (283)
T cd07830         156 TDYVSTRWYRAPEILLR  172 (283)
T ss_pred             CCCCCcccccCceeeec
Confidence            34568999999998754

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.91  E-value=7e-24  Score=209.41  Aligned_cols=163  Identities=22%  Similarity=0.342  Sum_probs=133.9

Q ss_pred             ccceeeeeee--cccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC
Q 010676          328 ITYWQKGDLL--GRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (504)
Q Consensus       328 ~~~y~i~k~L--G~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~  403 (504)
                      .++|.+.+.+  |.|+||.||++.. .++..+++|.+.......          .|+.....+ +|+||+++++++...+
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----------~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----------IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            4456666665  9999999999997 578899999876422110          122222222 6999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+++++|.+++... .+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            999999999999999998765 689999999999999999999999999999999999999988 999999999875542


Q ss_pred             CCcccccCCCcccccccccCC
Q 010676          482 NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .  ....++..|+|||++.+.
T Consensus       163 ~--~~~~~~~~y~aPE~~~~~  181 (267)
T PHA03390        163 P--SCYDGTLDYFSPEKIKGH  181 (267)
T ss_pred             C--ccCCCCCcccChhhhcCC
Confidence            2  234689999999998764

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.91  E-value=3e-24  Score=215.23  Aligned_cols=166  Identities=33%  Similarity=0.541  Sum_probs=143.0

Q ss_pred             eeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      |.....||+|+||.||++.. .++..||+|.+....     ......+.+|+.+++.++|+||+++++.+...+.+|+||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence            33346799999999999988 688999999875322     123456889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Ccccc
Q 010676          410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSC  487 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~s~  487 (504)
                      ||+++++|.+++....+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++......  .....
T Consensus        97 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657          97 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             ecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            9999999999988878999999999999999999999999999999999999999999999999998654322  22335


Q ss_pred             cCCCcccccccccC
Q 010676          488 RGTAFWMAPEVCSN  501 (504)
Q Consensus       488 ~GT~~YmAPEVL~g  501 (504)
                      .||+.|+|||++.+
T Consensus       177 ~~~~~y~~pE~~~~  190 (292)
T cd06657         177 VGTPYWMAPELISR  190 (292)
T ss_pred             ccCccccCHHHhcC
Confidence            68999999998864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.91  E-value=2.4e-24  Score=219.37  Aligned_cols=170  Identities=24%  Similarity=0.464  Sum_probs=141.1

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC----C
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----E  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~----~  402 (504)
                      .++|.+.+.||+|+||.||+|.+ .++..|++|.+......   ......+.+|+.+|+.++||||+++++++..    .
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV---PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc---ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence            36899999999999999999998 57999999988643221   1234567789999999999999999988753    4


Q ss_pred             CeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      ..+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            56899999996 478887754 4589999999999999999999999999999999999999999999999999876432


Q ss_pred             CC------cccccCCCcccccccccC
Q 010676          482 ND------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       482 ~~------~~s~~GT~~YmAPEVL~g  501 (504)
                      ..      .....|+..|+|||++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLS  185 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcC
Confidence            22      123468999999998754

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.91  E-value=3.6e-24  Score=218.60  Aligned_cols=171  Identities=29%  Similarity=0.463  Sum_probs=141.4

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC---
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---  402 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~---  402 (504)
                      +.++|.+.+.||+|+||+||+|.+ .++..||||.+.....   .......+.+|+.+++.++|+||+++++++...   
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~   79 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE   79 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence            345799999999999999999998 5789999998764221   112234567899999999999999999987654   


Q ss_pred             --CeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          403 --SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       403 --~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                        ..+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++++|+||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          80 AFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             ccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence              34899999997 578877755 45899999999999999999999999999999999999999999999999998765


Q ss_pred             ccC--CcccccCCCcccccccccC
Q 010676          480 KLN--DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       480 ~~~--~~~s~~GT~~YmAPEVL~g  501 (504)
                      ...  ......+|..|+|||++.+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~  182 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLN  182 (337)
T ss_pred             CCCcccccccccccCccChHHHhc
Confidence            432  1234468899999998764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.91  E-value=3.6e-24  Score=208.53  Aligned_cols=171  Identities=27%  Similarity=0.432  Sum_probs=138.9

Q ss_pred             ceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +|.+.+.||+|+||.||++.+. .+..+++|.++..............+.+|+.+++.++||||+++++++.....+|+|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4889999999999999999884 455566666554332222222234566889999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          409 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      |||+.+++|.+++..     ..+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988753     34889999999999999999999999999999999999964 679999999987654322


Q ss_pred             --cccccCCCcccccccccC
Q 010676          484 --VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 --~~s~~GT~~YmAPEVL~g  501 (504)
                        .....|++.|+|||.+.+
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~  179 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKH  179 (260)
T ss_pred             ccccCCCCCcCccCHHHHcc
Confidence              234458899999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.91  E-value=1e-23  Score=211.30  Aligned_cols=173  Identities=23%  Similarity=0.378  Sum_probs=127.1

Q ss_pred             cceeeeeeecccCceeEEEEEccC----CceEEEEEEeccccchhhHHH------HHHHHHHHHHHhhCCCCceeEEeee
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQS------ISQLEQEIALLSRFEHENIVQYYGT  398 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~----g~~vAVK~v~~~~~~~~~~~~------~~~~~~Ei~iL~~L~HpnIV~l~~~  398 (504)
                      ++|++.++||+|+||.||+|...+    +..+++|..............      ......++..+..+.|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            589999999999999999998743    456666654332211111100      0112234455667789999999987


Q ss_pred             ecCCC----eEEEEEEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEec
Q 010676          399 DKDES----KLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (504)
Q Consensus       399 ~~~~~----~lyLVmEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DF  473 (504)
                      +....    ..|++|+++.. ++.+++.... .++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF  170 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY  170 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence            65443    34778887754 5666665543 678888999999999999999999999999999999999999999999


Q ss_pred             CcccccccCC---------cccccCCCcccccccccCC
Q 010676          474 GLAKATKLND---------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       474 GLA~~~~~~~---------~~s~~GT~~YmAPEVL~g~  502 (504)
                      |+++....+.         .....||+.|||||++.+.
T Consensus       171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~  208 (294)
T PHA02882        171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA  208 (294)
T ss_pred             CCceeeccCCcccccccccccccCCCccccCHHHhCCC
Confidence            9997643211         1234699999999998765

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.91  E-value=5.6e-24  Score=217.92  Aligned_cols=168  Identities=30%  Similarity=0.482  Sum_probs=140.0

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~----  402 (504)
                      ..+|.+.+.||.|+||.||+|.+ .++..|++|.+.....     .....+.+|+.+++.++||||+++++.+...    
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence            46899999999999999999998 5789999998865432     2235677899999999999999999766543    


Q ss_pred             ----------CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEEEE
Q 010676          403 ----------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLA  471 (504)
Q Consensus       403 ----------~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd-~~g~VKL~  471 (504)
                                ..+|+||||+.+ +|.+++....+++..+..++.||+.||.|||++||+||||||+||+++ .++.++|+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                      358999999974 898888887899999999999999999999999999999999999997 45678999


Q ss_pred             ecCcccccccCC-----cccccCCCcccccccccC
Q 010676          472 DFGLAKATKLND-----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       472 DFGLA~~~~~~~-----~~s~~GT~~YmAPEVL~g  501 (504)
                      |||++.......     .....++..|+|||++.+
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  192 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS  192 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhC
Confidence            999987543211     122357889999998653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.91  E-value=4.6e-24  Score=218.65  Aligned_cols=171  Identities=29%  Similarity=0.470  Sum_probs=145.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++.+.||+|+||.||+|.+ .++..||+|.+.....   .......+.+|+.+++.++|+||+++++++.....
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ---SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS   88 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc---hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence            4566899999999999999999998 5788999998753211   12233557789999999999999999988766554


Q ss_pred             ------EEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          405 ------LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       405 ------lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                            +|+|+||+ +++|.+++....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..
T Consensus        89 ~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          89 LEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             ccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence                  89999999 56999999888899999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCcccccCCCcccccccccC
Q 010676          479 TKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       479 ~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      .... .....+|..|+|||++.+
T Consensus       168 ~~~~-~~~~~~~~~y~aPE~~~~  189 (343)
T cd07851         168 TDDE-MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             cccc-ccCCcccccccCHHHHhC
Confidence            5433 344568999999998764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.91  E-value=7.4e-24  Score=207.73  Aligned_cols=168  Identities=30%  Similarity=0.499  Sum_probs=142.2

Q ss_pred             eeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      |++.+.||+|++|.||+|.+ .++..+++|.+......   ......+.+|+.+++.++|+||+++++++...+.+|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            56778899999999999998 57899999987643222   123356778999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--cc
Q 010676          410 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~~  485 (504)
                      ||+++ +|..++...  .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......  ..
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            99986 787777654  68999999999999999999999999999999999999999999999999987654432  22


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...++..|+|||++.+.
T Consensus       157 ~~~~~~~~~~PE~~~~~  173 (283)
T cd05118         157 HYVVTRWYRAPELLLGD  173 (283)
T ss_pred             CccCcccccCcHHHhcC
Confidence            34588899999988654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.91  E-value=5e-24  Score=208.15  Aligned_cols=164  Identities=33%  Similarity=0.492  Sum_probs=134.2

Q ss_pred             eeecccCceeEEEEEccC-------CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          335 DLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~-------g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      +.||+|+||.||+|+..+       +..+++|.+....    .......+.+|+.+++.++||||+++++++......|+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc----chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            368999999999998632       2578888764321    11234567889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc--------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-----cEEEEecC
Q 010676          408 FLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-----SVKLADFG  474 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~--------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-----~VKL~DFG  474 (504)
                      ||||+++++|.+++...        .+++..+..++.||+.||.|||+++++|+||||+|||++.++     .++|+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999999988642        367788999999999999999999999999999999999877     89999999


Q ss_pred             cccccccCCc----ccccCCCcccccccccCC
Q 010676          475 LAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       475 LA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      ++........    ....++..|+|||++.++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  188 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDG  188 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccC
Confidence            9875433221    122357889999998764

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.1e-23  Score=202.81  Aligned_cols=164  Identities=34%  Similarity=0.534  Sum_probs=141.5

Q ss_pred             ecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccCC
Q 010676          337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (504)
Q Consensus       337 LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~gg  415 (504)
                      ||+|+||.||++.+ .++..+++|.+.....  ........+..|+.+++.++|+||+++++.+..+..+|+||||+.++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI--IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhh--cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence            69999999999998 4689999998864322  12234567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--CcccccCCCc
Q 010676          416 SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF  492 (504)
Q Consensus       416 sL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~s~~GT~~  492 (504)
                      +|.+++... .+++..+..++.|++.||.|||+++++|+||+|.||+++.++.++|+|||++......  ......++..
T Consensus        79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence            999988765 5899999999999999999999999999999999999999999999999998765443  2344568999


Q ss_pred             ccccccccCC
Q 010676          493 WMAPEVCSNP  502 (504)
Q Consensus       493 YmAPEVL~g~  502 (504)
                      |++||++.+.
T Consensus       159 ~~~Pe~~~~~  168 (250)
T cd05123         159 YLAPEVLLGK  168 (250)
T ss_pred             ccChHHhCCC
Confidence            9999988654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.91  E-value=6.9e-24  Score=209.89  Aligned_cols=168  Identities=27%  Similarity=0.435  Sum_probs=138.0

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCeEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~lyL  407 (504)
                      +|...+.||+|+||.||++.+ .++..+|+|.+......    .....+.+|+.++.++. |+||+++++++......|+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE----KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh----HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            566778899999999999998 57899999987643221    33456788999999986 9999999999999999999


Q ss_pred             EEEeccCCCHHHHHH------hcCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          408 FLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       408 VmEy~~ggsL~~ll~------~~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      +|||+.. +|.+++.      ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||++....
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9999875 5544332      2458899999999999999999997 499999999999999999999999999987543


Q ss_pred             cCC-cccccCCCcccccccccCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... .....||..|+|||++.+.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~  182 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPS  182 (288)
T ss_pred             cCCccccccCccCccCHHHhccc
Confidence            322 2334689999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.91  E-value=5.4e-24  Score=208.59  Aligned_cols=168  Identities=32%  Similarity=0.508  Sum_probs=142.7

Q ss_pred             eeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      |++.+.||+|+||.||+|+. .++..|++|.+.....   .......+.+|+.+++.++|+||+++++++.....+|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc---cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            56778899999999999998 4699999998875431   1122355678999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--cc
Q 010676          410 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~~  485 (504)
                      ||+.+ +|.+++...  .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence            99985 899988775  68999999999999999999999999999999999999999999999999987654332  22


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...++..|+|||++.++
T Consensus       157 ~~~~~~~~~aPE~~~~~  173 (282)
T cd07829         157 HEVVTLWYRAPEILLGS  173 (282)
T ss_pred             ccccCcCcCChHHhcCC
Confidence            34467889999988654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.91  E-value=8e-24  Score=215.40  Aligned_cols=168  Identities=31%  Similarity=0.498  Sum_probs=136.0

Q ss_pred             ceeeeeeecccCceeEEEEEcc-C--CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecC----
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD-D--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD----  401 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~-~--g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~----  401 (504)
                      +|.+.+.||+|+||.||++.+. +  +..||+|.+......   ....+.+.+|+.+++.+ +|+||+++++.+..    
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK---KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            4888999999999999999984 4  789999987532211   22245677899999998 59999999986432    


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      ...+|++|+|+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            245889999987 478877754 568999999999999999999999999999999999999999999999999987543


Q ss_pred             cCC------cccccCCCcccccccccC
Q 010676          481 LND------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~~------~~s~~GT~~YmAPEVL~g  501 (504)
                      ...      .....||..|+|||++.+
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~  183 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLS  183 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhC
Confidence            221      223468999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.91  E-value=1.9e-23  Score=211.23  Aligned_cols=167  Identities=34%  Similarity=0.563  Sum_probs=141.3

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ..|...+.||+|+||.||++.+ .++..+++|.+......  .......+.+|+.+++.++|+|++++++++...+..|+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC--chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            4588889999999999999997 57889999987643222  22334678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc
Q 010676          408 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (504)
Q Consensus       408 VmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~  485 (504)
                      ||||+.+ +|.+++.  ...+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++.....  ..
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--~~  179 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--AN  179 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--cc
Confidence            9999986 6766664  34588899999999999999999999999999999999999999999999999865432  23


Q ss_pred             cccCCCccccccccc
Q 010676          486 SCRGTAFWMAPEVCS  500 (504)
Q Consensus       486 s~~GT~~YmAPEVL~  500 (504)
                      ...|++.|+|||++.
T Consensus       180 ~~~~~~~y~aPE~~~  194 (317)
T cd06635         180 SFVGTPYWMAPEVIL  194 (317)
T ss_pred             cccCCccccChhhhh
Confidence            346899999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.91  E-value=1.2e-23  Score=205.92  Aligned_cols=169  Identities=25%  Similarity=0.393  Sum_probs=136.1

Q ss_pred             eeeeeeecccCceeEEEEEc----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC---
Q 010676          331 WQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES---  403 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~---  403 (504)
                      |.+.+.||+|+||.||+|..    .++..+|||++.....   .......+.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF---SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC---ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            56788999999999999985    2578999998854221   1223466889999999999999999999875432   


Q ss_pred             ---eEEEEEEeccCCCHHHHHHhc-------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEec
Q 010676          404 ---KLYIFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (504)
Q Consensus       404 ---~lyLVmEy~~ggsL~~ll~~~-------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DF  473 (504)
                         ..+++++|+.+++|..++...       .++...+..++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence               247889999999998876421       3678889999999999999999999999999999999999999999999


Q ss_pred             CcccccccCC----cccccCCCcccccccccCC
Q 010676          474 GLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       474 GLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |+++......    .....+++.|++||.+.++
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  190 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN  190 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcC
Confidence            9987653322    1223356789999988754

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.91  E-value=2.4e-23  Score=204.48  Aligned_cols=168  Identities=33%  Similarity=0.502  Sum_probs=137.6

Q ss_pred             eeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC---CCCceeEEeeeecCCCe--
Q 010676          331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESK--  404 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~~~~~--  404 (504)
                      |++.+.||+|+||.||+|.+. ++..||+|.+.......   .....+.+|+.++..+   +|+||+++++++...+.  
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE---GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc---hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            678899999999999999985 58999999986533211   1123455677666555   69999999999988776  


Q ss_pred             ---EEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          405 ---LYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       405 ---lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                         +|++|||+.+ +|.+++...   .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus        78 ~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          78 ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             CceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence               9999999985 788877653   489999999999999999999999999999999999999999999999999876


Q ss_pred             cccCC-cccccCCCcccccccccCC
Q 010676          479 TKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..... .....++..|+|||++.++
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~  181 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQS  181 (287)
T ss_pred             ccCCcccccccccccccChHHhccC
Confidence            54332 2334578899999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.91  E-value=1.1e-23  Score=214.14  Aligned_cols=165  Identities=25%  Similarity=0.411  Sum_probs=135.6

Q ss_pred             eeeccc--CceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEe
Q 010676          335 DLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (504)
Q Consensus       335 k~LG~G--~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy  411 (504)
                      ..||+|  +||+||++.+ .+|..||+|++......   ....+.+.+|+.+++.++||||++++++|...+.+|+||||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT---EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            346666  9999999998 58999999988643322   23346788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-----
Q 010676          412 VTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----  483 (504)
Q Consensus       412 ~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-----  483 (504)
                      +.+++|.+++.+.   .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||+.+.......     
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999999988753   48888999999999999999999999999999999999999999999998643221110     


Q ss_pred             ----cccccCCCcccccccccCC
Q 010676          484 ----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ----~~s~~GT~~YmAPEVL~g~  502 (504)
                          .....++..|||||++.+.
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~  183 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQD  183 (328)
T ss_pred             cccccccccCccCccChhhhcCC
Confidence                0112356679999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.91  E-value=1.1e-23  Score=211.26  Aligned_cols=168  Identities=24%  Similarity=0.357  Sum_probs=137.4

Q ss_pred             eeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmE  410 (504)
                      |.+++.+|.|+++.||++.. ++..||+|++.....   .......+.+|+.+++.++|+||+++++++...+.+|++||
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e   79 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC---SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP   79 (314)
T ss_pred             hhhhHhhcCCceEEEEEecC-CCCEEEEEEEecccc---chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence            44556666666666666554 789999999865321   22345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC----
Q 010676          411 LVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----  483 (504)
Q Consensus       411 y~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~----  483 (504)
                      |+++++|.+++..   ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++.+||+|||.+.......    
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            9999999998875   358889999999999999999999999999999999999999999999999886443211    


Q ss_pred             -----cccccCCCcccccccccCC
Q 010676          484 -----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -----~~s~~GT~~YmAPEVL~g~  502 (504)
                           .....++..|+|||++.+.
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~  183 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQN  183 (314)
T ss_pred             ccccccccccccccccCHHHhcCC
Confidence                 1223478889999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.91  E-value=9.6e-25  Score=217.84  Aligned_cols=165  Identities=29%  Similarity=0.413  Sum_probs=137.5

Q ss_pred             cccceeee-eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecC--
Q 010676          327 IITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD--  401 (504)
Q Consensus       327 ~~~~y~i~-k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~--  401 (504)
                      ++++|.+. ++||-|-.|.|..+.. .++..+|+|++.-          ..+..+|+++--.. .|||||++++.|+.  
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----------SPKARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            44556553 5799999999999987 6899999996631          13345777776555 49999999998754  


Q ss_pred             --CCeEEEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEec
Q 010676          402 --ESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADF  473 (504)
Q Consensus       402 --~~~lyLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~---~g~VKL~DF  473 (504)
                        ..++.+|||+++||.|+..++..+   |++.++..|++||..|+.|||+.+|.||||||+|+|+..   |..+||+||
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence              467999999999999999887643   999999999999999999999999999999999999974   456999999


Q ss_pred             Ccccccc-cCCcccccCCCcccccccccC
Q 010676          474 GLAKATK-LNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       474 GLA~~~~-~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      |||+... .....+.|-||+|.||||+..
T Consensus       209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~  237 (400)
T KOG0604|consen  209 GFAKETQEPGDLMTPCFTPYYVAPEVLGP  237 (400)
T ss_pred             ccccccCCCccccCCcccccccCHHHhCc
Confidence            9999866 455677889999999999874

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.91  E-value=3.1e-23  Score=209.66  Aligned_cols=166  Identities=34%  Similarity=0.558  Sum_probs=139.8

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .|...+.||+|+||.||+|++ .++..|++|.+......  .......+.+|+.+++.++|+|++++++++.+.+..|+|
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   99 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ--TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV   99 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            466778899999999999997 57889999988643222  223345678899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCccc
Q 010676          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (504)
Q Consensus       409 mEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s  486 (504)
                      |||+.+ +|.+++..  ..+++.++..++.||+.+|.|||++||+|+||+|+||+++.++.+||+|||++.....  ...
T Consensus       100 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--~~~  176 (313)
T cd06633         100 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--ANS  176 (313)
T ss_pred             EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--CCC
Confidence            999975 67666643  3488899999999999999999999999999999999999999999999999864322  234


Q ss_pred             ccCCCccccccccc
Q 010676          487 CRGTAFWMAPEVCS  500 (504)
Q Consensus       487 ~~GT~~YmAPEVL~  500 (504)
                      ..|+..|+|||++.
T Consensus       177 ~~~~~~y~aPE~~~  190 (313)
T cd06633         177 FVGTPYWMAPEVIL  190 (313)
T ss_pred             ccccccccChhhcc
Confidence            56899999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.91  E-value=1.5e-23  Score=214.71  Aligned_cols=170  Identities=27%  Similarity=0.452  Sum_probs=139.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--  402 (504)
                      .+..+|.+.+.||+|+||.||+|.+ .++..||+|.+.....   .......+.+|+.+++.++|+||+++++++...  
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~   88 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ---SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS   88 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc---cccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence            3456899999999999999999997 5789999998754221   112234577899999999999999999988654  


Q ss_pred             ----CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       403 ----~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                          ..+|+||||+.. +|..++ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.
T Consensus        89 ~~~~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          89 GDEFQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             CCCCceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence                346999999975 676655 34689999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCcccccCCCcccccccccC
Q 010676          479 TKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       479 ~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      .... .....+|..|||||++.+
T Consensus       167 ~~~~-~~~~~~~~~y~aPE~~~~  188 (342)
T cd07879         167 ADAE-MTGYVVTRWYRAPEVILN  188 (342)
T ss_pred             CCCC-CCCceeeecccChhhhcC
Confidence            4332 234468899999999865

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.90  E-value=5.1e-24  Score=208.17  Aligned_cols=175  Identities=27%  Similarity=0.375  Sum_probs=146.3

Q ss_pred             cccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       323 ~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      ......++|++.++||+|||+-||++.. .++..||+|.+....     .+.++..++|+.+.++++|||+++++++...
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~   89 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-----QEDIEEALREIDNHRKFNSPNVLRLVDHQLR   89 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence            3334456899999999999999999997 789999999886432     4456778899999999999999999998654


Q ss_pred             CC-----eEEEEEEeccCCCHHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCcEE
Q 010676          402 ES-----KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVK  469 (504)
Q Consensus       402 ~~-----~lyLVmEy~~ggsL~~ll~~~-----~l~e~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILLd~~g~VK  469 (504)
                      +.     ..||+++|...|+|.+.++..     .+++.+++.|+.+|+.||++||+..  +.||||||.|||+...+.++
T Consensus        90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v  169 (302)
T KOG2345|consen   90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV  169 (302)
T ss_pred             hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence            43     499999999999999987643     3899999999999999999999998  99999999999999999999


Q ss_pred             EEecCcccccccC-----------CcccccCCCcccccccccCC
Q 010676          470 LADFGLAKATKLN-----------DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       470 L~DFGLA~~~~~~-----------~~~s~~GT~~YmAPEVL~g~  502 (504)
                      |.|||.+......           +......|..|.|||+|+-+
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk  213 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK  213 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc
Confidence            9999988643211           11222368999999998743

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.90  E-value=4e-24  Score=236.17  Aligned_cols=171  Identities=30%  Similarity=0.451  Sum_probs=143.2

Q ss_pred             cceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .+.+..+.||+|.||+||+|..      .+...||||.++..    ...+..++|++|+.+|..|+|||||+|+|.|..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~----a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK----AENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc----ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            3566778899999999999985      35668999976532    2344567899999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc-----------C----CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY-----------H----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS  467 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~-----------~----l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~  467 (504)
                      +.+|||+|||..|+|.+++.-.           .    ++..+.+.|+.||+.|+.||-++.+|||||-..|+||.++..
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence            9999999999999999998532           1    677899999999999999999999999999999999999999


Q ss_pred             EEEEecCcccccccCCcccc----cCCCccccccccc-CCC
Q 010676          468 VKLADFGLAKATKLNDVKSC----RGTAFWMAPEVCS-NPF  503 (504)
Q Consensus       468 VKL~DFGLA~~~~~~~~~s~----~GT~~YmAPEVL~-g~~  503 (504)
                      |||+||||++.+-..+....    .-...||+||-+. |+|
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF  682 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF  682 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc
Confidence            99999999987554443222    2356799999554 544

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-23  Score=239.15  Aligned_cols=169  Identities=34%  Similarity=0.524  Sum_probs=141.9

Q ss_pred             ceeeeeeecccCceeEEEEEcc--CCc----eEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD--DGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~--~g~----~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      ..++++.||+|.||.||.|...  .|.    .||+|.+...    ...+....|.+|..+++.++|||||+++|.+.+..
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~----~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL----SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc----CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            4677889999999999999863  343    4777766532    23455678999999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGL  475 (504)
                      ..+|++|||.+|+|..++++.        .+....++.++.+|+.|+.||+++++|||||...|+||+....|||+|||+
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999999876        277788999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccc----CCCcccccccccCC
Q 010676          476 AKATKLNDVKSCR----GTAFWMAPEVCSNP  502 (504)
Q Consensus       476 A~~~~~~~~~s~~----GT~~YmAPEVL~g~  502 (504)
                      |+.+-........    --..|||||.|..+
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~  879 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDG  879 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhc
Confidence            9954433322221    23569999999843

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.90  E-value=6.4e-23  Score=204.66  Aligned_cols=172  Identities=28%  Similarity=0.445  Sum_probs=139.4

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~  403 (504)
                      ...+.|++.+.||+|+||.||+|.+. ++..||||.+......    .....+..|+.++.... |+||+++++++.+..
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   87 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK----EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS   87 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh----HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence            34568999999999999999999985 5899999988643221    12344556776666654 999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      .+|++|||+.+ +|.+++..  ..+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus        88 ~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          88 DVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99999999865 77776654  348888899999999999999997 699999999999999999999999999987643


Q ss_pred             cCC-cccccCCCcccccccccCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... .....++..|+|||++.+.
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~  189 (296)
T cd06618         167 DSKAKTRSAGCAAYMAPERIDPP  189 (296)
T ss_pred             CCCcccCCCCCccccCHhhcCCC
Confidence            222 2334578899999998754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.90  E-value=5.6e-23  Score=207.08  Aligned_cols=167  Identities=32%  Similarity=0.542  Sum_probs=139.8

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ..|...+.||+|+||.||+|++ .++..+++|.+......  .......+.+|+.+++.++|+|++++++++.....+|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            3477788999999999999998 57889999988643222  12334567789999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~  485 (504)
                      ||||+.+ +|.+++..  ..+++..+..++.|++.||.|||+++++|+||||+|||++.++.++|+|||++......  .
T Consensus        93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~  169 (308)
T cd06634          93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--N  169 (308)
T ss_pred             EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--c
Confidence            9999974 77766543  34888999999999999999999999999999999999999999999999998764432  2


Q ss_pred             cccCCCccccccccc
Q 010676          486 SCRGTAFWMAPEVCS  500 (504)
Q Consensus       486 s~~GT~~YmAPEVL~  500 (504)
                      ...+++.|+|||++.
T Consensus       170 ~~~~~~~y~aPE~~~  184 (308)
T cd06634         170 XFVGTPYWMAPEVIL  184 (308)
T ss_pred             cccCCccccCHHHHh
Confidence            345899999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.89  E-value=1.1e-22  Score=197.29  Aligned_cols=152  Identities=19%  Similarity=0.266  Sum_probs=127.3

Q ss_pred             cCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccCCCHH
Q 010676          340 GSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL  418 (504)
Q Consensus       340 G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~ggsL~  418 (504)
                      |.||.||++.+ .++..||+|.+....          .+.+|...+....||||+++++++...+.+|+||||+.+++|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence            88999999998 688999999886421          1223444555567999999999999999999999999999999


Q ss_pred             HHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcccccCCCcccccc
Q 010676          419 NLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE  497 (504)
Q Consensus       419 ~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPE  497 (504)
                      +++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... .....++..|||||
T Consensus        74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~y~aPE  152 (237)
T cd05576          74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAVENMYCAPE  152 (237)
T ss_pred             HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-cccCCcCccccCCc
Confidence            88754 46899999999999999999999999999999999999999999999999987654432 22344678899999


Q ss_pred             cccCC
Q 010676          498 VCSNP  502 (504)
Q Consensus       498 VL~g~  502 (504)
                      ++.++
T Consensus       153 ~~~~~  157 (237)
T cd05576         153 VGGIS  157 (237)
T ss_pred             ccCCC
Confidence            88654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1e-24  Score=215.37  Aligned_cols=169  Identities=32%  Similarity=0.498  Sum_probs=140.0

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-----
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-----  403 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-----  403 (504)
                      +.+..+.||-|.||+||.+++ ++|+.+++|.+...   .......+++-+|+++|..++|.|++..++...-..     
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv---fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV---FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchH---HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            344557899999999999999 79999999976532   233444567889999999999999999988765432     


Q ss_pred             eEEEEEEeccCCCHHHHH-HhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll-~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .+|.++|++.. +|..++ ....++.+.++-+++||+.||+|||+.||+||||||.|+|++.|..+||||||+|+....+
T Consensus       131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            36888888865 676655 4456899999999999999999999999999999999999999999999999999986655


Q ss_pred             C---cccccCCCcccccccccCC
Q 010676          483 D---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~---~~s~~GT~~YmAPEVL~g~  502 (504)
                      .   ++..+-|.+|.|||+|+|.
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGa  232 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGA  232 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcc
Confidence            4   3445679999999999874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=2.3e-24  Score=232.15  Aligned_cols=168  Identities=40%  Similarity=0.627  Sum_probs=148.8

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ...+|.++..+|.|+||.||++++ .++...|+|++++....     .+.-+.+||-+++.++|+|||.|++.+...+.+
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-----d~~~iqqei~~~~dc~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-----DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-----cccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence            346789999999999999999999 68999999999864332     234567899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--C
Q 010676          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--N  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~  482 (504)
                      ||.||||.+|+|.+++.- ..+++.++.+.++..+.||+|||+.|-+|||||-.|||++..|.|||+|||.+-.+..  .
T Consensus        88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~  167 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA  167 (829)
T ss_pred             EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence            999999999999998865 4599999999999999999999999999999999999999999999999998765442  3


Q ss_pred             CcccccCCCcccccccc
Q 010676          483 DVKSCRGTAFWMAPEVC  499 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL  499 (504)
                      ..+++.||++||||||-
T Consensus       168 KrksfiGtpywmapEva  184 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVA  184 (829)
T ss_pred             hhhcccCCccccchhHH
Confidence            45677899999999984

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=9.1e-25  Score=213.88  Aligned_cols=172  Identities=27%  Similarity=0.471  Sum_probs=137.5

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC---
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---  401 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~---  401 (504)
                      ...+.|....+||+|.||.||+|.. .+|+.||+|++.......  .. -....+|+.+|..++|+|++.++..|.+   
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe--Gf-pitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE--GF-PITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc--CC-cHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            3445677888999999999999998 567788888653211111  11 1234589999999999999999987643   


Q ss_pred             -----CCeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecC
Q 010676          402 -----ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (504)
Q Consensus       402 -----~~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFG  474 (504)
                           ...+|+||.+|+. +|.-++...  +++..+++.++.+++.||.|+|...|+|||+|+.|+||+.+|.+||+|||
T Consensus        91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence                 2349999999986 777777654  58899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC------cccccCCCcccccccccC
Q 010676          475 LAKATKLND------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       475 LA~~~~~~~------~~s~~GT~~YmAPEVL~g  501 (504)
                      +++.+....      .+..+-|.+|++||.+.|
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG  202 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG  202 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhc
Confidence            997654322      233456999999999876

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.88  E-value=3.8e-22  Score=216.67  Aligned_cols=174  Identities=25%  Similarity=0.345  Sum_probs=128.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-----------------cCCceEEEEEEeccccchhhH---------HHHHHHHHHH
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-----------------DDGFFFAVKEVSLLDQGSQAK---------QSISQLEQEI  381 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-----------------~~g~~vAVK~v~~~~~~~~~~---------~~~~~~~~Ei  381 (504)
                      .++|.+.++||+|+||+||+|..                 ..+..||||.+..........         ........|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            45799999999999999999964                 245689999886432211100         0112233567


Q ss_pred             HHHhhCCCCce-----eEEeeeecC--------CCeEEEEEEeccCCCHHHHHHhc------------------------
Q 010676          382 ALLSRFEHENI-----VQYYGTDKD--------ESKLYIFLELVTKGSLLNLYQRY------------------------  424 (504)
Q Consensus       382 ~iL~~L~HpnI-----V~l~~~~~~--------~~~lyLVmEy~~ggsL~~ll~~~------------------------  424 (504)
                      .++.+++|.++     ++++++|..        ....|+||||+.+++|.+++...                        
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     666776643        35689999999999999887532                        


Q ss_pred             -CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-ccc--ccCCCccccccccc
Q 010676          425 -HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKS--CRGTAFWMAPEVCS  500 (504)
Q Consensus       425 -~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-~~s--~~GT~~YmAPEVL~  500 (504)
                       .+++..++.++.|++.+|.|||+++|+||||||+|||++.++.+||+|||++....... ...  ..+|+.|+|||++.
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence             12456678899999999999999999999999999999999999999999986543222 111  23588999999875


Q ss_pred             C
Q 010676          501 N  501 (504)
Q Consensus       501 g  501 (504)
                      .
T Consensus       384 ~  384 (507)
T PLN03224        384 M  384 (507)
T ss_pred             C
Confidence            3

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.88  E-value=6.9e-22  Score=185.92  Aligned_cols=165  Identities=38%  Similarity=0.651  Sum_probs=144.0

Q ss_pred             eeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      |.+.+.||.|++|.||++... ++..+++|.+......    .....+.+|+..++.++|+|++++++++......++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            567889999999999999985 4889999988643322    23567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC---Cc
Q 010676          410 ELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---DV  484 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~---~~  484 (504)
                      ||+.+++|.+++....  +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||++......   ..
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            9999999999987755  889999999999999999999999999999999999999999999999998765543   22


Q ss_pred             ccccCCCcccccccc
Q 010676          485 KSCRGTAFWMAPEVC  499 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL  499 (504)
                      ....++..|++||++
T Consensus       157 ~~~~~~~~~~~pe~~  171 (225)
T smart00221      157 KTVKGTPFYLAPEVL  171 (225)
T ss_pred             cceeccCCcCCHhHh
Confidence            345688899999987

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.88  E-value=9.1e-23  Score=195.23  Aligned_cols=168  Identities=27%  Similarity=0.442  Sum_probs=138.3

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ....+..||+|+||.|-+-+. .+|...|+|.+...-.    .+...++.+|+.+.... .+|++|.+|+.......+||
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            344456799999999988777 7899999999875433    23345677888877654 69999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .||.|.. +|..++.+     ..+++.-+-+|+..++.||.|||++ .+||||+||+||||+.+|+|||||||++..+..
T Consensus       123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            9999975 77766543     3488888999999999999999975 899999999999999999999999999876655


Q ss_pred             CCccc-ccCCCcccccccccCC
Q 010676          482 NDVKS-CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~~~s-~~GT~~YmAPEVL~g~  502 (504)
                      ....+ -.|...|||||.+..+
T Consensus       202 SiAkt~daGCkpYmaPEri~~e  223 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPE  223 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcc
Confidence            54333 4588899999998754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.88  E-value=1.9e-22  Score=222.15  Aligned_cols=165  Identities=24%  Similarity=0.328  Sum_probs=118.7

Q ss_pred             cccceeeeeeecccCceeEEEEEcc-C----CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeee---
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISD-D----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT---  398 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~-~----g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~---  398 (504)
                      ..++|++.+.||+|+||.||+|++. +    +..||+|.+.....  .     .....+  .+....+.+++.++..   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~-----e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--V-----EIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--h-----HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            3568999999999999999999984 5    78999997643211  0     001111  1111122222222211   


Q ss_pred             ---ecCCCeEEEEEEeccCCCHHHHHHhcCCC---------------------hHHHHHHHHHHHHHHHHHHHCCceecC
Q 010676          399 ---DKDESKLYIFLELVTKGSLLNLYQRYHLR---------------------DSQVSAYTRQILLGLKYLHDQDVVHRD  454 (504)
Q Consensus       399 ---~~~~~~lyLVmEy~~ggsL~~ll~~~~l~---------------------e~~v~~i~~QIl~gL~yLHs~gIIHRD  454 (504)
                         ......+|+||||+.+++|.+++....+.                     ...+..|+.||+.||.|||+++|+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               24567799999999999999988654321                     234567999999999999999999999


Q ss_pred             CCCCcEEEcC-CCcEEEEecCcccccccC---CcccccCCCccccccccc
Q 010676          455 IKCANILVDA-NGSVKLADFGLAKATKLN---DVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       455 LKP~NILLd~-~g~VKL~DFGLA~~~~~~---~~~s~~GT~~YmAPEVL~  500 (504)
                      |||+|||++. ++.+||+|||+++.....   ......+|+.|||||++.
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~  330 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI  330 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence            9999999985 689999999999764322   124567899999999653

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.88  E-value=1.9e-22  Score=199.48  Aligned_cols=175  Identities=27%  Similarity=0.417  Sum_probs=142.2

Q ss_pred             ccccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeee
Q 010676          322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD  399 (504)
Q Consensus       322 ~~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~  399 (504)
                      .++..-+++.+++..||.|+.|.|++++. .+|...|||.+.....    ++..+++...+.+.... .+|+||+.+++|
T Consensus        85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N----kee~kRILmDldvv~~s~dcpyIV~c~GyF  160 (391)
T KOG0983|consen   85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVQCFGYF  160 (391)
T ss_pred             cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC----HHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence            34555566778888999999999999998 5799999999875443    33446677777766554 489999999999


Q ss_pred             cCCCeEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          400 KDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       400 ~~~~~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLH-s~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                      ..+..++|-||.|.. .+..++++  ..+++.-+-++...++.||.||- +++|||||+||+|||+|..|++||||||++
T Consensus       161 i~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIs  239 (391)
T KOG0983|consen  161 ITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGIS  239 (391)
T ss_pred             eeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccc
Confidence            999999999999854 45566654  34788888889999999999997 468999999999999999999999999998


Q ss_pred             ccccc-CCcccccCCCcccccccccC
Q 010676          477 KATKL-NDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       477 ~~~~~-~~~~s~~GT~~YmAPEVL~g  501 (504)
                      ..+.. .......|.+.|||||-+.-
T Consensus       240 GrlvdSkAhtrsAGC~~YMaPERidp  265 (391)
T KOG0983|consen  240 GRLVDSKAHTRSAGCAAYMAPERIDP  265 (391)
T ss_pred             ceeecccccccccCCccccCccccCC
Confidence            76443 34555679999999998864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.88  E-value=1.6e-21  Score=178.62  Aligned_cols=161  Identities=42%  Similarity=0.670  Sum_probs=140.8

Q ss_pred             ecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccCC
Q 010676          337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG  415 (504)
Q Consensus       337 LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~gg  415 (504)
                      ||+|.+|.||++... ++..+++|.+.......    ....+.+|+.+++.++|++|+++++++......+++|||+.++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~   76 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG   76 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence            689999999999985 48999999886433221    3466889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEecCcccccccCC--cccccCC
Q 010676          416 SLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLND--VKSCRGT  490 (504)
Q Consensus       416 sL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~-~g~VKL~DFGLA~~~~~~~--~~s~~GT  490 (504)
                      +|.+++...  .++...+..++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||++.......  .....++
T Consensus        77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            999999876  6899999999999999999999999999999999999998 8999999999987665443  3445588


Q ss_pred             CcccccccccC
Q 010676          491 AFWMAPEVCSN  501 (504)
Q Consensus       491 ~~YmAPEVL~g  501 (504)
                      ..|++||++..
T Consensus       157 ~~~~~pe~~~~  167 (215)
T cd00180         157 PAYMAPEVLLG  167 (215)
T ss_pred             CCccChhHhcc
Confidence            89999998865

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=5e-22  Score=189.73  Aligned_cols=144  Identities=17%  Similarity=0.162  Sum_probs=110.9

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEeccccchhh---------------------HHHHHHHHHHHHHHhhCCCCce
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA---------------------KQSISQLEQEIALLSRFEHENI  392 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~---------------------~~~~~~~~~Ei~iL~~L~HpnI  392 (504)
                      ...||+|+||.||+|.+.+|..||+|++.........                     ........+|+.++..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999889999999998753221110                     0011233569999999987766


Q ss_pred             eEEeeeecCCCeEEEEEEeccCCCHHHH-HHhcCCChHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEEcCCCcEEE
Q 010676          393 VQYYGTDKDESKLYIFLELVTKGSLLNL-YQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANILVDANGSVKL  470 (504)
Q Consensus       393 V~l~~~~~~~~~lyLVmEy~~ggsL~~l-l~~~~l~e~~v~~i~~QIl~gL~yL-Hs~gIIHRDLKP~NILLd~~g~VKL  470 (504)
                      .....+...  ..||||||++|++|... +....++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.++|
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L  158 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI  158 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence            433322222  23899999999877654 4556789999999999999999999 799999999999999998 588999


Q ss_pred             EecCcccccc
Q 010676          471 ADFGLAKATK  480 (504)
Q Consensus       471 ~DFGLA~~~~  480 (504)
                      +|||+|....
T Consensus       159 iDFG~a~~~~  168 (190)
T cd05147         159 IDVSQSVEHD  168 (190)
T ss_pred             EEccccccCC
Confidence            9999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.3e-21  Score=185.95  Aligned_cols=145  Identities=18%  Similarity=0.170  Sum_probs=114.2

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEeccccch---------------------hhHHHHHHHHHHHHHHhhCCCCce
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---------------------QAKQSISQLEQEIALLSRFEHENI  392 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~---------------------~~~~~~~~~~~Ei~iL~~L~HpnI  392 (504)
                      ...||+|+||.||+|.+.+|..||||++.......                     ........+.+|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            57899999999999998889999999987542110                     001112335689999999999887


Q ss_pred             eEEeeeecCCCeEEEEEEeccCCCHH-HHHHhcCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEE
Q 010676          393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKL  470 (504)
Q Consensus       393 V~l~~~~~~~~~lyLVmEy~~ggsL~-~ll~~~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL  470 (504)
                      .....+....  .||||||++|+++. ..+....++...+..++.|++.+|.+||. +||+||||||+|||++ ++.++|
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l  158 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI  158 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence            4443333222  48999999988554 34566678888999999999999999999 9999999999999998 899999


Q ss_pred             EecCccccccc
Q 010676          471 ADFGLAKATKL  481 (504)
Q Consensus       471 ~DFGLA~~~~~  481 (504)
                      +|||++.....
T Consensus       159 iDFG~a~~~~~  169 (190)
T cd05145         159 IDVSQAVELDH  169 (190)
T ss_pred             EEcccceecCC
Confidence            99999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.9e-22  Score=215.56  Aligned_cols=171  Identities=29%  Similarity=0.475  Sum_probs=146.2

Q ss_pred             ccccccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      |..-..+..+.++||-|.||.||.|.++ -.-.||||.++      ...-.+.+|+.|..+++.++|||+|+|+++|..+
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK------EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh------hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            3333345667789999999999999984 45678999765      2233467899999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ..+|||+|||..|+|.+|++++.   ++.-.+++++.||..|++||.++++|||||...|.|+.++..|||+||||++..
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            99999999999999999998765   555667888999999999999999999999999999999999999999999998


Q ss_pred             ccCCcccccC---CCccccccccc
Q 010676          480 KLNDVKSCRG---TAFWMAPEVCS  500 (504)
Q Consensus       480 ~~~~~~s~~G---T~~YmAPEVL~  500 (504)
                      ..+..+...|   .+.|.|||-|.
T Consensus       416 tgDTYTAHAGAKFPIKWTAPEsLA  439 (1157)
T KOG4278|consen  416 TGDTYTAHAGAKFPIKWTAPESLA  439 (1157)
T ss_pred             cCCceecccCccCcccccCccccc
Confidence            8777665555   44599999764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.87  E-value=7.7e-22  Score=228.23  Aligned_cols=162  Identities=24%  Similarity=0.402  Sum_probs=134.6

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      +...|...+.||+|+||.||+|.. .++..||+|.+......         ...|+.++++++|||||++++++.+.+.+
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---------PSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---------cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            344567778999999999999998 68899999987532211         12457889999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHH---HCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLH---s~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      |+||||+++|+|.++++.  +++..+..|+.||+.||+|||   ..+|+||||||+||+++.++..++. ||........
T Consensus       759 ~lv~Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             EEEEeCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence            999999999999999864  888999999999999999999   6699999999999999998888775 6665433221


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                        ....+|+.|||||++.++
T Consensus       836 --~~~~~t~~y~aPE~~~~~  853 (968)
T PLN00113        836 --TKCFISSAYVAPETRETK  853 (968)
T ss_pred             --CCccccccccCcccccCC
Confidence              233689999999998764

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.86  E-value=8.1e-22  Score=211.09  Aligned_cols=166  Identities=34%  Similarity=0.550  Sum_probs=137.7

Q ss_pred             ceeeeeeecccCceeEEEEEcc---CC--ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD---DG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~---~g--~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...+.++||.|-||.||+|+..   .|  -.||||..+....    ....+.|++|..++++++|||||+++|.|.+. .
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t----~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P  464 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT----PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P  464 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC----hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence            3456788999999999999863   23  3678887764322    22246799999999999999999999998754 6


Q ss_pred             EEEEEEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .|||||+++.|.|..+++.++  ++...+..|++||+.+|.|||++++|||||...|||+.....|||+||||++.+...
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999999999998764  777888999999999999999999999999999999999999999999999977655


Q ss_pred             C-cccccC--CCccccccccc
Q 010676          483 D-VKSCRG--TAFWMAPEVCS  500 (504)
Q Consensus       483 ~-~~s~~G--T~~YmAPEVL~  500 (504)
                      . .+...|  ...|||||-++
T Consensus       545 ~yYkaS~~kLPIKWmaPESIN  565 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESIN  565 (974)
T ss_pred             chhhccccccceeecCccccc
Confidence            4 233333  44599999765

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.86  E-value=8.6e-22  Score=201.84  Aligned_cols=167  Identities=25%  Similarity=0.338  Sum_probs=138.6

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC--CC----ceeEEeeee
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HE----NIVQYYGTD  399 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~--Hp----nIV~l~~~~  399 (504)
                      +..+|.+...||+|+||.|-++++ ..+..||||+++....      ..+..+-|+++|.++.  .|    -+|.+.+||
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k------YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK------YREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH------HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            356899999999999999999998 5689999998864322      2234457899999984  23    378889999


Q ss_pred             cCCCeEEEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC------------
Q 010676          400 KDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA------------  464 (504)
Q Consensus       400 ~~~~~lyLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~------------  464 (504)
                      ...++.|||+|.+. -++.+++..++   ++..++..+++|++.+++|||+.+|+|.||||+|||+..            
T Consensus       161 dyrghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  161 DYRGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             hccCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence            99999999999984 48999998754   888999999999999999999999999999999999932            


Q ss_pred             --------CCcEEEEecCcccccccCCcccccCCCcccccccccC
Q 010676          465 --------NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       465 --------~g~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                              +-.|+|+|||.|...... ....+.|..|.||||+.|
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-hs~iVsTRHYRAPEViLg  283 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH-HSTIVSTRHYRAPEVILG  283 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC-cceeeeccccCCchheec
Confidence                    235899999998764433 356779999999999976

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.86  E-value=4e-21  Score=181.40  Aligned_cols=157  Identities=38%  Similarity=0.630  Sum_probs=136.5

Q ss_pred             CceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccCCCHHH
Q 010676          341 SFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN  419 (504)
Q Consensus       341 ~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~ggsL~~  419 (504)
                      +||.||+|... ++..+++|++........    ...+.+|+.+++.++|+||+++++++......+++|||+.+++|..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   76 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD   76 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence            58999999985 589999998864332211    4678899999999999999999999999999999999999999999


Q ss_pred             HHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-CcccccCCCcccccc
Q 010676          420 LYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPE  497 (504)
Q Consensus       420 ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-~~~s~~GT~~YmAPE  497 (504)
                      ++.... ++...+..++.+++.+|.|||+.+|+|+||+|.||+++.++.++|+|||++...... ......++..|++||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            987665 889999999999999999999999999999999999999999999999998765543 344556899999999


Q ss_pred             cccC
Q 010676          498 VCSN  501 (504)
Q Consensus       498 VL~g  501 (504)
                      ++.+
T Consensus       157 ~~~~  160 (244)
T smart00220      157 VLLG  160 (244)
T ss_pred             HHcc
Confidence            8864

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.85  E-value=1.9e-22  Score=198.95  Aligned_cols=167  Identities=29%  Similarity=0.434  Sum_probs=135.3

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhh-CCCCceeEEeeeecCCCeEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ..+-+..||.|.||+|++-.. ..|+..|||.+.....    ....+++..|.....+ -+.||||++|++...++..||
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi  140 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI  140 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence            445567799999999999876 6899999999875433    2334567777766554 469999999999999999999


Q ss_pred             EEEeccCCCHHHHHH------hcCCChHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          408 FLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       408 VmEy~~ggsL~~ll~------~~~l~e~~v~~i~~QIl~gL~yLH-s~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      -||+|.- +|..+++      +..+++.-+-.|...++.||.||- +.+||||||||+|||++..|.|||||||++..+.
T Consensus       141 CMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  141 CMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             eHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            9999975 7776653      345888888899999999999997 4689999999999999999999999999987654


Q ss_pred             cCC-cccccCCCcccccccccC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g  501 (504)
                      ... .+.-.|...|||||-+..
T Consensus       220 ~SiAkT~daGCrpYmAPERi~p  241 (361)
T KOG1006|consen  220 DSIAKTVDAGCRPYMAPERIDP  241 (361)
T ss_pred             HHHHhhhccCCccccChhccCC
Confidence            333 233458999999998763

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.85  E-value=1.3e-21  Score=206.40  Aligned_cols=168  Identities=25%  Similarity=0.378  Sum_probs=146.5

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC------CceeEEeeeec
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH------ENIVQYYGTDK  400 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H------pnIV~l~~~~~  400 (504)
                      -++|.+....|+|-|++|..|.+ ..|..||||++...      ....+.-+.|+.+|++|+.      -|+++|+-+|.
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN------E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN------EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc------hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            35789999999999999999998 56789999999632      2333445689999999962      48999999999


Q ss_pred             CCCeEEEEEEeccCCCHHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEecCc
Q 010676          401 DESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGL  475 (504)
Q Consensus       401 ~~~~lyLVmEy~~ggsL~~ll~~~~----l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~-g~VKL~DFGL  475 (504)
                      ..+++|||+|.+.. +|..++++++    |....+..|+.|++.||.+|-.+||+|+||||+|||+++. ..+||||||.
T Consensus       505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence            99999999998864 8999998765    7778999999999999999999999999999999999865 4689999999


Q ss_pred             ccccccCCcccccCCCcccccccccCC
Q 010676          476 AKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       476 A~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      |.....+..+.+.-+..|.|||++.|.
T Consensus       584 A~~~~eneitPYLVSRFYRaPEIiLG~  610 (752)
T KOG0670|consen  584 ASFASENEITPYLVSRFYRAPEIILGL  610 (752)
T ss_pred             ccccccccccHHHHHHhccCcceeecC
Confidence            998888888888889999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.85  E-value=2.1e-21  Score=212.18  Aligned_cols=167  Identities=28%  Similarity=0.460  Sum_probs=142.0

Q ss_pred             ceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ...|.++||.|.||.||+|..+    ....||||.++.-    ..+.....|+.|..|+-+++||||++|.+.......+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccC----ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            4678899999999999999873    4568999987642    2233346799999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      .||+|||++|+|+.+++.+  .|...++..+++.|+.|++||-+.|+|||||...||||+.+-.+|++||||++.+..+.
T Consensus       706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            9999999999999999765  48888899999999999999999999999999999999999999999999999765443


Q ss_pred             ---cccccC--CCccccccccc
Q 010676          484 ---VKSCRG--TAFWMAPEVCS  500 (504)
Q Consensus       484 ---~~s~~G--T~~YmAPEVL~  500 (504)
                         .++.-|  ...|.|||.+.
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa  807 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIA  807 (996)
T ss_pred             CccccccCCccceeecChhHhh
Confidence               122222  35699999875

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.85  E-value=1.9e-21  Score=210.44  Aligned_cols=170  Identities=28%  Similarity=0.417  Sum_probs=142.5

Q ss_pred             cccceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      -.+...+.++||+|+||+|++|.+.    +...||||++.......    ....|.+|+.++.+|+|+|+++||+...+ 
T Consensus       108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~----~mddflrEas~M~~L~H~hliRLyGvVl~-  182 (1039)
T KOG0199|consen  108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA----IMDDFLREASHMLKLQHPHLIRLYGVVLD-  182 (1039)
T ss_pred             cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch----hHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence            3456777899999999999999983    34588999886543322    45679999999999999999999999877 


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ..+.||||+++.|+|.+.+...   .|-...+..|+.||+.|+.||..+++|||||-..|||+.....|||+||||.+.+
T Consensus       183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence            6789999999999999988762   3667788899999999999999999999999999999999999999999999987


Q ss_pred             ccCCcccc-----cCCCcccccccccC
Q 010676          480 KLNDVKSC-----RGTAFWMAPEVCSN  501 (504)
Q Consensus       480 ~~~~~~s~-----~GT~~YmAPEVL~g  501 (504)
                      ..+.-...     .--..|+|||-|..
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh  289 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRH  289 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhcc
Confidence            66543222     23456999998874

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.85  E-value=9.3e-22  Score=190.70  Aligned_cols=163  Identities=24%  Similarity=0.435  Sum_probs=138.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCC--C
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE--S  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~--~  403 (504)
                      .++|++.+.+|+|-|+.||.|+. .+...++||+++..+        .+.+.+|+.+|..|. ||||+++++...+.  .
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk  108 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESK  108 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--------HHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence            56899999999999999999997 678889999886432        256789999999998 99999999987665  3


Q ss_pred             eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~-~g~VKL~DFGLA~~~~~~  482 (504)
                      ..-+|+||+.+.++..++..  ++...+..|+.|++.||.|+|+.||+|||+||.|+||+. ...++|+|+|||.+...+
T Consensus       109 tpaLiFE~v~n~Dfk~ly~t--l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  109 TPSLIFEYVNNTDFKQLYPT--LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             CchhHhhhhccccHHHHhhh--hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            47899999999999888764  777889999999999999999999999999999999985 457999999999886655


Q ss_pred             C-cccccCCCccccccccc
Q 010676          483 D-VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       483 ~-~~s~~GT~~YmAPEVL~  500 (504)
                      . ..-.+.+.+|--||+|-
T Consensus       187 ~eYnVRVASRyfKGPELLV  205 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLV  205 (338)
T ss_pred             ceeeeeeehhhcCCchhee
Confidence            4 33345677888899874

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.83  E-value=9.8e-21  Score=204.16  Aligned_cols=166  Identities=29%  Similarity=0.378  Sum_probs=138.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~  403 (504)
                      .+...|.+...||.|+|+.|-.+.+ .++..+++|++.....         ...+|+.++... +||||+++.+.+.+..
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---------~~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---------DNQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheecccccc---------ccccccchhhhhcCCCcceeecceecCCc
Confidence            3566788888899999999999887 6888999998865311         123566555444 6999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-cCCCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV-DANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL-d~~g~VKL~DFGLA~~~~~~  482 (504)
                      .+|+|||++.|+.|.+-+.........+..|++||+.++.|||.+|+|||||||+|||+ +..|+++|+|||+++.....
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999999999988877666555547888899999999999999999999999999999 68999999999999876655


Q ss_pred             CcccccCCCcccccccccC
Q 010676          483 DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g  501 (504)
                       ....+-|..|.|||++..
T Consensus       470 -~~tp~~t~~y~APEvl~~  487 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAI  487 (612)
T ss_pred             -hcccchhhcccChhhhcc
Confidence             334457899999999874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.83  E-value=5.7e-21  Score=197.71  Aligned_cols=145  Identities=29%  Similarity=0.461  Sum_probs=127.9

Q ss_pred             ccccccceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeee
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGT  398 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~  398 (504)
                      ++.+...|.+.++||.|+|++||++++.    ...+||+|.+.....       ..++.+|+++|..+. +.||+++.++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-------p~ri~~El~~L~~~gG~~ni~~~~~~  103 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-------PSRILNELEMLYRLGGSDNIIKLNGC  103 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-------chHHHHHHHHHHHhccchhhhcchhh
Confidence            4456678999999999999999999873    578999998865433       245789999999886 9999999999


Q ss_pred             ecCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEEEEecCccc
Q 010676          399 DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAK  477 (504)
Q Consensus       399 ~~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd-~~g~VKL~DFGLA~  477 (504)
                      +..++++.+||||++.....+++..  ++...+..|++.++.||.|+|.+|||||||||.|||.+ ..+...|+|||||.
T Consensus       104 ~rnnd~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  104 FRNNDQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             hccCCeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence            9999999999999999999999876  55678999999999999999999999999999999998 45789999999996

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=1.9e-19  Score=171.86  Aligned_cols=167  Identities=38%  Similarity=0.556  Sum_probs=142.6

Q ss_pred             eeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC-ceeEEeeeecCCCeEEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-nIV~l~~~~~~~~~lyLVm  409 (504)
                      |.+.+.||.|+||.||++.+.  ..+++|.+........  .....+.+|+.++..+.|+ +|+++++.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence            778899999999999999887  7788888764333221  2356788999999999988 7999999998777889999


Q ss_pred             EeccCCCHHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEecCcccccccCC-
Q 010676          410 ELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLND-  483 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~----~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-~VKL~DFGLA~~~~~~~-  483 (504)
                      +++.+++|.+++...    .+.......++.|++.++.|+|..+++||||||+||+++..+ .++++|||+++...... 
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            999999999877765    588999999999999999999999999999999999999988 79999999987544332 


Q ss_pred             -------cccccCCCcccccccccC
Q 010676          484 -------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 -------~~s~~GT~~YmAPEVL~g  501 (504)
                             .....||..|+|||++.+
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~  182 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLG  182 (384)
T ss_pred             cccccccccccccccccCCHHHhcC
Confidence                   355679999999999876

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.82  E-value=6.3e-21  Score=191.98  Aligned_cols=168  Identities=26%  Similarity=0.387  Sum_probs=140.8

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~----  402 (504)
                      ..+|.-++.+|.|.- .|..|.+ -.+..||+|.+....   ......++..+|+.++..++|+||++++.+|.-.    
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf---~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF---QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc---ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            347888899999988 7777776 578899999775432   2233345677999999999999999999988544    


Q ss_pred             --CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          403 --SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       403 --~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                        ..+|+||||+.. +|...+. ..++-.++..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus        92 ~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   92 EFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence              348999999976 7877766 567888999999999999999999999999999999999999999999999998766


Q ss_pred             cC-CcccccCCCcccccccccC
Q 010676          481 LN-DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~-~~~s~~GT~~YmAPEVL~g  501 (504)
                      .. ..+.++.|.+|.|||++.|
T Consensus       170 ~~~~mtpyVvtRyyrapevil~  191 (369)
T KOG0665|consen  170 TDFMMTPYVVTRYYRAPEVILG  191 (369)
T ss_pred             cccccCchhheeeccCchheec
Confidence            66 4667889999999999865

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.82  E-value=1.5e-20  Score=207.03  Aligned_cols=162  Identities=35%  Similarity=0.544  Sum_probs=130.5

Q ss_pred             eeeeeeecccCcee-EEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCeEEEE
Q 010676          331 WQKGDLLGRGSFGS-VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       331 y~i~k~LG~G~FG~-VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~lyLV  408 (504)
                      |.-.+++|.|+-|+ ||+|... |+.||||.+..        .......+||.+|+.-+ |||||++|+.-.+...+||.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~--------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa  581 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE--------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA  581 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh--------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence            44457799999875 7899875 67999996642        22344568999999885 99999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CC--cEEEEecCcccc
Q 010676          409 LELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NG--SVKLADFGLAKA  478 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~-----l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~---~g--~VKL~DFGLA~~  478 (504)
                      +|+|.. +|.+++....     ........++.|++.||+|||+.+||||||||.||||..   ++  .++|+|||+++.
T Consensus       582 lELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  582 LELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             ehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            999976 8999987631     111345678899999999999999999999999999975   34  689999999998


Q ss_pred             cccCC-----cccccCCCcccccccccCC
Q 010676          479 TKLND-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      +..+.     .....||-+|+|||+|.+.
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~  689 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLRED  689 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhcc
Confidence            76543     2345699999999998753

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.1e-19  Score=176.74  Aligned_cols=136  Identities=23%  Similarity=0.365  Sum_probs=105.6

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-----CCCceeEEeeeecCCC---eE
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-----EHENIVQYYGTDKDES---KL  405 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIV~l~~~~~~~~---~l  405 (504)
                      .++||+|+||.||. .-.++.. +||++......     ....+.+|+.+++.+     .||||+++++++.++.   .+
T Consensus         7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~-----~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDG-----GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cceecCCCceEEEE-CCCCcCe-EEEEEeccccc-----hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            46799999999996 2234433 68877543221     235688999999999     5799999999998874   43


Q ss_pred             E-EEEEe--ccCCCHHHHHHhcCCChHHHHHHHHHHHHHH-HHHHHCCceecCCCCCcEEEcCC----CcEEEEe-cCcc
Q 010676          406 Y-IFLEL--VTKGSLLNLYQRYHLRDSQVSAYTRQILLGL-KYLHDQDVVHRDIKCANILVDAN----GSVKLAD-FGLA  476 (504)
Q Consensus       406 y-LVmEy--~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL-~yLHs~gIIHRDLKP~NILLd~~----g~VKL~D-FGLA  476 (504)
                      | +||||  +.+++|.+++++..+.+.  ..++.|++.++ +|||+++|+||||||+|||++.+    +.++|+| ||..
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            4 78999  557999999987766655  46688888888 89999999999999999999743    3799999 5544


Q ss_pred             cc
Q 010676          477 KA  478 (504)
Q Consensus       477 ~~  478 (504)
                      ..
T Consensus       158 ~~  159 (210)
T PRK10345        158 TF  159 (210)
T ss_pred             ce
Confidence            33

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.81  E-value=1e-19  Score=202.07  Aligned_cols=174  Identities=30%  Similarity=0.474  Sum_probs=143.2

Q ss_pred             ccccccceeeeeeecccCceeEEEEEcc--------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeE
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQ  394 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~--------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~  394 (504)
                      +....++..+.+.||.|.||.|++|...        ....||||.++....    ....+.+..|+++++.+. |+||+.
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~----~~~~~~~~~El~~m~~~g~H~niv~  366 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS----SSEKKDLMSELNVLKELGKHPNIVN  366 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC----cHHHHHHHHHHHHHHHhcCCcchhh
Confidence            3333445567779999999999999741        256788997653222    234567889999999885 999999


Q ss_pred             EeeeecCCCeEEEEEEeccCCCHHHHHHhcC-----------------CChHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 010676          395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC  457 (504)
Q Consensus       395 l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~-----------------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP  457 (504)
                      +++++.....+++|+||+..|+|..+++..+                 +....+..+++||+.|++||++.++|||||-.
T Consensus       367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa  446 (609)
T KOG0200|consen  367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA  446 (609)
T ss_pred             heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence            9999999999999999999999999998877                 88899999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEEecCcccccccCCccc---ccCCC--cccccccccC
Q 010676          458 ANILVDANGSVKLADFGLAKATKLNDVKS---CRGTA--FWMAPEVCSN  501 (504)
Q Consensus       458 ~NILLd~~g~VKL~DFGLA~~~~~~~~~s---~~GT~--~YmAPEVL~g  501 (504)
                      .||||..+..+||+|||||+.........   ..||.  .|||||.+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~  495 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD  495 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc
Confidence            99999999999999999998655443222   22333  3999998876

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=1e-19  Score=184.20  Aligned_cols=159  Identities=27%  Similarity=0.412  Sum_probs=134.5

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCeEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~lyL  407 (504)
                      .|+++++||+|+||++++|++ -++..||||.-....       ...++..|.+..+.|. .++|..+|.+..+..+-.|
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-------~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-------EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC-------CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            699999999999999999998 789999999654322       1245677888887775 7999999999999988899


Q ss_pred             EEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-----cEEEEecCcccccc
Q 010676          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-----SVKLADFGLAKATK  480 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-----~VKL~DFGLA~~~~  480 (504)
                      |||++ |-+|.+++.-+  .|+.+++..++.|++.-++|+|++.+|+|||||+|+||..-+     .+.|+|||+|+.+.
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            99998 55999998765  499999999999999999999999999999999999997543     58999999998764


Q ss_pred             cCC---------cccccCCCccccc
Q 010676          481 LND---------VKSCRGTAFWMAP  496 (504)
Q Consensus       481 ~~~---------~~s~~GT~~YmAP  496 (504)
                      ...         .++..||..||+-
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSI  205 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSI  205 (449)
T ss_pred             CccccccCccccccccccceeeeEe
Confidence            332         3456799999974

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.7e-20  Score=185.62  Aligned_cols=167  Identities=23%  Similarity=0.376  Sum_probs=137.8

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEee-eecCCC
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYG-TDKDES  403 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~-~~~~~~  403 (504)
                      +.+.|.|.+.||+|.||.+-++.+ .+...+++|.+..      ....+..|.+|+..--.|. |.||+.-|+ .|++.+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d   95 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD   95 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence            456899999999999999999998 5778899997753      2233567888887665554 899998876 588889


Q ss_pred             eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--CCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd--~~g~VKL~DFGLA~~~~~  481 (504)
                      .+++++||++.|+|..-+...++.+...+.++.|+++||.|||+++|||||||.+||||-  ...+|||||||+.+....
T Consensus        96 ~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen   96 AYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999999999999999889999999999999999999999999999999999999994  345899999998764332


Q ss_pred             CCcccccCCCccccccccc
Q 010676          482 NDVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       482 ~~~~s~~GT~~YmAPEVL~  500 (504)
                      . ......+..|.+||++.
T Consensus       176 t-V~~~~~~~~y~~pe~~~  193 (378)
T KOG1345|consen  176 T-VKYLEYVNNYHAPELCD  193 (378)
T ss_pred             e-ehhhhhhcccCCcHHHh
Confidence            1 22333567799999765

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=2e-18  Score=181.56  Aligned_cols=130  Identities=28%  Similarity=0.398  Sum_probs=109.0

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-----C---CceeEEeeee
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----H---ENIVQYYGTD  399 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----H---pnIV~l~~~~  399 (504)
                      .+|.+.++||.|-|++||+|++ .+.++||+|+++-      .+...+..+.||++|++++     |   .+||+|++.|
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            6899999999999999999999 6788999999873      2333455678999999884     2   3699999998


Q ss_pred             cC----CCeEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCC
Q 010676          400 KD----ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDAN  465 (504)
Q Consensus       400 ~~----~~~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~  465 (504)
                      ..    ..++|||+|++.. +|..++..   .+++...++.|++|||.||.|||. .||||.||||+|||+..+
T Consensus       152 khsGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             eecCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence            64    5679999999954 66666654   359999999999999999999995 699999999999999544

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=8.2e-19  Score=179.87  Aligned_cols=166  Identities=28%  Similarity=0.336  Sum_probs=130.7

Q ss_pred             ceeeeeeecccCceeEEEEEccC--CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC----CCceeEEeeee-cCC
Q 010676          330 YWQKGDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE----HENIVQYYGTD-KDE  402 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~~--g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~----HpnIV~l~~~~-~~~  402 (504)
                      .|.+.+.||+|+||.||++.+..  ...+|+|..........     ..+..|+.++..+.    ..++..+++.+ ...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            89999999999999999999854  35888887764322211     13556777777776    36899999999 578


Q ss_pred             CeEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-----CcEEEEecC
Q 010676          403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-----GSVKLADFG  474 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~-----g~VKL~DFG  474 (504)
                      ..-||||+++ |-+|.++...   ..++..++..++.|++.+|++||+.|+|||||||.|+++...     ..+.|+|||
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            8899999988 5689998754   358999999999999999999999999999999999999865     369999999


Q ss_pred             cccccc--cCC----------cccccCCCcccccccccC
Q 010676          475 LAKATK--LND----------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       475 LA~~~~--~~~----------~~s~~GT~~YmAPEVL~g  501 (504)
                      +++...  ...          .....||..|+++.+-.+
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~  211 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG  211 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC
Confidence            998321  111          122449999999875443

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=5.1e-19  Score=174.86  Aligned_cols=146  Identities=19%  Similarity=0.173  Sum_probs=113.7

Q ss_pred             ceeeeeeecccCceeEEEEE--ccCCceEEEEEEeccccch-------------------hhHHHHHHHHHHHHHHhhCC
Q 010676          330 YWQKGDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGS-------------------QAKQSISQLEQEIALLSRFE  388 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~--~~~g~~vAVK~v~~~~~~~-------------------~~~~~~~~~~~Ei~iL~~L~  388 (504)
                      -|.+.+.||+|+||.||+|.  ..+|..||+|++.......                   ........+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999998  4789999999987532110                   00111234678999999997


Q ss_pred             CC--ceeEEeeeecCCCeEEEEEEeccCCCHHHHH-HhcCCChHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCcEEEcC
Q 010676          389 HE--NIVQYYGTDKDESKLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDA  464 (504)
Q Consensus       389 Hp--nIV~l~~~~~~~~~lyLVmEy~~ggsL~~ll-~~~~l~e~~v~~i~~QIl~gL~yLHs~g-IIHRDLKP~NILLd~  464 (504)
                      +.  .+.+++.+    ...|+||||+.|.+|..++ ....+....+..++.||+.+|.+||.+| |+||||||+|||++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            53  34455543    2358999999998887654 3444666677899999999999999999 99999999999999 


Q ss_pred             CCcEEEEecCcccccc
Q 010676          465 NGSVKLADFGLAKATK  480 (504)
Q Consensus       465 ~g~VKL~DFGLA~~~~  480 (504)
                      ++.++|+|||++....
T Consensus       184 ~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCCEEEEEChhhhccC
Confidence            8899999999987544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=6.7e-19  Score=172.05  Aligned_cols=162  Identities=27%  Similarity=0.331  Sum_probs=132.8

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCe
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK  404 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~  404 (504)
                      +.+.|.+++.||.|+||.+|+|+. .+|..||||.-.....       ..++..|..+...|+ ...|..+..++.+..+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-------hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-------HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-------CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            457899999999999999999998 7899999997643222       134667888888887 4688888889999999


Q ss_pred             EEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEecCccccc
Q 010676          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKAT  479 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~---g~VKL~DFGLA~~~  479 (504)
                      -.+||+++ |-+|.++++-  ..++..+++.++-|++.-|+|+|.+++|||||||+|+|..-+   ..+.|+||||++.+
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            99999998 4589988764  458889999999999999999999999999999999999643   56999999999864


Q ss_pred             ccCC---------cccccCCCccccc
Q 010676          480 KLND---------VKSCRGTAFWMAP  496 (504)
Q Consensus       480 ~~~~---------~~s~~GT~~YmAP  496 (504)
                      ....         -....||..|.+-
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASi  190 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASI  190 (341)
T ss_pred             ccccccccCccccCCccceeeeehhh
Confidence            3221         2344688888763

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1e-18  Score=166.53  Aligned_cols=139  Identities=21%  Similarity=0.260  Sum_probs=113.9

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccccc---hhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEe
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~---~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy  411 (504)
                      +.||+|++|.||+|.. .|..+++|........   .........+.+|+.++..+.|++|+....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6678889975432211   11122335678899999999999887776666667788999999


Q ss_pred             ccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          412 VTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       412 ~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      ++|++|.+++.....   ....++.+++.+|.+||..|++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999998865432   7788999999999999999999999999999998 88999999999875

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.2e-18  Score=169.62  Aligned_cols=137  Identities=20%  Similarity=0.148  Sum_probs=106.7

Q ss_pred             eeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCeEEEEEE
Q 010676          332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       332 ~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~lyLVmE  410 (504)
                      .+...|++|+||+||++.. .+..++.+.+........ ......+.+|+++|++|. |++|++++++    +..|++|+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~-~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLR-GVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhh-hHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567899999999998766 677777665543222111 111225789999999996 5889999886    45799999


Q ss_pred             eccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCC-CCCcEEEcCCCcEEEEecCcccccc
Q 010676          411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI-KCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       411 y~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDL-KP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      |+.|.+|...+...      ...++.|++.+|.+||.+||+|||| ||.|||++.+|.++|+|||+|....
T Consensus        79 yI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         79 YLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             eecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            99999987544221      2457889999999999999999999 7999999999999999999998544

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.78  E-value=1.1e-19  Score=199.50  Aligned_cols=167  Identities=29%  Similarity=0.483  Sum_probs=137.3

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCC----ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDG----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g----~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ..+..++||+|.||+||+|.+ ..|    ..||+|++.....    .+.-.++..|..++..++|||+++|++++.... 
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~----~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS----PKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC----chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            456678999999999999987 333    4778887653222    233467889999999999999999999998765 


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +.||++|+++|.|.++++..  .+.....+.|..||+.|+.|||++.++||||-..||||..-..|||.|||+++.....
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            88999999999999998754  4888899999999999999999999999999999999999999999999999987655


Q ss_pred             Cccc----ccCCCcccccccccC
Q 010676          483 DVKS----CRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~~~s----~~GT~~YmAPEVL~g  501 (504)
                      ....    ..-.+.|||-|.+..
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~  874 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRI  874 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhc
Confidence            4221    123456888887654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=2.2e-18  Score=162.99  Aligned_cols=136  Identities=24%  Similarity=0.281  Sum_probs=108.0

Q ss_pred             eecccCceeEEEEEccCCceEEEEEEeccccc---hhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEec
Q 010676          336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       336 ~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~---~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      +||+|+||.||+|.. ++..+++|........   ........++.+|+.++..+.|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 5678999975432211   112233466789999999998887555444445566779999999


Q ss_pred             cCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          413 TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       413 ~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      +|++|.+++.....      .++.|++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++...
T Consensus        80 ~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999988755322      7899999999999999999999999999999 899999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.77  E-value=2.8e-18  Score=169.18  Aligned_cols=142  Identities=14%  Similarity=0.130  Sum_probs=114.4

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHH------HHHHHHHHhhCCCCceeEEeeeec
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQ------LEQEIALLSRFEHENIVQYYGTDK  400 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~------~~~Ei~iL~~L~HpnIV~l~~~~~  400 (504)
                      +.++|++.++||.|+||.||++.. ++..+|+|++.......  ......      +++|+..+.++.|++|..+.+++.
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~--~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT--ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCch--HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            346899999999999999999655 57789999886433222  222233      689999999999999999988755


Q ss_pred             CC--------CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 010676          401 DE--------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       401 ~~--------~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                      ..        ...+|+|||++|.+|.++..   +++    ....+++.+|..||..|++||||||+||+++.+| ++|+|
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            33        35899999999999987732   222    2466999999999999999999999999999988 99999


Q ss_pred             cCccccc
Q 010676          473 FGLAKAT  479 (504)
Q Consensus       473 FGLA~~~  479 (504)
                      ||.....
T Consensus       178 fg~~~~~  184 (232)
T PRK10359        178 LSGKRCT  184 (232)
T ss_pred             CCCcccc
Confidence            9987654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=2.9e-18  Score=163.25  Aligned_cols=143  Identities=20%  Similarity=0.188  Sum_probs=111.1

Q ss_pred             ceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchh-----------------hHHHHHHHHHHHHHHhhCCCC--
Q 010676          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ-----------------AKQSISQLEQEIALLSRFEHE--  390 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~-----------------~~~~~~~~~~Ei~iL~~L~Hp--  390 (504)
                      .|.+.+.||+|+||.||++...+|..||||++........                 .......+.+|+.++..+.|.  
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            3778899999999999999988899999998764321100                 001112356789999888777  


Q ss_pred             ceeEEeeeecCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEE
Q 010676          391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL  470 (504)
Q Consensus       391 nIV~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL  470 (504)
                      .++..++.    ...++||||++|++|..+...     .....++.+|+.++.++|..||+|+||||.||+|+.++.++|
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l  166 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI  166 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence            44555543    345899999999998765431     345678899999999999999999999999999999999999


Q ss_pred             EecCccccccc
Q 010676          471 ADFGLAKATKL  481 (504)
Q Consensus       471 ~DFGLA~~~~~  481 (504)
                      +|||++.....
T Consensus       167 iDfg~~~~~~~  177 (198)
T cd05144         167 IDWPQMVSTDH  177 (198)
T ss_pred             EECCccccCCC
Confidence            99999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=5.9e-18  Score=185.19  Aligned_cols=141  Identities=21%  Similarity=0.236  Sum_probs=112.5

Q ss_pred             ceeeeeeecccCceeEEEEEccCCceEEEEEEeccc-cc--hhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLD-QG--SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~-~~--~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .|...++||+|+||.||++.+.... +++|...... ..  ........++.+|+.++..++|++++..+.++......+
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            3456788999999999999875443 3444322111 11  112233466889999999999999988877777777889


Q ss_pred             EEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      +||||+++++|.+++.       ....++.|++.+|.|||++||+||||||+|||+ .++.++|+|||+++..
T Consensus       413 lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999999998875       356789999999999999999999999999999 6889999999999764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=8.1e-17  Score=150.61  Aligned_cols=142  Identities=23%  Similarity=0.243  Sum_probs=100.0

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHH-------------------HHHHHHHHHHHhhCCCC--ce
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-------------------ISQLEQEIALLSRFEHE--NI  392 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~-------------------~~~~~~Ei~iL~~L~Hp--nI  392 (504)
                      ++.||+|+||.||+|.+.++..||||++............                   ......|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            5679999999999999988999999987643221111100                   01113556666655433  24


Q ss_pred             eEEeeeecCCCeEEEEEEeccCCCHHH-HHHhcCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEE
Q 010676          393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKL  470 (504)
Q Consensus       393 V~l~~~~~~~~~lyLVmEy~~ggsL~~-ll~~~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL  470 (504)
                      .+++++    ...++||||++++.+.. .+...... ..+..++.+++.++.++|. +||+|+||||+|||++ ++.++|
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~l  155 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYI  155 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEE
Confidence            444443    23599999999954321 12211111 5678899999999999999 9999999999999999 999999


Q ss_pred             EecCccccccc
Q 010676          471 ADFGLAKATKL  481 (504)
Q Consensus       471 ~DFGLA~~~~~  481 (504)
                      +|||.+.....
T Consensus       156 iDfg~a~~~~~  166 (187)
T cd05119         156 IDVPQAVEIDH  166 (187)
T ss_pred             EECcccccccC
Confidence            99999875443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=3.3e-16  Score=154.93  Aligned_cols=142  Identities=18%  Similarity=0.203  Sum_probs=106.5

Q ss_pred             eeeec-ccCceeEEEEEccCCceEEEEEEecccc--------chhhHHHHHHHHHHHHHHhhCCCCce--eEEeeeecCC
Q 010676          334 GDLLG-RGSFGSVYEGISDDGFFFAVKEVSLLDQ--------GSQAKQSISQLEQEIALLSRFEHENI--VQYYGTDKDE  402 (504)
Q Consensus       334 ~k~LG-~G~FG~VYka~~~~g~~vAVK~v~~~~~--------~~~~~~~~~~~~~Ei~iL~~L~HpnI--V~l~~~~~~~  402 (504)
                      ...|| .||.|+||.+... +..++||.+.....        .........++.+|+.++..+.|++|  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            34577 7888888888764 67888887743110        00111233567889999999998775  6666654332


Q ss_pred             Ce----EEEEEEeccC-CCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          403 SK----LYIFLELVTK-GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       403 ~~----lyLVmEy~~g-gsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      ..    .++|||+++| .+|.+++....++..    .+.||+.+|.+||++||+|+||||.|||++.++.++|+|||.+.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~  190 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE  190 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence            22    3599999997 689988877666554    36789999999999999999999999999999999999999987


Q ss_pred             ccc
Q 010676          478 ATK  480 (504)
Q Consensus       478 ~~~  480 (504)
                      ...
T Consensus       191 ~~~  193 (239)
T PRK01723        191 LRT  193 (239)
T ss_pred             cCC
Confidence            643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=5e-16  Score=136.42  Aligned_cols=132  Identities=20%  Similarity=0.240  Sum_probs=110.4

Q ss_pred             eeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC--CceeEEeeeecCCCeEEEEEE
Q 010676          333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       333 i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~~~~~~~~lyLVmE  410 (504)
                      +.+.||+|.++.||++...+ ..+++|.+.....       ...+.+|+.++..++|  .++++++.++...+..|++||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e   73 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME   73 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence            35779999999999999855 6889997653221       3457789999999876  589999998888889999999


Q ss_pred             eccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---CceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---DVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       411 y~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~---gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      |+.++.+..+      +......++.+++.+|.+||..   +++|+||+|.|||++..+.++|+|||++..
T Consensus        74 ~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          74 WIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9998877654      4456677899999999999985   699999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=3.5e-16  Score=178.54  Aligned_cols=178  Identities=22%  Similarity=0.252  Sum_probs=133.3

Q ss_pred             CCccccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee
Q 010676          320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  399 (504)
Q Consensus       320 p~~~~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~  399 (504)
                      +...+..-...|.|-+.||+|+||.||+|...+|+.||+|+-+......  -..-.+++..++ +.  --+.|..+..++
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk-~~--~~~~~~~~~~a~  763 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLK-PQ--MLPSIMHISSAH  763 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhc-hh--hhcchHHHHHHH
Confidence            3333444456799999999999999999999889999999765432211  111112222222 11  134566666666


Q ss_pred             cCCCeEEEEEEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-------CCcEEEE
Q 010676          400 KDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-------NGSVKLA  471 (504)
Q Consensus       400 ~~~~~lyLVmEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~-------~g~VKL~  471 (504)
                      .-.+.-+||+||.+.|+|.++++..+ +++..+..+..||+.-|++||..+|||+||||+|+||..       ..-++|+
T Consensus       764 ~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  764 VFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             ccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence            77778899999999999999998654 888899999999999999999999999999999999943       2358999


Q ss_pred             ecCcccccc---cC-CcccccCCCcccccccccCC
Q 010676          472 DFGLAKATK---LN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       472 DFGLA~~~~---~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      |||-+....   .+ .....++|-.+-.+|++.|+
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr  878 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR  878 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCC
Confidence            999875432   22 34556789999999999886

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=2.3e-16  Score=174.90  Aligned_cols=171  Identities=27%  Similarity=0.402  Sum_probs=133.7

Q ss_pred             eeeeeecccCceeEEEEEc-cCCceEEEEEEeccc-cchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       332 ~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~-~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      ....++|.|.+|.|+.+.. .....++.|.+.... ...........+..|+.+-..+.|+|++..+....+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3467899999998888766 344445555443110 11222222333777888888999999998888777777777779


Q ss_pred             EeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-----
Q 010676          410 ELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----  483 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-----  483 (504)
                      |||++ +|..++... .+....+..++.|++.||.|||+.||.|||||++|+++..+|.+||+|||.+.......     
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99999 999988876 78999999999999999999999999999999999999999999999999987543222     


Q ss_pred             -cccccCCCcccccccccCCC
Q 010676          484 -VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g~~  503 (504)
                       ....+|+..|+|||++.+..
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~  500 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKE  500 (601)
T ss_pred             hhcCcccCCcCcCcccccccc
Confidence             23457999999999998753

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.63  E-value=1.3e-16  Score=182.17  Aligned_cols=115  Identities=15%  Similarity=0.203  Sum_probs=85.1

Q ss_pred             CCC-CceeEEeeee-------cCCCeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 010676          387 FEH-ENIVQYYGTD-------KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK  456 (504)
Q Consensus       387 L~H-pnIV~l~~~~-------~~~~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLK  456 (504)
                      ++| .||++++++|       .....++++|||+ +++|.+++...  .+++.+++.|++||+.||.|||++||||||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            344 4777777776       3335678888987 45999999643  48999999999999999999999999999999


Q ss_pred             CCcEEEcCCC-------------------cEEEEecCcccccccC------C------------cccccCCCcccccccc
Q 010676          457 CANILVDANG-------------------SVKLADFGLAKATKLN------D------------VKSCRGTAFWMAPEVC  499 (504)
Q Consensus       457 P~NILLd~~g-------------------~VKL~DFGLA~~~~~~------~------------~~s~~GT~~YmAPEVL  499 (504)
                      |+||||+..|                   .+||+|||+++.....      .            ....+||++|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            9999996544                   4556666665431100      0            0113589999999998


Q ss_pred             cCC
Q 010676          500 SNP  502 (504)
Q Consensus       500 ~g~  502 (504)
                      .+.
T Consensus       188 ~~~  190 (793)
T PLN00181        188 NGS  190 (793)
T ss_pred             ccC
Confidence            764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.62  E-value=3.7e-17  Score=176.74  Aligned_cols=162  Identities=27%  Similarity=0.447  Sum_probs=135.7

Q ss_pred             eecccCceeEEEEEc----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCeEEEEEE
Q 010676          336 LLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       336 ~LG~G~FG~VYka~~----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~lyLVmE  410 (504)
                      .+|+|.||.|+++..    ..|..||+|..+........+.   +...|..++..++ ||++|++...|+++..+|++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            379999999998754    4677899998765444333332   4556788888887 9999999999999999999999


Q ss_pred             eccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcccccC
Q 010676          411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG  489 (504)
Q Consensus       411 y~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~~G  489 (504)
                      |..||.|...+... .+.+..++.+...++-+++++|+.+|+|||+|++||+++.+|++++.|||+.+..-.....  ||
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--cg  155 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--CG  155 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--cc
Confidence            99999888766554 4677788889999999999999999999999999999999999999999998865444333  89


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |..|||||+++|.
T Consensus       156 t~eymApEI~~gh  168 (612)
T KOG0603|consen  156 TYEYRAPEIINGH  168 (612)
T ss_pred             chhhhhhHhhhcc
Confidence            9999999999854

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=1.7e-14  Score=149.35  Aligned_cols=174  Identities=25%  Similarity=0.379  Sum_probs=128.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEccC------------------------------------CceEEEEEEeccccchh
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDD------------------------------------GFFFAVKEVSLLDQGSQ  369 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~------------------------------------g~~vAVK~v~~~~~~~~  369 (504)
                      -.+++|++++.||+|.-..||.|...+                                    ....|||.+...+....
T Consensus       154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~  233 (598)
T KOG4158|consen  154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG  233 (598)
T ss_pred             cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence            346789999999999999999885321                                    12456776655555555


Q ss_pred             hHHHHHHHHHHHH------HH--------hh--------CCCCceeEEeeeecC--------------------------
Q 010676          370 AKQSISQLEQEIA------LL--------SR--------FEHENIVQYYGTDKD--------------------------  401 (504)
Q Consensus       370 ~~~~~~~~~~Ei~------iL--------~~--------L~HpnIV~l~~~~~~--------------------------  401 (504)
                      ....++.+-+|+.      ++        +.        -+|||||++..+|.+                          
T Consensus       234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g  313 (598)
T KOG4158|consen  234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG  313 (598)
T ss_pred             hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence            5555555555521      11        11        259999999887643                          


Q ss_pred             -CCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--CCC--cEEEEecCcc
Q 010676          402 -ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANG--SVKLADFGLA  476 (504)
Q Consensus       402 -~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd--~~g--~VKL~DFGLA  476 (504)
                       ...+|+||..+.. +|..++.....+......++.|++.|+.|||++||.|||+|.+||||.  .++  .+.|+|||.|
T Consensus       314 ~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc  392 (598)
T KOG4158|consen  314 EPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC  392 (598)
T ss_pred             CCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence             3458999988865 899999888888888999999999999999999999999999999995  333  5789999987


Q ss_pred             cccccCCc--------ccccCCCccccccccc
Q 010676          477 KATKLNDV--------KSCRGTAFWMAPEVCS  500 (504)
Q Consensus       477 ~~~~~~~~--------~s~~GT~~YmAPEVL~  500 (504)
                      -.-.....        -..-|.-.-||||+..
T Consensus       393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             eeccccccccccccccccCCCcceecchhhhh
Confidence            54322111        1223788899999976

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=1.6e-13  Score=147.20  Aligned_cols=145  Identities=20%  Similarity=0.121  Sum_probs=97.0

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccccchhh-----------------------------HHHH------HHHHH
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-----------------------------KQSI------SQLEQ  379 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~-----------------------------~~~~------~~~~~  379 (504)
                      +.||.|++|.||+|+..+|+.||||+..........                             .+..      ..+.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            569999999999999999999999987532111000                             0000      12344


Q ss_pred             HHHHHhhC----CCCceeEEeee-ecCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHH-HHHHHHHCCceec
Q 010676          380 EIALLSRF----EHENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-GLKYLHDQDVVHR  453 (504)
Q Consensus       380 Ei~iL~~L----~HpnIV~l~~~-~~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~-gL~yLHs~gIIHR  453 (504)
                      |...+.++    +|.+-+.+-.. +......+|||||++|++|.++........ ....++.+++. .+..+|..|++|+
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~H~  281 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFFHA  281 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCceeC
Confidence            55555444    23222232222 222345699999999999988764321111 23345555555 4678899999999


Q ss_pred             CCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          454 DIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       454 DLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      |+||.||+++.+|.++|+|||++....
T Consensus       282 D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       282 DLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.47  E-value=4.7e-14  Score=145.73  Aligned_cols=170  Identities=25%  Similarity=0.360  Sum_probs=134.1

Q ss_pred             cceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  401 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-  401 (504)
                      .++++.-++-+|+||.||.|++.      +.+.+.+|.++.    ....-.+..+.+|--+|..+.|||+..+.+.+.+ 
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            35777888999999999999763      334555664432    2223345667888888999999999999987654 


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhcC---------CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRYH---------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~~---------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                      ....+.++.++..|+|..++..++         ++..++..++.|+..|++|||++|+||.||...|.+|++.-+|||+|
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence            456788889999999999998433         55667788999999999999999999999999999999999999999


Q ss_pred             cCcccccccCCcccc----cCCCcccccccccCC
Q 010676          473 FGLAKATKLNDVKSC----RGTAFWMAPEVCSNP  502 (504)
Q Consensus       473 FGLA~~~~~~~~~s~----~GT~~YmAPEVL~g~  502 (504)
                      =.|++.....+....    -....||+||.+.+.
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~  473 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS  473 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhhh
Confidence            999987766554322    134569999988754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.45  E-value=5.3e-13  Score=135.59  Aligned_cols=167  Identities=25%  Similarity=0.327  Sum_probs=105.9

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC---C-------c------e
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH---E-------N------I  392 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H---p-------n------I  392 (504)
                      .+..++.||.|+|+.||.+++ .++..+|+|++....  ......++++++|.-....+.+   |       .      +
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc--ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            467789999999999999999 689999999987655  2334446677776644444322   1       1      2


Q ss_pred             eEEee---eecCC---C-----eEEEEEEeccCCCHHHHHHh---c-C----CChHHHHHHHHHHHHHHHHHHHCCceec
Q 010676          393 VQYYG---TDKDE---S-----KLYIFLELVTKGSLLNLYQR---Y-H----LRDSQVSAYTRQILLGLKYLHDQDVVHR  453 (504)
Q Consensus       393 V~l~~---~~~~~---~-----~lyLVmEy~~ggsL~~ll~~---~-~----l~e~~v~~i~~QIl~gL~yLHs~gIIHR  453 (504)
                      +++-+   ++...   .     ..+++|+-+. ++|.+++.-   . .    +.......+..|++..+++||.+||+|+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            22211   11111   1     2366777774 478776532   1 1    1122234566899999999999999999


Q ss_pred             CCCCCcEEEcCCCcEEEEecCcccccccCCcccccCCCccccccccc
Q 010676          454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       454 DLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~  500 (504)
                      ||+|+|||++.+|.++|+||+........... ...+..|.+||+..
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~  215 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELES  215 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhh
Confidence            99999999999999999999876544433222 34567799999753

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.42  E-value=2e-13  Score=149.51  Aligned_cols=146  Identities=16%  Similarity=0.121  Sum_probs=93.5

Q ss_pred             cccceeeeeeecccCceeEEEEEccC-CceEEEEEEeccccch-----------------------------hhHHHHHH
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS-----------------------------QAKQSISQ  376 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~-g~~vAVK~v~~~~~~~-----------------------------~~~~~~~~  376 (504)
                      +...|.. +.||.|++|.||+|+..+ |+.||||+........                             ...+....
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3445666 789999999999999976 9999999986321100                             00011122


Q ss_pred             ------HHHHHHHHhhC----CCCceeEEeeee-cCCCeEEEEEEeccCCCHHHH--HHhcCC-----ChHHHHHHHHHH
Q 010676          377 ------LEQEIALLSRF----EHENIVQYYGTD-KDESKLYIFLELVTKGSLLNL--YQRYHL-----RDSQVSAYTRQI  438 (504)
Q Consensus       377 ------~~~Ei~iL~~L----~HpnIV~l~~~~-~~~~~lyLVmEy~~ggsL~~l--l~~~~l-----~e~~v~~i~~QI  438 (504)
                            +.+|...+.++    .+.+.+.+-..+ .-....+|||||+.|+.+.++  +...+.     .+..+..++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                  23344333333    233323322222 113456899999999999774  333333     333344445554


Q ss_pred             HHHHHHHHHCCceecCCCCCcEEEcCCC----cEEEEecCcccccc
Q 010676          439 LLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKATK  480 (504)
Q Consensus       439 l~gL~yLHs~gIIHRDLKP~NILLd~~g----~VKL~DFGLA~~~~  480 (504)
                      +       ..|++|+|+||.||+++.+|    .++++|||++....
T Consensus       277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            4       58999999999999999888    99999999987554

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.39  E-value=1.2e-12  Score=120.03  Aligned_cols=128  Identities=20%  Similarity=0.164  Sum_probs=94.4

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eEEeeeecCCCeEEEEEEec
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~lyLVmEy~  412 (504)
                      .+.|+.|.++.||++... +..|++|.......      ....+.+|+.++..+.+.++ .+++.++.+  ..++||||+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEec
Confidence            356899999999999865 67899997643211      11235678888888764443 455555432  348999999


Q ss_pred             cCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          413 TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV-----VHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       413 ~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gI-----IHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      +|.++...    .   .....++.+++.+|..||..++     +|+|++|.|||++ ++.++|+|||.+..
T Consensus        74 ~G~~l~~~----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          74 EGSELLTE----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCCccccc----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99877643    1   1123457899999999999885     9999999999998 77899999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.38  E-value=5.3e-12  Score=121.92  Aligned_cols=142  Identities=17%  Similarity=0.148  Sum_probs=103.8

Q ss_pred             eeeecccCceeEEEEEccC-------CceEEEEEEeccccc---------------------hhhHHHHHHHHHHHHHHh
Q 010676          334 GDLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQG---------------------SQAKQSISQLEQEIALLS  385 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~-------g~~vAVK~v~~~~~~---------------------~~~~~~~~~~~~Ei~iL~  385 (504)
                      ...||.|-=+.||.|...+       +..+|||+.+.....                     ..........++|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999998753       579999997542110                     111122223458999999


Q ss_pred             hCCC--CceeEEeeeecCCCeEEEEEEeccCCCHH-HHHHhcCCChHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEE
Q 010676          386 RFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANIL  461 (504)
Q Consensus       386 ~L~H--pnIV~l~~~~~~~~~lyLVmEy~~ggsL~-~ll~~~~l~e~~v~~i~~QIl~gL~yL-Hs~gIIHRDLKP~NIL  461 (504)
                      ++..  -++..++++    ..-+|||||+.++.+. ..++...++...+..++.+++.+|..| |+.||||+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8863  456666654    4568999999875442 234444456667778889999999998 8999999999999999


Q ss_pred             EcCCCcEEEEecCcccccc
Q 010676          462 VDANGSVKLADFGLAKATK  480 (504)
Q Consensus       462 Ld~~g~VKL~DFGLA~~~~  480 (504)
                      ++ ++.++|+|||.+....
T Consensus       158 ~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EE-CCcEEEEECCCceeCC
Confidence            96 5789999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.36  E-value=1.7e-13  Score=155.26  Aligned_cols=168  Identities=22%  Similarity=0.225  Sum_probs=131.0

Q ss_pred             ceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      +|...+.||.+.|=.|.+|++..|. |+||++...+....-... .+...|++ ...++|||++.+.-+..++...|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPF-KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHH-HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            6788899999999999999998887 889988765543333332 33334555 66678999999998888888899999


Q ss_pred             EeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc--ccCC---
Q 010676          410 ELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT--KLND---  483 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~--~~~~---  483 (504)
                      +|+.. +|.+.+.... +...+.+.|+.||+.||.-+|+.||+|+|||.+||||+.=..+.|+||.-.+-.  ..++   
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            99976 7777766554 566778899999999999999999999999999999999999999999876532  1111   


Q ss_pred             cccc----cCCCcccccccccC
Q 010676          484 VKSC----RGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ~~s~----~GT~~YmAPEVL~g  501 (504)
                      ...+    ..-.+|.|||-|..
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~  201 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVS  201 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhc
Confidence            2212    23346999998764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.23  E-value=2.1e-11  Score=112.33  Aligned_cols=77  Identities=31%  Similarity=0.381  Sum_probs=66.6

Q ss_pred             CCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcccccCCCc
Q 010676          415 GSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF  492 (504)
Q Consensus       415 gsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~~GT~~  492 (504)
                      |+|.+++..  ..+++.+++.|+.||+.||.|||+++      ||+|||++.++.+|+  ||+++.....   ...||+.
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---~~~g~~~   69 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---QSRVDPY   69 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc---cCCCccc
Confidence            688998874  34999999999999999999999998      999999999999999  9998765432   2368999


Q ss_pred             ccccccccCC
Q 010676          493 WMAPEVCSNP  502 (504)
Q Consensus       493 YmAPEVL~g~  502 (504)
                      |||||++.++
T Consensus        70 y~aPE~~~~~   79 (176)
T smart00750       70 FMAPEVIQGQ   79 (176)
T ss_pred             ccChHHhcCC
Confidence            9999999765

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=6e-11  Score=112.67  Aligned_cols=140  Identities=19%  Similarity=0.193  Sum_probs=100.8

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC--CceeEEeeeecCC---CeEEEEE
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDE---SKLYIFL  409 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~~~~~~---~~lyLVm  409 (504)
                      +.|+.|.++.||++...+|..+++|........    .....+.+|+.++..+.+  .++.+++.+....   +..|+||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            568999999999998877788999976432211    123457789999998875  3456677776654   3678999


Q ss_pred             EeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 010676          410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD------------------------------------------  447 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs------------------------------------------  447 (504)
                      ||++|.+|...+....++......++.+++..|.+||+                                          
T Consensus        80 e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          80 ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99999877654422334555555566666666666652                                          


Q ss_pred             --------------CCceecCCCCCcEEEcC--CCcEEEEecCcccc
Q 010676          448 --------------QDVVHRDIKCANILVDA--NGSVKLADFGLAKA  478 (504)
Q Consensus       448 --------------~gIIHRDLKP~NILLd~--~g~VKL~DFGLA~~  478 (504)
                                    ..++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          24699999999999998  66789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=1.6e-12  Score=144.45  Aligned_cols=170  Identities=30%  Similarity=0.423  Sum_probs=138.4

Q ss_pred             cceeeeeeecccCceeEEEEEcc--CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCeE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKL  405 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~--~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~l  405 (504)
                      ..|.+.+.||+|.|+.|-.....  ....+|+|.+....   .......+...|..+-+.+. |.|++.+++.....+..
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            35777788999999999988773  44566666554432   22233445566888888887 99999999999999999


Q ss_pred             EEEEEeccCCCHHHHH-Hhc--CCChHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEcCCC-cEEEEecCcccccc
Q 010676          406 YIFLELVTKGSLLNLY-QRY--HLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANG-SVKLADFGLAKATK  480 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll-~~~--~l~e~~v~~i~~QIl~gL~yLH-s~gIIHRDLKP~NILLd~~g-~VKL~DFGLA~~~~  480 (504)
                      +++++|..|+++...+ ...  .++......++.|+..+|.|+| ..++.|+||||+|.+++..+ .+++.|||+|..+.
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999998877 433  5777888999999999999999 99999999999999999999 99999999998765


Q ss_pred             c-CC----cccccC-CCcccccccccC
Q 010676          481 L-ND----VKSCRG-TAFWMAPEVCSN  501 (504)
Q Consensus       481 ~-~~----~~s~~G-T~~YmAPEVL~g  501 (504)
                      . +.    ....+| ++.|+|||++.+
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~  203 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSG  203 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccc
Confidence            4 32    234468 999999999877

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=1.7e-10  Score=110.15  Aligned_cols=137  Identities=20%  Similarity=0.234  Sum_probs=100.6

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccc---cchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEe
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLD---QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~---~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy  411 (504)
                      .++++|.=+.+|.+.+. |..+++|.-....   .....+-...+..+|..++.++.--.|..-+-++.+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45789999999998664 3345666432211   1112233345677899999988755555444455566777899999


Q ss_pred             ccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          412 VTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       412 ~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ++|..|.+++...      ...++..+-.-+.-||..||+|+||.++||++...+ +.++||||+...
T Consensus        81 I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999999888765      245777888888889999999999999999996444 999999998754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.13  E-value=5e-10  Score=107.53  Aligned_cols=131  Identities=27%  Similarity=0.284  Sum_probs=88.7

Q ss_pred             eEEEEEccCCceEEEEEEeccc---------------------cchhhHHHHHHHHHHHHHHhhCCCC--ceeEEeeeec
Q 010676          344 SVYEGISDDGFFFAVKEVSLLD---------------------QGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDK  400 (504)
Q Consensus       344 ~VYka~~~~g~~vAVK~v~~~~---------------------~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~~~  400 (504)
                      .||.|...+|..+|+|+.....                     .............+|++.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999999999999875421                     1112233345677899999999865  566777553 


Q ss_pred             CCCeEEEEEEecc--CCCHHHHHHhcCCChHHHHHHHHHHHHHHHH-HHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          401 DESKLYIFLELVT--KGSLLNLYQRYHLRDSQVSAYTRQILLGLKY-LHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       401 ~~~~lyLVmEy~~--ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~y-LHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                         .-+|||||++  |..+..+. ...++......++.+++..+.. +|+.||||+||.+.|||++.+ .+.|+|||.+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~-~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav  154 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLK-DVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAV  154 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHH-HCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred             ---CCEEEEEecCCCccchhhHH-hccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcce
Confidence               2479999999  65554433 3333355667788888886655 579999999999999999877 99999999886


Q ss_pred             ccc
Q 010676          478 ATK  480 (504)
Q Consensus       478 ~~~  480 (504)
                      ...
T Consensus       155 ~~~  157 (188)
T PF01163_consen  155 DSS  157 (188)
T ss_dssp             ETT
T ss_pred             ecC
Confidence            544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.09  E-value=5.3e-11  Score=135.27  Aligned_cols=135  Identities=29%  Similarity=0.423  Sum_probs=94.0

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ....+|..+++|..|.||.||.+.++ +.+.+|+|+-+.   ..        +.+  ++|.....|++|           
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq---~l--------ilR--nilt~a~npfvv-----------  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---NL--------ILR--NILTFAGNPFVV-----------  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhccccc---ch--------hhh--ccccccCCccee-----------
Confidence            34468899999999999999999884 566778753221   00        000  033333455544           


Q ss_pred             EEEEEEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                                |+-..+++..+ ++.        +++.+++|||+.||+|||+||+|++|..-|++|++|||+.+......
T Consensus       136 ----------gDc~tllk~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----------GDCATLLKNIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----------chhhhhcccCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                      34444444322 322        23789999999999999999999999999999999999987532111


Q ss_pred             -----------------cccccCCCcccccccccCC
Q 010676          484 -----------------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -----------------~~s~~GT~~YmAPEVL~g~  502 (504)
                                       -+..|||+.|.||||+.-+
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq  233 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ  233 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhh
Confidence                             1235799999999998744

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.06  E-value=1.9e-09  Score=103.00  Aligned_cols=146  Identities=23%  Similarity=0.275  Sum_probs=104.1

Q ss_pred             eeeeecccCceeEEEEEccCCceEEEEEEeccc---cchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLD---QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       333 i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~---~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      .+.+|-+|.-+.|+++.+. |+.+.||.-....   .....+-...+..+|.++|.++.--.|.--.-+|.+...-+|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678899999999999775 6666777532211   11223344567789999999886545444434455555668899


Q ss_pred             EeccCC-CHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEEEecCccccc
Q 010676          410 ELVTKG-SLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKAT  479 (504)
Q Consensus       410 Ey~~gg-sL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g---~VKL~DFGLA~~~  479 (504)
                      ||++|. ++.+++...   ...+.....++++|-..|.-||.++|||+||..+||++..+|   .+.|+|||++...
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999883 566666432   233334478899999999999999999999999999997655   3589999997643

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.05  E-value=7e-11  Score=117.88  Aligned_cols=164  Identities=18%  Similarity=0.288  Sum_probs=124.8

Q ss_pred             ceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      ...+.-+|.+...|..|+|++.. ..++.|++.......   ..-..|..|+-.|+.+.||||+.+++.|.....+.++.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~---risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTA---RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhhhhhccCCCcccccccccC-cchhhhhhhhhhcch---hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            44455668888899999999864 445557665433221   12245778999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCcEEEE--ecCcccccccC
Q 010676          410 ELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLA--DFGLAKATKLN  482 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILLd~~g~VKL~--DFGLA~~~~~~  482 (504)
                      .|++.|+|+.++....   .+..++.+++..|+.|+.|||+..  |.---|....++||++-+.+|.  |--++-.   .
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq---e  343 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---E  343 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee---c
Confidence            9999999999998754   677889999999999999999875  4445788999999998877664  3222111   1


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .  ...-.|.||+||.|+.+
T Consensus       344 ~--gr~y~pawmspealqrk  361 (448)
T KOG0195|consen  344 V--GRAYSPAWMSPEALQRK  361 (448)
T ss_pred             c--ccccCcccCCHHHHhcC
Confidence            1  11246889999998765

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.00  E-value=1.8e-10  Score=123.34  Aligned_cols=97  Identities=28%  Similarity=0.457  Sum_probs=82.0

Q ss_pred             CeEEEEEEeccCCCHHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~~----l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      .++||.|++|...+|.+++.+..    .+....+.++.|+..+++|   ++.+|+|+||.||++..+..+||.||||...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            35899999999999999997543    4556788899999999999   9999999999999999999999999999765


Q ss_pred             cccCC--------cccccCCCcccccccccCC
Q 010676          479 TKLND--------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~--------~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....        ++..+||.+||+||.|.|.
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~  437 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ  437 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhh
Confidence            43322        3445699999999998864

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.96  E-value=1.1e-08  Score=103.29  Aligned_cols=141  Identities=12%  Similarity=0.074  Sum_probs=93.3

Q ss_pred             ecccCceeEEEEEccCCceEEEEEEeccccchhhHH------HHHHHHHHHHHHhhCCCCce--eEEeeeecC-----CC
Q 010676          337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQ------SISQLEQEIALLSRFEHENI--VQYYGTDKD-----ES  403 (504)
Q Consensus       337 LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~------~~~~~~~Ei~iL~~L~HpnI--V~l~~~~~~-----~~  403 (504)
                      +-.-....|+++.. +|+.|.||...........+.      ....+.+|+..+..|..-+|  +.++.++..     ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            33333344555533 566788886532111000000      01136688888877743222  233333322     23


Q ss_pred             eEEEEEEeccCC-CHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-------CCcEEEEe
Q 010676          404 KLYIFLELVTKG-SLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-------NGSVKLAD  472 (504)
Q Consensus       404 ~lyLVmEy~~gg-sL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~-------~g~VKL~D  472 (504)
                      .-+||||++++. +|.+++..   ..........++.+++..+.-||..||+|+|+++.||||+.       ++.+.|+|
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID  188 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID  188 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence            578999999986 79888864   23555677789999999999999999999999999999975       46899999


Q ss_pred             cCcccc
Q 010676          473 FGLAKA  478 (504)
Q Consensus       473 FGLA~~  478 (504)
                      |+.+..
T Consensus       189 l~r~~~  194 (268)
T PRK15123        189 LHRAQI  194 (268)
T ss_pred             CCcccc
Confidence            998753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.90  E-value=8.5e-09  Score=103.70  Aligned_cols=141  Identities=25%  Similarity=0.257  Sum_probs=107.7

Q ss_pred             eeeeeeecccCceeEEEEEccCCceEEEEEEecc-----------------ccchhhHHHHHHHHHHHHHHhhCCCC--c
Q 010676          331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL-----------------DQGSQAKQSISQLEQEIALLSRFEHE--N  391 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~-----------------~~~~~~~~~~~~~~~Ei~iL~~L~Hp--n  391 (504)
                      +.++..||-|-=+.||.|.+..|..++||.-..-                 ....+........++|+..|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            5678899999999999999999999999963221                 11122233344567899999998755  6


Q ss_pred             eeEEeeeecCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEE
Q 010676          392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  471 (504)
Q Consensus       392 IV~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~  471 (504)
                      +.+.+++    +...+||||++|-.|...-    ++......++..|+.-+..+-..||||+|+.+-|||++.+|.+.++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vI  244 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVI  244 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEE
Confidence            7777654    5678999999996665432    2345566677778877777779999999999999999999999999


Q ss_pred             ecCccccc
Q 010676          472 DFGLAKAT  479 (504)
Q Consensus       472 DFGLA~~~  479 (504)
                      ||--+...
T Consensus       245 DwPQ~v~~  252 (304)
T COG0478         245 DWPQAVPI  252 (304)
T ss_pred             eCcccccC
Confidence            99876543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.89  E-value=9.6e-10  Score=119.17  Aligned_cols=169  Identities=27%  Similarity=0.321  Sum_probs=131.8

Q ss_pred             ceeeeeeecc--cCceeEEEEEc---cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCC
Q 010676          330 YWQKGDLLGR--GSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  403 (504)
Q Consensus       330 ~y~i~k~LG~--G~FG~VYka~~---~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~  403 (504)
                      .|.+.+.+|.  |.+|.||.+..   .++..+|+|.-+.......   .-..-.+|+...++++ |+|.++.+..+...+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~---~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL---DSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc---ccccccchhhcccccCccccccccCcccccCC
Confidence            4566777999  99999999876   5788899986432221111   1112236676677775 999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHH----HHHHHHHCCceecCCCCCcEEEcCC-CcEEEEecCcc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILL----GLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLA  476 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~----gL~yLHs~gIIHRDLKP~NILLd~~-g~VKL~DFGLA  476 (504)
                      .+|+-+|++. .+|..+....  .+.+..++.++.+...    ||.++|..+|+|-|+||.||++..+ ...+++|||+.
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence            9999999997 5777766542  3788889999999999    9999999999999999999999999 88999999998


Q ss_pred             cccccCCccc-------ccCCCcccccccccCC
Q 010676          477 KATKLNDVKS-------CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       477 ~~~~~~~~~s-------~~GT~~YmAPEVL~g~  502 (504)
                      ..+.......       ..|...|++||++++-
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l  303 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL  303 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccc
Confidence            8766554221       1367779999998864

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.87  E-value=2e-09  Score=116.24  Aligned_cols=119  Identities=29%  Similarity=0.548  Sum_probs=98.6

Q ss_pred             HhhCCCCceeEEeeeecCCCeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCc-eecCCCCCcE
Q 010676          384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDV-VHRDIKCANI  460 (504)
Q Consensus       384 L~~L~HpnIV~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gI-IHRDLKP~NI  460 (504)
                      |+.+.|.|+.++++.+.....+++|.+||..|+|.+++...  .+++.-...+++.|+.||.|||...| .|+.|+..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            45688999999999999999999999999999999998764  36666677788999999999998776 9999999999


Q ss_pred             EEcCCCcEEEEecCccccccc----CCcccccCCCcccccccccCC
Q 010676          461 LVDANGSVKLADFGLAKATKL----NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       461 LLd~~g~VKL~DFGLA~~~~~----~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      +++....+||.|||+......    .......-...|.|||++.+.
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~  126 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA  126 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence            999999999999999765532    111122234569999999863

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.82  E-value=2.2e-08  Score=110.21  Aligned_cols=119  Identities=24%  Similarity=0.350  Sum_probs=98.4

Q ss_pred             cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccCCCHHHHHHhcCCChHH
Q 010676          351 DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ  430 (504)
Q Consensus       351 ~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~  430 (504)
                      .++.++.|..++....     .......+-++.|+.++||||++|++.++....+|||+|-+.  -|..++++.+  ...
T Consensus        35 ~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~--~~~  105 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG--KEE  105 (690)
T ss_pred             ccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--HHH
Confidence            5677888887764332     223445677888999999999999999999999999999985  4666776543  667


Q ss_pred             HHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          431 VSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       431 v~~i~~QIl~gL~yLH-s~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      +..-+.||+.||.||| +.+++|++|.-+.|+|+..|..||++|-++..
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~  154 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSK  154 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEec
Confidence            7788999999999997 67899999999999999999999999988753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=2.9e-08  Score=95.98  Aligned_cols=106  Identities=24%  Similarity=0.296  Sum_probs=80.5

Q ss_pred             HHHHHHHHHHhhCCCCc--eeEEeeeecCC----CeEEEEEEeccCC-CHHHHHHh-cCCChHHHHHHHHHHHHHHHHHH
Q 010676          375 SQLEQEIALLSRFEHEN--IVQYYGTDKDE----SKLYIFLELVTKG-SLLNLYQR-YHLRDSQVSAYTRQILLGLKYLH  446 (504)
Q Consensus       375 ~~~~~Ei~iL~~L~Hpn--IV~l~~~~~~~----~~lyLVmEy~~gg-sL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLH  446 (504)
                      .+..+|+..+..|..-.  .+..+.+....    ...+||||++++. +|.+++.. ...+......++.++...+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            45667877776664322  33334443331    3458999999885 78888876 23566677889999999999999


Q ss_pred             HCCceecCCCCCcEEEcCCC---cEEEEecCcccccc
Q 010676          447 DQDVVHRDIKCANILVDANG---SVKLADFGLAKATK  480 (504)
Q Consensus       447 s~gIIHRDLKP~NILLd~~g---~VKL~DFGLA~~~~  480 (504)
                      .+||+|+|+++.|||++.++   .+.|+||+-++...
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            99999999999999999887   89999999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.80  E-value=6.1e-09  Score=113.02  Aligned_cols=152  Identities=25%  Similarity=0.200  Sum_probs=120.0

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc--cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeec
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDK  400 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~--~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~  400 (504)
                      ......+|..+..||.|.|+.||....  .++..|++|.+.......  ...+. -..|+.+...+. |.++++++..|.
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~--~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~  336 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF--ASDIF-SLGEVILEAILGSHLPSVGKNSSWS  336 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch--Hhhhc-chhhhhHhhHhhcccccCCCCCCcc
Confidence            445667899999999999999998764  578899999765433222  11122 235666666654 999999999998


Q ss_pred             CCCeEEEEEEeccCCCHHHHHH-hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEecCcccc
Q 010676          401 DESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKA  478 (504)
Q Consensus       401 ~~~~lyLVmEy~~ggsL~~ll~-~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~-g~VKL~DFGLA~~  478 (504)
                      ...+.|+-.|||.++++..... ...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||....
T Consensus       337 ~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  337 QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence            8899999999999988765442 2347778889999999999999999999999999999999886 7789999998754

>PRK09902 hypothetical protein; Provisional

Probab=98.62  E-value=2.8e-07  Score=90.16  Aligned_cols=141  Identities=16%  Similarity=0.153  Sum_probs=98.0

Q ss_pred             ecccCceeEEEEEccCCceEEEEEEeccccchhh-HHHHHHHHHHHHHHhhCCCCc--eeEEeeeecC----CCeEEEEE
Q 010676          337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFEHEN--IVQYYGTDKD----ESKLYIFL  409 (504)
Q Consensus       337 LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~-~~~~~~~~~Ei~iL~~L~Hpn--IV~l~~~~~~----~~~lyLVm  409 (504)
                      -|+||-+.|+....... .|-+|.-......... ......|.+|+..|..|..-+  +.+.......    .-.-+||+
T Consensus        26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            36788899998655433 5777754311111100 113356889999988875322  4444422111    23468999


Q ss_pred             EeccC-CCHHHHHHhcCC---ChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc--EEEEecCcccc
Q 010676          410 ELVTK-GSLLNLYQRYHL---RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKA  478 (504)
Q Consensus       410 Ey~~g-gsL~~ll~~~~l---~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~--VKL~DFGLA~~  478 (504)
                      |-+.+ -+|.+++....+   +......++.++...|.-||..|+.|+|+.+.|||++.+|.  |+++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 488888876544   56666789999999999999999999999999999987777  99999986653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.61  E-value=1.1e-07  Score=104.24  Aligned_cols=144  Identities=17%  Similarity=0.203  Sum_probs=91.7

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEecccc----------------------c---hh----hHHHHHH------HHH
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ----------------------G---SQ----AKQSISQ------LEQ  379 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~----------------------~---~~----~~~~~~~------~~~  379 (504)
                      +.|+.++-|.||+|+..+|+.||||+....-.                      .   ..    ..+..+.      +.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            56899999999999999999999998542110                      0   00    0011111      233


Q ss_pred             HHHHHhhCC-----CCceeEEeeeecCCCeEEEEEEeccCCCHHHH--HHhcCCChHHHHHHHHHHHHHHHHHHHCCcee
Q 010676          380 EIALLSRFE-----HENIVQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH  452 (504)
Q Consensus       380 Ei~iL~~L~-----HpnIV~l~~~~~~~~~lyLVmEy~~ggsL~~l--l~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIH  452 (504)
                      |...+.++.     .++|.--.=++.-...-.|+|||++|..+.++  ++..+++...+.....+++-  ..+-..|++|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~--~q~~~dgffH  288 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL--RQLLRDGFFH  288 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--HHHHhcCccc
Confidence            444443332     23322111122333456899999999988876  55666775444333332222  2233479999


Q ss_pred             cCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          453 RDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       453 RDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      .|.+|.||+++.+|++.+.|||+...+.
T Consensus       289 aDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         289 ADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             cCCCccceEEecCCcEEEEcCcceecCC
Confidence            9999999999999999999999976554

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.61  E-value=4.4e-07  Score=90.56  Aligned_cols=140  Identities=19%  Similarity=0.197  Sum_probs=98.6

Q ss_pred             eecccCceeEEEEEccCCceEEEEEEeccccch-------------------hhHHHHHHHHHHHHHHhhCC--CCceeE
Q 010676          336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS-------------------QAKQSISQLEQEIALLSRFE--HENIVQ  394 (504)
Q Consensus       336 ~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~-------------------~~~~~~~~~~~Ei~iL~~L~--HpnIV~  394 (504)
                      .|..|--+.||+|...++..+|+|+++......                   .........+.|+..|.++.  +=.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            567777789999999899999999986532211                   11122233456787777764  333444


Q ss_pred             EeeeecCCCeEEEEEEeccCCCH-HHHHHhcCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEe
Q 010676          395 YYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       395 l~~~~~~~~~lyLVmEy~~ggsL-~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                      -+.+..    -.|||||+....+ .-.|+.-.+....+..+..+++..+.-|-. .++||+||+.-|||+. ++.+.|||
T Consensus       135 Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID  209 (268)
T COG1718         135 PIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIID  209 (268)
T ss_pred             ceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEE
Confidence            444432    3799999976421 112333334444678888999999998877 8999999999999998 99999999


Q ss_pred             cCcccccc
Q 010676          473 FGLAKATK  480 (504)
Q Consensus       473 FGLA~~~~  480 (504)
                      ||-|....
T Consensus       210 ~~QaV~~~  217 (268)
T COG1718         210 VSQAVTID  217 (268)
T ss_pred             CccccccC
Confidence            99887554

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.53  E-value=6.5e-07  Score=96.54  Aligned_cols=135  Identities=16%  Similarity=0.258  Sum_probs=105.3

Q ss_pred             eeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC----CCeEEEEEEeccCC-C
Q 010676          343 GSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKLYIFLELVTKG-S  416 (504)
Q Consensus       343 G~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~----~~~lyLVmEy~~gg-s  416 (504)
                      .+.|+++. .+|..|++|++.........     ....-+++++++.|.|||.+.++|.+    +..+++|++|.++. +
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-----k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTN-----KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcc-----cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            57899987 79999999988432222211     12345788999999999999988863    45699999999864 6


Q ss_pred             HHHHHH----------------hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          417 LLNLYQ----------------RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       417 L~~ll~----------------~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      |.+++-                ..+.++..++.|+.|+..||.++|+.|+..+-|.+.+||++.+.+++|...|+...+.
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            766542                1236778899999999999999999999999999999999988889998877765554


Q ss_pred             cC
Q 010676          481 LN  482 (504)
Q Consensus       481 ~~  482 (504)
                      .+
T Consensus       445 ~d  446 (655)
T KOG3741|consen  445 ED  446 (655)
T ss_pred             CC
Confidence            43

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=1.3e-06  Score=95.91  Aligned_cols=142  Identities=16%  Similarity=0.125  Sum_probs=92.4

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccccch--------------------------hhHHHHHH------HHHHHH
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS--------------------------QAKQSISQ------LEQEIA  382 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~--------------------------~~~~~~~~------~~~Ei~  382 (504)
                      +.||.-+.|.||+|+..+|..||||+-+..-...                          ...+..+.      |.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            4589999999999999999999999853211100                          00011111      223332


Q ss_pred             HH----hhCCCCc------eeEEeeeecCCCeEEEEEEeccCCCHHH--HHHhcCCChHHHHHHHHHHHHHHHHHHHCCc
Q 010676          383 LL----SRFEHEN------IVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV  450 (504)
Q Consensus       383 iL----~~L~Hpn------IV~l~~~~~~~~~lyLVmEy~~ggsL~~--ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gI  450 (504)
                      ..    +.+.|-+      |.++|..+.  ..-.|+||||+|..+.+  .+.+.+++...+...+.++..-+-  =..|+
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qI--f~~Gf  322 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQI--FKTGF  322 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHH--HhcCC
Confidence            22    2233444      455554443  34689999999986654  567778887765554444443332  24689


Q ss_pred             eecCCCCCcEEEcC----CCcEEEEecCcccccc
Q 010676          451 VHRDIKCANILVDA----NGSVKLADFGLAKATK  480 (504)
Q Consensus       451 IHRDLKP~NILLd~----~g~VKL~DFGLA~~~~  480 (504)
                      +|+|-+|.||++..    ++.+.|.|||+...+.
T Consensus       323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            99999999999984    5689999999987554

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.39  E-value=4.5e-06  Score=82.27  Aligned_cols=139  Identities=17%  Similarity=0.203  Sum_probs=85.0

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHH------HHHHHHHHhhCCCC---ceeEEe---
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQ------LEQEIALLSRFEHE---NIVQYY---  396 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~------~~~Ei~iL~~L~Hp---nIV~l~---  396 (504)
                      .+|.+.+++-.....-|.+.. .+|..+.+|.......  ........      ..+++..+..++..   .+..++   
T Consensus        31 ~~~~~~kv~k~~~r~~ValIe-i~~~kyIlK~pr~~~~--r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIE-IDGKKYILKEPREENR--RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             CCceEEEeecCCCccEEEEEE-ECCcEEEEeccchhhh--hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            456667777666655555543 4567888887643221  11111221      22344444333221   222221   


Q ss_pred             --eeecCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecC
Q 010676          397 --GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (504)
Q Consensus       397 --~~~~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFG  474 (504)
                        -.+.-....+|+|||++|..|.++..   +.+    .+...|...|.-||+.|++|+|++|.|++++.++ ++++||+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~  179 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ  179 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence              22333345679999999987766532   222    2445677889999999999999999999998544 9999998


Q ss_pred             cccc
Q 010676          475 LAKA  478 (504)
Q Consensus       475 LA~~  478 (504)
                      ..+.
T Consensus       180 ~k~~  183 (229)
T PF06176_consen  180 GKRM  183 (229)
T ss_pred             cccc
Confidence            7543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.37  E-value=4.4e-06  Score=79.32  Aligned_cols=137  Identities=21%  Similarity=0.267  Sum_probs=79.4

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC--ceeEEeeee---cCCCeEEEE
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTD---KDESKLYIF  408 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~~---~~~~~lyLV  408 (504)
                      ++.|+.|..+.||++...+ ..+++|.....       .....+.+|..+++.+...  .+.+++.+.   ......+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH-------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence            4679999999999999877 58888976421       2335566788777776522  345565533   233457999


Q ss_pred             EEeccCCCHHH----------------HHH---hc--C---CChHH---------HHHH------------HHHHHH-HH
Q 010676          409 LELVTKGSLLN----------------LYQ---RY--H---LRDSQ---------VSAY------------TRQILL-GL  442 (504)
Q Consensus       409 mEy~~ggsL~~----------------ll~---~~--~---l~e~~---------v~~i------------~~QIl~-gL  442 (504)
                      |++++|..+..                .+.   ..  .   +....         ....            ...+.. .+
T Consensus        74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (239)
T PF01636_consen   74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL  153 (239)
T ss_dssp             EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred             EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence            99999987766                111   11  0   00000         0000            011122 23


Q ss_pred             HHHH-------HCCceecCCCCCcEEEc-CCCcEEEEecCcccc
Q 010676          443 KYLH-------DQDVVHRDIKCANILVD-ANGSVKLADFGLAKA  478 (504)
Q Consensus       443 ~yLH-------s~gIIHRDLKP~NILLd-~~g~VKL~DFGLA~~  478 (504)
                      ..++       ...++|+|+.+.|||++ .++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            3333       23599999999999999 667778999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.37  E-value=3.4e-07  Score=94.04  Aligned_cols=93  Identities=27%  Similarity=0.492  Sum_probs=78.9

Q ss_pred             HHHHHHhhCCCCceeEEeeeecCC-----CeEEEEEEeccCCCHHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHHC
Q 010676          379 QEIALLSRFEHENIVQYYGTDKDE-----SKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ  448 (504)
Q Consensus       379 ~Ei~iL~~L~HpnIV~l~~~~~~~-----~~lyLVmEy~~ggsL~~ll~~~-----~l~e~~v~~i~~QIl~gL~yLHs~  448 (504)
                      .-+..|-++-|-|||+++.|+.+.     ....+++||+..|+|.+++++.     .+......+|+.||++||.|||+.
T Consensus       116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            345556667799999999887554     3478999999999999998754     377788899999999999999987


Q ss_pred             C--ceecCCCCCcEEEcCCCcEEEE
Q 010676          449 D--VVHRDIKCANILVDANGSVKLA  471 (504)
Q Consensus       449 g--IIHRDLKP~NILLd~~g~VKL~  471 (504)
                      .  |+|+++.++.|++..+|-+||.
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             CCccccCCcchhheeecCCceEEec
Confidence            4  9999999999999999998875

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.29  E-value=7.4e-06  Score=80.67  Aligned_cols=133  Identities=12%  Similarity=0.123  Sum_probs=81.0

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc--eeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~~~~~~~~~lyLVmEy~  412 (504)
                      .+||+|..+.||+.   .+..+++|......       ....+.+|.+++..+..-.  +.+.+.+....+.+++|||++
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i   76 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI   76 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence            46899999999984   24467788664211       1133578888888876333  466777777777789999999


Q ss_pred             cCCC-HHHHH---------------------Hhc---CCChHH-HHHHHHH----------HHHH-HHHHHH----CCce
Q 010676          413 TKGS-LLNLY---------------------QRY---HLRDSQ-VSAYTRQ----------ILLG-LKYLHD----QDVV  451 (504)
Q Consensus       413 ~ggs-L~~ll---------------------~~~---~l~e~~-v~~i~~Q----------Il~g-L~yLHs----~gII  451 (504)
                      +|.. +...+                     ..-   ...... ...+..+          +... ..+|..    ..++
T Consensus        77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            9963 21111                     000   001000 0111111          1111 122221    2478


Q ss_pred             ecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          452 HRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       452 HRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      |+|++|.||+++.++ +.|+||+.+..
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.28  E-value=7.2e-06  Score=80.39  Aligned_cols=132  Identities=18%  Similarity=0.149  Sum_probs=79.9

Q ss_pred             ecccCc-eeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCeEEEEEEeccC
Q 010676          337 LGRGSF-GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTK  414 (504)
Q Consensus       337 LG~G~F-G~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~lyLVmEy~~g  414 (504)
                      |-.|.. ..||+.... +..+.+|+.....        ...+.+|+.+++.+. +--+.++++++...+..++||++++|
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            444555 788998764 4677888654221        124567888777764 34466777777766778999999999


Q ss_pred             CCHHHHH----------------Hhc-CCCh-----H-HHHHHHHH-----------------------HHHHHHHHH--
Q 010676          415 GSLLNLY----------------QRY-HLRD-----S-QVSAYTRQ-----------------------ILLGLKYLH--  446 (504)
Q Consensus       415 gsL~~ll----------------~~~-~l~e-----~-~v~~i~~Q-----------------------Il~gL~yLH--  446 (504)
                      ..|....                ..- .++.     . .......+                       +...+..|-  
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            8775431                000 0100     0 00000000                       111112221  


Q ss_pred             -----HCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          447 -----DQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       447 -----s~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                           ...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                 1248999999999999988778899999875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.21  E-value=3.6e-07  Score=104.71  Aligned_cols=151  Identities=17%  Similarity=0.181  Sum_probs=116.4

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      |+.-.+.+.+.+.+-+|.|+.++.+.- ..|...+.|...+...  .....++....+-.++....+|.++.....+...
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~--i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPK--IRTNDYESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchh--hccccccccCCccCccccCCCCceecccCCCCCC
Confidence            566678899999999999999998876 4565566665432211  1111223333444455555678888887777778


Q ss_pred             CeEEEEEEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                      ..++++++|+.+++|...++.-+ .+.+-...+...++.+++|||...++|+|++|.|+|+..+|+.++.|||+.
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTL  951 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccc
Confidence            88999999999999999888766 666667778889999999999999999999999999999999999999843

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.12  E-value=4.7e-05  Score=73.92  Aligned_cols=137  Identities=21%  Similarity=0.322  Sum_probs=94.6

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccccch-----------hhHHHHHHHHHHHHHHhhCC------CCceeEEee
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS-----------QAKQSISQLEQEIALLSRFE------HENIVQYYG  397 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~-----------~~~~~~~~~~~Ei~iL~~L~------HpnIV~l~~  397 (504)
                      .+||+|+.-.||.-  .+....+||+........           .......+..+|+.....+.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            56999999999964  445566788775433000           00111234455555554444      789999999


Q ss_pred             eecCCCeEEEEEEeccCC------CHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----c
Q 010676          398 TDKDESKLYIFLELVTKG------SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----S  467 (504)
Q Consensus       398 ~~~~~~~lyLVmEy~~gg------sL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g----~  467 (504)
                      +.+++-.+-+|+|.+...      +|.+++....++. .+.   ..+-.-..||-.++|+.+||+|.||++..+.    .
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~  160 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFR  160 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceE
Confidence            999999999999988532      6888988877776 333   3344445678889999999999999996432    5


Q ss_pred             EEEEe-cCccc
Q 010676          468 VKLAD-FGLAK  477 (504)
Q Consensus       468 VKL~D-FGLA~  477 (504)
                      +.|+| ||-..
T Consensus       161 lvlIDG~G~~~  171 (199)
T PF10707_consen  161 LVLIDGLGEKE  171 (199)
T ss_pred             EEEEeCCCCcc
Confidence            77887 66543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.96  E-value=3.3e-05  Score=73.82  Aligned_cols=129  Identities=20%  Similarity=0.188  Sum_probs=89.8

Q ss_pred             eeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eEEeeeecCCCeEEEEEE
Q 010676          332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       332 ~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~lyLVmE  410 (504)
                      +..+.|++|++|.||++.+..+ .+|+|+-....       ....++.|.++|..++-.++ .++|.+..+    ++.||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds-------~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me   92 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDS-------PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME   92 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCc-eEEEEEecCCc-------chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence            4567899999999999988644 78888654221       23567889999998886554 455655443    45599


Q ss_pred             eccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCC-CCcEEEcCCCcEEEEecCcccc
Q 010676          411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK-CANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       411 y~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLK-P~NILLd~~g~VKL~DFGLA~~  478 (504)
                      |+.|-.|.......  ...+    ...++..---|-..||-|..|. |..++|..++.+.|+||.-|+.
T Consensus        93 ~i~G~~L~~~~~~~--~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIGG--DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhcc--cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            99998887765432  2222    3344444444667899999997 5555555666999999998874

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.95  E-value=2.8e-05  Score=74.67  Aligned_cols=95  Identities=25%  Similarity=0.213  Sum_probs=78.7

Q ss_pred             HHHHHHhhCCC-CceeEEeeeecCCCeEEEEEEeccCCCHHH----HHHhcCCChHHHHHHHHHHHHHHHHHHH---CCc
Q 010676          379 QEIALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLN----LYQRYHLRDSQVSAYTRQILLGLKYLHD---QDV  450 (504)
Q Consensus       379 ~Ei~iL~~L~H-pnIV~l~~~~~~~~~lyLVmEy~~ggsL~~----ll~~~~l~e~~v~~i~~QIl~gL~yLHs---~gI  450 (504)
                      .|..+++.+++ +++++++|+|..    ++|+||+..+++..    +.+-...++..+..|+.+++..+.+|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            58888888885 699999999843    67999999776642    2222346889999999999999999987   347


Q ss_pred             eecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          451 VHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       451 IHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      .-+|++++||.|+.+|++|++|...+.
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcc
Confidence            789999999999999999999998764

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=97.93  E-value=8.4e-05  Score=86.15  Aligned_cols=79  Identities=15%  Similarity=0.204  Sum_probs=53.8

Q ss_pred             eeeecccCceeEEEEEccCC---ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCce--eEEeeeecCC---Ce
Q 010676          334 GDLLGRGSFGSVYEGISDDG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENI--VQYYGTDKDE---SK  404 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g---~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI--V~l~~~~~~~---~~  404 (504)
                      .+.|+.|.+..+|+....++   ..+++|+.......    .....+.+|+.+|+.+. |.+|  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~----~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL----QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC----ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            46689999999999876543   35666654321110    11235779999999885 6654  7777776654   46


Q ss_pred             EEEEEEeccCCC
Q 010676          405 LYIFLELVTKGS  416 (504)
Q Consensus       405 lyLVmEy~~ggs  416 (504)
                      .|+||||++|..
T Consensus       119 ~flVME~v~G~~  130 (822)
T PLN02876        119 AFYIMEYLEGRI  130 (822)
T ss_pred             ceEEEEecCCcc
Confidence            789999999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.93  E-value=5.6e-05  Score=74.04  Aligned_cols=72  Identities=13%  Similarity=0.135  Sum_probs=43.3

Q ss_pred             eeecccCce-eEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC---ceeEEeeeecCC---CeEEE
Q 010676          335 DLLGRGSFG-SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE---NIVQYYGTDKDE---SKLYI  407 (504)
Q Consensus       335 k~LG~G~FG-~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIV~l~~~~~~~---~~lyL  407 (504)
                      +.|+.|+.. .||+.    +..+++|....   .    .....+.+|..+|..+...   -+.+++......   ...|+
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~---~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA---A----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc---c----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            467877776 48976    23466675331   1    1123577888888777521   344445444332   23588


Q ss_pred             EEEeccCCCH
Q 010676          408 FLELVTKGSL  417 (504)
Q Consensus       408 VmEy~~ggsL  417 (504)
                      +|++++|.++
T Consensus        72 l~~~i~G~~l   81 (235)
T cd05155          72 VYRWLEGETA   81 (235)
T ss_pred             EEEeecCCCC
Confidence            9999998765

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.92  E-value=7.8e-06  Score=84.57  Aligned_cols=138  Identities=17%  Similarity=0.218  Sum_probs=98.7

Q ss_pred             eeeeeeecccCceeEEEEEccCCceEEEEEEec-----------------cccchhhHHHHHHHHHHHHHHhhCC-CCc-
Q 010676          331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL-----------------LDQGSQAKQSISQLEQEIALLSRFE-HEN-  391 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~-----------------~~~~~~~~~~~~~~~~Ei~iL~~L~-Hpn-  391 (504)
                      +.++++||-|--+-||.+-+..|+.+++|.-.+                 .....+..-......+|+..|+.|. |-+ 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            567899999999999999999999999996322                 1111222222333457888888775 332 


Q ss_pred             eeEEeeeecCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEE
Q 010676          392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  471 (504)
Q Consensus       392 IV~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~  471 (504)
                      +.+.++    .+..++|||++.|..|.++-+   +  ..+..+...+..-|.-|..+|+||+|..-=||||+.++.+++|
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~---v--~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vI  244 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVRH---V--EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVI  244 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeeee---c--CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEe
Confidence            344444    356799999999977765432   1  1233455566666778899999999999999999999999999


Q ss_pred             ecCccc
Q 010676          472 DFGLAK  477 (504)
Q Consensus       472 DFGLA~  477 (504)
                      ||--+.
T Consensus       245 DFPQmv  250 (465)
T KOG2268|consen  245 DFPQMV  250 (465)
T ss_pred             echHhh
Confidence            997654

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.89  E-value=0.0003  Score=68.66  Aligned_cols=131  Identities=26%  Similarity=0.296  Sum_probs=90.5

Q ss_pred             ccceeeeeeecccCc-eeEEEEEccCCceEEEEEEeccc---c-------chhh------HHHHHHHHHHHHHHhhCC--
Q 010676          328 ITYWQKGDLLGRGSF-GSVYEGISDDGFFFAVKEVSLLD---Q-------GSQA------KQSISQLEQEIALLSRFE--  388 (504)
Q Consensus       328 ~~~y~i~k~LG~G~F-G~VYka~~~~g~~vAVK~v~~~~---~-------~~~~------~~~~~~~~~Ei~iL~~L~--  388 (504)
                      ...++.++.||.|.- |.||++... |..||+|.+....   .       ....      .....-|..|.+...+|+  
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            368999999999999 999999764 6699999932210   0       0000      022335667777766664  


Q ss_pred             -CCce--eEEeeeecCC------------------CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHH
Q 010676          389 -HENI--VQYYGTDKDE------------------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD  447 (504)
Q Consensus       389 -HpnI--V~l~~~~~~~------------------~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs  447 (504)
                       +.++  |++++|..-.                  ...-||.||++...        .+.    ..-+.+|++-|..+|+
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~----~~~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQ----IRDIPQMLRDLKILHK  182 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccc----hhHHHHHHHHHHHHHH
Confidence             5566  8888875211                  12457888877643        122    2235678888889999


Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          448 QDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       448 ~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                      .||+-+|+++.|..     ..+|+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc-----CCEEEecccC
Confidence            99999999999986     3589999864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.84  E-value=0.00012  Score=76.94  Aligned_cols=144  Identities=18%  Similarity=0.188  Sum_probs=99.1

Q ss_pred             eeeeecccCceeEEEEEccCCceEEEEEEecccc---------------------chhhHHHHHHHHHHHHHHhhCCCCc
Q 010676          333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ---------------------GSQAKQSISQLEQEIALLSRFEHEN  391 (504)
Q Consensus       333 i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~---------------------~~~~~~~~~~~~~Ei~iL~~L~Hpn  391 (504)
                      +-.+|..|--+.||.|...+|..+|||+++....                     ....+-..-..+.|++.|++|..-.
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            4456788888899999999999999999764211                     0111111233467888888876444


Q ss_pred             eeEEeeeecCCCeEEEEEEeccCCCHH-HHHHhcCCChHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEEcCCCcEE
Q 010676          392 IVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANILVDANGSVK  469 (504)
Q Consensus       392 IV~l~~~~~~~~~lyLVmEy~~ggsL~-~ll~~~~l~e~~v~~i~~QIl~gL~yL-Hs~gIIHRDLKP~NILLd~~g~VK  469 (504)
                      |..---+..  ....|||+|+...... -.++...++...+..+-.|++.-+.-| |.+++||.||.--|+|+ .+|.+.
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ly  304 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLY  304 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEE
Confidence            322111111  2347999999754332 245555677777777878888877776 57899999999999999 688999


Q ss_pred             EEecCccccc
Q 010676          470 LADFGLAKAT  479 (504)
Q Consensus       470 L~DFGLA~~~  479 (504)
                      |||.+-+...
T Consensus       305 iIDVSQSVE~  314 (520)
T KOG2270|consen  305 IIDVSQSVEH  314 (520)
T ss_pred             EEEccccccC
Confidence            9999976543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.69  E-value=1.1e-05  Score=89.07  Aligned_cols=162  Identities=24%  Similarity=0.222  Sum_probs=117.1

Q ss_pred             cccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc-eeEEeeeecCCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES  403 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~~~~~~  403 (504)
                      +...+.|...+-+++|+++.+|+.+....+....+.+...          ....-++++|.+++||| .+.+++-+..++
T Consensus       238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~  307 (829)
T KOG0576|consen  238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGED  307 (829)
T ss_pred             cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCccc
Confidence            3445566777789999999999998755555555555321          23345789999999999 778888888889


Q ss_pred             eEEEEEEeccCC-CHHHHH--HhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          404 KLYIFLELVTKG-SLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       404 ~lyLVmEy~~gg-sL~~ll--~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      ..+++|+++.++ +....+  ....+...+...+.+.-..+|++||+.-=+|+|    ||+.. ++.+++.||+....+.
T Consensus       308 ~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~  382 (829)
T KOG0576|consen  308 YLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLT  382 (829)
T ss_pred             ccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccC
Confidence            999999999887 222111  112244445566677788899999988778998    77764 4789999999876554


Q ss_pred             cCC-cccccCCCcccccccccC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g  501 (504)
                      ... .....+|+.+||||+..+
T Consensus       383 ~~~~~~t~~~~~~~~~pev~~~  404 (829)
T KOG0576|consen  383 RTMKPRTAIGTPEPLAPEVIQE  404 (829)
T ss_pred             cccccccCCCCCCCCCchhhcc
Confidence            432 345569999999997654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.58  E-value=0.00067  Score=65.91  Aligned_cols=74  Identities=12%  Similarity=0.067  Sum_probs=46.8

Q ss_pred             eeeecccCceeEEEEEccC--CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-CceeEEeeeecCCCeEEEEEE
Q 010676          334 GDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~--g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~~~~~~~lyLVmE  410 (504)
                      ++.|..|-...+|++...+  +..|++|+.......      .....+|+.++..+.. ...++++..+..    .++||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~------~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e   72 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL------IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYE   72 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc------eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEE
Confidence            3567778888999998764  678888865421111      1123467878877743 334555554432    47999


Q ss_pred             eccCCCH
Q 010676          411 LVTKGSL  417 (504)
Q Consensus       411 y~~ggsL  417 (504)
                      |++|..+
T Consensus        73 ~i~G~~l   79 (235)
T cd05157          73 FIPGRTL   79 (235)
T ss_pred             eeCCCcC
Confidence            9998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.49  E-value=0.0013  Score=67.39  Aligned_cols=76  Identities=13%  Similarity=0.109  Sum_probs=52.6

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC---CceeEEeeeecC---CCeEEE
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH---ENIVQYYGTDKD---ESKLYI  407 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIV~l~~~~~~---~~~lyL  407 (504)
                      .+.||.|..+.||.....+++ +.+|..+...       ....+..|...|+.+..   -.++++++++..   .+..||
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~-------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGN-PMPLMARSFS-------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             eeecCCccceeEEEEEcCCCC-EEEEEecccc-------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            467999999999998776664 5667543210       11356788888877752   357777776643   466899


Q ss_pred             EEEeccCCCH
Q 010676          408 FLELVTKGSL  417 (504)
Q Consensus       408 VmEy~~ggsL  417 (504)
                      |||+++|.++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998654

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.48  E-value=0.0017  Score=69.57  Aligned_cols=80  Identities=15%  Similarity=0.167  Sum_probs=52.5

Q ss_pred             eeecccCceeEEEEEccCC-ceEEEEEEecccc--chhhHHHHHHHHHHHHHHhhCC---CCceeEEeeeecCCCeEEEE
Q 010676          335 DLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g-~~vAVK~v~~~~~--~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~~~~~~~lyLV  408 (504)
                      +.||.|.+..||++...+| +.++||.......  .........+...|...|..+.   ..++++++.+..  ...++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence            5689999999999999776 5899997431111  0100122345556777776653   346777877744  457899


Q ss_pred             EEeccCCC
Q 010676          409 LELVTKGS  416 (504)
Q Consensus       409 mEy~~ggs  416 (504)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.39  E-value=0.0016  Score=66.45  Aligned_cols=137  Identities=18%  Similarity=0.159  Sum_probs=77.5

Q ss_pred             eeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC--ceeEEeeee------cCCCe
Q 010676          333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTD------KDESK  404 (504)
Q Consensus       333 i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~~------~~~~~  404 (504)
                      ..+.|+.|....+|+....+| .+++|+......       ...+..|+.++..|...  .+++++...      ...+.
T Consensus        26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~-------~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~   97 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK-------AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK   97 (307)
T ss_pred             eccccCCccccceEEEEeCCC-cEEEEEecCCCC-------HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence            356677787789999876555 567786643110       12233455555555321  234443321      22456


Q ss_pred             EEEEEEeccCCCHH-----H------HH---Hh--cCCC--------hHH---H--H----------HHHHHHHHHHHHH
Q 010676          405 LYIFLELVTKGSLL-----N------LY---QR--YHLR--------DSQ---V--S----------AYTRQILLGLKYL  445 (504)
Q Consensus       405 lyLVmEy~~ggsL~-----~------ll---~~--~~l~--------e~~---v--~----------~i~~QIl~gL~yL  445 (504)
                      .|++|+|++|..+.     .      .+   ..  .++.        ...   .  .          .....+...++++
T Consensus        98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l  177 (307)
T TIGR00938        98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL  177 (307)
T ss_pred             EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence            78999999985431     1      11   10  0110        000   0  0          0011122345555


Q ss_pred             HH-------CCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          446 HD-------QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       446 Hs-------~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      ..       .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            32       579999999999999988877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.36  E-value=0.00079  Score=66.70  Aligned_cols=131  Identities=18%  Similarity=0.239  Sum_probs=73.2

Q ss_pred             ecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eEEeeeecCCCeEEEEEEeccCC
Q 010676          337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELVTKG  415 (504)
Q Consensus       337 LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~lyLVmEy~~gg  415 (504)
                      +..|-...+|+.. .++..+++|.........    . ....+|..+++.+..-.+ .+++..+.    -++||||++|.
T Consensus         4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~----~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKAL----G-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             CCCcCcCCeEEEE-eCCccEEEeeCCcccccc----c-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence            4567778899886 456677788543211100    0 123577888877753322 34444432    26899999986


Q ss_pred             CHHH--------------HHHh---cC-----CCh-HHHHHHHHHH---------HHHHHHHHH--------CCceecCC
Q 010676          416 SLLN--------------LYQR---YH-----LRD-SQVSAYTRQI---------LLGLKYLHD--------QDVVHRDI  455 (504)
Q Consensus       416 sL~~--------------ll~~---~~-----l~e-~~v~~i~~QI---------l~gL~yLHs--------~gIIHRDL  455 (504)
                      .+..              .+.+   ..     +.. ..+..+..++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            5431              1111   11     111 1122222222         111222221        24899999


Q ss_pred             CCCcEEEcCCCcEEEEecCcccc
Q 010676          456 KCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       456 KP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      .|.|||++.++ +.|+||..|..
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCc
Confidence            99999999877 78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.21  E-value=0.0078  Score=61.44  Aligned_cols=30  Identities=27%  Similarity=0.411  Sum_probs=25.9

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          448 QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       448 ~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      .++||+|+++.|||++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            379999999999999866556899999875

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.18  E-value=0.0037  Score=62.95  Aligned_cols=135  Identities=15%  Similarity=0.120  Sum_probs=78.3

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC--ceeEEeee------ecCCCeE
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGT------DKDESKL  405 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~------~~~~~~l  405 (504)
                      .+.|..|....+|+....+ ..+++|+...  .   .   ...+..|+.++..+.+.  .+++++..      ....+..
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--V---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC--C---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            5567878778999986544 4688887642  1   1   12355666666666422  24444432      1234567


Q ss_pred             EEEEEeccCCCHHH----H-------H---Hh--cCCCh--------HHHHH------------HHHHHHHHHHHHHH--
Q 010676          406 YIFLELVTKGSLLN----L-------Y---QR--YHLRD--------SQVSA------------YTRQILLGLKYLHD--  447 (504)
Q Consensus       406 yLVmEy~~ggsL~~----l-------l---~~--~~l~e--------~~v~~------------i~~QIl~gL~yLHs--  447 (504)
                      +++++|++|..+..    .       +   ..  ..+..        .....            ....+...+.++..  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            89999999875421    1       1   00  00100        00000            01112233444443  


Q ss_pred             -----CCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          448 -----QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       448 -----~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                           .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                 469999999999999987777899999865

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.14  E-value=0.0028  Score=64.14  Aligned_cols=73  Identities=16%  Similarity=0.166  Sum_probs=44.5

Q ss_pred             eeecccCceeEEEEEccC-------CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc-eeEEeeeecCCCeEE
Q 010676          335 DLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESKLY  406 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~-------g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~~~~~~~ly  406 (504)
                      +.|..|-...||+....+       +..|++|+.......      .....+|+.++..+...+ ..++++++..    .
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~   73 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL------LIDRERELVVFARLSERNLGPKLYGIFPN----G   73 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc------eechHHHHHHHHHHHhCCCCCceEEEeCC----C
Confidence            446666667899887654       578888876432111      123457777777765322 3455555532    3


Q ss_pred             EEEEeccCCCH
Q 010676          407 IFLELVTKGSL  417 (504)
Q Consensus       407 LVmEy~~ggsL  417 (504)
                      +|++|++|..+
T Consensus        74 ~v~e~i~G~~l   84 (302)
T cd05156          74 RIEEFIPSRTL   84 (302)
T ss_pred             chhheeCCCcC
Confidence            58999988765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=96.95  E-value=0.0049  Score=65.99  Aligned_cols=159  Identities=18%  Similarity=0.154  Sum_probs=102.1

Q ss_pred             eeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEee------eecCCC-
Q 010676          332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG------TDKDES-  403 (504)
Q Consensus       332 ~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~------~~~~~~-  403 (504)
                      ..++.||+|+-+.+|-.-.- + ..+-|++.........        +-+..|... .||-+-.-+.      +..... 
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-~-d~VAKIYh~Pppa~~a--------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~   83 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-R-DQVAKIYHAPPPAAQA--------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK   83 (637)
T ss_pred             CCCccccCCccceeeecchh-h-chhheeecCCCchHHH--------HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence            34678999999999965331 1 1234655433222111        122334333 3554332111      122222 


Q ss_pred             eEEEEEEeccCC-CHHHHHHh------c-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCc
Q 010676          404 KLYIFLELVTKG-SLLNLYQR------Y-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (504)
Q Consensus       404 ~lyLVmEy~~gg-sL~~ll~~------~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGL  475 (504)
                      .+-++|..+.+. -...++..      + .+.+.-+++.++.++.+..-||..|.+-+|+.++|||+..++.|.|+|-..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            267888888765 23344421      1 267788899999999999999999999999999999999999999998654


Q ss_pred             cccccc-CCcccccCCCccccccccc
Q 010676          476 AKATKL-NDVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       476 A~~~~~-~~~~s~~GT~~YmAPEVL~  500 (504)
                      ...... ......+|...|.+||.=.
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~  189 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQT  189 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhc
Confidence            333222 2244556999999999755

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.89  E-value=0.0069  Score=61.50  Aligned_cols=30  Identities=33%  Similarity=0.495  Sum_probs=25.2

Q ss_pred             CceecCCCCCcEEEcCCCc-EEEEecCcccc
Q 010676          449 DVVHRDIKCANILVDANGS-VKLADFGLAKA  478 (504)
Q Consensus       449 gIIHRDLKP~NILLd~~g~-VKL~DFGLA~~  478 (504)
                      .++|+|+++.|||++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987565 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.54  E-value=0.012  Score=62.34  Aligned_cols=78  Identities=15%  Similarity=0.157  Sum_probs=47.0

Q ss_pred             eecccCceeEEEEEccCC-ceEEEEEEecccc--chhhHHHHHHHHHHHHHHhhCC--CC-ceeEEeeeecCCCeEEEEE
Q 010676          336 LLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFE--HE-NIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       336 ~LG~G~FG~VYka~~~~g-~~vAVK~v~~~~~--~~~~~~~~~~~~~Ei~iL~~L~--Hp-nIV~l~~~~~~~~~lyLVm  409 (504)
                      .||-|....||++.+.+| ..++||.-.....  .........+..-|...|+...  .| .++++|.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478999999999998654 5799997432111  1111222334445666665543  34 45566654  334457899


Q ss_pred             EeccCC
Q 010676          410 ELVTKG  415 (504)
Q Consensus       410 Ey~~gg  415 (504)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999654

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=96.52  E-value=0.0011  Score=74.14  Aligned_cols=65  Identities=31%  Similarity=0.411  Sum_probs=50.6

Q ss_pred             HHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCcccccccCC------c-----ccccCCCcccccccccC
Q 010676          437 QILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND------V-----KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       437 QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~------~-----~s~~GT~~YmAPEVL~g  501 (504)
                      ++..||.|+|. .++||+.|.|++|.++.+|.+||+.|+++.......      .     -...-...|.|||++.+
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34489999996 479999999999999999999999999976543311      1     11235677999999865

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.46  E-value=0.058  Score=54.47  Aligned_cols=29  Identities=28%  Similarity=0.468  Sum_probs=25.5

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          448 QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       448 ~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      .+++|+|+++.|||++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.42  E-value=0.039  Score=56.47  Aligned_cols=30  Identities=20%  Similarity=0.249  Sum_probs=27.5

Q ss_pred             CceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          449 DVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       449 gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      +++|+|+.+.|||++.++.+.|+||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999999999999998753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.28  E-value=0.061  Score=57.95  Aligned_cols=78  Identities=17%  Similarity=0.169  Sum_probs=48.0

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEecccc--chhhHHHHHHHHHHHHHHhhCC---CCceeEEeeeecCCCeEEEE
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~--~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .+.||.|....||+..+. +..++||.-.....  .........+-..|...|+.+.   ..+++++|.++.+  ..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence            466899999999998875 45688886531111  0000011223334455555443   3578888888774  45788


Q ss_pred             EEeccC
Q 010676          409 LELVTK  414 (504)
Q Consensus       409 mEy~~g  414 (504)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.19  E-value=0.028  Score=58.41  Aligned_cols=29  Identities=21%  Similarity=0.503  Sum_probs=25.2

Q ss_pred             ceecCCCCCcEEEcC-CCcEEEEecCcccc
Q 010676          450 VVHRDIKCANILVDA-NGSVKLADFGLAKA  478 (504)
Q Consensus       450 IIHRDLKP~NILLd~-~g~VKL~DFGLA~~  478 (504)
                      ++|.|+.+.|||++. ++.++|+||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            789999999999975 57899999998753

>PLN02236 choline kinase

Probab=96.17  E-value=0.049  Score=57.02  Aligned_cols=135  Identities=13%  Similarity=0.118  Sum_probs=75.8

Q ss_pred             eeeecccCceeEEEEEcc-----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eEEeeeecCCCeEEE
Q 010676          334 GDLLGRGSFGSVYEGISD-----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYI  407 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~-----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~lyL  407 (504)
                      ...|-.|-.-.+|++...     .+..|++|+......     ..+ .-.+|+.+++.+..-++ .++++.+...    .
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-----~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~  110 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-----LFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----R  110 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-----eee-chHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence            344555777889988642     236788886643211     111 12567777777753333 3556665432    5


Q ss_pred             EEEeccCCCHHH--------------HHHh---cCC-------ChHHHHHHHHHH-----------------HHHHHHH-
Q 010676          408 FLELVTKGSLLN--------------LYQR---YHL-------RDSQVSAYTRQI-----------------LLGLKYL-  445 (504)
Q Consensus       408 VmEy~~ggsL~~--------------ll~~---~~l-------~e~~v~~i~~QI-----------------l~gL~yL-  445 (504)
                      |++|+++.+|..              .+.+   ..+       ...++..+..++                 ...+..| 
T Consensus       111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            799998766531              1111   011       112233332221                 1111112 


Q ss_pred             ---H----HCCceecCCCCCcEEEcC-CCcEEEEecCcccc
Q 010676          446 ---H----DQDVVHRDIKCANILVDA-NGSVKLADFGLAKA  478 (504)
Q Consensus       446 ---H----s~gIIHRDLKP~NILLd~-~g~VKL~DFGLA~~  478 (504)
                         .    ...++|+|+++.|||++. ++.++|+||..+..
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence               1    225899999999999986 47899999998754

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.88  E-value=0.027  Score=60.42  Aligned_cols=80  Identities=16%  Similarity=0.156  Sum_probs=49.8

Q ss_pred             eeeecccCceeEEEEEccC-CceEEEEEEecccc-chhhHHHHHHHHHHHHHHhhCC--CC-ceeEEeeeecCCCeEEEE
Q 010676          334 GDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQ-GSQAKQSISQLEQEIALLSRFE--HE-NIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~-g~~vAVK~v~~~~~-~~~~~~~~~~~~~Ei~iL~~L~--Hp-nIV~l~~~~~~~~~lyLV  408 (504)
                      .+.||-|.-.-||++.+.+ +..++||.-..... .....-...+..-|...|+...  .| +++++|.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4568999999999999743 56789987432111 1111233445556667776553  34 56666655  34456789


Q ss_pred             EEeccCC
Q 010676          409 LELVTKG  415 (504)
Q Consensus       409 mEy~~gg  415 (504)
                      ||+++..
T Consensus       112 MEdL~~~  118 (409)
T PRK12396        112 MEDLSDH  118 (409)
T ss_pred             HHhCccc
Confidence            9998653

>PRK06148 hypothetical protein; Provisional

Probab=95.74  E-value=0.089  Score=62.81  Aligned_cols=31  Identities=45%  Similarity=0.622  Sum_probs=26.1

Q ss_pred             CCceecCCCCCcEEEcCCC--cEE-EEecCcccc
Q 010676          448 QDVVHRDIKCANILVDANG--SVK-LADFGLAKA  478 (504)
Q Consensus       448 ~gIIHRDLKP~NILLd~~g--~VK-L~DFGLA~~  478 (504)
                      +++||.|+.+.|||++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999998775  565 999998753

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.72  E-value=0.11  Score=54.30  Aligned_cols=30  Identities=27%  Similarity=0.457  Sum_probs=27.2

Q ss_pred             CceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          449 DVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       449 gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      .++|+|+++.||+|+.++-+-|+||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            489999999999999988899999998764

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.56  E-value=0.11  Score=53.34  Aligned_cols=74  Identities=18%  Similarity=0.184  Sum_probs=44.4

Q ss_pred             eeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC---CCCceeEEeeeecCCCeEEEEE
Q 010676          333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESKLYIFL  409 (504)
Q Consensus       333 i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~~~~~lyLVm  409 (504)
                      ..+.|+.|....+|+.. .++..+.||.-....        ...|..|..-|+.|   ..-.+++++.+....+.-||||
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~--------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSESG--------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG--------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecChhh--------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            35668889999999987 567788888665211        12355666666666   3456788888887777779999


Q ss_pred             EeccCC
Q 010676          410 ELVTKG  415 (504)
Q Consensus       410 Ey~~gg  415 (504)
                      ||++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.47  E-value=0.039  Score=58.55  Aligned_cols=74  Identities=23%  Similarity=0.353  Sum_probs=55.3

Q ss_pred             CCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          401 DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       401 ~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      +..+.|++|++- |+.|..+   ..-..+++..++++.+..+.-+.++ .+-|||+.-.||||+ +|+|.|+||-+++..
T Consensus       297 e~~y~yl~~kdh-gt~is~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISII---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             CceEEEEEEecC-Cceeeee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            345577778765 3333221   2245677888999888877766654 588999999999999 999999999999853

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.35  E-value=0.057  Score=54.41  Aligned_cols=29  Identities=41%  Similarity=0.578  Sum_probs=24.9

Q ss_pred             ceecCCCCCcEEEcCC--C---cEEEEecCcccc
Q 010676          450 VVHRDIKCANILVDAN--G---SVKLADFGLAKA  478 (504)
Q Consensus       450 IIHRDLKP~NILLd~~--g---~VKL~DFGLA~~  478 (504)
                      |+|+|++..|||+..+  |   .++++||-+++.
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~  250 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY  250 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeeccccccC
Confidence            8999999999999765  3   589999998764

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.17  E-value=0.5  Score=48.99  Aligned_cols=28  Identities=25%  Similarity=0.253  Sum_probs=24.0

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          448 QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       448 ~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      .++||+|+.+.|||++ + .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            3689999999999995 4 57899999875

>PTZ00384 choline kinase; Provisional

Probab=94.44  E-value=0.28  Score=52.31  Aligned_cols=79  Identities=15%  Similarity=0.203  Sum_probs=43.7

Q ss_pred             eeeecccCceeEEEEEccCC--ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc-eeEEeeeecCCCeEEEEEE
Q 010676          334 GDLLGRGSFGSVYEGISDDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g--~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~~~~~~~lyLVmE  410 (504)
                      .+.|..|-...+|++...++  ..+.+|.+.....+.. ....-.-.+|+.+++.+...+ -.++++.+..    +++.|
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            44565588889999875332  2332232111110111 111112346888888886544 4556666643    69999


Q ss_pred             eccCCCH
Q 010676          411 LVTKGSL  417 (504)
Q Consensus       411 y~~ggsL  417 (504)
                      |++|..|
T Consensus       130 fIeGr~l  136 (383)
T PTZ00384        130 WVEGNTM  136 (383)
T ss_pred             EeccccC
Confidence            9998765

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.19  E-value=0.27  Score=49.48  Aligned_cols=68  Identities=21%  Similarity=0.256  Sum_probs=44.6

Q ss_pred             eeEEEEEc--cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC---CCCceeEEeeeecCCCeEEEEEEeccCCCH
Q 010676          343 GSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESKLYIFLELVTKGSL  417 (504)
Q Consensus       343 G~VYka~~--~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~~~~~lyLVmEy~~ggsL  417 (504)
                      |.|..|..  .....|-+|+-.        ......|..|+.-|..|   +.-.+.+++.+....++.|+||||++-+.+
T Consensus        27 G~inea~~v~dg~~~~FvK~n~--------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKCNQ--------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccccceeEeecCCcceEEEecc--------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            44444433  234566677322        33345566776666555   345688899999999999999999988655


Q ss_pred             H
Q 010676          418 L  418 (504)
Q Consensus       418 ~  418 (504)
                      .
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            3

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=94.10  E-value=0.34  Score=57.83  Aligned_cols=163  Identities=21%  Similarity=0.234  Sum_probs=103.4

Q ss_pred             ecccCceeEEEEEccC-----CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe----EEE
Q 010676          337 LGRGSFGSVYEGISDD-----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK----LYI  407 (504)
Q Consensus       337 LG~G~FG~VYka~~~~-----g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~----lyL  407 (504)
                      |..-++|++|...+..     -..+-++.  ........+..+...+-|+..+.++.|+|++.++.|......    +.+
T Consensus       186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~--~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v  263 (1351)
T KOG1035|consen  186 LSHLTQGTLLLVKWVEQAQSLSEPIEISH--DYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDV  263 (1351)
T ss_pred             eccccCceEEEEehhhhHHhhcCcccccC--cccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHH
Confidence            6666778888776521     11111110  011112234445666778888999999999999988655433    234


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCC---cEEEcCCCcEEEE--ecCccccccc
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA---NILVDANGSVKLA--DFGLAKATKL  481 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~---NILLd~~g~VKL~--DFGLA~~~~~  481 (504)
                      ..+++...++..++..- .++...++.+..+++.||.|+|+..+.|.-|...   +..++..+.+.+.  ||+..+....
T Consensus       264 ~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d  343 (1351)
T KOG1035|consen  264 LQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD  343 (1351)
T ss_pred             HHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCC
Confidence            44777777887777654 4778888899999999999999996666655554   4455566677776  8887765544


Q ss_pred             CCcc-cccCCCcccccccccC
Q 010676          482 NDVK-SCRGTAFWMAPEVCSN  501 (504)
Q Consensus       482 ~~~~-s~~GT~~YmAPEVL~g  501 (504)
                      .... ...-+..|.++|.+..
T Consensus       344 ~~~~~~~~~~~~~~~~e~~~~  364 (1351)
T KOG1035|consen  344 NEKSFSDLLAEIRNADEDLKE  364 (1351)
T ss_pred             cccchhhcCcccccccccccc
Confidence            3322 1223444666666543

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.58  E-value=0.34  Score=48.61  Aligned_cols=84  Identities=23%  Similarity=0.265  Sum_probs=57.7

Q ss_pred             HHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHH--CCceec
Q 010676          376 QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD--QDVVHR  453 (504)
Q Consensus       376 ~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs--~gIIHR  453 (504)
                      -+.++..+++++.  .|+++..-  ....+-+++|+|-.-..            ....++..=+..|.-+|+  .+.+|+
T Consensus       104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~~N~i~agi~~L~~fH~~~~~~lHG  167 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NFSNFITAGIKDLMDFHSENQHCLHG  167 (308)
T ss_pred             hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------chhHHHHHhHHHHHHhhccCCCeecC
Confidence            3467788888753  67777632  44457789998853211            011222222556777884  469999


Q ss_pred             CCCCCcEEEcCCCcEEEEecCc
Q 010676          454 DIKCANILVDANGSVKLADFGL  475 (504)
Q Consensus       454 DLKP~NILLd~~g~VKL~DFGL  475 (504)
                      |-.|+|||-|..|.+||.|=+.
T Consensus       168 D~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  168 DCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             CCChhheeecCCCCEEecChhh
Confidence            9999999999999999999764

The function of this family is unknown.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=93.25  E-value=0.026  Score=68.49  Aligned_cols=124  Identities=18%  Similarity=0.067  Sum_probs=87.3

Q ss_pred             HHHHHHHHhhCCCCceeEEeeeec--CCCeEEEEEEeccCCCHHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC
Q 010676          377 LEQEIALLSRFEHENIVQYYGTDK--DESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQD  449 (504)
Q Consensus       377 ~~~Ei~iL~~L~HpnIV~l~~~~~--~~~~lyLVmEy~~ggsL~~ll~~~~-----l~e~~v~~i~~QIl~gL~yLHs~g  449 (504)
                      +..|...++...|+++...+.-..  +....|.+++|+.+|.+.+.+-++.     +...-+.....+.+....-+|.+.
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            344555666678999888766432  3345789999999999999875432     333444444445466666666532


Q ss_pred             -----ceecCCCCCcEEEcCCCcEEEEecCcccccccC--CcccccCCCccccccccc
Q 010676          450 -----VVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       450 -----IIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~s~~GT~~YmAPEVL~  500 (504)
                           .+|++||+-|.+|..+..+|+.++|+.+.....  ..+...+++.|+.|++.+
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N 1413 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN 1413 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH
Confidence                 689999999999999999999999999832211  234556888899988754

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=91.34  E-value=0.59  Score=50.60  Aligned_cols=60  Identities=17%  Similarity=0.166  Sum_probs=46.2

Q ss_pred             eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEEc
Q 010676          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANILVD  463 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yL-Hs~gIIHRDLKP~NILLd  463 (504)
                      ...|+=+|..|-++..+++....++.....++.-.+++|--+ --.|++|.|++|.||++.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            346677888998999999888777766667766666665443 346899999999999995

>PHA00451 protein kinase

Probab=91.09  E-value=0.34  Score=49.28  Aligned_cols=125  Identities=14%  Similarity=0.189  Sum_probs=71.4

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC--CCCceeEEeeeecCCCeEEEEEEec
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF--EHENIVQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIV~l~~~~~~~~~lyLVmEy~  412 (504)
                      ++||.|-|+..|.-..-.|+  +||+-.+.   .........       +.++  ..+.|..+|.+-....++.+|++++
T Consensus        71 ~~LGNGHFSAAy~H~lLPgr--VIKVGFKK---EDSGAAYtA-------FCRM~QGR~GIPnVY~VaRHaGCYTVVLD~L  138 (362)
T PHA00451         71 NLLGNGHFSAAYSHELLPGR--VIKVGFKK---EDSGAAYTA-------FCRMHQGRAGIPNVYHVARHAGCYTVVLDYL  138 (362)
T ss_pred             HHhcCcchhhHhhcccCCCe--eEEecccc---ccccHHHHH-------HHHHhcCCCCCccHHHHHHhcCceEEehhhc
Confidence            56999999999986554443  34432211   111222222       2233  2688899998888888999999987


Q ss_pred             cCC-----CHH-------HHHHhcCCChHHHHH---HHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 010676          413 TKG-----SLL-------NLYQRYHLRDSQVSA---YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       413 ~gg-----sL~-------~ll~~~~l~e~~v~~---i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                      ...     +..       .++.....+...-..   =|.+.+.-|.-+ =.||.--|.+..|||++.+|...|+|
T Consensus       139 ~~C~r~~nd~h~~ya~~a~~~~e~~~d~~~~~~~~~~FIETCk~IRkF-F~GIASFDmHSGNiMf~~~g~p~ITD  212 (362)
T PHA00451        139 NPCYRESNDVHHHYAAAAYIIIECCSDAAEEYPGSQEFIETCKMIRKF-FYGIASFDMHSGNIMFDQDGVPYITD  212 (362)
T ss_pred             cccccccchHHHHHHHHHHHHHhccCCHHhccCCchhHHHHHHHHHHH-HhhhhcccccCCceeeCCCCCeEecC
Confidence            532     111       122222111111110   111222211111 13777889999999999999999998

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=91.07  E-value=0.89  Score=45.90  Aligned_cols=75  Identities=23%  Similarity=0.171  Sum_probs=52.3

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHH---HHHhhCCCCceeEEeeeecCCCeEEEEEEe
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei---~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy  411 (504)
                      ..+..|..+.|+.++..+|...++|+......          +..|.   ..|+..+-...|++++....  .-.|+||.
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~----------~~~E~~g~~~L~~w~G~GaVrll~~d~~--~~AlLLEr   75 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE----------AEHEARGEAALRWWNGRGAVRLLAADPE--RGALLLER   75 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCccc----------chhhhhHHhHhheeCCCCceeeeccccc--cchhhhhh
Confidence            44667899999999999999999997753221          11232   45777777788999987533  45788898


Q ss_pred             c-cCCCHHHHH
Q 010676          412 V-TKGSLLNLY  421 (504)
Q Consensus       412 ~-~ggsL~~ll  421 (504)
                      + ++.+|.++.
T Consensus        76 l~~g~~L~~~~   86 (253)
T PF04655_consen   76 LDPGRSLASLP   86 (253)
T ss_pred             ccCCCchhhcc
Confidence            8 445665443

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	504
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-26
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-26
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-26
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-26
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-26
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-25
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-23
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-23
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-22
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-22
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-20
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-20
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-20
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-20
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-20
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-20
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-20
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-20
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-19
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-19
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-19
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-19
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-19
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-19
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-19
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-19
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-19
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-19
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-19
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-19
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-19
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-19
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-19
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-18
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-18
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-18
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-18
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-18
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-17
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-17
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-16
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-16
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-16
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-16
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-15
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-15
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-15
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-15
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-15
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-15
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-15
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-15
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-15
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-15
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-15
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-15
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-15
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-15
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-15
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-15
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-15
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-15
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-15
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-15
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-15
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-15
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-15
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-15
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-15
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-15
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-15
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-14
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-14
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-14
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-14
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-14
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-14
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-14
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-14
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-14
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-14
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-14
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-14
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-14
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-14
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-14
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-14
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-14
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-14
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-14
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-14
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-14
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-14
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-14
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-14
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-14
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-14
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-14
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-14
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-13
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-13
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-12
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-12
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-12
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-12
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-12
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-12
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-11
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-11
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-10
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-10
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-10
3soa_A	444	Full-Length Human Camkii Length = 444		2e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		9e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-07

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 68/168 (40%), Positives = 105/168 (62%), Gaps = 11/168 (6%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V++GI +      A+K + L     +A+  I  ++QEI +LS+ +   + +Y
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           YG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  +HRDI
Sbjct: 86  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 145
Query: 456 KCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVC 499
           K AN+L+  +G VKLADFG+  A +L D +  R    GT FWMAPEV 
Sbjct: 146 KAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVI 191

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 68/168 (40%), Positives = 105/168 (62%), Gaps = 11/168 (6%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V++GI +      A+K + L     +A+  I  ++QEI +LS+ +   + +Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           YG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  +HRDI
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 456 KCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVC 499
           K AN+L+  +G VKLADFG+  A +L D +  R    GT FWMAPEV 
Sbjct: 131 KAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVI 176

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 68/168 (40%), Positives = 105/168 (62%), Gaps = 11/168 (6%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V++GI +      A+K + L     +A+  I  ++QEI +LS+ +   + +Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           YG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  +HRDI
Sbjct: 71  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 456 KCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVC 499
           K AN+L+  +G VKLADFG+  A +L D +  R    GT FWMAPEV 
Sbjct: 131 KAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVI 176

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 68/168 (40%), Positives = 105/168 (62%), Gaps = 11/168 (6%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V++GI +      A+K + L     +A+  I  ++QEI +LS+ +   + +Y
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 90
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           YG+   ++KL+I +E +  GS L+L +   L ++Q++   R+IL GL YLH +  +HRDI
Sbjct: 91  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 150
Query: 456 KCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVC 499
           K AN+L+  +G VKLADFG+  A +L D +  R    GT FWMAPEV 
Sbjct: 151 KAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVI 196

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 70/173 (40%), Positives = 105/173 (60%), Gaps = 9/173 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           + K D +G+GSFG VY+GI  D     V  + ++D   +A+  I  ++QEI +LS+ +  
Sbjct: 21  FTKLDRIGKGSFGEVYKGI--DNHTKEVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 77
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
            I +Y+G+    +KL+I +E +  GS L+L +   L ++ ++   R+IL GL YLH +  
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK 137
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVC 499
           +HRDIK AN+L+   G VKLADFG+  A +L D +  R    GT FWMAPEV 
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVI 188

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 67/167 (40%), Positives = 101/167 (60%), Gaps = 9/167 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+GSFG V++GI  D     V  + ++D   +A+  I  ++QEI +LS+ +   + +YY
Sbjct: 31  IGKGSFGEVFKGI--DNRTQQVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
           G+    SKL+I +E +  GS L+L +     + Q++   ++IL GL YLH +  +HRDIK
Sbjct: 88  GSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 457 CANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVC 499
            AN+L+   G VKLADFG+  A +L D +  R    GT FWMAPEV 
Sbjct: 148 AANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVI 192

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 104/171 (60%), Gaps = 9/171 (5%)
Query: 337 LGRGSFG-SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG ++    ++DG  + +KE+++    S+ ++   +  +E+A+L+  +H NIVQY
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE---ESRREVAVLANMKHPNIVQY 88
Query: 396 YGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
             + ++   LYI ++    G L   +N  +    ++ Q+  +  QI L LK++HD+ ++H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 453 RDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVCSN 501
           RDIK  NI +  +G+V+L DFG+A+   + +   ++C GT ++++PE+C N
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 72/181 (39%), Positives = 107/181 (59%), Gaps = 19/181 (10%)
Query: 330 YWQKGD--LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           Y + GD  +LG+G++G VY G    +    A+KE+   D  S+  Q    L +EIAL   
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQP---LHEEIALHKH 75
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQ--VSAYTRQILLGL 442
            +H+NIVQY G+  +   + IF+E V  GSL  L +     L+D++  +  YT+QIL GL
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 443 KYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSC----RGTAFWMAPE 497
           KYLHD  +VHRDIK  N+L++  +G +K++DFG +K  +L  +  C     GT  +MAPE
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYMAPE 193
Query: 498 V 498
           +
Sbjct: 194 I 194

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/181 (39%), Positives = 107/181 (59%), Gaps = 19/181 (10%)
Query: 330 YWQKGD--LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           Y + GD  +LG+G++G VY G    +    A+KE+   D  S+  Q    L +EIAL   
Sbjct: 7   YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQP---LHEEIALHKH 61
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQ--VSAYTRQILLGL 442
            +H+NIVQY G+  +   + IF+E V  GSL  L +     L+D++  +  YT+QIL GL
Sbjct: 62  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 121
Query: 443 KYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSC----RGTAFWMAPE 497
           KYLHD  +VHRDIK  N+L++  +G +K++DFG +K  +L  +  C     GT  +MAPE
Sbjct: 122 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYMAPE 179
Query: 498 V 498
           +
Sbjct: 180 I 180

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 59/169 (34%), Positives = 99/169 (58%), Gaps = 16/169 (9%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG GS+GSVY+ I  + G   A+K+V +       +  + ++ +EI+++ + +  ++V+Y
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPV-------ESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           YG+    + L+I +E    GS+ ++ +  +  L + +++   +  L GL+YLH    +HR
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEV 498
           DIK  NIL++  G  KLADFG+  A +L D  + R    GT FWMAPEV
Sbjct: 150 DIKAGNILLNTEGHAKLADFGV--AGQLTDXMAKRNXVIGTPFWMAPEV 196

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/173 (34%), Positives = 94/173 (54%), Gaps = 8/173 (4%)
Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +W+    LG G+FG VY+  + +    A  +V      +++++ +     EI +L+  +H
Sbjct: 38  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDH 93
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+ L+I +E    G++  + L     L +SQ+    +Q L  L YLHD
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEV 498
             ++HRD+K  NIL   +G +KLADFG+ AK T+ +    S  GT +WMAPEV
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 206

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/173 (34%), Positives = 94/173 (54%), Gaps = 8/173 (4%)
Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +W+    LG G+FG VY+  + +    A  +V      +++++ +     EI +L+  +H
Sbjct: 38  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDH 93
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+ L+I +E    G++  + L     L +SQ+    +Q L  L YLHD
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEV 498
             ++HRD+K  NIL   +G +KLADFG+ AK T+ +    S  GT +WMAPEV
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEV 206

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 104/192 (54%), Gaps = 26/192 (13%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGS------------------QAKQ 372
           D +G+GS+G V    + +D  ++A+K +S   L+ Q                    Q + 
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 373 SISQLEQEIALLSRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
            I Q+ QEIA+L + +H N+V+      D +E  LY+  ELV +G ++ +     L + Q
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCR 488
              Y + ++ G++YLH Q ++HRDIK +N+LV  +G +K+ADFG++   K +D  + +  
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 489 GTAFWMAPEVCS 500
           GT  +MAPE  S
Sbjct: 199 GTPAFMAPESLS 210

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 91/167 (54%), Gaps = 8/167 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 213
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 273
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVCS 500
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+ S
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 320

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/173 (33%), Positives = 93/173 (53%), Gaps = 8/173 (4%)
Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +W+    LG G+FG VY+  + +    A  +V      +++++ +     EI +L+  +H
Sbjct: 38  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI----DTKSEEELEDYMVEIDILASCDH 93
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+ L+I +E    G++  + L     L +SQ+    +Q L  L YLHD
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEV 498
             ++HRD+K  NIL   +G +KLADFG+ AK T+ +       GT +WMAPEV
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEV 206

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 91/167 (54%), Gaps = 8/167 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 136
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 196
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVCS 500
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+ S
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 243

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 91/167 (54%), Gaps = 8/167 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 93
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 153
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVCS 500
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+ S
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 200

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 91/167 (54%), Gaps = 8/167 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 91
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 151
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVCS 500
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+ S
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 198

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 104/187 (55%), Gaps = 13/187 (6%)
Query: 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSI 374
           P+ + K  I  ++   +LG+GSFG V+         FFA+K    +V L+D   +     
Sbjct: 9   PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC---- 64
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSA 433
           + +E+ +  L+ +EH  +   + T + +  L+  +E +  G L+   Q  H  D S+ + 
Sbjct: 65  TMVEKRVLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF 123
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTA 491
           Y  +I+LGL++LH + +V+RD+K  NIL+D +G +K+ADFG+ K   L D K+    GT 
Sbjct: 124 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTP 183
Query: 492 FWMAPEV 498
            ++APE+
Sbjct: 184 DYIAPEI 190

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 91/167 (54%), Gaps = 8/167 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 82
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 142
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVCS 500
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+ S
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 189

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 8/165 (4%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG+VY      +    A+K++S    G Q+ +    + +E+  L +  H N +QY
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++HR
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           D+K  NIL+   G VKL DFG   A+ +       GT +WMAPEV
Sbjct: 179 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEV 221

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 91/167 (54%), Gaps = 8/167 (4%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V    +   G   AVK++ L  Q     Q    L  E+ ++  ++HEN+V+ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 86
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++A    +L  L  LH Q V+HRDI
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 146
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVCS 500
           K  +IL+  +G VKL+DFG  A+ +K +   K   GT +WMAPE+ S
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 193

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 8/165 (4%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GSFG+VY      +    A+K++S    G Q+ +    + +E+  L +  H N +QY
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            G    E   ++ +E  L +   LL ++++  L++ +++A T   L GL YLH  +++HR
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           D+K  NIL+   G VKL DFG   A+ +       GT +WMAPEV
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEV 182

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 97/171 (56%), Gaps = 13/171 (7%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V+         FFA+K    +V L+D   +     + +E+ +  L+ +EH 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLA-WEHP 78
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
            +   + T + +  L+  +E +  G L+   Q  H  D S+ + Y  +I+LGL++LH + 
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEV 498
           +V+RD+K  NIL+D +G +K+ADFG+ K   L D K+    GT  ++APE+
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEI 189

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 100/179 (55%), Gaps = 10/179 (5%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIA 382
           R +  + +G  LG+G F   YE    D    FA K V  S+L +  Q ++    +  EIA
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 94
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 441
           +    ++ ++V ++G  +D+  +Y+ LE+  + SLL L++R   + + +   + RQ + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEV 498
           ++YLH+  V+HRD+K  N+ ++ +  VK+ DFGLA   + +    K+  GT  ++APEV
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEV 213

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 96/171 (56%), Gaps = 10/171 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 83
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 84  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 143
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVCS 500
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K+  GT  ++APEV S
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS 194

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 96/171 (56%), Gaps = 10/171 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 79
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVCS 500
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K+  GT  ++APEV S
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS 190

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/170 (35%), Positives = 94/170 (55%), Gaps = 12/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G GSFG+V+      G   AVK   L++Q   A++ +++  +E+A++ R  H NIV + 
Sbjct: 45  IGAGSFGTVHRA-EWHGSDVAVK--ILMEQDFHAER-VNEFLREVAIMKRLRHPNIVLFM 100
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQD--V 450
           G       L I  E +++GSL  L      R  L + +  +    +  G+ YLH+++  +
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 451 VHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWMAPEV 498
           VHR++K  N+LVD   +VK+ DFGL+  KA+     KS  GT  WMAPEV
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 96/171 (56%), Gaps = 10/171 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 79
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 139
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVCS 500
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K+  GT  ++APEV S
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLS 190

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/170 (35%), Positives = 93/170 (54%), Gaps = 12/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G GSFG+V+      G   AVK   L++Q   A++ +++  +E+A++ R  H NIV + 
Sbjct: 45  IGAGSFGTVHRA-EWHGSDVAVK--ILMEQDFHAER-VNEFLREVAIMKRLRHPNIVLFM 100
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQD--V 450
           G       L I  E +++GSL  L      R  L + +  +    +  G+ YLH+++  +
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 451 VHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWMAPEV 498
           VHRD+K  N+LVD   +VK+ DFGL+  KA+     K   GT  WMAPEV
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEV 210

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 99/181 (54%), Gaps = 23/181 (12%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
           +L+G G++G VY+G     G   A+K   ++D     ++ I   +QEI +L ++  H NI
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEI---KQEINMLKKYSHHRNI 83
Query: 393 VQYYGT--DKD----ESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
             YYG    K+    + +L++ +E    GS+ +L +      L++  ++   R+IL GL 
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVC 499
           +LH   V+HRDIK  N+L+  N  VKL DFG+  + +L+     R    GT +WMAPEV 
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 500 S 500
           +
Sbjct: 202 A 202

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 93/174 (53%), Gaps = 10/174 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W+    LG G+FG VY+  + + G   A K +      +++++ +     EI +L+  +H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 75
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
             IV+  G    + KL+I +E    G++  + L     L + Q+    RQ+L  L +LH 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVC 499
           + ++HRD+K  N+L+   G ++LADFG+ AK  K L    S  GT +WMAPEV 
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 99/179 (55%), Gaps = 10/179 (5%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIA 382
           R +  + +G  LG+G F   YE    D    FA K V  S+L +  Q ++    +  EIA
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 94
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 441
           +    ++ ++V ++G  +D+  +Y+ LE+  + SLL L++R   + + +   + RQ + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEV 498
           ++YLH+  V+HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEV 213

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 93/174 (53%), Gaps = 10/174 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W+    LG G+FG VY+  + + G   A K +      +++++ +     EI +L+  +H
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYIVEIEILATCDH 67
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
             IV+  G    + KL+I +E    G++  + L     L + Q+    RQ+L  L +LH 
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVC 499
           + ++HRD+K  N+L+   G ++LADFG+ AK  K L    S  GT +WMAPEV 
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 181

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 99/179 (55%), Gaps = 10/179 (5%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIA 382
           R +  + +G  LG+G F   YE    D    FA K V  S+L +  Q ++    +  EIA
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 94
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 441
           +    ++ ++V ++G  +D+  +Y+ LE+  + SLL L++R   + + +   + RQ + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEV 498
           ++YLH+  V+HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEV 213

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 90/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI +E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPE 185

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 90/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI +E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 95/171 (55%), Gaps = 10/171 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 103
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 163
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVCS 500
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV S
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 95/171 (55%), Gaps = 10/171 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 101
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 102 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 161
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVCS 500
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV S
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 212

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 90/166 (54%), Gaps = 6/166 (3%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G+ G+VY  +         +EV++     Q +     +  EI ++   ++ NIV Y 
Sbjct: 28  IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
            +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   V+HRDIK
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 457 CANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEVCS 500
             NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV +
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 99/179 (55%), Gaps = 10/179 (5%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIA 382
           R +  + +G  LG+G F   YE    D    FA K V  S+L +  Q ++    +  EIA
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----MSTEIA 78
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLG 441
           +    ++ ++V ++G  +D+  +Y+ LE+  + SLL L++R   + + +   + RQ + G
Sbjct: 79  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 138
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEV 498
           ++YLH+  V+HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV
Sbjct: 139 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEV 197

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 93/170 (54%), Gaps = 12/170 (7%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRG F  VY      DG   A+K+V + D   ++A+   +   +EI LL +  H N+++
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIK 96
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQD 449
           YY +  ++++L I LEL   G L  + + +      + +  V  Y  Q+   L+++H + 
Sbjct: 97  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPE 497
           V+HRDIK AN+ + A G VKL D GL +  ++K     S  GT ++M+PE
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 90/167 (53%), Gaps = 8/167 (4%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS G V        G   AVK++ L  Q     Q    L  E+ ++  + H+N+V  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYHHDNVVDM 107
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           Y +     +L++ +E +  G+L ++     + + Q++     +L  L YLH+Q V+HRDI
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDI 167
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVCS 500
           K  +IL+ ++G +KL+DFG  A+ +K +   K   GT +WMAPEV S
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVIS 214

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 102/177 (57%), Gaps = 11/177 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSRFE 388
           ++ G+LLG+GSF  VY   S   G   A+K   ++D+ +  K  + Q ++ E+ +  + +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR---DSQVSAYTRQILLGLKYL 445
           H +I++ Y   +D + +Y+ LE+   G + N Y +  ++   +++   +  QI+ G+ YL
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVCS 500
           H   ++HRD+  +N+L+  N ++K+ADFGLA   K+   K  +  GT  +++PE+ +
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 90/166 (54%), Gaps = 6/166 (3%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G+ G+VY  +         +EV++     Q +     +  EI ++   ++ NIV Y 
Sbjct: 28  IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
            +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   V+HRDIK
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 457 CANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEVCS 500
             NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV +
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVT 189

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 72
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 73  AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 131
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 178

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 95/171 (55%), Gaps = 10/171 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            LG+G F   +E   +D    FA K V  SLL +  Q ++    +  EI++     H+++
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEISIHRSLAHQHV 77
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V ++G  +D   +++ LEL  + SLL L++R   L + +   Y RQI+LG +YLH   V+
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVI 137
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVCS 500
           HRD+K  N+ ++ +  VK+ DFGLA   + +    K   GT  ++APEV S
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 188

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 90/166 (54%), Gaps = 6/166 (3%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G+ G+VY  +         +EV++     Q +     +  EI ++   ++ NIV Y 
Sbjct: 29  IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
            +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   V+HRDIK
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 144
Query: 457 CANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEVCS 500
             NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV +
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVT 190

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 95/173 (54%), Gaps = 7/173 (4%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG+GSFG V +    D        V ++++ S   +  S + +E+ LL + +H NI++ 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 396 YGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           +   +D S  YI  EL T G L + + +R    +   +   +Q+  G+ Y+H  ++VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 455 IKCANILVDA---NGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVCSNPF 503
           +K  NIL+++   +  +K+ DFGL+   + N  +K   GTA+++APEV    +
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 76
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E + KGSLL+  +     +LR  Q+   + QI  G+ Y+   + VHR
Sbjct: 77  AVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHR 135
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 182

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 90/166 (54%), Gaps = 6/166 (3%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G+ G+VY  +         +EV++     Q +     +  EI ++   ++ NIV Y 
Sbjct: 28  IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
            +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   V+HRDIK
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 457 CANILVDANGSVKLADFGL-AKATKLNDVKS-CRGTAFWMAPEVCS 500
             NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV +
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVT 189

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 68
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 69  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 127
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 174

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 84/144 (58%), Gaps = 8/144 (5%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
           V ++D   Q ++ +  L  E+ ++  ++H N+V+ Y +     +L++ +E +  G+L ++
Sbjct: 75  VKMMDLRKQQRREL--LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI 132
Query: 421 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKAT 479
             +  L + Q++     +L  L YLH Q V+HRDIK  +IL+  +G VKL+DFG  A+ +
Sbjct: 133 VSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 192
Query: 480 KLNDV---KSCRGTAFWMAPEVCS 500
           K  DV   K   GT +WMAPEV S
Sbjct: 193 K--DVPKRKXLVGTPYWMAPEVIS 214

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 95/173 (54%), Gaps = 7/173 (4%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG+GSFG V +    D        V ++++ S   +  S + +E+ LL + +H NI++ 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 396 YGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           +   +D S  YI  EL T G L + + +R    +   +   +Q+  G+ Y+H  ++VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 455 IKCANILVDA---NGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVCSNPF 503
           +K  NIL+++   +  +K+ DFGL+   + N  +K   GTA+++APEV    +
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 70
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 71  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 129
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 176

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 76
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E + KGSLL+  +     +LR  Q+   + QI  G+ Y+   + VHR
Sbjct: 77  AVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHR 135
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPE 182

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 95/173 (54%), Gaps = 7/173 (4%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG+GSFG V +    D        V ++++ S   +  S + +E+ LL + +H NI++ 
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 396 YGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           +   +D S  YI  EL T G L + + +R    +   +   +Q+  G+ Y+H  ++VHRD
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRD 146
Query: 455 IKCANILVDA---NGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVCSNPF 503
           +K  NIL+++   +  +K+ DFGL+   + N  +K   GTA+++APEV    +
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKIRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 89/169 (52%), Gaps = 13/169 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 328
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 329 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 387
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVC 499
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE  
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI +E ++KG LL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 92/158 (58%), Gaps = 20/158 (12%)
Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
           A+K ++L     + + S+ +L +EI  +S+  H NIV YY +   + +L++ ++L++ GS
Sbjct: 39  AIKRINL----EKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 94
Query: 417 LLNLYQRY-----H----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467
           +L++ +       H    L +S ++   R++L GL+YLH    +HRD+K  NIL+  +GS
Sbjct: 95  VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 154
Query: 468 VKLADFGLAK-------ATKLNDVKSCRGTAFWMAPEV 498
           V++ADFG++         T+    K+  GT  WMAPEV
Sbjct: 155 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 192

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 92/158 (58%), Gaps = 20/158 (12%)
Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
           A+K ++L     + + S+ +L +EI  +S+  H NIV YY +   + +L++ ++L++ GS
Sbjct: 44  AIKRINL----EKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99
Query: 417 LLNLYQRY-----H----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467
           +L++ +       H    L +S ++   R++L GL+YLH    +HRD+K  NIL+  +GS
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159
Query: 468 VKLADFGLAK-------ATKLNDVKSCRGTAFWMAPEV 498
           V++ADFG++         T+    K+  GT  WMAPEV
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 90/166 (54%), Gaps = 6/166 (3%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G+ G+VY  +         +EV++     Q +     +  EI ++   ++ NIV Y 
Sbjct: 29  IGQGASGTVYTAMD----VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 84
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
            +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH   V+HR+IK
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIK 144
Query: 457 CANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEVCS 500
             NIL+  +GSVKL DFG  A+ T     +S   GT +WMAPEV +
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 190

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 245
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 246 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 88/167 (52%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D+  ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 245
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 246 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 88/167 (52%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KG LL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 80  AVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 98/185 (52%), Gaps = 20/185 (10%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFF---FAVKEVSLLDQGSQAKQSISQL 377
           N R+K +       D LG G   +VY  +++D       A+K + +     + ++++ + 
Sbjct: 10  NERYKIV-------DKLGGGGMSTVY--LAEDTILNIKVAIKAIFI--PPREKEETLKRF 58
Query: 378 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYT 435
           E+E+   S+  H+NIV     D+++   Y+ +E + +G  L+ Y   H  L       +T
Sbjct: 59  EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI-EGPTLSEYIESHGPLSVDTAINFT 117
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAF 492
            QIL G+K+ HD  +VHRDIK  NIL+D+N ++K+ DFG+AKA   T L       GT  
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 493 WMAPE 497
           + +PE
Sbjct: 178 YFSPE 182

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 89/167 (53%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 245
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 246 AVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 87/168 (51%), Gaps = 6/168 (3%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENI 392
           G  LG+G FG+VY        F  +  + +L +    K+ +  QL +EI + S   H NI
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKF--IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 77
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVV 451
           ++ Y    D  ++Y+ LE   +G L    Q++   D Q SA +  ++   L Y H++ V+
Sbjct: 78  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVI 137
Query: 452 HRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEV 498
           HRDIK  N+L+   G +K+ADFG +  A  L     C GT  ++ PE+
Sbjct: 138 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-GTLDYLPPEM 184

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 88/167 (52%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLY 69
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  + I  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 70  AVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 128
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPE 175

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 88/167 (52%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG+G FG V+ G  +     A+K    L  G+ + ++  Q   E  ++ +  HE +VQ Y
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGNMSPEAFLQ---EAQVMKKLRHEKLVQLY 246
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + VHR
Sbjct: 247 AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 305
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV  N   K+ADFGL +  + N+  + +G  F   W APE
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPE 352

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 86/165 (52%), Gaps = 6/165 (3%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 395
           LG+G FG+VY        F  +  + +L +    K+ +  QL +EI + S   H NI++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKF--IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
           Y    D  ++Y+ LE   +G L    Q++   D Q SA +  ++   L Y H++ V+HRD
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRD 139
Query: 455 IKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEV 498
           IK  N+L+   G +K+ADFG +  A  L     C GT  ++ PE+
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC-GTLDYLPPEM 183

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 95/180 (52%), Gaps = 16/180 (8%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           Y +K   LG G FG V    Y+  +D  G   AVK +   D G Q +   S  +QEI +L
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DCGPQHR---SGWKQEIDIL 70
Query: 385 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
               HE+I++Y G   D+ E  L + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 130
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 497
            YLH Q  +HR++   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 131 AYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/177 (33%), Positives = 95/177 (53%), Gaps = 27/177 (15%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEH 389
           LG GSFG V+   S  +G ++A+K +         K+ + +L+Q      E  +LS   H
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------VSAYTRQILLGLK 443
             I++ +GT +D  ++++ ++ +  G L +L     LR SQ         Y  ++ L L+
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-----LRKSQRFPNPVAKFYAAEVCLALE 120
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCS 500
           YLH +D+++RD+K  NIL+D NG +K+ DFG AK         C GT  ++APEV S
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-GTPDYIAPEVVS 176

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 95/180 (52%), Gaps = 16/180 (8%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           Y +K   LG G FG V    Y+  +D  G   AVK +   D G Q +   S  +QEI +L
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DCGPQHR---SGWKQEIDIL 70
Query: 385 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
               HE+I++Y G   D+ E  L + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 71  RTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 130
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 497
            YLH Q  +HR++   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 131 AYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 93/177 (52%), Gaps = 23/177 (12%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G++ +VY+G++   G + A+KEV L  +      +I    +EI+L+   +HENIV+ 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLMKELKHENIVRL 68
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------LRDSQVSAYTRQILLGLKY 444
           Y     E+KL +  E +      N  ++Y            L  + V  +  Q+L GL +
Sbjct: 69  YDVIHTENKLTLVFEFMD-----NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVC 499
            H+  ++HRD+K  N+L++  G +KL DFGLA+A    +N   S   T ++ AP+V 
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL 180

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 94/180 (52%), Gaps = 16/180 (8%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           Y +K   LG G FG V    Y+  +D  G   AVK +   D G Q +   S  +QEI +L
Sbjct: 32  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-DAGPQHR---SGWKQEIDIL 87
Query: 385 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
               HE+I++Y G   D   + L + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 147
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 497
            YLH Q  +HRD+   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE 207

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 2/167 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLRHPNIL 75
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC 499
           RDIK  N+L+ +NG +K+ADFG +     +   +  GT  ++ PE+ 
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 182

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 91/169 (53%), Gaps = 10/169 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +GRGSF +VY+G+ D      V    L D+    K    + ++E   L   +H NIV++Y
Sbjct: 34  IGRGSFKTVYKGL-DTETTVEVAWCELQDR-KLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 397 ----GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHDQD-- 449
                T K +  + +  EL T G+L    +R+ +   +V  ++ RQIL GL++LH +   
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 450 VVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           ++HRD+KC NI +    GSVK+ D GLA   + +  K+  GT  + APE
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPE 200

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 2/167 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQLRREVEIQSHLRHPNIL 75
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIH 135
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC 499
           RDIK  N+L+ +NG +K+ADFG +     +   +  GT  ++ PE+ 
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMI 182

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE   +G +    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEM 182

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 88/159 (55%), Gaps = 4/159 (2%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           N  F+ ++  +QK + +G G++G VY+     G   A+K + L    ++ +   S   +E
Sbjct: 13  NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---DAEDEGIPSTAIRE 69
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQIL 439
           I+LL    H NIV        E  L +  E + K     L + +  L+DSQ+  Y  Q+L
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            G+ + H   ++HRD+K  N+L++++G++KLADFGLA+A
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA 168

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 97
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 98  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 157
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 203

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 88/159 (55%), Gaps = 4/159 (2%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           N  F+ ++  +QK + +G G++G VY+     G   A+K + L    ++ +   S   +E
Sbjct: 13  NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---DAEDEGIPSTAIRE 69
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQIL 439
           I+LL    H NIV        E  L +  E + K     L + +  L+DSQ+  Y  Q+L
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            G+ + H   ++HRD+K  N+L++++G++KLADFGLA+A
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA 168

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE   +G +    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 182

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY     +  F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEM 177

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 8/169 (4%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 97
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 98  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 157
Query: 453 RDIKCANILVDANGSVKLADFGL---AKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG    A +++ +D+  C GT  ++ PE+
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL--C-GTLDYLPPEM 203

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 96/178 (53%), Gaps = 7/178 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +Q+   LG G++G V   +  D      + + ++ + S +  S S+L +E+A+L   +H 
Sbjct: 39  YQRVKKLGSGAYGEVL--LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NI++ Y   +D+   Y+ +E    G L + +  R    +   +   +Q+L G+ YLH  +
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 450 VVHRDIKCANILVDA---NGSVKLADFGLAKATK-LNDVKSCRGTAFWMAPEVCSNPF 503
           +VHRD+K  N+L+++   +  +K+ DFGL+   +    +K   GTA+++APEV    +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY 214

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 97/183 (53%), Gaps = 28/183 (15%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G GSFG+VY+G        AVK + ++D   +  Q+      E+A+L +  H NI+ + 
Sbjct: 44  IGSGSFGTVYKGKWHGDV--AVKILKVVDPTPEQFQA---FRNEVAVLRKTRHVNILLFM 98
Query: 397 GTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYLHDQ 448
           G    ++     L +VT+   GS  +LY+  H+++++   +      RQ   G+ YLH +
Sbjct: 99  GYMTKDN-----LAIVTQWCEGS--SLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK 151
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC----S 500
           +++HRD+K  NI +    +VK+ DFGLA    + +    V+   G+  WMAPEV     +
Sbjct: 152 NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211
Query: 501 NPF 503
           NPF
Sbjct: 212 NPF 214

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 30  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 88
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 89  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 148
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 149 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 194

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEM 178

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 87/170 (51%), Gaps = 12/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  ++    AVK    L  G+    S+    +E  L+   +H+ +V+ Y
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTM---SVQAFLEEANLMKTLQHDKLVRLY 73
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +      +   ++  ++ QI  G+ Y+  ++ +HR
Sbjct: 74  AVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 133
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ AN+LV  +   K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 183

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 91/176 (51%), Gaps = 18/176 (10%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G+ +G G FG VY+G  ++      K  +++D  ++  +   Q +QEI ++++ +HEN+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ--QFDQEIKVMAKCQHENLV 93
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYL 445
           +  G   D   L +    +  GSLL+            +H+R             G+ +L
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFL 149
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCR--GTAFWMAPE 497
           H+   +HRDIK ANIL+D   + K++DFGLA+A++     V   R  GT  +MAPE
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPE 205

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 177

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 86/158 (54%), Gaps = 18/158 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFE 388
           ++K D LG G F +VY+    +     A+K++ L    S+AK  I++   +EI LL    
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKL-GHRSEAKDGINRTALREIKLLQELS 70
Query: 389 HENIVQY---YGTDKDESKLYIFLE-----LVTKGSLLNLYQRYHLRDSQVSAYTRQILL 440
           H NI+     +G   + S ++ F+E     ++   SL+       L  S + AY    L 
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-------LTPSHIKAYMLMTLQ 123
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           GL+YLH   ++HRD+K  N+L+D NG +KLADFGLAK+
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 180

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/179 (35%), Positives = 93/179 (51%), Gaps = 19/179 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++    Q S   Q     ++EI +L     + 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQ-RDFQREIQILKALHSDF 69
Query: 392 IVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 447
           IV+Y G      +  L + +E +  G L +  QR+  R   S++  Y+ QI  G++YL  
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 129
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCR----GTAFWMAPEVCSN 501
           +  VHRD+   NILV++   VK+ADFGLAK   L+ D    R       FW APE  S+
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 182

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 99/184 (53%), Gaps = 9/184 (4%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           +GR K  I ++  GD LG G+FG V  G  +  G   AVK ++   Q  ++   + ++ +
Sbjct: 10  DGRVK--IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIRR 65
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQI 438
           EI  L  F H +I++ Y      S +++ +E V+ G L + + +   L + +     +QI
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAP 496
           L G+ Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      +    SC G+  + AP
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC-GSPNYAAP 184
Query: 497 EVCS 500
           EV S
Sbjct: 185 EVIS 188

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 91/176 (51%), Gaps = 18/176 (10%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G+ +G G FG VY+G  ++      K  +++D  ++  +   Q +QEI ++++ +HEN+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ--QFDQEIKVMAKCQHENLV 93
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYL 445
           +  G   D   L +    +  GSLL+            +H+R             G+ +L
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFL 149
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCR--GTAFWMAPE 497
           H+   +HRDIK ANIL+D   + K++DFGLA+A++     V   R  GT  +MAPE
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPE 205

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEM 178

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 91/176 (51%), Gaps = 18/176 (10%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G+ +G G FG VY+G  ++      K  +++D  ++  +   Q +QEI ++++ +HEN+V
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ--QFDQEIKVMAKCQHENLV 87
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYL 445
           +  G   D   L +    +  GSLL+            +H+R             G+ +L
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN----GINFL 143
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCR--GTAFWMAPE 497
           H+   +HRDIK ANIL+D   + K++DFGLA+A++     V   R  GT  +MAPE
Sbjct: 144 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPE 199

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEM 180

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 12  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 70
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 71  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 130
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 131 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 176

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 17  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 75
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 76  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 135
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 136 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 181

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEM 177

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEM 177

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 83/165 (50%), Gaps = 2/165 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPE 181

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 180

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 40/197 (20%)
Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G+FG V +  +  D  ++A+K++         ++ +S +  E+ LL+   H+ +V+
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 395 YYGT-------------DKDESKLYIFLELVTKGSLLNLYQRYHL---RDSQVSAYTRQI 438
           YY                K +S L+I +E    G+L +L    +L   RD     + RQI
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF-RQI 125
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-------KL---------N 482
           L  L Y+H Q ++HRD+K  NI +D + +VK+ DFGLAK         KL         +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 483 DVKSCRGTAFWMAPEVC 499
           ++ S  GTA ++A EV 
Sbjct: 186 NLTSAIGTAMYVATEVL 202

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 92/167 (55%), Gaps = 5/167 (2%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+GSFG V     +D    +A+K ++   Q    +  +  + +E+ ++   EH  +V  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMN--KQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 396 YGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + + +DE  +++ ++L+  G L  +L Q  H ++  V  +  ++++ L YL +Q ++HRD
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 455 IKCANILVDANGSVKLADFGLAKAT-KLNDVKSCRGTAFWMAPEVCS 500
           +K  NIL+D +G V + DF +A    +   + +  GT  +MAPE+ S
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 73
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 74  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 133
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+
Sbjct: 134 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEM 179

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEM 177

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 132
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEM 178

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEM 177

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 87/170 (51%), Gaps = 12/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  ++    AVK    L  G+    S+    +E  L+   +H+ +V+ Y
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTM---SVQAFLEEANLMKTLQHDKLVRLY 74
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +      +   ++  ++ QI  G+ Y+  ++ +HR
Sbjct: 75  AVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 134
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ AN+LV  +   K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 184

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/179 (35%), Positives = 93/179 (51%), Gaps = 19/179 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++    Q S   Q     ++EI +L     + 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQ-RDFQREIQILKALHSDF 73
Query: 392 IVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 447
           IV+Y G      +  L + +E +  G L +  QR+  R   S++  Y+ QI  G++YL  
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 133
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCR----GTAFWMAPEVCSN 501
           +  VHRD+   NILV++   VK+ADFGLAK   L+ D    R       FW APE  S+
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 192

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 76
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 77  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 136
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEM 182

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 76
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 191

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/179 (35%), Positives = 93/179 (51%), Gaps = 19/179 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++    Q S   Q     ++EI +L     + 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQ-RDFQREIQILKALHSDF 72
Query: 392 IVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 447
           IV+Y G      +  L + +E +  G L +  QR+  R   S++  Y+ QI  G++YL  
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 132
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCR----GTAFWMAPEVCSN 501
           +  VHRD+   NILV++   VK+ADFGLAK   L+ D    R       FW APE  S+
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 191

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 87/175 (49%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL    Q++  R   +    YT QI  G++YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEM 177

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 72  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEM 177

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 89/170 (52%), Gaps = 8/170 (4%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 453 RDIKCANILVDANGSVKLADFGL---AKATKLNDVKSCRGTAFWMAPEVC 499
           RDIK  N+L+ + G +K+ADFG    A +++ +D+  C GT  ++ PE+ 
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL--C-GTLDYLPPEMI 181

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 78
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 71
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 77
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 79
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 194

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 29  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSA-----YTRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H  +++          RQ   G+ YL
Sbjct: 84  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 500 --SNPF 503
             SNP+
Sbjct: 197 QDSNPY 202

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 83/167 (49%), Gaps = 2/167 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC 499
           RDIK  N+L+ + G +K+ADFG +     +      GT  ++ PE+ 
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI 181

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 103
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 70
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 10  GRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 68
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 69  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 128
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+
Sbjct: 129 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 174

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 90
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/179 (35%), Positives = 93/179 (51%), Gaps = 19/179 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++    Q S   Q     ++EI +L     + 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQ-RDFQREIQILKALHSDF 85
Query: 392 IVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 447
           IV+Y G      +  L + +E +  G L +  QR+  R   S++  Y+ QI  G++YL  
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCR----GTAFWMAPEVCSN 501
           +  VHRD+   NILV++   VK+ADFGLAK   L+ D    R       FW APE  S+
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 17  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSA-----YTRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H  +++          RQ   G+ YL
Sbjct: 72  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYL 124
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 125 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 500 --SNPF 503
             SNP+
Sbjct: 185 QDSNPY 190

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 72
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 73
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 74  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 133
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+A+FG +     +   +  GT  ++ PE+
Sbjct: 134 RDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEM 179

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 29  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSA-----YTRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H  +++          RQ   G+ YL
Sbjct: 84  LFMGYSTAPQ-----LAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 500 --SNPF 503
             SNP+
Sbjct: 197 QDSNPY 202

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 93/172 (54%), Gaps = 10/172 (5%)
Query: 336 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +LG+GSFG V+    ++  D G  +A+K   +L + +   +   + + E  +L+   H  
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMK---VLKKATLKVRDRVRTKMERDILADVNHPF 91
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           +V+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ LGL +LH   +
Sbjct: 92  VVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGI 151
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVCS 500
           ++RD+K  NIL+D  G +KL DFGL+K    ++ K+    GT  +MAPEV +
Sbjct: 152 IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN 203

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 2/166 (1%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  LG+G FG+VY        F    +V    Q  +A     QL +E+ + S   H NI+
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQLRREVEIQSHLRHPNIL 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVH 452
           + YG   D +++Y+ LE    G++    Q+    D Q +A Y  ++   L Y H + V+H
Sbjct: 75  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           RDIK  N+L+ + G +K+A+FG +     +   +  GT  ++ PE+
Sbjct: 135 RDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEM 180

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 100/189 (52%), Gaps = 8/189 (4%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQ 379
           N  F+ +   +Q+   LG G++G V   +  D    A + + ++ + S    S S  L  
Sbjct: 13  NLYFQGLSDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLD 70
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQI 438
           E+A+L + +H NI++ Y   +D+   Y+ +E+   G L + +  R    +   +   +Q+
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKATKL-NDVKSCRGTAFWM 494
           L G  YLH  ++VHRD+K  N+L+++   +  +K+ DFGL+   ++   +K   GTA+++
Sbjct: 131 LSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 190
Query: 495 APEVCSNPF 503
           APEV    +
Sbjct: 191 APEVLRKKY 199

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 100/180 (55%), Gaps = 20/180 (11%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 390
           +LG+GSFG V    + I+  G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 56  VLGKGSFGEVILCKDKIT--GQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y+H   
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 450 VVHRDIKCANILVDA---NGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVCSNPF 503
           +VHRD+K  N+L+++   + ++++ DFGL+   +A+K   +K   GTA+++APEV    +
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHGTY 227

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 100/180 (55%), Gaps = 20/180 (11%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 390
           +LG+GSFG V    + I+  G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 33  VLGKGSFGEVILCKDKIT--GQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y+H   
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 450 VVHRDIKCANILVDA---NGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVCSNPF 503
           +VHRD+K  N+L+++   + ++++ DFGL+   +A+K   +K   GTA+++APEV    +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHGTY 204

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 100/180 (55%), Gaps = 20/180 (11%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 390
           +LG+GSFG V    + I+  G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 57  VLGKGSFGEVILCKDKIT--GQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y+H   
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 450 VVHRDIKCANILVDA---NGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVCSNPF 503
           +VHRD+K  N+L+++   + ++++ DFGL+   +A+K   +K   GTA+++APEV    +
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHGTY 228

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 93/180 (51%), Gaps = 16/180 (8%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           Y +K   LG G FG V    Y+  +D  G   AVK    L +G    Q  S  ++EI +L
Sbjct: 10  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKEGC-GPQLRSGWQREIEIL 65
Query: 385 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
               HE+IV+Y G   D+ E  + + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 66  RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGM 125
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 497
            YLH Q  +HR +   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 126 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 185

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 93/180 (51%), Gaps = 16/180 (8%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           Y +K   LG G FG V    Y+  +D  G   AVK    L +G    Q  S  ++EI +L
Sbjct: 9   YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKEGC-GPQLRSGWQREIEIL 64
Query: 385 SRFEHENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
               HE+IV+Y G   D+ E  + + +E V  GSL +   R+ +  +Q+  + +QI  G+
Sbjct: 65  RTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGM 124
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKSCR----GTAFWMAPE 497
            YLH Q  +HR +   N+L+D +  VK+ DFGLAKA  + ++    R       FW APE
Sbjct: 125 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 184

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 85/167 (50%), Gaps = 13/167 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     A+K    L  G+ + +S  +   E  ++ + +H+ +VQ Y
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKT---LKPGTMSPESFLE---EAQIMKKLKHDKLVQLY 70
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
               +E  +YI  E + KGSLL+  +      L+   +     Q+  G+ Y+   + +HR
Sbjct: 71  AVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           D++ ANILV      K+ADFGLA+  + N+  + +G  F   W APE
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPE 176

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 88/175 (50%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 73
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q++  R   +    YT QI  G++YL  
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HR++   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 87/175 (49%), Gaps = 19/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG+G+FGSV    Y+ + D+ G   AVK++         ++ +   E+EI +L   +H+N
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREIEILKSLQHDN 75
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--AYTRQILLGLKYLHD 447
           IV+Y G         L + +E +  GSL +  Q +  R   +    YT QI  G++YL  
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKS-CRGTAFWMAPE 497
           +  +HRD+   NILV+    VK+ DFGL K      +   VK       FW APE
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 41  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 96  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 149 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 500 --SNPF 503
              NP+
Sbjct: 209 QDKNPY 214

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 95/184 (51%), Gaps = 8/184 (4%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           ++I  +  GDLLG GS+G V E +  +       ++    +  +     + +++EI LL 
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 386 RFEHENIVQYYGT--DKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLG 441
           R  H+N++Q      ++++ K+Y+ +E    G   +L+          Q   Y  Q++ G
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL----NDVKSCRGTAFWMAPE 497
           L+YLH Q +VH+DIK  N+L+   G++K++  G+A+A       +  ++ +G+  +  PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 498 VCSN 501
           + + 
Sbjct: 182 IANG 185

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 92/173 (53%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +   + ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 41  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 96  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 149 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 500 --SNPF 503
              NP+
Sbjct: 209 QDKNPY 214

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 92/173 (53%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E V +   + ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 33  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 88  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 140
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 141 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 200
Query: 500 --SNPF 503
              NP+
Sbjct: 201 QDKNPY 206

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 93/189 (49%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       +G GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +K+ADFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 14/176 (7%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 15  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 70  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 122
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 123 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 182
Query: 500 --SNPF 503
              NP+
Sbjct: 183 QDKNPY 188

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 14/176 (7%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 40  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 95  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 147
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 148 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 207
Query: 500 --SNPF 503
              NP+
Sbjct: 208 QDKNPY 213

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 14/176 (7%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEIXINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS+G   +     DG     KE   LD GS  +     L  E+ LL   +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 396 YG--TDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLH-- 446
           Y    D+  + LYI +E    G L ++      +R +L +  V     Q+ L LK  H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 447 ---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPE 497
                 V+HRD+K AN+ +D   +VKL DFGLA+    ++   K   GT ++M+PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPE 186

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 14/176 (7%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEIXINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 18  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 73  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 500 --SNPF 503
              NP+
Sbjct: 186 QDKNPY 191

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS+G   +     DG     KE   LD GS  +     L  E+ LL   +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 396 YG--TDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLH-- 446
           Y    D+  + LYI +E    G L ++      +R +L +  V     Q+ L LK  H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 447 ---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPE 497
                 V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GT ++M+PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 13  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 68  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 500 --SNPF 503
              NP+
Sbjct: 181 QDKNPY 186

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 13  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 68  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 500 --SNPF 503
              NP+
Sbjct: 181 QDKNPY 186

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 97/178 (54%), Gaps = 16/178 (8%)
Query: 336 LLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 390
           +LG+GSFG V   +  D   G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 39  VLGKGSFGEVI--LCKDKITGQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y+H   
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 450 VVHRDIKCANILVDA---NGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVCSNPF 503
           +VHRD+K  N+L+++   + ++++ DFGL+   + +  +K   GTA+++APEV    +
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 177

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 18  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 73  LFMGYSTKPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 126 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 185
Query: 500 --SNPF 503
              NP+
Sbjct: 186 QDKNPY 191

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 93/172 (54%), Gaps = 10/172 (5%)
Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           ++LG G+F  V+       G  FA+K +    + S A +  S LE EIA+L + +HENIV
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCI----KKSPAFRD-SSLENEIAVLKKIKHENIV 69
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                 +  +  Y+ ++LV+ G L + + +R    +   S   +Q+L  +KYLH+  +VH
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVH 129
Query: 453 RDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           RD+K  N+L    + N  + + DFGL+K  +   + +  GT  ++APEV + 
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQ 181

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 14/176 (7%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E ++      ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 91/174 (52%), Gaps = 8/174 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 65
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVC 499
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+ 
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 179

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/176 (33%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G GS+G   +     DG     KE   LD GS  +     L  E+ LL   +H NIV+Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 396 YG--TDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLH-- 446
           Y    D+  + LYI +E    G L ++      +R +L +  V     Q+ L LK  H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 447 ---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPE 497
                 V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GT ++M+PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 186

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 9/185 (4%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           +GR K  I ++  GD LG G+FG V  G     G   AVK ++   Q  ++   + ++++
Sbjct: 5   DGRVK--IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKR 60
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQ 437
           EI  L  F H +I++ Y      +  ++ +E V+ G L + Y   H R  ++ A    +Q
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD-YICKHGRVEEMEARRLFQQ 119
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAP 496
           IL  + Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      + +++  G+  + AP
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
Query: 497 EVCSN 501
           EV S 
Sbjct: 180 EVISG 184

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 40/197 (20%)
Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G+FG V +  +  D  ++A+K++         ++ +S +  E+ LL+   H+ +V+
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 395 YYGT-------------DKDESKLYIFLELVTKGSLLNLYQRYHL---RDSQVSAYTRQI 438
           YY                K +S L+I +E     +L +L    +L   RD     + RQI
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF-RQI 125
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-------KL---------N 482
           L  L Y+H Q ++HRD+K  NI +D + +VK+ DFGLAK         KL         +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 483 DVKSCRGTAFWMAPEVC 499
           ++ S  GTA ++A EV 
Sbjct: 186 NLTSAIGTAMYVATEVL 202

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 60
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 176

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  AVK   ++ +GS ++    Q  Q +  LS   H  +V++Y
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVK---MIKEGSMSEDEFFQEAQTMMKLS---HPKLVKFY 69
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           G    E  +YI  E ++ G LLN Y R H   L  SQ+      +  G+ +L     +HR
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           D+   N LVD +  VK++DFG+ +    +   S  GT F   W APEV
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV 176

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  FA+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHFAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  FA+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHFAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 93/177 (52%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI + +  
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINAML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  FA+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHFAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 91/174 (52%), Gaps = 8/174 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 68
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVC 499
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+ 
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 182

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 91/174 (52%), Gaps = 8/174 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 68
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVC 499
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+ 
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 182

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 177

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 28/186 (15%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G  +G GSFG+VY+G      +     V +L+  +   Q +   + E+ +L +  H NI+
Sbjct: 13  GQRIGSGSFGTVYKGK-----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 394 QYYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
            + G           L +VT+   GS  +LY   H+ +++          RQ   G+ YL
Sbjct: 68  LFMGYSTAPQ-----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEVC-- 499
           H + ++HRD+K  NI +  + +VK+ DFGLA    + +  +  +   G+  WMAPEV   
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 500 --SNPF 503
              NP+
Sbjct: 181 QDKNPY 186

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 65
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 178

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E ++      ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E ++      ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E ++      ++      +    + +Y  Q+L GL + H 
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 91/174 (52%), Gaps = 8/174 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVC 499
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+ 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E V +     ++      +    + +Y  Q+L GL + H 
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 173

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 99/181 (54%), Gaps = 12/181 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLSRFEH 389
           +Q+   LG G++G V   +  D    A + + ++ + S    S S  L  E+A+L + +H
Sbjct: 6   YQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN---LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            NI++ Y   +D+   Y+ +E+   G L +   L Q++   D+ V    +Q+L G  YLH
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV--IMKQVLSGTTYLH 121
Query: 447 DQDVVHRDIKCANILVDA---NGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCSNP 502
             ++VHRD+K  N+L+++   +  +K+ DFGL+   ++   +K   GTA+++APEV    
Sbjct: 122 KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK 181
Query: 503 F 503
           +
Sbjct: 182 Y 182

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 175

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEIXINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 177

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 83
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 84  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 142
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 192

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/175 (33%), Positives = 85/175 (48%), Gaps = 27/175 (15%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G FG VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 19  LGGGQFGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 126 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 62
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 177

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 177

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 173

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 98/186 (52%), Gaps = 11/186 (5%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           +GR K  I ++  GD LG G+FG V  G     G   AVK ++   Q  ++   + ++++
Sbjct: 5   DGRVK--IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKR 60
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQ 437
           EI  L  F H +I++ Y      +  ++ +E V+ G L + Y   H R  ++ A    +Q
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD-YICKHGRVEEMEARRLFQQ 119
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMA 495
           IL  + Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      +    SC G+  + A
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC-GSPNYAA 178
Query: 496 PEVCSN 501
           PEV S 
Sbjct: 179 PEVISG 184

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 81/179 (45%), Gaps = 21/179 (11%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHE 390
           +++G G FG VY        F+   EV++     D      Q+I  + QE  L +  +H 
Sbjct: 13  EIIGIGGFGKVYRA------FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           NI+   G    E  L + +E    G L  +     +    +  +  QI  G+ YLHD+ +
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 451 V---HRDIKCANILV--------DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           V   HRD+K +NIL+         +N  +K+ DFGLA+        S  G   WMAPEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEV 185

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 177

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G++G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 177

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 79
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 80  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 138
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 188

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 76
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 77  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 135
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 185

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/172 (33%), Positives = 90/172 (52%), Gaps = 10/172 (5%)
Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           + LG G+F  V        G  FAVK   +  +  + K+S   +E EIA+L + +HENIV
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVK--CIPKKALKGKES--SIENEIAVLRKIKHENIV 83
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                 +  + LY+ ++LV+ G L + + ++    +   S   RQ+L  + YLH   +VH
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 453 RDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVCS 500
           RD+K  N+L    D    + ++DFGL+K     DV S   GT  ++APEV +
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLA 195

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 80
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 81  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 189

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 80
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 81  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 189

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 82
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 83  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 141
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 191

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 86/175 (49%), Gaps = 27/175 (15%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI +E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 74
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 183

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 74
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 183

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 86/175 (49%), Gaps = 27/175 (15%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 19  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI +E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 126 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 90/183 (49%), Gaps = 32/183 (17%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS---------------QLEQE 380
           +LG+GSFG V          F VK++S    GS A+Q  +               + + E
Sbjct: 31  VLGQGSFGKV----------FLVKKIS----GSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQIL 439
             +L    H  IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ 
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPE 497
           L L +LH   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K+    GT  +MAPE
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196
Query: 498 VCS 500
           V +
Sbjct: 197 VVN 199

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 75
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 76  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 134
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 184

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 84
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 85  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 143
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 193

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 74
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 11/167 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 70
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 130
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           +   N LV+  G VK++DFGL++    ++  S RG+ F   W  PEV
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEV 177

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 86/175 (49%), Gaps = 27/175 (15%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI +E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 72
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 73  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 131
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPE 497
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 184

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 67
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 68  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPE 497
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 11/153 (7%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q   LLG G++G V        G   A+K++   D+   A +++    +EI +L  F+H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 390 ENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           ENI+  +   + +S     ++YI  EL+ +  L  +     L D  +  +  Q L  +K 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           LH  +V+HRD+K +N+L+++N  +K+ DFGLA+
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPE 497
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 182

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 73
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 74  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 132
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPE 497
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 185

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 54  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 103
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 163
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 164 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 222
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 223 PEYLAPEII 231

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 89/171 (52%), Gaps = 13/171 (7%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +LG+GSFG V    + + G  +AVK    +V L D   +   +    E+ I  L+R  H 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT----EKRILSLAR-NHP 84
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
            + Q +   +   +L+  +E V  G L+   Q+    D ++   Y  +I+  L +LHD+ 
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEV 498
           +++RD+K  N+L+D  G  KLADFG+ K    N V +    GT  ++APE+
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 98
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 99  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 157
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPE 497
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 210

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 203 PEYLAPEII 211

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPE 497
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 182

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 93/189 (49%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       +G GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E +  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +K+ADFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 75
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  +Y L  + +  Y  Q+   L YL  
Sbjct: 76  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPE 497
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 187

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 337 LGRGSFGSVYEGISDDGF---FFAVKEVSLLDQG--SQAKQSISQLEQEI----ALLSRF 387
           LG G++G V      +G       V + S  D+G  S   ++I +  +EI    +LL   
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H NI++ +   +D+   Y+  E    G L   +  R+   +   +   +QIL G+ YLH
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 447 DQDVVHRDIKCANILVDANGS---VKLADFGL----AKATKLNDVKSCRGTAFWMAPEVC 499
             ++VHRDIK  NIL++   S   +K+ DFGL    +K  KL D     GTA+++APEV 
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAYYIAPEVL 220
Query: 500 SNPF 503
              +
Sbjct: 221 KKKY 224

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 11/153 (7%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q   LLG G++G V        G   A+K++   D+   A +++    +EI +L  F+H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 390 ENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           ENI+  +   + +S     ++YI  EL+ +  L  +     L D  +  +  Q L  +K 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           LH  +V+HRD+K +N+L+++N  +K+ DFGLA+
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 203 PEYLAPEII 211

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 203 PEYLAPEII 211

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 69
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 70  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 178

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 93/189 (49%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       +G GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------IGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E +  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +K+ADFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 11/153 (7%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q   LLG G++G V        G   A+K++   D+   A +++    +EI +L  F+H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 390 ENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           ENI+  +   + +S     ++YI  EL+ +  L  +     L D  +  +  Q L  +K 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           LH  +V+HRD+K +N+L+++N  +K+ DFGLA+
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 26  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 75
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 76  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 135
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 136 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 194
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 195 PEYLAPEII 203

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 97/184 (52%), Gaps = 21/184 (11%)
Query: 327 IITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSL---LDQGSQAKQSISQLEQEIA 382
           +  Y+   + LG G+FG V+  +    G  F  K ++    LD+ +        ++ EI+
Sbjct: 49  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT--------VKNEIS 100
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILL 440
           ++++  H  ++  +   +D+ ++ + LE ++ G L +    + Y + +++V  Y RQ   
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 441 GLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATKLND---VKSCRGTAFWMA 495
           GLK++H+  +VH DIK  NI+ +     SVK+ DFGL  ATKLN    VK    TA + A
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL--ATKLNPDEIVKVTTATAEFAA 218
Query: 496 PEVC 499
           PE+ 
Sbjct: 219 PEIV 222

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 93/170 (54%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NIV+ 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 396 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + + ++ES  Y+  +LVT G L  ++  R    ++  S   +QIL  + Y H   +VHR+
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 153
Query: 455 IKCANILVDA---NGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           +K  N+L+ +     +VKLADFGL  A ++ND ++     GT  +++PEV
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEV 201

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 26  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 75
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 76  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 135
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 136 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 194
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 195 PEYLAPEII 203

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 85/160 (53%), Gaps = 26/160 (16%)
Query: 331 WQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           + K D LG G++ +VY+G   ++D+    A+KE+ L  +      +I    +E++LL   
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDN--LVALKEIRLEHEEGAPCTAI----REVSLLKDL 57
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTK---------GSLLNLYQRYHLRDSQVSAYTRQI 438
           +H NIV  +     E  L +  E + K         G+++N++         V  +  Q+
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHN--------VKLFLFQL 109
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           L GL Y H Q V+HRD+K  N+L++  G +KLADFGLA+A
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA 149

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 54  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 103
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 163
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 164 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 222
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 223 PEYLAPEII 231

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFGLAK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 203 PEYLAPEII 211

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 27/175 (15%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 19  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 126 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE 180

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 203 PEYLAPEII 211

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 82/170 (48%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI +E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 28  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 77
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 78  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 137
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 138 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 196
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 197 PEYLAPEII 205

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 203 PEYLAPEII 211

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 95/198 (47%), Gaps = 21/198 (10%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGS 368
           P + + P    KR +   +    LG G FG V    Y+   D+ G   AVK +     G+
Sbjct: 9   PATEVDPTHFEKRFLKRIRD---LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN 65
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLY--QRY 424
                I+ L++EI +L    HENIV+Y G  T+   + + + +E +  GSL       + 
Sbjct: 66  H----IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121
Query: 425 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND- 483
            +   Q   Y  QI  G+ YL  +  VHRD+   N+LV++   VK+ DFGL KA + +  
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 484 ---VKSCRGT-AFWMAPE 497
              VK  R +  FW APE
Sbjct: 182 XXTVKDDRDSPVFWYAPE 199

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GT 202
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 203 PEYLAPEII 211

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 92/185 (49%), Gaps = 36/185 (19%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-----------------SQLE 378
           +LG+GSFG V          F VK++S    GS A+Q                   +++E
Sbjct: 32  VLGQGSFGKV----------FLVKKIS----GSDARQLYAMKVLKKATLKVRDRVRTKME 77
Query: 379 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQ 437
           ++I  L    H  IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  +
Sbjct: 78  RDI--LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 135
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMA 495
           + L L +LH   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K+    GT  +MA
Sbjct: 136 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 195
Query: 496 PEVCS 500
           PEV +
Sbjct: 196 PEVVN 200

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 82/170 (48%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 22  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 73
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI +E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 183

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 90/183 (49%), Gaps = 32/183 (17%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS---------------QLEQE 380
           +LG+GSFG V          F VK++S    GS A+Q  +               + + E
Sbjct: 31  VLGQGSFGKV----------FLVKKIS----GSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQIL 439
             +L    H  IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ 
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPE 497
           L L +LH   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K+    GT  +MAPE
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196
Query: 498 VCS 500
           V +
Sbjct: 197 VVN 199

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 27/175 (15%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 132
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 20  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 69
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 70  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 129
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 130 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-GT 188
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 189 PEYLAPEII 197

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 19  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 68
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 69  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 128
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 129 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GT 187
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 188 PEYLAPEII 196

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 54  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 103
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 163
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 164 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC-GT 222
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 223 PEYLAPEII 231

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  ++ L  + +  Y  Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATK-LNDVKSCRGT--AFWMAPE 497
           +  VHRDI   N+LV +N  VKL DFGL++  +     K+ +G     WMAPE
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPE 182

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 91/172 (52%), Gaps = 8/172 (4%)
Query: 336 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +LG G++G V+    IS  D G  +A+K +       +AK +     +   L    +   
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           +V  +   + E+KL++ L+ +  G L  +L QR    + +V  Y  +I+L L++LH   +
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVC 499
           ++RDIK  NIL+D+NG V L DFGL+K    ++ +      GT  +MAP++ 
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIRT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +        +V+   + KD S LY+ LE    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +K+ADFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 203 PEYLAPEII 211

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 27/175 (15%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 86
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 27/175 (15%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 94/178 (52%), Gaps = 20/178 (11%)
Query: 337 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G++G   S Y+ +  +    A+K++S  +  +  ++++    +EI +L RF HENI+
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENII 84
Query: 394 QYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +V+HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHKETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 203 PEYLAPEII 211

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 16/177 (9%)
Query: 331 WQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           W     LG G+ G V      ++++    AVK V +     +A      +++EI +    
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAV--AVKIVDM----KRAVDCPENIKKEICINKML 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEV 498
              + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 177

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 94/178 (52%), Gaps = 20/178 (11%)
Query: 337 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G++G   S Y+ +  +    A+K++S  +  +  ++++    +EI +L RF HENI+
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENII 84
Query: 394 QYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +V+HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 84
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 106
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 107 NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 86
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 91
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 92
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 93  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 151
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 152 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 83
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 84  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 142
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 143 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTL----REIKILLRFRHENIIGI 90
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 84
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 88
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 93/170 (54%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NIV+ 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 396 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + + ++ES  Y+  +LVT G L  ++  R    ++  S   +QIL  + Y H   +VHR+
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 129
Query: 455 IKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           +K  N+L+ +     +VKLADFGL  A ++ND ++     GT  +++PEV
Sbjct: 130 LKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEV 177

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 91
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 90/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+ ++ L    ++ +   S   +EI+LL    H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 90/173 (52%), Gaps = 8/173 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+ ++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEV 498
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVN 190

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 93/170 (54%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 396 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + + ++ES  Y+  +LVT G L  ++  R    ++  S   +QIL  + Y H   +VHR+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 455 IKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           +K  N+L+ +     +VKLADFGL  A ++ND ++     GT  +++PEV
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEV 178

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 94/178 (52%), Gaps = 20/178 (11%)
Query: 337 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G++G   S Y+ +  +    A+K++S  +  +  ++++    +EI +L RF HENI+
Sbjct: 39  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENII 92
Query: 394 QYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 151
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +V+HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 152 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 94/178 (52%), Gaps = 20/178 (11%)
Query: 337 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G++G   S Y+ +  +    A+K++S  +  +  ++++    +EI +L RF HENI+
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENII 84
Query: 394 QYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +V+HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 144 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 70
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 71  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 129
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           +++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 179

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 93/170 (54%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NIV+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 396 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + + ++ES  Y+  +LVT G L  ++  R    ++  S   +QIL  + Y H   +VHR+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 455 IKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           +K  N+L+ +     +VKLADFGL  A ++ND ++     GT  +++PEV
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEV 178

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 97/180 (53%), Gaps = 20/180 (11%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFEHE 390
           +LG+GSFG V    + I+  G   AVK +S      Q KQ   +  L +E+ LL + +H 
Sbjct: 33  VLGKGSFGEVILCKDKIT--GQECAVKVIS----KRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NI + Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+ Y H   
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 450 VVHRDIKCANILVDA---NGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVCSNPF 503
           +VHRD+K  N+L+++   + ++++ DFGL+   +A+K    K   GTA+++APEV    +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KXKDKIGTAYYIAPEVLHGTY 204

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 187

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 93/167 (55%), Gaps = 10/167 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+  ++ G  FA+K++ L     +  + I S   +EI++L   +H NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL----EKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 396 YGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           Y     + +L +  E + +    LL++ +   L      ++  Q+L G+ Y HD+ V+HR
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG--TAFWMAPEV 498
           D+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 88/173 (50%), Gaps = 16/173 (9%)
Query: 337 LGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG G+FG V+  E  S  G    +K ++      +++  + Q+E EI +L   +H NI++
Sbjct: 30  LGSGAFGDVHLVEERSS-GLERVIKTIN----KDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR-----DSQVSAYTRQILLGLKYLHDQD 449
            +   +D   +YI +E    G LL        R     +  V+   +Q++  L Y H Q 
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 450 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKS-CRGTAFWMAPEV 498
           VVH+D+K  NIL      +  +K+ DFGLA+  K ++  +   GTA +MAPEV
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 93/167 (55%), Gaps = 10/167 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+  ++ G  FA+K++ L     +  + I S   +EI++L   +H NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL----EKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 396 YGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           Y     + +L +  E + +    LL++ +   L      ++  Q+L G+ Y HD+ V+HR
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG--TAFWMAPEV 498
           D+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDV 171

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 26  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 93/167 (55%), Gaps = 10/167 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 395
           +G G++G VY+  ++ G  FA+K++ L     +  + I S   +EI++L   +H NIV+ 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL----EKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 396 YGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
           Y     + +L +  E + +    LL++ +   L      ++  Q+L G+ Y HD+ V+HR
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG--TAFWMAPEV 498
           D+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDV 171

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 25  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 136
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +++ DFGLAK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 86/175 (49%), Gaps = 14/175 (8%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
           +G G++G+VY+      G F A+K V + + G           +E+ALL R   FEH N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+         TD+ E K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 77  VRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEV 498
           LH   +VHRD+K  NILV + G+VKLADFGLA+        +      W  APEV
Sbjct: 136 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEV 190

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 103/185 (55%), Gaps = 10/185 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 381
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 441 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 495
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 496 PEVCS 500
           PE+ +
Sbjct: 187 PEIVN 191

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 94/179 (52%), Gaps = 11/179 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++  +++G+G+F  V   I+ + G  FAVK V +    S    S   L++E ++    +H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQR----YHLRDSQVSAYTRQILLGLKY 444
            +IV+   T   +  LY+  E +    L   + +R    +   ++  S Y RQIL  L+Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 445 LHDQDVVHRDIKCANILV---DANGSVKLADFGLA-KATKLNDVKSCR-GTAFWMAPEV 498
            HD +++HRD+K  N+L+   + +  VKL DFG+A +  +   V   R GT  +MAPEV
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEV 204

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 103/185 (55%), Gaps = 10/185 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 381
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 441 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 495
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 496 PEVCS 500
           PE+ +
Sbjct: 187 PEIVN 191

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 79/140 (56%), Gaps = 2/140 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 480 KL-NDVKSCRGTAFWMAPEV 498
              N + +  G+  + APE+
Sbjct: 164 TFGNKLDTFCGSPPYAAPEL 183

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 87/175 (49%), Gaps = 18/175 (10%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           LG G FG V    Y+   D+ G   AVK +     G+     I+ L++EI +L    HEN
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHEN 72
Query: 392 IVQYYG--TDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHD 447
           IV+Y G  T+   + + + +E +  GSL       +  +   Q   Y  QI  G+ YL  
Sbjct: 73  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT-AFWMAPE 497
           +  VHRD+   N+LV++   VK+ DFGL KA + +     VK  R +  FW APE
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 187

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 22  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 73
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 183

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 103/185 (55%), Gaps = 10/185 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 381
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 441 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 495
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 496 PEVCS 500
           PE+ +
Sbjct: 187 PEIVN 191

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 79/140 (56%), Gaps = 2/140 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 480 KL-NDVKSCRGTAFWMAPEV 498
              N + +  G+  + APE+
Sbjct: 164 TFGNKLDTFCGSPPYAAPEL 183

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLL-DQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 23  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 184

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLL-DQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLL-DQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLL-DQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 91/175 (52%), Gaps = 16/175 (9%)
Query: 337 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL--LSRFEHENI 392
           +G G++G V++   + + G F A+K V +  Q  +    +S + +   L  L  FEH N+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+ +       TD+ E+KL +  E V +   + L+      +    +     Q+L GL +
Sbjct: 77  VRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEV 498
           LH   VVHRD+K  NILV ++G +KLADFGLA+       + S   T ++ APEV
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLL-DQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 21  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 103/185 (55%), Gaps = 10/185 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 381
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 441 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 495
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 496 PEVCS 500
           PE+ +
Sbjct: 187 PEIVN 191

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 23  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 23  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 79/140 (56%), Gaps = 2/140 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 480 KL-NDVKSCRGTAFWMAPEV 498
              N + +  G+  + APE+
Sbjct: 164 TFGNKLDTFCGSPPYAAPEL 183

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLL-DQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A++++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLL-DQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 90/176 (51%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 106
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +Y+   L+    L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 107 NDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 103/185 (55%), Gaps = 10/185 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEI 381
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +S  ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVSREEIEREV 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++L +  H N++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 441 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 495
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 496 PEVCS 500
           PE+ +
Sbjct: 187 PEIVN 191

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 97/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 88
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K     S  GTA +++PE+ +
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 85/175 (48%), Gaps = 27/175 (15%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 228 LGGGQYGEVYEGV--------WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYL 445
           Q  G    E   YI  E +T G+LL+     +LR+    +VSA        QI   ++YL
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
             ++ +HR++   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G+  G G FG VY+G  ++      K  +++D  ++  +   Q +QEI + ++ +HEN+V
Sbjct: 27  GNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ--QFDQEIKVXAKCQHENLV 84
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYL 445
           +  G   D   L +       GSLL+            +H R             G+ +L
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAAN----GINFL 140
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCR--GTAFWMAPE 497
           H+   +HRDIK ANIL+D   + K++DFGLA+A++     V   R  GT  + APE
Sbjct: 141 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE 196

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 85
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 145
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 97/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 87
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K     S  GTA +++PE+ +
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 34  LGGGQYGEVYEGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 85
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 145
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 195

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 95/179 (53%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLL-DQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 91/175 (52%), Gaps = 16/175 (9%)
Query: 337 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL--LSRFEHENI 392
           +G G++G V++   + + G F A+K V +  Q  +    +S + +   L  L  FEH N+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+ +       TD+ E+KL +  E V +   + L+      +    +     Q+L GL +
Sbjct: 77  VRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEV 498
           LH   VVHRD+K  NILV ++G +KLADFGLA+       + S   T ++ APEV
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 450
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  ++ L  + +  Y  Q+   L YL  
Sbjct: 451 PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPE 497
           +  VHRDI   N+LV +N  VKL DFGL++  + +   K+ +G     WMAPE
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 562

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 90/189 (47%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K        GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWXLXGT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 91/175 (52%), Gaps = 16/175 (9%)
Query: 337 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL--LSRFEHENI 392
           +G G++G V++   + + G F A+K V +  Q  +    +S + +   L  L  FEH N+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 393 VQYYG------TDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+ +       TD+ E+KL +  E V +   + L+      +    +     Q+L GL +
Sbjct: 77  VRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEV 498
           LH   VVHRD+K  NILV ++G +KLADFGLA+       + S   T ++ APEV
Sbjct: 136 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 78/140 (55%), Gaps = 2/140 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 480 KL-NDVKSCRGTAFWMAPEV 498
              N + +  G   + APE+
Sbjct: 164 TFGNKLDAFCGAPPYAAPEL 183

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 90/186 (48%), Gaps = 24/186 (12%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G++LG+G FG   +    + G    +KE+   D+ +Q         +E+ ++   EH N+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ-----RTFLKEVKVMRCLEHPNV 69
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDV 450
           +++ G    + +L    E +  G+L  + +        SQ  ++ + I  G+ YLH  ++
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 451 VHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCR-----------GTAFWM 494
           +HRD+   N LV  N +V +ADFGLA+      T+   ++S +           G  +WM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 495 APEVCS 500
           APE+ +
Sbjct: 190 APEMIN 195

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 90/189 (47%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
              +APE+ 
Sbjct: 202 PEALAPEII 210

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 70
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  ++ L  + +  Y  Q+   L YL  
Sbjct: 71  PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPE 497
           +  VHRDI   N+LV A   VKL DFGL++  + +   K+ +G     WMAPE
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 182

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+    +     AVK    +  GS    S+     E  ++   +H+ +V+ +
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVK---TMKPGSM---SVEAFLAEANVMKTLQHDKLVKLH 76
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA---YTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +        +     ++ QI  G+ ++  ++ +HR
Sbjct: 77  AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 135
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV A+   K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 185

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 69
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 70  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 129
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 176

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 40/197 (20%)
Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G+FG V +  +  D  ++A+K++         ++ +S +  E+ LL+   H+ +V+
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 395 YYGT-------------DKDESKLYIFLELVTKGSLLNLYQRYHL---RDSQVSAYTRQI 438
           YY                K +S L+I  E     +L +L    +L   RD     + RQI
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF-RQI 125
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-------KL---------N 482
           L  L Y+H Q ++HR++K  NI +D + +VK+ DFGLAK         KL         +
Sbjct: 126 LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 483 DVKSCRGTAFWMAPEVC 499
           ++ S  GTA ++A EV 
Sbjct: 186 NLTSAIGTAXYVATEVL 202

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 65
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 125
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 90/189 (47%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K        GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWXLAGT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 102/185 (55%), Gaps = 10/185 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSI--SQLEQEI 381
           +++  ++  G+ LG G F  V +      G  +A K +    Q   +++ +   ++E+E+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK-RQSRASRRGVCREEIEREV 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++L +  H NI+  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL 
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 441 GLKYLHDQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKLN-DVKSCRGTAFWMA 495
           G+ YLH + + H D+K  NI L+D N     +KL DFGLA   +   + K+  GT  ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 496 PEVCS 500
           PE+ +
Sbjct: 187 PEIVN 191

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 90/189 (47%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PSQNTAQLDQFDRIKT-------LGTGSFGRVMLVKHKESGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E V  G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++AP + 
Sbjct: 202 PEYLAPAII 210

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 79/140 (56%), Gaps = 2/140 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 37  VKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 96
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 97  LVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 156
Query: 480 KL-NDVKSCRGTAFWMAPEV 498
              N + +  G+  + APE+
Sbjct: 157 TFGNKLDTFCGSPPYAAPEL 176

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 93/173 (53%), Gaps = 6/173 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLSRFE 388
           +Q    LG GSFG V     +  G   A+K   ++++   AK  +  ++E+EI+ L    
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           H +I++ Y   K + ++ + +E         + QR  + + +   + +QI+  ++Y H  
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVCS 500
            +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+  + APEV S
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 175

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 101/183 (55%), Gaps = 16/183 (8%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEIAL 383
           +++ G+ LG G F  V     +G   +     +K+  L    S +++ +S  ++E+E+ +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRL----SSSRRGVSREEIEREVNI 61
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
           L    H NI+  +   ++++ + + LELV+ G L + L ++  L + + + + +QIL G+
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 443 KYLHDQDVVHRDIKCANI-LVDA---NGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPE 497
            YLH + + H D+K  NI L+D    N  +KL DFG+A K    N+ K+  GT  ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 498 VCS 500
           + +
Sbjct: 182 IVN 184

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 92/182 (50%), Gaps = 19/182 (10%)
Query: 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-----KQSISQLEQEI 381
           I  Y+   + +GRGS+G V           AV++ + + + ++       + + + +QEI
Sbjct: 7   INQYYTLENTIGRGSWGEVK---------IAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI 57
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
            ++   +H NI++ Y T +D + +Y+ +EL T G L   +  +   R+S  +   + +L 
Sbjct: 58  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 117
Query: 441 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAP 496
            + Y H  +V HRD+K  N L      +  +KL DFGLA   K   +   + GT ++++P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
Query: 497 EV 498
           +V
Sbjct: 178 QV 179

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 78/140 (55%), Gaps = 2/140 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 44  VRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 103
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF 163
Query: 480 KL-NDVKSCRGTAFWMAPEV 498
              N +    G+  + APE+
Sbjct: 164 TFGNKLDEFCGSPPYAAPEL 183

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 80/140 (57%), Gaps = 2/140 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 45  VKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDY 104
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KA 478
           L     +++ +  A  RQI+  ++Y H + +VHRD+K  N+L+D + ++K+ADFG + + 
Sbjct: 105 LVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF 164
Query: 479 TKLNDVKSCRGTAFWMAPEV 498
           T  N + +  G+  + APE+
Sbjct: 165 TVGNKLDTFCGSPPYAAPEL 184

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 33  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       +V+   + KD S LY+ +E    G + +  +R     +  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +++ DFG AK  K      C GT
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-GT 201
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 202 PEYLAPEII 210

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 85
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 145
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEV 192

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 92/182 (50%), Gaps = 19/182 (10%)
Query: 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-----KQSISQLEQEI 381
           I  Y+   + +GRGS+G V           AV++ + + + ++       + + + +QEI
Sbjct: 24  INQYYTLENTIGRGSWGEVK---------IAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI 74
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
            ++   +H NI++ Y T +D + +Y+ +EL T G L   +  +   R+S  +   + +L 
Sbjct: 75  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 134
Query: 441 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAP 496
            + Y H  +V HRD+K  N L      +  +KL DFGLA   K   +   + GT ++++P
Sbjct: 135 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 194
Query: 497 EV 498
           +V
Sbjct: 195 QV 196

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 76
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 136
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 183

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 94/176 (53%), Gaps = 6/176 (3%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSIS-QLEQEIALLS 385
           I  +Q    LG GSFG V     +  G   A+K   ++++   AK  +  ++E+EI+ L 
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLR 69
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
              H +I++ Y   K + ++ + +E         + QR  + + +   + +QI+  ++Y 
Sbjct: 70  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 129
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVCS 500
           H   +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+  + APEV S
Sbjct: 130 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 185

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 94/176 (53%), Gaps = 6/176 (3%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLS 385
           I  +Q    LG GSFG V     +  G   A+K   ++++   AK  +  ++E+EI+ L 
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLR 63
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
              H +I++ Y   K + ++ + +E         + QR  + + +   + +QI+  ++Y 
Sbjct: 64  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 123
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVCS 500
           H   +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+  + APEV S
Sbjct: 124 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 179

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +VQ Y
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 70
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +HRD
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 130
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           +   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 177

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 94/176 (53%), Gaps = 6/176 (3%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLS 385
           I  +Q    LG GSFG V     +  G   A+K   ++++   AK  +  ++E+EI+ L 
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALK---IINKKVLAKSDMQGRIEREISYLR 68
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
              H +I++ Y   K + ++ + +E         + QR  + + +   + +QI+  ++Y 
Sbjct: 69  LLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 128
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVCS 500
           H   +VHRD+K  N+L+D + +VK+ADFGL+   T  N +K+  G+  + APEV S
Sbjct: 129 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 184

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       + +   + KD S LY+ +E    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 203 PEYLAPEII 211

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/175 (34%), Positives = 88/175 (50%), Gaps = 17/175 (9%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
           +G G++G+VY+      G F A+K V +     +    IS + +E+ALL R   FEH N+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRV--PNGEEGLPISTV-REVALLRRLEAFEHPNV 68
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+         TD+ E K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 69  VRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEV 498
           LH   +VHRD+K  NILV + G+VKLADFGLA+        +      W  APEV
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEV 182

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       + +   + KD S LY+ +E    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 203 PEYLAPEII 211

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 14/189 (7%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAK- 371
           P  N +   +F+RI T       LG GSFG V      + G  +A+K   +LD+    K 
Sbjct: 34  PAQNTAHLDQFERIKT-------LGTGSFGRVMLVKHMETGNHYAMK---ILDKQKVVKL 83
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQ 430
           + I     E  +L       + +   + KD S LY+ +E    G + +  +R     +  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 143
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
              Y  QI+L  +YLH  D+++RD+K  N+++D  G +K+ DFG AK  K      C GT
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-GT 202
Query: 491 AFWMAPEVC 499
             ++APE+ 
Sbjct: 203 PEYLAPEII 211

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 93/178 (52%), Gaps = 20/178 (11%)
Query: 337 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G++G   S Y+ +  +    A+K++S  +  +  ++++    +EI +L  F HENI+
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTL----REIKILLAFRHENII 86
Query: 394 QYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +V+HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 146 NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 82
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 198

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 86
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 202

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV        G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 109
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++         + L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 169
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 85
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 201

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 101/183 (55%), Gaps = 16/183 (8%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSIS--QLEQEIAL 383
           +++ G+ LG G F  V     +G   +     +K+  L    S +++ +S  ++E+E+ +
Sbjct: 13  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRL----SSSRRGVSREEIEREVNI 68
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
           L    H NI+  +   ++++ + + LELV+ G L + L ++  L + + + + +QIL G+
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 128
Query: 443 KYLHDQDVVHRDIKCANI-LVDA---NGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPE 497
            YLH + + H D+K  NI L+D    N  +KL DFG+A K    N+ K+  GT  ++APE
Sbjct: 129 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 188
Query: 498 VCS 500
           + +
Sbjct: 189 IVN 191

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 97/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 85
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K     +  GTA +++PE+ +
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++ +    QE   + +F+H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL----QEALTMRQFDH 450
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q  ++ L  + +  Y  Q+   L YL  
Sbjct: 451 PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGT--AFWMAPE 497
           +  VHRDI   N+LV A   VKL DFGL++  + +   K+ +G     WMAPE
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 562

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 65
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 125
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 126 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 64
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 124
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 125 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VYEG+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 267 LGGGQYGEVYEGV--------WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 318
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++ 
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 378
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           +HR++   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 428

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 97/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 84
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K     S  GTA +++PE+ +
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 98/181 (54%), Gaps = 12/181 (6%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           +++ G+ LG G F  V     +G   +     +K+  L    S+   S  ++E+E+ +L 
Sbjct: 27  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRL--XSSRRGVSREEIEREVNILR 84
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKY 444
              H NI+  +   ++++ + + LELV+ G L + L ++  L + + + + +QIL G+ Y
Sbjct: 85  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 144
Query: 445 LHDQDVVHRDIKCANI-LVDA---NGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVC 499
           LH + + H D+K  NI L+D    N  +KL DFG+A K    N+ K+  GT  ++APE+ 
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 204
Query: 500 S 500
           +
Sbjct: 205 N 205

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 91
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 207

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 83/155 (53%), Gaps = 15/155 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K + +G G++G+V++  + +     A+K V L D       S  +   EI LL   +H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLK 443
           +NIV+ +     + KL +  E   +       ++Y       L    V ++  Q+L GL 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQD-----LKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           + H ++V+HRD+K  N+L++ NG +KLADFGLA+A
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLADFGLARA 150

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 85
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 201

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 88
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 149 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 62
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 122
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 123 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 82
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 198

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+    +     AVK    +  GS    S+     E  ++   +H+ +V+ +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVK---TMKPGSM---SVEAFLAEANVMKTLQHDKLVKLH 249
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---QVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +          ++  ++ QI  G+ ++  ++ +HR
Sbjct: 250 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV A+   K+ADFGLA+  + N+  +  G  F   W APE  +
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 87
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 63
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 100
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 216

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 87
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/175 (34%), Positives = 87/175 (49%), Gaps = 17/175 (9%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
           +G G++G+VY+      G F A+K V +     +    IS + +E+ALL R   FEH N+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRV--PNGEEGLPISTV-REVALLRRLEAFEHPNV 68
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+         TD+ E K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 69  VRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEV 498
           LH   +VHRD+K  NILV + G+VKLADFGLA+               W  APEV
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEV 182

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---KPFQSIIHAKRTYRELRLLKHMKH 92
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 208

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 87
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIMLN 203

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 87
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIMLN 203

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 90
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 91  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 150
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 151 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGXVATRWYRAPEIMLN 196

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 87
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYVATRWYRAPEIMLN 203

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 99
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 215

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 91/176 (51%), Gaps = 16/176 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L  F HENI+  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL----REIKILLAFRHENIIGI 88
Query: 396 YG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T +    +YI  +L+ +  L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+L++    +K+ DFGLA+    +      +     T ++ APE+  N
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 77
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 193

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGL + T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 87
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 103
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 219

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 85
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 201

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 76
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 192

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 77
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 193

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 87
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 92
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 208

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 78
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 138
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 139 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 194

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 92
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 208

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 85
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 201

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 79
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 139
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 140 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 195

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 91
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 207

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 87
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 203

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 87
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 148 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 82
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 198

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 6/162 (3%)
Query: 319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQL 377
           + N  F+ +  Y   G L+G GS+G V +  + D G   A+K+    D     K+   + 
Sbjct: 16  TENLYFQSMEKYENLG-LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR- 73
Query: 378 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTR 436
             EI LL +  HEN+V      K + + Y+  E V    L +L    +  D QV   Y  
Sbjct: 74  --EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF 131
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           QI+ G+ + H  +++HRDIK  NILV  +G VKL DFG A+ 
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART 173

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 86
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 202

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 82
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 198

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 85
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 85
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 86
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 202

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 394
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 82  VIGRGAFGEV--QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 139
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H   ++HRD
Sbjct: 140 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 199
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV
Sbjct: 200 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEV 246

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 103
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMXGYVATRWYRAPEIMLN 219

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/175 (34%), Positives = 87/175 (49%), Gaps = 17/175 (9%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
           +G G++G+VY+      G F A+K V +     +    IS + +E+ALL R   FEH N+
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRV--PNGEEGLPISTV-REVALLRRLEAFEHPNV 68
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           V+         TD+ E K+ +  E V +   + L+      L    +    RQ L GL +
Sbjct: 69  VRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 127
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEV 498
           LH   +VHRD+K  NILV + G+VKLADFGLA+               W  APEV
Sbjct: 128 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEV 182

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 100/179 (55%), Gaps = 13/179 (7%)
Query: 333 KGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           K ++LG G FG V++   +  G   A K +    +G + K+   +++ EI+++++ +H N
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKE---EVKNEISVMNQLDHAN 147
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           ++Q Y   + ++ + + +E V  G L +  + + Y+L +     + +QI  G++++H   
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 450 VVHRDIKCANILV---DANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVCSNPFV 504
           ++H D+K  NIL    DA   +K+ DFGLA+  K  + +K   GT  ++APEV +  FV
Sbjct: 208 ILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 100
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMXGXVATRWYRAPEIMLN 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 76
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 192

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 99
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 215

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 76
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIMLN 192

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 100
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 216

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 69
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 70  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 129
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 130 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 76
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKY 136
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 192

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIMLN 196

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFVATRWYRAPEIMLN 196

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 88/171 (51%), Gaps = 10/171 (5%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +HEN++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKHENVIGL 96
Query: 396 YGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                    L  F  + LVT      L N+ +   L D  V     QIL GLKY+H  D+
Sbjct: 97  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 156
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 157 IHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 206

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 86
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 202

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 93/173 (53%), Gaps = 15/173 (8%)
Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIV 393
           +G+G FG V++G +  D    A+K + L D   + +  +   + ++E+ ++S   H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQD-- 449
           + YG   +  ++   +E V  G L +  L + + ++ S        I LG++Y+ +Q+  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 450 VVHRDIKCANIL---VDANGSV--KLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +VHRD++  NI    +D N  V  K+ADFGL++ + ++ V    G   WMAPE
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-VHSVSGLLGNFQWMAPE 196

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 94/179 (52%), Gaps = 8/179 (4%)
Query: 330 YWQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLL-DQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + +  ELV  G L + L ++  L + + + + +QIL G+ YLH
Sbjct: 72  QHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 447 DQDVVHRDIKCANI-LVDAN---GSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVCS 500
              + H D+K  NI L+D N     +K+ DFGLA      N+ K+  GT  ++APE+ +
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 84
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 145 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 80/140 (57%), Gaps = 2/140 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           + ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 42  IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDY 101
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KA 478
           L     +++ +  +  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG + + 
Sbjct: 102 LVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 161
Query: 479 TKLNDVKSCRGTAFWMAPEV 498
           T    + +  G+  + APE+
Sbjct: 162 TVGGKLDTFCGSPPYAAPEL 181

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ D+GLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 83/155 (53%), Gaps = 15/155 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K + +G G++G+V++  + +     A+K V L D       S  +   EI LL   +H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLK 443
           +NIV+ +     + KL +  E   +       ++Y       L    V ++  Q+L GL 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQD-----LKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           + H ++V+HRD+K  N+L++ NG +KLA+FGLA+A
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA 150

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 94/178 (52%), Gaps = 20/178 (11%)
Query: 337 LGRGSFG---SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +G G++G   S Y+ +       A+K++S  +  +  ++++    +EI +L RF HEN++
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRV--AIKKISPFEHQTYCQRTL----REIQILLRFRHENVI 104
Query: 394 QY-----YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    T +    +YI  +L+ +  L  L +   L +  +  +  QIL GLKY+H  
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLM-ETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSA 163
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLND----VKSCRGTAFWMAPEVCSN 501
           +V+HRD+K +N+L++    +K+ DFGLA+ A   +D    +     T ++ APE+  N
Sbjct: 164 NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 95/180 (52%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +         S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 85
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y T +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 101/194 (52%), Gaps = 26/194 (13%)
Query: 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           G+F+ +  Y    +LLG G++  V   +S  +G  +AVK +       QA  S S++ +E
Sbjct: 8   GKFEDM--YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIE-----KQAGHSRSRVFRE 60
Query: 381 IALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQI 438
           +  L + + ++NI++     +D+++ Y+  E +  GS+L ++ ++ H  + + S   R +
Sbjct: 61  VETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDV 120
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVKSCR------- 488
              L +LH + + HRD+K  NIL ++      VK+ DF L    KLN+  SC        
Sbjct: 121 AAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNN--SCTPITTPEL 178
Query: 489 ----GTAFWMAPEV 498
               G+A +MAPEV
Sbjct: 179 TTPCGSAEYMAPEV 192

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 6/167 (3%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 394
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 76  VIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 193
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 6/167 (3%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 394
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 81  VIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 138
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 198
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV
Sbjct: 199 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 13/170 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G  G V+ G  +     AVK    L QGS +  +      E  L+ + +H+ +V+ Y
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLA---EANLMKQLQHQRLVRLY 74
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E +  GSL++  +      L  +++     QI  G+ ++ +++ +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           D++ ANILV    S K+ADFGLA+  +  +  +  G  F   W APE  +
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAIN 183

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 80/186 (43%), Gaps = 31/186 (16%)
Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+           D    AVK  +L D    A++      +E  LL+  +HE
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKD---FHREAELLTNLQHE 75
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------LRDSQVSAYT 435
           +IV++YG   +   L +  E +  G L N + R H               L  SQ+    
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
           +QI  G+ YL  Q  VHRD+   N LV  N  VK+ DFG+++     D     G      
Sbjct: 135 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 493 -WMAPE 497
            WM PE
Sbjct: 195 RWMPPE 200

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 79/140 (56%), Gaps = 2/140 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           + ++D+      S+ +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + 
Sbjct: 45  IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDY 104
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KA 478
           L     +++ +  +  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG + + 
Sbjct: 105 LVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
Query: 479 TKLNDVKSCRGTAFWMAPEV 498
           T    + +  G   + APE+
Sbjct: 165 TVGGKLDAFCGAPPYAAPEL 184

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI----SQLEQEIALLSRFEHE 390
           D+LG G+F  V   +++D      +   L+     AK+++      +E EIA+L + +H 
Sbjct: 24  DVLGTGAFSEVI--LAEDK-----RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 76
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 450 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVCSN 501
           +VHRD+K  N+L   +D +  + ++DFGL+K      V S   GT  ++APEV + 
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++LGRG FG VY+G   DG   AVK +    +  + +    Q + E+ ++S   H N+++
Sbjct: 44  NILGRGGFGKVYKGRLADGTLVAVKRL----KEERXQGGELQFQTEVEMISMAVHRNLLR 99
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-----GLKYLHDQ- 448
             G     ++  +    +  GS+ +  +        +    RQ +      GL YLHD  
Sbjct: 100 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 159
Query: 449 --DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVCSN 501
              ++HRD+K ANIL+D      + DFGLAK     D     + RGT   +APE  S 
Sbjct: 160 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLST 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI----SQLEQEIALLSRFEHE 390
           D+LG G+F  V   +++D      +   L+     AK+++      +E EIA+L + +H 
Sbjct: 24  DVLGTGAFSEVI--LAEDK-----RTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 450 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVCSN 501
           +VHRD+K  N+L   +D +  + ++DFGL+K      V S   GT  ++APEV + 
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 75/140 (53%), Gaps = 2/140 (1%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V ++D+      S+ +L +E+ +     H NIV+ +   + E  LY+  E  + G + + 
Sbjct: 44  VKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDY 103
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
           L      ++ +  A  RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +   
Sbjct: 104 LVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEF 163
Query: 480 KL-NDVKSCRGTAFWMAPEV 498
              N + +  G   + APE+
Sbjct: 164 TFGNKLDAFCGAPPYAAPEL 183

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI----SQLEQEIALLSRFEHE 390
           D+LG G+F  V   +++D      +   L+     AK+++      +E EIA+L + +H 
Sbjct: 24  DVLGTGAFSEVI--LAEDK-----RTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 450 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVCSN 501
           +VHRD+K  N+L   +D +  + ++DFGL+K      V S   GT  ++APEV + 
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 6/167 (3%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 394
           ++GRG+FG V   +        V  + LL +    K+S S    E   +  F +   +VQ
Sbjct: 81  VIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 138
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
            +   +D+  LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 198
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           +K  N+L+D +G +KLADFG         +  C    GT  +++PEV
Sbjct: 199 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 90/168 (53%), Gaps = 7/168 (4%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE---IALLSRFEHEN 391
           ++GRG FG VY    +D G  +A+K   L  +  + KQ  +    E   ++L+S  +   
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           IV          KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H++ V
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           V+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 361

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 90/168 (53%), Gaps = 7/168 (4%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE---IALLSRFEHEN 391
           ++GRG FG VY    +D G  +A+K   L  +  + KQ  +    E   ++L+S  +   
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 252
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           IV          KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H++ V
Sbjct: 253 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 312
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           V+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV
Sbjct: 313 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 360

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI----SQLEQEIALLSRFEHE 390
           D+LG G+F  V   +++D      +   L+     AK+++      +E EIA+L + +H 
Sbjct: 24  DVLGTGAFSEVI--LAEDK-----RTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD  
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 450 VVHRDIKCANIL---VDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVCSN 501
           +VHRD+K  N+L   +D +  + ++DFGL+K      V S   GT  ++APEV + 
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 82/189 (43%), Gaps = 34/189 (17%)
Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+         + D    AVK  +L D    A++     ++E  LL+  +HE
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHE 77
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------------SQVS 432
           +IV++YG   D   L +  E +  G L N + R H  D                  SQ+ 
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
               QI  G+ YL  Q  VHRD+   N LV AN  VK+ DFG+++     D     G   
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 493 ----WMAPE 497
               WM PE
Sbjct: 197 LPIRWMPPE 205

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 95/180 (52%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIALLS 385
           ++ G +LG GSF +V        S +   +A+K   +L++    K++ +  + +E  ++S
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSRE---YAIK---ILEKRHIIKENKVPYVTRERDVMS 92
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-AYTRQILLGLKY 444
           R +H   V+ Y   +D+ KLY  L     G LL   ++    D   +  YT +I+  L+Y
Sbjct: 93  RLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 152
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCS 500
           LH + ++HRD+K  NIL++ +  +++ DFG AK     +K        GTA +++PE+ +
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXXKKTT 217
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 218 NGRLPVKWMAPE 229

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 90/168 (53%), Gaps = 7/168 (4%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE---IALLSRFEHEN 391
           ++GRG FG VY    +D G  +A+K   L  +  + KQ  +    E   ++L+S  +   
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           IV          KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H++ V
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           V+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 361

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 90/168 (53%), Gaps = 7/168 (4%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE---IALLSRFEHEN 391
           ++GRG FG VY    +D G  +A+K   L  +  + KQ  +    E   ++L+S  +   
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK--CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           IV          KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H++ V
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           V+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 361

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 263
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 264 NGRLPVKWMAPE 275

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 82/169 (48%), Gaps = 2/169 (1%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           ++ G  LG+G FG+VY        F    +V L     + +    QL +EI + +   H 
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKV-LFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-GLKYLHDQD 449
           NI++ Y    D  ++Y+ LE   +G L    Q+    D Q +A   + L   L Y H + 
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK 143
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           V+HRDIK  N+L+   G +K+ADFG +        K+  GT  ++ PE+
Sbjct: 144 VIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEM 192

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKNTT 217
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 218 NGRLPVKWMAPE 229

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 12/175 (6%)
Query: 336 LLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           ++G G FG VY+G+  +  G       +  L  G   KQ +  L  E  ++ +F H NI+
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFSHHNII 109
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVV 451
           +  G       + I  E +  G+L    +      S  Q+    R I  G+KYL + + V
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF------WMAPEVCS 500
           HRD+   NILV++N   K++DFGL++  + +D ++   T+       W APE  S
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAIS 223

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 27/175 (15%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENIV 393
           LG G +G VY G+         K+ SL       K+   ++E+   E A++   +H N+V
Sbjct: 40  LGGGQYGEVYVGVW--------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 91
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKYL 445
           Q  G    E   YI  E +  G+LL+     +LR+      T  +LL         ++YL
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLD-----YLRECNREEVTAVVLLYMATQISSAMEYL 146
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
             ++ +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE
Sbjct: 147 EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 201

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDXXKKTT 217
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 218 NGRLPVKWMAPE 229

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+  FGLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 92/173 (53%), Gaps = 15/173 (8%)
Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIV 393
           +G+G FG V++G +  D    A+K + L D   + +  +   + ++E+ ++S   H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQD-- 449
           + YG   +  ++   +E V  G L +  L + + ++ S        I LG++Y+ +Q+  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 450 VVHRDIKCANIL---VDANGSV--KLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +VHRD++  NI    +D N  V  K+ADFG ++ + ++ V    G   WMAPE
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-VHSVSGLLGNFQWMAPE 196

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 218 NGRLPVKWMAPE 229

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 218 NGRLPVKWMAPE 229

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 218 NGRLPVKWMAPE 229

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++LGRG FG VY+G   DG   AVK   L ++ +Q  +   Q + E+ ++S   H N+++
Sbjct: 36  NILGRGGFGKVYKGRLADGXLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLR 91
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-----GLKYLHDQ- 448
             G     ++  +    +  GS+ +  +        +    RQ +      GL YLHD  
Sbjct: 92  LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151
Query: 449 --DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVCSN 501
              ++HRD+K ANIL+D      + DFGLAK     D     + RG    +APE  S 
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLST 209

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 95
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ D GLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 92/173 (53%), Gaps = 15/173 (8%)
Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIV 393
           +G+G FG V++G +  D    A+K + L D   + +  +   + ++E+ ++S   H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQD-- 449
           + YG   +  ++   +E V  G L +  L + + ++ S        I LG++Y+ +Q+  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 450 VVHRDIKCANIL---VDANGSV--KLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +VHRD++  NI    +D N  V  K+ADF L++ + ++ V    G   WMAPE
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-VHSVSGLLGNFQWMAPE 196

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 87
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 148 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 207

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 88/171 (51%), Gaps = 10/171 (5%)
Query: 336 LLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +LG+G +G V++      ++ G  FA+K +        AK + +  + E  +L   +H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT-AHTKAERNILEEVKHPF 82
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDV 450
           IV      +   KLY+ LE ++ G L    +R  +  +     Y  +I + L +LH + +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEV 498
           ++RD+K  NI+++  G VKL DFGL K + ++D     +  GT  +MAPE+
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGTVTHTFCGTIEYMAPEI 192

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 91/179 (50%), Gaps = 11/179 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++  +++G+G F  V   I+ + G  FAVK V +    S    S   L++E ++    +H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQR----YHLRDSQVSAYTRQILLGLKY 444
            +IV+   T   +  LY+  E +    L   + +R    +   ++  S Y RQIL  L+Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 445 LHDQDVVHRDIKCANILV---DANGSVKLADFGLA-KATKLNDVKSCR-GTAFWMAPEV 498
            HD +++HRD+K   +L+   + +  VKL  FG+A +  +   V   R GT  +MAPEV
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 206

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 147 VSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 204
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 205 NGRLPVKWMAPE 216

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 152 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 209
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 210 NGRLPVKWMAPE 221

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 149 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 206
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 207 NGRLPVKWMAPE 218

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 96
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 216

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ D GLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 12/177 (6%)
Query: 337 LGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG V+  +    + +     +K+  +L+        + ++  EIA+LSR EH NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYT-RQILLGLKYLHDQ 448
           ++    D  E++ +  L +   GS L+L+    R+   D  +++Y  RQ++  + YL  +
Sbjct: 92  IKV--LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK 149
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVC-SNPF 503
           D++HRDIK  NI++  + ++KL DFG A   +   +  +  GT  + APEV   NP+
Sbjct: 150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPY 206

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 112
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 173 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 232

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ D GLA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 9/169 (5%)
Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEHENI 392
           ++G+GSFG V       +  F+AVK   +L + +  + K+    + +   LL   +H  +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVK---VLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
           V  + + +   KLY  L+ +  G L    QR     + +   Y  +I   L YLH  ++V
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 161
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEV 498
           +RD+K  NIL+D+ G + L DFGL K    ++  +    GT  ++APEV
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 10/177 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    +G G++GSV     +  G   AVK++S   +  Q+     +  +E+ LL   +H
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS---RPFQSIIHAKRTYRELRLLKHMKH 80
Query: 390 ENIVQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           EN++           L  F  + LVT      L N+ +   L D  V     QIL GLKY
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +H  D++HRD+K +N+ V+ +  +K+ DF LA+ T  +++     T ++ APE+  N
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTD-DEMTGYVATRWYRAPEIMLN 196

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 91/179 (50%), Gaps = 11/179 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++  +++G+G F  V   I+ + G  FAVK V +    S    S   L++E ++    +H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQR----YHLRDSQVSAYTRQILLGLKY 444
            +IV+   T   +  LY+  E +    L   + +R    +   ++  S Y RQIL  L+Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 445 LHDQDVVHRDIKCANILV---DANGSVKLADFGLA-KATKLNDVKSCR-GTAFWMAPEV 498
            HD +++HRD+K   +L+   + +  VKL  FG+A +  +   V   R GT  +MAPEV
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 96
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPE 216

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 113
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 174 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 233

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 95
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I +EL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 215

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +E  +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +++ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLAR--DINNIDYYKKTT 217
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 218 NGRLPVKWMAPE 229

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 122
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 183 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 242

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 102
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 163 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 222

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 66/233 (28%)
Query: 330 YWQKGDLL------------GRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAK---QSI 374
           Y+Q G LL            G+GS+G V   I +     A++ + ++++    +   + +
Sbjct: 15  YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTR--AIRAIKIMNKNKIRQINPKDV 72
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL---NLY---------- 421
            +++ E+ L+ +  H NI + Y   +DE  + + +EL   G LL   N++          
Sbjct: 73  ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 422 ----------------------------QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
                                         +  R+  +S   RQI   L YLH+Q + HR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 454 DIKCANILVDANGS--VKLADFGLAKA-TKLND-----VKSCRGTAFWMAPEV 498
           DIK  N L   N S  +KL DFGL+K   KLN+     + +  GT +++APEV
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 80/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V    QG   K       +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QGKAFKN------RELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 86/170 (50%), Gaps = 8/170 (4%)
Query: 336 LLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +LG+G +G V++      ++ G  FA+K +        AK + +  + E  +L   +H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT-AHTKAERNILEEVKHPF 82
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDV 450
           IV      +   KLY+ LE ++ G L    +R  +  +     Y  +I + L +LH + +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEV 498
           ++RD+K  NI+++  G VKL DFGL K +  +   +    GT  +MAPE+
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEI 192

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 136
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE 256

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 90/174 (51%), Gaps = 23/174 (13%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENI 392
           +++GRG+FG V +        +  K+V++  ++  S+ K  I +L Q    LSR  H NI
Sbjct: 15  EVVGRGAFGVVCKAK------WRAKDVAIKQIESESERKAFIVELRQ----LSRVNHPNI 64
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQ 448
           V+ YG   +   + + +E    GSL N+        +   +   ++  Q   G+ YLH  
Sbjct: 65  VKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 449 D---VVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
               ++HRD+K  N+L+ A G+V K+ DFG A   + +   + +G+A WMAPEV
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-KGSAAWMAPEV 175

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSE--QDELDFLMEALIISKFNHQNI 110
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 91/166 (54%), Gaps = 17/166 (10%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           ++ ++K   +G+G+FG V++      G   A+K+V  L +  +    I+ L +EI +L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQL 73
Query: 387 FEHENIVQYYGT--------DKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYT 435
            +HEN+V             ++ ++ +Y+   F E    G L N+  ++ L  S++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 131
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
           + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A  L
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 177

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 90/166 (54%), Gaps = 17/166 (10%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           ++ ++K   +G+G+FG V++      G   A+K+V  L +  +    I+ L +EI +L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQL 73
Query: 387 FEHENIVQYYGT--------DKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYT 435
            +HEN+V             ++ +  +Y+   F E    G L N+  ++ L  S++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 131
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
           + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A  L
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 177

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/182 (32%), Positives = 88/182 (48%), Gaps = 23/182 (12%)
Query: 329 TYWQKGDL-LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
            +W    L LGRGSFG V+  + D   GF  AVK+V L          + + E E+   +
Sbjct: 92  VHWATHQLRLGRGSFGEVHR-MEDKQTGFQCAVKKVRL---------EVFRAE-ELMACA 140
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKY 444
                 IV  YG  ++   + IF+EL+  GSL  L +    L + +   Y  Q L GL+Y
Sbjct: 141 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEY 200
Query: 445 LHDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLNDVKS-------CRGTAFWMAP 496
           LH + ++H D+K  N+L+ ++GS   L DFG A   + + +           GT   MAP
Sbjct: 201 LHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAP 260
Query: 497 EV 498
           EV
Sbjct: 261 EV 262

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+F H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNI 110
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I +EL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 90/174 (51%), Gaps = 23/174 (13%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENI 392
           +++GRG+FG V +        +  K+V++  ++  S+ K  I +L Q    LSR  H NI
Sbjct: 14  EVVGRGAFGVVCKAK------WRAKDVAIKQIESESERKAFIVELRQ----LSRVNHPNI 63
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQ 448
           V+ YG   +   + + +E    GSL N+        +   +   ++  Q   G+ YLH  
Sbjct: 64  VKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 449 D---VVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
               ++HRD+K  N+L+ A G+V K+ DFG A   + +   + +G+A WMAPEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-KGSAAWMAPEV 174

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 87/186 (46%), Gaps = 17/186 (9%)
Query: 328 ITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           ++Y +  +++G G FG V  G +   G   +   +  L  G   +Q   +   E +++ +
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASIMGQ 73
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILLG 441
           FEH NI++  G   +   + I  E +  G+L +  +   L D Q +        R I  G
Sbjct: 74  FEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASG 130
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WM 494
           ++YL +   VHRD+   NILV++N   K++DFGL++  + N       ++        W 
Sbjct: 131 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 495 APEVCS 500
           APE  +
Sbjct: 191 APEAIA 196

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 96/178 (53%), Gaps = 23/178 (12%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEI-ALLSR 386
           +LG+GSFG V     +G  +    +A+K    +V + D   +     + +E+ + ALL +
Sbjct: 26  VLGKGSFGKVMLADRKGTEE---LYAIKILKKDVVIQDDDVEC----TMVEKRVLALLDK 78
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYL 445
                + Q +   +   +LY  +E V  G L+ ++ Q    ++ Q   Y  +I +GL +L
Sbjct: 79  --PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVCS 500
           H + +++RD+K  N+++D+ G +K+ADFG+ K   ++ V +   C GT  ++APE+ +
Sbjct: 137 HKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFC-GTPDYIAPEIIA 193

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/182 (32%), Positives = 88/182 (48%), Gaps = 23/182 (12%)
Query: 329 TYWQKGDL-LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
            +W    L LGRGSFG V+  + D   GF  AVK+V L          + + E E+   +
Sbjct: 73  VHWATHQLRLGRGSFGEVHR-MEDKQTGFQCAVKKVRL---------EVFRAE-ELMACA 121
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKY 444
                 IV  YG  ++   + IF+EL+  GSL  L +    L + +   Y  Q L GL+Y
Sbjct: 122 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEY 181
Query: 445 LHDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLNDVKS-------CRGTAFWMAP 496
           LH + ++H D+K  N+L+ ++GS   L DFG A   + + +           GT   MAP
Sbjct: 182 LHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAP 241
Query: 497 EV 498
           EV
Sbjct: 242 EV 243

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 12/170 (7%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENI 392
           +LG G FG VYEG+  +      +++++  +  +   ++   E+   E  ++   +H +I
Sbjct: 31  ILGEGFFGEVYEGVYTN---HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDV 450
           V+  G  ++E   +I +EL   G L +  +R    L+   +  Y+ QI   + YL   + 
Sbjct: 88  VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 146
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           VHRDI   NILV +   VKL DFGL++  +  D      T     WM+PE
Sbjct: 147 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 196

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 88/175 (50%), Gaps = 26/175 (14%)
Query: 337 LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LGRGSFG V+  + D   GF  AVK+V L          + ++E+ +A  +      IV 
Sbjct: 80  LGRGSFGEVHR-MKDKQTGFQCAVKKVRL---------EVFRVEELVAC-AGLSSPRIVP 128
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            YG  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL+YLH + ++H 
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 188
Query: 454 DIKCANILVDANGS-VKLADF---------GLAKATKLNDVKSCRGTAFWMAPEV 498
           D+K  N+L+ ++GS   L DF         GL K+    D     GT   MAPEV
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP--GTETHMAPEV 241

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 80/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V    QG   K       +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QGKAFKN------RELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 80/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V    QG   K       +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QGKAFKN------RELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 90/166 (54%), Gaps = 17/166 (10%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           ++ ++K   +G+G+FG V++      G   A+K+V  L +  +    I+ L +EI +L  
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQL 72
Query: 387 FEHENIVQYYGT--------DKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYT 435
            +HEN+V             ++ +  +Y+   F E    G L N+  ++ L  S++    
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 130
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
           + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A  L
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 12/170 (7%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENI 392
           +LG G FG VYEG+  +      +++++  +  +   ++   E+   E  ++   +H +I
Sbjct: 15  ILGEGFFGEVYEGVYTNH---KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDV 450
           V+  G  ++E   +I +EL   G L +  +R    L+   +  Y+ QI   + YL   + 
Sbjct: 72  VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 130
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           VHRDI   NILV +   VKL DFGL++  +  D      T     WM+PE
Sbjct: 131 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 180

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 90/166 (54%), Gaps = 17/166 (10%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           ++ ++K   +G+G+FG V++      G   A+K+V  L +  +    I+ L +EI +L  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITAL-REIKILQL 73
Query: 387 FEHENIVQYYGT--------DKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYT 435
            +HEN+V             ++ +  +Y+   F E    G L N+  ++ L  S++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL--SEIKRVM 131
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
           + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A  L
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 177

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 12/170 (7%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ---EIALLSRFEHENI 392
           +LG G FG VYEG+  +      +++++  +  +   ++   E+   E  ++   +H +I
Sbjct: 19  ILGEGFFGEVYEGVYTN---HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDV 450
           V+  G  ++E   +I +EL   G L +  +R    L+   +  Y+ QI   + YL   + 
Sbjct: 76  VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
           VHRDI   NILV +   VKL DFGL++  +  D      T     WM+PE
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 184

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 64/113 (56%), Gaps = 3/113 (2%)
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCR-GTAFWMAPEV 498
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S   GT  ++APE+
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 224

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +   +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 218 NGRLPVKWMAPE 229

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 25/177 (14%)
Query: 320 PNGRFKRIITYWQKGD------LLGRGSFGSVYEGISD-DGFFFAVKEV-----SLLDQG 367
           P     R  + WQ  D      L+G GS+G V E     +    A+K++      L+D  
Sbjct: 38  PTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID-- 95
Query: 368 SQAKQSISQLEQEIALLSRFEHENIVQYYGT--DKDESK---LYIFLELVTKGSLLNLYQ 422
                   ++ +EIA+L+R  H+++V+       KD  K   LY+ LE+           
Sbjct: 96  ------CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT 149
Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
             +L +  +      +L+G+KY+H   ++HRD+K AN LV+ + SVK+ DFGLA+  
Sbjct: 150 PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 88/175 (50%), Gaps = 26/175 (14%)
Query: 337 LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRGSFG V+  + D   GF  AVK+V L          + ++E+ +A  +      IV 
Sbjct: 66  VGRGSFGEVHR-MKDKQTGFQCAVKKVRL---------EVFRVEELVAC-AGLSSPRIVP 114
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            YG  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL+YLH + ++H 
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 174
Query: 454 DIKCANILVDANGS-VKLADF---------GLAKATKLNDVKSCRGTAFWMAPEV 498
           D+K  N+L+ ++GS   L DF         GL K+    D     GT   MAPEV
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP--GTETHMAPEV 227

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 93/180 (51%), Gaps = 24/180 (13%)
Query: 335 DLLGRGSFGS-VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
           D+LG G+ G+ VY G+ D+    AVK +          +  S  ++E+ LL    EH N+
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDV-AVKRI--------LPECFSFADREVQLLRESDEHPNV 80
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDV 450
           ++Y+ T+KD    YI +EL        + Q+   HL    ++   +Q   GL +LH  ++
Sbjct: 81  IRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL-LQQTTSGLAHLHSLNI 139
Query: 451 VHRDIKCANILV---DANGSVK--LADFGLAKATKLNDVKSCR-----GTAFWMAPEVCS 500
           VHRD+K  NIL+   +A+G +K  ++DFGL K   +      R     GT  W+APE+ S
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 84/159 (52%), Gaps = 26/159 (16%)
Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           + +G G++G V        G   A+K++ +  D  + AK+++    +E+ +L  F+H+NI
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL----RELKILKHFKHDNI 116
Query: 393 VQY---------YGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQIL 439
           +           YG  K    +Y+ L+L+      +L+Q  H    L    V  +  Q+L
Sbjct: 117 IAIKDILRPTVPYGEFKS---VYVVLDLMES----DLHQIIHSSQPLTLEHVRYFLYQLL 169
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            GLKY+H   V+HRD+K +N+LV+ N  +K+ DFG+A+ 
Sbjct: 170 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 208

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      GI  D    AV     + +    ++ +S L  E+ ++    +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-----------------LNLYQRYHLRDSQV 431
           H+NI+   G    +  LY+ +   +KG+L                 +N      +    +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
            + T Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+   +N++   + T 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKKTT 217
Query: 492 F------WMAPE 497
                  WMAPE
Sbjct: 218 NGRLPVKWMAPE 229

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 32/199 (16%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           KR    +++ +L+G G FG V++     DG  + +K V         K +  + E+E+  
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---------KYNNEKAEREVKA 57
Query: 384 LSRFEHENIVQYYG-----------TDKDESK-----LYIFLELVTKGSLLN-LYQRYHL 426
           L++ +H NIV Y G           + K+ S+     L+I +E   KG+L   + +R   
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 427 RDSQVSAYT--RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484
           +  +V A     QI  G+ Y+H + +++RD+K +NI +     VK+ DFGL  + K ND 
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDG 176
Query: 485 KSCR--GTAFWMAPEVCSN 501
           K  R  GT  +M+PE  S+
Sbjct: 177 KRXRSKGTLRYMSPEQISS 195

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 13/177 (7%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS------QLEQEIALLSRFEH 389
            +  GS+G+V  G+  +G   A+K V       +    +S      ++ +EI LL+ F H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 390 ENI-----VQYYGTDKDESKLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLK 443
            NI     +  +  +    KLY+  EL+       ++ QR  +    +  +   ILLGL 
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVC 499
            LH+  VVHRD+   NIL+  N  + + DF LA+    +  K+   T  W  APE+ 
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 87/186 (46%), Gaps = 17/186 (9%)
Query: 328 ITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           ++Y +  +++G G FG V  G +   G   +   +  L  G   +Q   +   E +++ +
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASIMGQ 71
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILLG 441
           FEH NI++  G   +   + I  E +  G+L +  +   L D Q +        R I  G
Sbjct: 72  FEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASG 128
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WM 494
           ++YL +   VHRD+   NILV++N   K++DFGL++  + N       ++        W 
Sbjct: 129 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 495 APEVCS 500
           APE  +
Sbjct: 189 APEAIA 194

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 108
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 169 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 65/114 (57%), Gaps = 5/114 (4%)
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 139
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEV 498
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S  C GT  ++APE+
Sbjct: 140 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEI 192

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 106
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 77/180 (42%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+  H+NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKLNHQNI 96
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 216

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 106
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 13/177 (7%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS------QLEQEIALLSRFEH 389
            +  GS+G+V  G+  +G   A+K V       +    +S      ++ +EI LL+ F H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 390 ENI-----VQYYGTDKDESKLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLK 443
            NI     +  +  +    KLY+  EL+       ++ QR  +    +  +   ILLGL 
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVC 499
            LH+  VVHRD+   NIL+  N  + + DF LA+    +  K+   T  W  APE+ 
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 21/154 (13%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H NIV+
Sbjct: 65  VIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDHCNIVR 115
Query: 395 --YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQILLGLKY 444
             Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+   L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 445 LHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
           +H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 176 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 209

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 88/175 (50%), Gaps = 26/175 (14%)
Query: 337 LGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRGSFG V+  + D   GF  AVK+V L          + ++E+ +A  +      IV 
Sbjct: 82  VGRGSFGEVHR-MKDKQTGFQCAVKKVRL---------EVFRVEELVAC-AGLSSPRIVP 130
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
            YG  ++   + IF+EL+  GSL  L ++   L + +   Y  Q L GL+YLH + ++H 
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 190
Query: 454 DIKCANILVDANGS-VKLADF---------GLAKATKLNDVKSCRGTAFWMAPEV 498
           D+K  N+L+ ++GS   L DF         GL K+    D     GT   MAPEV
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP--GTETHMAPEV 243

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 20/197 (10%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS 375
           S  S +GRF+ +  Y  + D+LG G+   V   I+        +E ++     Q     S
Sbjct: 2   STDSFSGRFEDV--YQLQEDVLGEGAHARVQTCIN----LITSQEYAVKIIEKQPGHIRS 55
Query: 376 QLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSA 433
           ++ +E+ +L + + H N+++     ++E + Y+  E +  GS+L ++++R H  + + S 
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV 115
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLN-------- 482
             + +   L +LH++ + HRD+K  NIL +       VK+ DFGL    KLN        
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIST 175
Query: 483 -DVKSCRGTAFWMAPEV 498
            ++ +  G+A +MAPEV
Sbjct: 176 PELLTPCGSAEYMAPEV 192

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 100
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 161 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 199

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 151
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 212 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 250

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 94/180 (52%), Gaps = 10/180 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFF-FAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 385
           ++  ++LGRG    V   I       +AVK + +   GS + + + +L +    E+ +L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 386 RFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
           +   H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEV--CS 500
            LH  ++VHRD+K  NIL+D + ++KL DFG + +      ++S  GT  ++APE+  CS
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECS 198

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 77/180 (42%), Gaps = 21/180 (11%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LG G+FG VYEG    + +D     V   +L +  S+  Q       E  ++S+  H+NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKLNHQNI 110
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY--------TRQILLGLKY 444
           V+  G        +I LEL+  G L +  +    R SQ S+          R I  G +Y
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
           L +   +HRDI   N L+   G     K+ DFG+A+           G A     WM PE
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE 230

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 65/114 (57%), Gaps = 5/114 (4%)
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEV 498
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S  C GT  ++APE+
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEI 181

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVK-EVSLLDQGSQ----------AKQSISQLEQEIALLS 385
           L +G F  +     D+ F+   K E SLL++              K      + E+ +++
Sbjct: 39  LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT---------R 436
             ++E  +   G   +  ++YI  E +   S+L   + + + D   + +          +
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 437 QILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            +L    Y+H++ ++ HRD+K +NIL+D NG VKL+DFG ++      +K  RGT  +M 
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMP 218
Query: 496 PEVCSN 501
           PE  SN
Sbjct: 219 PEFFSN 224

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 84
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 145 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 90/182 (49%), Gaps = 12/182 (6%)
Query: 325 KRIITYWQKGDLLGRGSFGSV-----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           KR I  +   + LG GSFG V     Y+        F  ++  LL +         ++E+
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMH----MRVER 58
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
           EI+ L    H +I++ Y      + + + +E         + ++  + + +   + +QI+
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQII 118
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEV 498
             ++Y H   +VHRD+K  N+L+D N +VK+ADFGL+   T  N +K+  G+  + APEV
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
Query: 499 CS 500
            +
Sbjct: 179 IN 180

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 65/114 (57%), Gaps = 5/114 (4%)
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
           H  +V  +   + ES+L+  +E V  G L+   QR   L +     Y+ +I L L YLH+
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEV 498
           + +++RD+K  N+L+D+ G +KL D+G+ K   +  D  S  C GT  ++APE+
Sbjct: 125 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEI 177

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 17/175 (9%)
Query: 336 LLGRGSFGSVYEG-ISDDG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G +   G    F A+K    L  G   KQ    L  E +++ +F+H N
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKT---LKSGYTEKQRRDFLS-EASIMGQFDHPN 95
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 449
           ++   G     + + I  E +  GSL +  ++        Q+    R I  G+KYL D +
Sbjct: 96  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 155
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WMAPE 497
            VHRD+   NILV++N   K++DFGL++  + +       +A        W APE
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 26/158 (16%)
Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           + +G G++G V        G   A+K++ +  D  + AK+++    +E+ +L  F+H+NI
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL----RELKILKHFKHDNI 115
Query: 393 VQY---------YGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQIL 439
           +           YG  K    +Y+ L+L+      +L+Q  H    L    V  +  Q+L
Sbjct: 116 IAIKDILRPTVPYGEFKS---VYVVLDLMES----DLHQIIHSSQPLTLEHVRYFLYQLL 168
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            GLKY+H   V+HRD+K +N+LV+ N  +K+ DFG+A+
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 91
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 152 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 190

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 80
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 141 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 179

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 91/171 (53%), Gaps = 12/171 (7%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V    + +    +A+K ++  +   +A+ +  + E+++  L   + + I  
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV--LVNGDCQWITA 138
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
            +   +DE+ LY+ ++    G LL L  ++   L +     Y  +++L +  +H    VH
Sbjct: 139 LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH 198
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEV 498
           RDIK  N+L+D NG ++LADFG     K+ND  + +     GT  +++PE+
Sbjct: 199 RDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEI 247

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G FG V+    +     AVK    +  GS    S+     E  ++   +H+ +V+ +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVK---TMKPGSM---SVEAFLAEANVMKTLQHDKLVKLH 243
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---QVSAYTRQILLGLKYLHDQDVVHR 453
                E  +YI  E + KGSLL+  +          ++  ++ QI  G+ ++  ++ +HR
Sbjct: 244 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 302
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCS 500
           D++ ANILV A+   K+ADFGLA+      +K       W APE  +
Sbjct: 303 DLRAANILVSASLVCKIADFGLARVGAKFPIK-------WTAPEAIN 342

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 77
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 138 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 176

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 84
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 145 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 16/183 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFF-FAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 385
           ++  ++LGRG    V   I       +AVK + +   GS + + + +L +    E+ +L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 386 RFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
           +   H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEV- 498
            LH  ++VHRD+K  NIL+D + ++KL DFG    L    KL +V  C GT  ++APE+ 
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--C-GTPSYLAPEII 195
Query: 499 -CS 500
            CS
Sbjct: 196 ECS 198

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 85
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 146 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 184

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 91/171 (53%), Gaps = 12/171 (7%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V    + +    +A+K ++  +   +A+ +  + E+++  L   + + I  
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV--LVNGDCQWITA 154
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
            +   +DE+ LY+ ++    G LL L  ++   L +     Y  +++L +  +H    VH
Sbjct: 155 LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH 214
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEV 498
           RDIK  N+L+D NG ++LADFG     K+ND  + +     GT  +++PE+
Sbjct: 215 RDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEI 263

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 30/190 (15%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 41  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 96
Query: 388 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR-------------YHLRDSQV 431
              +HENIV   G       + +  E    G LLN  +R               LRD  +
Sbjct: 97  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD--L 154
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
             ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G A
Sbjct: 155 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 492 ----FWMAPE 497
                WMAPE
Sbjct: 215 RLPVKWMAPE 224

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 12/173 (6%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 15  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 70
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 71  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 130
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSN 501
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K+  GT  ++APEV  +
Sbjct: 131 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLED 182

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 73
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 134 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 172

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 15/173 (8%)
Query: 334 GDLLGRGSFGSVYEG-ISDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G+ +GRG+FG V+ G +  D    AVK     L    +AK       QE  +L ++ H N
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPN 173
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQD 449
           IV+  G    +  +YI +ELV  G  L   +     LR   +         G++YL  + 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG-----TAFWMAPE 497
            +HRD+   N LV     +K++DFG+++  + + V +  G        W APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQVPVKWTAPE 285

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G++GSV      D        V  L +  Q+     +  +E+ LL   +HEN++   
Sbjct: 36  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 397 ------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  + +D S++Y+   L+    L N+ +   L D  V     Q+L GLKY+H   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM-GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGI 152
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+ V+ +  +++ DFGLA+     ++     T ++ APE+  N
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQAD-EEMTGYVATRWYRAPEIMLN 202

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 76
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 137 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 175

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    ++G GSFG VY+  + D G   A+K+V L D+  +         +E+ ++ + +H
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK--------NRELQIMRKLDH 72
Query: 390 ENIVQ--YYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQIL 439
            NIV+  Y+     E K  ++L LV       +Y+  R++ R  Q      V  Y  Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
             L Y+H   + HRDIK  N+L+D + +V KL DFG AK
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 49  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 388 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR----------YHLRDSQVSA- 433
              +HENIV   G       + +  E    G LLN  +R          + + +S +S  
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTR 164
Query: 434 ----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
               ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 490 TAF----WMAPE 497
            A     WMAPE
Sbjct: 225 NARLPVKWMAPE 236

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSI 374
           S + P G  + +       ++  RG FG V++  + +D  F AVK   L D+ S      
Sbjct: 9   SGLVPRGSLQLL-------EIKARGRFGCVWKAQLMND--FVAVKIFPLQDKQSW----- 54
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT----KGSLLNLYQRYHLRDSQ 430
            Q E+EI      +HEN++Q+   +K  S L + L L+T    KGSL +  +   +  ++
Sbjct: 55  -QSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNE 113
Query: 431 VSAYTRQILLGLKYLHDQ-----------DVVHRDIKCANILVDANGSVKLADFGLA--- 476
           +      +  GL YLH+             + HRD K  N+L+ ++ +  LADFGLA   
Sbjct: 114 LCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRF 173
Query: 477 -KATKLNDVKSCRGTAFWMAPEV 498
                  D     GT  +MAPEV
Sbjct: 174 EPGKPPGDTHGQVGTRRYMAPEV 196

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 10/170 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPE 497
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 194

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 10/170 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPE 497
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 184

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 82/157 (52%), Gaps = 22/157 (14%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G  G V+  + +D     A+K++ L D      QS+    +EI ++ R +H+NIV+ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKV 73
Query: 396 Y--------------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 441
           +              G+  + + +YI  E + +  L N+ ++  L +     +  Q+L G
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRG 132
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAK 477
           LKY+H  +V+HRD+K AN+ ++    V K+ DFGLA+
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 16/183 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFF-FAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 385
           ++  ++LGRG    V   I       +AVK + +   GS + + + +L +    E+ +L 
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 386 RFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
           +   H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  + 
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 125
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEV- 498
            LH  ++VHRD+K  NIL+D + ++KL DFG    L    KL +V  C GT  ++APE+ 
Sbjct: 126 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV--C-GTPSYLAPEII 182
Query: 499 -CS 500
            CS
Sbjct: 183 ECS 185

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 12/173 (6%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSN 501
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K+  GT  ++APEV  +
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLED 179

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 10/170 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPE 497
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 12/173 (6%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSN 501
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K+  GT  ++APEV  +
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEVLED 179

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 30/190 (15%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 49  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 388 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR-------------YHLRDSQV 431
              +HENIV   G       + +  E    G LLN  +R               LRD  +
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD--L 162
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
             ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G A
Sbjct: 163 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 492 F----WMAPE 497
                WMAPE
Sbjct: 223 RLPVKWMAPE 232

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 10/170 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPE 497
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 15/173 (8%)
Query: 334 GDLLGRGSFGSVYEG-ISDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G+ +GRG+FG V+ G +  D    AVK     L    +AK       QE  +L ++ H N
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPN 173
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQD 449
           IV+  G    +  +YI +ELV  G  L   +     LR   +         G++YL  + 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG-----TAFWMAPE 497
            +HRD+   N LV     +K++DFG+++  + + V +  G        W APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPE 285

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 32/194 (16%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 49  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 388 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVS 432
              +HENIV   G       + +  E    G LLN             Y   H  + Q+S
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLS 164
Query: 433 A-----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 487
           +     ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     
Sbjct: 165 SRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 224
Query: 488 RGTA----FWMAPE 497
           +G A     WMAPE
Sbjct: 225 KGNARLPVKWMAPE 238

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 11/183 (6%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           +   ++ ++   + LG G+FG V+       G  FA K V    +  +       + +EI
Sbjct: 151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-----ETVRKEI 205
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQIL 439
             +S   H  +V  +   +D++++ +  E ++ G L       H + S+  A  Y RQ+ 
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGL-AKATKLNDVKSCRGTAFWMAP 496
            GL ++H+ + VH D+K  NI+     S  +KL DFGL A       VK   GTA + AP
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
Query: 497 EVC 499
           EV 
Sbjct: 326 EVA 328

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 10/170 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPE 497
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 11/183 (6%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           +   ++ ++   + LG G+FG V+       G  FA K V    +  +       + +EI
Sbjct: 45  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-----ETVRKEI 99
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQIL 439
             +S   H  +V  +   +D++++ +  E ++ G L       H + S+  A  Y RQ+ 
Sbjct: 100 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 159
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGL-AKATKLNDVKSCRGTAFWMAP 496
            GL ++H+ + VH D+K  NI+     S  +KL DFGL A       VK   GTA + AP
Sbjct: 160 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 219
Query: 497 EVC 499
           EV 
Sbjct: 220 EVA 222

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 98/190 (51%), Gaps = 26/190 (13%)
Query: 330 YWQK---GDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQ------ 379
           ++QK    D++GRG    V   +    G  FAVK + +    +  + S  QLE+      
Sbjct: 92  FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV----TAERLSPEQLEEVREATR 147
Query: 380 -EIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTR 436
            E  +L +   H +I+    + +  S +++  +L+ KG L + L ++  L + +  +  R
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR 207
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAF 492
            +L  + +LH  ++VHRD+K  NIL+D N  ++L+DFG    L    KL ++  C GT  
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL--C-GTPG 264
Query: 493 WMAPEV--CS 500
           ++APE+  CS
Sbjct: 265 YLAPEILKCS 274

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 30/192 (15%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 49  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 388 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR----------YHLRDSQVSA- 433
              +HENIV   G       + +  E    G LLN  +R          + + +S  S  
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 434 ----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
               ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 490 TA----FWMAPE 497
            A     WMAPE
Sbjct: 225 NARLPVKWMAPE 236

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 70/124 (56%), Gaps = 5/124 (4%)
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQI 438
           EI +L R  H NI++     +  +++ + LELVT G L + + ++ +  +   +   +QI
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKATKLNDV-KSCRGTAFWM 494
           L  + YLH+  +VHRD+K  N+L      +  +K+ADFGL+K  +   + K+  GT  + 
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217
Query: 495 APEV 498
           APE+
Sbjct: 218 APEI 221

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 10/175 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFF-FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q  + LG+G+F  V   +       +A K ++     ++  Q   +LE+E  +    +H
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARICRLLKH 89
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
            NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S    QIL  + ++H  
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 449 DVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEV 498
           D+VHRD+K  N+L+ +     +VKLADFGLA   +          GT  +++PEV
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEV 204

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 10/170 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPE 497
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 10/172 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FGSV +G+           + +L QG++ K    ++ +E  ++ + ++  IV+  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G  + E+ L + +E+   G L      +R  +  S V+    Q+ +G+KYL +++ VHRD
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-----WMAPEVCSN 501
           +   N+L+      K++DFGL+KA   +D      +A      W APE C N
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CIN 186

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 10/170 (5%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LG GSFG V  G  D   G   +V    L        +++    +E+  +   +H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
            YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ YL  +  +H
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF-WMAPE 497
           RD+   N+L+     VK+ DFGL +A   ND    ++  R   F W APE
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 12/173 (6%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 17  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 72
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 73  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 132
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSN 501
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K   GT  ++APEV  +
Sbjct: 133 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLED 184

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G++GSV      D        V  L +  Q+     +  +E+ LL   +HEN++   
Sbjct: 36  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 397 ------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  + +D S++Y+   L+    L N+ +   L D  V     Q+L GLKY+H   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI 152
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+ V+ +  +++ DFGLA+     ++     T ++ APE+  N
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQAD-EEMTGYVATRWYRAPEIMLN 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 12/173 (6%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSN 501
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K   GT  ++APEV  +
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLED 179

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 12/173 (6%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSN 501
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K   GT  ++APEV  +
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLED 179

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 88/172 (51%), Gaps = 10/172 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FGSV +G+           + +L QG++ K    ++ +E  ++ + ++  IV+  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G  + E+ L + +E+   G L      +R  +  S V+    Q+ +G+KYL +++ VHR+
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-----WMAPEVCSN 501
           +   N+L+      K++DFGL+KA   +D      +A      W APE C N
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CIN 512

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 45/212 (21%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           KR    +++ +L+G G FG V++     DG  + ++ V         K +  + E+E+  
Sbjct: 8   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV---------KYNNEKAEREVKA 58
Query: 384 LSRFEHENIVQYYGT--------------------DKDESK---------LYIFLELVTK 414
           L++ +H NIV Y G                     D + SK         L+I +E   K
Sbjct: 59  LAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 415 GSLLN-LYQRYHLRDSQVSAYT--RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA 471
           G+L   + +R   +  +V A     QI  G+ Y+H + ++HRD+K +NI +     VK+ 
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIG 178
Query: 472 DFGLAKATKLNDVKSCR--GTAFWMAPEVCSN 501
           DFGL  + K ND K  R  GT  +M+PE  S+
Sbjct: 179 DFGLVTSLK-NDGKRTRSKGTLRYMSPEQISS 209

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 82/156 (52%), Gaps = 13/156 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI--SQLEQEIALLSRFE 388
           ++   L+GRGS+G VY     +    A K V++       +  I   ++ +EI +L+R +
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKN----ANKNVAIKKVNRMFEDLIDCKRILREITILNRLK 85
Query: 389 HENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGL 442
            + I++ +     E      +LYI LE +    L  L++    L +  V      +LLG 
Sbjct: 86  SDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGE 144
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           K++H+  ++HRD+K AN L++ + SVK+ DFGLA+ 
Sbjct: 145 KFIHESGIIHRDLKPANCLLNQDCSVKICDFGLART 180

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 12/173 (6%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           LLG+G+FG V    E  +  G ++A+K   L  +   AK  ++    E  +L    H  +
Sbjct: 12  LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
                  +   +L   +E    G L  +L +     + +   Y  +I+  L+YLH +DVV
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSN 501
           +RDIK  N+++D +G +K+ DFGL K   ++D   +K   GT  ++APEV  +
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKXFCGTPEYLAPEVLED 179

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 92/183 (50%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M PE
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPE 185
Query: 498 VCS 500
           V +
Sbjct: 186 VVT 188

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G++GSV      D        V  L +  Q+     +  +E+ LL   +HEN++   
Sbjct: 28  VGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 397 ------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  + +D S++Y+   L+    L N+ +   L D  V     Q+L GLKY+H   +
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI 144
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +HRD+K +N+ V+ +  +++ DFGLA+     ++     T ++ APE+  N
Sbjct: 145 IHRDLKPSNVAVNEDCELRILDFGLARQAD-EEMTGYVATRWYRAPEIMLN 194

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 437 GICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 495
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSNPF 503
              N+L+      K++DFGL+KA + ++         +    W APE C N +
Sbjct: 496 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYY 547

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVCS 500
            VHRD+   NIL+++N   K++DFGLA+   L D      + RG      W +PE  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLARV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 223

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 488 RGTAFWMAPE 497
           R    WMAPE
Sbjct: 198 RLPVKWMAPE 207

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 438 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 496
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSNPF 503
              N+L+      K++DFGL+KA + ++         +    W APE C N +
Sbjct: 497 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYY 548

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 89/174 (51%), Gaps = 19/174 (10%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 387
           +LG+GSFG V     +G  +    +AVK    +V + D   +     + +E+ +  L   
Sbjct: 348 VLGKGSFGKVMLSERKGTDE---LYAVKILKKDVVIQDDDVEC----TMVEKRVLALPG- 399
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +   + Q +   +   +LY  +E V  G L+ ++ Q    ++     Y  +I +GL +L 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEV 498
            + +++RD+K  N+++D+ G +K+ADFG+ K    + V  K   GT  ++APE+
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEI 513

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 488 RGTAFWMAPE 497
           R    WMAPE
Sbjct: 213 RLPVKWMAPE 222

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 20/197 (10%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSIS 375
           S  S +GRF+ +  Y  + D+LG G+   V   I+        +E ++     Q     S
Sbjct: 2   STDSFSGRFEDV--YQLQEDVLGEGAHARVQTCIN----LITSQEYAVKIIEKQPGHIRS 55
Query: 376 QLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSA 433
           ++ +E+ +L + + H N+++     ++E + Y+  E +  GS+L ++++R H  + + S 
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV 115
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLN-------- 482
             + +   L +LH++ + HRD+K  NIL +       VK+ DF L    KLN        
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 483 -DVKSCRGTAFWMAPEV 498
            ++ +  G+A +MAPEV
Sbjct: 176 PELLTPCGSAEYMAPEV 192

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 142 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 488 RGTAFWMAPE 497
           R    WMAPE
Sbjct: 202 RLPVKWMAPE 211

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 93/176 (52%), Gaps = 20/176 (11%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LGRG FG V+   +   G  +A K+++      +     + +E++I  L++     IV 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVS 249
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL----------RDSQVSAYTRQILLGLKY 444
                + ++ L + + ++  G +     RYH+          ++ +   YT QI+ GL++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEV 498
           LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+    GT  +MAPE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 146 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 488 RGTAFWMAPE 497
           R    WMAPE
Sbjct: 206 RLPVKWMAPE 215

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 93/176 (52%), Gaps = 20/176 (11%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LGRG FG V+   +   G  +A K+++      +     + +E++I  L++     IV 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVS 249
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL----------RDSQVSAYTRQILLGLKY 444
                + ++ L + + ++  G +     RYH+          ++ +   YT QI+ GL++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEV 498
           LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+    GT  +MAPE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 488 RGTAFWMAPE 497
           R    WMAPE
Sbjct: 213 RLPVKWMAPE 222

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 145 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 488 RGTAFWMAPE 497
           R    WMAPE
Sbjct: 205 RLPVKWMAPE 214

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 91/168 (54%), Gaps = 8/168 (4%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAK 371
           S  +PN    RI+  T  ++  +LG G+FG+VY+GI   +G    +   + +L++ +  K
Sbjct: 23  SGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK 82
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDS 429
            ++  +++ + +++  +H ++V+  G     + + +  +L+  G LL     +  ++   
Sbjct: 83  ANVEFMDEAL-IMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQ 140
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +  +  QI  G+ YL ++ +VHRD+   N+LV +   VK+ DFGLA+
Sbjct: 141 LLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 188

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 93/176 (52%), Gaps = 20/176 (11%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LGRG FG V+   +   G  +A K+++      +     + +E++I  L++     IV 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVS 249
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL----------RDSQVSAYTRQILLGLKY 444
                + ++ L + + ++  G +     RYH+          ++ +   YT QI+ GL++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEV 498
           LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+    GT  +MAPE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 93/176 (52%), Gaps = 20/176 (11%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LGRG FG V+   +   G  +A K+++      +     + +E++I  L++     IV 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVS 249
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL----------RDSQVSAYTRQILLGLKY 444
                + ++ L + + ++  G +     RYH+          ++ +   YT QI+ GL++
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEV 498
           LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+    GT  +MAPE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 21/181 (11%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQ--RYHLRDSQVSAYTRQIL 439
           +    H+NI+        +  L  F ++     L+  NL Q  +  L   ++S    Q+L
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC 499
            G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P V 
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 500 S 500
           +
Sbjct: 188 T 188

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 151
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSNPF 503
              N+L+      K++DFGL+KA + ++         +    W APE C N +
Sbjct: 152 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYY 203

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 153
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSNPF 503
              N+L+      K++DFGL+KA + ++         +    W APE C N +
Sbjct: 154 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYY 205

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 153
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSNPF 503
              N+L+      K++DFGL+KA + ++         +    W APE C N +
Sbjct: 154 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYY 205

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 137
Query: 456 KCANILVDANGSVKLADFGLAKATKL--NDVKSCRGTAF---WMAPEVCSNPF 503
              N+L+      K++DFGL+KA +   N  K+     +   W APE C N +
Sbjct: 138 AARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE-CINYY 189

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 488 RGTAFWMAPE 497
           R    WMAPE
Sbjct: 213 RLPVKWMAPE 222

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 90/176 (51%), Gaps = 24/176 (13%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           L+G G FG VY+G+  DG      +V+L  +  ++ Q I + E EI  LS   H ++V  
Sbjct: 46  LIGHGVFGKVYKGVLRDG-----AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR------QILLG----LKYL 445
            G   + +++ +  + +  G+L     + HL  S +   +       +I +G    L YL
Sbjct: 101 IGFCDERNEMILIYKYMENGNL-----KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVK---SCRGTAFWMAPE 497
           H + ++HRD+K  NIL+D N   K+ DFG++ K T+L+        +GT  ++ PE
Sbjct: 156 HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPE 211

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 92/183 (50%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M PE
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMEPE 185
Query: 498 VCS 500
           V +
Sbjct: 186 VVT 188

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR------------YHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L    Q              H  + Q+S+   
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 488 RGTAFWMAPE 497
           R    WMAPE
Sbjct: 213 RLPVKWMAPE 222

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 93/186 (50%), Gaps = 25/186 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M PE
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMEPE 185
Query: 498 VCSNPF 503
           V +  +
Sbjct: 186 VVTRYY 191

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 90/169 (53%), Gaps = 8/169 (4%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+FG V    + +    FA+K ++  +   +A+ +  + E+++  L   + + I  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDSKWITT 138
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
            +   +D++ LY+ ++    G LL L  ++   L +     Y  ++++ +  +H    VH
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198
Query: 453 RDIKCANILVDANGSVKLADFG-LAKATKLNDVKS--CRGTAFWMAPEV 498
           RDIK  NIL+D NG ++LADFG   K  +   V+S    GT  +++PE+
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 92/185 (49%), Gaps = 29/185 (15%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L+G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMT 183
Query: 496 PEVCS 500
           P V +
Sbjct: 184 PYVVT 188

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 17/175 (9%)
Query: 336 LLGRGSFGSVYEG-ISDDG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G +   G    F A+K    L  G   KQ    L  E +++ +F+H N
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKT---LKSGYTEKQRRDFLS-EASIMGQFDHPN 69
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 449
           ++   G     + + I  E +  GSL +  ++        Q+    R I  G+KYL D +
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 129
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WMAPE 497
            VHR +   NILV++N   K++DFGL++  + +       +A        W APE
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 92/185 (49%), Gaps = 29/185 (15%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVVAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L+G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMT 183
Query: 496 PEVCS 500
           P V +
Sbjct: 184 PYVVT 188

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVCS 500
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE  +
Sbjct: 168 AVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 223

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSNPF 503
              N+L+      K++DFGL+KA + ++         +    W APE C N +
Sbjct: 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYY 195

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 21/181 (11%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQ--RYHLRDSQVSAYTRQIL 439
           +    H+NI+        +  L  F ++     L+  NL Q  +  L   ++S    Q+L
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC 499
            G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P V 
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 500 S 500
           +
Sbjct: 188 T 188

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 92/185 (49%), Gaps = 29/185 (15%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L+G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMT 183
Query: 496 PEVCS 500
           P V +
Sbjct: 184 PYVVT 188

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 9/170 (5%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H NI+ 
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASIMGQFDHPNIIH 94
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVH 452
             G       + I  E +  GSL    ++   R +  Q+    R I  G+KYL D   VH
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVH 154
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPE 497
           RD+   NILV++N   K++DFG+++  + +     + RG      W APE
Sbjct: 155 RDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 204

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVCS 500
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE  +
Sbjct: 168 FVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 223

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 70/127 (55%), Gaps = 6/127 (4%)
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 126
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 491
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 127 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 492 FWMAPEV 498
            ++APEV
Sbjct: 187 TYLAPEV 193

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LG G+FG V      G+  D      K    + +    ++ +S L  E+ ++    +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAY-- 434
           H+NI+   G    +  LY+ +E  +KG+L               Y   H  + Q+S+   
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 435 ---TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487
                Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D      + 
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 488 RGTAFWMAPE 497
           R    WMAPE
Sbjct: 254 RLPVKWMAPE 263

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 10/169 (5%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G+G+F  V   +    G  +A K ++     ++  Q   +LE+E  +    +H NIV+ 
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ---KLEREARICRLLKHSNIVRL 68
Query: 396 YGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  + + H   VVHRD
Sbjct: 69  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRD 128
Query: 455 IKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEV 498
           +K  N+L+ +     +VKLADFGLA   + +        GT  +++PEV
Sbjct: 129 LKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV 177

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 90/175 (51%), Gaps = 10/175 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q  + LG+G+F  V   +    G  +A K ++     ++  Q   +LE+E  +    +H
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
            NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  + + H  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 449 DVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEV 498
            +VHRD+K  N+L+ +     +VKLADFGLA   + +        GT  +++PEV
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV 177

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 137
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSNPF 503
              N+L+      K++DFGL+KA + ++         +    W APE C N +
Sbjct: 138 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYY 189

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 90/176 (51%), Gaps = 19/176 (10%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 387
           +LG+GSFG V     +G  +    +AVK    +V + D   +     + +E+ +  L   
Sbjct: 27  VLGKGSFGKVMLSERKGTDE---LYAVKILKKDVVIQDDDVEC----TMVEKRVLALPG- 78
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +   + Q +   +   +LY  +E V  G L+ ++ Q    ++     Y  +I +GL +L 
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVCS 500
            + +++RD+K  N+++D+ G +K+ADFG+ K    + V  K   GT  ++APE+ +
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA 194

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 70/127 (55%), Gaps = 6/127 (4%)
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 491
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 492 FWMAPEV 498
            ++APEV
Sbjct: 181 TYLAPEV 187

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 70/127 (55%), Gaps = 6/127 (4%)
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 491
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 492 FWMAPEV 498
            ++APEV
Sbjct: 181 TYLAPEV 187

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 70/127 (55%), Gaps = 6/127 (4%)
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 119
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 491
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 120 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 492 FWMAPEV 498
            ++APEV
Sbjct: 180 TYLAPEV 186

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/130 (36%), Positives = 74/130 (56%), Gaps = 12/130 (9%)
Query: 379 QEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYT 435
           +EI +L R+ +H NI+       D   +Y+  EL+  G LL+  L Q++   + + SA  
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVL 122
Query: 436 RQILLGLKYLHDQDVVHRDIKCANIL-VDANG---SVKLADFGLAKATKLND---VKSCR 488
             I   ++YLH Q VVHRD+K +NIL VD +G   S+++ DFG AK  +  +   +  C 
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182
Query: 489 GTAFWMAPEV 498
            TA ++APEV
Sbjct: 183 -TANFVAPEV 191

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 87/194 (44%), Gaps = 19/194 (9%)
Query: 317 NISPNGRFKRII-----TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAK 371
            + P G    +I     T+ Q+   +G G FG V+ G   +    A+K +    +GS ++
Sbjct: 13  GLVPRGSLHMVIDPSELTFVQE---IGSGQFGLVHLGYWLNKDKVAIKTIK---EGSMSE 66
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDS 429
               +   E  ++ +  H  +VQ YG   +++ + +  E +  G L +    QR      
Sbjct: 67  DDFIE---EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE 123
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
            +      +  G+ YL +  V+HRD+   N LV  N  +K++DFG+ +    +   S  G
Sbjct: 124 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 183
Query: 490 TAF---WMAPEVCS 500
           T F   W +PEV S
Sbjct: 184 TKFPVKWASPEVFS 197

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 70/127 (55%), Gaps = 6/127 (4%)
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
           +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGTA 491
            Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT 
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 492 FWMAPEV 498
            ++APEV
Sbjct: 181 TYLAPEV 187

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVCS 500
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 223

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 11/169 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 68
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRD 128
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV S
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 177

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 89/176 (50%), Gaps = 24/176 (13%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           L+G G FG VY+G+  DG      +V+L  +  ++ Q I + E EI  LS   H ++V  
Sbjct: 46  LIGHGVFGKVYKGVLRDG-----AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR------QILLG----LKYL 445
            G   + +++ +  + +  G+L     + HL  S +   +       +I +G    L YL
Sbjct: 101 IGFCDERNEMILIYKYMENGNL-----KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVK---SCRGTAFWMAPE 497
           H + ++HRD+K  NIL+D N   K+ DFG++ K T+L         +GT  ++ PE
Sbjct: 156 HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPE 211

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           + +Q  + LG+G+F  V   +    G  +A K ++     ++  Q   +LE+E  +    
Sbjct: 22  SMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLL 78
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +H NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  + + H
Sbjct: 79  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 138
Query: 447 DQDVVHRDIKCANILVDA---NGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEV 498
              VVHRD+K  N+L+ +     +VKLADFGLA   +          GT  +++PEV
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 195

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 19/175 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 40  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 95
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 96  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 155
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPE 497
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE
Sbjct: 156 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPE 208

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVCS 500
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 223

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVCS 500
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 223

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 19/175 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 23  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 78
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 79  IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPE 497
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPE 191

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 19/175 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 23  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 78
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 79  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPE 497
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPE 191

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 131
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSNPF 503
              N+L+      K++DFGL+KA + ++         +    W APE C N +
Sbjct: 132 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYY 183

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVCS 500
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 223

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 19/178 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVCS 500
            VHRD+   NIL+++N   K++DFGL +   L D      + RG      W +PE  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 223

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 84/178 (47%), Gaps = 25/178 (14%)
Query: 339 RGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT 398
           RG FG V++    + +  AVK   + D+ S       Q E E+  L   +HENI+Q+ G 
Sbjct: 34  RGRFGCVWKAQLLNEYV-AVKIFPIQDKQSW------QNEYEVYSLPGMKHENILQFIGA 86
Query: 399 DKDESKLYIFLELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ------ 448
           +K  + + + L L+T    KGSL +  +   +  +++      +  GL YLH+       
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 449 ----DVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCRGTAFWMAPEV 498
                + HRDIK  N+L+  N +  +ADFGLA          D     GT  +MAPEV
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           LG G+FG+V +G            V +L   +       +L  E  ++ + ++  IV+  
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
           G  + ES + + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VHRD+
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVCSNPF 503
              N+L+      K++DFGL+KA + ++         +    W APE C N +
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYY 185

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 50  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 105
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 106 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 165
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVCS 500
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE  +
Sbjct: 166 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 221

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 9/170 (5%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H NI+ 
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASIMGQFDHPNIIH 73
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVH 452
             G       + I  E +  GSL    ++   R +  Q+    R I  G+KYL D   VH
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 133
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPE 497
           RD+   NILV++N   K++DFG+++  + +     + RG      W APE
Sbjct: 134 RDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 183

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 9/170 (5%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H NI+ 
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASIMGQFDHPNIIH 79
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVH 452
             G       + I  E +  GSL    ++   R +  Q+    R I  G+KYL D   VH
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 139
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPE 497
           RD+   NILV++N   K++DFG+++  + +     + RG      W APE
Sbjct: 140 RDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 189

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSL----LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           ++G G FG V  G        + KE+S+    L  G   KQ    L  E +++ +F+H N
Sbjct: 52  VVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQD 449
           I++  G       + I  E +  GSL +  +++  + +  Q+    R I  G+KYL D  
Sbjct: 108 IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVCS 500
            VHRD+   NIL+++N   K++DFGL++   L D      + RG      W +PE  +
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 223

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 21/181 (11%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQ--RYHLRDSQVSAYTRQIL 439
           +    H+NI+        +  L  F ++     L+  NL Q  +  L   ++S    Q+L
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC 499
            G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P V 
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVV 187
Query: 500 S 500
           +
Sbjct: 188 T 188

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 94/186 (50%), Gaps = 25/186 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPY 185
Query: 498 VCSNPF 503
           V +  +
Sbjct: 186 VVTRYY 191

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 21/181 (11%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 69
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQ--RYHLRDSQVSAYTRQIL 439
           +    H+NI+        +  L  F ++     L+  NL Q  +  L   ++S    Q+L
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 129
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC 499
            G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P V 
Sbjct: 130 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---------GTSFMMTPYVV 180
Query: 500 S 500
           +
Sbjct: 181 T 181

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 89
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +  VHRD+   N ++D   +VK+ADFGLA+
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 9/173 (5%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H NI+ 
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIH 87
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
             G       + I  E +  GSL    ++        Q+    R I  G+KYL D   VH
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVH 147
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVCS 500
           RD+   NIL+++N   K++DFGL++  + +     + RG      W APE  +
Sbjct: 148 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 200

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 108
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 168
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +  VHRD+   N ++D   +VK+ADFGLA+
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 90/175 (51%), Gaps = 10/175 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q  + LG+G+F  V   +    G  +A K ++     ++  Q   +LE+E  +    +H
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
            NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  + + H  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 449 DVVHRDIKCANILVDAN---GSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEV 498
            +VHRD+K  N+L+ +     +VKLADFGLA   + +        GT  +++PEV
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV 177

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 71/144 (49%), Gaps = 8/144 (5%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           G+L+G+G FG VY G      +     + L+D     +  +   ++E+    +  HEN+V
Sbjct: 38  GELIGKGRFGQVYHGR-----WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
            + G       L I   L    +L ++ +  +  L  ++     ++I+ G+ YLH + ++
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152
Query: 452 HRDIKCANILVDANGSVKLADFGL 475
           H+D+K  N+  D NG V + DFGL
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGL 175

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 90/178 (50%), Gaps = 9/178 (5%)
Query: 327 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           ++  +Q+   +G G+ G V        G   AVK++S   +  Q +    +  +E+ LL 
Sbjct: 20  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS---RPFQNQTHAKRAYRELVLLK 76
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQRYH--LRDSQVSAYTRQILLG 441
              H+NI+        +  L  F ++     L+  NL Q  H  L   ++S    Q+L G
Sbjct: 77  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCG 136
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS-CRGTAFWMAPEV 498
           +K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+    N + +    T ++ APEV
Sbjct: 137 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEV 194

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 37/198 (18%)
Query: 327 IITYWQKGDLLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           I+  W+    LG G+FG V+           D    AVK  +L +    A+Q     ++E
Sbjct: 20  IVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQRE 70
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS----------- 429
             LL+  +H++IV+++G   +   L +  E +  G L N + R H  D+           
Sbjct: 71  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAP 129
Query: 430 ------QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
                 Q+ A   Q+  G+ YL     VHRD+   N LV     VK+ DFG+++     D
Sbjct: 130 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 189
Query: 484 VKSCRGTAF----WMAPE 497
                G       WM PE
Sbjct: 190 YYRVGGRTMLPIRWMPPE 207

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 109
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 169
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +  VHRD+   N ++D   +VK+ADFGLA+
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 82
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 142
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +  VHRD+   N ++D   +VK+ADFGLA+
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V+ G    G   AVK  S  ++ S  +      E EI       HENI+ + 
Sbjct: 50  IGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFR------EAEIYQTVMLRHENILGFI 102
Query: 397 GTDKDESKLYIFLELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV-- 450
             D  ++  +  L LV+     GSL +   RY +    +         GL +LH + V  
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 451 ------VHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCR--GTAFWMAPEV 498
                  HRD+K  NILV  NG+  +AD GLA     AT   D+      GT  +MAPEV
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 70/128 (54%), Gaps = 6/128 (4%)
Query: 376 QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAY 434
            +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 244
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGT 490
             Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304
Query: 491 AFWMAPEV 498
             ++APEV
Sbjct: 305 PTYLAPEV 312

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 37/198 (18%)
Query: 327 IITYWQKGDLLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           I+  W+    LG G+FG V+           D    AVK  +L +    A+Q     ++E
Sbjct: 43  IVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQRE 93
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS----------- 429
             LL+  +H++IV+++G   +   L +  E +  G L N + R H  D+           
Sbjct: 94  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAP 152
Query: 430 ------QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
                 Q+ A   Q+  G+ YL     VHRD+   N LV     VK+ DFG+++     D
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
Query: 484 VKSCRGTAF----WMAPE 497
                G       WM PE
Sbjct: 213 YYRVGGRTMLPIRWMPPE 230

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 86/171 (50%), Gaps = 12/171 (7%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++GRG+F  V    +   G  +A+K ++  D   + + S  + E+++  L   +   I Q
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV--LVNGDRRWITQ 125
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQILLGLKYLHDQDVVH 452
            +   +DE+ LY+ +E    G LL L  ++  R     A  Y  +I++ +  +H    VH
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEV 498
           RDIK  NIL+D  G ++LADFG     KL    + R     GT  +++PE+
Sbjct: 186 RDIKPDNILLDRCGHIRLADFG--SCLKLRADGTVRSLVAVGTPDYLSPEI 234

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +  VHRD+   N ++D   +VK+ADFGLA+
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 37/198 (18%)
Query: 327 IITYWQKGDLLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           I+  W+    LG G+FG V+           D    AVK  +L +    A+Q     ++E
Sbjct: 14  IVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQRE 64
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS----------- 429
             LL+  +H++IV+++G   +   L +  E +  G L N + R H  D+           
Sbjct: 65  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAP 123
Query: 430 ------QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
                 Q+ A   Q+  G+ YL     VHRD+   N LV     VK+ DFG+++     D
Sbjct: 124 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 183
Query: 484 VKSCRGTAF----WMAPE 497
                G       WM PE
Sbjct: 184 YYRVGGRTMLPIRWMPPE 201

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 29/185 (15%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMT 183
Query: 496 PEVCS 500
           P V +
Sbjct: 184 PYVVT 188

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V+ G    G   AVK  S  ++ S  +      E EI       HENI+ + 
Sbjct: 17  IGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFR------EAEIYQTVMLRHENILGFI 69
Query: 397 GTDKDESKLYIFLELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV-- 450
             D  ++  +  L LV+     GSL +   RY +    +         GL +LH + V  
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 451 ------VHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCR--GTAFWMAPEV 498
                  HRD+K  NILV  NG+  +AD GLA     AT   D+      GT  +MAPEV
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 189

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 87
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 147
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +  VHRD+   N ++D   +VK+ADFGLA+
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185
Query: 498 VCS 500
           V +
Sbjct: 186 VVT 188

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V+ G    G   AVK  S  ++ S  +      E EI       HENI+ + 
Sbjct: 11  IGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFR------EAEIYQTVMLRHENILGFI 63
Query: 397 GTDKDESKLYIFLELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV-- 450
             D  ++  +  L LV+     GSL +   RY +    +         GL +LH + V  
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 451 ------VHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCR--GTAFWMAPEV 498
                  HRD+K  NILV  NG+  +AD GLA     AT   D+      GT  +MAPEV
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 11/169 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 66
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 126
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV S
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 13/172 (7%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           ++G G FG V  G +   G       +  L  G   KQ    L  E +++ +F+H N+V 
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFL-CEASIMGQFDHPNVVH 108
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVV 451
             G       + I +E +  G+L + + R H       Q+    R I  G++YL D   V
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYV 167
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF------WMAPE 497
           HRD+   NILV++N   K++DFGL++  + +D ++   T        W APE
Sbjct: 168 HRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVYTTTGGKIPVRWTAPE 218

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 11/169 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 68
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 128
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV S
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 177

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 77
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 135
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 186
Query: 498 VCS 500
           V +
Sbjct: 187 VVT 189

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V+ G    G   AVK  S  ++ S  +      E EI       HENI+ + 
Sbjct: 14  IGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFR------EAEIYQTVMLRHENILGFI 66
Query: 397 GTDKDESKLYIFLELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV-- 450
             D  ++  +  L LV+     GSL +   RY +    +         GL +LH + V  
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 451 ------VHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCR--GTAFWMAPEV 498
                  HRD+K  NILV  NG+  +AD GLA     AT   D+      GT  +MAPEV
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 186

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 114
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 172
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 223
Query: 498 VCS 500
           V +
Sbjct: 224 VVT 226

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V+ G    G   AVK  S  ++ S  +      E EI       HENI+ + 
Sbjct: 12  IGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFR------EAEIYQTVMLRHENILGFI 64
Query: 397 GTDKDESKLYIFLELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV-- 450
             D  ++  +  L LV+     GSL +   RY +    +         GL +LH + V  
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 124
Query: 451 ------VHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCR--GTAFWMAPEV 498
                  HRD+K  NILV  NG+  +AD GLA     AT   D+      GT  +MAPEV
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 184

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185
Query: 498 VCS 500
           V +
Sbjct: 186 VVT 188

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V+ G    G   AVK  S  ++ S  +      E EI       HENI+ + 
Sbjct: 37  IGKGRFGEVWRG-KWRGEEVAVKIFSSREERSWFR------EAEIYQTVMLRHENILGFI 89
Query: 397 GTDKDESKLYIFLELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV-- 450
             D  ++  +  L LV+     GSL +   RY +    +         GL +LH + V  
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 149
Query: 451 ------VHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSCR--GTAFWMAPEV 498
                  HRD+K  NILV  NG+  +AD GLA     AT   D+      GT  +MAPEV
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 209

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 149
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPE 497
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 11/169 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 71
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 131
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV S
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 180

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 21  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 75
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 76  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 133
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 134 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 184
Query: 498 VCS 500
           V +
Sbjct: 185 VVT 187

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 92/173 (53%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 4   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 59
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 60  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 116
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 117 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 169

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 90/181 (49%), Gaps = 12/181 (6%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS--LLDQGSQAKQSISQLEQEIAL 383
           R    +Q  + LG+G+F  V   +       A +E +  +++    + +   +LE+E  +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVK----VLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGL 442
               +H NIV+ + +  +E   Y+  +LVT G L  ++  R +  ++  S   +QIL  +
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV 123
Query: 443 KYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPE 497
            + H   VVHR++K  N+L+ +     +VKLADFGLA   +          GT  +++PE
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183
Query: 498 V 498
           V
Sbjct: 184 V 184

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 69
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 127
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 178
Query: 498 VCS 500
           V +
Sbjct: 179 VVT 181

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 88
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 148
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +  VHRD+   N ++D   +VK+ADFGLA+
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 91/170 (53%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 61
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D+  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KDNIG 118
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 119 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 168

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 92/173 (53%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 1   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 56
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 57  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 113
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 114 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 166

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 89
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +  VHRD+   N ++D   +VK+ADFGLA+
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 70
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 128
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 179
Query: 498 VCS 500
           V +
Sbjct: 180 VVT 182

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 92/173 (53%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 114
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 167

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 70/128 (54%), Gaps = 6/128 (4%)
Query: 376 QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAY 434
            +E EI +L +  H  I++      D    YI LEL+  G L + +     L+++    Y
Sbjct: 200 NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 258
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKAT-KLNDVKSCRGT 490
             Q+LL ++YLH+  ++HRD+K  N+L+ +      +K+ DFG +K   + + +++  GT
Sbjct: 259 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 318
Query: 491 AFWMAPEV 498
             ++APEV
Sbjct: 319 PTYLAPEV 326

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +  VHRD+   N ++D   +VK+ADFGLA+
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 85
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+KYL 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +  VHRD+   N ++D   +VK+ADFGLA+
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 91/170 (53%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KDNIG 115
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 70
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 128
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 179
Query: 498 VCS 500
           V +
Sbjct: 180 VVT 182

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 77
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 135
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 186
Query: 498 VCS 500
           V +
Sbjct: 187 VVT 189

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 29/185 (15%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---------GTSFMMT 183
Query: 496 PEVCS 500
           P V +
Sbjct: 184 PYVVT 188

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 91/170 (53%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 4   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 59
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D+  
Sbjct: 60  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGXLLD-YVREH-KDNIG 116
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 117 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 166

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 93/183 (50%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ + D     A+K++S   +  Q +    +  +E+ L
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 114
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+          T ++   +Y+ +EL+   +L  + Q   L   ++S    Q
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-ELDHERMSYLLYQ 172
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 223
Query: 498 VCS 500
           V +
Sbjct: 224 VVT 226

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 89/171 (52%), Gaps = 9/171 (5%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 124
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 125 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE
Sbjct: 185 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 235

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 90/178 (50%), Gaps = 9/178 (5%)
Query: 327 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           ++  +Q+   +G G+ G V        G   AVK++S   +  Q +    +  +E+ LL 
Sbjct: 22  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS---RPFQNQTHAKRAYRELVLLK 78
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--NLYQRYH--LRDSQVSAYTRQILLG 441
              H+NI+        +  L  F ++     L+  NL Q  H  L   ++S    Q+L G
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCG 138
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS-CRGTAFWMAPEV 498
           +K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+    N + +    T ++ APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 196

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 73/129 (56%), Gaps = 10/129 (7%)
Query: 379 QEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYT 435
           +EI +L R+ +H NI+       D   +Y+  EL   G LL+  L Q++   + + SA  
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-FSEREASAVL 122
Query: 436 RQILLGLKYLHDQDVVHRDIKCANIL-VDANG---SVKLADFGLAKATKLND--VKSCRG 489
             I   ++YLH Q VVHRD+K +NIL VD +G   S+++ DFG AK  +  +  + +   
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY 182
Query: 490 TAFWMAPEV 498
           TA ++APEV
Sbjct: 183 TANFVAPEV 191

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 84/169 (49%), Gaps = 15/169 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G+FG     +  D     +  V  +++G+   +++   ++EI       H NIV++ 
Sbjct: 28  IGSGNFGVA--RLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIVRFK 82
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                 + L I +E  + G    LY+R        + +   + +Q+L G+ Y H   + H
Sbjct: 83  EVILTPTHLAIIMEYASGG---ELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 453 RDIKCANILVDANGS--VKLADFGLAKATKLN-DVKSCRGTAFWMAPEV 498
           RD+K  N L+D + +  +K+ DFG +K++ L+   KS  GT  ++APEV
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 18  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 72
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 73  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 132
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 133 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 192
Query: 495 APE 497
           +PE
Sbjct: 193 SPE 195

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPE 497
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 43/203 (21%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           Q G  LG G+FG V E  +    F   KE ++L    +  +S +  +++ AL+S      
Sbjct: 34  QFGKTLGAGAFGKVVEATA----FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 89
Query: 388 ---EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--------------------- 423
              +HENIV   G       + +  E    G LLN  +R                     
Sbjct: 90  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK 149
Query: 424 -----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
                  LRD  +  ++ Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+ 
Sbjct: 150 EDGRPLELRD--LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 479 TKLNDVKSCRGTA----FWMAPE 497
              +     +G A     WMAPE
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPE 230

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 11/169 (6%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G FG V+ G   +    A+K +    +G+ +++   +   E  ++ +  H  +VQ Y
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIE---EAEVMMKLSHPKLVQLY 69
Query: 397 GTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
           G   +++ + +  E +  G L +    QR       +      +  G+ YL +  V+HRD
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 129
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVCS 500
           +   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV S
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 178

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 95
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 155
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPE 497
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 91/183 (49%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 27  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 81
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 82  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 139
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 140 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 190
Query: 498 VCS 500
           V +
Sbjct: 191 VVT 193

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 88
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 148
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPE 497
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 13/151 (8%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI--SQLEQEIALLSRFEHENIV 393
           L+GRGS+G VY     +      K V++       +  I   ++ +EI +L+R + + I+
Sbjct: 33  LIGRGSYGYVYLAYDKN----TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYII 88
Query: 394 QYYGTDKDES-----KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD 447
           + Y     +      +LYI LE +    L  L++    L +  +      +LLG  ++H+
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE 147
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA 478
             ++HRD+K AN L++ + SVK+ DFGLA+ 
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 91
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPE 497
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE 208

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPE 497
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 335 DLLGRGSFGSVYEG--ISDDG--FFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEH 389
           +++GRG FG VY G  + +DG     AVK ++ + D G      +SQ   E  ++  F H
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSH 91
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N    + ++     +  +  Q+  G+K+L 
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT---KLNDVKSCRGTAF---WMAPE 497
            +  VHRD+   N ++D   +VK+ADFGLA+     + + V +  G      WMA E
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G G++G+V   +  DG   A   +  L +  Q++    +  +E+ LL    HEN++   
Sbjct: 33  VGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 397 G------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
                  T  D +  Y+ +  +    L  L +   L + ++     Q+L GL+Y+H   +
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +HRD+K  N+ V+ +  +K+ DFGLA+    +++     T ++ APEV  N
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMXGXVVTRWYRAPEVILN 199

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 27  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 81
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 82  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 142 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 201
Query: 495 APE 497
           +PE
Sbjct: 202 SPE 204

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 91/183 (49%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185
Query: 498 VCS 500
           V +
Sbjct: 186 VVT 188

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 91/183 (49%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 70
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 71  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 128
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 179
Query: 498 VCS 500
           V +
Sbjct: 180 VVT 182

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 90/165 (54%), Gaps = 8/165 (4%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSI 374
           +PN    RI+  T  ++  +LG G+FG+VY+GI   +G    +   + +L++ +  K ++
Sbjct: 3   APNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 62
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVS 432
             +++ + +++  +H ++V+  G     + + +  +L+  G LL     +  ++    + 
Sbjct: 63  EFMDEAL-IMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLL 120
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +  QI  G+ YL ++ +VHRD+   N+LV +   VK+ DFGLA+
Sbjct: 121 NWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 165

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 90/169 (53%), Gaps = 10/169 (5%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQ 372
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+   +G    +    +  + + + +
Sbjct: 34  SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPK 93
Query: 373 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS 432
           +  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  S
Sbjct: 94  ANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIGS 150
Query: 433 AYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 151 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 199

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 24/184 (13%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           D++G G+FG V +  I  DG     A+K +         +    +LE    L     H N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPN 87
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILL-- 440
           I+   G  +    LY+ +E    G+LL+  ++         + + +S  S  + Q LL  
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 441 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 493
                 G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K+  R    W
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 207
Query: 494 MAPE 497
           MA E
Sbjct: 208 MAIE 211

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 89/171 (52%), Gaps = 9/171 (5%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 91/183 (49%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 77
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 135
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 186
Query: 498 VCS 500
           V +
Sbjct: 187 VVT 189

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 91/183 (49%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 134
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMTPY 185
Query: 498 VCS 500
           V +
Sbjct: 186 VVT 188

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 29/185 (15%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 76
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
           +    H+NI+        +  L      YI +EL+      NL Q  +  L   ++S   
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLSQVIQMELDHERMSYLL 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
            Q+L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M 
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMT 183
Query: 496 PEVCS 500
           P V +
Sbjct: 184 PYVVT 188

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 91/183 (49%), Gaps = 25/183 (13%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           ++  +Q    +G G+ G V   Y+ I +     A+K++S   +  Q +    +  +E+ L
Sbjct: 24  VLKRYQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLS---RPFQNQTHAKRAYRELVL 78
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
           +    H+NI+        +  L      YI +EL+   +L  + Q   L   ++S    Q
Sbjct: 79  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM-ELDHERMSYLLYQ 136
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +L G+K+LH   ++HRD+K +NI+V ++ ++K+ DFGLA+           GT+F M P 
Sbjct: 137 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMVPF 187
Query: 498 VCS 500
           V +
Sbjct: 188 VVT 190

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 24/184 (13%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           D++G G+FG V +  I  DG     A+K +         +    +LE    L     H N
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPN 77
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILL-- 440
           I+   G  +    LY+ +E    G+LL+  ++         + + +S  S  + Q LL  
Sbjct: 78  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 441 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 493
                 G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K+  R    W
Sbjct: 138 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 197
Query: 494 MAPE 497
           MA E
Sbjct: 198 MAIE 201

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 69/125 (55%), Gaps = 2/125 (1%)
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 433
           +Q+ +E+ +L       IV +YG    + ++ I +E +  GSL   L +   + +  +  
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 118
Query: 434 YTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
            +  +L GL YL ++  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  
Sbjct: 119 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 178
Query: 493 WMAPE 497
           +MAPE
Sbjct: 179 YMAPE 183

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 89/171 (52%), Gaps = 9/171 (5%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 89/171 (52%), Gaps = 9/171 (5%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 90/170 (52%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 13  APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 68
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 69  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 125
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 126 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 175

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 35/203 (17%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R +T ++    LGRG FG V+E  +  D   +A+K + L ++   A++ + +   E+  L
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMR---EVKAL 57
Query: 385 SRFEHENIVQYYGT--DKDESK----------LYIFLELVTKGSL---LNLYQRYHLRDS 429
           ++ EH  IV+Y+    +K+ ++          LYI ++L  K +L   +N       R+ 
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 430 QVSAYT-RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC- 487
            V  +   QI   +++LH + ++HRD+K +NI    +  VK+ DFGL  A   ++ +   
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 488 -------------RGTAFWMAPE 497
                         GT  +M+PE
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPE 200

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 89/170 (52%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE   L + +  K
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPK 59
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
            +  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 60  AN-KEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 115
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 33  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 87
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 147
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 495 APE 497
           +PE
Sbjct: 208 SPE 210

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 87/173 (50%), Gaps = 11/173 (6%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G FG V    +   G  +A K++       +  ++++  E++I  L +     +V 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVVS 248
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-----RDSQVSAYTRQILLGLKYLHDQD 449
                + +  L + L L+  G L   +  YH+      +++   Y  +I  GL+ LH + 
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 450 VVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVCSN 501
           +V+RD+K  NIL+D +G ++++D GLA    +   +K   GT  +MAPEV  N
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 90/170 (52%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 61
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 118
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 119 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 168

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 90/170 (52%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 115
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V  +++G +  +++   ++EI       H NIV++       + L I +E  + G L   
Sbjct: 49  VKYIERGEKIDENV---KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 105
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK 477
           +       + +   + +Q++ G+ Y H   V HRD+K  N L+D + +  +K+ADFG +K
Sbjct: 106 ICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK 165
Query: 478 ATKLN-DVKSCRGTAFWMAPEV 498
           A+ L+   KS  GT  ++APEV
Sbjct: 166 ASVLHSQPKSAVGTPAYIAPEV 187

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 90/170 (52%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 61
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 118
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 119 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 168

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 90/170 (52%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 6   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 61
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 118
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 119 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 168

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 87/173 (50%), Gaps = 11/173 (6%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +LG+G FG V    +   G  +A K++       +  ++++  E++I  L +     +V 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVVS 248
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-----RDSQVSAYTRQILLGLKYLHDQD 449
                + +  L + L L+  G L   +  YH+      +++   Y  +I  GL+ LH + 
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 450 VVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVCSN 501
           +V+RD+K  NIL+D +G ++++D GLA    +   +K   GT  +MAPEV  N
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 90/170 (52%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGXLLD-YVREH-KDNIG 115
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 20  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 74
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 75  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 135 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 194
Query: 495 APE 497
           +PE
Sbjct: 195 SPE 197

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 26  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 80
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 81  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 141 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 495 APE 497
           +PE
Sbjct: 201 SPE 203

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 6   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 61
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 62  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 118
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 119 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 171

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 62
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 119
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 172

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 114
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 167

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 8/177 (4%)
Query: 315 MSNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK-EVSLLDQGSQA 370
           MS  +PN    RI+  T  +K  +LG G+FG+VY+GI   DG    +   + +L + +  
Sbjct: 1   MSGAAPNQALLRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP 60
Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRD 428
           K +  ++  E  +++      + +  G     S + +  +L+  G LL+  +  R  L  
Sbjct: 61  KAN-KEILDEAYVMAGVGSPYVSRLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGS 118
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
             +  +  QI  G+ YL D  +VHRD+   N+LV +   VK+ DFGLA+   +++ +
Sbjct: 119 QDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 175

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 89/171 (52%), Gaps = 9/171 (5%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 89
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 200

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 24  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 78
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 79  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 138
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 139 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 495 APE 497
           +PE
Sbjct: 199 SPE 201

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 35/197 (17%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G +LG G+FG V      GIS  G    V  V +L + + + +    L  E+ ++++   
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVA-VKMLKEKADSSER-EALMSELKMMTQLGS 107
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVS-------------- 432
           HENIV   G       +Y+  E    G LLN    +R    + ++               
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 433 --------AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484
                    +  Q+  G+++L  +  VHRD+   N+LV     VK+ DFGLA+    +  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 485 KSCRGTAF----WMAPE 497
              RG A     WMAPE
Sbjct: 228 YVVRGNARLPVKWMAPE 244

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 17/165 (10%)
Query: 334 GDLLGRGSFGSVYEG--ISDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHE 390
           G +LG G FGSV EG    +DG    V   ++ LD  SQ  + I +   E A +  F H 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ--REIEEFLSEAACMKDFSHP 96
Query: 391 NIVQYYGTDKDES-----KLYIFLELVTKGSLLN--LYQRY-----HLRDSQVSAYTRQI 438
           N+++  G   + S     K  + L  +  G L    LY R      H+    +  +   I
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
            LG++YL +++ +HRD+   N ++  + +V +ADFGL+K     D
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 26  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 80
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 81  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 141 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 495 APE 497
           +PE
Sbjct: 201 SPE 203

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 22/183 (12%)
Query: 330 YWQKGDL------LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
           ++Q  DL      LG GSF    + +       FAVK +S        K+  +  ++EI 
Sbjct: 6   FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--------KRMEANTQKEIT 57
Query: 383 LLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
            L   E H NIV+ +    D+   ++ +EL+  G L   + ++ H  +++ S   R+++ 
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117
Query: 441 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLND--VKSCRGTAFWMA 495
            + ++HD  VVHRD+K  N+L    + N  +K+ DFG A+    ++  +K+   T  + A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 496 PEV 498
           PE+
Sbjct: 178 PEL 180

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 27  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 81
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 82  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 142 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 201
Query: 495 APE 497
           +PE
Sbjct: 202 SPE 204

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 89/171 (52%), Gaps = 9/171 (5%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 89/171 (52%), Gaps = 9/171 (5%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 62
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 91/173 (52%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 25  SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 80
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 81  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 137
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 138 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 190

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 73/130 (56%), Gaps = 12/130 (9%)
Query: 379 QEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYT 435
           +EI +L R+ +H NI+       D   +Y+  EL+  G LL+  L Q++   + + S   
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVL 127
Query: 436 RQILLGLKYLHDQDVVHRDIKCANIL-VDANGS---VKLADFGLAKATKLND---VKSCR 488
             I   ++YLH Q VVHRD+K +NIL VD +G+   +++ DFG AK  +  +   +  C 
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY 187
Query: 489 GTAFWMAPEV 498
            TA ++APEV
Sbjct: 188 -TANFVAPEV 196

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 78/150 (52%), Gaps = 7/150 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K   +G GS+G V++  + D G   A+K+  L  +     + I+   +EI +L + +H
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIAL--REIRMLKQLKH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
            N+V      + + +L++  E      L  L+ YQR  + +  V + T Q L  + + H 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHK 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477
            + +HRD+K  NIL+  +  +KL DFG A+
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFAR 150

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 55  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 109
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 110 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 169
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G       WM
Sbjct: 170 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 229
Query: 495 APE 497
           +PE
Sbjct: 230 SPE 232

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 9/172 (5%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSN 501
           RD+K  N+++D +G +K+ DFGL K   + D   +K+  GT  ++APEV  +
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVLED 323

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 9/172 (5%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 275
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSN 501
           RD+K  N+++D +G +K+ DFGL K   + D   +K+  GT  ++APEV  +
Sbjct: 276 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVLED 326

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 73/130 (56%), Gaps = 12/130 (9%)
Query: 379 QEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYT 435
           +EI +L R+ +H NI+       D   +Y+  EL+  G LL+  L Q++   + + S   
Sbjct: 69  EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVL 127
Query: 436 RQILLGLKYLHDQDVVHRDIKCANIL-VDANGS---VKLADFGLAKATKLND---VKSCR 488
             I   ++YLH Q VVHRD+K +NIL VD +G+   +++ DFG AK  +  +   +  C 
Sbjct: 128 HTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY 187
Query: 489 GTAFWMAPEV 498
            TA ++APEV
Sbjct: 188 -TANFVAPEV 196

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 37/188 (19%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 33  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 87
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSA 433
            ++V+  G         + +EL+T+G L     + +LR                 S++  
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
              +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G    
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 493 ---WMAPE 497
              WM+PE
Sbjct: 203 PVRWMSPE 210

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +L  G+FG+VY+G+            A+KE+    + +
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 62
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 119
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 172

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 37/188 (19%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 23  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 77
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSA 433
            ++V+  G         + +EL+T+G L     + +LR                 S++  
Sbjct: 78  HHVVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
              +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G    
Sbjct: 133 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 192
Query: 493 ---WMAPE 497
              WM+PE
Sbjct: 193 PVRWMSPE 200

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 9/168 (5%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++GSV   I    G   A+K++S   +  Q++    +  +E+ LL   +HEN++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS---RPFQSEIFAKRAYRELLLLKHMQHENVIGL 88
Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQ--VSAYTRQILLGLKYLHDQDVV 451
                  S L  F +  LV      +L +   L+ S+  +     Q+L GLKY+H   VV
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC 499
           HRD+K  N+ V+ +  +K+ DFGLA+     ++     T ++ APEV 
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYVVTRWYRAPEVI 195

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 24/184 (13%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           D++G G+FG V +  I  DG     A+K +         +    +LE    L     H N
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPN 84
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILL-- 440
           I+   G  +    LY+ +E    G+LL+  ++         + + +S  S  + Q LL  
Sbjct: 85  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 441 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 493
                 G+ YL  +  +HR++   NILV  N   K+ADFGL++  ++   K+  R    W
Sbjct: 145 AADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 204
Query: 494 MAPE 497
           MA E
Sbjct: 205 MAIE 208

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 30  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 89
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 90  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 141
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 142 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 199 LLKDTVYTDFDGTRVYSPPE 218

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 43  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 102
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 103 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 154
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 155 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 211
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 212 LLKDTVYTDFDGTRVYSPPE 231

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 38  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 97
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 98  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 149
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 150 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 206
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 207 LLKDTVYTDFDGTRVYSPPE 226

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 134
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 135 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 192 LLKDTVYTDFDGTRVYSPPE 211

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 114
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAK 167

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KD 114
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAK 167

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 90/170 (52%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 7   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 62
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + + ++L+  G LL+ Y R H +D+  
Sbjct: 63  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLD-YVREH-KDNIG 119
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK
Sbjct: 120 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAK 169

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 10  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 69
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 70  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 121
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 122 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 178
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 179 LLKDTVYTDFDGTRVYSPPE 198

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 134
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 135 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 192 LLKDTVYTDFDGTRVYSPPE 211

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 134
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 135 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 192 LLKDTVYTDFDGTRVYSPPE 211

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 10  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 69
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 70  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 121
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 122 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 178
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 179 LLKDTVYTDFDGTRVYSPPE 198

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 135
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 136 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 193 LLKDTVYTDFDGTRVYSPPE 212

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 122
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 123 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 180 LLKDTVYTDFDGTRVYSPPE 199

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 135
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 136 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 193 LLKDTVYTDFDGTRVYSPPE 212

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 134
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 135 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 192 LLKDTVYTDFDGTRVYSPPE 211

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 135
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 136 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 193 LLKDTVYTDFDGTRVYSPPE 212

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 122
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 123 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 180 LLKDTVYTDFDGTRVYSPPE 199

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 122
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 123 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 180 LLKDTVYTDFDGTRVYSPPE 199

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 135
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 136 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 193 LLKDTVYTDFDGTRVYSPPE 212

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G +G V+ G S  G   AVK  S  D+ S  +      E E+       HENI+ + 
Sbjct: 16  VGKGRYGEVWRG-SWQGENVAVKIFSSRDEKSWFR------ETELYNTVMLRHENILGFI 68
Query: 397 GTD----KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---- 448
            +D       ++L++       GSL +  Q   L           I  GL +LH +    
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 449 ----DVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSC--RGTAFWMAPEV 498
                + HRD+K  NILV  NG   +AD GLA    ++T   DV +    GT  +MAPEV
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 82/177 (46%), Gaps = 7/177 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q+   LG GS+G V++  S +DG  +AVK      +G   K    +L +  +     +H
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP--KDRARKLAEVGSHEKVGQH 116
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHD 447
              V+     ++   LY+  EL    SL    + +   L ++QV  Y R  LL L +LH 
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVCSNPF 503
           Q +VH D+K ANI +   G  KL DFGL            + G   +MAPE+    +
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSY 232

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQ 394
           LG+G++G V++ I    G   AVK++    Q S   Q   +  +EI +L+    HENIV 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREIMILTELSGHENIVN 73
Query: 395 YYGT-----DKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    D+D   ++ ++E      +  N+ +  H    Q   Y  Q++  +KYLH  
Sbjct: 74  LLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH---KQYVVY--QLIKVIKYLHSG 128
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA 478
            ++HRD+K +NIL++A   VK+ADFGL+++
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRS 158

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G +G V+ G S  G   AVK  S  D+ S  +      E E+       HENI+ + 
Sbjct: 45  VGKGRYGEVWRG-SWQGENVAVKIFSSRDEKSWFR------ETELYNTVMLRHENILGFI 97
Query: 397 GTD----KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---- 448
            +D       ++L++       GSL +  Q   L           I  GL +LH +    
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 449 ----DVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSC--RGTAFWMAPEV 498
                + HRD+K  NILV  NG   +AD GLA    ++T   DV +    GT  +MAPEV
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 217

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 29/200 (14%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQ 366
           + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V          L  
Sbjct: 38  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 97
Query: 367 GSQAKQSISQLEQE-------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLL 418
           G++    +  L++        I LL  FE  ++ V      +    L+ F+         
Sbjct: 98  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-------- 149
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
              +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 150 ---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 206
Query: 478 ATKLNDVKSCRGTAFWMAPE 497
             K        GT  +  PE
Sbjct: 207 LLKDTVYTDFDGTRVYSPPE 226

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 35/194 (18%)
Query: 337 LGRGSFGSVYEGISDDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           +G G+FG V++  +  G      F +  V +L + + A    +  ++E AL++ F++ NI
Sbjct: 55  IGEGAFGRVFQARAP-GLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNI 112
Query: 393 VQYYGTDKDESKLYIFLELVTKGSL------LNLYQRYHLRDSQVS-------------- 432
           V+  G       + +  E +  G L      ++ +    L  S +S              
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 433 -----AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 487
                   RQ+  G+ YL ++  VHRD+   N LV  N  VK+ADFGL++     D    
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 232
Query: 488 RGT----AFWMAPE 497
            G       WM PE
Sbjct: 233 DGNDAIPIRWMPPE 246

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 315 MSNISPNGRFKRII--TYWQ------KGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLD 365
           MS I   G +K+ +  T W+          +G G++GSV   I    G   A+K++S   
Sbjct: 20  MSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS--- 76
Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL----LNLY 421
           +  Q++    +  +E+ LL   +HEN++         S L  F +           L   
Sbjct: 77  RPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKI 136
Query: 422 QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
                 + ++     Q+L GLKY+H   VVHRD+K  N+ V+ +  +K+ DFGLA+    
Sbjct: 137 MGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 195
Query: 482 NDVKSCRGTAFWMAPEVC 499
            ++     T ++ APEV 
Sbjct: 196 AEMTGYVVTRWYRAPEVI 213

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 83/183 (45%), Gaps = 27/183 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           LG+GSFG VYEG++       VK+       +  +++ +  ++ I  L  E +++  F  
Sbjct: 20  LGQGSFGMVYEGVAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 74
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSA---------YTRQI 438
            ++V+  G         + +EL+T+G L +  +  R  + ++ V A            +I
Sbjct: 75  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM 494
             G+ YL+    VHRD+   N  V  + +VK+ DFG+ +     D     G       WM
Sbjct: 135 ADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 194
Query: 495 APE 497
           +PE
Sbjct: 195 SPE 197

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 90/180 (50%), Gaps = 16/180 (8%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W   D+LG+G+  +V+ G     G  FA+K   + +  S  +    Q+ +E  +L +  H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQM-REFEVLKKLNH 66
Query: 390 ENIVQYYGTDKDESKLY--IFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLK 443
           +NIV+ +  +++ +  +  + +E    GSL  + +     Y L +S+     R ++ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 444 YLHDQDVVHRDIKCANIL----VDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEV 498
           +L +  +VHR+IK  NI+     D     KL DFG A+  + ++   S  GT  ++ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 15/178 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSR 386
           +Q G LLG G FGSVY GI   D    A+K V    + D G     +  ++  E+ LL +
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT--RVPMEVVLLKK 67
Query: 387 FEHE-----NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
                     ++ ++  ++ +S + I   +     L + + +R  L++    ++  Q+L 
Sbjct: 68  VSSGFSGVIRLLDWF--ERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 441 GLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
            +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  +  PE
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 183

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 89/171 (52%), Gaps = 9/171 (5%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 81
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 82  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +  ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE
Sbjct: 142 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 192

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G +G V+ G S  G   AVK  S  D+ S  +      E E+       HENI+ + 
Sbjct: 16  VGKGRYGEVWRG-SWQGENVAVKIFSSRDEKSWFR------ETELYNTVMLRHENILGFI 68
Query: 397 GTD----KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---- 448
            +D       ++L++       GSL +  Q   L           I  GL +LH +    
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 449 ----DVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSC--RGTAFWMAPEV 498
                + HRD+K  NILV  NG   +AD GLA    ++T   DV +    GT  +MAPEV
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 20  IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 71
Query: 397 GTDKDE-SKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           G   +E   LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 72  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 131
Query: 453 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPE 497
           RD+   N+LV  +   K++DFGL K A+   D  + +    W APE
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPE 175

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 64/130 (49%), Gaps = 11/130 (8%)
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTR 436
           E +++ +F+H NI++  G         I  E +  GSL + + R H       Q+    R
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLR 158
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---- 492
            +  G++YL D   VHRD+   N+LVD+N   K++DFGL++  + +D  +   T      
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAXTTTGGKIP 217
Query: 493 --WMAPEVCS 500
             W APE  +
Sbjct: 218 IRWTAPEAIA 227

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 87/171 (50%), Gaps = 9/171 (5%)
Query: 331 WQKGDLLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
           ++K   LG G+ G V++      G   A K + L     + K +I +Q+ +E+ +L    
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-----EIKPAIRNQIIRELQVLHECN 65
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
              IV +YG    + ++ I +E +  GSL  + ++      Q+    +  ++ GL YL +
Sbjct: 66  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 448 QD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
           +  ++HRD+K +NILV++ G +KL DFG++            GT  +M+PE
Sbjct: 126 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPE 176

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 201 IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 252
Query: 397 GTDKDE-SKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           G   +E   LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312
Query: 453 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPE 497
           RD+   N+LV  +   K++DFGL K A+   D  + +    W APE
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPE 356

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 9/172 (5%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 17  LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 74
Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 134
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSN 501
           RD+K  N+++D +G +K+ DFGL K   + D   +K   GT  ++APEV  +
Sbjct: 135 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKXFCGTPEYLAPEVLED 185

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 14  IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 65
Query: 397 GTDKDE-SKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           G   +E   LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 125
Query: 453 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPE 497
           RD+   N+LV  +   K++DFGL K A+   D  + +    W APE
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPE 169

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 89/170 (52%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +L  G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 115
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 64/130 (49%), Gaps = 11/130 (8%)
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTR 436
           E +++ +F+H NI++  G         I  E +  GSL + + R H       Q+    R
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLR 158
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---- 492
            +  G++YL D   VHRD+   N+LVD+N   K++DFGL++  + +D  +   T      
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIP 217
Query: 493 --WMAPEVCS 500
             W APE  +
Sbjct: 218 IRWTAPEAIA 227

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 90/173 (52%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +L  G+FG+VY+G+            A+KE+    + +
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 62
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 119
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 172

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 89/170 (52%), Gaps = 18/170 (10%)
Query: 319 SPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAK 371
           +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + + + 
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSP 58
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIG 115
Query: 432 SAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAK 165

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 19/177 (10%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 15  LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 72
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLGLKYLH-D 447
              + +   +L   +E    G L      +HL   +V +      Y  +I+  L YLH +
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYLHSE 127
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSN 501
           ++VV+RD+K  N+++D +G +K+ DFGL K   + D   +K   GT  ++APEV  +
Sbjct: 128 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKXFCGTPEYLAPEVLED 183

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 9/172 (5%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           LLG+G+FG V        G ++A+K   L  +   AK  ++    E  +L    H  +  
Sbjct: 16  LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 73
Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
              + +   +L   +E    G L  +L +     + +   Y  +I+  L YLH +++VV+
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 133
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVCSN 501
           RD+K  N+++D +G +K+ DFGL K   + D   +K   GT  ++APEV  +
Sbjct: 134 RDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKXFCGTPEYLAPEVLED 184

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 90/173 (52%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 7   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 62
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 119
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAK 172

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 90/173 (52%), Gaps = 18/173 (10%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGS 368
           S  +PN    RI+  T ++K  +LG G+FG+VY+G+            A+KE+    + +
Sbjct: 2   SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REA 57
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
            + ++  ++  E  +++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KD 114
Query: 429 SQVSAYTR----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           +  S Y      QI  G+ YL D+ +VHRD+   N+LV     VK+ DFG AK
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAK 167

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 15/166 (9%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G FG V  G    G   AVK +   D  +QA         E +++++  H N+VQ  
Sbjct: 29  IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 80
Query: 397 GTDKDE-SKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           G   +E   LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   + VH
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 453 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPE 497
           RD+   N+LV  +   K++DFGL K A+   D  + +    W APE
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPE 184

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 81/185 (43%), Gaps = 29/185 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 114
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 115 FFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 493 WMAPE 497
           +  PE
Sbjct: 175 YSPPE 179

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 81/185 (43%), Gaps = 29/185 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 119
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 179
Query: 493 WMAPE 497
           +  PE
Sbjct: 180 YSPPE 184

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGISDDG----FFFAVKEVSLLDQGSQAKQSISQLEQE 380
           +R++T+  +  ++G+G FG VY G   D        A+K +S + +     Q +    +E
Sbjct: 19  ERVVTHSDR--VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE----MQQVEAFLRE 72
Query: 381 IALLSRFEHENIVQYYGTDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVS---AYTR 436
             L+    H N++   G       L ++ L  +  G LL  + R   R+  V    ++  
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ-FIRSPQRNPTVKDLISFGL 131
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
           Q+  G++YL +Q  VHRD+   N ++D + +VK+ADFGLA+
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 11/172 (6%)
Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G+ G V++      G   AVK++       + K+ +  L+    +L   +   IVQ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD---VVLKSHDCPYIVQC 89
Query: 396 YGTDKDESKLYIFLELV-TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD-VVHR 453
           +GT    + ++I +EL+ T    L    +  + +  +   T  I+  L YL ++  V+HR
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR 149
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVCSNP 502
           D+K +NIL+D  G +KL DFG+  + +L D K+     G A +MAPE    P
Sbjct: 150 DVKPSNILLDERGQIKLCDFGI--SGRLVDDKAKDRSAGCAAYMAPERIDPP 199

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 81/185 (43%), Gaps = 29/185 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 119
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 179
Query: 493 WMAPE 497
           +  PE
Sbjct: 180 YSPPE 184

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 90/172 (52%), Gaps = 17/172 (9%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +GRG++GSV + +    G   AVK + S +D+  Q KQ +  L+    ++   +   IVQ
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ-KQLLMDLD---VVMRSSDCPYIVQ 85
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQV-----SAYTRQILLGLKYLHDQ 448
           +YG    E   +I +EL++  S    Y+  Y + D  +        T   +  L +L + 
Sbjct: 86  FYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPE 497
             ++HRDIK +NIL+D +G++KL DFG++    ++ +   R  G   +MAPE
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGIS-GQLVDSIAKTRDAGCRPYMAPE 195

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 80/200 (40%), Gaps = 38/200 (19%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 44  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 99
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 431
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 100 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK--RDSFICSKTSPAIMEDDELA 157
Query: 432 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 158 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 486 SCRGTA----FWMAPEVCSN 501
             +G A     WMAPE   N
Sbjct: 218 VVKGNARLPVKWMAPESIFN 237

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 80/200 (40%), Gaps = 38/200 (19%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 106
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 431
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR--KRDSFICSKTSPAIMEDDELA 164
Query: 432 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 486 SCRGTA----FWMAPEVCSN 501
             +G A     WMAPE   N
Sbjct: 225 VVKGNARLPVKWMAPESIFN 244

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 81/185 (43%), Gaps = 29/185 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 118
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 119 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 178
Query: 493 WMAPE 497
           +  PE
Sbjct: 179 YSPPE 183

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 81/185 (43%), Gaps = 29/185 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 119
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 120 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 179
Query: 493 WMAPE 497
           +  PE
Sbjct: 180 YSPPE 184

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 81/185 (43%), Gaps = 29/185 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 141
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 142 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 201
Query: 493 WMAPE 497
           +  PE
Sbjct: 202 YSPPE 206

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 27/190 (14%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL----------------NLYQRYHLRDSQVS 432
            N+V   G   K    L + +E    G+L                 +LY+ + L    + 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDF-LTLEHLI 151
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
            Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G A 
Sbjct: 152 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 493 ----WMAPEV 498
               WMAPE 
Sbjct: 212 LPLKWMAPET 221

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 80/200 (40%), Gaps = 38/200 (19%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 83
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 431
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK--RDSFICSKTSPAIMEDDELA 141
Query: 432 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 486 SCRGTA----FWMAPEVCSN 501
             +G A     WMAPE   N
Sbjct: 202 VVKGNARLPVKWMAPESIFN 221

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 82/191 (42%), Gaps = 28/191 (14%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL-----------------NLYQRYHLRDSQV 431
            N+V   G   K    L + +E    G+L                  +LY+ + L    +
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDF-LTLEHL 150
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
             Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G A
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 492 F----WMAPEV 498
                WMAPE 
Sbjct: 211 RLPLKWMAPET 221

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 82/188 (43%), Gaps = 25/188 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSL--------------LNLYQRYHLRDSQVSAY 434
            N+V   G   K    L + +E    G+L               +LY+ + L    +  Y
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF-LTLEHLICY 149
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-- 492
           + Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G A   
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 493 --WMAPEV 498
             WMAPE 
Sbjct: 210 LKWMAPET 217

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W   D+LG+G+  +V+ G     G  FA+K   + +  S  +    Q+ +E  +L +  H
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQM-REFEVLKKLNH 66
Query: 390 ENIVQYYGTDKDESKLY--IFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLK 443
           +NIV+ +  +++ +  +  + +E    GSL  + +     Y L +S+     R ++ G+ 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 444 YLHDQDVVHRDIKCANIL----VDANGSVKLADFGLAK 477
           +L +  +VHR+IK  NI+     D     KL DFG A+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 29/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 149
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 491 AF----WMAPEV 498
           A     WMAPE 
Sbjct: 210 ARLPLKWMAPET 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 16/158 (10%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           T ++K  +LG G+FG+VY+G+            A+KE+    + + + ++  ++  E  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSPKANKEILDEAYV 64
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----QIL 439
           ++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  S Y      QI 
Sbjct: 65  MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIGSQYLLNWCVQIA 121
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 81/185 (43%), Gaps = 29/185 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 117
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 118 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 177
Query: 493 WMAPE 497
           +  PE
Sbjct: 178 YSPPE 182

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 80/200 (40%), Gaps = 38/200 (19%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 51  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 106
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 431
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR--KRDSFICSKTSPAIMEDDELA 164
Query: 432 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 486 SCRGTA----FWMAPEVCSN 501
             +G A     WMAPE   N
Sbjct: 225 VVKGNARLPVKWMAPESIFN 244

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 33/181 (18%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ- 394
           ++G GSFG V++    +    A+K+V    Q  + K       +E+ ++   +H N+V  
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVL---QDKRFKN------RELQIMRIVKHPNVVDL 97
Query: 395 ---YY--GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQILLG 441
              +Y  G  KDE    +FL LV +     +Y+  R++ +  Q      +  Y  Q+L  
Sbjct: 98  KAFFYSNGDKKDE----VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 442 LKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAK---ATKLNDVKSCRGTAFWMAPE 497
           L Y+H   + HRDIK  N+L+D  +G +KL DFG AK   A + N    C  + ++ APE
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC--SRYYRAPE 211
Query: 498 V 498
           +
Sbjct: 212 L 212

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 35/190 (18%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG GS G+V    S  G   AVK + L+D    A   I  L +        +H N+++Y
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESD------DHPNVIRY 74
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--------AYTRQILLGLKYLHD 447
           Y ++  +  LYI LEL    +L +L +  ++ D  +         +  RQI  G+ +LH 
Sbjct: 75  YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 448 QDVVHRDIKCANILVDA-------------NGSVKLADFGLAK------ATKLNDVKSCR 488
             ++HRD+K  NILV               N  + ++DFGL K      ++   ++ +  
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 489 GTAFWMAPEV 498
           GT+ W APE+
Sbjct: 194 GTSGWRAPEL 203

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 80/200 (40%), Gaps = 38/200 (19%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 46  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTER-EALMSELKVLSYL 101
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV--------------- 431
             H NIV   G         +  E    G LLN  +R   RDS +               
Sbjct: 102 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK--RDSFICSKTSPAIMEDDELA 159
Query: 432 ------SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
                  +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +   
Sbjct: 160 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 486 SCRGTAF----WMAPEVCSN 501
             +G A     WMAPE   N
Sbjct: 220 VVKGNARLPVKWMAPESIFN 239

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 81/185 (43%), Gaps = 29/185 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 114
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 493 WMAPE 497
           +  PE
Sbjct: 175 YSPPE 179

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 81/185 (43%), Gaps = 29/185 (15%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--------LDQGSQAKQSISQLEQE- 380
           +Q G LLG G FGSVY GI   D    A+K V          L  G++    +  L++  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 381 ------IALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                 I LL  FE  ++ V      +    L+ F+            +R  L++    +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARS 114
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAF 492
           +  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  
Sbjct: 115 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 493 WMAPE 497
           +  PE
Sbjct: 175 YSPPE 179

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 73/142 (51%), Gaps = 7/142 (4%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V  +++G +  +++   ++EI       H NIV++       + L I +E  + G L   
Sbjct: 48  VKYIERGEKIDENV---KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 104
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK 477
           +       + +   + +Q++ G+ Y H   V HRD+K  N L+D + +  +K+ DFG +K
Sbjct: 105 ICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 164
Query: 478 ATKLN-DVKSCRGTAFWMAPEV 498
           ++ L+   KS  GT  ++APEV
Sbjct: 165 SSVLHSQPKSTVGTPAYIAPEV 186

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 82/188 (43%), Gaps = 25/188 (13%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSL--------------LNLYQRYHLRDSQVSAY 434
            N+V   G   K    L + +E    G+L               +LY+ + L    +  Y
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF-LTLEHLIXY 149
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-- 492
           + Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G A   
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 493 --WMAPEV 498
             WMAPE 
Sbjct: 210 LKWMAPET 217

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 39/192 (20%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG GS G+V    S  G   AVK + L+D    A   I  L +        +H N+++Y
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESD------DHPNVIRY 92
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--------AYTRQILLGLKYLHD 447
           Y ++  +  LYI LEL    +L +L +  ++ D  +         +  RQI  G+ +LH 
Sbjct: 93  YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 448 QDVVHRDIKCANILVDA-------------NGSVKLADFGLAKATKLN--------DVKS 486
             ++HRD+K  NILV               N  + ++DFGL K  KL+        ++ +
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNLNN 209
Query: 487 CRGTAFWMAPEV 498
             GT+ W APE+
Sbjct: 210 PSGTSGWRAPEL 221

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 16/158 (10%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           T ++K  +LG G+FG+VY+G+            A+KE+    + + + ++  ++  E  +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSPKANKEILDEAYV 67
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----QIL 439
           ++  ++ ++ +  G     S + +  +L+  G LL+ Y R H +D+  S Y      QI 
Sbjct: 68  MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD-YVREH-KDNIGSQYLLNWCVQIA 124
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK
Sbjct: 125 EGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 162

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 29/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 140
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 491 AF----WMAPEV 498
           A     WMAPE 
Sbjct: 201 ARLPLKWMAPET 212

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 66/128 (51%), Gaps = 4/128 (3%)
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 433
           + +++EI       H NIV++       + L I +E  + G L   +       + +   
Sbjct: 60  ANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 119
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKATKLN-DVKSCRGT 490
           + +Q++ G+ Y H   V HRD+K  N L+D + +  +K+ DFG +K++ L+   KS  GT
Sbjct: 120 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 179
Query: 491 AFWMAPEV 498
             ++APEV
Sbjct: 180 PAYIAPEV 187

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 39/192 (20%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG GS G+V    S  G   AVK + L+D    A   I  L +        +H N+++Y
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESD------DHPNVIRY 92
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--------AYTRQILLGLKYLHD 447
           Y ++  +  LYI LEL    +L +L +  ++ D  +         +  RQI  G+ +LH 
Sbjct: 93  YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 448 QDVVHRDIKCANILVDA-------------NGSVKLADFGLAKATKLN--------DVKS 486
             ++HRD+K  NILV               N  + ++DFGL K  KL+        ++ +
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNLNN 209
Query: 487 CRGTAFWMAPEV 498
             GT+ W APE+
Sbjct: 210 PSGTSGWRAPEL 221

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 29/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 149
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 491 AF----WMAPEV 498
           A     WMAPE 
Sbjct: 210 ARLPLKWMAPET 221

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 39/192 (20%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LG GS G+V    S  G   AVK + L+D    A   I  L +        +H N+++Y
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESD------DHPNVIRY 74
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS--------AYTRQILLGLKYLHD 447
           Y ++  +  LYI LEL    +L +L +  ++ D  +         +  RQI  G+ +LH 
Sbjct: 75  YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 448 QDVVHRDIKCANILVDA-------------NGSVKLADFGLAKATKLN--------DVKS 486
             ++HRD+K  NILV               N  + ++DFGL K  KL+        ++ +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNLNN 191
Query: 487 CRGTAFWMAPEV 498
             GT+ W APE+
Sbjct: 192 PSGTSGWRAPEL 203

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 87/171 (50%), Gaps = 12/171 (7%)
Query: 337 LGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQ 394
           LGRG F  V + IS   G  +A K    L +  + +   +++  EIA+L   +    ++ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
            +   ++ S++ + LE    G + +L        + ++ V    +QIL G+ YLH  ++V
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 452 HRDIKCANILVDAN---GSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEV 498
           H D+K  NIL+ +    G +K+ DFG++ K     +++   GT  ++APE+
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 29/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 149
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 491 AF----WMAPEV 498
           A     WMAPE 
Sbjct: 210 ARLPLKWMAPET 221

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 29/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDF-LTLEH 151
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 152 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 491 AF----WMAPEV 498
           A     WMAPE 
Sbjct: 212 ARLPLKWMAPET 223

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 81/192 (42%), Gaps = 29/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L +  E    G+L                   +LY+ + L    
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 140
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 491 AF----WMAPEV 498
           A     WMAPE 
Sbjct: 201 ARLPLKWMAPET 212

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 29/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L + +E    G+L                   +LY+ + L    
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 186
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 187 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 491 AF----WMAPEV 498
           A     WMAPE 
Sbjct: 247 ARLPLKWMAPET 258

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 93/189 (49%), Gaps = 22/189 (11%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 51  ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 101
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 432
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 158
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 488
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 489 GTAFWMAPE 497
           GT  +M PE
Sbjct: 218 GTVNYMPPE 226

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 29/184 (15%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 494 MAPE 497
           MAPE
Sbjct: 199 MAPE 202

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 29/184 (15%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 494 MAPE 497
           MAPE
Sbjct: 199 MAPE 202

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 29/184 (15%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 80
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 136 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 195
Query: 494 MAPE 497
           MAPE
Sbjct: 196 MAPE 199

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 93/189 (49%), Gaps = 22/189 (11%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 51  ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 101
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 432
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 158
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 488
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 489 GTAFWMAPE 497
           GT  +M PE
Sbjct: 218 GTVNYMPPE 226

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 93/189 (49%), Gaps = 22/189 (11%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 7   ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 57
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 432
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 58  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 114
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 488
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 115 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 173
Query: 489 GTAFWMAPE 497
           GT  +M PE
Sbjct: 174 GTVNYMPPE 182

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 87/179 (48%), Gaps = 22/179 (12%)
Query: 337 LGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LGRG FG V+   E  S   +     +V   DQ          +++EI++L+   H NI+
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ--------VLVKKEISILNIARHRNIL 64
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ 448
             + + +   +L +  E +   S L++++R     + L + ++ +Y  Q+   L++LH  
Sbjct: 65  HLHESFESMEELVMIFEFI---SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 449 DVVHRDIKCANILVDA--NGSVKLADFGLAKATKLNDVKSCRGTA-FWMAPEVCSNPFV 504
           ++ H DI+  NI+     + ++K+ +FG A+  K  D      TA  + APEV  +  V
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 18/181 (9%)
Query: 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           T  +K  +LG G FG+V++G+   +G    +     + +    +QS   +   +  +   
Sbjct: 31  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 90
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTK----GSLLNLYQRYH---LRDSQVSAYTRQILL 440
           +H +IV+  G     S     L+LVT+    GSLL+ + R H   L    +  +  QI  
Sbjct: 91  DHAHIVRLLGLCPGSS-----LQLVTQYLPLGSLLD-HVRQHRGALGPQLLLNWGVQIAK 144
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAP 496
           G+ YL +  +VHR++   N+L+ +   V++ADFG+A     +D +     A     WMA 
Sbjct: 145 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 497 E 497
           E
Sbjct: 205 E 205

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 81/192 (42%), Gaps = 29/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L +  E    G+L                   +LY+ + L    
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 140
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 491 AF----WMAPEV 498
           A     WMAPE 
Sbjct: 201 ARLPLKWMAPET 212

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 81/192 (42%), Gaps = 29/192 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  LGRG+FG V E    GI        V  V +L +G+   +  + + +   L+    H
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLL------------------NLYQRYHLRDSQ 430
            N+V   G   K    L +  E    G+L                   +LY+ + L    
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEH 140
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
           +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +     +G 
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 491 AF----WMAPEV 498
           A     WMAPE 
Sbjct: 201 ARLPLKWMAPET 212

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 29/184 (15%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 82
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 138 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 494 MAPE 497
           MAPE
Sbjct: 198 MAPE 201

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 93/189 (49%), Gaps = 22/189 (11%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 3   ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 53
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 432
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 54  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 110
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 488
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 111 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 169
Query: 489 GTAFWMAPE 497
           GT  +M PE
Sbjct: 170 GTVNYMPPE 178

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 93/189 (49%), Gaps = 22/189 (11%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 4   ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 54
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 432
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 111
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 488
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 112 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 489 GTAFWMAPE 497
           GT  +M PE
Sbjct: 171 GTVNYMPPE 179

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 26/194 (13%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           R ++ +  +Q   + G+G+FG+V  G     G   A+K+V    Q  + +    Q+ Q++
Sbjct: 17  RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---QDPRFRNRELQIMQDL 73
Query: 382 ALLSRFEHENIVQ---YYGTDKDESKLYIFLELVTK---GSLLNLYQRYHLRDSQ----- 430
           A+L    H NIVQ   Y+ T  +  +  I+L +V +    +L    + Y+ R        
Sbjct: 74  AVL---HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL 130
Query: 431 VSAYTRQIL--LGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAK---ATKLNDV 484
           +  +  Q++  +G  +L   +V HRDIK  N+LV+ A+G++KL DFG AK    ++ N  
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 485 KSCRGTAFWMAPEV 498
             C  + ++ APE+
Sbjct: 191 YIC--SRYYRAPEL 202

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 18/178 (10%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +K  +LG G FG+V++G+   +G    +     + +    +QS   +   +  +   +H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 391 NIVQYYGTDKDESKLYIFLELVTK----GSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
           +IV+  G     S     L+LVT+    GSLL+ + R H   L    +  +  QI  G+ 
Sbjct: 76  HIVRLLGLCPGSS-----LQLVTQYLPLGSLLD-HVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPE 497
           YL +  +VHR++   N+L+ +   V++ADFG+A     +D +     A     WMA E
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 29/184 (15%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 494 MAPE 497
           MAPE
Sbjct: 199 MAPE 202

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 25/182 (13%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           + +G+G +G V+ G+   G   AVK  S  D+ S  +      E EI       H+NI+ 
Sbjct: 14  ECVGKGRYGEVWRGLWH-GESVAVKIFSSRDEQSWFR------ETEIYNTVLLRHDNILG 66
Query: 395 YYGTD----KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-- 448
           +  +D       ++L++       GSL +  QR  L              GL +LH +  
Sbjct: 67  FIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 449 ------DVVHRDIKCANILVDANGSVKLADFGLA----KATKLNDVKSC--RGTAFWMAP 496
                  + HRD K  N+LV +N    +AD GLA    + +   D+ +    GT  +MAP
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 497 EV 498
           EV
Sbjct: 187 EV 188

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 33/189 (17%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +L+GRG +G+VY+G S D    AVK  S  ++ +         E+ I  +   EH+NI +
Sbjct: 19  ELIGRGRYGAVYKG-SLDERPVAVKVFSFANRQNFIN------EKNIYRVPLMEHDNIAR 71
Query: 395 YYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 448
           +   D+  +     +  + +E    GSL   Y   H  D   S      +  GL YLH +
Sbjct: 72  FIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 449 ---------DVVHRDIKCANILVDANGSVKLADFGLA---KATKL-------NDVKSCRG 489
                     + HRD+   N+LV  +G+  ++DFGL+      +L       N   S  G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 490 TAFWMAPEV 498
           T  +MAPEV
Sbjct: 191 TIRYMAPEV 199

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 72/142 (50%), Gaps = 7/142 (4%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V  +++G +  +++   ++EI       H NIV++       + L I +E  + G L   
Sbjct: 49  VKYIERGEKIDENV---KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 105
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK 477
           +       + +   + +Q++ G+ Y H   V HRD+K  N L+D + +  +K+  FG +K
Sbjct: 106 ICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK 165
Query: 478 ATKLN-DVKSCRGTAFWMAPEV 498
           ++ L+   KS  GT  ++APEV
Sbjct: 166 SSVLHSQPKSTVGTPAYIAPEV 187

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 87/170 (51%), Gaps = 16/170 (9%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQ 394
           +G G    V++ +++    +A+K V+L +  +Q   ++     EIA L++ +   + I++
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 395 YYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
            Y  +  +  +Y+ +E    G++ LN  L ++  +   +  +Y + +L  +  +H   +V
Sbjct: 93  LYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 149
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPE 497
           H D+K AN L+  +G +KL DFG+A   + +     +    GT  +M PE
Sbjct: 150 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 16/124 (12%)
Query: 387 FEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-- 440
             H  IV  Y T + E+      YI +E V   +L ++    H           +++   
Sbjct: 69  LNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 125
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFW 493
              L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       +    +  GTA +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 494 MAPE 497
           ++PE
Sbjct: 186 LSPE 189

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 32/186 (17%)
Query: 337 LGRGSFGSVYEGISDDGFF---FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           +GRG++G VY+    DG     +A+K++    +G+    S  +   EIALL   +H N++
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACR---EIALLRELKHPNVI 81
Query: 394 --QYYGTDKDESKLYIFLELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLG 441
             Q       + K+++  +   +  L ++ + +           L    V +   QIL G
Sbjct: 82  SLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 442 LKYLHDQDVVHRDIKCANILVDANGS----VKLADFGLAKATK-----LNDVKSCRGTAF 492
           + YLH   V+HRD+K ANILV   G     VK+AD G A+        L D+     T +
Sbjct: 141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200
Query: 493 WMAPEV 498
           + APE+
Sbjct: 201 YRAPEL 206

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 16/124 (12%)
Query: 387 FEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-- 440
             H  IV  Y T + E+      YI +E V   +L ++    H           +++   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 125
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFW 493
              L + H   ++HRD+K ANIL+ A  +VK+ DFG+A+A       +    +  GTA +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQY 185
Query: 494 MAPE 497
           ++PE
Sbjct: 186 LSPE 189

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 80/167 (47%), Gaps = 26/167 (15%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           R++RI         LG G++G VY+ I +      A+K + L  +      +  +   E+
Sbjct: 35  RYRRITK-------LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---EV 84
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTR 436
           +LL   +H NI++         +L++  E        N  ++Y  ++  VS     ++  
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFLY 139
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAKA 478
           Q++ G+ + H +  +HRD+K  N+L+  + +     +K+ DFGLA+A
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 87/170 (51%), Gaps = 16/170 (9%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQ 394
           +G G    V++ +++    +A+K V+L +  +Q   ++     EIA L++ +   + I++
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 395 YYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
            Y  +  +  +Y+ +E    G++ LN  L ++  +   +  +Y + +L  +  +H   +V
Sbjct: 93  LYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIV 149
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPE 497
           H D+K AN L+  +G +KL DFG+A   + +     +    GT  +M PE
Sbjct: 150 HSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPE 198

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 92/189 (48%), Gaps = 22/189 (11%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR   I+        +G G    V++ +++    +A+K V+L +  +Q   ++   
Sbjct: 51  ISVKGRIYSILKQ------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ---TLDSY 101
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSL-LN--LYQRYHLRDSQVS 432
             EIA L++ +   + I++ Y  +  +  +Y+ +E    G++ LN  L ++  +   +  
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERK 158
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---- 488
           +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +     +    
Sbjct: 159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 489 GTAFWMAPE 497
           G   +M PE
Sbjct: 218 GAVNYMPPE 226

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 16/124 (12%)
Query: 387 FEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-- 440
             H  IV  Y T + E+      YI +E V   +L ++    H           +++   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 125
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFW 493
              L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       +    +  GTA +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 494 MAPE 497
           ++PE
Sbjct: 186 LSPE 189

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 16/124 (12%)
Query: 387 FEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-- 440
             H  IV  Y T + E+      YI +E V   +L ++    H           +++   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 125
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFW 493
              L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       +    +  GTA +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 494 MAPE 497
           ++PE
Sbjct: 186 LSPE 189

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 16/124 (12%)
Query: 387 FEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-- 440
             H  IV  Y T + E+      YI +E V   +L ++    H           +++   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 125
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFW 493
              L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       +    +  GTA +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 494 MAPE 497
           ++PE
Sbjct: 186 LSPE 189

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 79/184 (42%), Gaps = 29/184 (15%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 84
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHR++   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 140 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 494 MAPE 497
           MAPE
Sbjct: 200 MAPE 203

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 79/184 (42%), Gaps = 29/184 (15%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHR++   N +V  + +VK+ DFG+ +     D     G       W
Sbjct: 139 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 494 MAPE 497
           MAPE
Sbjct: 199 MAPE 202

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 75/147 (51%), Gaps = 8/147 (5%)
Query: 322 GRFKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
           G   R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+  +    
Sbjct: 4   GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRY----HLRDSQVSAYT 435
            A+L   +H ++V+Y+    ++  + I  E    GSL + + + Y    + +++++    
Sbjct: 64  HAVLG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILV 462
            Q+  GL+Y+H   +VH DIK +NI +
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFI 148

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 334 GDLLGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G +LG+G FGSV E     +DG F  V  V +L     A   I +  +E A +  F+H +
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVA-VKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 392 IVQYYGTD---KDESKL---YIFLELVTKGSL--LNLYQR-----YHLRDSQVSAYTRQI 438
           + +  G     + + +L    + L  +  G L    L  R     ++L    +  +   I
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
             G++YL  ++ +HRD+   N ++  + +V +ADFGL++     D
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 74/143 (51%), Gaps = 8/143 (5%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+  +     A+L
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRY----HLRDSQVSAYTRQIL 439
              +H ++V+Y+    ++  + I  E    GSL + + + Y    + +++++     Q+ 
Sbjct: 66  G--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 440 LGLKYLHDQDVVHRDIKCANILV 462
            GL+Y+H   +VH DIK +NI +
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFI 146

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 43/201 (21%)
Query: 334 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           G  LG G FG V +  +        +    V +L + +   + +  L  E  +L +  H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSEFNVLKQVNHP 86
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-------------------- 430
           ++++ YG    +  L + +E    GSL     R  LR+S+                    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL-----RGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 431 ----------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
                     + ++  QI  G++YL +  +VHRD+   NILV     +K++DFGL++   
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 481 LND--VKSCRG--TAFWMAPE 497
             D  VK  +G     WMA E
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIE 222

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 74/143 (51%), Gaps = 8/143 (5%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+  +     A+L
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRY----HLRDSQVSAYTRQIL 439
              +H ++V+Y+    ++  + I  E    GSL + + + Y    + +++++     Q+ 
Sbjct: 66  G--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 440 LGLKYLHDQDVVHRDIKCANILV 462
            GL+Y+H   +VH DIK +NI +
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFI 146

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 16/124 (12%)
Query: 387 FEHENIVQYYGTDKDESKL----YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-- 440
             H  IV  Y T + E+      YI +E V   +L ++    H           +++   
Sbjct: 86  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADA 142
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFW 493
              L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A       +    +  GTA +
Sbjct: 143 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 202
Query: 494 MAPE 497
           ++PE
Sbjct: 203 LSPE 206

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 71/142 (50%), Gaps = 7/142 (4%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
           V  +++G +  +++   ++EI       H NIV++       + L I +E  + G L   
Sbjct: 49  VKYIERGEKIDENV---KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 105
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK 477
           +       + +   + +Q++ G+ Y H   V HRD+K  N L+D + +  +K+  FG +K
Sbjct: 106 ICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK 165
Query: 478 ATKLN-DVKSCRGTAFWMAPEV 498
           ++ L+   K   GT  ++APEV
Sbjct: 166 SSVLHSQPKDTVGTPAYIAPEV 187

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 43/201 (21%)
Query: 334 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           G  LG G FG V +  +        +    V +L + +   + +  L  E  +L +  H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSEFNVLKQVNHP 86
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-------------------- 430
           ++++ YG    +  L + +E    GSL     R  LR+S+                    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL-----RGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 431 ----------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
                     + ++  QI  G++YL +  +VHRD+   NILV     +K++DFGL++   
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 481 LND--VKSCRG--TAFWMAPE 497
             D  VK  +G     WMA E
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIE 222

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 74/143 (51%), Gaps = 8/143 (5%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+  +     A+L
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 63
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRY----HLRDSQVSAYTRQIL 439
              +H ++V+Y+    ++  + I  E    GSL + + + Y    + +++++     Q+ 
Sbjct: 64  G--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 440 LGLKYLHDQDVVHRDIKCANILV 462
            GL+Y+H   +VH DIK +NI +
Sbjct: 122 RGLRYIHSMSLVHMDIKPSNIFI 144

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 43/201 (21%)
Query: 334 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           G  LG G FG V +  +        +    V +L + +   + +  L  E  +L +  H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-LRDLLSEFNVLKQVNHP 86
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-------------------- 430
           ++++ YG    +  L + +E    GSL     R  LR+S+                    
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSL-----RGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 431 ----------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
                     + ++  QI  G++YL +  +VHRD+   NILV     +K++DFGL++   
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 481 LND--VKSCRG--TAFWMAPE 497
             D  VK  +G     WMA E
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIE 222

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 78/180 (43%), Gaps = 25/180 (13%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
           +G+G +G V+ G    G   AVK     ++ S  +      E EI       HENI+ + 
Sbjct: 45  IGKGRYGEVWMG-KWRGEKVAVKVFFTTEEASWFR------ETEIYQTVLMRHENILGFI 97
Query: 397 GTD----KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---- 448
             D       ++LY+  +    GSL +  +   L    +       + GL +LH +    
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 449 ----DVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDV----KSCRGTAFWMAPEV 498
                + HRD+K  NILV  NG+  +AD GLA    +  N+V     +  GT  +M PEV
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 29/184 (15%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG+GSFG VYEG + D   G       V  +++ +  ++ I  L  E +++  F   ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 83
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAYTRQ 437
           +  G         + +EL+  G L     + +LR                  ++     +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDL-----KSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----W 493
           I  G+ YL+ +  VHRD+   N +V  + +VK+ DFG+ +           G       W
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
Query: 494 MAPE 497
           MAPE
Sbjct: 199 MAPE 202

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + +   R I   +++LH  ++ HRD+K  N+L
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 462 V---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
               + +  +KL DFG AK T  N +++   T +++APEV
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV 200

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 405 LYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L +  Q        + + +   R I   +++LH  ++ HRD+K  N+L
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 462 V---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
               + +  +KL DFG AK T  N +++   T +++APEV
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV 181
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	504
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-87
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-79
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-72
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-65
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-65
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-61
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-60
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-56
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-56
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-54
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-51
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-51
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-50
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-50
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-49
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-47
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-47
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-47
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-47
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-47
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-47
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-47
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-46
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-45
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-43
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-42
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-42
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-42
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-41
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-41
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-41
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-41
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-41
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-40
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-40
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-40
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-40
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-40
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-39
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-39
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-38
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-38
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-38
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-38
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-38
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-38
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-37
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-37
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-37
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-37
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-37
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-37
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-37
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-37
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-36
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-36
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-36
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-36
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-36
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-36
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-36
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-36
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-35
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-35
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-35
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-35
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-35
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-35
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-35
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-35
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-35
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-34
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-34
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-34
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-34
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-34
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-34
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-34
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-34
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-33
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-33
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-33
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-33
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-33
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-33
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-33
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-33
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-33
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-33
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-32
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-32
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-32
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-32
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-32
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-31
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-31
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-31
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-31
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-31
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-31
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-30
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-30
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-30
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-30
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-30
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-30
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-30
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-30
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-29
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-29
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-29
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-29
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-29
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-29
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-29
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-28
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-28
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-28
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-28
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-28
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-28
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-28
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-28
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-28
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-28
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-28
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-28
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-28
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-28
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-28
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-28
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-28
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-27
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-27
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-27
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-27
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-27
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-27
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-26
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-26
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-26
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-26
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-26
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-26
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-26
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-25
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-25
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-25
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-25
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-24
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-24
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-24
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-23
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-23
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-23
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-23
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-23
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-22
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-22
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-22
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-22
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-22
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-21
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-21
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-20
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-19
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-15
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-15
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-05

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  270 bits (692), Expect = 1e-87
 Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 13/199 (6%)

Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 366
           S  +TE     S    +           +LG+G++G VY G    +    A+KE+   D 
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH- 425
                +    L +EIAL    +H+NIVQY G+  +   + IF+E V  GSL  L +    
Sbjct: 61  -----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115

Query: 426 ---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAK--AT 479
                +  +  YT+QIL GLKYLHD  +VHRDIK  N+L++  +G +K++DFG +K  A 
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

Query: 480 KLNDVKSCRGTAFWMAPEV 498
                ++  GT  +MAPE+
Sbjct: 176 INPCTETFTGTLQYMAPEI 194

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  247 bits (633), Expect = 6e-79
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 18/209 (8%)

Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKE 360
             + D           +S +GR      + +    +GRGSF +VY+G+ ++     A  E
Sbjct: 5   NQQQDDIEELETKAVGMSNDGR------FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCE 58

Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG----TDKDESKLYIFLELVTKGS 416
           +         K    + ++E  +L   +H NIV++Y     T K +  + +  EL+T G+
Sbjct: 59  LQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 115

Query: 417 LLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLAD 472
           L    +R+  ++   + ++ RQIL GL++LH +   ++HRD+KC NI +    GSVK+ D
Sbjct: 116 LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175

Query: 473 FGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
            GLA   + +  K+  GT  +MAPE+   
Sbjct: 176 LGLATLKRASFAKAVIGTPEFMAPEMYEE 204

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  231 bits (591), Expect = 4e-72
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 22/208 (10%)

Query: 301 TEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK 359
            E ED+     TE +  +  +  ++  + +      +GRGSFG V+       GF  AVK
Sbjct: 32  PETEDNEGVLLTEKLKPV--DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89

Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
           +V L               +E+   +      IV  YG  ++   + IF+EL+  GSL  
Sbjct: 90  KVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139

Query: 420 LYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-VKLADFGLAK 477
           L ++   L + +   Y  Q L GL+YLH + ++H D+K  N+L+ ++GS   L DFG A 
Sbjct: 140 LIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199

Query: 478 -------ATKLNDVKSCRGTAFWMAPEV 498
                     L       GT   MAPEV
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEV 227

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  212 bits (543), Expect = 1e-65
 Identities = 45/201 (22%), Positives = 86/201 (42%), Gaps = 29/201 (14%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R  T + + + +G G FGSV++ +   DG  +A+K       GS  +Q+   L +  A  
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNA--LREVYAHA 65

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQIL 439
              +H ++V+Y+    ++  + I  E    GSL +          + +++++     Q+ 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGS-------------------VKLADFGLAKATK 480
            GL+Y+H   +VH DIK +NI +                         K+ D G    T+
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH--VTR 183

Query: 481 LNDVKSCRGTAFWMAPEVCSN 501
           ++  +   G + ++A EV   
Sbjct: 184 ISSPQVEEGDSRFLANEVLQE 204

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  213 bits (544), Expect = 2e-65
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 9/206 (4%)

Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKE 360
               ++S T   P  +  P+         +Q+   LG GS+G V++  S +DG  +AVK 
Sbjct: 32  SFRGEASETLQSPGYD--PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR 89

Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
                +G + +     L +  +     +H   V+     ++   LY+  EL    SL   
Sbjct: 90  SMSPFRGPKDRARK--LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQH 146

Query: 421 YQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            + +   L ++QV  Y R  LL L +LH Q +VH D+K ANI +   G  KL DFGL   
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206

Query: 479 -TKLNDVKSCRGTAFWMAPEVCSNPF 503
                  +   G   +MAPE+    +
Sbjct: 207 LGTAGAGEVQEGDPRYMAPELLQGSY 232

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  203 bits (519), Expect = 6e-61
 Identities = 44/204 (21%), Positives = 88/204 (43%), Gaps = 12/204 (5%)

Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 361
             +     T  +  ++ S N         +     +G G    V++ +++    +A+K V
Sbjct: 29  HMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 88

Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
           +L        Q++     EIA L++ +   + I++ Y  +  +  +Y+ +E      L +
Sbjct: 89  NL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 144

Query: 420 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            L ++  +   +  +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A  
Sbjct: 145 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203

Query: 479 ----TKLNDVKSCRGTAFWMAPEV 498
               T      S  G   +M PE 
Sbjct: 204 MQPDTTSVVKDSQVGAVNYMPPEA 227

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  200 bits (510), Expect = 2e-60
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 11/203 (5%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD 365
                 +P   + P+  +  +  + +    +GRG F  VY      DG   A+K+V + D
Sbjct: 11  PPVPQFQPQKALRPDMGYNTLANF-RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD 69

Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY- 424
                 ++ +   +EI LL +  H N+++YY +  ++++L I LEL   G L  + + + 
Sbjct: 70  LMDA--KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK 127

Query: 425 ----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-- 478
                + +  V  Y  Q+   L+++H + V+HRDIK AN+ + A G VKL D GL +   
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187

Query: 479 TKLNDVKSCRGTAFWMAPEVCSN 501
           +K     S  GT ++M+PE    
Sbjct: 188 SKTTAAHSLVGTPYYMSPERIHE 210

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  189 bits (483), Expect = 2e-56
 Identities = 45/199 (22%), Positives = 89/199 (44%), Gaps = 18/199 (9%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ 366
              T      ++S  GR       +     +G G    V++ +++    +A+K V+L   
Sbjct: 12  DLGTENLYFQSMSVKGR------IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL--- 62

Query: 367 GSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQR 423
                Q++     EIA L++ +   + I++ Y  +  +  +Y+ +E      L + L ++
Sbjct: 63  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK 121

Query: 424 YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
             +   +  +Y + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + + 
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 180

Query: 484 V----KSCRGTAFWMAPEV 498
                 S  GT  +M PE 
Sbjct: 181 TSVVKDSQVGTVNYMPPEA 199

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  190 bits (484), Expect = 2e-56
 Identities = 45/191 (23%), Positives = 88/191 (46%), Gaps = 18/191 (9%)

Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
           IS  GR       +     +G G    V++ +++    +A+K V+L        Q++   
Sbjct: 4   ISVKGR------IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSY 54

Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAY 434
             EIA L++ +   + I++ Y  +  +  +Y+ +E      L + L ++  +   +  +Y
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSY 113

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGT 490
            + +L  +  +H   +VH D+K AN L+  +G +KL DFG+A   + +       S  GT
Sbjct: 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 491 AFWMAPEVCSN 501
             +M PE   +
Sbjct: 173 VNYMPPEAIKD 183

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  184 bits (469), Expect = 5e-54
 Identities = 58/196 (29%), Positives = 108/196 (55%), Gaps = 10/196 (5%)

Query: 312 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA 370
           +  +   + N  F+ +  Y  +   +G GSFG      S +DG  + +KE+++    S+ 
Sbjct: 8   SSGVDLGTENLYFQSMEKY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66

Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLR 427
           ++      +E+A+L+  +H NIVQY  + ++   LYI ++    G L   +N  +    +
Sbjct: 67  REES---RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123

Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--K 485
           + Q+  +  QI L LK++HD+ ++HRDIK  NI +  +G+V+L DFG+A+         +
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183

Query: 486 SCRGTAFWMAPEVCSN 501
           +C GT ++++PE+C N
Sbjct: 184 ACIGTPYYLSPEICEN 199

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  175 bits (445), Expect = 5e-51
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 38/208 (18%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R  + +++  +LG+G+FG V +  +  D  ++A+K++         ++ +S +  E+ LL
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLL 56

Query: 385 SRFEHENIVQYYGTDKDE-------------SKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           +   H+ +V+YY    +              S L+I +E    G+L +L    +L   + 
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 432 SA--YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK------------ 477
                 RQIL  L Y+H Q ++HRD+K  NI +D + +VK+ DFGLAK            
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 478 ----ATKLNDVKSCRGTAFWMAPEVCSN 501
                   +++ S  GTA ++A EV   
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDG 204

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  174 bits (443), Expect = 9e-51
 Identities = 72/202 (35%), Positives = 111/202 (54%), Gaps = 18/202 (8%)

Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKE 360
            H    S           P   F ++       + +G+GSFG V++GI        A+K 
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKL-------EKIGKGSFGEVFKGIDNRTQKVVAIKI 54

Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
           + L     +A+  I  ++QEI +LS+ +   + +YYG+   ++KL+I +E +  GS L+L
Sbjct: 55  IDL----EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL 110

Query: 421 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
            +   L ++Q++   R+IL GL YLH +  +HRDIK AN+L+  +G VKLADFG+  A +
Sbjct: 111 LEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGV--AGQ 168

Query: 481 LNDVKSCR----GTAFWMAPEV 498
           L D +  R    GT FWMAPEV
Sbjct: 169 LTDTQIKRNTFVGTPFWMAPEV 190

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  177 bits (451), Expect = 1e-50
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 35/223 (15%)

Query: 293 LSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD 352
           +  S S   +  D+ +S            G+       +   D+LG G+ G++      D
Sbjct: 1   MGSSPSLEQDDGDEETSVVIV--------GKIS-----FCPKDVLGHGAEGTIVYRGMFD 47

Query: 353 GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLEL 411
               AVK +          +  S  ++E+ LL    EH N+++Y+ T+KD    YI +EL
Sbjct: 48  NRDVAVKRIL--------PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99

Query: 412 VTKGSLLNLYQRYHLRDSQVSAYT--RQILLGLKYLHDQDVVHRDIKCANILVDANGS-- 467
               +L    ++       +   T  +Q   GL +LH  ++VHRD+K  NIL+    +  
Sbjct: 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHG 158

Query: 468 ---VKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVCSNP 502
                ++DFGL K         +      GT  W+APE+ S  
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  171 bits (436), Expect = 6e-50
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 30/191 (15%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           ++ +L+G G FG V++     DG  + +K V   ++         + E+E+  L++ +H 
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHV 64

Query: 391 NIVQYYG----------------TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQV 431
           NIV Y G                +      L+I +E   KG+L    ++     L     
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGT 490
                QI  G+ Y+H + +++RD+K +NI +     VK+ DFGL  + K +      +GT
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184

Query: 491 AFWMAPEVCSN 501
             +M+PE  S+
Sbjct: 185 LRYMSPEQISS 195

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  170 bits (434), Expect = 2e-49
 Identities = 53/175 (30%), Positives = 89/175 (50%), Gaps = 14/175 (8%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W+    LG G+FG VY+  + + G   A K +       ++++ +     EI +L+  +H
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYIVEIEILATCDH 75

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 447
             IV+  G    + KL+I +E    G++  +       L + Q+    RQ+L  L +LH 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEV 498
           + ++HRD+K  N+L+   G ++LADFG+  + K       R    GT +WMAPEV
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGV--SAKNLKTLQKRDSFIGTPYWMAPEV 188

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  165 bits (420), Expect = 1e-47
 Identities = 54/175 (30%), Positives = 94/175 (53%), Gaps = 12/175 (6%)

Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
             + + + +G+G+ G+VY  +    G   A+++++L  Q          +  EI ++   
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMREN 74

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
           ++ NIV Y  +     +L++ +E +  GSL ++     + + Q++A  R+ L  L++LH 
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEV 498
             V+HRDIK  NIL+  +GSVKL DFG     ++   +S R    GT +WMAPEV
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGF--CAQITPEQSKRSTMVGTPYWMAPEV 187

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  165 bits (419), Expect = 2e-47
 Identities = 56/185 (30%), Positives = 86/185 (46%), Gaps = 18/185 (9%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +    +G GS+G   +     DG     KE+         KQ    L  E+ LL   +H 
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ---MLVSEVNLLRELKHP 65

Query: 391 NIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLK 443
           NIV+YY    D+  + LYI +E    G L ++  +      +L +  V     Q+ L LK
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 444 YLHDQ-----DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAP 496
             H +      V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GT ++M+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185

Query: 497 EVCSN 501
           E  + 
Sbjct: 186 EQMNR 190

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  166 bits (421), Expect = 2e-47
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 18/195 (9%)

Query: 315 MSNISPNGRFKRIIT------YWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG 367
           +++       + ++              +G GS G V        G   AVK + L  Q 
Sbjct: 25  VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ- 83

Query: 368 SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR 427
               Q    L  E+ ++  ++H N+V+ Y +     +L++ +E +  G+L ++  +  L 
Sbjct: 84  ----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN 139

Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 487
           + Q++     +L  L YLH Q V+HRDIK  +IL+  +G VKL+DFG     +++     
Sbjct: 140 EEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGF--CAQISKDVPK 197

Query: 488 R----GTAFWMAPEV 498
           R    GT +WMAPEV
Sbjct: 198 RKSLVGTPYWMAPEV 212

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  165 bits (420), Expect = 5e-47
 Identities = 59/190 (31%), Positives = 93/190 (48%), Gaps = 15/190 (7%)

Query: 312 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA 370
            E      P   F  +         +G GSFG+VY      +    A+K++S   +  Q+
Sbjct: 44  AELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QS 94

Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRD 428
            +    + +E+  L +  H N +QY G    E   ++ +E    GS  +L + +   L++
Sbjct: 95  NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE 153

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
            +++A T   L GL YLH  +++HRD+K  NIL+   G VKL DFG   A+ +    S  
Sbjct: 154 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS--ASIMAPANSFV 211

Query: 489 GTAFWMAPEV 498
           GT +WMAPEV
Sbjct: 212 GTPYWMAPEV 221

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  164 bits (418), Expect = 5e-47
 Identities = 59/177 (33%), Positives = 100/177 (56%), Gaps = 16/177 (9%)

Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
             +   + LG GS+GSVY+ I  + G   A+K+V +          + ++ +EI+++ + 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQC 81

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYL 445
           +  ++V+YYG+    + L+I +E    GS+ ++ +  +  L + +++   +  L GL+YL
Sbjct: 82  DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEV 498
           H    +HRDIK  NIL++  G  KLADFG+  A +L D  + R    GT FWMAPEV
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGV--AGQLTDTMAKRNTVIGTPFWMAPEV 196

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  164 bits (416), Expect = 6e-47
 Identities = 48/201 (23%), Positives = 83/201 (41%), Gaps = 35/201 (17%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +    LGRG FG V+E  +  D   +A+K + L       + +  ++ +E+  L++ EH 
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHP 63

Query: 391 NIVQYYGTDKDESK------------LYIFLELVTKGSLLNLYQR----YHLRDSQVSAY 434
            IV+Y+    +++             LYI ++L  K +L +             S     
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--------------TK 480
             QI   +++LH + ++HRD+K +NI    +  VK+ DFGL  A                
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 481 LNDVKSCRGTAFWMAPEVCSN 501
                   GT  +M+PE    
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG 204

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  164 bits (418), Expect = 7e-47
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 31/207 (14%)

Query: 315 MSNISPNGRFKRII--------TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLD 365
           M++ SP      I           ++  +L+G G++G VY+G     G   A+K + +  
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-- 59

Query: 366 QGSQAKQSISQLEQEIALLSRF-EHENIVQYYG------TDKDESKLYIFLELVTKGSLL 418
                     +++QEI +L ++  H NI  YYG          + +L++ +E    GS+ 
Sbjct: 60  ----TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115

Query: 419 NLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
           +L +      L++  ++   R+IL GL +LH   V+HRDIK  N+L+  N  VKL DFG+
Sbjct: 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175

Query: 476 AKATKLNDVKSCR----GTAFWMAPEV 498
             + +L+     R    GT +WMAPEV
Sbjct: 176 --SAQLDRTVGRRNTFIGTPYWMAPEV 200

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  162 bits (412), Expect = 3e-46
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 21/201 (10%)

Query: 315 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS 373
           MS  S    +      ++  +++G G+   V            A+K ++L     + + S
Sbjct: 1   MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTS 56

Query: 374 ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------- 425
           + +L +EI  +S+  H NIV YY +   + +L++ ++L++ GS+L++ +           
Sbjct: 57  MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116

Query: 426 -LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKL 481
            L +S ++   R++L GL+YLH    +HRD+K  NIL+  +GSV++ADFG++        
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176

Query: 482 NDVKSCR----GTAFWMAPEV 498
                 R    GT  WMAPEV
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEV 197

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  161 bits (409), Expect = 5e-45
 Identities = 42/211 (19%), Positives = 88/211 (41%), Gaps = 24/211 (11%)

Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRG--SFGSVYEGI-SDDGFFFAVK 359
           H     +   + MS+  P G        ++   ++G+G     +V        G +  V+
Sbjct: 5   HHHHMENLYFQGMSSFLPEG------GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58

Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
            ++L    + + + ++ L+ E+ +   F H NIV Y  T   +++L++    +  GS  +
Sbjct: 59  RINL---EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD 115

Query: 420 LYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
           L   +    + +  ++   + +L  L Y+H    VHR +K ++IL+  +G V L+     
Sbjct: 116 LICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175

Query: 477 ---------KATKLNDVKSCRGTAFWMAPEV 498
                    +    +  K       W++PEV
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  154 bits (392), Expect = 1e-43
 Identities = 49/188 (26%), Positives = 96/188 (51%), Gaps = 13/188 (6%)

Query: 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLE 378
                 I  ++ G+LLG+GSF  VY   S   G   A+K +    + +    ++    ++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR----VQ 59

Query: 379 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTR 436
            E+ +  + +H +I++ Y   +D + +Y+ LE+   G +    +       +++   +  
Sbjct: 60  NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFW 493
           QI+ G+ YLH   ++HRD+  +N+L+  N ++K+ADFGLA   K+   K    C GT  +
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNY 178

Query: 494 MAPEVCSN 501
           ++PE+ + 
Sbjct: 179 ISPEIATR 186

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  151 bits (385), Expect = 2e-42
 Identities = 60/184 (32%), Positives = 97/184 (52%), Gaps = 13/184 (7%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEI 381
           +    Y  +G  LG+G F   +E    D    FA K V  SLL +  Q ++    +  EI
Sbjct: 12  RSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEI 66

Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
           ++     H+++V ++G  +D   +++ LEL  + SLL    +R  L + +   Y RQI+L
Sbjct: 67  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 126

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPE 497
           G +YLH   V+HRD+K  N+ ++ +  VK+ DFGLA   + +  +    C GT  ++APE
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPE 185

Query: 498 VCSN 501
           V S 
Sbjct: 186 VLSK 189

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  153 bits (388), Expect = 2e-42
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 12/202 (5%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SL 363
            +     P   I       R    + +G  LG+G F   +E    D    FA K V  SL
Sbjct: 19  GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78

Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQ 422
           L +  Q ++    +  EI++     H+++V ++G  +D   +++ LEL  + SLL    +
Sbjct: 79  LLKPHQREK----MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR 134

Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
           R  L + +   Y RQI+LG +YLH   V+HRD+K  N+ ++ +  VK+ DFGLA   + +
Sbjct: 135 RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194

Query: 483 DVK---SCRGTAFWMAPEVCSN 501
             +    C GT  ++APEV S 
Sbjct: 195 GERKKVLC-GTPNYIAPEVLSK 215

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  151 bits (384), Expect = 9e-42
 Identities = 48/220 (21%), Positives = 92/220 (41%), Gaps = 24/220 (10%)

Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS- 362
           +D  S+ +     N     +  + I  ++    L +G F  +      D  F+A+K+   
Sbjct: 7   KDILSNYSNLIYLNKYVKEK-DKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEK 64

Query: 363 -----------LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411
                        +     K      + E+ +++  ++E  +   G   +  ++YI  E 
Sbjct: 65  SLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEY 124

Query: 412 VTKGSL---------LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANIL 461
           +   S+         L+      +    +    + +L    Y+H++ ++ HRD+K +NIL
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184

Query: 462 VDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +D NG VKL+DFG ++      +K  RGT  +M PE  SN
Sbjct: 185 MDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSN 224

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  149 bits (378), Expect = 3e-41
 Identities = 47/192 (24%), Positives = 76/192 (39%), Gaps = 26/192 (13%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
                LG G F  V       DG F+A+K +   +     +Q   + ++E  +   F H 
Sbjct: 32  LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-----QQDREEAQREADMHRLFNHP 86

Query: 391 NIVQYYG----TDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLG 441
           NI++           + + ++ L    +G+L N  +R       L + Q+      I  G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-----------KATKLNDVKSCRGT 490
           L+ +H +   HRD+K  NIL+   G   L D G             +A  L D  + R T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 491 AFWMAPEVCSNP 502
             + APE+ S  
Sbjct: 207 ISYRAPELFSVQ 218

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  149 bits (378), Expect = 3e-41
 Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 16/181 (8%)

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
            W   D+LG+G+  +V+ G     G  FA+K  +         + +    +E  +L +  
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLN 65

Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLN-LYQR---YHLRDSQVSAYTRQILLGL 442
           H+NIV+ +    +       + +E    GSL   L +    Y L +S+     R ++ G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 443 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPE 497
            +L +  +VHR+IK  NI+     D     KL DFG A+  + ++   S  GT  ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 498 V 498
           +
Sbjct: 186 M 186

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  147 bits (374), Expect = 5e-41
 Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 6/171 (3%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G  LG+G FG+VY        F  A+K V    Q  +A     QL +E+ + S   H NI
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALK-VLFKAQLEKAGV-EHQLRREVEIQSHLRHPNI 71

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVV 451
           ++ YG   D +++Y+ LE    G++    Q+     + + + Y  ++   L Y H + V+
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFWMAPEVCSN 501
           HRDIK  N+L+ + G +K+ADFG +     +     C GT  ++ PE+   
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-GTLDYLPPEMIEG 181

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  147 bits (373), Expect = 5e-41
 Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 13/179 (7%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            +++G G FG VY      G   AVK  +  D      Q+I  + QE  L +  +H NI+
Sbjct: 12  EEIIGIGGFGKVYRAFWI-GDEVAVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---DV 450
              G    E  L + +E    G L  +     +    +  +  QI  G+ YLHD+    +
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 451 VHRDIKCANILVD--------ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +HRD+K +NIL+         +N  +K+ DFGLA+        S  G   WMAPEV   
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRA 188

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  151 bits (383), Expect = 6e-41
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 38/212 (17%)

Query: 316 SNISPNGRFKRIIT-YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI 374
           S I+    F++ +        +LG GS G+V    S  G   AVK +             
Sbjct: 1   SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--------IDFC 52

Query: 375 SQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
                EI LL+   +H N+++YY ++  +  LYI LEL    +L +L +  ++ D  +  
Sbjct: 53  DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKL 111

Query: 434 YT--------RQILLGLKYLHDQDVVHRDIKCANILVD-------------ANGSVKLAD 472
                     RQI  G+ +LH   ++HRD+K  NILV               N  + ++D
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171

Query: 473 FGLAK------ATKLNDVKSCRGTAFWMAPEV 498
           FGL K      ++   ++ +  GT+ W APE+
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPEL 203

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  148 bits (376), Expect = 1e-40
 Identities = 48/173 (27%), Positives = 88/173 (50%), Gaps = 11/173 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K   LG G+ G V++      G   A K + L           +Q+ +E+ +L     
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNS 90

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQ 448
             IV +YG    + ++ I +E +  GSL  + ++   + +  +   +  ++ GL YL ++
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEV 498
             ++HRD+K +NILV++ G +KL DFG+  + +L D    S  GT  +M+PE 
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPER 201

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  147 bits (374), Expect = 2e-40
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 309 STTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG 367
           S  +     ISP   +       +    +GRG++GSV + +    G   AVK +      
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS---- 57

Query: 368 SQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH- 425
           +  ++   QL  ++  ++   +   IVQ+YG    E   +I +EL++  S    Y+  + 
Sbjct: 58  TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYS 116

Query: 426 -----LRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKAT 479
                + +  +   T   +  L +L +   ++HRDIK +NIL+D +G++KL DFG+  + 
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI--SG 174

Query: 480 KLNDVKSCR---GTAFWMAPEV 498
           +L D  +     G   +MAPE 
Sbjct: 175 QLVDSIAKTRDAGCRPYMAPER 196

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  145 bits (369), Expect = 4e-40
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 28/210 (13%)

Query: 319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--------------- 362
           S +      +  +   D +G+GS+G V    + +D  ++A+K +S               
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 363 ------LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTK 414
                       Q +  I Q+ QEIA+L + +H N+V+      D +E  LY+  ELV +
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122

Query: 415 GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474
           G ++ +     L + Q   Y + ++ G++YLH Q ++HRDIK +N+LV  +G +K+ADFG
Sbjct: 123 GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 475 LAKATKLNDV---KSCRGTAFWMAPEVCSN 501
           ++   K +D     +  GT  +MAPE  S 
Sbjct: 183 VSNEFKGSDALLSNTV-GTPAFMAPESLSE 211

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  145 bits (369), Expect = 5e-40
 Identities = 58/173 (33%), Positives = 92/173 (53%), Gaps = 12/173 (6%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            + +G GSFG+V+      G   AVK   +L +     + +++  +E+A++ R  H NIV
Sbjct: 42  KEKIGAGSFGTVHRAEWH-GSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
            + G       L I  E +++GSL  L      R  L + +  +    +  G+ YLH+++
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 450 --VVHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWMAPEV 498
             +VHR++K  N+LVD   +VK+ DFGL+  KA+     KS  GT  WMAPEV
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  145 bits (367), Expect = 6e-40
 Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 18/179 (10%)

Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFE 388
            +    LGRG++G V +      G   AVK +      +   Q   +L  ++   +   +
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA----TVNSQEQKRLLMDLDISMRTVD 64

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-----SQVSAYTRQILLGLK 443
               V +YG    E  ++I +EL+   SL   Y++   +        +      I+  L+
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 444 YLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           +LH +  V+HRD+K +N+L++A G VK+ DFG++    L D  +     G   +MAPE 
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPER 180

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  147 bits (372), Expect = 1e-39
 Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 16/181 (8%)

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
            W   D+LG+G+  +V+ G     G  FA+K  +         + +    +E  +L +  
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLN 65

Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLN-LYQR---YHLRDSQVSAYTRQILLGL 442
           H+NIV+ +    +       + +E    GSL   L +    Y L +S+     R ++ G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 443 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPE 497
            +L +  +VHR+IK  NI+     D     KL DFG A+  + ++   S  GT  ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 498 V 498
           +
Sbjct: 186 M 186

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  142 bits (360), Expect = 6e-39
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 10/173 (5%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           G  LG+G FG+VY      + F  A+K +  S L++     Q    L +EI + S   H 
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----LRREIEIQSHLRHP 74

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 449
           NI++ Y    D  ++Y+ LE   +G L    Q++    + + + +  ++   L Y H++ 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFWMAPEVCSN 501
           V+HRDIK  N+L+   G +K+ADFG +        +  C GT  ++ PE+   
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-GTLDYLPPEMIEG 186

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  142 bits (359), Expect = 1e-38
 Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 24/184 (13%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G++LG+G FG   +    + G    +KE  L+    + ++      +E+ ++   EH N+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQR---TFLKEVKVMRCLEHPNV 69

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDV 450
           +++ G    + +L    E +  G+L  + +        SQ  ++ + I  G+ YLH  ++
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129

Query: 451 VHRDIKCANILVDANGSVKLADFGLA----------------KATKLNDVKSCRGTAFWM 494
           +HRD+   N LV  N +V +ADFGLA                K        +  G  +WM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 495 APEV 498
           APE+
Sbjct: 190 APEM 193

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  141 bits (357), Expect = 1e-38
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 18/181 (9%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G  +G GSFG+VY+G    D    AVK   +L+  +   Q +   + E+ +L +  H NI
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           + + G      +L I  +     SL +            ++    RQ   G+ YLH + +
Sbjct: 83  LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKL----NDVKSCRGTAFWMAPEV----CSNP 502
           +HRD+K  NI +  + +VK+ DFGLA         +  +   G+  WMAPEV     SNP
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 503 F 503
           +
Sbjct: 202 Y 202

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  141 bits (358), Expect = 2e-38
 Identities = 50/170 (29%), Positives = 86/170 (50%), Gaps = 15/170 (8%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQ 394
           +G G+ G V++      G   AVK++      S  K+   ++  ++  +L   +   IVQ
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRR----SGNKEENKRILMDLDVVLKSHDCPYIVQ 88

Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQ-DVV 451
            +GT    + ++I +EL+       L +R    + +  +   T  I+  L YL ++  V+
Sbjct: 89  CFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
           HRD+K +NIL+D  G +KL DFG+  + +L D K+     G A +MAPE 
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGI--SGRLVDDKAKDRSAGCAAYMAPER 195

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  139 bits (353), Expect = 5e-38
 Identities = 47/180 (26%), Positives = 85/180 (47%), Gaps = 21/180 (11%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHE 390
              +G+G FG V++G    D    A+K +     +  ++  +   + ++E+ ++S   H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR-----QILLGLKYL 445
           NIV+ YG   +     + +E V  G    LY R   +   +    +      I LG++Y+
Sbjct: 84  NIVKLYGLMHN--PPRMVMEFVPCGD---LYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138

Query: 446 HDQD--VVHRDIKCANILVDANG-----SVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
            +Q+  +VHRD++  NI + +         K+ADFGL++   ++ V    G   WMAPE 
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSVSGLLGNFQWMAPET 197

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  140 bits (354), Expect = 7e-38
 Identities = 44/178 (24%), Positives = 82/178 (46%), Gaps = 17/178 (9%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G+L+G+G FG VY G    +    A++   L+D     +  +   ++E+    +  HEN+
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIR---LIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           V + G       L I   L    +L ++    +  L  ++     ++I+ G+ YLH + +
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 451 VHRDIKCANILVDANGSVKLADFGLAK-------ATKLNDVKSCRGTAFWMAPEVCSN 501
           +H+D+K  N+  D NG V + DFGL           + + ++   G    +APE+   
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  141 bits (357), Expect = 2e-37
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 12/175 (6%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSRFEH 389
              LG G+ G V            A++ +S        ++       +E EI +L +  H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             I++      D    YI LEL+  G L + +     L+++    Y  Q+LL ++YLH+ 
Sbjct: 200 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258

Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEV 498
            ++HRD+K  N+L+   + +  +K+ DFG +K      +    C GT  ++APEV
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAPEV 312

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  138 bits (350), Expect = 7e-37
 Identities = 57/271 (21%), Positives = 107/271 (39%), Gaps = 31/271 (11%)

Query: 258 MNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSN 317
           M+     SS  D    KE   A R I      +     +   +   +   S+        
Sbjct: 1   MHHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKK 60

Query: 318 ISP----------------------NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGF 354
           ++                           K     +   D++GRG    V   +    G 
Sbjct: 61  LNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120

Query: 355 FFAVKEVS---LLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLE 410
            FAVK +          Q ++      +E  +L +   H +I+    + +  S +++  +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180

Query: 411 LVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469
           L+ KG L + L ++  L + +  +  R +L  + +LH  ++VHRD+K  NIL+D N  ++
Sbjct: 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIR 240

Query: 470 LADFGLAKATKLNDV--KSCRGTAFWMAPEV 498
           L+DFG +   +  +   + C GT  ++APE+
Sbjct: 241 LSDFGFSCHLEPGEKLRELC-GTPGYLAPEI 270

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  137 bits (347), Expect = 7e-37
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 12/175 (6%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSRFEH 389
              LG G+ G V            A+K +S        ++       +E EI +L +  H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             I++      D    YI LEL+  G L + +     L+++    Y  Q+LL ++YLH+ 
Sbjct: 75  PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133

Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEV 498
            ++HRD+K  N+L+   + +  +K+ DFG +K      +    C GT  ++APEV
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAPEV 187

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  137 bits (348), Expect = 8e-37
 Identities = 57/218 (26%), Positives = 87/218 (39%), Gaps = 39/218 (17%)

Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL 363
           E   SS +   +  +      K+I    Q    +G+G +G V+ G    G   AVK    
Sbjct: 16  EQSQSSGSGSGLPLLVQRTIAKQI----QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT 70

Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT----KGSLLN 419
            ++ S  +      E EI       HENI+ +   D   +  +  L L+T     GSL  
Sbjct: 71  TEEASWFR------ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL-- 122

Query: 420 LYQRYHLRDSQVSAYTR-----QILLGLKYLHDQD--------VVHRDIKCANILVDANG 466
                +L+ + + A +        + GL +LH +         + HRD+K  NILV  NG
Sbjct: 123 ---YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179

Query: 467 SVKLADFGLA------KATKLNDVKSCRGTAFWMAPEV 498
           +  +AD GLA               +  GT  +M PEV
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  136 bits (345), Expect = 8e-37
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 17/198 (8%)

Query: 311 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 369
            +    N+   G        +     LG G+FG V+       G    +K ++      +
Sbjct: 7   HSSGRENLYFQGTIDD---LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINK----DR 59

Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL-----NLYQRY 424
           ++  + Q+E EI +L   +H NI++ +   +D   +YI +E    G LL        +  
Sbjct: 60  SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK 119

Query: 425 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKL 481
            L +  V+   +Q++  L Y H Q VVH+D+K  NIL      +  +K+ DFGLA+  K 
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179

Query: 482 NDV-KSCRGTAFWMAPEV 498
           ++   +  GTA +MAPEV
Sbjct: 180 DEHSTNAAGTALYMAPEV 197

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  136 bits (345), Expect = 9e-37
 Identities = 45/173 (26%), Positives = 83/173 (47%), Gaps = 8/173 (4%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS----LLDQGSQAKQSISQLEQEIALLSR-F 387
            ++LGRG    V   I       +AVK +           + ++      +E+ +L +  
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
            H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  +  LH
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
             ++VHRD+K  NIL+D + ++KL DFG +      +  +   GT  ++APE+
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  136 bits (344), Expect = 1e-36
 Identities = 52/185 (28%), Positives = 75/185 (40%), Gaps = 25/185 (13%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
              + +G+G +G V+ G    G   AVK  S     S+ ++S  + E E+       HEN
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ-GENVAVKIFS-----SRDEKSWFR-ETELYNTVMLRHEN 63

Query: 392 IVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
           I+ +  +D        +L++       GSL +  Q   L           I  GL +LH 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 448 QD--------VVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFW 493
           +         + HRD+K  NILV  NG   +AD GLA                  GT  +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 494 MAPEV 498
           MAPEV
Sbjct: 184 MAPEV 188

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  137 bits (346), Expect = 1e-36
 Identities = 55/248 (22%), Positives = 92/248 (37%), Gaps = 52/248 (20%)

Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV 361
           H     S+  E +      G    +   +     +G+GS+G V   I        A+K +
Sbjct: 2   HHHHHHSSGRENL--YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIM 59

Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--- 418
           +         + + +++ E+ L+ +  H NI + Y   +DE  + + +EL   G LL   
Sbjct: 60  NKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119

Query: 419 --------------------------------------NLYQRYHLRDSQVSAYTRQILL 440
                                                      +  R+  +S   RQI  
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179

Query: 441 GLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLNDVKSCR------GTAF 492
            L YLH+Q + HRDIK  N L   + +  +KL DFGL+K     +           GT +
Sbjct: 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239

Query: 493 WMAPEVCS 500
           ++APEV +
Sbjct: 240 FVAPEVLN 247

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  136 bits (344), Expect = 2e-36
 Identities = 59/178 (33%), Positives = 85/178 (47%), Gaps = 16/178 (8%)

Query: 332 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           +K   LG G FG V            G   AVK    L   +  +   S  +QEI +L  
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKADAGPQH-RSGWKQEIDILRT 89

Query: 387 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
             HE+I++Y G   D   + L + +E V  GSL +   R+ +  +Q+  + +QI  G+ Y
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAY 149

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTA--FWMAPE 497
           LH Q  +HRD+   N+L+D +  VK+ DFGLAKA             G +  FW APE
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  135 bits (343), Expect = 2e-36
 Identities = 53/170 (31%), Positives = 88/170 (51%), Gaps = 10/170 (5%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            ++LG G+F  V+       G  FA+K +             S LE EIA+L + +HENI
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIK-----KSPAFRDSSLENEIAVLKKIKHENI 68

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           V      +  +  Y+ ++LV+ G L + + +R    +   S   +Q+L  +KYLH+  +V
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128

Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           HRD+K  N+L    + N  + + DFGL+K  +   + +  GT  ++APEV
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEV 178

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  137 bits (346), Expect = 2e-36
 Identities = 37/273 (13%), Positives = 80/273 (29%), Gaps = 39/273 (14%)

Query: 261 RALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISP 320
              SS  ++   +  G+     +        V + S    +  +   S++          
Sbjct: 5   HHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRV 64

Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
                       +G +LG+    +  E    + G  F V      ++      +I Q+++
Sbjct: 65  ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKE 122

Query: 380 EIALLSRF-------------------------EHENIVQYYGTDKDESKLYIFLEL-VT 413
           E+  L                            + + +++    ++D   L  F      
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182

Query: 414 KGSLLNLY--------QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465
           + +L                L        T Q++  L  LH   +VH  ++  +I++D  
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 242

Query: 466 GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           G V L  F      +         +  +  PE+
Sbjct: 243 GGVFLTGFEHLV--RDGARVVSSVSRGFEPPEL 273

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  135 bits (341), Expect = 3e-36
 Identities = 54/180 (30%), Positives = 95/180 (52%), Gaps = 9/180 (5%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
                 +    +LG+GSFG V +         +AVK   ++++ S   +  S + +E+ L
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVEL 74

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
           L + +H NI++ +   +D S  YI  EL T G L + + +R    +   +   +Q+  G+
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 443 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
            Y+H  ++VHRD+K  NIL+   + +  +K+ DFGL+   + N   K   GTA+++APEV
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  134 bits (340), Expect = 4e-36
 Identities = 51/171 (29%), Positives = 88/171 (51%), Gaps = 9/171 (5%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            + LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NI
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           V+ + + ++ES  Y+  +LVT G L   +  R    ++  S   +QIL  + Y H   +V
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127

Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
           HR++K  N+L+       +VKLADFGLA     ++      GT  +++PEV
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 178

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  136 bits (343), Expect = 4e-36
 Identities = 62/228 (27%), Positives = 94/228 (41%), Gaps = 29/228 (12%)

Query: 289 DDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEG 348
           D   +SE  +      D ++S +   +  +      + I       + +G+G FG V+ G
Sbjct: 6   DRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTI----VLQESIGKGRFGEVWRG 61

Query: 349 ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408
               G   AVK  S     S+ ++S  + E EI       HENI+ +   D  ++  +  
Sbjct: 62  KWR-GEEVAVKIFS-----SREERSWFR-EAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114

Query: 409 LELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIK 456
           L LV+     GSL +   RY +    +         GL +LH +         + HRD+K
Sbjct: 115 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174

Query: 457 CANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEV 498
             NILV  NG+  +AD GLA        T         GT  +MAPEV
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  135 bits (341), Expect = 7e-36
 Identities = 49/187 (26%), Positives = 87/187 (46%), Gaps = 18/187 (9%)

Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           +  F +      K   LG GSF    + +       FAVK +S        K+  +  ++
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--------KRMEANTQK 54

Query: 380 EIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQ 437
           EI  L     H NIV+ +    D+   ++ +EL+  G L   + ++ H  +++ S   R+
Sbjct: 55  EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK 114

Query: 438 ILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVK---SCRGTA 491
           ++  + ++HD  VVHRD+K  N+L    + N  +K+ DFG A+    ++      C  T 
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173

Query: 492 FWMAPEV 498
            + APE+
Sbjct: 174 HYAAPEL 180

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  132 bits (335), Expect = 1e-35
 Identities = 27/172 (15%), Positives = 60/172 (34%), Gaps = 14/172 (8%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              L     G +++G    G    VK   +L     + +      +E   L  F H N++
Sbjct: 15  LTKLNENHSGELWKGR-WQGNDIVVK---VLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 394 QYYG--TDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ 448
              G           +    +  GSL N+      + +  SQ   +   +  G+ +LH  
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 449 D--VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           +  +    +   ++++D + + +++   +  +              W+APE 
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSF---QSPGRMYAPAWVAPEA 179

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  133 bits (337), Expect = 1e-35
 Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 19/176 (10%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            +++GRG+FG V +         A+K++       +++        E+  LSR  H NIV
Sbjct: 13  EEVVGRGAFGVVCKAK-WRAKDVAIKQI-------ESESERKAFIVELRQLSRVNHPNIV 64

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           + YG   +   + + +E    GSL N+        +   +   ++  Q   G+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 450 ---VVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
              ++HRD+K  N+L+ A G+V K+ DFG A   +   + + +G+A WMAPEV   
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-THMTNNKGSAAWMAPEVFEG 177

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  132 bits (335), Expect = 2e-35
 Identities = 48/174 (27%), Positives = 86/174 (49%), Gaps = 17/174 (9%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE---QEIALLSRFEH 389
            + +GRGS+G V   +        A K++         K  +  ++   QEI ++   +H
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIP--------KYFVEDVDRFKQEIEIMKSLDH 65

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
            NI++ Y T +D + +Y+ +EL T G L   +  +   R+S  +   + +L  + Y H  
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
           +V HRD+K  N L      +  +KL DFGLA   K   + ++  GT ++++P+V
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 179

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  136 bits (345), Expect = 3e-35
 Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 12/194 (6%)

Query: 311 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 369
            +    N+   G F     Y     +LG+GSFG V +         +AVK ++     S 
Sbjct: 7   HSSGRENLYFQGTFAER--Y-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA---SA 60

Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRD 428
             +  S + +E+ LL + +H NI++ +   +D S  YI  EL T G L + + +R    +
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV- 484
              +   +Q+  G+ Y+H  ++VHRD+K  NIL+   + +  +K+ DFGL+   + N   
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180

Query: 485 KSCRGTAFWMAPEV 498
           K   GTA+++APEV
Sbjct: 181 KDRIGTAYYIAPEV 194

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  133 bits (338), Expect = 3e-35
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 17/179 (9%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            +++G+G F  V   I+ + G  FAVK V +    S    S   L++E ++    +H +I
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDS----QVSAYTRQILLGLKYLHD 447
           V+   T   +  LY+  E +    L   + +R            S Y RQIL  L+Y HD
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 448 QDVVHRDIKCANILV---DANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEV 498
            +++HRD+K   +L+   + +  VKL  FG+A                 GT  +MAPEV
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--V-GTPHFMAPEV 204

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  136 bits (344), Expect = 3e-35
 Identities = 53/180 (29%), Positives = 92/180 (51%), Gaps = 8/180 (4%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
                 ++   +LG+GSFG V        G   AVK +S   +  + K     L +E+ L
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK--RQVKQKTDKESLLREVQL 79

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
           L + +H NI++ Y   +D+   Y+  E+ T G L + +  R    +   +   RQ+L G+
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139

Query: 443 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
            Y+H   +VHRD+K  N+L+     + ++++ DFGL+   + +   K   GTA+++APEV
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 199

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  131 bits (333), Expect = 4e-35
 Identities = 50/173 (28%), Positives = 91/173 (52%), Gaps = 8/173 (4%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G+ LG G F  V +      G  +A K +       S+   S  ++E+E+ +L    H N
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           I+  +   ++++ + + LELV+ G L + L ++  L + + + + +QIL G+ YLH + +
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRI 129

Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
            H D+K  NI++      N  +KL DFG+A   +  +  K+  GT  ++APE+
Sbjct: 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  135 bits (343), Expect = 7e-35
 Identities = 51/190 (26%), Positives = 91/190 (47%), Gaps = 14/190 (7%)

Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--------LLDQGSQAKQS 373
           +  +I   + K   LG G++G V      +     A+K +           D     ++ 
Sbjct: 30  KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89

Query: 374 ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVS 432
             ++  EI+LL   +H NI++ +   +D+   Y+  E    G L   +  R+   +   +
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCR 488
              +QIL G+ YLH  ++VHRDIK  NIL+   ++  ++K+ DFGL+     +   +   
Sbjct: 150 NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209

Query: 489 GTAFWMAPEV 498
           GTA+++APEV
Sbjct: 210 GTAYYIAPEV 219

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  135 bits (342), Expect = 7e-35
 Identities = 50/171 (29%), Positives = 87/171 (50%), Gaps = 9/171 (5%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
              LG G++G V            A+K +      S +  S S+L +E+A+L   +H NI
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKT---SVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           ++ Y   +D+   Y+ +E    G L + +  R    +   +   +Q+L G+ YLH  ++V
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158

Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
           HRD+K  N+L+   + +  +K+ DFGL+   +     K   GTA+++APEV
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV 209

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  132 bits (335), Expect = 9e-35
 Identities = 51/172 (29%), Positives = 88/172 (51%), Gaps = 11/172 (6%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            + LG+G+F  V   +    G  FA K   +++    + +   +LE+E  +  + +H NI
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           V+ + + ++ES  Y+  +LVT G L   +  R    ++  S   +QIL  + Y H   +V
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 150

Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEV 498
           HR++K  N+L+       +VKLADFGLA     ++       GT  +++PEV
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-GTPGYLSPEV 201

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  131 bits (332), Expect = 1e-34
 Identities = 39/180 (21%), Positives = 81/180 (45%), Gaps = 12/180 (6%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           K +   +   + LGRG FG V+  +       +  K V +             +++EI++
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISI 54

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLG 441
           L+   H NI+  + + +   +L +  E ++   +        + L + ++ +Y  Q+   
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114

Query: 442 LKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
           L++LH  ++ H DI+  NI+     + ++K+ +FG A+  K  D  +       + APEV
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  132 bits (333), Expect = 1e-34
 Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 13/171 (7%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
              LGRG+   VY          +A+K +               +  EI +L R  H NI
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNI 110

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           ++     +  +++ + LELVT G L + + ++ +  +   +   +QIL  + YLH+  +V
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170

Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
           HRD+K  N+L      +  +K+ADFGL+K  +   + K+  GT  + APE+
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI 221

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  131 bits (331), Expect = 1e-34
 Identities = 64/220 (29%), Positives = 87/220 (39%), Gaps = 43/220 (19%)

Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 361
            H   S                        Q  ++  RG FG V++       + AVK  
Sbjct: 5   HHHHSSGVDLGTENLYFQSMPL--------QLLEVKARGRFGCVWKAQLL-NEYVAVKIF 55

Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT----KGSL 417
                  Q KQS  Q E E+  L   +HENI+Q+ G +K  + + + L L+T    KGSL
Sbjct: 56  P-----IQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL 109

Query: 418 LNLYQRYHLRDSQVSAYTR-QILL----GLKYLHDQD----------VVHRDIKCANILV 462
                   L+ + VS      I      GL YLH+            + HRDIK  N+L+
Sbjct: 110 -----SDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164

Query: 463 DANGSVKLADFGLAK----ATKLNDVKSCRGTAFWMAPEV 498
             N +  +ADFGLA          D     GT  +MAPEV
Sbjct: 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  131 bits (331), Expect = 2e-34
 Identities = 50/173 (28%), Positives = 92/173 (53%), Gaps = 8/173 (4%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G+ LG G F  V +      G  +A K +     + S+   S  ++E+E+++L +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           ++  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL G+ YLH + +
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136

Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
            H D+K  NI++         +KL DFGLA   +     K+  GT  ++APE+
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  131 bits (331), Expect = 2e-34
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 21/207 (10%)

Query: 307 SSSTTTEPMSNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVK 359
           + +   +     +   R        + +    LG+G+FGSV          + G   AVK
Sbjct: 17  TENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76

Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSL 417
           +   L   ++        E+EI +L   +H+NIV+Y G         L + +E +  GSL
Sbjct: 77  K---LQHSTEEHLR--DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131

Query: 418 LNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
            +  Q++   +   ++  YT QI  G++YL  +  +HRD+   NILV+    VK+ DFGL
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191

Query: 476 AKATKLNDV--KSCRGTAF---WMAPE 497
            K    +    K          W APE
Sbjct: 192 TKVLPQDKEYYKVKEPGESPIFWYAPE 218

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  130 bits (328), Expect = 2e-34
 Identities = 54/180 (30%), Positives = 83/180 (46%), Gaps = 19/180 (10%)

Query: 332 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           +    LG+G+FGSV          + G   AVK+   L   ++        E+EI +L  
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLR--DFEREIEILKS 67

Query: 387 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGL 442
            +H+NIV+Y G         L + +E +  GSL +  Q++   +   ++  YT QI  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPE 497
           +YL  +  +HRD+   NILV+    VK+ DFGL K    +    K          W APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  129 bits (327), Expect = 3e-34
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 21/203 (10%)

Query: 309 STTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSL 363
            +  +P + + P   F++   + ++   LG G FG V          + G   AVK    
Sbjct: 4   VSEKKPATEVDPT-HFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS--- 57

Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLY 421
           L   S     I+ L++EI +L    HENIV+Y G  T+   + + + +E +  GSL    
Sbjct: 58  LKPESGGNH-IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL 116

Query: 422 Q--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
              +  +   Q   Y  QI  G+ YL  +  VHRD+   N+LV++   VK+ DFGL KA 
Sbjct: 117 PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176

Query: 480 KLNDV--KSCRGTAF---WMAPE 497
           + +               W APE
Sbjct: 177 ETDKEYYTVKDDRDSPVFWYAPE 199

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  130 bits (329), Expect = 4e-34
 Identities = 49/189 (25%), Positives = 78/189 (41%), Gaps = 31/189 (16%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            +L+GRG +G+VY+G  D     AVK  S        +Q+    E+ I  +   EH+NI 
Sbjct: 18  LELIGRGRYGAVYKGSLD-ERPVAVKVFS-----FANRQNFIN-EKNIYRVPLMEHDNIA 70

Query: 394 QYYGTDK-----DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           ++   D+        +  + +E    GSL      +             +  GL YLH +
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTE 130

Query: 449 D---------VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----------G 489
                     + HRD+   N+LV  +G+  ++DFGL+     N +              G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190

Query: 490 TAFWMAPEV 498
           T  +MAPEV
Sbjct: 191 TIRYMAPEV 199

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  128 bits (324), Expect = 5e-34
 Identities = 52/183 (28%), Positives = 90/183 (49%), Gaps = 12/183 (6%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
             +  W     LG G++G V   +        AVK V +     +A      +++EI + 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 59

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
               HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEV 498
           YLH   + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

Query: 499 CSN 501
              
Sbjct: 179 LKR 181

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  128 bits (323), Expect = 6e-34
 Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 11/170 (6%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG G FG V  G     +  AVK   ++ +GS ++    +  QE   + +  H  +V
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVK---MIKEGSMSED---EFFQEAQTMMKLSHPKLV 66

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           ++YG    E  +YI  E ++ G LLN  +     L  SQ+      +  G+ +L     +
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           HRD+   N LVD +  VK++DFG+ +    +   S  GT F   W APEV
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV 176

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  129 bits (326), Expect = 7e-34
 Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 22/195 (11%)

Query: 319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQL 377
           S +GRF+ +  Y  + D+LG G+   V   I+      +AVK +       Q     S++
Sbjct: 5   SFSGRFEDV--YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK-----QPGHIRSRV 57

Query: 378 EQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
            +E+ +L + + H N+++     ++E + Y+  E +  GS+L+ +++R H  + + S   
Sbjct: 58  FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV 117

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR---- 488
           + +   L +LH++ + HRD+K  NIL    +    VK+ DF L    KLN   S      
Sbjct: 118 QDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 489 -----GTAFWMAPEV 498
                G+A +MAPEV
Sbjct: 178 LLTPCGSAEYMAPEV 192

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  129 bits (326), Expect = 8e-34
 Identities = 48/173 (27%), Positives = 89/173 (51%), Gaps = 8/173 (4%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   +H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           ++  +   ++++ + + LELV  G L + L ++  L + + + + +QIL G+ YLH   +
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135

Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
            H D+K  NI++         +K+ DFGLA      +  K+  GT  ++APE+
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  130 bits (328), Expect = 9e-34
 Identities = 50/173 (28%), Positives = 91/173 (52%), Gaps = 8/173 (4%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           G+ LG G F  V +      G  +A K +     + S+      ++E+E+++L +  H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           I+  +   ++ + + + LELV+ G L + L Q+  L + + +++ +QIL G+ YLH + +
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136

Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
            H D+K  NI++         +KL DFGLA   +     K+  GT  ++APE+
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  128 bits (323), Expect = 1e-33
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 13/171 (7%)

Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG G+FG+V +G           AVK    L   +       +L  E  ++ + ++  IV
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKI---LKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           +  G  + ES   + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VH
Sbjct: 82  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEV 498
           RD+   N+L+      K++DFGL+KA + ++   K+     +   W APE 
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  130 bits (330), Expect = 2e-33
 Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 12/173 (6%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
            + LG+G+F  V   +    G  +A   +   +    + +   +LE+E  +    +H NI
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMII---NTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           V+ + +  +E   Y+  +LVT G L   +  R +  ++  S   +QIL  + + H   VV
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 132

Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEV 498
           HR++K  N+L+       +VKLADFGLA   +           GT  +++PEV
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEV 184

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  126 bits (319), Expect = 2e-33
 Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 11/170 (6%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              +G G FG V+ G   +    A+K    + +G+ +++      +E  ++ +  H  +V
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIK---TIREGAMSEE---DFIEEAEVMMKLSHPKLV 66

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           Q YG   +++ + +  E +  G L +  +  R       +      +  G+ YL +  V+
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           HRD+   N LV  N  +K++DFG+ +    +   S  GT F   W +PEV
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  132 bits (333), Expect = 2e-33
 Identities = 51/239 (21%), Positives = 97/239 (40%), Gaps = 11/239 (4%)

Query: 266 SSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFK 325
                     G+E  R    + ++   +       + + D+      +         +  
Sbjct: 94  CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
            ++ ++   + LG G+FG V+       G  FA K V      +  +     + +EI  +
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKETVRKEIQTM 208

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGL 442
           S   H  +V  +   +D++++ +  E ++ G L      +   + + +   Y RQ+  GL
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 268

Query: 443 KYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEV 498
            ++H+ + VH D+K  NI+     +  +KL DFGL         VK   GTA + APEV
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  127 bits (322), Expect = 3e-33
 Identities = 55/181 (30%), Positives = 82/181 (45%), Gaps = 21/181 (11%)

Query: 332 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           +    LG+G+FGSV          + G   AVK   L   G   ++     ++EI +L  
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRD---FQREIQILKA 80

Query: 387 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLG 441
              + IV+Y G         L + +E +  G L + +    R  L  S++  Y+ QI  G
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKG 139

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAP 496
           ++YL  +  VHRD+   NILV++   VK+ADFGLAK   L+               W AP
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199

Query: 497 E 497
           E
Sbjct: 200 E 200

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  129 bits (324), Expect = 3e-33
 Identities = 26/234 (11%), Positives = 60/234 (25%), Gaps = 40/234 (17%)

Query: 300 TTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAV 358
                +  ++T     +  + +    +     +  + L  G    V+     +    FA+
Sbjct: 33  PAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFAL 92

Query: 359 KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT-------------------- 398
           K          ++  + +L +     +R   E+  +                        
Sbjct: 93  K--VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQ 150

Query: 399 ------DKDESKLYIFLELVTKGSLLNLY--------QRYHLRDSQVSAYTRQILLGLKY 444
                 D   +   + +       L  L+         R       +   T Q++     
Sbjct: 151 LSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           L  + +VH      N+ +  +G + L D       K+             AP  
Sbjct: 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASSVPVTYAPRE 261

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  132 bits (333), Expect = 3e-33
 Identities = 48/189 (25%), Positives = 79/189 (41%), Gaps = 19/189 (10%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
            +    W+  + LG G FG V   I  D G   A+K+     Q    K +  +   EI +
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQ---CRQELSPK-NRERWCLEIQI 65

Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSL---LNLYQRYH-LRDSQVSA 433
           + +  H N+V          KL       + +E    G L   LN ++    L++  +  
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDV-KSCRG 489
               I   L+YLH+  ++HRD+K  NI++         K+ D G AK     ++     G
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185

Query: 490 TAFWMAPEV 498
           T  ++APE+
Sbjct: 186 TLQYLAPEL 194

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  126 bits (320), Expect = 4e-33
 Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 24/211 (11%)

Query: 301 TEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK 359
           T  E    + + +         + +     ++ G +LG GSF +V           +A+K
Sbjct: 4   TAAEPRPGAGSLQHAQPPPQPRKKR--PEDFKFGKILGEGSFSTVVLARELATSREYAIK 61

Query: 360 EVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
            +         K+ I +  +      E  ++SR +H   V+ Y T +D+ KLY  L    
Sbjct: 62  ILE--------KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113

Query: 414 KGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472
            G LL   ++    D   +  YT +I+  L+YLH + ++HRD+K  NIL++ +  +++ D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173

Query: 473 FGLAKATKLNDVKS-----CRGTAFWMAPEV 498
           FG AK       ++       GTA +++PE+
Sbjct: 174 FGTAKVLSPESKQARANSFV-GTAQYVSPEL 203

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  128 bits (324), Expect = 4e-33
 Identities = 50/220 (22%), Positives = 96/220 (43%), Gaps = 11/220 (5%)

Query: 285 KEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGS 344
                  V  +         D       +         +   +  Y+   + LG G+FG 
Sbjct: 7   HHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGV 66

Query: 345 VYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403
           V+  +    G  F  K ++     +        ++ EI+++++  H  ++  +   +D+ 
Sbjct: 67  VHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121

Query: 404 KLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           ++ + LE ++ G L +    + Y + +++V  Y RQ   GLK++H+  +VH DIK  NI+
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 181

Query: 462 V--DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
                  SVK+ DFGLA     +++ K    TA + APE+
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  128 bits (323), Expect = 4e-33
 Identities = 52/252 (20%), Positives = 109/252 (43%), Gaps = 22/252 (8%)

Query: 264 SSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGR 323
              +++   +      D+       +   +  +   T      S  T+   +   +P   
Sbjct: 13  DLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAP 72

Query: 324 FKRIITYWQKGDL-----------LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 371
           F   I   ++G +           LG G FG V++      G   A K +      ++  
Sbjct: 73  FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGM 127

Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDS 429
           +   +++ EI+++++ +H N++Q Y   + ++ + + +E V  G L +  + + Y+L + 
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL 187

Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLNDVKSC 487
               + +QI  G++++H   ++H D+K  NIL        +K+ DFGLA+  K  +    
Sbjct: 188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

Query: 488 R-GTAFWMAPEV 498
             GT  ++APEV
Sbjct: 248 NFGTPEFLAPEV 259

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  128 bits (322), Expect = 5e-33
 Identities = 41/214 (19%), Positives = 74/214 (34%), Gaps = 32/214 (14%)

Query: 312 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLD 365
              +  I P   F+          LLG G+F  VYE    D         F +K      
Sbjct: 48  QCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--- 104

Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH 425
                        Q +  L        +++Y     ++   +  EL + G+LLN    Y 
Sbjct: 105 --PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK 162

Query: 426 LRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILV-----------DANGSV 468
               +      V ++  ++L  ++ +HD +++H DIK  N ++           D +  +
Sbjct: 163 NTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222

Query: 469 KLADFGLAKATKLND----VKSCRGTAFWMAPEV 498
            L D G +   KL        +   T+ +   E+
Sbjct: 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEM 256

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  125 bits (317), Expect = 5e-33
 Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 11/170 (6%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG G FG V  G     +  A+K   ++ +GS ++    +  +E  ++    HE +V
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 82

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           Q YG    +  ++I  E +  G LLN  +  R+  +  Q+    + +   ++YL  +  +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           HRD+   N LV+  G VK++DFGL++    ++  S  G+ F   W  PEV
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 192

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  126 bits (319), Expect = 7e-33
 Identities = 52/183 (28%), Positives = 90/183 (49%), Gaps = 12/183 (6%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
             +  W     LG G++G V   +        AVK V +     +A      +++EI + 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 59

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
               HEN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEV 498
           YLH   + HRDIK  N+L+D   ++K++DFGLA   + N+      K C GT  ++APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178

Query: 499 CSN 501
              
Sbjct: 179 LKR 181

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  126 bits (318), Expect = 1e-32
 Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 18/191 (9%)

Query: 320 PNGRFKRIITYWQ--KGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAKQ 372
           PN    RI+   +  K  +LG G+FG+VY+G+   +G       A+KE   L + +  K 
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKA 60

Query: 373 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQ 430
           +   L  E  +++  ++ ++ +  G     + + +  +L+  G LL+     + ++    
Sbjct: 61  NKEIL-DEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQY 118

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRG 489
           +  +  QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK     +      G
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 490 TAF---WMAPE 497
                 WMA E
Sbjct: 179 GKVPIKWMALE 189

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  125 bits (315), Expect = 1e-32
 Identities = 51/196 (26%), Positives = 79/196 (40%), Gaps = 16/196 (8%)

Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQ 369
           +   P      +I     +  + LG GSFG V  G     S      AVK   L      
Sbjct: 3   AGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK--CLKPDVLS 60

Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLR 427
             +++    +E+  +   +H N+++ YG       + +  EL   GSLL+     + H  
Sbjct: 61  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL 119

Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK 485
              +S Y  Q+  G+ YL  +  +HRD+   N+L+     VK+ DFGL +A   ND    
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179

Query: 486 SCRGTAF---WMAPEV 498
                     W APE 
Sbjct: 180 MQEHRKVPFAWCAPES 195

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  126 bits (320), Expect = 2e-32
 Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 13/173 (7%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
           G+ +GRG+FG V+ G    D    AVK      +          L QE  +L ++ H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVK---SCRETLPPDLKAKFL-QEARILKQYSHPNI 174

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           V+  G    +  +YI +ELV  G  L  +   +   LR   +         G++YL  + 
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAPEV 498
            +HRD+   N LV     +K++DFG+++        +  G       W APE 
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  125 bits (316), Expect = 2e-32
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 18/207 (8%)

Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV 361
           H   S                F     Y      LGRG F  V + IS   G  +A K  
Sbjct: 5   HHHSSGVDLGTENLYFQSMENFNNF--YILTSKELGRGKFAVVRQCISKSTGQEYAAK-- 60

Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
             L +  + +   +++  EIA+L   +    ++  +   ++ S++ + LE    G + + 
Sbjct: 61  -FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119

Query: 420 ----LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLAD 472
               L +     D  V    +QIL G+ YLH  ++VH D+K  NIL+      G +K+ D
Sbjct: 120 CLPELAEMVSEND--VIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177

Query: 473 FGLAKATKLNDV-KSCRGTAFWMAPEV 498
           FG+++        +   GT  ++APE+
Sbjct: 178 FGMSRKIGHACELREIMGTPEYLAPEI 204

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  124 bits (312), Expect = 6e-32
 Identities = 48/248 (19%), Positives = 83/248 (33%), Gaps = 72/248 (29%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK----------------EVSLLDQ-- 366
           R +T ++    +GRG FG V+E  +  D   +A+K                EV  L +  
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 367 -----------------------------------GSQAKQSISQLEQEIALLSRFEHEN 391
                                                 +   +     +I  +  F  +N
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----SQVSAYTRQILLGLKYLHD 447
            V        +  LYI ++L  K +L +   R    +            QI   +++LH 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--------------GTAFW 493
           + ++HRD+K +NI    +  VK+ DFGL  A   ++ +                 GT  +
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 494 MAPEVCSN 501
           M+PE    
Sbjct: 243 MSPEQIHG 250

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  124 bits (313), Expect = 6e-32
 Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 20/175 (11%)

Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHEN 391
            + +G GS+      I       FAVK +          +S     +EI +L R+ +H N
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIID---------KSKRDPTEEIEILLRYGQHPN 77

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           I+       D   +Y+  EL+  G LL+ + ++    + + SA    I   ++YLH Q V
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137

Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEV 498
           VHRD+K +NIL         S+++ DFG AK  +  +      C  TA ++APEV
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEV 191

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  122 bits (309), Expect = 8e-32
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 16/175 (9%)

Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             +LG G FG VYEG+      +    AVK      +          +  E  ++   +H
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKT---CKKDCTLDNKEKFM-SEAVIMKNLDH 72

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLGLKYLH 446
            +IV+  G  ++E   +I +EL   G L + Y    +  L+   +  Y+ QI   + YL 
Sbjct: 73  PHIVKLIGIIEEEP-TWIIMELYPYGELGH-YLERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
             + VHRDI   NILV +   VKL DFGL++  +  D      T     WM+PE 
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  122 bits (309), Expect = 1e-31
 Identities = 54/188 (28%), Positives = 96/188 (51%), Gaps = 16/188 (8%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG--SQAKQSISQLEQEIA 382
           ++I  +  GDLLG GS+G V E + S+     AVK   +L +    +     + +++EI 
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQ 58

Query: 383 LLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGS--LLNLYQRYHLRDSQVSAYTRQI 438
           LL R  H+N++Q      ++++ K+Y+ +E    G   +L+          Q   Y  Q+
Sbjct: 59  LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL 118

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-----SCRGTAFW 493
           + GL+YLH Q +VH+DIK  N+L+   G++K++  G+A+A            S  G+  +
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAF 177

Query: 494 MAPEVCSN 501
             PE+ + 
Sbjct: 178 QPPEIANG 185

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  122 bits (308), Expect = 1e-31
 Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 15/172 (8%)

Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG G+FGSV +G+          A+K    L QG++   +  ++ +E  ++ + ++  IV
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADT-EEMMREAQIMHQLDNPYIV 73

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           +  G  + E+ L + +E+   G L       R  +  S V+    Q+ +G+KYL +++ V
Sbjct: 74  RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPEV 498
           HRD+   N+L+      K++DFGL+KA   +D    +     +   W APE 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  121 bits (307), Expect = 1e-31
 Identities = 55/175 (31%), Positives = 83/175 (47%), Gaps = 18/175 (10%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI  S +      A+K        +        L QE   + +F+H
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKT---CKNCTSDSVREKFL-QEALTMRQFDH 75

Query: 390 ENIVQYYG--TDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYL 445
            +IV+  G  T   E+ ++I +EL T G L +    ++Y L  + +  Y  Q+   L YL
Sbjct: 76  PHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPE 497
             +  VHRDI   N+LV +N  VKL DFGL++  + +             WMAPE
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 187

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  123 bits (310), Expect = 2e-31
 Identities = 41/198 (20%), Positives = 77/198 (38%), Gaps = 34/198 (17%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEH 389
           +   +L  G F  VYE      G  +A+K +   +     ++    + QE+  + +   H
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-----EEKNRAIIQEVCFMKKLSGH 85

Query: 390 ENIVQYYG-------TDKDESKLYIFLELVTKGSLLNLYQRYHLRD----SQVSAYTRQI 438
            NIVQ+                 ++ L  + KG L+   ++   R       V     Q 
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 439 LLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLA--------------KATKLN 482
              ++++H Q   ++HRD+K  N+L+   G++KL DFG A              +   + 
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 483 DVKSCRGTAFWMAPEVCS 500
           +  +   T  +  PE+  
Sbjct: 206 EEITRNTTPMYRTPEIID 223

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  122 bits (309), Expect = 2e-31
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 17/177 (9%)

Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             ++G G  G V  G            A+K    L  G   +Q    L  E +++ +F+H
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIK---ALKAGYTERQRRDFL-SEASIMGQFDH 109

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
            NI++  G         I  E +  GSL   + R H       Q+    R +  G++YL 
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEV 498
           D   VHRD+   N+LVD+N   K++DFGL++  + +     +  G      W APE 
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  122 bits (308), Expect = 3e-31
 Identities = 42/175 (24%), Positives = 74/175 (42%), Gaps = 20/175 (11%)

Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            +LG G  G V E      G   A+K +             ++ E +          +IV
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDH-HWQASGGPHIV 85

Query: 394 QYYGT----DKDESKLYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILLGLKYLH 446
                       +  L I +E +  G L + + +R     +  + +   R I   +++LH
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 447 DQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
             ++ HRD+K  N+L    + +  +KL DFG AK T  N +++   T +++APEV
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV 200

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  121 bits (305), Expect = 3e-31
 Identities = 52/172 (30%), Positives = 79/172 (45%), Gaps = 13/172 (7%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
              LG G +G VYEG+        AVK    L + +   +   +  +E A++   +H N+
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNL 71

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
           VQ  G    E   YI  E +T G+LL+      R  +    +     QI   ++YL  ++
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
            +HRD+   N LV  N  VK+ADFGL++    +   +  G  F   W APE 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  121 bits (306), Expect = 4e-31
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 45/220 (20%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQ---------KGDLLGRGSFGSVYEGISDDGFFFA 357
           ++++  + +S+          +                L+G G FG VY+G+  DG   A
Sbjct: 8   ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67

Query: 358 VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKL-YIFLELVTK 414
           +K        S   Q I + E EI  LS   H ++V   G   +++E  L Y   + +  
Sbjct: 68  LK---RRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY---KYMEN 119

Query: 415 GSLLNLYQRYHLRDSQVSAY-----TR-QILL----GLKYLHDQDVVHRDIKCANILVDA 464
           G+L     + HL  S +         R +I +    GL YLH + ++HRD+K  NIL+D 
Sbjct: 120 GNL-----KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE 174

Query: 465 NGSVKLADFGLAKATKLND-------VKSCRGTAFWMAPE 497
           N   K+ DFG++K     D       VK   GT  ++ PE
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVK---GTLGYIDPE 211

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  120 bits (303), Expect = 5e-31
 Identities = 53/174 (30%), Positives = 86/174 (49%), Gaps = 19/174 (10%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            + LG G FG V+ G  +     AVK    L QGS +         E  L+ + +H+ +V
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVK---SLKQGSMSPD---AFLAEANLMKQLQHQRLV 71

Query: 394 QYYG--TDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHD 447
           + Y   T   +  +YI  E +  GSL++ +        L  +++     QI  G+ ++ +
Sbjct: 72  RLYAVVT---QEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           ++ +HRD++ ANILV    S K+ADFGLA+  + N+  +  G  F   W APE 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  121 bits (305), Expect = 7e-31
 Identities = 47/187 (25%), Positives = 95/187 (50%), Gaps = 8/187 (4%)

Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI 374
           ++I+     +  I  ++    +G+G+F  V        G   A+K   ++D+      S+
Sbjct: 2   NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSL 58

Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 433
            +L +E+ ++    H NIV+ +   + E  LY+ +E  + G + + L     +++ +  +
Sbjct: 59  QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 118

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTA 491
             RQI+  ++Y H + +VHRD+K  N+L+DA+ ++K+ADFG +    +       C G  
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-GAP 177

Query: 492 FWMAPEV 498
            + APE+
Sbjct: 178 PYAAPEL 184

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  121 bits (305), Expect = 8e-31
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 9/182 (4%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS---LLDQGSQAKQSISQLEQE 380
                 +     LG G+FG V+  +  +      VK +    +L+        + ++  E
Sbjct: 20  GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79

Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQI 438
           IA+LSR EH NI++     +++    + +E    G  L  +  +   L +   S   RQ+
Sbjct: 80  IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAP 496
           +  + YL  +D++HRDIK  NI++  + ++KL DFG A   +   +    C GT  + AP
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-GTIEYCAP 198

Query: 497 EV 498
           EV
Sbjct: 199 EV 200

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  122 bits (308), Expect = 1e-30
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 19/218 (8%)

Query: 292 VLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI-ITYWQKGDLLGRGSFGSVYE-GI 349
            L     F    ++ +         +     R  R+    ++   ++GRG+FG V     
Sbjct: 31  ALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 90

Query: 350 SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTDKDES 403
                 +A+K +S        K  + +         E  +++      +VQ +   +D+ 
Sbjct: 91  KSTRKVYAMKLLS--------KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142

Query: 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD 463
            LY+ +E +  G L+NL   Y + +     YT +++L L  +H    +HRD+K  N+L+D
Sbjct: 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202

Query: 464 ANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
            +G +KLADFG         +  C    GT  +++PEV
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  120 bits (303), Expect = 1e-30
 Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 26/186 (13%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G +LG+G FGSV E     +DG F   AVK   +L     A   I +  +E A +  F+H
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVK---MLKADIIASSDIEEFLREAACMKEFDH 84

Query: 390 ENIVQYYG--TDKD----ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--- 440
            ++ +  G               + L  +  G L   +               Q L+   
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA-FLLASRIGENPFNLPLQTLVRFM 143

Query: 441 -----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
                G++YL  ++ +HRD+   N ++  + +V +ADFGL++     D       +    
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203

Query: 493 -WMAPE 497
            W+A E
Sbjct: 204 KWLALE 209

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  120 bits (303), Expect = 1e-30
 Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 18/178 (10%)

Query: 334 GDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
             ++G G FG VY+G+            A+K    L  G   KQ +  L  E  ++ +F 
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFL-GEAGIMGQFS 104

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYL 445
           H NI++  G       + I  E +  G+L   + R         Q+    R I  G+KYL
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGMKYL 163

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEV 498
            + + VHRD+   NILV++N   K++DFGL++  + +     +  G      W APE 
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  119 bits (301), Expect = 2e-30
 Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 18/191 (9%)

Query: 320 PNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAKQ 372
                 RI   T  +K  +LG G FG+V++G+   +G        +K    ++  S   Q
Sbjct: 2   AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV---IEDKSGR-Q 57

Query: 373 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQ 430
           S   +   +  +   +H +IV+  G     S L +  + +  GSLL+     R  L    
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQL 116

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRG 489
           +  +  QI  G+ YL +  +VHR++   N+L+ +   V++ADFG+A     +D       
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176

Query: 490 TAF---WMAPE 497
                 WMA E
Sbjct: 177 AKTPIKWMALE 187

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  119 bits (301), Expect = 2e-30
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 11/201 (5%)

Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS--- 362
            +       + ++P    + + + +Q G LLG G FGSVY GI   D    A+K V    
Sbjct: 21  MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80

Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDESKLYIFLELVT-KGSLLN 419
           + D G     +  ++  E+ LL +       +++     +      + LE       L +
Sbjct: 81  ISDWGELPNGT--RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 138

Query: 420 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
            + +R  L++    ++  Q+L  +++ H+  V+HRDIK  NIL+D N G +KL DFG   
Sbjct: 139 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198

Query: 478 ATKLNDVKSCRGTAFWMAPEV 498
             K        GT  +  PE 
Sbjct: 199 LLKDTVYTDFDGTRVYSPPEW 219

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  118 bits (298), Expect = 2e-30
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 9/187 (4%)

Query: 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS-ISQL 377
                +  I ++  GD LG G+FG V  G     G   AVK   +L++        + ++
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKI 58

Query: 378 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTR 436
           ++EI  L  F H +I++ Y      +  ++ +E V+ G L + + +   + + +     +
Sbjct: 59  KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWM 494
           QIL  + Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      +    SC G+  + 
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYA 177

Query: 495 APEVCSN 501
           APEV S 
Sbjct: 178 APEVISG 184

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  121 bits (306), Expect = 3e-30
 Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 15/172 (8%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG G FG V+    +     AVK    +  GS + +       E  ++   +H+ +V
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVK---TMKPGSMSVE---AFLAEANVMKTLQHDKLV 246

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----YTRQILLGLKYLHDQD 449
           + +     E  +YI  E + KGSLL+ + +      Q       ++ QI  G+ ++  ++
Sbjct: 247 KLHAVVTKEP-IYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
            +HRD++ ANILV A+   K+ADFGLA+  + N+  +  G  F   W APE 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 356

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  118 bits (299), Expect = 4e-30
 Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 18/192 (9%)

Query: 319 SPNGRFKRIITYWQ--KGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAK 371
           +PN    RI+   +  K  +LG G+FG+VY+G+   +G       A+KE   L + +  K
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPK 59

Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDS 429
               ++  E  +++  ++ ++ +  G     + + +  +L+  G LL+     + ++   
Sbjct: 60  A-NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQ 117

Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCR 488
            +  +  QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK     +      
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

Query: 489 GTAF---WMAPE 497
           G      WMA E
Sbjct: 178 GGKVPIKWMALE 189

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  119 bits (301), Expect = 5e-30
 Identities = 53/177 (29%), Positives = 80/177 (45%), Gaps = 17/177 (9%)

Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             ++G G FG V  G     S      A+K    L  G   KQ    L  E +++ +F+H
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIK---TLKVGYTEKQRRDFL-GEASIMGQFDH 105

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
            NI++  G       + I  E +  GSL + + R H       Q+    R I  G+KYL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYLS 164

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEV 498
           D   VHRD+   NIL+++N   K++DFGL +  + +     + RG      W +PE 
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  120 bits (302), Expect = 5e-30
 Identities = 48/178 (26%), Positives = 87/178 (48%), Gaps = 29/178 (16%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
            +G+GSFG V      D    +A+K ++        KQ   +  +      E+ ++   E
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMN--------KQKCVERNEVRNVFKELQIMQGLE 73

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR------DSQVSAYTRQILLGL 442
           H  +V  + + +DE  +++ ++L+  G L     RYHL+      +  V  +  ++++ L
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDL-----RYHLQQNVHFKEETVKLFICELVMAL 128

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEV 498
            YL +Q ++HRD+K  NIL+D +G V + DF +A         +    GT  +MAPE+
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-GTKPYMAPEM 185

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  121 bits (304), Expect = 5e-30
 Identities = 58/171 (33%), Positives = 87/171 (50%), Gaps = 13/171 (7%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG+G FG V+ G  +     A+K    L  G+ + +      QE  ++ +  HE +V
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPE---AFLQEAQVMKKLRHEKLV 242

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q Y    +E  +YI  E ++KGSLL+        +LR  Q+     QI  G+ Y+   + 
Sbjct: 243 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           VHRD++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  122 bits (308), Expect = 8e-30
 Identities = 68/241 (28%), Positives = 105/241 (43%), Gaps = 27/241 (11%)

Query: 273 EKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI----I 328
           +KEGE A  +I K   ++     S + +    DD +    E  +   P+ R   I    I
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392

Query: 329 TYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
                G  +G G FG V++GI     +     A+K        +        L QE   +
Sbjct: 393 E---LGRCIGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVREKFL-QEALTM 445

Query: 385 SRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQIL 439
            +F+H +IV+  G  T   E+ ++I +EL T G L + + +     L  + +  Y  Q+ 
Sbjct: 446 RQFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLS 501

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAP 496
             L YL  +  VHRDI   N+LV +N  VKL DFGL++  + +             WMAP
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561

Query: 497 E 497
           E
Sbjct: 562 E 562

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  121 bits (306), Expect = 1e-29
 Identities = 47/171 (27%), Positives = 87/171 (50%), Gaps = 15/171 (8%)

Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG G+FGSV +G+          A+K    L QG++   +   + +E  ++ + ++  IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMM-REAQIMHQLDNPYIV 399

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           +  G  + E+ L + +E+   G L    + +R  +  S V+    Q+ +G+KYL +++ V
Sbjct: 400 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPE 497
           HR++   N+L+      K++DFGL+KA   +D    +     +   W APE
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  116 bits (294), Expect = 1e-29
 Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 17/177 (9%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
            +++GRG FG VY G    +DG     AVK    L++ +   + +SQ   E  ++  F H
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 85

Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N  +   ++     +  +  Q+  G+KYL 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF------WMAPE 497
            +  VHRD+   N ++D   +VK+ADFGLA+     +  S            WMA E
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  116 bits (293), Expect = 1e-29
 Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 19/172 (11%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              +G+G FG V  G    G   AVK    +   + A+        E +++++  H N+V
Sbjct: 26  LQTIGKGEFGDVMLGDYR-GNKVAVK---CIKNDATAQA----FLAEASVMTQLRHSNLV 77

Query: 394 QYYGT-DKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQD 449
           Q  G   +++  LYI  E + KGSL++  +   R  L    +  ++  +   ++YL   +
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
            VHRD+   N+LV  +   K++DFGL K        +         W APE 
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEA 185

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  116 bits (293), Expect = 2e-29
 Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 25/185 (13%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G +LG G FGSV EG    +DG     AVK    +   + +++ I +   E A +  F H
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVK---TMKLDNSSQREIEEFLSEAACMKDFSH 95

Query: 390 ENIVQYYG--TDKD---ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------R 436
            N+++  G   +       K  + L  +  G L   Y  Y   ++               
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT-YLLYSRLETGPKHIPLQTLLKFMV 154

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---- 492
            I LG++YL +++ +HRD+   N ++  + +V +ADFGL+K     D       A     
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214

Query: 493 WMAPE 497
           W+A E
Sbjct: 215 WIAIE 219

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  118 bits (298), Expect = 2e-29
 Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 26/221 (11%)

Query: 294 SESCSFTTEHEDDSSSTTTEPMSNISPNGRFKR---IITYWQKGDLLGRGSFGSVYEGIS 350
                     +         P  ++    + K+   I  Y     +LG G  G V +  +
Sbjct: 24  PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFN 83

Query: 351 -DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD----ESK 404
                 FA+K +              +  +E+ L  R  +  +IV+     ++       
Sbjct: 84  KRTQEKFALKMLQ----------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133

Query: 405 LYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
           L I +E +  G L + +  R     +  + S   + I   ++YLH  ++ HRD+K  N+L
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193

Query: 462 V---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
                 N  +KL DFG AK T  ++   +   T +++APEV
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  119 bits (301), Expect = 3e-29
 Identities = 58/171 (33%), Positives = 87/171 (50%), Gaps = 13/171 (7%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG+G FG V+ G  +     A+K    L  G+ + +      QE  ++ +  HE +V
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPE---AFLQEAQVMKKLRHEKLV 325

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q Y    +E  +YI  E ++KGSLL+        +LR  Q+     QI  G+ Y+   + 
Sbjct: 326 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           VHRD++ ANILV  N   K+ADFGLA+  + N+  + +G  F   W APE 
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  119 bits (299), Expect = 4e-29
 Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 15/173 (8%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
              LG G +G VYEG+        AVK    L + +   +      +E A++   +H N+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEE---FLKEAAVMKEIKHPNL 278

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           VQ  G    E   YI  E +T G+LL+ Y     R  +    +     QI   ++YL  +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
           + +HR++   N LV  N  VK+ADFGL++    +   +  G  F   W APE 
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 390

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  115 bits (290), Expect = 5e-29
 Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 17/179 (9%)

Query: 332 QKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
               ++G+G FG VY G     + +    A+K +S         Q +    +E  L+   
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS----RITEMQQVEAFLREGLLMRGL 79

Query: 388 EHENIVQYYGT-DKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKY 444
            H N++   G     E   ++ L  +  G LL      + +     + ++  Q+  G++Y
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAF---WMAPE 497
           L +Q  VHRD+   N ++D + +VK+ADFGLA+     +   V+  R       W A E
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  114 bits (289), Expect = 7e-29
 Identities = 55/170 (32%), Positives = 91/170 (53%), Gaps = 12/170 (7%)

Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAK 371
             S+   N  F+ ++  +QK + +G G++G VY+     G   A+K + L   D+G    
Sbjct: 6   HHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI--- 62

Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRD 428
              + + +EI+LL    H NIV        E  L +   F+E   K  L     +  L+D
Sbjct: 63  -PSTAI-REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQD 118

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           SQ+  Y  Q+L G+ + H   ++HRD+K  N+L++++G++KLADFGLA+A
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA 168

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  116 bits (292), Expect = 7e-29
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)

Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
            +++GRG FG VY G    +DG     AVK    L++ +   + +SQ   E  ++  F H
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 149

Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
            N++   G   + E    + L  +  G L N  +   ++     +  +  Q+  G+K+L 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF------WMAPE 497
            +  VHRD+   N ++D   +VK+ADFGLA+     +  S            WMA E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  115 bits (290), Expect = 1e-28
 Identities = 56/179 (31%), Positives = 84/179 (46%), Gaps = 27/179 (15%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
            LG GSFG V      + G  +A+K +         KQ + +L+Q      E  +L    
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILD--------KQKVVKLKQIEHTLNEKRILQAVN 99

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV----SA--YTRQILLGL 442
              +V+   + KD S LY+ +E V  G +       HLR         A  Y  QI+L  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMF-----SHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           +YLH  D+++RD+K  N+L+D  G +++ DFG AK  K      C GT   +APE+  +
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GTPEALAPEIILS 212

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  115 bits (290), Expect = 1e-28
 Identities = 54/159 (33%), Positives = 81/159 (50%), Gaps = 8/159 (5%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIA 382
           K     ++K D LG G F +VY+    +     A+K++  L   S+AK  I     +EI 
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIK 64

Query: 383 LLSRFEHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
           LL    H NI+        +S + +   F+E   +  + +      L  S + AY    L
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTL 122

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            GL+YLH   ++HRD+K  N+L+D NG +KLADFGLAK+
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  114 bits (287), Expect = 1e-28
 Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 20/215 (9%)

Query: 298 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFF 356
           S  T+      +    P        R +     ++ G LLG+G FG+V+ G    D    
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDR-EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQV 59

Query: 357 AVKEVS---LLDQGSQAKQSISQLEQEIALLSR----FEHENIVQYYGTDKDESKLYIFL 409
           A+K +    +L     +         E+ALL +      H  +++     + +    + L
Sbjct: 60  AIKVIPRNRVLGWSPLSDSV--TCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117

Query: 410 ELVTKGS-LLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NG 466
           E       L + + ++  L +     +  Q++  +++ H + VVHRDIK  NIL+D   G
Sbjct: 118 ERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG 177

Query: 467 SVKLADFGLA---KATKLNDVKSCRGTAFWMAPEV 498
             KL DFG           D     GT  +  PE 
Sbjct: 178 CAKLIDFGSGALLHDEPYTD--FD-GTRVYSPPEW 209

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  114 bits (288), Expect = 1e-28
 Identities = 57/173 (32%), Positives = 98/173 (56%), Gaps = 21/173 (12%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
            LG GSFG V+   S  +G ++A+K +         K+ + +L+Q      E  +LS   
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLKQVEHTNDERLMLSIVT 64

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHD 447
           H  I++ +GT +D  ++++ ++ +  G L +L ++     + V+  Y  ++ L L+YLH 
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEV 498
           +D+++RD+K  NIL+D NG +K+ DFG AK   + DV    C GT  ++APEV
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYTLC-GTPDYIAPEV 174

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  116 bits (293), Expect = 2e-28
 Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 10/193 (5%)

Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQ 372
           PM+        +  I ++  GD LG G+FG V  G     G   AVK   +L++      
Sbjct: 2   PMAE-KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSL 57

Query: 373 S-ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQ 430
             + ++ +EI  L  F H +I++ Y      S +++ +E V+ G L + + +   L + +
Sbjct: 58  DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE 117

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCR 488
                +QIL G+ Y H   VVHRD+K  N+L+DA+ + K+ADFGL+      +    SC 
Sbjct: 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC- 176

Query: 489 GTAFWMAPEVCSN 501
           G+  + APEV S 
Sbjct: 177 GSPNYAAPEVISG 189

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  115 bits (290), Expect = 2e-28
 Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 32/191 (16%)

Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL 363
           +D +           +     +R I Y     ++G GSFG V++    +    A+K+V L
Sbjct: 19  DDPNKVIKVLASDGKTG---EQREIAY-TNCKVIGNGSFGVVFQAKLVESDEVAIKKV-L 73

Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGSL 417
            D+  + +        E+ ++   +H N+V         G  KDE  L + LE V +   
Sbjct: 74  QDKRFKNR--------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE--- 122

Query: 418 LNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSV 468
             +Y+  R++ +  Q      +  Y  Q+L  L Y+H   + HRDIK  N+L+D   G +
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVL 181

Query: 469 KLADFGLAKAT 479
           KL DFG AK  
Sbjct: 182 KLIDFGSAKIL 192

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  113 bits (285), Expect = 2e-28
 Identities = 48/153 (31%), Positives = 83/153 (54%), Gaps = 10/153 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRF 387
           +QK + +G G++G VY+  +   G   A+K++ L    +G       + + +EI+LL   
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV----PSTAI-REISLLKEL 59

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
            H NIV+       E+KLY+  E + +     ++      +    + +Y  Q+L GL + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           H   V+HRD+K  N+L++  G++KLADFGLA+A
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 152

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  115 bits (291), Expect = 3e-28
 Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 27/176 (15%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLE--QEIALLSRFEHEN 391
              +G+G FG V  G    G   AVK +         K   +      E +++++  H N
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI---------KNDATAQAFLAEASVMTQLRHSN 247

Query: 392 IVQYYG--TDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYL 445
           +VQ  G    +++  LYI  E + KGSL++ Y     R  L    +  ++  +   ++YL
Sbjct: 248 LVQLLGVIV-EEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEV 498
              + VHRD+   N+LV  +   K++DFGL K        +         W APE 
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEA 357

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  113 bits (286), Expect = 3e-28
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 7/176 (3%)

Query: 306 DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLL 364
                      ++     + + +  ++   L+G GS+G V +  + D G   A+K+    
Sbjct: 2   GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES 61

Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY 424
           D     K     + +EI LL +  HEN+V      K + + Y+  E V   ++L+  + +
Sbjct: 62  DDDKMVK--KIAM-REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELF 117

Query: 425 --HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
              L    V  Y  QI+ G+ + H  +++HRDIK  NILV  +G VKL DFG A+ 
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART 173

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  113 bits (284), Expect = 4e-28
 Identities = 59/186 (31%), Positives = 100/186 (53%), Gaps = 28/186 (15%)

Query: 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
                G+ +G G FG VY+G  ++    AVK+++ ++D  +  ++   Q +QEI ++++ 
Sbjct: 31  PISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITT--EELKQQFDQEIKVMAKC 87

Query: 388 EHENIVQYYG--TDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVSA----YTR-QIL 439
           +HEN+V+  G  +D D+  L Y     +  GSLL+      L     +     + R +I 
Sbjct: 88  QHENLVELLGFSSDGDDLCLVY---VYMPNGSLLD-----RLSCLDGTPPLSWHMRCKIA 139

Query: 440 L----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCR--GTA 491
                G+ +LH+   +HRDIK ANIL+D   + K++DFGLA+A++       + R  GT 
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT 199

Query: 492 FWMAPE 497
            +MAPE
Sbjct: 200 AYMAPE 205

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  115 bits (290), Expect = 4e-28
 Identities = 51/241 (21%), Positives = 102/241 (42%), Gaps = 23/241 (9%)

Query: 273 EKEGEEADRAIVKEEEDD--MVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI-IT 329
           +   +   +    E   D  + L + C+ +    + +     E     +   +  R+   
Sbjct: 15  DGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHRE 74

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIA 382
            ++   ++GRG+FG V      +    FA+K ++        K  + +  +      E  
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--------KWEMLKRAETACFREERD 126

Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQILL 440
           +L   + + I   +   +D++ LY+ ++    G LL L  ++  R  +  A  Y  ++++
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPE 497
            +  +H    VHRDIK  NIL+D NG ++LADFG       +         GT  +++PE
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

Query: 498 V 498
           +
Sbjct: 247 I 247

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  112 bits (283), Expect = 4e-28
 Identities = 36/188 (19%), Positives = 74/188 (39%), Gaps = 29/188 (15%)

Query: 334 GDLLGRGSFGSVYEGI---SDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFE 388
            + LG+G+F  +++G+     D       EV L  LD+  +         +  +++S+  
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE--SFFEAASMMSKLS 70

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
           H+++V  YG      +  +  E V  GSL    +  +  +         +Q+   + +L 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130

Query: 447 DQDVVHRDIKCANILVDA--------NGSVKLADFGLAKATKLND-----VKSCRGTAFW 493
           +  ++H ++   NIL+             +KL+D G++      D     +        W
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-------W 183

Query: 494 MAPEVCSN 501
           + PE   N
Sbjct: 184 VPPECIEN 191

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  115 bits (289), Expect = 4e-28
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 30/196 (15%)

Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS 362
            D   S  T  ++         + ++Y     ++G GSFG VY+    D G   A+K+V 
Sbjct: 30  RDKDGSKVTTVVATPGQGPDRPQEVSY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV- 87

Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGS 416
           L D+  + +        E+ ++ + +H NIV+        G  KDE  L + L+ V +  
Sbjct: 88  LQDKRFKNR--------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-- 137

Query: 417 LLNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GS 467
              +Y+  R++ R  Q      V  Y  Q+   L Y+H   + HRDIK  N+L+D +   
Sbjct: 138 --TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195

Query: 468 VKLADFGLAKATKLND 483
           +KL DFG AK     +
Sbjct: 196 LKLCDFGSAKQLVRGE 211

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  112 bits (283), Expect = 5e-28
 Identities = 41/151 (27%), Positives = 76/151 (50%), Gaps = 7/151 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K   +G GS+G V++  + D G   A+K+    +     K     L +EI +L + +H
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK--KIAL-REIRMLKQLKH 61

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHD 447
            N+V      + + +L++  E     ++L+   RY   + +  V + T Q L  + + H 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            + +HRD+K  NIL+  +  +KL DFG A+ 
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARL 151

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  113 bits (284), Expect = 5e-28
 Identities = 50/182 (27%), Positives = 89/182 (48%), Gaps = 10/182 (5%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIA 382
           KR I  +   + LG GSFG V            A+K    + +    K     ++E+EI+
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREIS 61

Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLG 441
            L    H +I++ Y      + + + +E    G L + + ++  + + +   + +QI+  
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVC 499
           ++Y H   +VHRD+K  N+L+D N +VK+ADFGL+      +    SC G+  + APEV 
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAPEVI 179

Query: 500 SN 501
           + 
Sbjct: 180 NG 181

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  113 bits (285), Expect = 5e-28
 Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 16/201 (7%)

Query: 306 DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLL 364
           D +  TT P+               +     +G G+FG              AVK    +
Sbjct: 2   DRAPVTTGPLDM-----PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YI 53

Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQR 423
           ++G         +++EI       H NIV++       + L I +E  + G L   +   
Sbjct: 54  ERG---AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA 110

Query: 424 YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATKL 481
               + +   + +Q+L G+ Y H   + HRD+K  N L+D +    +K+ DFG +K++ L
Sbjct: 111 GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170

Query: 482 NDV-KSCRGTAFWMAPEVCSN 501
           +   KS  GT  ++APEV   
Sbjct: 171 HSQPKSTVGTPAYIAPEVLLR 191

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  112 bits (282), Expect = 6e-28
 Identities = 47/153 (30%), Positives = 83/153 (54%), Gaps = 12/153 (7%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFE 388
           +   + +G G++G VY+  ++ G  FA+K++ L   D+G       + + +EI++L   +
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTI-REISILKELK 58

Query: 389 HENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
           H NIV+ Y     + +L +    L+   K  L        L      ++  Q+L G+ Y 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYC 116

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           HD+ V+HRD+K  N+L++  G +K+ADFGLA+A
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARA 149

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  111 bits (281), Expect = 9e-28
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 13/166 (7%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIA 382
               + ++    +G G++G+VY+      G F A+K V +    G      IS + +E+A
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV-REVA 63

Query: 383 LL---SRFEHENIVQ-----YYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVS 432
           LL     FEH N+V+            E K+ +  E V +   + L+      L    + 
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123

Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
              RQ L GL +LH   +VHRD+K  NILV + G+VKLADFGLA+ 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI 169

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  112 bits (281), Expect = 1e-27
 Identities = 45/186 (24%), Positives = 80/186 (43%), Gaps = 27/186 (14%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
              LG+GSFG VYEG++            A+K    +++ +  ++   +   E +++  F
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRE-RIEFLNEASVMKEF 85

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------------LRDSQVSAYT 435
              ++V+  G         + +EL+T+G L + Y R                 S++    
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS-YLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
            +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D     G      
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204

Query: 493 -WMAPE 497
            WM+PE
Sbjct: 205 RWMSPE 210

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  111 bits (280), Expect = 2e-27
 Identities = 52/186 (27%), Positives = 75/186 (40%), Gaps = 27/186 (14%)

Query: 334 GDLLGRGSFGSVYEG----ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
              LG G+FG VYEG    + +D      AVK    L +    +        E  ++S+F
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQD-ELDFLMEALIISKF 90

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------LRDSQVSAYTRQI 438
            H+NIV+  G        +I +EL+  G L + + R           L    +    R I
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKS-FLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF--- 492
             G +YL +   +HRDI   N L+   G     K+ DFG+A+           G A    
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209

Query: 493 -WMAPE 497
            WM PE
Sbjct: 210 KWMPPE 215

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  112 bits (282), Expect = 2e-27
 Identities = 35/201 (17%), Positives = 66/201 (32%), Gaps = 39/201 (19%)

Query: 333 KGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---- 387
           +G +LG+    +  E    + G  F V      ++      +I Q+++E+  L       
Sbjct: 82  RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIK 139

Query: 388 ---------------------EHENIVQYYGTDKDESKLYIFL-------ELVTKGSLLN 419
                                + + +++    ++D   L  F         L T G +L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 420 LYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477
            +   H  L        T Q++  L  LH   +VH  ++  +I++D  G V L  F    
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 478 ATKLNDVKSCRGTAFWMAPEV 498
             +            +  PE 
Sbjct: 260 --RDGASAVSPIGRGFAPPET 278

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  110 bits (277), Expect = 3e-27
 Identities = 56/189 (29%), Positives = 80/189 (42%), Gaps = 34/189 (17%)

Query: 337 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+         + D    AVK  +L D    A++     ++E  LL+  +HE
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARK---DFQREAELLTNLQHE 77

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------------- 435
           +IV++YG   D   L +  E +  G L   + R H  D+ +                   
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNK-FLRAHGPDAMILVDGQPRQAKGELGLSQML 136

Query: 436 ---RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
               QI  G+ YL  Q  VHRD+   N LV AN  VK+ DFG+++     D     G   
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 493 ----WMAPE 497
               WM PE
Sbjct: 197 LPIRWMPPE 205

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  109 bits (275), Expect = 5e-27
 Identities = 49/154 (31%), Positives = 85/154 (55%), Gaps = 13/154 (8%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRF 387
           ++K + +G G++G+V++  + +     A+K V L   D+G       S L +EI LL   
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSAL-REICLLKEL 58

Query: 388 EHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           +H+NIV+ +     + KL +   F +   K    +      L    V ++  Q+L GL +
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGF 116

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            H ++V+HRD+K  N+L++ NG +KLA+FGLA+A
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARA 150

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  109 bits (276), Expect = 5e-27
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 17/167 (10%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSL--LDQG--SQAKQSISQLE 378
            R    ++    +G G++G V++     + G F A+K V +   ++G      + ++ L 
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66

Query: 379 QEIALLSRFEHENIVQ-----YYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQV 431
                L  FEH N+V+            E+KL +  E V +   + L+      +    +
Sbjct: 67  H----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122

Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
                Q+L GL +LH   VVHRD+K  NILV ++G +KLADFGLA+ 
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  110 bits (278), Expect = 6e-27
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 30/190 (15%)

Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 366
            S  +   +  +     K +  + Q   + G+G+FG+V  G     G   A+K+V  +  
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--IQD 59

Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYY-------GTDKDESKLYIFLELVTKGSLLN 419
                + +    Q +  L+   H NIVQ           D+ +  L + +E V       
Sbjct: 60  PRFRNREL----QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD----T 111

Query: 420 LYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQ--DVVHRDIKCANILVD-ANGSV 468
           L++  R + R         +  +  Q++  +  LH    +V HRDIK  N+LV+ A+G++
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171

Query: 469 KLADFGLAKA 478
           KL DFG AK 
Sbjct: 172 KLCDFGSAKK 181

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  111 bits (280), Expect = 6e-27
 Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 29/224 (12%)

Query: 292 VLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGD-----LLGRGSFGSVY 346
            + +    +   +D   +   +    I    +  R+    Q+ D     ++GRG+F  V 
Sbjct: 23  GVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRL----QRDDFEILKVIGRGAFSEVA 78

Query: 347 EGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTD 399
                  G  +A+K ++        K  + +  +      E  +L   +   I Q +   
Sbjct: 79  VVKMKQTGQVYAMKIMN--------KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130

Query: 400 KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQILLGLKYLHDQDVVHRDIKC 457
           +DE+ LY+ +E    G LL L  ++  R     A  Y  +I++ +  +H    VHRDIK 
Sbjct: 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190

Query: 458 ANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEV 498
            NIL+D  G ++LADFG     + +         GT  +++PE+
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  109 bits (275), Expect = 9e-27
 Identities = 40/191 (20%), Positives = 82/191 (42%), Gaps = 17/191 (8%)

Query: 298 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFF 356
                H     + T  P S           I  +++   LG G++G VY+ I        
Sbjct: 3   HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62

Query: 357 AVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK 414
           A+K + L   ++G       + + +E++LL   +H NI++         +L++  E    
Sbjct: 63  AIKRIRLEHEEEGV----PGTAI-REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117

Query: 415 --GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-----GS 467
                ++  +   +    + ++  Q++ G+ + H +  +HRD+K  N+L+  +       
Sbjct: 118 DLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175

Query: 468 VKLADFGLAKA 478
           +K+ DFGLA+A
Sbjct: 176 LKIGDFGLARA 186

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  109 bits (274), Expect = 1e-26
 Identities = 50/156 (32%), Positives = 89/156 (57%), Gaps = 13/156 (8%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
           +++ + LG G++ +VY+G++   G + A+KEV L  ++G+      + + +EI+L+   +
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAI-REISLMKELK 61

Query: 389 HENIVQYYGTDKDESKLYI---FLELVTKG---SLLNLYQRYHLRDSQVSAYTRQILLGL 442
           HENIV+ Y     E+KL +   F++   K    S         L  + V  +  Q+L GL
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
            + H+  ++HRD+K  N+L++  G +KL DFGLA+A
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  108 bits (273), Expect = 1e-26
 Identities = 51/153 (33%), Positives = 82/153 (53%), Gaps = 12/153 (7%)

Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
           + K D LG G++ +VY+G S       A+KE+ L  ++G+      + + +E++LL   +
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAI-REVSLLKDLK 58

Query: 389 HENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
           H NIV  +     E  L +   +L+   K  L +      +    V  +  Q+L GL Y 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYC 116

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
           H Q V+HRD+K  N+L++  G +KLADFGLA+A
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARA 149

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  108 bits (273), Expect = 2e-26
 Identities = 63/184 (34%), Positives = 86/184 (46%), Gaps = 37/184 (20%)

Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +LGRG FG VY+G   DG   AVK   L ++ +Q  +   Q + E+ ++S   H N+++ 
Sbjct: 37  ILGRGGFGKVYKGRLADGTLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLRL 92

Query: 396 YG--TDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TR-QILLG----L 442
            G      E  L Y     +  GS+        LR+   S        R +I LG    L
Sbjct: 93  RGFCMTPTERLLVY---PYMANGSV-----ASCLRERPESQPPLDWPKRQRIALGSARGL 144

Query: 443 KYLHDQ---DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC------RGTAFW 493
            YLHD     ++HRD+K ANIL+D      + DFGLA   KL D K        RGT   
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---KLMDYKDTHVTTAVRGTIGH 201

Query: 494 MAPE 497
           +APE
Sbjct: 202 IAPE 205

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  110 bits (277), Expect = 2e-26
 Identities = 48/207 (23%), Positives = 95/207 (45%), Gaps = 15/207 (7%)

Query: 279 ADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLG 338
           +  A   ++ +            E +      +++P +++       +I   ++   L+G
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62

Query: 339 RGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
            GS+G V E     +    A+K++    +     K+ +    +EIA+L+R  H+++V+  
Sbjct: 63  TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILNRLNHDHVVKVL 118

Query: 397 GTDKDES-----KLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
                +      +LY+ LE+    S          +L +  +      +L+G+KY+H   
Sbjct: 119 DIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG 176

Query: 450 VVHRDIKCANILVDANGSVKLADFGLA 476
           ++HRD+K AN LV+ + SVK+ DFGLA
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  109 bits (274), Expect = 2e-26
 Identities = 52/183 (28%), Positives = 72/183 (39%), Gaps = 27/183 (14%)

Query: 337 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG VYEG              AVK    L +    +        E  ++S+F H+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQD-ELDFLMEALIISKFNHQ 134

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------LRDSQVSAYTRQILLG 441
           NIV+  G        +I LEL+  G L + + R           L    +    R I  G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKS-FLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 442 LKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WM 494
            +YL +   +HRDI   N L+   G     K+ DFG+A+           G A     WM
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253

Query: 495 APE 497
            PE
Sbjct: 254 PPE 256

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  108 bits (272), Expect = 2e-26
 Identities = 48/188 (25%), Positives = 77/188 (40%), Gaps = 33/188 (17%)

Query: 337 LGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           LG G+FG V+     +          AVK    L + S  + +    ++E  LL+  +H+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVK---ALKEAS--ESARQDFQREAELLTMLQHQ 103

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------------- 435
           +IV+++G   +   L +  E +  G L   + R H  D+++ A                 
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNR-FLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162

Query: 436 --RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
              Q+  G+ YL     VHRD+   N LV     VK+ DFG+++     D     G    
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 493 ---WMAPE 497
              WM PE
Sbjct: 223 PIRWMPPE 230

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  108 bits (273), Expect = 2e-26
 Identities = 48/179 (26%), Positives = 85/179 (47%), Gaps = 21/179 (11%)

Query: 315 MSNISPNGRFK--RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 371
           M+    +        ++ ++K   +G+G+FG V++      G   A+K+V +       K
Sbjct: 1   MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM----ENEK 56

Query: 372 QSI-SQLEQEIALLSRFEHENIVQ--------YYGTDKDESKLYI---FLELVTKGSLLN 419
           +       +EI +L   +HEN+V             ++ +  +Y+   F E    G L N
Sbjct: 57  EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 116

Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
                    S++    + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A
Sbjct: 117 --VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  107 bits (270), Expect = 2e-26
 Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 22/160 (13%)

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF- 387
           Y     +LG G  G V +  +      FA+K +              +  +E+ L  R  
Sbjct: 19  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----------DCPKARREVELHWRAS 68

Query: 388 EHENIVQYYG----TDKDESKLYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILL 440
           +  +IV+              L I +E +  G L + +  R     +  + S   + I  
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 441 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAK 477
            ++YLH  ++ HRD+K  N+L      N  +KL DFG AK
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  106 bits (268), Expect = 3e-26
 Identities = 46/192 (23%), Positives = 70/192 (36%), Gaps = 33/192 (17%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
            + LG   FG VY+G              A+K    L   ++      +   E  L +R 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPL-REEFRHEAMLRARL 69

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT------------ 435
           +H N+V   G    +  L +     + G L   +       S V +              
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE-FLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 436 ------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
                  QI  G++YL    VVH+D+   N+LV    +VK++D GL +     D     G
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 490 TAF----WMAPE 497
            +     WMAPE
Sbjct: 189 NSLLPIRWMAPE 200

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  110 bits (277), Expect = 6e-26
 Identities = 63/264 (23%), Positives = 113/264 (42%), Gaps = 34/264 (12%)

Query: 261 RALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCS--FTTEHEDDSSSTTTEPMSNI 318
           R +  +   ++         ++ ++  +  +V  +     F    E+   +   +     
Sbjct: 106 REIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKF 165

Query: 319 SPNGRFKRIITY-WQKGD------------LLGRGSFGSVYEGIS-DDGFFFAVKEVSLL 364
             + +F R   +   + +            ++GRG FG VY     D G  +A+K    L
Sbjct: 166 IESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK---CL 222

Query: 365 DQGSQAKQSISQLEQE---------IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415
           D     K+ I   + E         ++L+S  +   IV          KL   L+L+  G
Sbjct: 223 D-----KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277

Query: 416 SLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474
            L   L Q     ++ +  Y  +I+LGL+++H++ VV+RD+K ANIL+D +G V+++D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337

Query: 475 LAKATKLNDVKSCRGTAFWMAPEV 498
           LA         +  GT  +MAPEV
Sbjct: 338 LACDFSKKKPHASVGTHGYMAPEV 361

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  106 bits (266), Expect = 1e-25
 Identities = 54/195 (27%), Positives = 81/195 (41%), Gaps = 36/195 (18%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           G  LG G+FG V    +              AVK   L D  ++  + +S L  E+ ++ 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE--KDLSDLVSEMEMMK 95

Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 435
              +H+NI+   G    +  LY+ +E  +KG+L   Y R         +Y          
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLRARRPPGMEYSYDINRVPEEQM 154

Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
                     Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+     D  K
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214

Query: 486 SCRGTAF---WMAPE 497
                     WMAPE
Sbjct: 215 KTTNGRLPVKWMAPE 229

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  105 bits (265), Expect = 2e-25
 Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 22/176 (12%)

Query: 336 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSR 386
           +LG+GSFG V+       SD    +A+K +         K ++   ++     E  +L  
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLK--------KATLKVRDRVRTKMERDILVE 82

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
             H  IV+ +   + E KLY+ L+ +  G L   L +     +  V  Y  ++ L L +L
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
           H   +++RD+K  NIL+D  G +KL DFGL+K +  ++ K+   C GT  +MAPEV
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEV 197

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  105 bits (265), Expect = 2e-25
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 24/178 (13%)

Query: 336 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-------LL 384
           +LG+G +G V+       ++ G  FA+K +         K  I +  ++ A       +L
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--------KAMIVRNAKDTAHTKAERNIL 75

Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
              +H  IV      +   KLY+ LE ++ G L   L +     +     Y  +I + L 
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
           +LH + +++RD+K  NI+++  G VKL DFGL K +  +   +   C GT  +MAPE+
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEI 192

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  106 bits (266), Expect = 2e-25
 Identities = 57/241 (23%), Positives = 100/241 (41%), Gaps = 32/241 (13%)

Query: 274 KEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQK 333
              EE   +                  T   +  ++  T     +     F+ +      
Sbjct: 7   HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE-NFELL------ 59

Query: 334 GDLLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA------- 382
             +LG G++G V+        D G  +A+K +         K +I Q  +          
Sbjct: 60  -KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK--------KATIVQKAKTTEHTRTERQ 110

Query: 383 -LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
            L    +   +V  +   + E+KL++ L+ +  G L   L QR    + +V  Y  +I+L
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPE 497
            L++LH   +++RDIK  NIL+D+NG V L DFGL+K    ++ +      GT  +MAP+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230

Query: 498 V 498
           +
Sbjct: 231 I 231

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  105 bits (264), Expect = 2e-25
 Identities = 47/200 (23%), Positives = 77/200 (38%), Gaps = 41/200 (20%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G FG V +  +            AVK   +L + +   + +  L  E  +L + 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSE-LRDLLSEFNVLKQV 83

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------------- 425
            H ++++ YG    +  L + +E    GSL   + R                        
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG-FLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 426 ----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
               L    + ++  QI  G++YL +  +VHRD+   NILV     +K++DFGL++    
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 482 NDV-KSCRGTAF---WMAPE 497
            D             WMA E
Sbjct: 203 EDSYVKRSQGRIPVKWMAIE 222

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  105 bits (263), Expect = 2e-25
 Identities = 50/195 (25%), Positives = 73/195 (37%), Gaps = 37/195 (18%)

Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LGRG+FG V E        +      AVK   L +  +        L  E+ +L   
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATH--SEHRALMSELKILIHI 87

Query: 388 -EHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYH------------------L 426
             H N+V   G  T      L + +E    G+L   Y R                    L
Sbjct: 88  GHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLST-YLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 427 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
               +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +    
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205

Query: 486 SCRGTAF---WMAPE 497
                     WMAPE
Sbjct: 206 RKGDARLPLKWMAPE 220

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  106 bits (266), Expect = 3e-25
 Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 36/195 (18%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           G  LG G+FG V    +              AVK   L    ++  + +S L  E+ ++ 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATE--KDLSDLISEMEMMK 129

Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 435
              +H+NI+   G    +  LY+ +E  +KG+L   Y +         +Y          
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLQARRPPGLEYSYNPSHNPEEQL 188

Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
                     Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D  K
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 486 SCRGTAF---WMAPE 497
                     WMAPE
Sbjct: 249 KTTNGRLPVKWMAPE 263

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  104 bits (261), Expect = 3e-25
 Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 20/192 (10%)

Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQA 370
            M     N R+ +I+      D LG G   +VY     D       A+K  ++     + 
Sbjct: 3   HMIGKIINERY-KIV------DKLGGGGMSTVYLAE--DTILNIKVAIK--AIFIPPREK 51

Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRD 428
           ++++ + E+E+   S+  H+NIV     D+++   Y+ +E + +G  L+  +     L  
Sbjct: 52  EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI-EGPTLSEYIESHGPLSV 110

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVK 485
                +T QIL G+K+ HD  +VHRDIK  NIL+D+N ++K+ DFG+AKA   T L    
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170

Query: 486 SCRGTAFWMAPE 497
              GT  + +PE
Sbjct: 171 HVLGTVQYFSPE 182

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  105 bits (264), Expect = 5e-25
 Identities = 54/195 (27%), Positives = 80/195 (41%), Gaps = 36/195 (18%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           G  LG G FG V    +              AVK   L D  ++  + +S L  E+ ++ 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE--KDLSDLVSEMEMMK 141

Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 435
              +H+NI+   G    +  LY+ +E  +KG+L   Y R         +Y          
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLRARRPPGMEYSYDINRVPEEQM 200

Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
                     Q+  G++YL  Q  +HRD+   N+LV  N  +K+ADFGLA+     D  K
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260

Query: 486 SCRGTAF---WMAPE 497
                     WMAPE
Sbjct: 261 KTTNGRLPVKWMAPE 275

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  103 bits (260), Expect = 6e-25
 Identities = 51/195 (26%), Positives = 71/195 (36%), Gaps = 36/195 (18%)

Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK   +L   +   +    L  E+ +LS  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTE-REALMSELKVLSYL 83

Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT----------- 435
             H NIV   G         +  E    G LLN + R        S  +           
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN-FLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
                     Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +    
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 486 SCRGTAF---WMAPE 497
                     WMAPE
Sbjct: 203 VKGNARLPVKWMAPE 217

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  103 bits (260), Expect = 1e-24
 Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 41/200 (20%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
              +G G+FG V++  +     +      AVK   +L + + A    +  ++E AL++ F
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADM-QADFQREAALMAEF 107

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT------------ 435
           ++ NIV+  G       + +  E +  G L   + R     +  S               
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE-FLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 436 --------------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
                         RQ+  G+ YL ++  VHRD+   N LV  N  VK+ADFGL++    
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 482 NDVKSCRGTAF----WMAPE 497
            D     G       WM PE
Sbjct: 227 ADYYKADGNDAIPIRWMPPE 246

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  103 bits (258), Expect = 2e-24
 Identities = 46/189 (24%), Positives = 73/189 (38%), Gaps = 32/189 (16%)

Query: 334 GDLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EH 389
            D++G G+FG V +  I  DG     A+K    + + +           E+ +L +   H
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDD-HRDFAGELEVLCKLGHH 85

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-------------- 435
            NI+   G  +    LY+ +E    G+LL+ + R         A+               
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 436 ----RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
                 +  G+ YL  +  +HRD+   NILV  N   K+ADFGL++              
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 202

Query: 492 F---WMAPE 497
               WMA E
Sbjct: 203 LPVRWMAIE 211

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  104 bits (261), Expect = 2e-24
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 25/167 (14%)

Query: 330 YWQKGDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
           +  +G  +GRG++G VY+    D      +A+K++        A +       EIALL  
Sbjct: 22  FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EIALLRE 74

Query: 387 FEHENIVQYYG--TDKDESKLYI---FLE------LVTKGSLLNLYQRYHLRDSQVSAYT 435
            +H N++          + K+++   + E      +    +     +   L    V +  
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134

Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDA----NGSVKLADFGLAKA 478
            QIL G+ YLH   V+HRD+K ANILV       G VK+AD G A+ 
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  104 bits (262), Expect = 2e-24
 Identities = 56/240 (23%), Positives = 102/240 (42%), Gaps = 22/240 (9%)

Query: 271 DNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITY 330
           +  +E EE   AI +   D +    +          S ++  E M       + +  +  
Sbjct: 91  ETPEEREEWTTAI-QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149

Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIAL 383
           ++   LLG+G+FG V        G ++A+K +         K+ I   ++      E  +
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--------KEVIVAKDEVAHTLTENRV 201

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
           L    H  +     + +   +L   +E    G L   L +     + +   Y  +I+  L
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 261

Query: 443 KYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
            YLH +++VV+RD+K  N+++D +G +K+ DFGL K    +       C GT  ++APEV
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 320

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  102 bits (256), Expect = 2e-24
 Identities = 52/182 (28%), Positives = 78/182 (42%), Gaps = 33/182 (18%)

Query: 334 GDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
             L+GRG  G VYE   +D       A+K   L+            L  +    +R + E
Sbjct: 39  RRLVGRGGMGDVYEA--EDTVRERIVALK---LMS---------ETLSSDPVFRTRMQRE 84

Query: 391 ----------NIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQI 438
                     ++V  +   + + +LY+ + L+  G  L   L ++  L   +  A  RQI
Sbjct: 85  ARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI-NGVDLAAMLRRQGPLAPPRAVAIVRQI 143

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMA 495
              L   H     HRD+K  NILV A+    L DFG+A A    KL  + +  GT ++MA
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203

Query: 496 PE 497
           PE
Sbjct: 204 PE 205

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  102 bits (256), Expect = 4e-24
 Identities = 50/191 (26%), Positives = 76/191 (39%), Gaps = 32/191 (16%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E  +            AVK   +L   + A +    L  E+ ++S  
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADE-KEALMSELKIMSHL 106

Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT----------- 435
            +HENIV   G       + +  E    G LLN + R   R  +                
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLN-FLRRKSRVLETDPAFAIANSTASTRD 165

Query: 436 -----RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
                 Q+  G+ +L  ++ +HRD+   N+L+      K+ DFGLA+    +     +G 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 491 AF----WMAPE 497
           A     WMAPE
Sbjct: 226 ARLPVKWMAPE 236

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  101 bits (253), Expect = 8e-24
 Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 20/174 (11%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
           LLG+G+FG V        G ++A+K +         K+ I   ++      E  +L    
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILR--------KEVIIAKDEVAHTVTESRVLQNTR 63

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHD 447
           H  +       +   +L   +E    G L   L +     + +   Y  +I+  L+YLH 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
           +DVV+RDIK  N+++D +G +K+ DFGL K    +       C GT  ++APEV
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEV 176

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  103 bits (258), Expect = 1e-23
 Identities = 48/183 (26%), Positives = 91/183 (49%), Gaps = 34/183 (18%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
           +LGRG FG V+   +   G  +A K+++        K+ + + +       E  +L++  
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--------KKRLKKRKGYQGAMVEKKILAKVH 243

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----------YTRQI 438
              IV      + ++ L + + ++  G +     RYH+ +               YT QI
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQI 298

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMA 495
           + GL++LH +++++RD+K  N+L+D +G+V+++D GLA   K    K+     GT  +MA
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMA 357

Query: 496 PEV 498
           PE+
Sbjct: 358 PEL 360

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  103 bits (257), Expect = 2e-23
 Identities = 71/355 (20%), Positives = 129/355 (36%), Gaps = 42/355 (11%)

Query: 167 TQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPP 226
            + A+        G +D    ++    P S   + +    SS   +  +  R  L +   
Sbjct: 178 VRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDK 237

Query: 227 GMRQPVIDNACSTWDILR--DFAPKDGITPSSVMNDRALSSSSDDEDNEKE----GEEAD 280
             R  V       WD+    DF        S +               E E        +
Sbjct: 238 DRRLSV---EIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPE 294

Query: 281 RAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFK----RIITYWQKGDL 336
            +   EE             T+  ++ ++ T     N     R K      +       +
Sbjct: 295 GSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLM------V 348

Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSRF 387
           LG+GSFG V           +AVK +         K  + Q        +E+ + L    
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRV-LALPG 399

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
           +   + Q +   +   +LY  +E V  G L  ++ Q    ++     Y  +I +GL +L 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
            + +++RD+K  N+++D+ G +K+ADFG+ K    + V +   C GT  ++APE+
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEI 513

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =   99 bits (250), Expect = 2e-23
 Identities = 45/176 (25%), Positives = 85/176 (48%), Gaps = 23/176 (13%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
           ++GRGS+  V    +      +A+K V         K+ ++          E+ +     
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVK--------KELVNDDEDIDWVQTEKHV-FEQA 66

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
             H  +V  +   + ES+L+  +E V  G L+  + ++  L +     Y+ +I L L YL
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
           H++ +++RD+K  N+L+D+ G +KL D+G+ K        +   C GT  ++APE+
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEI 181

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  100 bits (250), Expect = 3e-23
 Identities = 53/200 (26%), Positives = 79/200 (39%), Gaps = 41/200 (20%)

Query: 334 GDLLGRGSFGSVYEG----ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G +LG G+FG V       IS  G     AVK   +L + + + +    L  E+ ++++ 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVK---MLKEKADSSE-REALMSELKMMTQL 105

Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--------------------- 425
             HENIV   G       +Y+  E    G LLN Y R                       
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN-YLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 426 ----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
               L    +  +  Q+  G+++L  +  VHRD+   N+LV     VK+ DFGLA+    
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 482 NDV-KSCRGTAF---WMAPE 497
           +              WMAPE
Sbjct: 225 DSNYVVRGNARLPVKWMAPE 244

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (255), Expect = 3e-23
 Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 19/174 (10%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
           +LG+G FG V    +   G  +A K++         K+ I + +       E  +L +  
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--------KKRIKKRKGEAMALNEKQILEKVN 242

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYL 445
              +V      + +  L + L L+  G L   +    +    +++   Y  +I  GL+ L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEV 498
           H + +V+RD+K  NIL+D +G ++++D GLA        +K   GT  +MAPEV
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 20/163 (12%)

Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLE------QEIALLSRFEHE 390
           +  GS+G+V  G+  +G   A+K V       +    +S         +EI LL+ F H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 391 NIVQYYGTDKDESK-----LYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILL 440
           NI+          +     LY+  EL+      +L Q     R  +    +  +   ILL
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQHIQYFMYHILL 145

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
           GL  LH+  VVHRD+   NIL+  N  + + DF LA+    + 
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 99.0 bits (247), Expect = 9e-23
 Identities = 44/176 (25%), Positives = 85/176 (48%), Gaps = 23/176 (13%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
           ++GRGS+  V    +      +A++ V         K+ ++          E+ +     
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVK--------KELVNDDEDIDWVQTEKHV-FEQA 109

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
             H  +V  +   + ES+L+  +E V  G L+  + ++  L +     Y+ +I L L YL
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
           H++ +++RD+K  N+L+D+ G +KL D+G+ K        +   C GT  ++APE+
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEI 224

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 23/176 (13%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
           +LG+GSFG V      + G  +AVK +         K  I Q         E+ I L   
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLK--------KDVILQDDDVECTMTEKRI-LSLA 80

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
             H  + Q +   +   +L+  +E V  G L+  + +     +++   Y  +I+  L +L
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
           HD+ +++RD+K  N+L+D  G  KLADFG+ K    N V +   C GT  ++APE+
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEI 195

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  100 bits (250), Expect = 2e-22
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 17/173 (9%)

Query: 334 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
              +  G  G +Y  + D   +G    +K   L+  G    Q+++  E++    +   H 
Sbjct: 85  KGCIAHGGLGWIYLAL-DRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFL--AEVVHP 139

Query: 391 NIVQYY--GTDKD---ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
           +IVQ +      D   +   YI +E V  G  L   +   L  ++  AY  +IL  L YL
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVG-GQSLKRSKGQKLPVAEAIAYLLEILPALSYL 198

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
           H   +V+ D+K  NI++     +KL D G      +N      GT  + APE+
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSR--INSFGYLYGTPGFQAPEI 248

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 54/182 (29%), Positives = 87/182 (47%), Gaps = 35/182 (19%)

Query: 336 LLGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLS 385
           ++G+GSFG V        +  F+AVK +         K++I +         E+ + LL 
Sbjct: 45  VIGKGSFGKVLLARHK-AEEVFYAVKVLQ--------KKAILKKKEEKHIMSERNV-LLK 94

Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQIL 439
             +H  +V  + + +   KLY  L+ +  G L      YHL+  +         Y  +I 
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIA 149

Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAP 496
             L YLH  ++V+RD+K  NIL+D+ G + L DFGL K    ++  +   C GT  ++AP
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAP 208

Query: 497 EV 498
           EV
Sbjct: 209 EV 210

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 98.7 bits (246), Expect = 2e-22
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 17/183 (9%)

Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEV 361
           H     S+  E +           +   +    L+GRGS+G VY     +     A+K+V
Sbjct: 2   HHHHHHSSGRENLYFQGIK-NVH-VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV 59

Query: 362 S-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-----LYIFLELVTKG 415
           + + +     K+ +    +EI +L+R + + I++ Y     +       LYI LE+    
Sbjct: 60  NRMFEDLIDCKRIL----REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--D 113

Query: 416 SLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
           S L         L +  +      +LLG  ++H+  ++HRD+K AN L++ + SVK+ DF
Sbjct: 114 SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDF 173

Query: 474 GLA 476
           GLA
Sbjct: 174 GLA 176

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 23/181 (12%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           LG G++G V        G   A+K++   D+   A +++    +EI +L  F+HENI+  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENIITI 74

Query: 396 YGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           +   + +S      +YI  EL+    L  +     L D  +  +  Q L  +K LH  +V
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNV 133

Query: 451 VHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWM----------APEV 498
           +HRD+K +N+L+++N  +K+ DFGLA        D     G    M          APEV
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193

Query: 499 C 499
            
Sbjct: 194 M 194

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 53/176 (30%), Positives = 92/176 (52%), Gaps = 23/176 (13%)

Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
           +LG+GSFG V+         FFA+K +         K  +          +E+ + L   
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALK--------KDVVLMDDDVECTMVEKRV-LSLA 74

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
           +EH  +   + T + +  L+  +E +  G L+  +   +    S+ + Y  +I+LGL++L
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
           H + +V+RD+K  NIL+D +G +K+ADFG+ K   L D K+   C GT  ++APE+
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 189

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 96.1 bits (240), Expect = 6e-22
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 23/176 (13%)

Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
           +LG+GSFG V           +AVK +         K  + Q        +E+ + L   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRV-LALP 77

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
            +   + Q +   +   +LY  +E V  G L+  + Q    ++     Y  +I +GL +L
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
             + +++RD+K  N+++D+ G +K+ADFG+ K    + V +   C GT  ++APE+
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEI 192

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 95.4 bits (238), Expect = 6e-22
 Identities = 46/188 (24%), Positives = 76/188 (40%), Gaps = 39/188 (20%)

Query: 334 GDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-- 388
           G++LG G    V+     D       AVK   +L          + L ++ +   RF   
Sbjct: 17  GEILGFGGMSEVHLAR--DLRDHRDVAVK---VLR---------ADLARDPSFYLRFRRE 62

Query: 389 --------HENIVQYY--GTDKDESKL--YIFLELVTKGSLLN--LYQRYHLRDSQVSAY 434
                   H  IV  Y  G  +  +    YI +E V  G  L   ++    +   +    
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEV 121

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----G 489
                  L + H   ++HRD+K ANI++ A  +VK+ DFG+A+A   +     +     G
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

Query: 490 TAFWMAPE 497
           TA +++PE
Sbjct: 182 TAQYLSPE 189

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 49/174 (28%), Positives = 90/174 (51%), Gaps = 16/174 (9%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           +G G++G V     + +    A+K++S  +  +  ++++    +EI +L RF HENI+  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90

Query: 396 YGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
               +  +      +YI  +L+    L  L +  HL +  +  +  QIL GLKY+H  +V
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM-APEVC 499
           +HRD+K +N+L++    +K+ DFGLA+    +   +   T +    W  APE+ 
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 96.5 bits (240), Expect = 1e-21
 Identities = 54/231 (23%), Positives = 103/231 (44%), Gaps = 24/231 (10%)

Query: 287 EEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKR---------IITYWQKGDLL 337
           E    V    C    +  D S       MS    + +F           ++  +Q    +
Sbjct: 11  EPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPI 70

Query: 338 GRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
           G G+ G V     +      A+K++S      + AK++     +E+ L+    H+NI+  
Sbjct: 71  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIISL 126

Query: 396 Y------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
                   T ++   +Y+ +EL+   + L    +  L   ++S    Q+L G+K+LH   
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 184

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMAPEVC 499
           ++HRD+K +NI+V ++ ++K+ DFGLA+    + + +    T ++ APEV 
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 44/208 (21%), Positives = 78/208 (37%), Gaps = 61/208 (29%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
            +     +  G  LG GSFG V E    + G  FA+K+V         +       +E+ 
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKN----RELD 52

Query: 383 LLSRFEHENIVQ----YYGTD----------------------------------KDESK 404
           ++   +H NI++    +Y T                                        
Sbjct: 53  IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112

Query: 405 LYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIK 456
           L + +E V       L++  +  +R  +      +S Y  Q+   + ++H   + HRDIK
Sbjct: 113 LNVIMEYVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK 168

Query: 457 CANILVDAN-GSVKLADFGLAKATKLND 483
             N+LV++   ++KL DFG AK    ++
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSE 196

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 18/153 (11%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +G G++GSV   I    G   A+K++S        AK++     +E+ LL   +HEN++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENVIG 87

Query: 395 YY------GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
                    + ++    Y+ +  +      +L +       + ++     Q+L GLKY+H
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIMGLKFSEEKIQYLVYQMLKGLKYIH 143

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
              VVHRD+K  N+ V+ +  +K+ DFGLA+  
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 93.6 bits (233), Expect = 6e-21
 Identities = 47/174 (27%), Positives = 87/174 (50%), Gaps = 19/174 (10%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +G G+ G V     +      A+K++S      + AK++     +E+ L+    H+NI+ 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIIG 88

Query: 395 YYGTDKDESK------LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
                  +        +YI +EL+      NL Q  +  L   ++S    Q+L G+K+LH
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLH 144

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMAPEVC 499
              ++HRD+K +NI+V ++ ++K+ DFGLA+    + + +    T ++ APEV 
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 92.3 bits (230), Expect = 8e-21
 Identities = 44/168 (26%), Positives = 72/168 (42%), Gaps = 16/168 (9%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394
           LGRG +  V+E I   +     VK +  +      K+      +EI +L       NI+ 
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIK----REIKILENLRGGPNIIT 95

Query: 395 YYGTDKDES--KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                KD       +  E V       LYQ   L D  +  Y  +IL  L Y H   ++H
Sbjct: 96  LADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMH 153

Query: 453 RDIKCANILVD-ANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEV 498
           RD+K  N+++D  +  ++L D+GLA+        + R  + ++  PE+
Sbjct: 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 34/181 (18%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +G G++GSV     +  G   AVK++S        AK++     +E+ LL   +HEN++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 92

Query: 395 YY------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    + ++ + +Y+   L+    L N+ +   L D  V     QIL GLKY+H  
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM----------APEV 498
           D++HRD+K +N+ V+ +  +K+ DFGLA           R TA  M          APE+
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLA-----------RHTADEMTGYVATRWYRAPEI 200

Query: 499 C 499
            
Sbjct: 201 M 201

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 14/171 (8%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
           +G G++G+V   +    G   A+K++         AK++     +E+ LL    HEN++ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMRHENVIG 88

Query: 395 YY------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
                    T  D +  Y+ +  +    L  L +   L + ++     Q+L GL+Y+H  
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC 499
            ++HRD+K  N+ V+ +  +K+ DFGLA+    +++     T ++ APEV 
Sbjct: 148 GIIHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMTGYVVTRWYRAPEVI 197

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 24/154 (15%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF-EHEN 391
             LG+G++G V++ I    G   AVK++       + A+++     +EI +L+    HEN
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILTELSGHEN 70

Query: 392 IVQYYGTDKDESK--LYIFLEL-------VTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
           IV      + ++   +Y+  +        V + ++L                  Q++  +
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILE--------PVHKQYVVYQLIKVI 122

Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
           KYLH   ++HRD+K +NIL++A   VK+ADFGL+
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS 156

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 47/184 (25%), Positives = 87/184 (47%), Gaps = 27/184 (14%)

Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV-- 393
           LG G  G V+  + +D     A+K++ L D     K ++    +EI ++ R +H+NIV  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHAL----REIKIIRRLDHDNIVKV 73

Query: 394 ------------QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 441
                          G+  + + +YI  E + +  L N+ ++  L +     +  Q+L G
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRG 132

Query: 442 LKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCRGTAF----WM-A 495
           LKY+H  +V+HRD+K AN+ ++  +  +K+ DFGLA+    +       +      W  +
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192

Query: 496 PEVC 499
           P + 
Sbjct: 193 PRLL 196

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 21/164 (12%), Positives = 47/164 (28%), Gaps = 7/164 (4%)

Query: 334 GDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
               G       ++ + D       A+    +  QG      + +       LSR +   
Sbjct: 36  LIFHGGVPPLQFWQAL-DTALDRQVALTF--VDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           + +        +   +  E +  GSL  +               + +       H   V 
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRAMQSLAAAADAAHRAGVA 151

Query: 452 HRDIKCANILVDANGSVKLADFG-LAKATKLNDVKSCRGTAFWM 494
                 + + V  +G V LA    +  A   +D++    + + +
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATMPDANPQDDIRGIGASLYAL 195

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 76.5 bits (187), Expect = 2e-15
 Identities = 34/217 (15%), Positives = 66/217 (30%), Gaps = 51/217 (23%)

Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ- 366
           S     P S+  P  + +R     +K   +G G FG V++ I+D     A+K +++    
Sbjct: 6   SQKGPVPFSHCLPTEKLQRC----EK---IGEGVFGEVFQTIADHTPV-AIKIIAIEGPD 57

Query: 367 --GSQAKQSISQLEQEIALLSRFE---------HENIVQYYG------------------ 397
                 +++  ++  EI +               E  +                      
Sbjct: 58  LVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDH 117

Query: 398 ------------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
                           + +L+I LE    G  L   +      +   +   Q+   L   
Sbjct: 118 YNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177

Query: 446 HDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
                  HRD+   N+L+      KL      K++ +
Sbjct: 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI 214

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 41/196 (20%), Positives = 69/196 (35%), Gaps = 36/196 (18%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           W+ G  +G+G FG +Y    +           ++            L  E+    R    
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE---PSDNGPLFTELKFYQRAAKP 93

Query: 391 NIVQ-----------------YYGTDKDESKLYIFL--ELVTKGSLLNLYQRYHLRDSQ- 430
             +Q                   G      K Y F+  +      L  +Y+    R S+ 
Sbjct: 94  EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRK 152

Query: 431 -VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK---------A 478
            V   + +IL  L+Y+H+ + VH DIK +N+L++      V L D+GLA          A
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212

Query: 479 TKLNDVKSCRGTAFWM 494
              +  +   GT  + 
Sbjct: 213 YAADPKRCHDGTIEFT 228

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 44/190 (23%), Positives = 79/190 (41%), Gaps = 34/190 (17%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R+   ++ G  +G GSFG +Y G     G   A+K           K    QL  E  + 
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-------VKTKHPQLHIESKIY 58

Query: 385 SRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-----R 436
              +    I  +++ G + D +   + +EL+      +L   ++    + S  T      
Sbjct: 59  KMMQGGVGIPTIRWCGAEGDYN--VMVMELLGP----SLEDLFNFCSRKFSLKTVLLLAD 112

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKATKLN---------DV 484
           Q++  ++Y+H ++ +HRD+K  N L+        V + DFGLAK  +           + 
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

Query: 485 KSCRGTAFWM 494
           K+  GTA + 
Sbjct: 173 KNLTGTARYA 182

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 35/200 (17%)

Query: 315 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS 373
           MS  +       +  +++ G  +G GSFG ++EG +  +    A+K           +  
Sbjct: 1   MSGQN-----NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-------RRSD 48

Query: 374 ISQLEQEIALLSRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
             QL  E            I  V Y+G +   +   + ++L+   SL +L      + S 
Sbjct: 49  APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN--VLVIDLLGP-SLEDLLDLCGRKFSV 105

Query: 431 --VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK-----A 478
             V+   +Q+L  ++ +H++ +V+RDIK  N L+    S     + + DFG+ K      
Sbjct: 106 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165

Query: 479 TKL----NDVKSCRGTAFWM 494
           TK      + K+  GTA +M
Sbjct: 166 TKQHIPYREKKNLSGTARYM 185

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 40/197 (20%), Positives = 68/197 (34%), Gaps = 41/197 (20%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W  G  +G G FG +Y     +     A   V +        Q    L  E+    R   
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV------EYQENGPLFSELKFYQRVAK 92

Query: 390 ENIVQ-----------------YYGTDKDESKLYIFL--ELVTK--GSLLNLYQRYHLRD 428
           ++ ++                   G  + + + Y F+  E +      +      +    
Sbjct: 93  KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK--------- 477
             V     ++L  L+Y+H+ + VH DIK AN+L+       V LAD+GL+          
Sbjct: 153 --VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

Query: 478 ATKLNDVKSCRGTAFWM 494
             + N  K   GT  + 
Sbjct: 211 QYQENPRKGHNGTIEFT 227

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 36/192 (18%), Positives = 64/192 (33%), Gaps = 28/192 (14%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFF---------FAVK---EVSLLDQGSQAKQSISQLE 378
           W+      R + G +YE                 F++K   +   L       Q  ++  
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 379 Q--EIALLSRFEHENIVQYYGTDKDESKLYIF-LELVTK--GSLLNLYQRYHLRDSQVSA 433
           Q  +   L       I    G    + K     L  + +   S L++  ++ L +  V  
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ 163

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK---------ATKLN 482
              ++L  L++LH+ + VH ++   NI VD      V LA +G A          A    
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223

Query: 483 DVKSCRGTAFWM 494
                 G   ++
Sbjct: 224 SRSPHEGDLEFI 235

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 45/188 (23%), Positives = 81/188 (43%), Gaps = 28/188 (14%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
            R+   ++ G  +G GSFG +Y G +       A+K  +        K    QL  E  +
Sbjct: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-------VKTKHPQLLYESKI 55

Query: 384 LSRFE-HENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--VSAYTRQI 438
               +    I  V+++G + D +   + ++L+   SL +L+     + S   V     Q+
Sbjct: 56  YRILQGGTGIPNVRWFGVEGDYN--VLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQM 112

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLN---------DVKS 486
           +  ++++H +  +HRDIK  N L+        V + DFGLAK  +           + K+
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172

Query: 487 CRGTAFWM 494
             GTA + 
Sbjct: 173 LTGTARYA 180

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 32/190 (16%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIAL 383
            +   ++ G  +G G+FG +  G +     + A+K E          K    QL  E   
Sbjct: 6   MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE--------PMKSRAPQLHLEYRF 57

Query: 384 LSRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--VSAYTRQI 438
             +    + I  V Y+G     +   + LEL+   SL +L+       S   V     Q+
Sbjct: 58  YKQLGSGDGIPQVYYFGPCGKYN--AMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQL 114

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK-----ATKL----NDV 484
           +  ++Y+H +++++RD+K  N L+   G+     + + DF LAK      TK      + 
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174

Query: 485 KSCRGTAFWM 494
           KS  GTA +M
Sbjct: 175 KSLTGTARYM 184

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 36/161 (22%), Positives = 62/161 (38%), Gaps = 33/161 (20%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEV----SLLDQGSQAKQSISQLEQEIALLSRF-- 387
            ++G+GSFG V +          A+K V        Q            +EI +L     
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----------AEEIRILEHLRK 152

Query: 388 ----EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-----RYH-LRDSQVSAYTRQ 437
                  N++         + + +  EL++    +NLY+     ++       V  +   
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLS----MNLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLA 476
           IL  L  LH   ++H D+K  NIL+   G   +K+ DFG +
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 25/79 (31%), Positives = 40/79 (50%), Gaps = 4/79 (5%)

Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
           +  L    +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246

Query: 483 DVKSCRGTAF----WMAPE 497
                +G A     WMAPE
Sbjct: 247 PDYVRKGDARLPLKWMAPE 265

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 32/160 (20%), Positives = 53/160 (33%), Gaps = 11/160 (6%)

Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           G  LGRG+FG V E    GI        V    L +  +        L  E+ +L     
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGH 84

Query: 389 HENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
           H N+V   G   K    L + +E    G+L    +              +   G  Y+  
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 487
              +  D+K     + ++ S   + F   K+    + +  
Sbjct: 145 ---IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 42/213 (19%), Positives = 79/213 (37%), Gaps = 59/213 (27%)

Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLD 365
           + R+  ++        LG G F +V+      +    A+K              E+ LL 
Sbjct: 18  DARYI-LV------RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70

Query: 366 QGSQAKQSISQLEQE---IALLSRFEHEN-------IVQYYGTDKDESKLYIFLELVTKG 415
           + + A  +          + LL  F H+        +V     +     L   ++     
Sbjct: 71  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMV----FEVLGENLLALIKK---- 122

Query: 416 SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVD------ANGSV 468
                ++   L    V   ++Q+LLGL Y+H +  ++H DIK  N+L++          +
Sbjct: 123 ---YEHRGIPL--IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177

Query: 469 KLADFGLA---KATKLNDVKSCRGTAFWMAPEV 498
           K+AD G A        N +++      + +PEV
Sbjct: 178 KIADLGNACWYDEHYTNSIQTR----EYRSPEV 206

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 39/183 (21%), Positives = 61/183 (33%), Gaps = 63/183 (34%)

Query: 335 DLLGRGSFGSVYEGI--SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLE 378
           D LG G+FG V E I     G   AVK              E+ +L       + ++  +
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVL-------EHLNTTD 72

Query: 379 QE-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
                  + +L  FEH     IV     +      Y F++        N +  + L    
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIV----FELLGLSTYDFIKE-------NGFLPFRL--DH 119

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------------------SVKLA 471
           +     QI   + +LH   + H D+K  NIL   +                     +K+ 
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 472 DFG 474
           DFG
Sbjct: 180 DFG 182

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 35/183 (19%), Positives = 61/183 (33%), Gaps = 59/183 (32%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLEQ 379
             +G G+FG V      D+  ++AVK              E  +L +      + + +  
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNI-- 98

Query: 380 EIALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR 436
            +    +F + +   ++     +     LY  +         N Y  +H+    +  Y  
Sbjct: 99  -VKYHGKFMYYDHMCLI----FEPLGPSLYEIITR-------NNYNGFHI--EDIKLYCI 144

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANG-------------------------SVKLA 471
           +IL  L YL    + H D+K  NIL+D                             +KL 
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 472 DFG 474
           DFG
Sbjct: 205 DFG 207

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 37/183 (20%), Positives = 64/183 (34%), Gaps = 63/183 (34%)

Query: 335 DLLGRGSFGSVYEGI--SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLE 378
             LG G+FG V E +  +      A+K              E+++L       + I + +
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVL-------KKIKEKD 77

Query: 379 QE-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
           +E     + +   F       I      +      + FL+        N +Q Y L    
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIA----FELLGKNTFEFLKE-------NNFQPYPL--PH 124

Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------------------SVKLA 471
           V     Q+   L++LH+  + H D+K  NIL   +                    S+++A
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 472 DFG 474
           DFG
Sbjct: 185 DFG 187

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 41/195 (21%), Positives = 74/195 (37%), Gaps = 56/195 (28%)

Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLEQ 379
            L+G+GSFG V +     +  + A+K              EV LL+        +++ + 
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLEL-------MNKHDT 112

Query: 380 E-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
           E     + L   F   N   +V     +     LY  L           ++   L  +  
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLV----FEMLSYNLYDLLRN-------TNFRGVSL--NLT 159

Query: 432 SAYTRQILLGLKYLHDQD--VVHRDIKCANILV--DANGSVKLADFGLAKATKLNDVKSC 487
             + +Q+   L +L   +  ++H D+K  NIL+      ++K+ DFG   + +L      
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQ 217

Query: 488 ----RGTAFWMAPEV 498
               R   F+ +PEV
Sbjct: 218 YIQSR---FYRSPEV 229

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.7 bits (115), Expect = 4e-06
 Identities = 54/462 (11%), Positives = 126/462 (27%), Gaps = 118/462 (25%)

Query: 95  EDF---AIPAAAWEARKNRSASDLL-PRSRLKQLDTLKETVER-QSDAAGAVVGELCDRV 149
           ++F    +               ++  +  +     L  T+   Q +     V E+    
Sbjct: 31  DNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN 90

Query: 150 SDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSN 209
              +    +TE  +  +     +  R     +N   A    + L P              
Sbjct: 91  YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP-------------- 136

Query: 210 YVKGIKGVRPPL--LKPPP-----GM----RQPVIDNACSTWDILRDFAPKDGI------ 252
                  +R  L  L+P       G+    +  V  + C ++ +         I      
Sbjct: 137 ----YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD--FKIFWLNLK 190

Query: 253 ---TPSSVMN---------DRALSSSSDDEDNEK----EGEEADRAIVKEEE-------- 288
              +P +V+          D   +S SD   N K      +   R ++K +         
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL 250

Query: 289 DDMVLSESC--SFTTEHEDDSSST--TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGS 344
            + V +     +F     + S     TT          RFK++       D L   +   
Sbjct: 251 LN-VQNAKAWNAF-----NLSCKILLTT----------RFKQVT------DFLSAATTTH 288

Query: 345 VYEGISDDGF-------FFA-VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV--- 393
           +                      +    D   +     +     +++++    + +    
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT-TNPRR--LSIIAESIRDGLATWD 345

Query: 394 --QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL--RDSQVSAYTRQIL-LGLKYLHDQ 448
             ++   DK  + +   L ++       ++ R  +    + +      ++   +      
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM 405

Query: 449 DVVHRDIKCANI-LVD---ANGSVKLADFGLAKATKLNDVKS 486
            VV+   K     LV+      ++ +    L    KL +  +
Sbjct: 406 VVVN---KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA 444

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 24/92 (26%), Positives = 36/92 (39%), Gaps = 4/92 (4%)

Query: 416 SLLNLYQRYHLR---DSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLA 471
            LL    + + +      V    +Q+L GL YLH +  ++H DIK  NIL+  N      
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189

Query: 472 DFGLAKATKLNDVKSCRGTAFWMAPEVCSNPF 503
               A   + +      G+A   AP    N  
Sbjct: 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	504
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.98
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.98
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.98
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.98
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.98
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.98
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.97
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.97
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.97
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.97
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.97
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.97
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.97
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.97
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.97
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.97
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.97
3niz_A	311	Rhodanese family protein; structural genomics, str	99.97
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.97
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.97
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.97
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.97
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.97
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.97
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.97
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.97
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.97
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.97
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.97
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.97
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.97
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.97
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.97
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.96
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.96
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.96
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.96
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.96
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.96
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.96
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.96
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.96
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.96
3bhy_A	283	Death-associated protein kinase 3; death associate	99.96
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.96
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.96
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.96
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.96
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.96
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.96
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.96
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.96
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.96
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.96
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.96
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.96
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.96
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.96
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.96
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.96
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.96
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.96
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.96
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.96
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.96
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.96
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.96
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.96
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.96
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.96
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.96
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.96
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.96
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.96
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.96
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.96
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.96
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.96
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.96
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.96
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.96
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.96
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.96
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.96
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.96
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.96
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.96
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.96
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.96
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.96
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.96
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.96
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.96
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.96
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.96
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.96
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.96
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.96
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.96
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.96
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.96
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.96
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.96
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.96
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.96
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.96
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.96
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.96
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.96
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.96
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.95
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.95
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.95
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.95
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.95
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.95
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.95
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.95
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.95
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.95
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.95
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.95
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.95
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.95
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.95
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.95
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.95
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.95
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.95
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.95
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.94
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.94
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.94
3uqc_A	286	Probable conserved transmembrane protein; structur	99.93
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.93
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.37
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.75
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.63
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.54
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.35
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.22
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.2
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.15
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.12
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.77
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.64
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.58
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.56
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.5
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.3
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.25
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.87
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.83
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.78
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.75
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.58
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.37
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.26
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.5
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	80.73

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.7e-40  Score=337.01  Aligned_cols=174  Identities=28%  Similarity=0.453  Sum_probs=153.7

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..++|++++.||+|+||+||+|++ .+|+.||||++......  .......+.+|+.+|+.++|||||+++++|.+++.+
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII--KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            346899999999999999999998 68999999998643211  122346788999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--
Q 010676          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--  482 (504)
                      |||||||+||+|.+++.+ ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....  
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            999999999999998876 46999999999999999999999999999999999999999999999999999875432  


Q ss_pred             --CcccccCCCcccccccccCC
Q 010676          483 --DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 --~~~s~~GT~~YmAPEVL~g~  502 (504)
                        .....+||+.|||||++.++
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~  209 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEK  209 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHS
T ss_pred             cccccCcccCcccCCHHHHcCC
Confidence              24567899999999999765

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.9e-40  Score=339.07  Aligned_cols=169  Identities=33%  Similarity=0.541  Sum_probs=153.3

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ..|++++.||+|+||+||+|++ .+|+.||||++.......     .+.+.+|+.+|+.++|||||+++++|.+++.+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4699999999999999999998 589999999997544322     2457799999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Ccc
Q 010676          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  485 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~  485 (504)
                      |||||+||+|.+++.+..+++.++..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....  ...
T Consensus       149 vmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             EECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             EEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999876433  345


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ..+||+.|||||++.++
T Consensus       229 ~~~GTp~YmAPEvl~~~  245 (346)
T 4fih_A          229 SLVGTPYWMAPELISRL  245 (346)
T ss_dssp             CCCSCGGGCCHHHHTTC
T ss_pred             ccccCcCcCCHHHHCCC
Confidence            67899999999999865

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5e-40  Score=340.09  Aligned_cols=174  Identities=30%  Similarity=0.586  Sum_probs=148.0

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      -+++|++++.||+|+||+||+|++ .+|+.||||++......   ......+.+|+.+|++++|||||+++++|.+++.+
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   98 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS---SKEREESRREVAVLANMKHPNIVQYRESFEENGSL   98 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC---HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence            357899999999999999999998 68999999998754332   23356789999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          406 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      |||||||+||+|.+++...   .+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            9999999999999998643   3688999999999999999999999999999999999999999999999999876533


Q ss_pred             C--cccccCCCcccccccccCCC
Q 010676          483 D--VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       483 ~--~~s~~GT~~YmAPEVL~g~~  503 (504)
                      .  ....+||+.|||||++.++.
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~  201 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKP  201 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCC
T ss_pred             cccccccCCCccccCHHHHCCCC
Confidence            2  34567999999999998763

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=342.36  Aligned_cols=169  Identities=33%  Similarity=0.541  Sum_probs=153.6

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      +.|++++.||+|+||.||+|++ .+|+.||||++.......     .+.+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            5799999999999999999998 689999999997644322     2457799999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Ccc
Q 010676          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  485 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~  485 (504)
                      |||||+||+|.+++....+++.++..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...  ...
T Consensus       226 VmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             EEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             EEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999875433  345


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ..+||+.|||||++.++
T Consensus       306 ~~~GTp~YmAPEvl~~~  322 (423)
T 4fie_A          306 SLVGTPYWMAPELISRL  322 (423)
T ss_dssp             CCEECTTTCCHHHHTTC
T ss_pred             ccccCcCcCCHHHHCCC
Confidence            67899999999999865

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.1e-39  Score=323.81  Aligned_cols=171  Identities=32%  Similarity=0.577  Sum_probs=149.7

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC----CCe
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESK  404 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~----~~~  404 (504)
                      +|++.+.||+|+||+||+|.+ .++..||+|.+......   ....+.+.+|+.+|++++|||||+++++|.+    ...
T Consensus        27 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             eEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            357788899999999999998 67899999998754322   2335678999999999999999999998864    456


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEc-CCCcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILLd-~~g~VKL~DFGLA~~~~  480 (504)
                      +|||||||+||+|.+++.+. .+++..+..|+.||+.||.|||++|  ||||||||+||||+ .+|.+||+|||+|+...
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999999998764 5999999999999999999999998  99999999999997 48999999999998766


Q ss_pred             cCCcccccCCCcccccccccCCC
Q 010676          481 LNDVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       481 ~~~~~s~~GT~~YmAPEVL~g~~  503 (504)
                      .......+||+.|||||++.++|
T Consensus       184 ~~~~~~~~GTp~YmAPE~~~~~y  206 (290)
T 3fpq_A          184 ASFAKAVIGTPEFMAPEMYEEKY  206 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGTCC
T ss_pred             CCccCCcccCccccCHHHcCCCC
Confidence            66666788999999999998764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.4e-39  Score=321.01  Aligned_cols=172  Identities=28%  Similarity=0.447  Sum_probs=136.4

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++++.||+|+||+||+|.+ .+|+.||||++.......  ......+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   89 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK--SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII   89 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            57899999999999999999998 689999999986533221  223456889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-Cc
Q 010676          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DV  484 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-~~  484 (504)
                      |||||+ +|+|.+++.+ ..+++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..... ..
T Consensus        90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence            999999 5688887754 56999999999999999999999999999999999999999999999999999875443 34


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ...+||+.|||||++.+.
T Consensus       169 ~~~~GT~~Y~APE~~~~~  186 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGK  186 (275)
T ss_dssp             ------CTTSCHHHHSSS
T ss_pred             CCeeECcccCChhhhcCC
Confidence            567899999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-38  Score=322.36  Aligned_cols=173  Identities=29%  Similarity=0.479  Sum_probs=140.0

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-  403 (504)
                      +++++|++++.||+|+||+||+|++ .+|+.||||++.....    ....+.+.+|+.+|++++|||||+++++|.+.+ 
T Consensus         2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~----~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   77 (299)
T 4g31_A            2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT   77 (299)
T ss_dssp             HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred             CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence            3467899999999999999999998 6899999999875432    233467889999999999999999999986543 


Q ss_pred             -----------eEEEEEEeccCCCHHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcE
Q 010676          404 -----------KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV  468 (504)
Q Consensus       404 -----------~lyLVmEy~~ggsL~~ll~~~~----l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~V  468 (504)
                                 .+|||||||.+|+|.+++....    ..+..++.|+.||+.||+|||++|||||||||+||||+.+|.+
T Consensus        78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence                       4799999999999999997653    3445688999999999999999999999999999999999999


Q ss_pred             EEEecCcccccccCC--------------cccccCCCcccccccccCC
Q 010676          469 KLADFGLAKATKLND--------------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       469 KL~DFGLA~~~~~~~--------------~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||+|||+|+......              ....+||+.|||||++.++
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~  205 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN  205 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTC
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC
Confidence            999999998654322              1235799999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-38  Score=327.80  Aligned_cols=169  Identities=32%  Similarity=0.474  Sum_probs=147.3

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .....+|++.+.||+|+||+||+|++ .+|+.||||++.....          ..+|+.+|+.++|||||+++++|.+++
T Consensus        54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~  123 (336)
T 4g3f_A           54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGP  123 (336)
T ss_dssp             CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred             hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            34456899999999999999999998 6899999999874321          236999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-~VKL~DFGLA~~~~~  481 (504)
                      .+|||||||+||+|.+++++. .+++.++..|+.||+.||.|||++|||||||||+||||+.+| .+||+|||+|+....
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            999999999999999999764 599999999999999999999999999999999999999988 699999999987643


Q ss_pred             CC-------cccccCCCcccccccccCCC
Q 010676          482 ND-------VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       482 ~~-------~~s~~GT~~YmAPEVL~g~~  503 (504)
                      ..       ....+||+.|||||++.++-
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~  232 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKP  232 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCC
T ss_pred             CCcccceecCCccccCccccCHHHHCCCC
Confidence            32       12357999999999998763

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.6e-39  Score=326.27  Aligned_cols=173  Identities=29%  Similarity=0.432  Sum_probs=144.4

Q ss_pred             ccceeeeeeecccCceeEEEEEc----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .++|++++.||+|+||+||+|++    .+++.||||++.........   ..++.+|+.+|++++|||||+++++|.+++
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE---CC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH---HHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            35799999999999999999986    35789999998653322211   135778999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc-
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~-  481 (504)
                      .+|||||||+||+|.+++.+. .+++.++..|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.... 
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999999988764 599999999999999999999999999999999999999999999999999986433 


Q ss_pred             -CCcccccCCCcccccccccCCC
Q 010676          482 -NDVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       482 -~~~~s~~GT~~YmAPEVL~g~~  503 (504)
                       ......+||+.|||||++.++.
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~  202 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRG  202 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSC
T ss_pred             CccccccccCcccCCHHHhccCC
Confidence             2345678999999999998653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.9e-38  Score=316.57  Aligned_cols=169  Identities=30%  Similarity=0.445  Sum_probs=145.7

Q ss_pred             cceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      ++|.+.+.||+|+||+||+|.+.      ++..||||.+...     .....+.|.+|+.+|++++|||||+++++|.+.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            57999999999999999999853      5789999988632     223456799999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc--------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcE
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY--------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV  468 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~--------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~V  468 (504)
                      +.+|||||||++|+|.+++...              .+++.++..|+.||+.||.|||+++||||||||+||||+.++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence            9999999999999999999753              48999999999999999999999999999999999999999999


Q ss_pred             EEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          469 KLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       469 KL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||+|||+|+......    ....+||+.|||||++.++
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~  205 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR  205 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCC
Confidence            999999998654332    2234699999999998754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=316.65  Aligned_cols=171  Identities=26%  Similarity=0.386  Sum_probs=142.6

Q ss_pred             ccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      .++|.+.+.||+|+||+||+|.+.      ++..||||++...     .....+.|.+|+.+|++++|||||+++++|.+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~  114 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTMLQHQHIVRFFGVCTE  114 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            357899999999999999999853      5789999988632     23345679999999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhc----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRY----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  465 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~  465 (504)
                      .+.+|||||||++|+|.+++...                .+++.++..|+.||+.||.|||+++||||||||+||||+.+
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence            99999999999999999998653                38899999999999999999999999999999999999999


Q ss_pred             CcEEEEecCcccccccCC----cccccCCCcccccccccCCC
Q 010676          466 GSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       466 g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~~  503 (504)
                      +.+||+|||+++......    ....+||+.|||||++.++.
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~  236 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK  236 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCC
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCC
Confidence            999999999998654332    23457999999999998753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=314.10  Aligned_cols=170  Identities=30%  Similarity=0.468  Sum_probs=143.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      .-.++|++++.||+|+||+||+|+...  .||||+++.....   ....+.|.+|+.+|++++|||||++++++.. +.+
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~---~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~  106 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPT---PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL  106 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence            344678899999999999999998753  5899987654322   3445789999999999999999999998754 578


Q ss_pred             EEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-
Q 010676          406 YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-  482 (504)
                      |||||||++|+|.+++..  ..+++.++..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|+..... 
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            999999999999999865  35999999999999999999999999999999999999999999999999999865422 


Q ss_pred             ---CcccccCCCcccccccccC
Q 010676          483 ---DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ---~~~s~~GT~~YmAPEVL~g  501 (504)
                         .....+||+.|||||++.+
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~  208 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRM  208 (307)
T ss_dssp             -------CCCCTTSCCHHHHHC
T ss_pred             cceeecccccCCCccCHHHhhc
Confidence               2345679999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.8e-37  Score=310.50  Aligned_cols=171  Identities=25%  Similarity=0.381  Sum_probs=146.2

Q ss_pred             ccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      ...+++++.||+|+||+||+|..      .++..||||.+.....    ....+.|.+|+.++++++|||||+++++|.+
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~----~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE----GPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC----hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            35788999999999999999985      3578999998753322    1223578999999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh-----------------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA  464 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~-----------------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~  464 (504)
                      .+.+|||||||++|+|.+++..                 ..+++..+..|+.||+.||.|||+++||||||||+||||+.
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            9999999999999999999854                 24888999999999999999999999999999999999999


Q ss_pred             CCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          465 NGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       465 ~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ++.+||+|||+++......    ....+||+.|||||++.++
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~  222 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG  222 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC
Confidence            9999999999998654322    3445799999999998754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.2e-36  Score=307.48  Aligned_cols=168  Identities=30%  Similarity=0.427  Sum_probs=141.4

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----  403 (504)
                      .++|.+.+.||+|+||+||+|++ +|..||||++....      ......+.|+.++..++|||||++++++..++    
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence            35789999999999999999987 58899999885321      11123456777778899999999999987654    


Q ss_pred             eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEEcCCCcEEEEecCc
Q 010676          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLADFGL  475 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~--------gIIHRDLKP~NILLd~~g~VKL~DFGL  475 (504)
                      .+|||||||++|+|.++++...+++..+..|+.|++.||.|||++        +||||||||+||||+.++.+||+|||+
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            589999999999999999999999999999999999999999987        999999999999999999999999999


Q ss_pred             ccccccCC------cccccCCCcccccccccCC
Q 010676          476 AKATKLND------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       476 A~~~~~~~------~~s~~GT~~YmAPEVL~g~  502 (504)
                      |+......      ....+||+.|||||++.+.
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~  187 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS  187 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred             CccccCCCCceeeecccccccccccCHHHhccc
Confidence            98654332      1235799999999999764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-36  Score=336.31  Aligned_cols=176  Identities=29%  Similarity=0.396  Sum_probs=152.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccch-hhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      ..+++|+++++||+|+||.||+|++ .+|..||||++....... ...........++.+++.++|||||+++++|.+.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            3467899999999999999999998 689999999986432211 11222233344567778889999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .+|||||||.||+|..++.+. .+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            999999999999999988764 5999999999999999999999999999999999999999999999999999987766


Q ss_pred             CcccccCCCcccccccccC
Q 010676          483 DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g  501 (504)
                      ...+.+||+.|||||++.+
T Consensus       346 ~~~t~~GTp~YmAPEvl~~  364 (689)
T 3v5w_A          346 KPHASVGTHGYMAPEVLQK  364 (689)
T ss_dssp             CCCSCCSCGGGCCHHHHST
T ss_pred             CCCCccCCcCccCHHHHhC
Confidence            6777899999999999964

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-36  Score=316.16  Aligned_cols=170  Identities=26%  Similarity=0.416  Sum_probs=145.6

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-----  401 (504)
                      .++|++++.||+|+||+||+|++ .+|+.||||++......   ....+.+.+|+.+|+.++|||||++++++..     
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV---VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS---HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc---hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence            45799999999999999999998 68999999998643322   2334678899999999999999999998653     


Q ss_pred             -CCeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          402 -ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       402 -~~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                       .+.+|||||||+ |+|.+++.. ..+++..++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus       130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence             467999999997 568887765 46999999999999999999999999999999999999999999999999999865


Q ss_pred             cc------CCcccccCCCcccccccccC
Q 010676          480 KL------NDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       480 ~~------~~~~s~~GT~~YmAPEVL~g  501 (504)
                      ..      ......+||+.|||||++.+
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~  236 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLS  236 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTT
T ss_pred             ccCccccccccccceeChHhcCHHHhcC
Confidence            32      22446789999999999876

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-35  Score=306.83  Aligned_cols=169  Identities=25%  Similarity=0.362  Sum_probs=144.5

Q ss_pred             cccccceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeee
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD  399 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~  399 (504)
                      +.+.+.|++++.||+|+||+||+|++.    +++.||+|.+.....       ..++.+|+.+|+.+ +|||||+++++|
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~E~~~l~~~~~h~nIv~l~~~~   89 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-------PIRIAAELQCLTVAGGQDNVMGVKYCF   89 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-------HHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-------HHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence            456678999999999999999999863    578999998754221       23577899999988 599999999999


Q ss_pred             cCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEecCcccc
Q 010676          400 KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKA  478 (504)
Q Consensus       400 ~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~-g~VKL~DFGLA~~  478 (504)
                      .+.+.+||||||+++|+|.++++  .+++.+++.|++||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+.
T Consensus        90 ~~~~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           90 RKNDHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EETTEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EECCEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            99999999999999999999984  58999999999999999999999999999999999999876 8999999999975


Q ss_pred             cccC------------------------------CcccccCCCcccccccccCC
Q 010676          479 TKLN------------------------------DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~------------------------------~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....                              .....+||++|||||++.+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~  221 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC  221 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence            4321                              12345799999999998763

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.2e-35  Score=320.72  Aligned_cols=172  Identities=27%  Similarity=0.438  Sum_probs=152.6

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .++++|++++.||+|+||+||+|++ .+|+.||+|++....     ......+.+|+.+|+.++|||||+++++|.+.+.
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            4567899999999999999999998 689999999886432     2223568899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--CcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~--g~VKL~DFGLA~~~~  480 (504)
                      +|||||||.||+|.+++..  ..+++.++..|++||+.||.|||++||+||||||+||||+.+  +.+||+|||+|+.+.
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            9999999999999998853  469999999999999999999999999999999999999854  899999999998765


Q ss_pred             cCC-cccccCCCcccccccccCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... ....+||+.|||||++.++
T Consensus       309 ~~~~~~~~~GT~~y~APEv~~~~  331 (573)
T 3uto_A          309 PKQSVKVTTGTAEFAAPEVAEGK  331 (573)
T ss_dssp             TTSEEEEECSSGGGCCHHHHTTC
T ss_pred             CCCceeeeEECccccCHHHhCCC
Confidence            443 4566899999999999876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.9e-35  Score=303.54  Aligned_cols=173  Identities=27%  Similarity=0.385  Sum_probs=145.4

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-CceeEEeee
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGT  398 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~  398 (504)
                      .-.++|++++.||+|+||+||+|.+.      .++.||||.+.....    ....+.+.+|+.+|.++.| ||||+++++
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~----~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----HSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC----HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC----hHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            33568999999999999999999863      346799998753221    2334678999999999975 899999999


Q ss_pred             ecC-CCeEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 010676          399 DKD-ESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  460 (504)
Q Consensus       399 ~~~-~~~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NI  460 (504)
                      |.. .+.+|||||||++|+|.++++..                 .+++.++..|+.||+.||.|||+++||||||||+||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI  216 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  216 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence            865 46799999999999999999642                 278899999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          461 LVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       461 LLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||+.++.+||+|||+|+......    ....+||+.|||||++.++
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~  262 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR  262 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC
Confidence            99999999999999998654332    2345699999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.3e-32  Score=276.54  Aligned_cols=174  Identities=25%  Similarity=0.452  Sum_probs=154.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ..+++|++++.||+|+||.||+|.+ .+|..||||++......   ......+.+|+.+|+.++||||+++++++.+.+.
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN---PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence            4567899999999999999999998 68999999998754322   3345678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-  482 (504)
                      +|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            9999999999999998754 56999999999999999999999999999999999999999999999999999865433 


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....+||+.|+|||++.+.
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~  188 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGK  188 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTC
T ss_pred             ccccccCCcceeCcccccCC
Confidence            34566799999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.98  E-value=3.9e-32  Score=270.50  Aligned_cols=171  Identities=30%  Similarity=0.543  Sum_probs=152.5

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..++|++.+.||+|+||.||+|.+ .++..||+|.+.......     ...+.+|+.+++.++||||+++++++...+.+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-----HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            456899999999999999999997 689999999987543322     24578999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |+||||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            999999999999999999899999999999999999999999999999999999999999999999999987654332  


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....||+.|+|||++.++
T Consensus       173 ~~~~~gt~~y~aPE~~~~~  191 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRK  191 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCS
T ss_pred             cCCccCCcCccChhhhcCC
Confidence            3445799999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.98  E-value=3.9e-32  Score=277.49  Aligned_cols=173  Identities=28%  Similarity=0.435  Sum_probs=150.9

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++++.||+|+||.||+|.+ .+|+.||+|++.....  ........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            57899999999999999999998 5799999999864221  11223456789999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--CC
Q 010676          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--ND  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~~  483 (504)
                      +||||+++|+|..++... .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....  ..
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            999999999999988654 589999999999999999999999999999999999999999999999999986332  23


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....+||+.|||||++.++
T Consensus       162 ~~~~~gt~~y~aPE~~~~~  180 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDN  180 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSS
T ss_pred             ccccccChhhCChhhhcCC
Confidence            4566799999999999764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.98  E-value=1e-31  Score=267.15  Aligned_cols=170  Identities=26%  Similarity=0.510  Sum_probs=149.2

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .++|+++++||+|+||.||+|.+ .++..||+|.+...     .......+.+|+.+++.++||||+++++++.+...+|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            46899999999999999999998 57899999987432     2344567889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      +||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999986  4589999999999999999999999999999999999999999999999999976533221


Q ss_pred             ----------------ccccCCCcccccccccCC
Q 010676          485 ----------------KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ----------------~s~~GT~~YmAPEVL~g~  502 (504)
                                      ...+||+.|+|||++.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  197 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR  197 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTC
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCC
Confidence                            145699999999998765

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.98  E-value=1.8e-32  Score=288.01  Aligned_cols=175  Identities=26%  Similarity=0.422  Sum_probs=152.4

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...++|++++.||+|+||.||+|.+ .++..||+|++......  .......+.+|+.++..++|||||+++++|.+...
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh--hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            4467899999999999999999998 57899999998642111  11112346789999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      +||||||++||+|.+++....+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...... 
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            9999999999999999998899999999999999999999999999999999999999999999999999998655433 


Q ss_pred             --cccccCCCcccccccccCC
Q 010676          484 --VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 --~~s~~GT~~YmAPEVL~g~  502 (504)
                        ....+||+.|||||++.+.
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~  244 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQ  244 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTT
T ss_pred             ccccCCcCCccccCHHHhhcc
Confidence              2356799999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.98  E-value=3.8e-32  Score=279.28  Aligned_cols=174  Identities=28%  Similarity=0.442  Sum_probs=145.4

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~  403 (504)
                      ..+++|++++.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.+|..+ +||||+++++++.+.+
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh--cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            3467899999999999999999998 5789999999864221  1222345677899999988 6999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .+|+||||+.+|+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            99999999999999998865 46999999999999999999999999999999999999999999999999999853322


Q ss_pred             --CcccccCCCcccccccccC
Q 010676          483 --DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 --~~~s~~GT~~YmAPEVL~g  501 (504)
                        .....+||+.|||||++.+
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~  198 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQE  198 (353)
T ss_dssp             --------CCGGGCCHHHHHH
T ss_pred             CccccccCCCcCeEChhhcCC
Confidence              2445679999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.98  E-value=1.3e-31  Score=274.08  Aligned_cols=173  Identities=27%  Similarity=0.439  Sum_probs=151.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL  405 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~l  405 (504)
                      .++|++++.||+|+||.||+|.+ .++..||+|++......  .......+.+|+.++.++ +||||+++++++.+.+.+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC--SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc--chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            56899999999999999999998 57899999998754322  233456788999999887 899999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc--cC
Q 010676          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LN  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~--~~  482 (504)
                      |+||||+.+|+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...  ..
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            999999999999998865 469999999999999999999999999999999999999999999999999998532  22


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....+||+.|+|||++.+.
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~  185 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGE  185 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTC
T ss_pred             cccccCCCccccCccccCCC
Confidence            34556899999999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.97  E-value=7.3e-32  Score=267.99  Aligned_cols=173  Identities=28%  Similarity=0.488  Sum_probs=145.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-  403 (504)
                      ++.++|++++.||+|+||.||+|.+. ++..||||++.....    ......+.+|+.+|+.++||||++++++|.+.. 
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----ELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST----TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            46789999999999999999999984 899999999875332    223466889999999999999999999875433 


Q ss_pred             --------------------------------------------------------eEEEEEEeccCCCHHHHHHhcC--
Q 010676          404 --------------------------------------------------------KLYIFLELVTKGSLLNLYQRYH--  425 (504)
Q Consensus       404 --------------------------------------------------------~lyLVmEy~~ggsL~~ll~~~~--  425 (504)
                                                                              .+|+||||+.+++|.+++....  
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    3899999999999999998643  


Q ss_pred             --CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--------------cccccC
Q 010676          426 --LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--------------VKSCRG  489 (504)
Q Consensus       426 --l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--------------~~s~~G  489 (504)
                        ..+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......              ....+|
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence              4555688999999999999999999999999999999999999999999998654432              233469


Q ss_pred             CCcccccccccCC
Q 010676          490 TAFWMAPEVCSNP  502 (504)
Q Consensus       490 T~~YmAPEVL~g~  502 (504)
                      |+.|+|||++.+.
T Consensus       239 t~~y~aPE~~~~~  251 (332)
T 3qd2_B          239 TKLYMSPEQIHGN  251 (332)
T ss_dssp             CGGGSCHHHHHCC
T ss_pred             CcCccChHHhcCC
Confidence            9999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.97  E-value=1.1e-31  Score=266.57  Aligned_cols=175  Identities=29%  Similarity=0.443  Sum_probs=149.0

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|.+......  .......+.+|+.++..++||||+++++++...+.
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE--KEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc--cHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence            3457899999999999999999997 57899999988654332  23445778999999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +|+||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999999988764 58999999999999999999999999999999999999999999999999997654332


Q ss_pred             ---cccccCCCcccccccccCC
Q 010676          484 ---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ---~~s~~GT~~YmAPEVL~g~  502 (504)
                         .....||+.|+|||++.+.
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~  187 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGE  187 (294)
T ss_dssp             ---------CCSSCCHHHHHTC
T ss_pred             ccccCccccCccccCHhHhcCC
Confidence               2345699999999998765

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.97  E-value=6.7e-32  Score=282.71  Aligned_cols=174  Identities=26%  Similarity=0.427  Sum_probs=149.8

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCe
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~  404 (504)
                      ..++|+++++||+|+||.||+|++ .++..||+|++......  .......+.+|..+|.++ +|||||+++++|.+.+.
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~--~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc--CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            356899999999999999999998 57899999998753322  223345577899998876 89999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc--c
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--L  481 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~--~  481 (504)
                      +||||||+.+|+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...  .
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            9999999999999998865 469999999999999999999999999999999999999999999999999998532  2


Q ss_pred             CCcccccCCCcccccccccCC
Q 010676          482 NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ......+||+.|||||++.+.
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~  228 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGE  228 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTC
T ss_pred             CccccccCCcccCCchhhcCC
Confidence            334567899999999999865

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.97  E-value=1.1e-31  Score=271.71  Aligned_cols=172  Identities=30%  Similarity=0.494  Sum_probs=150.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++++.||+|+||.||+|.+ .+|..||+|++......  .......+.+|+.+++.++||||+++++++.+...+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV--RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            57899999999999999999998 58999999998642211  1122456778999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc
Q 010676          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~  485 (504)
                      +||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..... ..
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-~~  161 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TY  161 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-BC
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-cc
Confidence            99999999999999876 45899999999999999999999999999999999999999999999999999865433 34


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ..+||+.|||||++.++
T Consensus       162 ~~~gt~~y~aPE~~~~~  178 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTK  178 (318)
T ss_dssp             CCCSCTTTCCHHHHTTC
T ss_pred             cccCCccccCHhHhcCC
Confidence            56799999999998764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.97  E-value=6.1e-32  Score=267.27  Aligned_cols=176  Identities=34%  Similarity=0.578  Sum_probs=146.7

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchh---------------------hHHHHHHHHHHHHHH
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ---------------------AKQSISQLEQEIALL  384 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~---------------------~~~~~~~~~~Ei~iL  384 (504)
                      ..++|++.+.||+|+||.||+|.+ .++..||||++........                     .......+.+|+.+|
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            357899999999999999999998 6789999999865332111                     112235688999999


Q ss_pred             hhCCCCceeEEeeeecC--CCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 010676          385 SRFEHENIVQYYGTDKD--ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV  462 (504)
Q Consensus       385 ~~L~HpnIV~l~~~~~~--~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL  462 (504)
                      +.++||||+++++++.+  ...+|+||||+++++|.+++....+++..+..++.||+.||.|||++||+||||||+||||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            99999999999999876  5789999999999999888777789999999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecCcccccccCC--cccccCCCcccccccccCC
Q 010676          463 DANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       463 d~~g~VKL~DFGLA~~~~~~~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      +.++.+||+|||+++......  .....||+.|+|||++.+.
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  212 (298)
T 2zv2_A          171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET  212 (298)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTT
T ss_pred             CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccC
Confidence            999999999999998654332  3445799999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.97  E-value=5.7e-32  Score=276.05  Aligned_cols=176  Identities=29%  Similarity=0.450  Sum_probs=148.8

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      +.+.|++++.||+|+||.||+|.+ .++..||||++...............+.+|+.+++.++||||+++++++.+.+.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            456899999999999999999998 5799999999864321111111235688999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc---EEEEecCccc
Q 010676          406 YIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAK  477 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~-----~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~---VKL~DFGLA~  477 (504)
                      |+||||+.+++|.+++...     .+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999999998876543     3899999999999999999999999999999999999987654   9999999998


Q ss_pred             ccccCC--cccccCCCcccccccccCC
Q 010676          478 ATKLND--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       478 ~~~~~~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      ......  ....+||+.|+|||++.+.
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~  208 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVKRE  208 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHTTC
T ss_pred             EecCCCeeecCCcCCcCccCHHHHcCC
Confidence            755433  3345799999999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.97  E-value=1.2e-31  Score=279.59  Aligned_cols=173  Identities=26%  Similarity=0.486  Sum_probs=152.1

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..++|++++.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.+|+.++|||||+++++|.+...+
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   90 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM   90 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc--ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            357899999999999999999998 5789999998864221  1122346688999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-C
Q 010676          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-D  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-~  483 (504)
                      |+||||+.+|+|..++... .+++..+..|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..... .
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            9999999999999998765 5999999999999999999999999999999999999999999999999999875433 3


Q ss_pred             cccccCCCcccccccccC
Q 010676          484 VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g  501 (504)
                      ....+||+.|||||++.+
T Consensus       171 ~~~~~gt~~Y~aPE~~~~  188 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSS  188 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCC
T ss_pred             eeccCCCccccCCeeecc
Confidence            456789999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.97  E-value=1.3e-31  Score=274.81  Aligned_cols=175  Identities=30%  Similarity=0.470  Sum_probs=149.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~  403 (504)
                      ...++|++++.||+|+||.||+|.+ .+++.||+|++......  .......+..|..++..+ +||||+++++++.+.+
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh--hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            4467899999999999999999998 57999999998642211  112234567888888876 8999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc-
Q 010676          404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~-  481 (504)
                      .+|+||||+++|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... 
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            99999999999999998876 5699999999999999999999999999999999999999999999999999986432 


Q ss_pred             -CCcccccCCCcccccccccCC
Q 010676          482 -NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 -~~~~s~~GT~~YmAPEVL~g~  502 (504)
                       ......+||+.|+|||++.++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~  193 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQ  193 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTC
T ss_pred             CCcccCCCCCcccCChhhhcCC
Confidence             234566899999999998764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.97  E-value=2.2e-31  Score=262.53  Aligned_cols=171  Identities=29%  Similarity=0.481  Sum_probs=146.4

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++++.||+|+||+||+|.+ .++..||+|++.......   .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE---GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST---THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC---CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence            36899999999999999999998 578999999987544322   22356779999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--
Q 010676          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--  482 (504)
                      +||||+.++ |..++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        78 lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           78 LVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EEEECCSEE-HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             EEEecCCCC-HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            999999874 5554433  46999999999999999999999999999999999999999999999999999865432  


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ......||+.|+|||++.+.
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~  176 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGA  176 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTC
T ss_pred             cccCCccccCCcChHHHcCC
Confidence            23445789999999998654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.97  E-value=1.9e-31  Score=276.47  Aligned_cols=176  Identities=28%  Similarity=0.423  Sum_probs=143.6

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHH-HhhCCCCceeEEeeeecCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIV~l~~~~~~~  402 (504)
                      ....++|++++.||+|+||.||+|++ .++..||+|++.......  ......+.+|..+ ++.++||||+++++++.+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~  111 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA  111 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECS
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence            34567899999999999999999998 578899999987543222  2223456677766 5678999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      +.+|+||||+.||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999999998876 4589999999999999999999999999999999999999999999999999986332


Q ss_pred             --CCcccccCCCcccccccccCC
Q 010676          482 --NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 --~~~~s~~GT~~YmAPEVL~g~  502 (504)
                        ......+||+.|||||++.++
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~  214 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQ  214 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTC
T ss_pred             CCCccccccCCccccCHHHhCCC
Confidence              234566899999999998765

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.97  E-value=2.6e-31  Score=266.17  Aligned_cols=174  Identities=32%  Similarity=0.512  Sum_probs=147.8

Q ss_pred             ccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      ...+.++|++++.||+|+||+||+|.+.++..||+|++.....   .......+.+|+.+++.++||||+++++++.+.+
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER   92 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc---cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence            4467789999999999999999999998899999998864322   1222356789999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+.+ +|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99999999986 777777654  389999999999999999999999999999999999999999999999999986543


Q ss_pred             C--CcccccCCCcccccccccC
Q 010676          482 N--DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       482 ~--~~~s~~GT~~YmAPEVL~g  501 (504)
                      .  ......||+.|+|||++.+
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~  193 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMG  193 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTT
T ss_pred             CcccccCCcccCCcCCHHHhcC
Confidence            2  2344578999999999865

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.97  E-value=2.2e-31  Score=274.66  Aligned_cols=177  Identities=27%  Similarity=0.489  Sum_probs=152.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchh-hHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .+.+.|++++.||+|+||.||+|.+ .+|..||+|++........ .......+.+|+.+|+.++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            4567899999999999999999998 5799999999875433211 1112356889999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----cEEEEecCcccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKA  478 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g----~VKL~DFGLA~~  478 (504)
                      .+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++.
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~  168 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence            999999999999999998654 589999999999999999999999999999999999998777    799999999987


Q ss_pred             cccC-CcccccCCCcccccccccCC
Q 010676          479 TKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .... .....+||+.|+|||++.++
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~  193 (361)
T 2yab_A          169 IEDGVEFKNIFGTPEFVAPEIVNYE  193 (361)
T ss_dssp             CCTTCCCCCCCSCGGGCCHHHHTTC
T ss_pred             cCCCCccccCCCCccEECchHHcCC
Confidence            5543 34556799999999998864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.1e-31  Score=268.99  Aligned_cols=171  Identities=22%  Similarity=0.382  Sum_probs=150.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|.+....      .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   75 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc------ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence            4567899999999999999999998 578999999886321      223567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC--CCcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~--~g~VKL~DFGLA~~~~  480 (504)
                      +|+||||+++++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++....
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            99999999999999999764  4899999999999999999999999999999999999987  7899999999998765


Q ss_pred             cCC-cccccCCCcccccccccCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... .....||+.|+|||++.+.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~  178 (321)
T 1tki_A          156 PGDNFRLLFTAPEYYAPEVHQHD  178 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTC
T ss_pred             CCCccccccCChhhcCcHHhcCC
Confidence            443 3445699999999998765

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.97  E-value=1.8e-31  Score=273.78  Aligned_cols=173  Identities=28%  Similarity=0.430  Sum_probs=151.7

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      .+++|++++.||+|+||.||+|.+ .+|..||+|++.....  ........+.+|+.+|+.++||||+++++++.+...+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh--ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            357899999999999999999998 5799999999864221  1112345678999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      |+||||+++++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..... .
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-~  195 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-T  195 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-B
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-c
Confidence            999999999999998876 46999999999999999999999999999999999999999999999999999866543 3


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ...+||+.|+|||++.++
T Consensus       196 ~~~~gt~~y~aPE~~~~~  213 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSK  213 (350)
T ss_dssp             CCCEECGGGCCHHHHTTC
T ss_pred             ccccCCccccCHHHhcCC
Confidence            456799999999998764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=1.2e-31  Score=284.17  Aligned_cols=173  Identities=25%  Similarity=0.378  Sum_probs=149.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...++|+++++||+|+||+||+|++ .+++.||+|++......  .......+.+|+.++..++||||++++++|.+.+.
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  148 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML--KRAETACFREERDVLVNGDSKWITTLHYAFQDDNN  148 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH--HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh--hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence            3456899999999999999999998 56899999998642211  11112347789999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +||||||+.+|+|.+++..  ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.....
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            9999999999999999976  46999999999999999999999999999999999999999999999999999765433


Q ss_pred             C---cccccCCCccccccccc
Q 010676          483 D---VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       483 ~---~~s~~GT~~YmAPEVL~  500 (504)
                      .   ....+||+.|||||++.
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~  249 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQ  249 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHH
T ss_pred             CCcccccccCCcCeeChHHHh
Confidence            2   23357999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=6e-33  Score=279.84  Aligned_cols=171  Identities=18%  Similarity=0.280  Sum_probs=139.2

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccch---hhHHHHHHHHHHHHHHhhCC---------CCceeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFE---------HENIVQY  395 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~---~~~~~~~~~~~Ei~iL~~L~---------HpnIV~l  395 (504)
                      .++|++++.||+|+||.||+|++ +|..||||++.......   ........+.+|+.+++.++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46899999999999999999998 78999999997643210   11112345778888887775         5555544


Q ss_pred             -----------------eeeecC-------------CCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHH
Q 010676          396 -----------------YGTDKD-------------ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL  445 (504)
Q Consensus       396 -----------------~~~~~~-------------~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yL  445 (504)
                                       +++|.+             .+.+||||||+.+|++.+.+.+..+++..++.|+.||+.||.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence                             444443             78899999999999776666667799999999999999999999


Q ss_pred             H-HCCceecCCCCCcEEEcCCC--------------------cEEEEecCcccccccCCcccccCCCcccccccccCC
Q 010676          446 H-DQDVVHRDIKCANILVDANG--------------------SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       446 H-s~gIIHRDLKP~NILLd~~g--------------------~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      | ++||+||||||+||||+.++                    .+||+|||+|+.....   ..+||+.|||||++.+.
T Consensus       178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~g~  252 (336)
T 2vuw_A          178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFTGD  252 (336)
T ss_dssp             HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGCCC
T ss_pred             HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhcCC
Confidence            9 99999999999999999887                    8999999999876533   34799999999999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.97  E-value=2.9e-31  Score=267.95  Aligned_cols=175  Identities=27%  Similarity=0.420  Sum_probs=141.3

Q ss_pred             cccceeeeeeecccCceeEEEEEc----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      ..++|++++.||+|+||.||+|.+    .++..||+|++....... .......+.+|+.+|+.++||||+++++++...
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-NAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            356899999999999999999987    478999999986432211 122345677899999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      +.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            9999999999999999988754 589999999999999999999999999999999999999999999999999875432


Q ss_pred             C--CcccccCCCcccccccccCC
Q 010676          482 N--DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~--~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .  .....+||+.|||||++.+.
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~  196 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRS  196 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTS
T ss_pred             CCccccccCCCcCccCHhhCcCC
Confidence            2  23456799999999998764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.97  E-value=2.2e-31  Score=273.77  Aligned_cols=175  Identities=25%  Similarity=0.378  Sum_probs=150.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~  403 (504)
                      ...++|++++.||+|+||.||+|.+ .++..||+|++......  .......+.+|..+|..+ +||||+++++++.+.+
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            3467899999999999999999998 46889999998643211  112245677899999887 7999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc-
Q 010676          404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~-  481 (504)
                      .+|+||||++||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... 
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            99999999999999998876 5699999999999999999999999999999999999999999999999999986332 


Q ss_pred             -CCcccccCCCcccccccccCC
Q 010676          482 -NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 -~~~~s~~GT~~YmAPEVL~g~  502 (504)
                       ......+||+.|||||++.++
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~  196 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQ  196 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTC
T ss_pred             CcccccccCCccccChhhhcCC
Confidence             234566799999999998764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=3.4e-31  Score=270.32  Aligned_cols=175  Identities=22%  Similarity=0.314  Sum_probs=147.2

Q ss_pred             CCccccccccceeeeeeecccCceeEEEEE------ccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC---CC
Q 010676          320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HE  390 (504)
Q Consensus       320 p~~~~~~~~~~y~i~k~LG~G~FG~VYka~------~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~---Hp  390 (504)
                      +...+....++|.+.++||+|+||+||+|+      ..++..||+|++....        ...+.+|+.++..++   |+
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~l~~~~~~  127 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--------PWEFYIGTQLMERLKPSMQH  127 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--------HHHHHHHHHHHHHSCGGGGG
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--------hhHHHHHHHHHHHhhhhhhh
Confidence            334444556789999999999999999994      3578999999885321        234667777777776   99


Q ss_pred             ceeEEeeeecCCCeEEEEEEeccCCCHHHHHHh------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC
Q 010676          391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA  464 (504)
Q Consensus       391 nIV~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~  464 (504)
                      ||+++++++...+.+||||||+++|+|.+++..      ..+++..+..|+.||+.||.|||++|||||||||+||||+.
T Consensus       128 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~  207 (365)
T 3e7e_A          128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN  207 (365)
T ss_dssp             GBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred             hhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence            999999999999999999999999999999863      45999999999999999999999999999999999999998


Q ss_pred             -----------CCcEEEEecCccccccc----CCcccccCCCcccccccccCC
Q 010676          465 -----------NGSVKLADFGLAKATKL----NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       465 -----------~g~VKL~DFGLA~~~~~----~~~~s~~GT~~YmAPEVL~g~  502 (504)
                                 ++.+||+|||+++....    ......+||+.|||||++.++
T Consensus       208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  260 (365)
T 3e7e_A          208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK  260 (365)
T ss_dssp             GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC
T ss_pred             cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC
Confidence                       89999999999975431    123456799999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.97  E-value=1.8e-31  Score=280.76  Aligned_cols=175  Identities=27%  Similarity=0.420  Sum_probs=142.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...++|++++.||+|+||.||+|.+ .++..||||++.....  ........+.+|+.+|+.++||||+++++++.+.+.
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--C-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh--hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            3467899999999999999999998 6899999999864221  122334567789999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCccccccc-
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL-  481 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~-  481 (504)
                      +||||||+++++|..++.. ..+++..+..|+.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++.... 
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            9999999999999988865 458999999999999999999998 9999999999999999999999999999975332 


Q ss_pred             -CCcccccCCCcccccccccCC
Q 010676          482 -NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 -~~~~s~~GT~~YmAPEVL~g~  502 (504)
                       ......+||+.|||||++.++
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~  324 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDN  324 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTS
T ss_pred             CcccccccCCccccCHhhcCCC
Confidence             224556799999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.97  E-value=5.8e-31  Score=264.07  Aligned_cols=175  Identities=31%  Similarity=0.500  Sum_probs=143.7

Q ss_pred             ccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +.....+|++.+.||+|+||+||+|.+ ++..||+|++.....   .......+.+|+.++++++||||+++++++....
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF---HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            334467899999999999999999987 588899998864332   2334567889999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~----l~e~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      .+|+||||+.+++|.+++....    +++..+..++.||+.||.|||++|  |+||||||+||||+.++.+||+|||+++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            9999999999999999997654    899999999999999999999999  9999999999999999999999999997


Q ss_pred             ccccCC--cccccCCCcccccccccCC
Q 010676          478 ATKLND--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       478 ~~~~~~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      ......  .....||+.|+|||++.+.
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~  214 (309)
T 3p86_A          188 LKASTFLSSKSAAGTPEWMAPEVLRDE  214 (309)
T ss_dssp             --------------CCTTSCHHHHTTC
T ss_pred             cccccccccccCCCCccccChhhhcCC
Confidence            544332  3445799999999998765

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.97  E-value=2.3e-31  Score=279.83  Aligned_cols=172  Identities=27%  Similarity=0.399  Sum_probs=149.8

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..++|++++.||+|+||.||+|.+ .+++.||+|++......  .......+.+|+.++..++||||++++++|.+.+.+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~--~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML--KRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh--hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            457899999999999999999998 58999999998642211  111234577899999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      ||||||+++|+|.+++.+.  .+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            9999999999999999763  59999999999999999999999999999999999999999999999999998765433


Q ss_pred             ---cccccCCCccccccccc
Q 010676          484 ---VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 ---~~s~~GT~~YmAPEVL~  500 (504)
                         ....+||+.|||||++.
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~  236 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQ  236 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHH
T ss_pred             ccccceeccccCcCCHHHHh
Confidence               23457999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.97  E-value=1.6e-31  Score=269.79  Aligned_cols=173  Identities=28%  Similarity=0.532  Sum_probs=149.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|++.....    ......+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc----cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            3567899999999999999999998 4899999999864322    1223567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            99999999999999988654 59999999999999999999999999999999999999999999999999997654322


Q ss_pred             ----cccccCCCcccccccccCC
Q 010676          484 ----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ----~~s~~GT~~YmAPEVL~g~  502 (504)
                          ....+||+.|+|||++.+.
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~  182 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRR  182 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCS
T ss_pred             cccccCCCccCcCccCcHHhccC
Confidence                3456799999999998754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=6.9e-31  Score=270.51  Aligned_cols=173  Identities=29%  Similarity=0.464  Sum_probs=148.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEc--------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  396 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~--------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~  396 (504)
                      ...++|++++.||+|+||.||+|.+        .++..||+|++....    .......+.+|+.+++.+ +||||++++
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpnIv~~~  153 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLL  153 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC----BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc----CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            3457899999999999999999985        245679999875432    233456789999999999 899999999


Q ss_pred             eeecCCCeEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 010676          397 GTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (504)
Q Consensus       397 ~~~~~~~~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~N  459 (504)
                      +++...+.+|+||||+.+|+|.+++...                 .+++..+..++.||+.||.|||++||+||||||+|
T Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            9999999999999999999999998764                 37888999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          460 ILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       460 ILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |||+.++.+||+|||+++......    .....+|+.|||||++.++
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  280 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR  280 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC
Confidence            999999999999999998654322    2334578899999998765

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.97  E-value=3.2e-31  Score=270.84  Aligned_cols=174  Identities=28%  Similarity=0.442  Sum_probs=149.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ..+++|++.+.||+|+||.||+|.+ .++..||+|++......  .......+.+|+.+++.++||||+++++++.+.+.
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK--KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc--chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            4578999999999999999999998 68899999988642111  11123468899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHH-HhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll-~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +|+||||+ +|+|.+++ ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            99999999 56777766 45679999999999999999999999999999999999999999999999999998654433


Q ss_pred             -cccccCCCcccccccccCC
Q 010676          484 -VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g~  502 (504)
                       ....+||+.|+|||++.+.
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~  182 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGK  182 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCS
T ss_pred             ccccccCCcCcCCHHHHcCC
Confidence             4556799999999999865

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.97  E-value=7.4e-31  Score=269.81  Aligned_cols=174  Identities=29%  Similarity=0.471  Sum_probs=151.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|++......   ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF  102 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            4567899999999999999999998 57899999998754332   2334678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~---g~VKL~DFGLA~~~~  480 (504)
                      +|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.+   +.+||+|||++....
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            99999999999999887654 58999999999999999999999999999999999999865   459999999998655


Q ss_pred             cCC-cccccCCCcccccccccCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... ....+||+.|+|||++.+.
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~~~  205 (362)
T 2bdw_A          183 DSEAWHGFAGTPGYLSPEVLKKD  205 (362)
T ss_dssp             TCCSCCCSCSCTTTCCHHHHTTC
T ss_pred             CCcccccCCCCccccCHHHHccC
Confidence            332 3456799999999998764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.97  E-value=6e-31  Score=265.55  Aligned_cols=177  Identities=27%  Similarity=0.496  Sum_probs=152.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhh-HHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|++......... ......+.+|+.+|+.++||||+++++++.+..
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            4557899999999999999999998 57899999998754332111 112356889999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----cEEEEecCcccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKA  478 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g----~VKL~DFGLA~~  478 (504)
                      .+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++.
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            999999999999999998654 589999999999999999999999999999999999999887    899999999987


Q ss_pred             cccC-CcccccCCCcccccccccCC
Q 010676          479 TKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .... ......||+.|+|||++.+.
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~  192 (326)
T 2y0a_A          168 IDFGNEFKNIFGTPEFVAPEIVNYE  192 (326)
T ss_dssp             CCTTSCCCCCCSCTTTCCHHHHTTC
T ss_pred             CCCCCccccccCCcCcCCceeecCC
Confidence            6433 34456799999999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=7.3e-31  Score=256.86  Aligned_cols=175  Identities=25%  Similarity=0.405  Sum_probs=148.4

Q ss_pred             ccccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          322 GRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       322 ~~~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      +.+....++|++++.||+|+||.||+|.+.++..||+|++......      ...+.+|+.++..++||||+++++++.+
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~   90 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTK   90 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC------HHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence            3444556799999999999999999999988889999988643322      1457899999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      .+.+|+||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence            9999999999999999999976  56999999999999999999999999999999999999999999999999999765


Q ss_pred             ccCC---cccccCCCcccccccccCC
Q 010676          480 KLND---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~---~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....   .....+|+.|+|||++.+.
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYS  196 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHC
T ss_pred             cccccccccCCccCcccCCHHHhccC
Confidence            4322   2233478889999998643

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.97  E-value=3.8e-31  Score=260.75  Aligned_cols=169  Identities=30%  Similarity=0.498  Sum_probs=144.0

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      ++|++++.||+|+||.||+|.+.++..||+|++.......   .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE---GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG---CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc---ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            5799999999999999999999889999999986543221   1124577999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Cc
Q 010676          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV  484 (504)
Q Consensus       409 mEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~  484 (504)
                      |||+.+ +|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            999986 88888865  45899999999999999999999999999999999999999999999999998765422  23


Q ss_pred             ccccCCCcccccccccC
Q 010676          485 KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g  501 (504)
                      ....||+.|+|||++.+
T Consensus       158 ~~~~~t~~y~aPE~~~~  174 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMG  174 (288)
T ss_dssp             ----CCCTTCCHHHHTT
T ss_pred             ccccccccccCchheeC
Confidence            44568999999999865

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=6.7e-31  Score=255.70  Aligned_cols=172  Identities=22%  Similarity=0.338  Sum_probs=149.1

Q ss_pred             ccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +....++|++.+.||+|+||.||+|.+.++..||+|++......      ...+.+|+.++++++||||+++++++.+..
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC------HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            33445789999999999999999999988899999988643322      145789999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+++++|.+++....  +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            9999999999999999996543  89999999999999999999999999999999999999999999999999976543


Q ss_pred             CC---cccccCCCcccccccccC
Q 010676          482 ND---VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       482 ~~---~~s~~GT~~YmAPEVL~g  501 (504)
                      ..   .....+|+.|+|||++.+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~  181 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSF  181 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHH
T ss_pred             cccccccCcccccccCCHHHhcC
Confidence            22   233457888999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.97  E-value=9.7e-31  Score=277.42  Aligned_cols=174  Identities=28%  Similarity=0.382  Sum_probs=150.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++++.||+|+||.||+|.+ .+|..||+|++.....   .......+.+|+.+++.++||||+++++++.+.+.
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRLLKHPNIVRLHDSISEEGH   84 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC---HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence            5667899999999999999999988 6899999999875432   22334678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---CCCcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd---~~g~VKL~DFGLA~~~~  480 (504)
                      +|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            9999999999999887765 4599999999999999999999999999999999999998   46789999999997655


Q ss_pred             cCC--cccccCCCcccccccccCC
Q 010676          481 LND--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...  ....+||+.|||||++.+.
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~  188 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKD  188 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTC
T ss_pred             CCCceeecccCCcccCCHHHhcCC
Confidence            432  3456799999999999764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=5.7e-31  Score=271.20  Aligned_cols=172  Identities=27%  Similarity=0.436  Sum_probs=139.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~  403 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||||++.....   .......+.+|+.+|..+. ||||+++++++...+
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ---NSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C---CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc---ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            4567999999999999999999998 6899999998853222   2334466789999999997 999999999986544


Q ss_pred             --eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 --KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 --~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                        .+|+||||+.+ +|..++....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus        83 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           83 DRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             CCEEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence              79999999985 899999888899999999999999999999999999999999999999999999999999975422


Q ss_pred             -----------------------CCcccccCCCcccccccccC
Q 010676          482 -----------------------NDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       482 -----------------------~~~~s~~GT~~YmAPEVL~g  501 (504)
                                             ......+||++|+|||++.+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  204 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG  204 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence                                   11234579999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.97  E-value=5.1e-31  Score=277.61  Aligned_cols=171  Identities=28%  Similarity=0.485  Sum_probs=133.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec----
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----  400 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~----  400 (504)
                      .+.++|++++.||+|+||+||+|.+ .++..||||++.....   ......++.+|+.+|+.++|||||++++++.    
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE---DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc---CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence            3457899999999999999999998 5889999998854322   2334567889999999999999999999984    


Q ss_pred             -CCCeEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          401 -DESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       401 -~~~~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                       ....+|+||||+. ++|..++... .+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.
T Consensus       127 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          127 EKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             ccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence             3467999999985 5888888765 499999999999999999999999999999999999999999999999999986


Q ss_pred             cccC-----------------------------CcccccCCCccccccccc
Q 010676          479 TKLN-----------------------------DVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       479 ~~~~-----------------------------~~~s~~GT~~YmAPEVL~  500 (504)
                      ....                             .....+||++|||||++.
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  256 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL  256 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence            5321                             123456899999999763

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.97  E-value=2.6e-30  Score=258.55  Aligned_cols=174  Identities=31%  Similarity=0.406  Sum_probs=141.6

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHH-hhCCCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIV~l~~~~~~~~  403 (504)
                      .+.++|++.+.||+|+||+||+|.+. ++..||||++.......  .. ......|+..+ ...+|+||+++++++.+.+
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP--KD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH--HH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh--HH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            34578999999999999999999984 89999999875432222  22 23344555544 4458999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+ +++|.+++...  .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999999999 56888877653  499999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-cccccCCCcccccccccCCC
Q 010676          482 ND-VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       482 ~~-~~s~~GT~~YmAPEVL~g~~  503 (504)
                      .. .....||+.|+|||++.+.+
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~  232 (311)
T 3p1a_A          210 AGAGEVQEGDPRYMAPELLQGSY  232 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGTCC
T ss_pred             CCCCcccCCCccccCHhHhcCCC
Confidence            33 33456999999999998753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=9.3e-31  Score=256.00  Aligned_cols=176  Identities=27%  Similarity=0.498  Sum_probs=148.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ..+++|++++.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++++.+...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc--chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            3467899999999999999999988 5778999998864221  112223568899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            9999999999999998865 568999999999999999999999999999999999999999999999999987665555


Q ss_pred             cccccCCCcccccccccCCC
Q 010676          484 VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~~  503 (504)
                      .....||+.|+|||++.+..
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~  183 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRM  183 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCC
T ss_pred             ccccCCCCCccCHhHhccCC
Confidence            55667999999999987653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.97  E-value=1.2e-30  Score=267.74  Aligned_cols=170  Identities=26%  Similarity=0.359  Sum_probs=140.3

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..++|++++.||+|+||+||++.+ .++..||+|++.......      ..+.+|+.+++.++||||+++++++.+...+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID------ENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC------HHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc------HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            456899999999999999999998 489999999986432211      3567999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc--EEEEecCccccccc-
Q 010676          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKATKL-  481 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~--VKL~DFGLA~~~~~-  481 (504)
                      |+||||+.+++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.  +||+|||+++.... 
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999999998854 56999999999999999999999999999999999999987765  99999999875332 


Q ss_pred             CCcccccCCCcccccccccCC
Q 010676          482 NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ......+||+.|+|||++.+.
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~  192 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQ  192 (361)
T ss_dssp             ---------CTTSCHHHHHCS
T ss_pred             CCCCCCcCCCCcCChhhhcCC
Confidence            233456799999999998654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=3.1e-31  Score=264.53  Aligned_cols=175  Identities=25%  Similarity=0.355  Sum_probs=143.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-  403 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++++.... 
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT--TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc--CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            4567899999999999999999997 6899999999865322  22344567889999999999999999999886654 


Q ss_pred             ---eEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          404 ---KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       404 ---~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                         .+|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence               35999999999999999865 45999999999999999999999999999999999999999999999999999765


Q ss_pred             ccCC-----cccccCCCcccccccccCC
Q 010676          480 KLND-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....     .....||+.|+|||++.+.
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~  194 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGD  194 (311)
T ss_dssp             ---------------CCTTCCHHHHHTC
T ss_pred             cccccccccccccCcCcccCCHHHhcCC
Confidence            4322     2335699999999998765

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=2.1e-30  Score=266.69  Aligned_cols=174  Identities=21%  Similarity=0.332  Sum_probs=151.4

Q ss_pred             cccccceeeeeeeccc--CceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          325 KRIITYWQKGDLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G--~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      ....++|++++.||+|  +||.||+|.+ .++..||||++......   ......+.+|+.+++.++|||||++++++.+
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS---NEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC---hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            3446789999999999  9999999998 48999999998754322   3445678899999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      .+.+|+||||+.+++|.+++..   ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            9999999999999999999876   4589999999999999999999999999999999999999999999999998764


Q ss_pred             cccC---------CcccccCCCcccccccccC
Q 010676          479 TKLN---------DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       479 ~~~~---------~~~s~~GT~~YmAPEVL~g  501 (504)
                      ....         .....+||+.|+|||++.+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  209 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ  209 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred             eccccccccccccccccccccccccCHHHHhc
Confidence            3211         1223469999999999976

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=3.6e-31  Score=266.21  Aligned_cols=181  Identities=29%  Similarity=0.499  Sum_probs=148.9

Q ss_pred             CccccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee
Q 010676          321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  399 (504)
Q Consensus       321 ~~~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~  399 (504)
                      .+.+..+.++|++.+.||+|+||.||+|.+ .++..||+|++...............+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   97 (345)
T 3hko_A           18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY   97 (345)
T ss_dssp             CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence            345567788999999999999999999998 6788999999865332222233456788999999999999999999999


Q ss_pred             cCCCeEEEEEEeccCCCHHHHHHh-----------------------------------------cCCChHHHHHHHHHH
Q 010676          400 KDESKLYIFLELVTKGSLLNLYQR-----------------------------------------YHLRDSQVSAYTRQI  438 (504)
Q Consensus       400 ~~~~~lyLVmEy~~ggsL~~ll~~-----------------------------------------~~l~e~~v~~i~~QI  438 (504)
                      .+.+.+|+||||+++++|.+++..                                         ..+++..++.++.||
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            999999999999999999998851                                         123567788999999


Q ss_pred             HHHHHHHHHCCceecCCCCCcEEEcCCC--cEEEEecCcccccccCC------cccccCCCcccccccccC
Q 010676          439 LLGLKYLHDQDVVHRDIKCANILVDANG--SVKLADFGLAKATKLND------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       439 l~gL~yLHs~gIIHRDLKP~NILLd~~g--~VKL~DFGLA~~~~~~~------~~s~~GT~~YmAPEVL~g  501 (504)
                      +.||.|||++||+||||||+||||+.++  .+||+|||++.......      .....||+.|+|||++.+
T Consensus       178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  248 (345)
T 3hko_A          178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT  248 (345)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred             HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence            9999999999999999999999998776  89999999997643211      234569999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.97  E-value=1.3e-30  Score=261.45  Aligned_cols=169  Identities=32%  Similarity=0.554  Sum_probs=133.0

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .++|++++.||+|+||.||+|.+ .++..||+|++.......    ....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   79 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG----TPSTAIREISLMKELKHENIVRLYDVIHTENKLT   79 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTC----SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc----cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence            35799999999999999999998 578999999987543221    1245678999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc-------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          407 IFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      +||||+.+ +|.+++...       .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus        80 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           80 LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             EEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            99999984 898888653       4889999999999999999999999999999999999999999999999999865


Q ss_pred             ccC--CcccccCCCcccccccccC
Q 010676          480 KLN--DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       480 ~~~--~~~s~~GT~~YmAPEVL~g  501 (504)
                      ...  ......||+.|+|||++.+
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~  182 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMG  182 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTT
T ss_pred             CCCcccCCCCcccccccCchHhhC
Confidence            432  2345579999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=2.7e-30  Score=250.82  Aligned_cols=172  Identities=24%  Similarity=0.401  Sum_probs=147.7

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~  403 (504)
                      ++.++|++++.||+|+||.||+|.+ .++..||+|++.......   .....+.+|+.++..+ +||||+++++++.+.+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS---VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS---HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc---HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            4567899999999999999999998 489999999987533222   2345677899999998 8999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-------------
Q 010676          404 KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-------------  465 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~-------------  465 (504)
                      .+|+||||+++++|.+++..     ..+++..+..++.||+.||.|||++||+||||||+|||++.+             
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999999999998875     348999999999999999999999999999999999999844             


Q ss_pred             ------CcEEEEecCcccccccCCcccccCCCcccccccccCC
Q 010676          466 ------GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       466 ------g~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                            ..+||+|||++......  ....||+.|+|||++.+.
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~  205 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQEN  205 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTC
T ss_pred             cccCCceEEEEcccccccccCCc--cccCCCccccChhHhcCC
Confidence                  47999999998765433  234599999999999765

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=1.2e-30  Score=262.29  Aligned_cols=169  Identities=31%  Similarity=0.435  Sum_probs=146.5

Q ss_pred             ccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC--
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~--  403 (504)
                      .-.++|++++.||+|+||.||+|.+. +..||||++....      ......++|+.++..++||||+++++++....  
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD------KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc------hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            34568999999999999999999876 7899999885421      22244567999999999999999999987643  


Q ss_pred             --eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCcEEEcCCCcEEEE
Q 010676          404 --KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ----------DVVHRDIKCANILVDANGSVKLA  471 (504)
Q Consensus       404 --~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~----------gIIHRDLKP~NILLd~~g~VKL~  471 (504)
                        .+|+||||+++|+|.+++....+++..+..++.||+.||.|||++          ||+||||||+||||+.++.+||+
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             CceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence              479999999999999999998999999999999999999999999          99999999999999999999999


Q ss_pred             ecCcccccccCC----cccccCCCcccccccccC
Q 010676          472 DFGLAKATKLND----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       472 DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g  501 (504)
                      |||+++......    .....||+.|+|||++.+
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  207 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG  207 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred             cCCcccccccccCccccccCccCccccCHhhccc
Confidence            999997654332    233569999999999876

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.97  E-value=2.6e-30  Score=251.01  Aligned_cols=170  Identities=27%  Similarity=0.390  Sum_probs=148.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      -..++|++.+.||+|+||.||+|.+.++..||+|++......      ...+.+|+.++..++||||+++++++.....+
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS------EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            345689999999999999999999988889999988643322      14578999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      |+||||+++++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            9999999999999988764  48999999999999999999999999999999999999999999999999998655443


Q ss_pred             cc---cccCCCcccccccccC
Q 010676          484 VK---SCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ~~---s~~GT~~YmAPEVL~g  501 (504)
                      ..   ...+|+.|+|||++.+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~  179 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHY  179 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHH
T ss_pred             hhcccCCCcCcccCCHHHHhc
Confidence            22   2346778999999764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=3.3e-30  Score=251.45  Aligned_cols=172  Identities=28%  Similarity=0.519  Sum_probs=150.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++.+.||+|+||.||+|.+ .++..+|+|.+.......     ...+.+|+.+++.++||||+++++++.+...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-----VDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            3567899999999999999999998 567899999886533222     3567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL---d~~g~VKL~DFGLA~~~~  480 (504)
                      +|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999999999887755 458999999999999999999999999999999999999   788999999999997654


Q ss_pred             cCC-cccccCCCcccccccccCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... .....||+.|+|||++.+.
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~  183 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGL  183 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTC
T ss_pred             CccchhccCCCCCccChHHhccc
Confidence            333 4456799999999998765

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.97  E-value=2.4e-30  Score=258.67  Aligned_cols=170  Identities=26%  Similarity=0.477  Sum_probs=146.4

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC--
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  403 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~--  403 (504)
                      ..++|++.++||+|+||.||+|.+ .++..||||++.......    ....+.+|+.+++.++||||+++++++....  
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR----PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS----CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc----hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            356899999999999999999998 568999999886433211    2355679999999999999999999887654  


Q ss_pred             eEEEEEEeccCCCHHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----cCCCcEEEEecCc
Q 010676          404 KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGL  475 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~----l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL----d~~g~VKL~DFGL  475 (504)
                      .+|+||||+.+++|.+++....    +++..+..++.||+.||.|||++||+||||||+||||    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            7899999999999999997643    8999999999999999999999999999999999999    7788899999999


Q ss_pred             ccccccCC-cccccCCCccccccccc
Q 010676          476 AKATKLND-VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       476 A~~~~~~~-~~s~~GT~~YmAPEVL~  500 (504)
                      ++...... .....||+.|+|||++.
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~  188 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYE  188 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhh
Confidence            98754433 34567999999999885

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.97  E-value=2.5e-30  Score=260.45  Aligned_cols=168  Identities=33%  Similarity=0.532  Sum_probs=149.7

Q ss_pred             ceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .|...+.||+|+||.||+|.+. +|..||||++......     ....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-----RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            4778889999999999999984 8999999998754322     134578999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Cccc
Q 010676          409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKS  486 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~s  486 (504)
                      |||+++++|.+++....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......  ....
T Consensus       121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             ECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence            99999999999999888999999999999999999999999999999999999999999999999998765433  2345


Q ss_pred             ccCCCcccccccccCC
Q 010676          487 CRGTAFWMAPEVCSNP  502 (504)
Q Consensus       487 ~~GT~~YmAPEVL~g~  502 (504)
                      ..||+.|+|||++.++
T Consensus       201 ~~gt~~y~aPE~~~~~  216 (321)
T 2c30_A          201 LVGTPYWMAPEVISRS  216 (321)
T ss_dssp             CCSCGGGCCHHHHTTC
T ss_pred             ccCCccccCHhhhcCC
Confidence            6799999999998765

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.97  E-value=1.1e-30  Score=259.47  Aligned_cols=175  Identities=32%  Similarity=0.496  Sum_probs=141.6

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC---CCCceeEEeeeecCC
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDE  402 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~~~  402 (504)
                      +.++|++++.||+|+||+||+|.+ .++..||+|++...............+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999998 6889999999875432211111112345666666555   599999999998765


Q ss_pred             C-----eEEEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecC
Q 010676          403 S-----KLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG  474 (504)
Q Consensus       403 ~-----~lyLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFG  474 (504)
                      .     .+|+||||+.+ +|.+++....   +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  165 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG  165 (308)
T ss_dssp             CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred             CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence            5     58999999985 9999887654   8999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCC-cccccCCCcccccccccCC
Q 010676          475 LAKATKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       475 LA~~~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      +++...... .....||+.|+|||++.++
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  194 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQS  194 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTS
T ss_pred             cccccCCCcccCCccccccccCchHHcCC
Confidence            998654333 3456799999999998654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.97  E-value=2.9e-30  Score=271.09  Aligned_cols=171  Identities=29%  Similarity=0.506  Sum_probs=145.5

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--  402 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||||++....   .......++.+|+.+|+.++||||+++++++...  
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence            4567899999999999999999998 678999999886432   2234456788999999999999999999998766  


Q ss_pred             ---CeEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          403 ---SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       403 ---~~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                         ..+|+||||+.+ +|.+++... .+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          100 LKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             TTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence               579999999975 899988765 499999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC------------------------cccccCCCccccccccc
Q 010676          479 TKLND------------------------VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       479 ~~~~~------------------------~~s~~GT~~YmAPEVL~  500 (504)
                      .....                        ....+||++|+|||++.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~  224 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL  224 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHT
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHh
Confidence            54321                        24567999999999863

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=1.2e-30  Score=256.62  Aligned_cols=168  Identities=30%  Similarity=0.413  Sum_probs=141.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhh--CCCCceeEEeeeecC--
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKD--  401 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~~~~~~--  401 (504)
                      .+.++|++++.||+|+||.||+|.+ ++..||||++....        ...+.+|.+++..  ++||||+++++++..  
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--------EKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            4567899999999999999999987 68899999885321        1234455555555  889999999988543  


Q ss_pred             --CCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCcEEEcCCCcEEEE
Q 010676          402 --ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--------DQDVVHRDIKCANILVDANGSVKLA  471 (504)
Q Consensus       402 --~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLH--------s~gIIHRDLKP~NILLd~~g~VKL~  471 (504)
                        ...+|+||||+.+|+|.++++...+++..+..++.||+.||.|||        ++||+||||||+||||+.++.+||+
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence              456899999999999999999888999999999999999999999        9999999999999999999999999


Q ss_pred             ecCcccccccCC------cccccCCCcccccccccCC
Q 010676          472 DFGLAKATKLND------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       472 DFGLA~~~~~~~------~~s~~GT~~YmAPEVL~g~  502 (504)
                      |||+++......      .....||+.|+|||++.+.
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  192 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET  192 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCc
Confidence            999997644332      2234799999999998865

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=1.6e-30  Score=261.50  Aligned_cols=168  Identities=24%  Similarity=0.341  Sum_probs=146.8

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCe
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK  404 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~  404 (504)
                      +.++|++++.||+|+||.||+|.+ .++..||||++......       ..+.+|+.+++.+ +||||+++++++...+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   79 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY   79 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence            446899999999999999999997 68999999988643221       2467899999999 89999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc-----EEEEecCccc
Q 010676          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK  477 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~-----VKL~DFGLA~  477 (504)
                      +|+||||+ +++|.+++..  ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.     +||+|||+++
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99999999 8999999984  56999999999999999999999999999999999999998887     9999999998


Q ss_pred             ccccCC---------cccccCCCcccccccccCC
Q 010676          478 ATKLND---------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       478 ~~~~~~---------~~s~~GT~~YmAPEVL~g~  502 (504)
                      ......         ....+||+.|+|||++.++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  192 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGK  192 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCC
Confidence            654322         2356799999999998875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=5.5e-30  Score=250.32  Aligned_cols=174  Identities=29%  Similarity=0.468  Sum_probs=150.4

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++.+.||+|+||.||+|.+ .++..||+|++......   ......+.+|+.+++.++||||+++++++...+.
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF   79 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC---HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE
Confidence            3567899999999999999999998 57899999998754332   2334678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc---EEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~---VKL~DFGLA~~~~  480 (504)
                      .|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999999999877654 45899999999999999999999999999999999999986655   9999999997654


Q ss_pred             cCC-cccccCCCcccccccccCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... .....||+.|+|||++.+.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~  182 (284)
T 3kk8_A          160 DSEAWHGFAGTPGYLSPEVLKKD  182 (284)
T ss_dssp             SSCBCCCSCSCGGGCCHHHHTTC
T ss_pred             cCccccCCCCCcCCcCchhhcCC
Confidence            333 3456799999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.97  E-value=1.7e-30  Score=262.09  Aligned_cols=172  Identities=24%  Similarity=0.360  Sum_probs=145.1

Q ss_pred             cccceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      ..++|++.+.||+|+||.||+|.+.    .+..||||.+....    .......+.+|+.+++.++||||+++++++.+.
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            3568999999999999999999983    44569999886422    233346788999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      +.+|+||||+.+++|.+++...  .+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999999999653  69999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC-----cccccCCCcccccccccCC
Q 010676          481 LND-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...     .....+|+.|+|||++.++
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~  229 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFR  229 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHC
T ss_pred             cCccceeeccCCCCcccccCHhHhcCC
Confidence            332     1223467889999998643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=6.7e-31  Score=262.86  Aligned_cols=176  Identities=28%  Similarity=0.416  Sum_probs=151.6

Q ss_pred             ccccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          322 GRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       322 ~~~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      ..+....++|++.+.||+|+||.||+|.+.++..||+|.+.....     .....+.+|+.+++.++||||+++++++..
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-----QGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-----SHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            345567789999999999999999999998899999997754322     224568899999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~-----~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                      .+.+|+||||+.+++|.+++...     .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            99999999999999999988654     3888999999999999999999999999999999999999999999999998


Q ss_pred             cccccCC----cccccCCCcccccccccCC
Q 010676          477 KATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       477 ~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      +......    .....||+.|+|||++.++
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  216 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKG  216 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHC
T ss_pred             cccccccccccccccCCCccccCHHHhcCC
Confidence            7543221    2334589999999988543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=4e-30  Score=265.00  Aligned_cols=176  Identities=28%  Similarity=0.466  Sum_probs=150.3

Q ss_pred             cccccccceeeeeeecccCceeEEEEEc--------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCcee
Q 010676          323 RFKRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIV  393 (504)
Q Consensus       323 ~~~~~~~~y~i~k~LG~G~FG~VYka~~--------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV  393 (504)
                      .+....++|++++.||+|+||.||+|.+        ..+..||+|++....    .......+.+|+.+++.+ +||||+
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpnIv  138 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNII  138 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc----CHHHHHHHHHHHHHHHHhcCCchhh
Confidence            3444567899999999999999999986        234679999886432    233456788999999999 899999


Q ss_pred             EEeeeecCCCeEEEEEEeccCCCHHHHHHhcC-----------------CChHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 010676          394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIK  456 (504)
Q Consensus       394 ~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~-----------------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLK  456 (504)
                      ++++++...+.+|+||||+.+++|.+++....                 +++..++.|+.||+.||.|||++||+|||||
T Consensus       139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  218 (382)
T 3tt0_A          139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA  218 (382)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence            99999999999999999999999999997643                 8999999999999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          457 CANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       457 P~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |+||||+.++.+||+|||+++......    .....+|+.|+|||++.++
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  268 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR  268 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC
T ss_pred             cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC
Confidence            999999999999999999998654322    2334578899999998765

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=2.3e-30  Score=275.28  Aligned_cols=175  Identities=30%  Similarity=0.535  Sum_probs=149.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++++.||+|+||+||+|.+ .++..||||++........   ....+.+|+.+|+.++||||+++++++.+...
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch---HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence            4667899999999999999999998 5899999999864322111   23567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHH-hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---CCCcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~-~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd---~~g~VKL~DFGLA~~~~  480 (504)
                      +|+||||+.+++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||||+   .++.+||+|||+++...
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999999988765 45699999999999999999999999999999999999995   45679999999998654


Q ss_pred             cCC-cccccCCCcccccccccCCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~~  503 (504)
                      ... ....+||+.|+|||++.+.+
T Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~  199 (486)
T 3mwu_A          176 QNTKMKDRIGTAYYIAPEVLRGTY  199 (486)
T ss_dssp             CC----CCTTGGGGCCGGGGGSCC
T ss_pred             CCCccCCCcCCCCCCCHHHhCCCC
Confidence            433 44567999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=2.1e-30  Score=256.93  Aligned_cols=171  Identities=24%  Similarity=0.387  Sum_probs=143.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++++.||+|+||.||+|.+ .++..||+|++.....   .......+.+|+.+++.++||||+++++++...+.+|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED---DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc---chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence            57899999999999999999998 5699999998854322   2333466789999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      +||||+.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            99999999999988875 459999999999999999999999999999999999999999999999999997654322  


Q ss_pred             cccccCCCcccccccccC
Q 010676          484 VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g  501 (504)
                      .....||+.|+|||++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~  176 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVG  176 (311)
T ss_dssp             -------GGGCCHHHHHT
T ss_pred             cCCCcCCccccChHHHhc
Confidence            344579999999999865

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=6.6e-30  Score=251.31  Aligned_cols=173  Identities=31%  Similarity=0.547  Sum_probs=150.3

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC----C
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----E  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~----~  402 (504)
                      ...|++.+.||+|+||.||+|.+ .++..||+|.+......   ......+.+|+.+++.++||||+++++++..    .
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC---HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            34689999999999999999998 67889999988753322   2335678899999999999999999998754    4


Q ss_pred             CeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEc-CCCcEEEEecCcccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKLADFGLAKA  478 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILLd-~~g~VKL~DFGLA~~  478 (504)
                      ..+|+||||+++++|.+++.. ..+++..+..|+.||+.||.|||++|  |+|+||||+|||++ .++.+||+|||++..
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            669999999999999999876 56899999999999999999999999  99999999999997 789999999999977


Q ss_pred             cccCCcccccCCCcccccccccCCC
Q 010676          479 TKLNDVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       479 ~~~~~~~s~~GT~~YmAPEVL~g~~  503 (504)
                      ..........||+.|+|||++.+++
T Consensus       182 ~~~~~~~~~~~t~~y~aPE~~~~~~  206 (290)
T 1t4h_A          182 KRASFAKAVIGTPEFMAPEMYEEKY  206 (290)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGGTCC
T ss_pred             ccccccccccCCcCcCCHHHHhccC
Confidence            6655556677999999999988653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.97  E-value=2.1e-30  Score=283.95  Aligned_cols=174  Identities=26%  Similarity=0.391  Sum_probs=151.6

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..++|++.++||+|+||.||+|.+ .+|..||+|++......  .......+.+|+.+|+.++|||||++++++.+.+.+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh--hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            356899999999999999999998 58999999998643211  112235678999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          406 YIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      |+||||++||+|.+++...+   +++..+..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.....
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999999887643   899999999999999999999999999999999999999999999999999876543


Q ss_pred             C-cccccCCCcccccccccCC
Q 010676          483 D-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      . ....+||+.|||||++.++
T Consensus       340 ~~~~~~~GT~~Y~APEvl~~~  360 (576)
T 2acx_A          340 QTIKGRVGTVGYMAPEVVKNE  360 (576)
T ss_dssp             CCEECCCSCGGGCCHHHHTTC
T ss_pred             ccccccCCCccccCHHHHcCC
Confidence            3 3456899999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=4.3e-30  Score=253.19  Aligned_cols=173  Identities=31%  Similarity=0.491  Sum_probs=145.7

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.+.|++.+.||+|+||.||+|.+ .++..+|+|.+.......    ....+.+|+.+|+.++||||+++++++.+...
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV----PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch----hHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            4567899999999999999999998 578999999887543221    23568899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEecCcc
Q 010676          405 LYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLA  476 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL---d~~g~VKL~DFGLA  476 (504)
                      +|+||||+.+++|.+++..     ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            9999999999999987743     459999999999999999999999999999999999999   45688999999999


Q ss_pred             cccccCC-cccccCCCcccccccccCC
Q 010676          477 KATKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       477 ~~~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....... .....||+.|+|||++.+.
T Consensus       175 ~~~~~~~~~~~~~~t~~y~aPE~~~~~  201 (285)
T 3is5_A          175 ELFKSDEHSTNAAGTALYMAPEVFKRD  201 (285)
T ss_dssp             CC----------CTTGGGCCHHHHTTC
T ss_pred             eecCCcccCcCcccccCcCChHHhccC
Confidence            7654333 3455799999999998765

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=1.4e-30  Score=252.91  Aligned_cols=173  Identities=31%  Similarity=0.484  Sum_probs=138.1

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      .++|++.+.||+|+||.||+|.+. +..||+|++...... ........+.+|+.+++.++||||+++++++...+.+|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDE-DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcc-cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            468999999999999999999975 889999987543221 112334678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCcEEEcC--------CCcEEEEecCcc
Q 010676          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD---VVHRDIKCANILVDA--------NGSVKLADFGLA  476 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~g---IIHRDLKP~NILLd~--------~g~VKL~DFGLA  476 (504)
                      ||||+.+++|.+++....+++..+..++.||+.||.|||++|   |+||||||+|||++.        ++.+||+|||++
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~  163 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA  163 (271)
T ss_dssp             EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred             EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence            999999999999998888999999999999999999999999   899999999999986        778999999999


Q ss_pred             cccccCCcccccCCCcccccccccCC
Q 010676          477 KATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       477 ~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ............||+.|+|||++.+.
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~  189 (271)
T 3dtc_A          164 REWHRTTKMSAAGAYAWMAPEVIRAS  189 (271)
T ss_dssp             ------------CCGGGSCHHHHHHC
T ss_pred             cccccccccCCCCccceeCHHHhccC
Confidence            87665555566799999999988654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=3.2e-30  Score=252.81  Aligned_cols=174  Identities=28%  Similarity=0.501  Sum_probs=151.6

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..++|++++.||+|+||.||+|.+ .++..||+|++......  .......+.+|+.+++.++||||+++++++.+.+.+
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE--KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc--hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            457899999999999999999998 57889999988642211  111235688999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      |+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  169 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR  169 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence            999999999999998865 4589999999999999999999999999999999999999999999999999876655445


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....||+.|+|||++.+.
T Consensus       170 ~~~~~~~~y~aPE~~~~~  187 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGK  187 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTC
T ss_pred             ccccCCCCcCCHHHhccC
Confidence            566799999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=1.6e-30  Score=262.90  Aligned_cols=175  Identities=27%  Similarity=0.403  Sum_probs=146.6

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEe
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  396 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~  396 (504)
                      +....++|++++.||+|+||.||+|.+      .++..||||++....    .......+.+|+.++..+ +||||++++
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC----CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            444567899999999999999999973      467899999886422    223346788999999999 799999999


Q ss_pred             eeecCCCe-EEEEEEeccCCCHHHHHHhcC--------------------------------------------------
Q 010676          397 GTDKDESK-LYIFLELVTKGSLLNLYQRYH--------------------------------------------------  425 (504)
Q Consensus       397 ~~~~~~~~-lyLVmEy~~ggsL~~ll~~~~--------------------------------------------------  425 (504)
                      +++...+. +|+||||+.+|+|.+++....                                                  
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            99887654 999999999999999987542                                                  


Q ss_pred             -----------------CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC----c
Q 010676          426 -----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----V  484 (504)
Q Consensus       426 -----------------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~----~  484 (504)
                                       +++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......    .
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                             8889999999999999999999999999999999999999999999999998653322    2


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....||+.|||||++.+.
T Consensus       253 ~~~~~t~~y~aPE~~~~~  270 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDR  270 (359)
T ss_dssp             --CEECGGGCCHHHHHHC
T ss_pred             cccCCCceeEChhhhcCC
Confidence            334589999999988643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=2.7e-30  Score=263.79  Aligned_cols=171  Identities=28%  Similarity=0.429  Sum_probs=135.4

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      ..+.++|++.+.||+|+||.||+|.+ .++..||||++....       ....+.+|+.+|+.++||||+++++++.+.+
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            45667899999999999999999998 468899999886422       1245778999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEecCccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKAT  479 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~---~g~VKL~DFGLA~~~  479 (504)
                      .+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.   ++.+||+|||+++..
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            999999999999999988654 4899999999999999999999999999999999999975   889999999999865


Q ss_pred             ccCC-cccccCCCcccccccccCC
Q 010676          480 KLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      .... ....+||+.|+|||++.+.
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~  225 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGC  225 (349)
T ss_dssp             -----------CGGGSCHHHHTTC
T ss_pred             CcccccccccCCCCccCHHHhcCC
Confidence            4332 3456799999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=3.3e-30  Score=255.04  Aligned_cols=175  Identities=26%  Similarity=0.414  Sum_probs=148.6

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEee
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG  397 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~  397 (504)
                      +....++|++++.||+|+||.||+|.+      .++..||+|++....    .......+.+|+.+++.++||||+++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~   93 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SPSELRDLLSEFNVLKQVNHPHVIKLYG   93 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence            334457899999999999999999986      345789999875322    2334567889999999999999999999


Q ss_pred             eecCCCeEEEEEEeccCCCHHHHHHhc-------------------------CCChHHHHHHHHHHHHHHHHHHHCCcee
Q 010676          398 TDKDESKLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVH  452 (504)
Q Consensus       398 ~~~~~~~lyLVmEy~~ggsL~~ll~~~-------------------------~l~e~~v~~i~~QIl~gL~yLHs~gIIH  452 (504)
                      ++...+.+|+||||+.+++|.+++...                         .+++..+..++.||+.||.|||++||+|
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  173 (314)
T 2ivs_A           94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH  173 (314)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            999999999999999999999998753                         2788899999999999999999999999


Q ss_pred             cCCCCCcEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       453 RDLKP~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |||||+||||+.++.+||+|||++.......    .....+|+.|+|||++.+.
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  227 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH  227 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC
Confidence            9999999999999999999999997654332    2234578899999987643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=6.4e-30  Score=259.32  Aligned_cols=169  Identities=28%  Similarity=0.380  Sum_probs=147.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-----CCceeEEeeee
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----HENIVQYYGTD  399 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----HpnIV~l~~~~  399 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||||++...      ......+..|+.+++.++     ||||+++++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc------hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            4567899999999999999999998 67899999988531      223355678999999886     99999999999


Q ss_pred             cCCCeEEEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC------------
Q 010676          400 KDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA------------  464 (504)
Q Consensus       400 ~~~~~lyLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~------------  464 (504)
                      ...+.+|+||||+ +++|.+++....   +++..+..|+.||+.||.|||++||+||||||+||||+.            
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence            9999999999999 889999987654   899999999999999999999999999999999999975            


Q ss_pred             -------------CCcEEEEecCcccccccCCcccccCCCcccccccccCC
Q 010676          465 -------------NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       465 -------------~g~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                                   ++.+||+|||++..... ......||+.|+|||++.+.
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~  234 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNL  234 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCC
Confidence                         78999999999976443 33456799999999998764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.5e-30  Score=266.04  Aligned_cols=171  Identities=25%  Similarity=0.448  Sum_probs=143.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-  403 (504)
                      .+.+.|++++.||+|+||.||+|.+ .+|..||||++....   ........+.+|+.+|+.++||||+++++++.... 
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   98 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence            4567899999999999999999998 689999999875422   22334567889999999999999999999987653 


Q ss_pred             -----eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          404 -----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       404 -----~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                           .+|+||||+ +++|.+++....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence                 469999999 78999999988899999999999999999999999999999999999999999999999999986


Q ss_pred             cccCCcccccCCCcccccccccC
Q 010676          479 TKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       479 ~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      ... .....+||++|+|||++.+
T Consensus       178 ~~~-~~~~~~~t~~y~aPE~~~~  199 (367)
T 1cm8_A          178 ADS-EMTGYVVTRWYRAPEVILN  199 (367)
T ss_dssp             CCS-SCCSSCSCGGGCCTHHHHT
T ss_pred             ccc-ccCcCcCCCCcCCHHHHhC
Confidence            543 3445679999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=1.1e-29  Score=250.35  Aligned_cols=175  Identities=33%  Similarity=0.515  Sum_probs=151.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...++|++++.||+|+||.||+|.+ .++..||+|++.......  ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   89 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF   89 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC--HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE
Confidence            3456899999999999999999998 478899999886533222  2344678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC-
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~-  482 (504)
                      +|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            9999999999999998865 45899999999999999999999999999999999999999999999999998765422 


Q ss_pred             -CcccccCCCcccccccccCC
Q 010676          483 -DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 -~~~s~~GT~~YmAPEVL~g~  502 (504)
                       ......||+.|+|||++.+.
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~  190 (294)
T 2rku_A          170 ERKKVLCGTPNYIAPEVLSKK  190 (294)
T ss_dssp             CCBCCCCSCCSSCCHHHHTTS
T ss_pred             cccccccCCCCcCCcchhccC
Confidence             23445699999999998764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.97  E-value=4e-30  Score=267.75  Aligned_cols=172  Identities=28%  Similarity=0.479  Sum_probs=149.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|++....     ......+.+|+.+|+.++||||+++++++.+...
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            3567899999999999999999998 578999999886432     1223468899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC--CCcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~--~g~VKL~DFGLA~~~~  480 (504)
                      +|+||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++...
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            99999999999999988654  5899999999999999999999999999999999999974  4789999999998765


Q ss_pred             cCC-cccccCCCcccccccccCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... ....+||+.|+|||++.+.
T Consensus       203 ~~~~~~~~~gt~~y~aPE~~~~~  225 (387)
T 1kob_A          203 PDEIVKVTTATAEFAAPEIVDRE  225 (387)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTC
T ss_pred             CCcceeeeccCCCccCchhccCC
Confidence            443 3445799999999998765

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.97  E-value=2.8e-30  Score=281.15  Aligned_cols=173  Identities=25%  Similarity=0.420  Sum_probs=151.1

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .++|++.++||+|+||.||+|.+ .+|+.||+|++......  .......+.+|+.+|+.++||||+++++++.+...+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK--KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh--hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            46899999999999999999998 57999999998642211  1122456789999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          407 IFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-----~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      +||||++||+|..++...     .+++..+..|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999999988653     489999999999999999999999999999999999999999999999999987554


Q ss_pred             CC--cccccCCCcccccccccCC
Q 010676          482 ND--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..  ....+||+.|||||++.+.
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~  364 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGE  364 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTC
T ss_pred             CCcccccccCCccccChhhhcCC
Confidence            33  3345899999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=2.5e-30  Score=275.21  Aligned_cols=172  Identities=26%  Similarity=0.395  Sum_probs=141.5

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--  402 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||||++....   .......++.+|+.+|+.++||||+++++++...  
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  135 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT  135 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG---GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc---cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence            4567899999999999999999998 579999999886432   2234456788999999999999999999998654  


Q ss_pred             ----CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       403 ----~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                          ..+||||||+.++ |.+.+.. .+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       136 ~~~~~~~~lv~E~~~~~-l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          136 LEEFQDVYLVMELMDAN-LCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             TTTCCEEEEEEECCSEE-HHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             cccCCeEEEEEeCCCCC-HHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence                4579999999875 6665543 589999999999999999999999999999999999999999999999999987


Q ss_pred             cccC-CcccccCCCcccccccccCC
Q 010676          479 TKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .... .....+||+.|+|||++.+.
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~  238 (464)
T 3ttj_A          214 AGTSFMMTPYVVTRYYRAPEVILGM  238 (464)
T ss_dssp             ---CCCC----CCCTTCCHHHHTTC
T ss_pred             cCCCcccCCCcccccccCHHHHcCC
Confidence            6543 24556799999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=2.1e-30  Score=260.00  Aligned_cols=173  Identities=26%  Similarity=0.364  Sum_probs=147.7

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  399 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~  399 (504)
                      ...++|++++.||+|+||.||+|.+.      ++..||+|.+....    .......+.+|+.+++.++||||+++++++
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34578999999999999999999874      35889999876322    233456788999999999999999999999


Q ss_pred             cCCCeEEEEEEeccCCCHHHHHHh-------------------------cCCChHHHHHHHHHHHHHHHHHHHCCceecC
Q 010676          400 KDESKLYIFLELVTKGSLLNLYQR-------------------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRD  454 (504)
Q Consensus       400 ~~~~~lyLVmEy~~ggsL~~ll~~-------------------------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRD  454 (504)
                      .+.+.+|+||||+.+++|.+++..                         ..+++..++.++.||+.||.|||++||+|||
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            999999999999999999999876                         4588899999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          455 IKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       455 LKP~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |||+||||+.++.+||+|||+++......    .....+|+.|+|||++.++
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  251 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN  251 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC
Confidence            99999999999999999999987543221    2344589999999987643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.97  E-value=2.2e-30  Score=277.45  Aligned_cols=175  Identities=31%  Similarity=0.497  Sum_probs=153.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ..+++|.+++.||+|+||.||+|.+ .+|..||||++.....  ........+.+|+.+++.++||||+++++++.+.+.
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~   90 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD   90 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH--HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4567899999999999999999998 5899999999864221  111224578899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999999988654 59999999999999999999999999999999999999999999999999998755433


Q ss_pred             -cccccCCCcccccccccCC
Q 010676          484 -VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g~  502 (504)
                       ....+||+.|+|||++.+.
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~  190 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGR  190 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTC
T ss_pred             cccccCCCcCeEChhhccCC
Confidence             4556799999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=8.3e-30  Score=257.49  Aligned_cols=174  Identities=32%  Similarity=0.508  Sum_probs=151.5

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..++|.+++.||+|+||.||++.+ .++..||+|++......  .......+.+|+.+++.++||||+++++++.+.+.+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            346899999999999999999998 56889999988643322  223456788999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--
Q 010676          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--  482 (504)
                      |+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            999999999999998875 45899999999999999999999999999999999999999999999999999765422  


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ......||+.|+|||++.+.
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~  216 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKK  216 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTS
T ss_pred             cccccCCCccccCHHHhccC
Confidence            23445699999999998764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.8e-30  Score=263.57  Aligned_cols=175  Identities=30%  Similarity=0.448  Sum_probs=141.4

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...++|++++.||+|+||.||+|.+ .+|..||+|++...............+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            3457899999999999999999998 578999999886433222222223467799999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +|+||||+.+ +|..++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            9999999987 788888654  4889999999999999999999999999999999999999999999999999865432


Q ss_pred             --CcccccCCCcccccccccC
Q 010676          483 --DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 --~~~s~~GT~~YmAPEVL~g  501 (504)
                        .....+||+.|+|||++.+
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~  186 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFG  186 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTT
T ss_pred             cccCCcccccccccCchHhhC
Confidence              2345679999999999865

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=3.7e-30  Score=251.19  Aligned_cols=175  Identities=27%  Similarity=0.535  Sum_probs=135.6

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ..+++|++++.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++++...+.
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY   85 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh--hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence            4467899999999999999999998 6899999998864221  111224668899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +|+||||+++++|.+++...  .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999999998763  5899999999999999999999999999999999999999999999999998765432


Q ss_pred             --CcccccCCCcccccccccCC
Q 010676          483 --DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 --~~~s~~GT~~YmAPEVL~g~  502 (504)
                        ......||+.|+|||++.+.
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~  187 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATRS  187 (278)
T ss_dssp             ----------------------
T ss_pred             CCcceeccCCCCcCCcchhcCC
Confidence              22345699999999998764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=8.9e-31  Score=265.92  Aligned_cols=177  Identities=27%  Similarity=0.387  Sum_probs=151.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchh---hHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ---AKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||||++........   .......+.+|+.+|+.++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            4567899999999999999999997 6899999999875432111   01112346689999999999999999999999


Q ss_pred             CCeEEEEEEeccCC-CHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          402 ESKLYIFLELVTKG-SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       402 ~~~lyLVmEy~~gg-sL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      .+.+|+||||+.+| +|.+++... .+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            99999999999776 999988765 5999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCC-cccccCCCcccccccccCC
Q 010676          480 KLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      .... ....+||+.|+|||++.+.
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~~~  204 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLMGN  204 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHTTC
T ss_pred             CCCCceeccCCCccccChhhhcCC
Confidence            5433 3456799999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.97  E-value=2.6e-30  Score=254.84  Aligned_cols=170  Identities=31%  Similarity=0.516  Sum_probs=142.4

Q ss_pred             ccceeeeeeecccCceeEEEEEc-----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-  401 (504)
                      .++|++++.||+|+||.||+|..     .++..||+|++...     .......+.+|+.+++.++||||+++++++.. 
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            46899999999999999999983     57899999988632     23345678899999999999999999998854 


Q ss_pred             -CCeEEEEEEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          402 -ESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       402 -~~~lyLVmEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                       ...+|+||||+++++|.+++....  +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence             356899999999999999997643  89999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC-----cccccCCCcccccccccCC
Q 010676          479 TKLND-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....     .....+|..|+|||++.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  192 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTES  192 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHC
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCC
Confidence            54332     2233478889999988653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.7e-30  Score=257.11  Aligned_cols=169  Identities=28%  Similarity=0.426  Sum_probs=141.9

Q ss_pred             cccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhh--CCCCceeEEeeeecCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDE  402 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~~~~~~~  402 (504)
                      ..+.++|++++.||+|+||.||+|.+. +..||||++....      .  ..+.+|..++..  ++||||+++++++...
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE------E--ASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG------H--HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc------c--chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            345678999999999999999999876 8899999885321      1  223344455544  5899999999998776


Q ss_pred             ----CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEEcCCCcEEE
Q 010676          403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKL  470 (504)
Q Consensus       403 ----~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~--------gIIHRDLKP~NILLd~~g~VKL  470 (504)
                          ..+|+||||+.+++|.++++...+++..+..++.|++.||.|||++        ||+||||||+||||+.++.+||
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence                7899999999999999999988999999999999999999999998        9999999999999999999999


Q ss_pred             EecCcccccccCCc------ccccCCCcccccccccCC
Q 010676          471 ADFGLAKATKLNDV------KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       471 ~DFGLA~~~~~~~~------~s~~GT~~YmAPEVL~g~  502 (504)
                      +|||+++.......      ....||+.|+|||++.+.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  221 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES  221 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTC
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccc
Confidence            99999976543321      245799999999998764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=4.6e-30  Score=273.75  Aligned_cols=175  Identities=28%  Similarity=0.497  Sum_probs=145.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.+.|++++.||+|+||+||+|.+ .++..||+|++........   ....+.+|+.+|+.++||||+++++++.+...
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  110 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS---SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN  110 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C---TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch---HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            4556899999999999999999998 5889999999875432221   13567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~---g~VKL~DFGLA~~~~  480 (504)
                      +|+||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.+   +.+||+|||++....
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            9999999999999887654 569999999999999999999999999999999999999764   559999999998655


Q ss_pred             cCC-cccccCCCcccccccccCCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~~  503 (504)
                      ... ....+||+.|+|||++.+.+
T Consensus       191 ~~~~~~~~~gt~~y~aPE~l~~~~  214 (494)
T 3lij_A          191 NQKKMKERLGTAYYIAPEVLRKKY  214 (494)
T ss_dssp             TTBCBCCCCSCTTTCCHHHHTTCB
T ss_pred             CCccccccCCCcCeeCHHHHcccC
Confidence            432 44567999999999987653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=4.1e-30  Score=257.56  Aligned_cols=177  Identities=27%  Similarity=0.493  Sum_probs=152.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchh-hHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|++........ .......+.+|+.+++.++||||+++++++.+..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            4567899999999999999999998 5789999999875433211 1112356889999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----cEEEEecCcccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKA  478 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g----~VKL~DFGLA~~  478 (504)
                      .+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++..
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            999999999999999998764 488999999999999999999999999999999999999888    799999999986


Q ss_pred             cccC-CcccccCCCcccccccccCC
Q 010676          479 TKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .... ......||+.|+|||++.++
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~  193 (321)
T 2a2a_A          169 IEDGVEFKNIFGTPEFVAPEIVNYE  193 (321)
T ss_dssp             CCTTCCCCCCCSCGGGCCHHHHTTC
T ss_pred             cCccccccccCCCCCccCcccccCC
Confidence            5443 23456799999999998764

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=4.6e-30  Score=251.35  Aligned_cols=171  Identities=32%  Similarity=0.571  Sum_probs=142.0

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC---
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---  401 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~---  401 (504)
                      ++.++|++++.||+|+||.||+|.+ .++..||+|++...      ......+.+|+.+++.++||||+++++++..   
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (303)
T 1zy4_A            3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN   76 (303)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred             cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence            3467899999999999999999998 58999999988531      2334678899999999999999999998754   


Q ss_pred             ----------CCeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEE
Q 010676          402 ----------ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK  469 (504)
Q Consensus       402 ----------~~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VK  469 (504)
                                ...+|+||||+++++|.+++...  .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+|
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence                      45789999999999999999754  377788999999999999999999999999999999999999999


Q ss_pred             EEecCcccccccC----------------CcccccCCCcccccccccCC
Q 010676          470 LADFGLAKATKLN----------------DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       470 L~DFGLA~~~~~~----------------~~~s~~GT~~YmAPEVL~g~  502 (504)
                      |+|||++......                ......||+.|+|||++.+.
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  205 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT  205 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSC
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence            9999998764321                12345699999999998753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=7.3e-30  Score=272.83  Aligned_cols=178  Identities=28%  Similarity=0.469  Sum_probs=148.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchh--------hHHHHHHHHHHHHHHhhCCCCceeEEe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ--------AKQSISQLEQEIALLSRFEHENIVQYY  396 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~--------~~~~~~~~~~Ei~iL~~L~HpnIV~l~  396 (504)
                      .+.++|++++.||+|+||+||+|.+ .++..||+|++........        .......+.+|+.+|+.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4667899999999999999999998 5788999999865332110        012245688999999999999999999


Q ss_pred             eeecCCCeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEEEe
Q 010676          397 GTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLAD  472 (504)
Q Consensus       397 ~~~~~~~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g---~VKL~D  472 (504)
                      +++.+...+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++   .+||+|
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            999999999999999999999887754 5699999999999999999999999999999999999998776   699999


Q ss_pred             cCcccccccC-CcccccCCCcccccccccCCC
Q 010676          473 FGLAKATKLN-DVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       473 FGLA~~~~~~-~~~s~~GT~~YmAPEVL~g~~  503 (504)
                      ||++...... .....+||+.|+|||++.+.+
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  224 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKY  224 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHTTCB
T ss_pred             CCCCEEcCCCCccccccCCcCCCCHHHhccCC
Confidence            9999865543 345567999999999988653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=6.2e-30  Score=252.90  Aligned_cols=177  Identities=29%  Similarity=0.422  Sum_probs=150.6

Q ss_pred             ccccccccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeE
Q 010676          322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ  394 (504)
Q Consensus       322 ~~~~~~~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~  394 (504)
                      ..+....++|++++.||+|+||.||+|.+      .++..||+|++.....    ......+.+|+.++.++ +||||++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~i~~   91 (313)
T 1t46_A           16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHMNIVN   91 (313)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh----HHHHHHHHHHHHHHhhcccCCCeee
Confidence            34445567899999999999999999984      4678999998864321    22346788999999999 8999999


Q ss_pred             EeeeecCCCeEEEEEEeccCCCHHHHHHhcC-------------------CChHHHHHHHHHHHHHHHHHHHCCceecCC
Q 010676          395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDI  455 (504)
Q Consensus       395 l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~-------------------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDL  455 (504)
                      +++++...+.+|+||||+++++|.+++....                   +++..+..++.||+.||.|||++||+||||
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl  171 (313)
T 1t46_A           92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL  171 (313)
T ss_dssp             EEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence            9999999999999999999999999987643                   889999999999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEEecCcccccccCCc----ccccCCCcccccccccCC
Q 010676          456 KCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       456 KP~NILLd~~g~VKL~DFGLA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      ||+|||++.++.+||+|||++........    ....+|+.|+|||++.+.
T Consensus       172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  222 (313)
T 1t46_A          172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC  222 (313)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC
T ss_pred             ccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC
Confidence            99999999999999999999986544322    234478899999987643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=1.4e-29  Score=261.58  Aligned_cols=171  Identities=26%  Similarity=0.480  Sum_probs=141.8

Q ss_pred             ccceee--eeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          328 ITYWQK--GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       328 ~~~y~i--~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...|.+  .+.||+|+||.||+|.+ .+|..||+|++....     ......+.+|+.+|++++||||+++++++.+.+.
T Consensus        86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKND  160 (373)
T ss_dssp             GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            344555  67899999999999997 679999999987532     1234578899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE--cCCCcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL--d~~g~VKL~DFGLA~~~~  480 (504)
                      +||||||+++++|.+++...  .+++..+..++.||+.||.|||++||+||||||+||||  +.++.+||+|||+++...
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            99999999999999887543  58999999999999999999999999999999999999  567899999999998765


Q ss_pred             cCC-cccccCCCcccccccccCCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~~  503 (504)
                      ... ....+||+.|+|||++.++.
T Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~  264 (373)
T 2x4f_A          241 PREKLKVNFGTPEFLAPEVVNYDF  264 (373)
T ss_dssp             TTCBCCCCCSSCTTCCHHHHTTCB
T ss_pred             CccccccccCCCcEeChhhccCCC
Confidence            433 34456999999999987653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=4.6e-30  Score=259.34  Aligned_cols=167  Identities=28%  Similarity=0.421  Sum_probs=127.8

Q ss_pred             ccceeee---eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCC
Q 010676          328 ITYWQKG---DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE  402 (504)
Q Consensus       328 ~~~y~i~---k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~  402 (504)
                      .++|++.   +.||+|+||.||+|.+ .++..||||++...        ....+.+|+.+++.+. ||||+++++++.+.
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~   78 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ   78 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            3456664   7899999999999998 57899999988632        1245678999999997 99999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEEEecCcccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKA  478 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g---~VKL~DFGLA~~  478 (504)
                      ..+|+||||+.+++|.+++... .+++..+..|+.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            9999999999999999988765 489999999999999999999999999999999999998766   899999999976


Q ss_pred             cccC--CcccccCCCcccccccccCC
Q 010676          479 TKLN--DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~--~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....  .....+||+.|+|||++.+.
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~  184 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELLNQN  184 (325)
T ss_dssp             CCC----------------------C
T ss_pred             cCCCCCcccccCCCcCccCHHHhcCC
Confidence            5433  23456789999999998764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.97  E-value=5.5e-30  Score=284.82  Aligned_cols=175  Identities=25%  Similarity=0.376  Sum_probs=150.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~  403 (504)
                      ..+++|+++++||+|+||.||+|.+ .++..||||++.....  ........+..|..+|..+ +||||+++++++.+.+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH--HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            3467899999999999999999998 5788999999874221  1122235677899999887 6999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc--
Q 010676          404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--  480 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~--  480 (504)
                      .+||||||+.+|+|..++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++...  
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            99999999999999998876 569999999999999999999999999999999999999999999999999998633  


Q ss_pred             cCCcccccCCCcccccccccCC
Q 010676          481 LNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .......+||+.|||||++.++
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~~  517 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAYQ  517 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTCC
T ss_pred             CcccccccCCCcccCHhhhcCC
Confidence            2234567899999999999764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.96  E-value=3.9e-30  Score=261.30  Aligned_cols=171  Identities=27%  Similarity=0.421  Sum_probs=149.5

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .++|++.+.||+|+||.||+|.+ .++..||+|++....    .......+.+|+.+++.++||||+++++++...+.+|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            46899999999999999999998 588999999886532    2333467889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      +||||+++++|.+++... .+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++........
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  187 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  187 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc
Confidence            999999999999998764 689999999999999999999996 999999999999999999999999999976554445


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....||+.|+|||++.+.
T Consensus       188 ~~~~gt~~y~aPE~~~~~  205 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGT  205 (360)
T ss_dssp             ---CCCCTTCCHHHHTTC
T ss_pred             cCCCCCCCeECHHHHcCC
Confidence            566799999999998765

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.96  E-value=8.5e-30  Score=258.24  Aligned_cols=170  Identities=24%  Similarity=0.435  Sum_probs=143.9

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC--CceeEEeeeecCCCe
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESK  404 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~~~~~~~~  404 (504)
                      ..+.|++++.||+|+||.||++.+.++..||||++.....   .......+.+|+.+|..++|  +||+++++++.....
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc---chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            3467999999999999999999998899999999875432   23445678899999999986  999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +|+||| +.+++|.+++... .+++..+..|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++......
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999999 5577999988764 589999999999999999999999999999999999996 7889999999998654332


Q ss_pred             ----cccccCCCcccccccccC
Q 010676          484 ----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ----~~s~~GT~~YmAPEVL~g  501 (504)
                          ....+||+.|+|||++.+
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~  183 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKD  183 (343)
T ss_dssp             --------CCCCSSCCHHHHHH
T ss_pred             ccccCCCCcCCcCcCCHHHHhh
Confidence                234579999999999853

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=1.8e-30  Score=259.47  Aligned_cols=174  Identities=30%  Similarity=0.454  Sum_probs=149.1

Q ss_pred             ccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +....++|++.+.||+|+||.||+|...++..||+|++.......    ....+.+|+.+++.++||||+++++++.+..
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             HHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred             HHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch----HHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence            445567899999999999999999998889999999876432211    1125789999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CceecCCCCCcEEEcCCCcEEEEecCc
Q 010676          404 KLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQ---DVVHRDIKCANILVDANGSVKLADFGL  475 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~-----l~e~~v~~i~~QIl~gL~yLHs~---gIIHRDLKP~NILLd~~g~VKL~DFGL  475 (504)
                      .+|+||||+.+++|.+++....     +++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence            9999999999999999997643     88999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCC---cccccCCCcccccccccC
Q 010676          476 AKATKLND---VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       476 A~~~~~~~---~~s~~GT~~YmAPEVL~g  501 (504)
                      +.......   .....||+.|+|||++.+
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  209 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLST  209 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHH
T ss_pred             ccccCcccccccccccCCcCccCHHHhcc
Confidence            98654332   234459999999998854

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=6.9e-30  Score=246.99  Aligned_cols=170  Identities=22%  Similarity=0.332  Sum_probs=148.2

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      -.++|++.+.||+|+||.||+|.+.++..||+|.+......      ...+.+|+.+++.++||||+++++++...+.+|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            34689999999999999999999988899999998643322      146789999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      +||||+++++|.+++...  .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... 
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            999999999999998764  38999999999999999999999999999999999999999999999999987653221 


Q ss_pred             --cccccCCCcccccccccCC
Q 010676          484 --VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 --~~s~~GT~~YmAPEVL~g~  502 (504)
                        .....+|+.|+|||++.+.
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~  180 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFS  180 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHC
T ss_pred             cccccccccccccChhhhcCC
Confidence              2334578899999998643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.96  E-value=6.9e-30  Score=266.20  Aligned_cols=167  Identities=27%  Similarity=0.387  Sum_probs=135.8

Q ss_pred             ccccceeee-eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHH-hhCCCCceeEEeeeecC-
Q 010676          326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYYGTDKD-  401 (504)
Q Consensus       326 ~~~~~y~i~-k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIV~l~~~~~~-  401 (504)
                      .+.+.|.+. ++||+|+||+||+|.+ .++..||||++...          ..+.+|+.++ +..+||||++++++|.. 
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            345667776 7999999999999998 57899999988521          2355788776 45689999999998765 


Q ss_pred             ---CCeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEe
Q 010676          402 ---ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLAD  472 (504)
Q Consensus       402 ---~~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~---~g~VKL~D  472 (504)
                         ...+||||||+.+|+|.+++...   .+++..+..|+.||+.||.|||++||+||||||+||||+.   ++.+||+|
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence               66799999999999999999764   3899999999999999999999999999999999999997   78999999


Q ss_pred             cCcccccccC-CcccccCCCcccccccccCC
Q 010676          473 FGLAKATKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       473 FGLA~~~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||+++..... .....+||+.|||||++.++
T Consensus       208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  238 (400)
T 1nxk_A          208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPE  238 (400)
T ss_dssp             CTTCEECC-----------CTTCCGGGSCCC
T ss_pred             cccccccCCCCccccCCCCCCccCHhhcCCC
Confidence            9999865433 24556799999999999764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.96  E-value=1.9e-29  Score=248.21  Aligned_cols=176  Identities=26%  Similarity=0.437  Sum_probs=151.6

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccc----hhhHHHHHHHHHHHHHHhhCC-CCceeEEeee
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG----SQAKQSISQLEQEIALLSRFE-HENIVQYYGT  398 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~----~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~  398 (504)
                      ..+.++|++.+.||+|+||.||+|.+ .++..||+|++......    .........+.+|+.+++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            35667999999999999999999998 57899999998754321    122334566889999999996 9999999999


Q ss_pred             ecCCCeEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          399 DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       399 ~~~~~~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      +.....+|+||||+++++|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence            99999999999999999999988754 68999999999999999999999999999999999999999999999999987


Q ss_pred             ccccC-CcccccCCCccccccccc
Q 010676          478 ATKLN-DVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       478 ~~~~~-~~~s~~GT~~YmAPEVL~  500 (504)
                      ..... ......||+.|+|||++.
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~  196 (298)
T 1phk_A          173 QLDPGEKLREVCGTPSYLAPEIIE  196 (298)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred             hcCCCcccccccCCccccCHHHhc
Confidence            65433 244557999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.96  E-value=4.1e-30  Score=251.85  Aligned_cols=167  Identities=19%  Similarity=0.315  Sum_probs=144.6

Q ss_pred             ccceeeeeeecccCceeEEEEEcc-CC-------ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD-DG-------FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  399 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~-~g-------~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~  399 (504)
                      .++|++.+.||+|+||.||+|.+. ++       ..||+|.+....     ......+.+|+.+++.++||||+++++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-----RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-----GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-----HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            468999999999999999999874 33       469999875422     22235688999999999999999999999


Q ss_pred             cCCCeEEEEEEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc--------EE
Q 010676          400 KDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--------VK  469 (504)
Q Consensus       400 ~~~~~lyLVmEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~--------VK  469 (504)
                      ...+.+|+||||+.+++|.+++....  +++..+..++.||+.||.|||++||+||||||+||||+.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999999997654  899999999999999999999999999999999999998887        99


Q ss_pred             EEecCcccccccCCcccccCCCcccccccccC
Q 010676          470 LADFGLAKATKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       470 L~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      |+|||++......  ....||+.|+|||++.+
T Consensus       162 l~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~  191 (289)
T 4fvq_A          162 LSDPGISITVLPK--DILQERIPWVPPECIEN  191 (289)
T ss_dssp             ECCCCSCTTTSCH--HHHHHTTTTSCHHHHHC
T ss_pred             eccCcccccccCc--cccCCcCcccCHHHhCC
Confidence            9999998654322  33458999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.96  E-value=8.4e-30  Score=252.63  Aligned_cols=172  Identities=31%  Similarity=0.470  Sum_probs=148.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|.+.+.||+|+||.||+|.+ .+|..||+|++.....     .....+.+|+.+++.++||||+++++++.....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-----FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH   80 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-----cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence            3457899999999999999999998 5899999999874322     122467899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL---d~~g~VKL~DFGLA~~~~  480 (504)
                      +|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999999999988764 458999999999999999999999999999999999999   788999999999987655


Q ss_pred             cCCcccccCCCcccccccccCC
Q 010676          481 LNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ........||+.|+|||++.+.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~  182 (304)
T 2jam_A          161 NGIMSTACGTPGYVAPEVLAQK  182 (304)
T ss_dssp             CBTTHHHHSCCCBCCTTTBSSC
T ss_pred             CCccccccCCCCccChHHhccC
Confidence            4444455699999999998765

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.96  E-value=1.4e-29  Score=250.60  Aligned_cols=172  Identities=38%  Similarity=0.661  Sum_probs=152.3

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ..+.|++++.||+|+||.||+|.+ .++..||+|++.......    ....+.+|+.+++.++||||+++++++.....+
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED----EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST----THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH----HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            345799999999999999999987 578999999987543222    245688999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--
Q 010676          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--  483 (504)
                      |+||||+++++|.+++....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......  
T Consensus        96 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  175 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  175 (303)
T ss_dssp             EEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred             EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence            999999999999999998889999999999999999999999999999999999999999999999999997654332  


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....||+.|+|||++.+.
T Consensus       176 ~~~~~~~~~y~aPE~~~~~  194 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQS  194 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTC
T ss_pred             cCccCCCcCccCHHHHhcC
Confidence            3345699999999998764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.96  E-value=3.6e-30  Score=273.04  Aligned_cols=176  Identities=30%  Similarity=0.498  Sum_probs=151.7

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++.+.||+|+||.||+|.+ .++..||||++.......  ......+.+|+.+++.++||||+++++++.+...
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB--SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc--chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            4567899999999999999999998 589999999986543221  1123568899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL---d~~g~VKL~DFGLA~~~~  480 (504)
                      +|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++...
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            9999999999999987755 469999999999999999999999999999999999999   567899999999997654


Q ss_pred             cCC-cccccCCCcccccccccCCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~~  503 (504)
                      ... ....+||+.|+|||++.+.+
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~  204 (484)
T 3nyv_A          181 ASKKMKDKIGTAYYIAPEVLHGTY  204 (484)
T ss_dssp             CCCSHHHHTTGGGTCCHHHHHTCC
T ss_pred             cccccccCCCCccccCceeecCCC
Confidence            333 34567999999999987753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.96  E-value=9.3e-30  Score=256.01  Aligned_cols=176  Identities=31%  Similarity=0.453  Sum_probs=147.6

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      +-..+++|++++.||+|+||.||+|.+ .++..||+|++......   ......+.+|+.+++.++||||+++++++...
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   96 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD---KMVKKIAMREIKLLKQLRHENLVNLLEVCKKK   96 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc---hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence            335578999999999999999999998 56899999988644322   33345678999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHH-hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~-~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      +.+|+||||+.+++|..++. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999999999999988765 35699999999999999999999999999999999999999999999999999976443


Q ss_pred             C--CcccccCCCcccccccccCC
Q 010676          482 N--DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~--~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .  ......||+.|+|||++.+.
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~  199 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGD  199 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTC
T ss_pred             CccccCCCcCCccccCcccccCC
Confidence            2  23445699999999998764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.96  E-value=1e-29  Score=248.20  Aligned_cols=176  Identities=27%  Similarity=0.465  Sum_probs=147.7

Q ss_pred             cccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhh-HHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      +.++|++++.||+|+||.||+|.+. ++..||+|++......... ......+.+|+.+++.++||||+++++++.....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            3468999999999999999999984 7999999998754322111 1123568899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----cEEEEecCccccc
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKAT  479 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g----~VKL~DFGLA~~~  479 (504)
                      +|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++    .+||+|||++...
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            9999999999999998865 4689999999999999999999999999999999999998877    8999999998765


Q ss_pred             ccC-CcccccCCCcccccccccCC
Q 010676          480 KLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... ......||+.|+|||++.++
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~  186 (283)
T 3bhy_A          163 EAGNEFKNIFGTPEFVAPEIVNYE  186 (283)
T ss_dssp             C--------CCCGGGCCHHHHTTC
T ss_pred             cCCCcccccCCCcCccCcceecCC
Confidence            433 23445699999999998764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.96  E-value=1.2e-29  Score=247.02  Aligned_cols=175  Identities=30%  Similarity=0.474  Sum_probs=143.7

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...++|++++.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.+++.++||||+++++++...+.
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc--cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            3457899999999999999999998 4899999998864221  112224568899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      +|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            9999999999999998865 468999999999999999999999999999999999999999999999999987654432


Q ss_pred             -cccccCCCcccccccccCC
Q 010676          484 -VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g~  502 (504)
                       .....||+.|+|||++.+.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~  185 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGR  185 (276)
T ss_dssp             -----------CCTGGGTTS
T ss_pred             ceecccCCccccCHHHHcCC
Confidence             3345699999999998865

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.96  E-value=6.3e-30  Score=248.42  Aligned_cols=172  Identities=28%  Similarity=0.534  Sum_probs=150.5

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      +.++|++++.||+|+||.||+|.+ .++..||+|++......    .....+.+|+.+++.++||||+++++++.+.+.+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV----DCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   80 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT----THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch----hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE
Confidence            467899999999999999999998 47899999998653322    2345688999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      |+||||+++++|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            9999999999999888654 68999999999999999999999999999999999999999999999999987654322 


Q ss_pred             ---cccccCCCcccccccccCC
Q 010676          484 ---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ---~~s~~GT~~YmAPEVL~g~  502 (504)
                         .....||+.|+|||++.+.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~  182 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRR  182 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCS
T ss_pred             hhcccCCccccCccChHHHhcC
Confidence               3445699999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.96  E-value=4.2e-30  Score=264.12  Aligned_cols=171  Identities=29%  Similarity=0.432  Sum_probs=144.5

Q ss_pred             ccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      .++|++++.||+|+||.||+|..      .++..||||.+....    .......+.+|+.+++.++||||+++++++..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc----ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            46899999999999999999984      367789999875321    22334568899999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEE
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRYH--------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKL  470 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~~--------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g---~VKL  470 (504)
                      ...+|+||||+.+|+|.+++....        +++..++.++.||+.||.|||++||+||||||+||||+.+|   .+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999999997643        88899999999999999999999999999999999999555   5999


Q ss_pred             EecCccccccc----CCcccccCCCcccccccccCC
Q 010676          471 ADFGLAKATKL----NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       471 ~DFGLA~~~~~----~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      +|||+++....    .......||+.|||||++.++
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  261 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG  261 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCC
Confidence            99999975422    122345589999999988643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.96  E-value=4.1e-30  Score=264.82  Aligned_cols=174  Identities=26%  Similarity=0.432  Sum_probs=148.3

Q ss_pred             ccccccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      +....++|++++.||+|+||.||+|.+. ++..||||.+....    .......+.+|+.+++.++||||+++++++...
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL----PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS----CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            3344568999999999999999999984 88999999875321    123345688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      +.+|+||||+++|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            9999999999999999998754  48999999999999999999999999999999999999999999999999997644


Q ss_pred             cCCcc----cccCCCcccccccccC
Q 010676          481 LNDVK----SCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~~~~----s~~GT~~YmAPEVL~g  501 (504)
                      .....    ...+++.|+|||++.+
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~  289 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNY  289 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHH
T ss_pred             CCceeecCCCCCCCcCcCCHhHhcc
Confidence            33221    1235778999998864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.96  E-value=1.2e-29  Score=250.15  Aligned_cols=171  Identities=31%  Similarity=0.507  Sum_probs=144.2

Q ss_pred             ccceeeeeeecccCceeEEEEE----c-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~----~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .++|++++.||+|+||.||+|.    + .++..||+|++.....    ......+.+|+.+++.++||||+++++++...
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG----GNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            3579999999999999999998    2 5789999998864322    12235688999999999999999999999876


Q ss_pred             --CeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          403 --SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       403 --~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                        ..+|+||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence              6799999999999999998543  589999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC-----cccccCCCcccccccccCC
Q 010676          479 TKLND-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....     .....||..|+|||++.+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  204 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQS  204 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHC
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCC
Confidence            55432     2334588899999987643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=7.2e-30  Score=256.98  Aligned_cols=175  Identities=27%  Similarity=0.435  Sum_probs=146.8

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEe
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  396 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~  396 (504)
                      +....++|++++.||+|+||.||+|.+      .++..||+|++....    .......+.+|+.++.++ +||||++++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~  115 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLL  115 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            334457899999999999999999986      356789999886322    122346788999999999 899999999


Q ss_pred             eeecCCCeEEEEEEeccCCCHHHHHHhcC------------------------CChHHHHHHHHHHHHHHHHHHHCCcee
Q 010676          397 GTDKDESKLYIFLELVTKGSLLNLYQRYH------------------------LRDSQVSAYTRQILLGLKYLHDQDVVH  452 (504)
Q Consensus       397 ~~~~~~~~lyLVmEy~~ggsL~~ll~~~~------------------------l~e~~v~~i~~QIl~gL~yLHs~gIIH  452 (504)
                      +++...+.+|+||||+++++|.+++....                        +++..+..++.||+.||.|||++||+|
T Consensus       116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  195 (344)
T 1rjb_A          116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  195 (344)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            99999999999999999999999987542                        688899999999999999999999999


Q ss_pred             cCCCCCcEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       453 RDLKP~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |||||+||||+.++.+||+|||++.......    .....||+.|+|||++.++
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  249 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG  249 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC
Confidence            9999999999999999999999998654332    1234578899999988643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.96  E-value=4.2e-30  Score=259.05  Aligned_cols=172  Identities=23%  Similarity=0.414  Sum_probs=138.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ..+++|++++.||+|+||.||+|.+ .++..||||++.....   .......+.+|+.+++.++||||+++++++.+.+.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc---ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            4567899999999999999999997 6899999998864322   22234567799999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-----CCCcEEEEecCcccc
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-----ANGSVKLADFGLAKA  478 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd-----~~g~VKL~DFGLA~~  478 (504)
                      +|+||||+.+ +|.+++... .+++..+..|+.||+.||.|||++||+||||||+||||+     .++.+||+|||+++.
T Consensus       108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9999999986 898888764 599999999999999999999999999999999999994     455699999999976


Q ss_pred             cccC--CcccccCCCcccccccccC
Q 010676          479 TKLN--DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       479 ~~~~--~~~s~~GT~~YmAPEVL~g  501 (504)
                      ....  ......||+.|+|||++.+
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~  211 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLG  211 (329)
T ss_dssp             HC-----------CCTTCCHHHHTT
T ss_pred             cCCcccccCCCcCCccccCHHHhcC
Confidence            5422  2344568999999999876

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.96  E-value=1.7e-30  Score=261.07  Aligned_cols=170  Identities=26%  Similarity=0.415  Sum_probs=138.8

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCce----EEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~----vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .++|++++.||+|+||.||+|.+ .++..    |++|.+.....    ......+.+|+.++..++||||+++++++. .
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG----RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS----CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc----HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            35899999999999999999997 45555    66665532211    111234668999999999999999999986 5


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      ..+|+||||+.+++|.+++...  .+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            6799999999999999988753  68999999999999999999999999999999999999999999999999998754


Q ss_pred             cCC----cccccCCCcccccccccCC
Q 010676          481 LND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...    .....||+.|+|||++.++
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~  192 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFG  192 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHC
T ss_pred             cccccccccCCCCcccccChHHhccC
Confidence            332    2344588899999998743

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.96  E-value=1.3e-29  Score=262.98  Aligned_cols=169  Identities=23%  Similarity=0.436  Sum_probs=144.3

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC--CCceeEEeeeecCCCeE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDESKL  405 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~~~~~~~~l  405 (504)
                      .+.|++++.||+|+||.||+|.+.++..||||++.....   .......+.+|+.+|..++  ||||+++++++...+.+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc---cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            457999999999999999999998899999999875432   2344567889999999997  59999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      ||||| +.+++|.+++... .+++..+..|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++...... 
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            99999 5677999988764 588889999999999999999999999999999999995 6899999999998654332 


Q ss_pred             ---cccccCCCcccccccccC
Q 010676          484 ---VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ---~~s~~GT~~YmAPEVL~g  501 (504)
                         ....+||+.|||||++.+
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~  230 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKD  230 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHC
T ss_pred             cccCCCCCcCCCccChHHhhh
Confidence               234579999999999865

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.96  E-value=1.6e-29  Score=258.28  Aligned_cols=171  Identities=29%  Similarity=0.519  Sum_probs=147.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--  402 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|++....    .......+.+|+.+|..++||||+++++++...  
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc----CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            4456899999999999999999998 588999999886422    233346788999999999999999999998654  


Q ss_pred             ---CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       403 ---~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                         ..+|+||||+.+ +|.+++....+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus       100 ~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          100 EQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             TTCCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence               469999999985 8999999889999999999999999999999999999999999999999999999999999765


Q ss_pred             ccCC-----cccccCCCcccccccccC
Q 010676          480 KLND-----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       480 ~~~~-----~~s~~GT~~YmAPEVL~g  501 (504)
                      ....     ....+||+.|+|||++.+
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~  205 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLN  205 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHT
T ss_pred             CCCCCccccccccccccCCCCCHHhcC
Confidence            4322     234579999999998653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.96  E-value=1.3e-29  Score=254.00  Aligned_cols=168  Identities=29%  Similarity=0.424  Sum_probs=138.5

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee-----cC
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-----KD  401 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~-----~~  401 (504)
                      ..++|++++.||+|+||.||+|.. ++..||||++.....    .  ....+.++..+..++|+||+++++.+     ..
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~----~--~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR----Q--NFINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH----H--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch----h--hHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            357899999999999999999976 688999999864221    1  11123444445568999999998743     33


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCcEEEcCCCcEEEEe
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---------DVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~---------gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                      ...+|+||||+++|+|.+++.....++..+..++.||+.||.|||++         ||+||||||+||||+.++.+||+|
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             CceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            45689999999999999999988899999999999999999999999         999999999999999999999999


Q ss_pred             cCcccccccCC----------cccccCCCcccccccccC
Q 010676          473 FGLAKATKLND----------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       473 FGLA~~~~~~~----------~~s~~GT~~YmAPEVL~g  501 (504)
                      ||+++......          ....+||+.|+|||++.+
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG  202 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence            99997654221          224469999999999976

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.96  E-value=1.8e-29  Score=250.70  Aligned_cols=171  Identities=29%  Similarity=0.457  Sum_probs=141.7

Q ss_pred             ccccceeee-eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCC
Q 010676          326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE  402 (504)
Q Consensus       326 ~~~~~y~i~-k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~  402 (504)
                      ++.+.|++. +.||+|+||.||+|.+ .++..||||++......     ....+.+|+.++.++ +||||+++++++.+.
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-----IRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC-----CHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch-----hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            345678885 7899999999999997 58999999998653221     134678999999885 799999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc---EEEEecCcccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKA  478 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~---VKL~DFGLA~~  478 (504)
                      +.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999999998865 45899999999999999999999999999999999999988776   99999999875


Q ss_pred             cccCC---------cccccCCCcccccccccC
Q 010676          479 TKLND---------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       479 ~~~~~---------~~s~~GT~~YmAPEVL~g  501 (504)
                      .....         ....+||+.|+|||++.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  195 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEA  195 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhc
Confidence            43221         223459999999999853

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.96  E-value=7.8e-30  Score=250.10  Aligned_cols=174  Identities=30%  Similarity=0.449  Sum_probs=136.6

Q ss_pred             ccccccceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  399 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~  399 (504)
                      +....++|++++.||+|+||.||+|.+.    .+..||+|.+....    .......+.+|+.+++.++||||+++++++
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence            3445678999999999999999999873    34578898765321    233456788999999999999999999998


Q ss_pred             cCCCeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          400 KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       400 ~~~~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      . ++.+|+||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence            4 56789999999999999998754  48999999999999999999999999999999999999999999999999997


Q ss_pred             ccccCC---cccccCCCcccccccccCC
Q 010676          478 ATKLND---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       478 ~~~~~~---~~s~~GT~~YmAPEVL~g~  502 (504)
                      ......   .....+|+.|+|||++.++
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~  192 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFR  192 (281)
T ss_dssp             --------------CCGGGCCHHHHHHC
T ss_pred             ccCcccccccccCCCcccccChhhcccC
Confidence            654332   2233478899999998643

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.96  E-value=1.7e-29  Score=252.14  Aligned_cols=176  Identities=28%  Similarity=0.368  Sum_probs=144.0

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      ....++|++.+.||+|+||.||+|.+ .++..||+|++.....  ........+.+|+.++..++||||+++++++...+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS--SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG--GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc--cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            34567899999999999999999998 5789999998754322  22344567889999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .+|+||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999999999988764 5999999999999999999999999999999999999999999999999998765433


Q ss_pred             C---cccccCCCcccccccccCC
Q 010676          483 D---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~---~~s~~GT~~YmAPEVL~g~  502 (504)
                      .   .....||+.|+|||++.+.
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~  210 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSES  210 (309)
T ss_dssp             ---------CCGGGCCGGGTCC-
T ss_pred             ccccccccCCCcCccCHHHHcCC
Confidence            2   2345699999999998764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.96  E-value=8.5e-30  Score=260.24  Aligned_cols=167  Identities=31%  Similarity=0.434  Sum_probs=142.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~  403 (504)
                      .+.+.|++++.||+|+||.||+|.+ .++..||+|++......         ..+|+.++.++ +||||+++++++.+..
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---------PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            4567899999999999999999998 57899999998653321         23677777776 7999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC----CcEEEEecCcccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLADFGLAKA  478 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~----g~VKL~DFGLA~~  478 (504)
                      .+|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+..+    +.+||+|||+++.
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999999999999988654 58999999999999999999999999999999999998533    3599999999986


Q ss_pred             cccC--CcccccCCCcccccccccC
Q 010676          479 TKLN--DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       479 ~~~~--~~~s~~GT~~YmAPEVL~g  501 (504)
                      ....  .....+||+.|+|||++.+
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~  194 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLER  194 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHH
T ss_pred             CcCCCCceeccCCCccccCHHHhcC
Confidence            5433  2345679999999999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.96  E-value=5.2e-30  Score=258.15  Aligned_cols=170  Identities=26%  Similarity=0.456  Sum_probs=136.3

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceE----EEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~v----AVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .++|++.+.||+|+||.||+|.+ .++..+    |+|.+..    .........+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            45799999999999999999997 455554    6665432    12223346788999999999999999999999875


Q ss_pred             CeEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      . .++||+|+.+|+|.+++..  ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            4 8899999999999998876  348999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC----cccccCCCcccccccccCC
Q 010676          481 LND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...    .....+|+.|+|||++.++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~  194 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHR  194 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHC
T ss_pred             CCcccccccCCCccccccChHHhccC
Confidence            332    1233478899999988654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.5e-30  Score=264.37  Aligned_cols=174  Identities=28%  Similarity=0.443  Sum_probs=146.9

Q ss_pred             cccceeeeeeecccCceeEEEEEc----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecC
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD  401 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~  401 (504)
                      .+++|++++.||+|+||.||+|.+    .++..||||++........ ......+.+|+.+|..+ +||||+++++++..
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh-hhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            357899999999999999999987    4789999998854321100 01123456789999998 69999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      .+.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            9999999999999999998865 459999999999999999999999999999999999999999999999999997643


Q ss_pred             cCC---cccccCCCcccccccccC
Q 010676          481 LND---VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~~---~~s~~GT~~YmAPEVL~g  501 (504)
                      ...   ....+||+.|+|||++.+
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~  234 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRG  234 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred             cCCCCcccCcccCcCccChhhhcC
Confidence            222   234579999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.96  E-value=1e-29  Score=259.73  Aligned_cols=175  Identities=21%  Similarity=0.323  Sum_probs=140.3

Q ss_pred             cccceeeeeeecccCceeEEEEEccC------CceEEEEEEeccccchhhH-HH-----HHHHHHHHHHHhhCCCCceeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAK-QS-----ISQLEQEIALLSRFEHENIVQ  394 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~------g~~vAVK~v~~~~~~~~~~-~~-----~~~~~~Ei~iL~~L~HpnIV~  394 (504)
                      ..++|++++.||+|+||.||+|.+..      +..||||++.......... ..     ...+.+|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34589999999999999999998843      5789999886533211111 00     112345667788899999999


Q ss_pred             EeeeecCC----CeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--CCC
Q 010676          395 YYGTDKDE----SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANG  466 (504)
Q Consensus       395 l~~~~~~~----~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd--~~g  466 (504)
                      +++++...    ..+||||||+ +++|.+++...  .+++..+..|+.||+.||.|||++||+||||||+||||+  .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            99998764    5589999999 89999999764  599999999999999999999999999999999999999  889


Q ss_pred             cEEEEecCcccccccCC---------cccccCCCcccccccccCC
Q 010676          467 SVKLADFGLAKATKLND---------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       467 ~VKL~DFGLA~~~~~~~---------~~s~~GT~~YmAPEVL~g~  502 (504)
                      .+||+|||+++......         ....+||+.|||||++.+.
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  236 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV  236 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC
Confidence            99999999997643221         1334599999999998875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.96  E-value=1.5e-29  Score=244.18  Aligned_cols=169  Identities=16%  Similarity=0.260  Sum_probs=147.3

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--Ce
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK  404 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--~~  404 (504)
                      ..++|++.+.||+|+||.||+|.+. +..||+|++......   ......+.+|+.+++.++||||+++++++.+.  ..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWS---TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCC---HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccC---HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence            4568999999999999999999985 889999988754322   23346788999999999999999999999887  78


Q ss_pred             EEEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          405 LYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      +|+||||+++++|.+++....   +++..+..++.||+.||.|||++|  |+||||||+|||++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999999999999999998754   899999999999999999999999  999999999999999999999999987543


Q ss_pred             ccCCcccccCCCcccccccccCC
Q 010676          480 KLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..   ....||+.|+|||++.+.
T Consensus       164 ~~---~~~~~t~~y~aPE~~~~~  183 (271)
T 3kmu_A          164 QS---PGRMYAPAWVAPEALQKK  183 (271)
T ss_dssp             SC---TTCBSCGGGSCHHHHHSC
T ss_pred             cc---cCccCCccccChhhhccC
Confidence            32   234689999999998764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.96  E-value=9.4e-30  Score=247.78  Aligned_cols=168  Identities=30%  Similarity=0.518  Sum_probs=145.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC---
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---  401 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~---  401 (504)
                      .+..+|++.+.||+|+||.||+|.+. ++..||+|.+....         ..+.+|+.+++.++||||+++++++..   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence            45678999999999999999999984 89999999886432         235689999999999999999998754   


Q ss_pred             -------------CCeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC
Q 010676          402 -------------ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN  465 (504)
Q Consensus       402 -------------~~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~  465 (504)
                                   ...+|+||||+++++|.+++...   .+++..+..++.||+.||.|||++||+|+||||+|||++.+
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence                         45589999999999999998653   58999999999999999999999999999999999999999


Q ss_pred             CcEEEEecCcccccccCC-cccccCCCcccccccccCC
Q 010676          466 GSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       466 g~VKL~DFGLA~~~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      +.+||+|||++....... .....||+.|+|||++.+.
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ  196 (284)
T ss_dssp             TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS
T ss_pred             CCEEECcchhheeccccccccccCCcccccChhhhccC
Confidence            999999999987655432 3445699999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.96  E-value=9.1e-30  Score=249.24  Aligned_cols=173  Identities=28%  Similarity=0.438  Sum_probs=149.6

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      +....++|++.+.||+|+||.||+|.+ .++..||+|.+....      .....+.+|+.+++.++||||+++++++...
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   81 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS------THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            445567899999999999999999998 468899999886322      1245688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ..+|+||||+.+++|.+++...   .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            9999999999999999999753   3899999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCc---ccccCCCcccccccccCC
Q 010676          480 KLNDV---KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~~---~s~~GT~~YmAPEVL~g~  502 (504)
                      .....   ....+|+.|+|||++.+.
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~  187 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYN  187 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHC
T ss_pred             cCCccccccCCccccCcCChhhhccC
Confidence            54332   223478899999988643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.96  E-value=1.5e-29  Score=251.99  Aligned_cols=175  Identities=25%  Similarity=0.387  Sum_probs=148.2

Q ss_pred             ccccccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEee
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG  397 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~  397 (504)
                      +....++|++.+.||+|+||.||+|.+.      ++..||+|.+....    .......+.+|+.+++.++||||+++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc----CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            4455678999999999999999999864      47889999875322    1233456889999999999999999999


Q ss_pred             eecCCCeEEEEEEeccCCCHHHHHHh-----------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 010676          398 TDKDESKLYIFLELVTKGSLLNLYQR-----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  466 (504)
Q Consensus       398 ~~~~~~~lyLVmEy~~ggsL~~ll~~-----------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g  466 (504)
                      ++.+.+.+|+||||+.+++|.+++..           ..+++..+..++.||+.||.|||++||+||||||+||||+.++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            99999999999999999999998865           2368899999999999999999999999999999999999999


Q ss_pred             cEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          467 SVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       467 ~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      .+||+|||+++......    .....+|+.|+|||++.++
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  215 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG  215 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccC
Confidence            99999999987654322    2233578999999998654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.96  E-value=4.2e-30  Score=264.88  Aligned_cols=173  Identities=30%  Similarity=0.470  Sum_probs=131.6

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .-.+.++|++++.||+|+||.||+|.+ .+|..||||++....   ........+.+|+.+|+.++||||+++++++...
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA  100 (367)
T ss_dssp             EEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            335568999999999999999999997 689999999875422   1233456788999999999999999999998654


Q ss_pred             ------CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          403 ------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       403 ------~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                            ..+|+||||+ +++|.+++....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence                  5689999999 678999988888999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcccccCCCcccccccccC
Q 010676          477 KATKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       477 ~~~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      +..... .....||+.|+|||++.+
T Consensus       180 ~~~~~~-~~~~~~t~~y~aPE~~~~  203 (367)
T 2fst_X          180 RHTADE-MTGYVATRWYRAPEIMLN  203 (367)
T ss_dssp             ------------CCCTTCCHHHHTT
T ss_pred             cccccc-CCCcCcCcCccChHHHcC
Confidence            765432 345679999999999876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.96  E-value=2.2e-29  Score=253.64  Aligned_cols=173  Identities=29%  Similarity=0.465  Sum_probs=146.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc--------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  396 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~--------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~  396 (504)
                      ...++|++++.||+|+||.||+|.+        .++..||+|++....    .......+.+|+.+++.+ +||||++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC----cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            3457899999999999999999986        356789999875322    233456788999999999 899999999


Q ss_pred             eeecCCCeEEEEEEeccCCCHHHHHHhcC-----------------CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 010676          397 GTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (504)
Q Consensus       397 ~~~~~~~~lyLVmEy~~ggsL~~ll~~~~-----------------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~N  459 (504)
                      +++...+.+|+||||+.+++|.+++....                 +++..+..++.||+.||.|||++||+||||||+|
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  187 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence            99999999999999999999999987643                 7889999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          460 ILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       460 ILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |||+.++.+||+|||+++......    .....+|+.|+|||++.++
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  234 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR  234 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC
Confidence            999999999999999997654332    2233578899999987543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.96  E-value=2.3e-29  Score=258.40  Aligned_cols=178  Identities=25%  Similarity=0.451  Sum_probs=153.7

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccc---hhhHHHHHHHHHHHHHHhhC-CCCceeEEeee
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRF-EHENIVQYYGT  398 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~---~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~  398 (504)
                      +..+.++|++.+.||+|+||.||+|.+ .+|..||||++......   .........+.+|+.+++.+ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            345667899999999999999999998 47999999998754322   12233356688999999998 79999999999


Q ss_pred             ecCCCeEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          399 DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       399 ~~~~~~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      +.....+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+|+||||+||||+.+|.+||+|||++.
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~  248 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC  248 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence            99999999999999999999988754 69999999999999999999999999999999999999999999999999987


Q ss_pred             ccccC-CcccccCCCcccccccccC
Q 010676          478 ATKLN-DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       478 ~~~~~-~~~s~~GT~~YmAPEVL~g  501 (504)
                      ..... .....+||+.|+|||++.+
T Consensus       249 ~~~~~~~~~~~~gt~~y~aPE~~~~  273 (365)
T 2y7j_A          249 HLEPGEKLRELCGTPGYLAPEILKC  273 (365)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHH
T ss_pred             ccCCCcccccCCCCCCccChhhccc
Confidence            65543 3455679999999999853

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.96  E-value=2.7e-29  Score=253.24  Aligned_cols=171  Identities=30%  Similarity=0.513  Sum_probs=146.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC--
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--  402 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~--  402 (504)
                      .+.++|++.+.||+|+||.||+|.+ .+|..||||.+....    .......+.+|+.+++.++||||+++++++...  
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   83 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD----KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF   83 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS----SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc----cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence            4567899999999999999999998 579999999885322    233345678999999999999999999987654  


Q ss_pred             ---CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       403 ---~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                         ..+|+||||+.+ +|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        84 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           84 ENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             TTCCCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CccceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence               679999999984 8999998888999999999999999999999999999999999999999999999999999765


Q ss_pred             ccCC------------cccccCCCcccccccccC
Q 010676          480 KLND------------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       480 ~~~~------------~~s~~GT~~YmAPEVL~g  501 (504)
                      ....            ....+||+.|+|||++.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  196 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT  196 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHS
T ss_pred             ccccccccCccccccchhhccccccccCCeeecc
Confidence            4221            223468999999998754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.96  E-value=1.6e-29  Score=255.93  Aligned_cols=171  Identities=28%  Similarity=0.485  Sum_probs=143.4

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC----
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----  401 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~----  401 (504)
                      ..++|++++.||+|+||.||+|.+ .+|..||+|++........   ....+.+|+.+++.++||||+++++++..    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   91 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNLIEICRTKASP   91 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS---SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc---chHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence            457899999999999999999998 6899999998754332221   12356789999999999999999998876    


Q ss_pred             ----CCeEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCc
Q 010676          402 ----ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (504)
Q Consensus       402 ----~~~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGL  475 (504)
                          .+.+|+||||+.+ +|...+..  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus        92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence                4568999999986 67666654  3599999999999999999999999999999999999999999999999999


Q ss_pred             cccccc------CCcccccCCCcccccccccC
Q 010676          476 AKATKL------NDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       476 A~~~~~------~~~~s~~GT~~YmAPEVL~g  501 (504)
                      ++....      .......||+.|+|||++.+
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG  202 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred             cccccccccccccccCCcccccCccCchhhcC
Confidence            976532      12344568999999999865

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.96  E-value=2.4e-29  Score=245.53  Aligned_cols=171  Identities=27%  Similarity=0.446  Sum_probs=146.7

Q ss_pred             ccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +....++|++++.||+|+||.||+|.+.++..||+|.+......      ...+.+|+.+++.++||||+++++++.. +
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   80 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E   80 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc------HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence            34455789999999999999999999988889999988643221      2467899999999999999999999864 5


Q ss_pred             eEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      .+|+||||+.+++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            689999999999999998653   59999999999999999999999999999999999999999999999999998655


Q ss_pred             cCCc---ccccCCCcccccccccC
Q 010676          481 LNDV---KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~~~---~s~~GT~~YmAPEVL~g  501 (504)
                      ....   ....+|+.|+|||++.+
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~  184 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINY  184 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHH
T ss_pred             CcccccccCCCCccCccChhhhcc
Confidence            4332   23447889999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=7.6e-30  Score=263.29  Aligned_cols=171  Identities=26%  Similarity=0.423  Sum_probs=137.6

Q ss_pred             ccceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      ..+|.+.+.||+|+||.||+|.+.    ++..||||.+....    .......+.+|+.++.+++||||+++++++...+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            458999999999999999999874    67789999876422    2233467889999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+++++|.+++...  .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999999999999999764  589999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc-----ccccCCCcccccccccCC
Q 010676          482 NDV-----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~~-----~s~~GT~~YmAPEVL~g~  502 (504)
                      ...     ....+|+.|+|||++.++
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~  225 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYR  225 (373)
T ss_dssp             --------------CTTSCHHHHHHC
T ss_pred             CCccceeccCCCcCCCccChhhhccC
Confidence            321     122357889999998643

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.96  E-value=2.1e-29  Score=252.37  Aligned_cols=168  Identities=35%  Similarity=0.519  Sum_probs=144.9

Q ss_pred             ceeeeeeecccCceeEEEEEc-----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC--C
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--E  402 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--~  402 (504)
                      +|++++.||+|+||.||++..     .++..||||++....    .......+.+|+.+|+.++||||+++++++..  .
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA----GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc----ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            459999999999999998853     378899999886432    23345678899999999999999999999876  4


Q ss_pred             CeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      ..+|+||||+++++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             ceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            67999999999999999999988999999999999999999999999999999999999999999999999999876543


Q ss_pred             C-----cccccCCCcccccccccC
Q 010676          483 D-----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~-----~~s~~GT~~YmAPEVL~g  501 (504)
                      .     .....+|+.|+|||++.+
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~  211 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKE  211 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHH
T ss_pred             ccccccccCCCCCceeeChHHhcC
Confidence            2     233458889999999865

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.96  E-value=4.1e-29  Score=247.98  Aligned_cols=175  Identities=31%  Similarity=0.520  Sum_probs=140.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...++|++.+.||+|+||.||+|.+ .++..||+|++......  .......+.+|+.+++.++||||+++++++...+.
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM--DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            3456899999999999999999997 68999999988653322  23345678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          405 LYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      +|+||||+.+++|.+++..     ..+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999998864     34889999999999999999999999999999999999999999999999998765


Q ss_pred             ccCC--cccccCCCcccccccccCC
Q 010676          480 KLND--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....  .....||+.|+|||++.++
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~  211 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHEN  211 (310)
T ss_dssp             ------------CCSSCCHHHHTTC
T ss_pred             cCCCccccccCCCeeEeChHHhCCC
Confidence            4332  2345699999999998764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.96  E-value=2.9e-29  Score=257.58  Aligned_cols=172  Identities=27%  Similarity=0.392  Sum_probs=138.8

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-  403 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||||++.....   .......+.+|+.+++.++||||+++++++.... 
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   98 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS   98 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC---ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence            4567899999999999999999998 5789999999864322   2334467889999999999999999999987665 


Q ss_pred             -----eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          404 -----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       404 -----~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                           .+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus        99 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A           99 LEEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             TTTCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             cccccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence                 78999999986 6777775 4689999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC-cccccCCCcccccccccCC
Q 010676          479 TKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..... ....+||+.|+|||++.+.
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~~~~~  201 (371)
T 2xrw_A          177 AGTSFMMTPYVVTRYYRAPEVILGM  201 (371)
T ss_dssp             -------------CTTCCHHHHTTC
T ss_pred             cccccccCCceecCCccCHHHhcCC
Confidence            54332 3456799999999998764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.96  E-value=6.8e-30  Score=267.56  Aligned_cols=174  Identities=26%  Similarity=0.428  Sum_probs=138.6

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccch---hhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      .+.++|.+.+.||+|+||.||+|.+ .++..||+|++.......   ........+.+|+.+|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4567899999999999999999998 678999999987543211   112223457899999999999999999999864


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC---cEEEEecCccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAK  477 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g---~VKL~DFGLA~  477 (504)
                       ..+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++   .+||+|||+++
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence             458999999999999887754 4599999999999999999999999999999999999997544   59999999998


Q ss_pred             ccccCC-cccccCCCccccccccc
Q 010676          478 ATKLND-VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       478 ~~~~~~-~~s~~GT~~YmAPEVL~  500 (504)
                      ...... ....+||+.|||||++.
T Consensus       291 ~~~~~~~~~~~~gt~~y~aPE~~~  314 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAPEVLV  314 (419)
T ss_dssp             SCC-----------CTTCCTTTTC
T ss_pred             ecCCCccccccCCCCCccCceeee
Confidence            755433 34567999999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.96  E-value=4.3e-30  Score=258.47  Aligned_cols=168  Identities=31%  Similarity=0.476  Sum_probs=137.9

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++++.||+|+||.||+|.+ .++..||+|++......    .....+.+|+.+++.++||||+++++++...+.+|+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE----GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   77 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc----ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence            6799999999999999999998 48899999988643211    111234579999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--C
Q 010676          408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~  483 (504)
                      ||||+.+ +|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  .
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           78 VFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             Eeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence            9999985 888877654  3889999999999999999999999999999999999999999999999998764422  2


Q ss_pred             cccccCCCcccccccccC
Q 010676          484 VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g  501 (504)
                      .....||+.|+|||++.+
T Consensus       157 ~~~~~~t~~y~aPE~~~~  174 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLG  174 (324)
T ss_dssp             ------CGGGCCHHHHTT
T ss_pred             cccccCcccccChhhhcC
Confidence            344568999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.96  E-value=1.4e-29  Score=262.52  Aligned_cols=171  Identities=26%  Similarity=0.474  Sum_probs=146.3

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC--
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  403 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~--  403 (504)
                      ..++|++.++||+|+||.||+|.+ .++..||||++.......    ....+.+|+.+++.++||||+++++++...+  
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR----PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS----CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc----hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            356899999999999999999998 569999999986432211    2355678999999999999999999987654  


Q ss_pred             eEEEEEEeccCCCHHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----cCCCcEEEEecCc
Q 010676          404 KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGL  475 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~----l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL----d~~g~VKL~DFGL  475 (504)
                      .+|+||||+.+++|.+++....    +++..++.++.||+.||.|||++||+||||||+||||    +.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            7899999999999999987543    8999999999999999999999999999999999999    7778899999999


Q ss_pred             ccccccCC-cccccCCCcccccccccC
Q 010676          476 AKATKLND-VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       476 A~~~~~~~-~~s~~GT~~YmAPEVL~g  501 (504)
                      ++...... .....||+.|+|||++.+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~  189 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYER  189 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHH
T ss_pred             ceEccCCCccccccCCccccCHHHhhc
Confidence            98654332 345679999999998753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.96  E-value=2.8e-29  Score=256.77  Aligned_cols=168  Identities=32%  Similarity=0.547  Sum_probs=146.2

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .+.|++++.||+|+||.||+|.+ .++..||||++......  .......+.+|+.+++.++||||+++++++...+.+|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence            35699999999999999999997 68999999998654322  2344567889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          407 IFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      +||||+.| +|.+++.  ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....  .
T Consensus       131 lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~  207 (348)
T 1u5q_A          131 LVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--A  207 (348)
T ss_dssp             EEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--B
T ss_pred             EEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--C
Confidence            99999985 7777664  34589999999999999999999999999999999999999999999999999876542  2


Q ss_pred             ccccCCCccccccccc
Q 010676          485 KSCRGTAFWMAPEVCS  500 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~  500 (504)
                      ....||+.|+|||++.
T Consensus       208 ~~~~gt~~y~aPE~~~  223 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVIL  223 (348)
T ss_dssp             CCCCSCGGGCCHHHHH
T ss_pred             CcccCCcceeCHhhhc
Confidence            3467999999999984

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.96  E-value=2.1e-29  Score=252.55  Aligned_cols=176  Identities=27%  Similarity=0.438  Sum_probs=148.0

Q ss_pred             cccccccceeeeeeecccCceeEEEEEcc-CC-----ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEE
Q 010676          323 RFKRIITYWQKGDLLGRGSFGSVYEGISD-DG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY  395 (504)
Q Consensus       323 ~~~~~~~~y~i~k~LG~G~FG~VYka~~~-~g-----~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l  395 (504)
                      .+....++|++++.||+|+||.||+|.+. ++     ..||+|.+....    .......+.+|+.++..+ +||||+++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~  115 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEALMSELKIMSHLGQHENIVNL  115 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----ChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            45555678999999999999999999873 33     479999886432    123346788999999999 89999999


Q ss_pred             eeeecCCCeEEEEEEeccCCCHHHHHHhc---------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 010676          396 YGTDKDESKLYIFLELVTKGSLLNLYQRY---------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI  460 (504)
Q Consensus       396 ~~~~~~~~~lyLVmEy~~ggsL~~ll~~~---------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NI  460 (504)
                      ++++...+.+|+||||+++|+|.+++...               .+++..+..++.||+.||.|||++||+||||||+||
T Consensus       116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI  195 (333)
T 2i1m_A          116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV  195 (333)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGC
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceE
Confidence            99999999999999999999999988643               378899999999999999999999999999999999


Q ss_pred             EEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          461 LVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       461 LLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||+.++.+||+|||++.......    .....+|+.|+|||++.+.
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  241 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC  241 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC
Confidence            99999999999999998654332    1234478899999987643

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.96  E-value=5.1e-29  Score=244.64  Aligned_cols=169  Identities=24%  Similarity=0.320  Sum_probs=146.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~  403 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|++......       ..+.+|+.++..+ +|+||+++++++....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-------HHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            3456899999999999999999997 68999999988643221       2467899999999 7999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc-----EEEEecCcc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLA  476 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~-----VKL~DFGLA  476 (504)
                      .+|+||||+ +++|.+++...  .+++..+..++.||+.||.|||++||+||||||+||||+.++.     +||+|||++
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999999999 89999999753  4899999999999999999999999999999999999987776     999999999


Q ss_pred             cccccCC---------cccccCCCcccccccccCC
Q 010676          477 KATKLND---------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       477 ~~~~~~~---------~~s~~GT~~YmAPEVL~g~  502 (504)
                      +......         .....||+.|+|||++.++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  193 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR  193 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCC
Confidence            8654332         2345699999999998765

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.96  E-value=2.4e-29  Score=255.29  Aligned_cols=176  Identities=26%  Similarity=0.435  Sum_probs=140.7

Q ss_pred             cccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccc------hhhHHHHHHHHHHHHHHhhCCCCceeEEeee
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG------SQAKQSISQLEQEIALLSRFEHENIVQYYGT  398 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~------~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~  398 (504)
                      ..+.++|++++.||+|+||.||+|.+.++..||||++......      .........+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            4566789999999999999999999988999999988543221      1223345678999999999999999999998


Q ss_pred             e-----cCCCeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEE
Q 010676          399 D-----KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA  471 (504)
Q Consensus       399 ~-----~~~~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~  471 (504)
                      +     .....+|+||||+.+ +|.+++...  .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence            8     444579999999985 777777654  48999999999999999999999999999999999999999999999


Q ss_pred             ecCcccccccC-CcccccCCCcccccccccC
Q 010676          472 DFGLAKATKLN-DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       472 DFGLA~~~~~~-~~~s~~GT~~YmAPEVL~g  501 (504)
                      |||++...... ......||+.|+|||++.+
T Consensus       177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~  207 (362)
T 3pg1_A          177 DFNLAREDTADANKTHYVTHRWYRAPELVMQ  207 (362)
T ss_dssp             CTTC---------------CGGGCCHHHHTT
T ss_pred             ecCcccccccccccceecccceecCcHHhcC
Confidence            99999754333 2344579999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.96  E-value=1.5e-29  Score=246.67  Aligned_cols=173  Identities=31%  Similarity=0.471  Sum_probs=146.6

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee--cCCC
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--KDES  403 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~--~~~~  403 (504)
                      ..++|++++.||+|+||.||+|.+ .++..||+|.+......   ......+.+|+.+++.++||||+++++++  ....
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence            457899999999999999999998 57899999998754322   23356788999999999999999999977  4567


Q ss_pred             eEEEEEEeccCCCHHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEEcCCCcEEEEec
Q 010676          404 KLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQD-----VVHRDIKCANILVDANGSVKLADF  473 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~-----l~e~~v~~i~~QIl~gL~yLHs~g-----IIHRDLKP~NILLd~~g~VKL~DF  473 (504)
                      .+|+||||+++++|.+++....     +++..+..++.||+.||.|||++|     |+||||||+|||++.++.+||+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            8999999999999999886532     899999999999999999999999     999999999999999999999999


Q ss_pred             CcccccccCC--cccccCCCcccccccccCC
Q 010676          474 GLAKATKLND--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       474 GLA~~~~~~~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      |++.......  .....||+.|+|||++.+.
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  191 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRM  191 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC
T ss_pred             chheeeccccccccccCCCccccChHHhccC
Confidence            9987654332  2234699999999998764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.96  E-value=2.2e-29  Score=252.38  Aligned_cols=169  Identities=30%  Similarity=0.451  Sum_probs=147.0

Q ss_pred             cccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhh--CCCCceeEEeeeecCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDE  402 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~~~~~~~  402 (504)
                      ..+.++|++.+.||+|+||.||+|.+ ++..||||++....        ...+.+|+.++..  ++||||+++++++...
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--------ERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG--------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh--------HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            34567899999999999999999988 58899999885321        2346678888877  7899999999999877


Q ss_pred             C----eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCcEEEcCCCcEEE
Q 010676          403 S----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--------DQDVVHRDIKCANILVDANGSVKL  470 (504)
Q Consensus       403 ~----~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLH--------s~gIIHRDLKP~NILLd~~g~VKL  470 (504)
                      .    .+|+||||+.+++|.+++....+++..+..++.||+.||.|||        ++||+||||||+||||+.++.+||
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence            6    8999999999999999999989999999999999999999999        899999999999999999999999


Q ss_pred             EecCcccccccCC------cccccCCCcccccccccCC
Q 010676          471 ADFGLAKATKLND------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       471 ~DFGLA~~~~~~~------~~s~~GT~~YmAPEVL~g~  502 (504)
                      +|||++.......      .....||+.|+|||++.+.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  226 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS  226 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhccc
Confidence            9999997654332      2345699999999998764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.96  E-value=3.8e-29  Score=249.92  Aligned_cols=164  Identities=26%  Similarity=0.440  Sum_probs=144.2

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecC--CC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD--ES  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~--~~  403 (504)
                      .++|++++.||+|+||.||+|.+ .++..||+|++....        ...+.+|+.+++.++ ||||+++++++..  ..
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            46899999999999999999987 688999999886321        245789999999997 9999999999987  67


Q ss_pred             eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-~VKL~DFGLA~~~~~~  482 (504)
                      .+++||||+.+++|.+++.  .+++..+..++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++.....
T Consensus       107 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             ceEEEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            7999999999999999885  488999999999999999999999999999999999999777 8999999999865433


Q ss_pred             -CcccccCCCcccccccccC
Q 010676          483 -DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 -~~~s~~GT~~YmAPEVL~g  501 (504)
                       ......||+.|+|||++.+
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~  204 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVD  204 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTT
T ss_pred             CccccccccccccChhhhcC
Confidence             3445679999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.96  E-value=1.7e-29  Score=252.18  Aligned_cols=174  Identities=24%  Similarity=0.373  Sum_probs=132.6

Q ss_pred             ccccceeeeeeecccCceeEEEEEccC-C---ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDD-G---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~-g---~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      ...++|++++.||+|+||.||+|.+.. +   ..||+|++.....   .......+.+|+.+++.++||||+++++++..
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII---ASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc---CHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            345689999999999999999999843 3   2799998754221   22335678899999999999999999999987


Q ss_pred             CCeE------EEEEEeccCCCHHHHHHhc-------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcE
Q 010676          402 ESKL------YIFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV  468 (504)
Q Consensus       402 ~~~l------yLVmEy~~ggsL~~ll~~~-------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~V  468 (504)
                      ....      |+||||+.+++|.+++...       .+++..+..++.||+.||.|||++||+||||||+||||+.++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence            7655      9999999999999988643       48899999999999999999999999999999999999999999


Q ss_pred             EEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          469 KLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       469 KL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||+|||+++......    .....+|+.|+|||++.+.
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  214 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN  214 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHC
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCC
Confidence            999999997654332    1233478899999998654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.96  E-value=5.5e-29  Score=243.98  Aligned_cols=170  Identities=28%  Similarity=0.488  Sum_probs=143.8

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhH--HHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .++|++.+.||+|+||.||+|.+ .++..||+|++..........  .....+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46899999999999999999998 688999999886533322111  11257889999999999999999999997765 


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCc-----EEEEecCc
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGS-----VKLADFGL  475 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILLd~~g~-----VKL~DFGL  475 (504)
                       ++||||+.+++|.+++...  .+++..+..++.||+.||.|||++|  |+||||||+|||++.++.     +||+|||+
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~  175 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL  175 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence             7999999999998887543  5899999999999999999999999  999999999999988776     99999999


Q ss_pred             ccccccCCcccccCCCccccccccc
Q 010676          476 AKATKLNDVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       476 A~~~~~~~~~s~~GT~~YmAPEVL~  500 (504)
                      ++.... ......||+.|+|||++.
T Consensus       176 ~~~~~~-~~~~~~g~~~y~aPE~~~  199 (287)
T 4f0f_A          176 SQQSVH-SVSGLLGNFQWMAPETIG  199 (287)
T ss_dssp             CBCCSS-CEECCCCCCTTSCGGGSS
T ss_pred             cccccc-cccccCCCccccCchhhc
Confidence            875443 334567999999999984

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.96  E-value=4e-29  Score=250.59  Aligned_cols=169  Identities=33%  Similarity=0.530  Sum_probs=145.5

Q ss_pred             cceeeeeeecccCceeEEEEEc-----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec--C
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--D  401 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~--~  401 (504)
                      ++|++++.||+|+||.||+|..     .++..||+|++....     ......+.+|+.+++.++||||+++++++.  .
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-----PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-----HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            5899999999999999999982     578999999886432     233466889999999999999999999875  5


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ...+|+||||+++++|.+++..  ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            5679999999999999999875  35999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCC-----cccccCCCcccccccccCC
Q 010676          480 KLND-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....     .....||+.|+|||++.+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~  205 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDN  205 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHC
T ss_pred             ccCCccceeeccCCccccccCHHHhccC
Confidence            4332     2234588899999988653

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.96  E-value=3.4e-29  Score=248.88  Aligned_cols=170  Identities=26%  Similarity=0.354  Sum_probs=143.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec----CC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----DE  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~----~~  402 (504)
                      .++|++++.||+|+||.||++.+ .++..||+|++....     ......+.+|+.+++.++||||+++++++.    ..
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-----QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-----HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-----HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            46899999999999999999998 689999999886422     234567889999999999999999999886    44


Q ss_pred             CeEEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      ..+|+||||+.+++|.+++..     ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            579999999999999998865     458999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCC-----------cccccCCCcccccccccCC
Q 010676          478 ATKLND-----------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       478 ~~~~~~-----------~~s~~GT~~YmAPEVL~g~  502 (504)
                      ......           .....||+.|+|||++.+.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  218 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ  218 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccC
Confidence            543211           1223579999999998753

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.96  E-value=2.8e-29  Score=265.27  Aligned_cols=172  Identities=26%  Similarity=0.426  Sum_probs=147.6

Q ss_pred             ccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +....++|++.+.||+|+||.||+|.+.++..||||.+.....      ..+.+.+|+.+|+.++||||+++++++. ..
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc------cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            3445578999999999999999999998889999998864321      1356889999999999999999999986 56


Q ss_pred             eEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      .+|+||||+.+|+|.+++...   .++...+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            799999999999999998743   58889999999999999999999999999999999999999999999999998654


Q ss_pred             cCC---cccccCCCcccccccccCC
Q 010676          481 LND---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~---~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...   .....+|+.|+|||++.++
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~  360 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFG  360 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHC
T ss_pred             CCceeccCCCcccccccCHHHhccC
Confidence            322   2234467889999998643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.96  E-value=3.2e-29  Score=247.96  Aligned_cols=170  Identities=31%  Similarity=0.487  Sum_probs=144.6

Q ss_pred             eeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEE
Q 010676          331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmE  410 (504)
                      |..++.||+|+||.||+|.. ++..||+|.+...... ........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI-TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTS-CTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE-CCceEEEEEEecccCc-chHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44568999999999999987 5789999988643221 122334678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHh----cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC---
Q 010676          411 LVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (504)
Q Consensus       411 y~~ggsL~~ll~~----~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~---  483 (504)
                      |+++++|.+++..    ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            9999999998863    248899999999999999999999999999999999999999999999999987654322   


Q ss_pred             -cccccCCCcccccccccCC
Q 010676          484 -VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g~  502 (504)
                       .....||+.|+|||++.+.
T Consensus       191 ~~~~~~g~~~y~aPE~~~~~  210 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRGE  210 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTTE
T ss_pred             cccccCCCcCcCChHHhcCC
Confidence             2335699999999998764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.96  E-value=2.3e-29  Score=256.53  Aligned_cols=169  Identities=27%  Similarity=0.328  Sum_probs=141.5

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC--------CCceeEEe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--------HENIVQYY  396 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~--------HpnIV~l~  396 (504)
                      .+.++|++++.||+|+||.||+|++ .++..||||++...      ......+.+|+.+|+.++        |+||++++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            3457899999999999999999997 67899999988532      223456788999998885        78899999


Q ss_pred             eeec----CCCeEEEEEEeccCCCHHHHH-Hh--cCCChHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCC--
Q 010676          397 GTDK----DESKLYIFLELVTKGSLLNLY-QR--YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANG--  466 (504)
Q Consensus       397 ~~~~----~~~~lyLVmEy~~ggsL~~ll-~~--~~l~e~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILLd~~g--  466 (504)
                      +++.    ....+|+||||+.+ +|.+++ ..  ..+++..++.|+.||+.||.|||++ ||+||||||+||||+.++  
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred             cceeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence            9987    66789999999955 555544 43  3499999999999999999999998 999999999999999775  


Q ss_pred             -----------------------------------------------cEEEEecCcccccccCCcccccCCCcccccccc
Q 010676          467 -----------------------------------------------SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC  499 (504)
Q Consensus       467 -----------------------------------------------~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL  499 (504)
                                                                     .+||+|||++...... .....||+.|||||++
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhh
Confidence                                                           7999999999765533 3455799999999998


Q ss_pred             cCC
Q 010676          500 SNP  502 (504)
Q Consensus       500 ~g~  502 (504)
                      .+.
T Consensus       266 ~~~  268 (397)
T 1wak_A          266 IGS  268 (397)
T ss_dssp             HTS
T ss_pred             cCC
Confidence            764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.96  E-value=1.2e-29  Score=253.92  Aligned_cols=174  Identities=27%  Similarity=0.445  Sum_probs=142.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccc---hhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~---~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      .+.++|++.+.||+|+||.||+|.+ .++..||||++......   .........+.+|+.+|+.++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            4557899999999999999999998 57899999988643221   1112223457899999999999999999999876


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc---EEEEecCccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAK  477 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~---VKL~DFGLA~  477 (504)
                      .. +|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.   +||+|||++.
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence            65 8999999999999988765 45899999999999999999999999999999999999987664   9999999998


Q ss_pred             ccccCC-cccccCCCccccccccc
Q 010676          478 ATKLND-VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       478 ~~~~~~-~~s~~GT~~YmAPEVL~  500 (504)
                      ...... .....||+.|+|||++.
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~  189 (322)
T 2ycf_A          166 ILGETSLMRTLCGTPTYLAPEVLV  189 (322)
T ss_dssp             ECCCCHHHHHHHSCCTTCCHHHHH
T ss_pred             ecccccccccccCCcCccCchhhc
Confidence            654332 23456999999999973

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.96  E-value=3.8e-29  Score=244.64  Aligned_cols=171  Identities=26%  Similarity=0.357  Sum_probs=134.0

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...++|++.+.||+|+||.||+|.+ .++..||+|++.....   .......+.++..+++.++||||+++++++...+.
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD   80 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C---HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC---cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence            3457899999999999999999998 6899999998864322   12223344556666888999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          405 LYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      +|+||||+++ +|.+++..     ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            9999999985 78776643     4599999999999999999999998 999999999999999999999999999976


Q ss_pred             cccCC-cccccCCCccccccccc
Q 010676          479 TKLND-VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       479 ~~~~~-~~s~~GT~~YmAPEVL~  500 (504)
                      ..... .....||+.|+|||++.
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~  182 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERIN  182 (290)
T ss_dssp             ----------CCCCCCSCHHHHS
T ss_pred             ccccccccccCCCccccChhhcC
Confidence            54433 23346999999999973

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=4.5e-29  Score=256.91  Aligned_cols=166  Identities=27%  Similarity=0.414  Sum_probs=138.3

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec-----
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-----  400 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~-----  400 (504)
                      ..++|++++.||+|+||.||+|.+ .+|..||+|++......         ..+|+.+++.++||||++++++|.     
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            356899999999999999999998 68999999988643221         237999999999999999999883     


Q ss_pred             ---------------------------------CCCeEEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHH
Q 010676          401 ---------------------------------DESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGL  442 (504)
Q Consensus       401 ---------------------------------~~~~lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL  442 (504)
                                                       ....+|+||||+++ +|.+++..     ..+++..++.|+.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                             34458999999985 77766543     4599999999999999999


Q ss_pred             HHHHHCCceecCCCCCcEEEc-CCCcEEEEecCcccccccC-CcccccCCCcccccccccCC
Q 010676          443 KYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       443 ~yLHs~gIIHRDLKP~NILLd-~~g~VKL~DFGLA~~~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .|||++||+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++.+.
T Consensus       155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~  216 (383)
T 3eb0_A          155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA  216 (383)
T ss_dssp             HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTC
T ss_pred             HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCC
Confidence            999999999999999999998 6899999999999865433 34456789999999998763

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.96  E-value=4.5e-29  Score=263.63  Aligned_cols=168  Identities=27%  Similarity=0.433  Sum_probs=143.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-e
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-K  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-~  404 (504)
                      ...++|++++.||+|+||.||+|.+. +..||||.+....       ..+.+.+|+.++++++||||+++++++.... .
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            44578999999999999999999875 7799999886422       2356889999999999999999999976654 7


Q ss_pred             EEEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          405 LYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      +||||||+.+|+|.+++...+   +++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999999999999999997653   68899999999999999999999999999999999999999999999999985433


Q ss_pred             CCcccccCCCcccccccccCC
Q 010676          482 NDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .. ....+|+.|+|||++.++
T Consensus       342 ~~-~~~~~~~~y~aPE~~~~~  361 (450)
T 1k9a_A          342 TQ-DTGKLPVKWTAPEALREK  361 (450)
T ss_dssp             ------CCCTTTSCHHHHHSS
T ss_pred             cc-cCCCCCcceeCHHHhcCC
Confidence            22 233578999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.96  E-value=5.5e-29  Score=247.06  Aligned_cols=171  Identities=33%  Similarity=0.606  Sum_probs=143.2

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      ....+.|++.+.||+|+||.||+|.+ .+|..||+|.+.....       ...+.+|+.++..++||||+++++++...+
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-------CHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-------HHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            34556899999999999999999998 5689999998864321       245788999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+.+++|.+++.  ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            9999999999999999886  34699999999999999999999999999999999999999999999999999976543


Q ss_pred             CC--cccccCCCcccccccccCC
Q 010676          482 ND--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..  .....||+.|+|||++.+.
T Consensus       178 ~~~~~~~~~~~~~y~aPE~~~~~  200 (314)
T 3com_A          178 TMAKRNTVIGTPFWMAPEVIQEI  200 (314)
T ss_dssp             TBSCBCCCCSCGGGCCHHHHSSS
T ss_pred             hccccCccCCCCCccChhhcCCC
Confidence            32  3345699999999998764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.96  E-value=2.5e-29  Score=253.02  Aligned_cols=176  Identities=26%  Similarity=0.445  Sum_probs=152.5

Q ss_pred             ccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhh------------HHHHHHHHHHHHHHhhCCCCcee
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA------------KQSISQLEQEIALLSRFEHENIV  393 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~------------~~~~~~~~~Ei~iL~~L~HpnIV  393 (504)
                      ...++|++++.||+|+||.||+|.+ ++..||+|.+.........            ......+.+|+.+++.++||||+
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            4467999999999999999999999 8999999998643221100            01125688999999999999999


Q ss_pred             EEeeeecCCCeEEEEEEeccCCCHHHH------HHh---cCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEc
Q 010676          394 QYYGTDKDESKLYIFLELVTKGSLLNL------YQR---YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVD  463 (504)
Q Consensus       394 ~l~~~~~~~~~lyLVmEy~~ggsL~~l------l~~---~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd  463 (504)
                      ++++++.+.+.+|+||||+++++|.++      +..   ..+++..+..++.||+.||.|||+ +||+|+||||+|||++
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD  186 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence            999999999999999999999999987      543   458999999999999999999999 9999999999999999


Q ss_pred             CCCcEEEEecCcccccccCCcccccCCCcccccccccCC
Q 010676          464 ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       464 ~~g~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .++.+||+|||++............||+.|+|||++.+.
T Consensus       187 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~  225 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNE  225 (348)
T ss_dssp             TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSC
T ss_pred             CCCcEEEeccccccccccccccCCCCCcCccCchhhcCC
Confidence            999999999999987655555667799999999999865

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.96  E-value=3.4e-29  Score=247.15  Aligned_cols=174  Identities=29%  Similarity=0.511  Sum_probs=142.4

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee--cCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--KDE  402 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~--~~~  402 (504)
                      ++.++|++++.||+|+||.||+|.+ .++..||+|++....... .......+.+|+.+++.++||||+++++++  ...
T Consensus         2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (305)
T 2wtk_C            2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK   80 (305)
T ss_dssp             ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred             ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc-cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence            3567899999999999999999998 578999999886432111 112346788999999999999999999988  455


Q ss_pred             CeEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ..+|+||||+.++ |.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            6899999999987 6666653   45899999999999999999999999999999999999999999999999998765


Q ss_pred             ccC----CcccccCCCcccccccccC
Q 010676          480 KLN----DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       480 ~~~----~~~s~~GT~~YmAPEVL~g  501 (504)
                      ...    ......||+.|+|||++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~  185 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANG  185 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred             CccccccccccCCCCCCCcChhhccC
Confidence            322    1234569999999999875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=5.5e-29  Score=245.97  Aligned_cols=170  Identities=27%  Similarity=0.468  Sum_probs=139.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee-----
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-----  399 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~-----  399 (504)
                      .+.++|++++.||+|+||.||+|.+. ++..||+|.+....     ......+.+|+.+++.++||||+++++++     
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-----hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            45678999999999999999999984 69999999886432     33456788999999999999999999886     


Q ss_pred             ---------cCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEE
Q 010676          400 ---------KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVK  469 (504)
Q Consensus       400 ---------~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd-~~g~VK  469 (504)
                               .....+|+||||+. ++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence                     34578999999998 5999999888899999999999999999999999999999999999997 567999


Q ss_pred             EEecCcccccccC-----CcccccCCCcccccccccC
Q 010676          470 LADFGLAKATKLN-----DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       470 L~DFGLA~~~~~~-----~~~s~~GT~~YmAPEVL~g  501 (504)
                      |+|||+++.....     ......+|+.|+|||++.+
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  198 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS  198 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcC
Confidence            9999999865322     2234458999999998754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.96  E-value=2.1e-29  Score=249.46  Aligned_cols=174  Identities=27%  Similarity=0.399  Sum_probs=146.3

Q ss_pred             cccccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEee
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG  397 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~  397 (504)
                      ....++|++++.||+|+||.||+|.+      .++..||+|++....    .......+.+|+.++..+ +||||+++++
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC----CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            34457899999999999999999974      467899999886432    123345788999999999 6999999999


Q ss_pred             eecCCC-eEEEEEEeccCCCHHHHHHhcC-----------------CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 010676          398 TDKDES-KLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (504)
Q Consensus       398 ~~~~~~-~lyLVmEy~~ggsL~~ll~~~~-----------------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~N  459 (504)
                      ++...+ .+|+||||+.+++|.+++....                 +++..+..++.||+.||.|||++||+||||||+|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            987654 5999999999999999997653                 7889999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          460 ILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       460 ILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |||+.++.+||+|||+++......    .....||+.|+|||++.++
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  225 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR  225 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc
Confidence            999999999999999997654332    2234578999999988643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.96  E-value=9e-30  Score=250.20  Aligned_cols=172  Identities=31%  Similarity=0.534  Sum_probs=130.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...++|++++.||+|+||.||+|.+ .++..||+|.+.....    ......+.+|+.++..++||||+++++++...+.
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC----QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc----chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            4457899999999999999999998 5789999997753221    2234567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh---------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCc
Q 010676          405 LYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL  475 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~---------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGL  475 (504)
                      +|+||||+++++|.+++..         ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999998863         3489999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC-------cccccCCCcccccccccC
Q 010676          476 AKATKLND-------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       476 A~~~~~~~-------~~s~~GT~~YmAPEVL~g  501 (504)
                      +.......       .....||+.|+|||++.+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  200 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ  200 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHH
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhcc
Confidence            87543221       234469999999998753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.96  E-value=3.1e-29  Score=268.39  Aligned_cols=172  Identities=28%  Similarity=0.437  Sum_probs=148.5

Q ss_pred             ccccccceeeeeeecccCceeEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      +.....+|++.+.||+|+||.||+|.+. ++..||||.+.....      ....+.+|+.+|++++||||+++++++...
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc------chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3444568999999999999999999984 588999998764321      135688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      ..+||||||+.+|+|.+++...   .+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            9999999999999999999753   4889999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCc---ccccCCCcccccccccC
Q 010676          480 KLNDV---KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       480 ~~~~~---~s~~GT~~YmAPEVL~g  501 (504)
                      .....   ....+|+.|+|||++.+
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~  393 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAY  393 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHH
T ss_pred             cCCceeecCCCcCCcceeCHhHHhc
Confidence            44332   23346788999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.96  E-value=5.2e-29  Score=245.44  Aligned_cols=171  Identities=27%  Similarity=0.432  Sum_probs=141.4

Q ss_pred             ccceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee-cCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDE  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~-~~~  402 (504)
                      ...|++.+.||+|+||.||+|.+.    ....+|+|.+....    .......+.+|+.++++++||||+++++++ ..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC----CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            457999999999999999999863    23468888775322    233456788999999999999999999985 556


Q ss_pred             CeEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      +.+|+||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            788999999999999999965  348889999999999999999999999999999999999999999999999997653


Q ss_pred             cCC------cccccCCCcccccccccCC
Q 010676          481 LND------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~------~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...      .....+|+.|+|||++.+.
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~  207 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQ  207 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHC
T ss_pred             ccchhccccccCCCCCccccChHHhcCC
Confidence            322      2334578899999988653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=9.2e-29  Score=242.82  Aligned_cols=169  Identities=26%  Similarity=0.409  Sum_probs=143.1

Q ss_pred             ceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      .|.+.++||+|+||.||+|.+.    ++..+|+|.+....    .......+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT----EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc----cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            6788899999999999999862    33479999875322    233456788999999999999999999999876665


Q ss_pred             -EEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          406 -YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       406 -yLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                       |+||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence             999999999999999976  45888999999999999999999999999999999999999999999999999754322


Q ss_pred             ------CcccccCCCcccccccccCC
Q 010676          483 ------DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ------~~~s~~GT~~YmAPEVL~g~  502 (504)
                            ......+|+.|+|||++.+.
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~  203 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTY  203 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTC
T ss_pred             cccccccCcCCCCCccccChhhhccC
Confidence                  23345688999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.96  E-value=1.7e-29  Score=255.07  Aligned_cols=170  Identities=26%  Similarity=0.451  Sum_probs=135.4

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceE----EEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~v----AVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .++|+++++||+|+||.||+|.+ .++..+    ++|.+.....    ......+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS----PKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS----CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC----HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            46899999999999999999997 456655    5554432211    12235688999999999999999999999876


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      . .++||+|+.+++|.+++...  .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            4 88999999999999988753  48999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC----cccccCCCcccccccccCC
Q 010676          481 LND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...    .....+|+.|+|||++.+.
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~  194 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHR  194 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHC
T ss_pred             CccccccccCCCccccccCHHHHcCC
Confidence            322    2233478899999988654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.96  E-value=1.1e-29  Score=260.85  Aligned_cols=171  Identities=19%  Similarity=0.223  Sum_probs=137.7

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHH---HHHhhCCCCceeEEe------
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYY------  396 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei---~iL~~L~HpnIV~l~------  396 (504)
                      ..++|++++.||+|+||.||+|++ .+|..||||++.......  ......+.+|+   .+|+.++|||||+++      
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~  148 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  148 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC--TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc--hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence            356899999999999999999998 679999999987432222  22346688999   555566899999998      


Q ss_pred             -eeecCCC-----------------eEEEEEEeccCCCHHHHHHhc-CCCh-------HHHHHHHHHHHHHHHHHHHCCc
Q 010676          397 -GTDKDES-----------------KLYIFLELVTKGSLLNLYQRY-HLRD-------SQVSAYTRQILLGLKYLHDQDV  450 (504)
Q Consensus       397 -~~~~~~~-----------------~lyLVmEy~~ggsL~~ll~~~-~l~e-------~~v~~i~~QIl~gL~yLHs~gI  450 (504)
                       +++...+                 ..||||||+ +|+|.+++... .+++       ..+..|+.||+.||.|||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  227 (377)
T 3byv_A          149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  227 (377)
T ss_dssp             SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence             5554443                 289999999 57999988753 3554       7778899999999999999999


Q ss_pred             eecCCCCCcEEEcCCCcEEEEecCcccccccCCcccccCCCcccccccccCC
Q 010676          451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       451 IHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      +||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+.
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~  277 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARR  277 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-cccCCCC-cCccChhhhccc
Confidence            9999999999999999999999999985332 3345568 999999998653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.96  E-value=8.2e-29  Score=247.06  Aligned_cols=171  Identities=33%  Similarity=0.628  Sum_probs=142.8

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD  401 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~  401 (504)
                      +....+.|++++.||+|+||.||+|.+ .++..||+|++......      ...+.+|+.+++.+ +||||+++++++..
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST------THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc------HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            345567899999999999999999998 58899999998653321      24577899999998 79999999999876


Q ss_pred             ------CCeEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 010676          402 ------ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       402 ------~~~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                            .+.+|+||||+.+++|.+++..   ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence                  5689999999999999999876   3589999999999999999999999999999999999999999999999


Q ss_pred             cCcccccccC--CcccccCCCccccccccc
Q 010676          473 FGLAKATKLN--DVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       473 FGLA~~~~~~--~~~s~~GT~~YmAPEVL~  500 (504)
                      ||++......  ......||+.|+|||++.
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  202 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIA  202 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC
T ss_pred             CcCceecCcCccccccccCCccccChhhhc
Confidence            9998765432  233456999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.96  E-value=5.1e-29  Score=245.66  Aligned_cols=168  Identities=29%  Similarity=0.511  Sum_probs=135.1

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ..++|++++.||+|+||.||+|.+..  .+|+|++.....   .......+.+|+.+++.++||||+++++++ ....++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            34689999999999999999998743  599998865432   233456788999999999999999999965 456789


Q ss_pred             EEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc---
Q 010676          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL---  481 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~---  481 (504)
                      +||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....   
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999999998854  4589999999999999999999999999999999999999999999999999875432   


Q ss_pred             -CCcccccCCCccccccccc
Q 010676          482 -NDVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       482 -~~~~s~~GT~~YmAPEVL~  500 (504)
                       .......||+.|+|||++.
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~  195 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIR  195 (289)
T ss_dssp             --------CCCTTCCHHHHC
T ss_pred             cccccccCCCccccCchhhc
Confidence             1233456999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.96  E-value=3.1e-29  Score=259.99  Aligned_cols=168  Identities=30%  Similarity=0.478  Sum_probs=129.9

Q ss_pred             ccccceee-eeeecccCceeEEEEEcc---CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee--
Q 010676          326 RIITYWQK-GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--  399 (504)
Q Consensus       326 ~~~~~y~i-~k~LG~G~FG~VYka~~~---~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~--  399 (504)
                      ++.+.|.+ +++||+|+||.||+|.+.   ++..||+|++......       ..+.+|+.+|+.++||||+++++++  
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-------MSACREIALLRELKHPNVISLQKVFLS   89 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-------HHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-------HHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence            45567777 668999999999999964   6889999987532211       3467899999999999999999998  


Q ss_pred             cCCCeEEEEEEeccCCCHHHHHHhc----------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----cCC
Q 010676          400 KDESKLYIFLELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DAN  465 (504)
Q Consensus       400 ~~~~~lyLVmEy~~ggsL~~ll~~~----------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL----d~~  465 (504)
                      .....+|+||||+.+ +|.+++...          .+++..++.|+.||+.||.|||++||+||||||+||||    +.+
T Consensus        90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred             CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence            557889999999986 677766422          38999999999999999999999999999999999999    678


Q ss_pred             CcEEEEecCcccccccC-----CcccccCCCcccccccccC
Q 010676          466 GSVKLADFGLAKATKLN-----DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       466 g~VKL~DFGLA~~~~~~-----~~~s~~GT~~YmAPEVL~g  501 (504)
                      +.+||+|||+++.....     .....+||+.|+|||++.+
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  209 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG  209 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTT
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence            89999999999865432     2344679999999999876

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.96  E-value=8e-29  Score=254.31  Aligned_cols=169  Identities=28%  Similarity=0.457  Sum_probs=142.1

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      +.++|.+.+.||+|+||.||+|.+ .+|..||||++.....   .......+.+|+.+++.++||||+++++++...+..
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  116 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL  116 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc---chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence            457899999999999999999998 5799999998864322   233456788999999999999999999999877665


Q ss_pred             ------EEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          406 ------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       406 ------yLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                            |+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus       117 ~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          117 RNFYDFYLVMPFMQT-DLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             TTCCCCEEEEECCCE-EHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             ccceeEEEEEccccc-cHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence                  999999984 7877764 45999999999999999999999999999999999999999999999999999765


Q ss_pred             ccCCcccccCCCcccccccccC
Q 010676          480 KLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       480 ~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      ... .....||+.|+|||++.+
T Consensus       195 ~~~-~~~~~~t~~y~aPE~~~~  215 (371)
T 4exu_A          195 DAE-MTGYVVTRWYRAPEVILS  215 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSC
T ss_pred             ccC-cCCcccCccccCHHHhcC
Confidence            433 345578999999999876

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.96  E-value=4.7e-29  Score=245.81  Aligned_cols=169  Identities=31%  Similarity=0.577  Sum_probs=142.0

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ...+.|++++.||+|+||.||+|.+ .++..||+|++.....     .....+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-----EELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-----HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            3456899999999999999999998 4689999998864322     223567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc-
Q 010676          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-  481 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~-  481 (504)
                      +|+||||+++++|.+++..  ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..... 
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999999998865  4599999999999999999999999999999999999999999999999998754221 


Q ss_pred             -CCcccccCCCcccccccc
Q 010676          482 -NDVKSCRGTAFWMAPEVC  499 (504)
Q Consensus       482 -~~~~s~~GT~~YmAPEVL  499 (504)
                       .......||+.|+|||++
T Consensus       171 ~~~~~~~~~~~~y~aPE~~  189 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVV  189 (302)
T ss_dssp             HHC-----CCGGGCCHHHH
T ss_pred             ccccccccCChhhcCCeee
Confidence             122345699999999998

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=4.3e-29  Score=250.40  Aligned_cols=171  Identities=27%  Similarity=0.498  Sum_probs=141.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceE--EEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~v--AVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~  403 (504)
                      .++|++.+.||+|+||.||+|.+ .++..+  ++|.+....    .......+.+|+.++.++ +||||+++++++.+.+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc----chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            46899999999999999999998 456644  888876322    223345688999999999 8999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  466 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g  466 (504)
                      .+|+||||+++++|.+++...                 .+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            999999999999999998764                 489999999999999999999999999999999999999999


Q ss_pred             cEEEEecCcccccccC-CcccccCCCcccccccccCC
Q 010676          467 SVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       467 ~VKL~DFGLA~~~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .+||+|||+++..... ......+|+.|+|||++.+.
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  216 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS  216 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccc
Confidence            9999999998743322 12334578899999988643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.2e-28  Score=242.46  Aligned_cols=169  Identities=27%  Similarity=0.428  Sum_probs=142.5

Q ss_pred             ccceeeee-eecccCceeEEEEEc---cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          328 ITYWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       328 ~~~y~i~k-~LG~G~FG~VYka~~---~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .++|.+.+ .||+|+||.||+|.+   .++..||+|++....    .......+.+|+.+++.++||||+++++++ ..+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc----chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            34666666 999999999999985   367889999886432    234456788999999999999999999999 456


Q ss_pred             eEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            79999999999999999854  3589999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-----cccccCCCcccccccccC
Q 010676          482 ND-----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       482 ~~-----~~s~~GT~~YmAPEVL~g  501 (504)
                      ..     .....+|+.|+|||++.+
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~  187 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINF  187 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHH
T ss_pred             CcceeeccccccccccccCHHHhcc
Confidence            32     123347899999998864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=9.1e-29  Score=256.74  Aligned_cols=166  Identities=26%  Similarity=0.339  Sum_probs=137.4

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC----
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----  402 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~----  402 (504)
                      ...+|+++++||+|+||+||+|.+..+..+|+|.+......         ..+|+.+++.++||||+++++++...    
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            45689999999999999999999976667999987542211         23699999999999999999998433    


Q ss_pred             --CeEEEEEEeccCCCHHHHHH----hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEEEEecCc
Q 010676          403 --SKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGL  475 (504)
Q Consensus       403 --~~lyLVmEy~~ggsL~~ll~----~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd-~~g~VKL~DFGL  475 (504)
                        ..+|+||||++++.+..+..    ...+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+
T Consensus       109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence              34899999999864443332    34589999999999999999999999999999999999999 799999999999


Q ss_pred             ccccccC-CcccccCCCcccccccccC
Q 010676          476 AKATKLN-DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       476 A~~~~~~-~~~s~~GT~~YmAPEVL~g  501 (504)
                      ++..... ......||+.|+|||++.+
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~  215 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFG  215 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTT
T ss_pred             cccccCCCCCcccccCcCccCHHHHcC
Confidence            9865433 3445679999999999865

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.96  E-value=4.8e-29  Score=251.12  Aligned_cols=175  Identities=26%  Similarity=0.443  Sum_probs=146.1

Q ss_pred             cccccceeee-eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecC
Q 010676          325 KRIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD  401 (504)
Q Consensus       325 ~~~~~~y~i~-k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~  401 (504)
                      ..+.++|.+. +.||+|+||.||+|.+ .++..||+|++........   ....+.+|+.++..+. ||||+++++++..
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD---CRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE---CHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH---HHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3456678887 8999999999999998 5799999999875433222   2356789999999985 6999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEecCc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGL  475 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~---~g~VKL~DFGL  475 (504)
                      ...+|+||||+.+++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+||||+.   ++.+||+|||+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            9999999999999999998754   45899999999999999999999999999999999999987   78999999999


Q ss_pred             ccccccCC-cccccCCCcccccccccCC
Q 010676          476 AKATKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       476 A~~~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ++...... .....||+.|+|||++.+.
T Consensus       181 a~~~~~~~~~~~~~gt~~y~aPE~~~~~  208 (327)
T 3lm5_A          181 SRKIGHACELREIMGTPEYLAPEILNYD  208 (327)
T ss_dssp             CEEC---------CCCGGGCCHHHHTTC
T ss_pred             ccccCCccccccccCCcCccCCeeecCC
Confidence            98654332 3456799999999998764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.96  E-value=1.1e-28  Score=242.60  Aligned_cols=174  Identities=30%  Similarity=0.529  Sum_probs=149.0

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|++........   ....+.+|+.++++++||||+++++++...+.
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH---HHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            4567899999999999999999998 4789999999865433221   23567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHH-hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC---CcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~-~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~---g~VKL~DFGLA~~~~  480 (504)
                      +|+||||+.+++|.+++. ...+++..+..++.||+.||.|||++||+|+||||+|||++.+   +.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            999999999999988765 4569999999999999999999999999999999999999754   469999999987654


Q ss_pred             cCC-cccccCCCcccccccccCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... .....||+.|+|||++.+.
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~  198 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGT  198 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTC
T ss_pred             CCCccccccCcccccChHHhcCC
Confidence            332 3344589999999998765

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.96  E-value=6.8e-29  Score=251.78  Aligned_cols=174  Identities=22%  Similarity=0.298  Sum_probs=138.8

Q ss_pred             ccceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHH------HHHHHHHHHHHHhhCCCCceeEEee
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQ------SISQLEQEIALLSRFEHENIVQYYG  397 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIV~l~~  397 (504)
                      .++|++++.||+|+||.||+|.+.    ++..+|+|.+...........      ....+.+|+.++..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999984    678999998875432111111      1123567889999999999999999


Q ss_pred             eecC----CCeEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC--cEEE
Q 010676          398 TDKD----ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG--SVKL  470 (504)
Q Consensus       398 ~~~~----~~~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g--~VKL  470 (504)
                      ++..    ...+|+||||+ +++|.+++... .+++..++.|+.||+.||.|||++||+||||||+||||+.++  .+||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence            9877    78899999999 89999998754 699999999999999999999999999999999999999887  9999


Q ss_pred             EecCcccccccCC---------cccccCCCcccccccccCC
Q 010676          471 ADFGLAKATKLND---------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       471 ~DFGLA~~~~~~~---------~~s~~GT~~YmAPEVL~g~  502 (504)
                      +|||+++......         .....||+.|+|||++.+.
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  235 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV  235 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCC
Confidence            9999997653221         1345699999999998765

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=1.3e-28  Score=244.91  Aligned_cols=169  Identities=27%  Similarity=0.347  Sum_probs=144.0

Q ss_pred             ccccceeeeeeecccCceeEEEEEc--cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC------ceeEEee
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE------NIVQYYG  397 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~--~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp------nIV~l~~  397 (504)
                      .+.++|++.+.||+|+||.||+|.+  .++..||+|++...      ......+.+|+.+++.++|+      +|+++++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~   84 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE   84 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence            4557899999999999999999987  47899999988532      22345677888888887655      4999999


Q ss_pred             eecCCCeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC----------
Q 010676          398 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA----------  464 (504)
Q Consensus       398 ~~~~~~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~----------  464 (504)
                      ++...+.+|+||||+ +++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.          
T Consensus        85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence            999999999999999 78999988765   3789999999999999999999999999999999999987          


Q ss_pred             ---------CCcEEEEecCcccccccCCcccccCCCcccccccccCC
Q 010676          465 ---------NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       465 ---------~g~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                               ++.+||+|||++...... .....||+.|+|||++.+.
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~  209 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH-HSTLVSTRHYRAPEVILAL  209 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC-CCSSCSCGGGCCHHHHTTS
T ss_pred             cccccccccCCCceEeeCcccccCccc-cccccCCccccChHHhhCC
Confidence                     678999999998764432 3455799999999998764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.96  E-value=1.6e-28  Score=244.52  Aligned_cols=173  Identities=31%  Similarity=0.496  Sum_probs=142.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEc--cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC---CCCceeEEeeeec
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDK  400 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~--~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIV~l~~~~~  400 (504)
                      +..++|++++.||+|+||.||+|.+  .++..||+|++..........   ..+.+|+.+++.+   +||||+++++++.
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   84 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCT   84 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC---chhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence            4557899999999999999999998  478899999986533221111   1244566665554   8999999999986


Q ss_pred             -----CCCeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEe
Q 010676          401 -----DESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD  472 (504)
Q Consensus       401 -----~~~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~D  472 (504)
                           ....+|+||||+. ++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEec
Confidence                 5678999999998 5999988764   389999999999999999999999999999999999999999999999


Q ss_pred             cCcccccccC-CcccccCCCcccccccccCC
Q 010676          473 FGLAKATKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       473 FGLA~~~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||++...... ......||+.|+|||++.+.
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  194 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS  194 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcC
Confidence            9998765432 23455799999999998764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.4e-28  Score=248.61  Aligned_cols=171  Identities=26%  Similarity=0.431  Sum_probs=140.3

Q ss_pred             ccceeeeeeecccCceeEEEEEccC-----CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDD-----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~-----g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      ...|.+.+.||+|+||.||+|.+..     +..||+|.+....    .......+.+|+.+++.++||||+++++++...
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            4579999999999999999998732     3469999886422    123345688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      +.+|+||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999999998763  58999999999999999999999999999999999999999999999999997654


Q ss_pred             cCC-----cccccCCCcccccccccCC
Q 010676          481 LND-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...     .....+|+.|+|||++.++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~  225 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYR  225 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSC
T ss_pred             cccccccccCCCCccccccCchhcccC
Confidence            322     1123468899999998754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=1.9e-28  Score=243.87  Aligned_cols=167  Identities=25%  Similarity=0.418  Sum_probs=128.5

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeee------
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTD------  399 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~------  399 (504)
                      ..+|++.++||+|+||.||+|.+ .++..||+|++....     ......+.+|+.++.++. ||||+++++++      
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-----EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-----HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-----hHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            45899999999999999999997 588999999885322     233456889999999996 99999999988      


Q ss_pred             --cCCCeEEEEEEeccCCCHHHHHHh----cCCChHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcCCCcEEEE
Q 010676          400 --KDESKLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLA  471 (504)
Q Consensus       400 --~~~~~lyLVmEy~~ggsL~~ll~~----~~l~e~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILLd~~g~VKL~  471 (504)
                        .....+|+||||+. |+|.+++..    ..+++..++.|+.||+.||.|||++|  |+||||||+||||+.++.+||+
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence              44556899999997 588887754    45999999999999999999999999  9999999999999999999999


Q ss_pred             ecCcccccccCCc--------------ccccCCCccccccccc
Q 010676          472 DFGLAKATKLNDV--------------KSCRGTAFWMAPEVCS  500 (504)
Q Consensus       472 DFGLA~~~~~~~~--------------~s~~GT~~YmAPEVL~  500 (504)
                      |||+++.......              ....||+.|+|||++.
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  223 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID  223 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence            9999976543221              1345999999999983

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.96  E-value=1.1e-28  Score=245.14  Aligned_cols=174  Identities=27%  Similarity=0.430  Sum_probs=136.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      ...++|.+++.||+|+||.||+|...    ++..||+|.+.....   .......+.+|+.+++.++||||+++++++..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS---SQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC---CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc---chhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            34568999999999999999999863    456899998764322   23335678899999999999999999999876


Q ss_pred             CC-----eEEEEEEeccCCCHHHHHHh-------cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEE
Q 010676          402 ES-----KLYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK  469 (504)
Q Consensus       402 ~~-----~lyLVmEy~~ggsL~~ll~~-------~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VK  469 (504)
                      ..     .+|+||||+.+++|.+++..       ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+|
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence            55     35999999999999998842       3488999999999999999999999999999999999999999999


Q ss_pred             EEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          470 LADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       470 L~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |+|||++.......    .....+++.|+|||++.+.
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  224 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR  224 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSS
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCC
Confidence            99999987654332    2234578899999998764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=2.2e-29  Score=250.15  Aligned_cols=177  Identities=25%  Similarity=0.383  Sum_probs=141.2

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhh-HHHHHHHHHHHHHHhhC----CCCceeEEeee
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRF----EHENIVQYYGT  398 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~-~~~~~~~~~Ei~iL~~L----~HpnIV~l~~~  398 (504)
                      ..+.++|++++.||+|+||.||+|.+ .++..||+|++......... ......+.+|+.++.++    +|+||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            35567899999999999999999988 67889999988643322111 11223456788888888    89999999999


Q ss_pred             ecCCCeEEEEEEe-ccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEEEEecCc
Q 010676          399 DKDESKLYIFLEL-VTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGL  475 (504)
Q Consensus       399 ~~~~~~lyLVmEy-~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd-~~g~VKL~DFGL  475 (504)
                      +...+.+|+|||| +.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            9999999999999 7899999988754 599999999999999999999999999999999999999 889999999999


Q ss_pred             ccccccCCcccccCCCcccccccccC
Q 010676          476 AKATKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       476 A~~~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      +............||+.|+|||++.+
T Consensus       187 ~~~~~~~~~~~~~~~~~y~aPE~~~~  212 (312)
T 2iwi_A          187 GALLHDEPYTDFDGTRVYSPPEWISR  212 (312)
T ss_dssp             CEECCSSCBCCCCSCTTTSCHHHHHH
T ss_pred             hhhcccCcccccCCcccccCceeeec
Confidence            98776666666779999999998764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.96  E-value=1.3e-28  Score=257.83  Aligned_cols=165  Identities=28%  Similarity=0.424  Sum_probs=136.2

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-----  401 (504)
                      ...|++++.||+|+||.||+|++ .++..||||++.....         .+.+|+.+|+.++|||||+++++|..     
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            44799999999999999999998 5799999998864221         12379999999999999999988732     


Q ss_pred             -CCeEEEEEEeccCCCHHHHHH-----hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC-CcEEEEecC
Q 010676          402 -ESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFG  474 (504)
Q Consensus       402 -~~~lyLVmEy~~ggsL~~ll~-----~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~-g~VKL~DFG  474 (504)
                       ...+++||||+++ +|..++.     ...+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence             2347899999987 5655543     2458999999999999999999999999999999999999965 578999999


Q ss_pred             cccccccC-CcccccCCCcccccccccCC
Q 010676          475 LAKATKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       475 LA~~~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      +++..... .....+||+.|+|||++.+.
T Consensus       203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~  231 (420)
T 1j1b_A          203 SAKQLVRGEPNVSYICSRYYRAPELIFGA  231 (420)
T ss_dssp             TCEECCTTCCCCSCCSCTTSCCHHHHTTC
T ss_pred             hhhhcccCCCceeeeeCCCcCCHHHHcCC
Confidence            99865433 34456799999999998653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=5.7e-29  Score=249.48  Aligned_cols=172  Identities=27%  Similarity=0.409  Sum_probs=141.6

Q ss_pred             cccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK  400 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~  400 (504)
                      ..++|++++.||+|+||.||+|.+      .++..||+|.+....    .......+.+|+.+++.++||||+++++++.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc----chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            356899999999999999999984      467799999875322    2233457889999999999999999999999


Q ss_pred             CCCeEEEEEEeccCCCHHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEE
Q 010676          401 DESKLYIFLELVTKGSLLNLYQRYH--------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVK  469 (504)
Q Consensus       401 ~~~~lyLVmEy~~ggsL~~ll~~~~--------l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~---~g~VK  469 (504)
                      ....+|+||||+++++|.+++....        +++..+..++.||+.||.|||++||+||||||+||||+.   +..+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999999997643        888999999999999999999999999999999999984   44699


Q ss_pred             EEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          470 LADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       470 L~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |+|||++.......    .....||+.|+|||++.++
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  220 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG  220 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCC
Confidence            99999987543222    2334589999999988643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.96  E-value=1.3e-28  Score=240.92  Aligned_cols=172  Identities=30%  Similarity=0.438  Sum_probs=142.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      ...++|++.+.||+|+||.||+|.+.    ++..||+|.+....    .......+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            44578999999999999999999863    34469999875422    12334678899999999999999999999875


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      + ..|+||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            4 578999999999999998764  3899999999999999999999999999999999999999999999999998765


Q ss_pred             ccCC---cccccCCCcccccccccCC
Q 010676          480 KLND---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~---~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....   .....+|+.|+|||++.++
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~  189 (281)
T 3cc6_A          164 EDEDYYKASVTRLPIKWMSPESINFR  189 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHC
T ss_pred             ccccccccccCCCCcceeCchhhccC
Confidence            4332   2334578899999988643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.96  E-value=2.8e-28  Score=239.21  Aligned_cols=169  Identities=24%  Similarity=0.343  Sum_probs=142.7

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEee-eecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG-TDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~-~~~~~~  403 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|++......       ..+.+|+.+++.++|++++..+. ++....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-------CHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-------hHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence            4567899999999999999999997 78999999988653322       24778999999999887655554 446677


Q ss_pred             eEEEEEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEecCcccc
Q 010676          404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKA  478 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL---d~~g~VKL~DFGLA~~  478 (504)
                      .+|+||||+ +++|.+++.  ...+++..+..++.||+.||.|||++||+||||||+||||   +.++.+||+|||++..
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            899999999 889999987  3459999999999999999999999999999999999999   4889999999999986


Q ss_pred             cccCC---------cccccCCCcccccccccCC
Q 010676          479 TKLND---------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~---------~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....         .....||+.|+|||++.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  190 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGI  190 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC
T ss_pred             ccccccccccccccccccccccccCChhhhcCC
Confidence            54332         2345699999999998875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=8.4e-29  Score=241.97  Aligned_cols=169  Identities=27%  Similarity=0.426  Sum_probs=137.6

Q ss_pred             cccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC-C
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-S  403 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~-~  403 (504)
                      ....++|++.+.||+|+||.||+|.+. +..||+|++....       ..+.+.+|+.+++.++||||+++++++... +
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   88 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             cCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence            344678999999999999999999874 8899999875321       235688999999999999999999986554 5


Q ss_pred             eEEEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      .+|+||||+.+++|.+++....   +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            7999999999999999987643   8899999999999999999999999999999999999999999999999987544


Q ss_pred             cCCcccccCCCcccccccccCC
Q 010676          481 LNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .. .....+|+.|+|||++.++
T Consensus       169 ~~-~~~~~~~~~y~aPE~~~~~  189 (278)
T 1byg_A          169 ST-QDTGKLPVKWTAPEALREK  189 (278)
T ss_dssp             --------CCTTTSCHHHHHHC
T ss_pred             cc-ccCCCccccccCHHHhCCC
Confidence            33 2234578999999998643

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.96  E-value=1.7e-28  Score=246.36  Aligned_cols=169  Identities=31%  Similarity=0.518  Sum_probs=144.4

Q ss_pred             ccceeeeeeecccCceeEEEEEc-----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      .++|++++.||+|+||.||+|..     .++..||+|++....     ......+.+|+.+++.++||||+++++++...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-----EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-----SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            46799999999999999999982     578999999886422     23346788999999999999999999988765


Q ss_pred             C--eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          403 S--KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       403 ~--~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      +  .+|+||||+++++|.+++...  .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            4  789999999999999999764  489999999999999999999999999999999999999999999999999986


Q ss_pred             cccCC-----cccccCCCcccccccccC
Q 010676          479 TKLND-----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       479 ~~~~~-----~~s~~GT~~YmAPEVL~g  501 (504)
                      .....     .....+|..|+|||++.+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~  222 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTE  222 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcC
Confidence            54332     123457888999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=1.5e-28  Score=242.17  Aligned_cols=170  Identities=25%  Similarity=0.411  Sum_probs=141.8

Q ss_pred             ccceeeee-eecccCceeEEEEEc---cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          328 ITYWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       328 ~~~y~i~k-~LG~G~FG~VYka~~---~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .++|++.+ .||+|+||.||+|.+   .++..||+|++.....   .......+.+|+.+++.++||||+++++++ ..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            45788888 999999999999964   4578999998864322   223356788999999999999999999999 566


Q ss_pred             eEEEEEEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .+|+||||+.+++|.+++.... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            7999999999999999987654 899999999999999999999999999999999999999999999999999765433


Q ss_pred             Cc-----ccccCCCcccccccccC
Q 010676          483 DV-----KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~~-----~s~~GT~~YmAPEVL~g  501 (504)
                      ..     ....+|+.|+|||++.+
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~  194 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINY  194 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHH
T ss_pred             CCcccccccCCCCceeeChHHhcc
Confidence            21     22346788999998864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.96  E-value=1.4e-28  Score=241.21  Aligned_cols=168  Identities=38%  Similarity=0.604  Sum_probs=142.2

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ..|....+||+|+||.||+|.+ .++..||+|.+.....     .....+.+|+.+++.++||||+++++++...+.+|+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   96 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI   96 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-----HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence            3455556899999999999997 6788999998864322     223568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEecCcccccccC
Q 010676          408 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLN  482 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~----~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~-~g~VKL~DFGLA~~~~~~  482 (504)
                      ||||+++++|.+++...    .+++..+..++.||+.||.|||++||+|+||||+|||++. ++.+||+|||++......
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            99999999999998764    3568889999999999999999999999999999999987 899999999998765432


Q ss_pred             C--cccccCCCcccccccccC
Q 010676          483 D--VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~--~~s~~GT~~YmAPEVL~g  501 (504)
                      .  .....||+.|+|||++.+
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~  197 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDK  197 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHH
T ss_pred             CCcccccCCCccccChhhhcC
Confidence            2  334569999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.96  E-value=1.3e-28  Score=260.32  Aligned_cols=172  Identities=31%  Similarity=0.452  Sum_probs=142.5

Q ss_pred             ccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +....+.|++.+.||+|+||.||+|.+..+..||||.+......      ...+.+|+.++++++||||+++++++.. .
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            33445789999999999999999999988888999988643211      2468899999999999999999999876 6


Q ss_pred             eEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      .+|+||||+.+|+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            79999999999999999864   348999999999999999999999999999999999999999999999999998654


Q ss_pred             cCCc---ccccCCCcccccccccCC
Q 010676          481 LNDV---KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~~---~s~~GT~~YmAPEVL~g~  502 (504)
                      ....   ....+|+.|+|||++.++
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~  356 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYG  356 (452)
T ss_dssp             -----------CCGGGSCHHHHHHC
T ss_pred             CCceecccCCcccccccCHhHHhcC
Confidence            3322   233478899999988643

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=2.4e-28  Score=239.17  Aligned_cols=169  Identities=24%  Similarity=0.343  Sum_probs=138.5

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEee-eecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG-TDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~-~~~~~~  403 (504)
                      .+.++|++++.||+|+||.||+|.+ .++..||+|++......       ..+.+|+.+++.++|++++..+. ++...+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-------CCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-------hHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            3457899999999999999999997 68999999986543221       24678999999999877666555 446778


Q ss_pred             eEEEEEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEecCcccc
Q 010676          404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKA  478 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL---d~~g~VKL~DFGLA~~  478 (504)
                      .+|+||||+ +++|.+++.  ...+++..+..++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            899999999 889999987  3569999999999999999999999999999999999999   7899999999999986


Q ss_pred             cccCC---------cccccCCCcccccccccCC
Q 010676          479 TKLND---------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~---------~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....         .....||+.|+|||++.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  190 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGI  190 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCC
Confidence            54332         2345699999999998864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=1.8e-28  Score=244.87  Aligned_cols=164  Identities=30%  Similarity=0.499  Sum_probs=134.8

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      .++|++.+.||+|+||.||+|.+. +..||+|.+...       .....+.+|+.++++++||||+++++++.+  .+|+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-------SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL   76 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence            458999999999999999999875 678999977421       123568899999999999999999998874  4899


Q ss_pred             EEEeccCCCHHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH---CCceecCCCCCcEEEcCCCc-EEEEecCccccc
Q 010676          408 FLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHD---QDVVHRDIKCANILVDANGS-VKLADFGLAKAT  479 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~~----l~e~~v~~i~~QIl~gL~yLHs---~gIIHRDLKP~NILLd~~g~-VKL~DFGLA~~~  479 (504)
                      ||||+++++|.+++....    ++...+..++.||+.||.|||+   +||+||||||+||||+.++. +||+|||++...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999999999999997643    6788999999999999999999   89999999999999998886 799999998755


Q ss_pred             ccCCcccccCCCcccccccccCC
Q 010676          480 KLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... .....||+.|+|||++.+.
T Consensus       157 ~~~-~~~~~gt~~y~aPE~~~~~  178 (307)
T 2eva_A          157 QTH-MTNNKGSAAWMAPEVFEGS  178 (307)
T ss_dssp             ---------CCTTSSCHHHHTCC
T ss_pred             ccc-cccCCCCCceEChhhhCCC
Confidence            432 2344699999999998764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.95  E-value=1.9e-28  Score=248.21  Aligned_cols=168  Identities=25%  Similarity=0.351  Sum_probs=122.3

Q ss_pred             ccccceeeee-eecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC--
Q 010676          326 RIITYWQKGD-LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--  401 (504)
Q Consensus       326 ~~~~~y~i~k-~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--  401 (504)
                      .+.++|++.+ +||+|+||.||+|.+ .++..||||++...      ..   ...+....++.+.||||+++++++..  
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PK---ARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HH---HHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            5677899855 699999999999998 47999999988531      11   11122334567789999999998865  


Q ss_pred             --CCeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEec
Q 010676          402 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADF  473 (504)
Q Consensus       402 --~~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~---~g~VKL~DF  473 (504)
                        ...+|+||||+.+++|.+++...   .+++..++.++.||+.||.|||++||+||||||+||||+.   ++.+||+||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence              55689999999999999999765   4899999999999999999999999999999999999976   455999999


Q ss_pred             CcccccccCCcccccCCCcccccccccCC
Q 010676          474 GLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       474 GLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      |+++...........||+.|+|||++.+.
T Consensus       176 g~~~~~~~~~~~~~~~t~~y~aPE~~~~~  204 (336)
T 3fhr_A          176 GFAKETTQNALQTPCYTPYYVAPEVLGPE  204 (336)
T ss_dssp             TTCEEC----------------------C
T ss_pred             ccceeccccccccCCCCcCccChhhhCCC
Confidence            99987665555667799999999998653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.95  E-value=6.3e-29  Score=252.36  Aligned_cols=164  Identities=20%  Similarity=0.270  Sum_probs=138.8

Q ss_pred             ccceeeeeeecccCceeEEEEEcc---------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeE----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD---------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ----  394 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~---------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~----  394 (504)
                      .++|++.+.||+|+||.||+|.+.         ++..||+|++...          ..+.+|+.+++.++||||++    
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~  110 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKK  110 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhh
Confidence            468999999999999999999985         3889999988632          24678999999999999988    


Q ss_pred             -----------EeeeecC-CCeEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 010676          395 -----------YYGTDKD-ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (504)
Q Consensus       395 -----------l~~~~~~-~~~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~N  459 (504)
                                 +++++.. ...+|+||||+ +++|.+++..   ..+++..+..|+.||+.||.|||++||+||||||+|
T Consensus       111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N  189 (352)
T 2jii_A          111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN  189 (352)
T ss_dssp             HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred             hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence                       4555554 67899999999 8999999976   469999999999999999999999999999999999


Q ss_pred             EEEcCCC--cEEEEecCcccccccCC---------cccccCCCcccccccccCC
Q 010676          460 ILVDANG--SVKLADFGLAKATKLND---------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       460 ILLd~~g--~VKL~DFGLA~~~~~~~---------~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||++.++  .+||+|||+++......         .....||+.|+|||++.+.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  243 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC  243 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC
Confidence            9999998  89999999997644221         1334699999999998874

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.95  E-value=3.8e-29  Score=251.10  Aligned_cols=179  Identities=27%  Similarity=0.402  Sum_probs=149.6

Q ss_pred             cccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhH-HHHHHHHHHHHHHhhCC--CCceeEEeee
Q 010676          323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK-QSISQLEQEIALLSRFE--HENIVQYYGT  398 (504)
Q Consensus       323 ~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~-~~~~~~~~Ei~iL~~L~--HpnIV~l~~~  398 (504)
                      ....+.++|++++.||+|+||.||+|.+ .++..||||++.......... .....+.+|+.+++.++  |+||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3445677899999999999999999987 688999999987543221000 01134567899999986  5999999999


Q ss_pred             ecCCCeEEEEEEeccC-CCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-CCCcEEEEecCc
Q 010676          399 DKDESKLYIFLELVTK-GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGL  475 (504)
Q Consensus       399 ~~~~~~lyLVmEy~~g-gsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd-~~g~VKL~DFGL  475 (504)
                      +...+.+|+|||++.+ ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||+
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            9999999999999976 899998865 4689999999999999999999999999999999999999 789999999999


Q ss_pred             ccccccCCcccccCCCcccccccccC
Q 010676          476 AKATKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       476 A~~~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      +............||+.|+|||++.+
T Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~~~~  222 (320)
T 3a99_A          197 GALLKDTVYTDFDGTRVYSPPEWIRY  222 (320)
T ss_dssp             CEECCSSCBCCCCSCGGGSCHHHHHH
T ss_pred             ccccccccccCCCCCccCCChHHhcc
Confidence            98776665666779999999998764

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=2.5e-29  Score=274.74  Aligned_cols=165  Identities=16%  Similarity=0.113  Sum_probs=127.7

Q ss_pred             eecccCceeEEEEEc-cCCceEEEEEEeccc-----cchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeEEEE
Q 010676          336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD-----QGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       336 ~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~-----~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      .++.|++|.+..+.. ..|..|+||.+....     .........++|.+|+.+|+++ .|+||++++++++++..+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            466777777666554 578899999986432     1223344567799999999999 699999999999999999999


Q ss_pred             EEeccCCCHHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Ccc
Q 010676          409 LELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  485 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~-l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~  485 (504)
                      |||++|++|.+++...+ ++.   ..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....  ...
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~  397 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT  397 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred             EecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence            99999999999998765 544   358999999999999999999999999999999999999999999875433  244


Q ss_pred             cccCCCcccccccccCCC
Q 010676          486 SCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~~  503 (504)
                      ..+||+.|||||++.|++
T Consensus       398 t~vGTp~YmAPE~l~g~~  415 (569)
T 4azs_A          398 NLVQSFFVFVNELFAENK  415 (569)
T ss_dssp             HHHHHHHHHHHHHC----
T ss_pred             CceechhhccHHHhCCCC
Confidence            567999999999998753

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.95  E-value=1.1e-28  Score=266.71  Aligned_cols=172  Identities=31%  Similarity=0.451  Sum_probs=147.0

Q ss_pred             ccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +....++|++.+.||+|+||.||+|.+..+..||||++......      ...+.+|+.+|++++|+||+++++++.. .
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            44456789999999999999999999988888999988643221      2468899999999999999999999876 6


Q ss_pred             eEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      .+||||||+.+|+|.+++..   ..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++...
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            79999999999999999864   348999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC---cccccCCCcccccccccCC
Q 010676          481 LND---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~---~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...   .....+|..|||||++.++
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~  439 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYG  439 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHC
T ss_pred             CCceecccCCcCcccccCHHHhccC
Confidence            322   2234478899999987643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.95  E-value=7.3e-29  Score=275.07  Aligned_cols=169  Identities=24%  Similarity=0.319  Sum_probs=143.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc--CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~--~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .+.++|++.+.||+|+||.||+|.+.  +++.||||++....    .......+.+|+.++..++||||+++++++...+
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG----DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC----CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            34578999999999999999999984  68999999775321    1233456889999999999999999999998765


Q ss_pred             e-----EEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          404 K-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       404 ~-----lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      .     +||||||+++++|.+++.. .+++.++..|+.||+.||.|||++|||||||||+||||+.+ .+||+|||+++.
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            5     7999999999999988765 79999999999999999999999999999999999999875 899999999986


Q ss_pred             cccCCcccccCCCcccccccccCC
Q 010676          479 TKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....  ....||+.|||||++.++
T Consensus       231 ~~~~--~~~~gt~~y~aPE~~~~~  252 (681)
T 2pzi_A          231 INSF--GYLYGTPGFQAPEIVRTG  252 (681)
T ss_dssp             TTCC--SCCCCCTTTSCTTHHHHC
T ss_pred             cccC--CccCCCccccCHHHHcCC
Confidence            5433  456799999999998754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.95  E-value=1.6e-28  Score=249.06  Aligned_cols=170  Identities=27%  Similarity=0.448  Sum_probs=142.0

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|.+.+.||+|+||.||+|.+ .+|..||||++.....   .......+.+|+.+++.++||||+++++++.....
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   97 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS   97 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc---chHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence            3457899999999999999999998 5799999998864322   23345678899999999999999999999987654


Q ss_pred             ------EEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          405 ------LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       405 ------lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                            +|+||||+.+ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        98 ~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A           98 LRNFYDFYLVMPFMQT-DLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             GGGCCCCEEEEECCSE-EGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             cccceeEEEEeccccC-CHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence                  5999999984 78776643 599999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCcccccCCCcccccccccC
Q 010676          479 TKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       479 ~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      .... .....||+.|+|||++.+
T Consensus       176 ~~~~-~~~~~~t~~y~aPE~~~~  197 (353)
T 3coi_A          176 ADAE-MTGYVVTRWYRAPEVILS  197 (353)
T ss_dssp             ---------CCSBCCSCHHHHSC
T ss_pred             CCCC-ccccccCcCcCCHHHHhC
Confidence            5433 344578999999999876

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.95  E-value=2.8e-28  Score=256.26  Aligned_cols=169  Identities=25%  Similarity=0.370  Sum_probs=143.5

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC------CCCceeEEeee
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF------EHENIVQYYGT  398 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L------~HpnIV~l~~~  398 (504)
                      .+..+|++++.||+|+||.||+|.+ .++..||||++...      ......+.+|+.+++.+      .|+||++++++
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            4556899999999999999999988 57899999988632      22234566777777766      57899999999


Q ss_pred             ecCCCeEEEEEEeccCCCHHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc--EEEEec
Q 010676          399 DKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADF  473 (504)
Q Consensus       399 ~~~~~~lyLVmEy~~ggsL~~ll~~~~---l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~--VKL~DF  473 (504)
                      +...+.+|+||||+. ++|.+++....   +++..++.|+.||+.||.|||++||+||||||+||||+.++.  +||+||
T Consensus       168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence            999999999999997 58888887643   899999999999999999999999999999999999999887  999999


Q ss_pred             CcccccccCCcccccCCCcccccccccCC
Q 010676          474 GLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       474 GLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      |++...... ....+||+.|||||++.+.
T Consensus       247 G~a~~~~~~-~~~~~gt~~y~aPE~~~~~  274 (429)
T 3kvw_A          247 GSSCYEHQR-VYTYIQSRFYRAPEVILGA  274 (429)
T ss_dssp             TTCEETTCC-CCSSCSCGGGCCHHHHHTB
T ss_pred             ccceecCCc-ccccCCCCCccChHHHhCC
Confidence            999764433 3456799999999998764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.95  E-value=1.9e-28  Score=239.80  Aligned_cols=172  Identities=28%  Similarity=0.430  Sum_probs=135.2

Q ss_pred             ccceeeeeeecccCceeEEEEEc--cCC--ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS--DDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~--~~g--~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .++|++++.||+|+||.||+|.+  .++  ..||+|++.....  ........+.+|+.+++.++||||+++++++....
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            46899999999999999999985  233  3689998754321  12234567889999999999999999999998765


Q ss_pred             eEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                       +++||||+.+++|.+++..  ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence             8999999999999998875  3599999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-----cccccCCCcccccccccCC
Q 010676          482 ND-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..     .....+|+.|+|||++.++
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~  199 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTR  199 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHC
T ss_pred             cccchhhhccCCCCceeeCchhhcCC
Confidence            32     1234578899999988643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.95  E-value=2.8e-28  Score=244.07  Aligned_cols=177  Identities=27%  Similarity=0.418  Sum_probs=130.4

Q ss_pred             CCCccccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHH-HHhhCCCCceeEEe
Q 010676          319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYY  396 (504)
Q Consensus       319 sp~~~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIV~l~  396 (504)
                      .+...+....++|++++.||+|+||.||+|.+ .++..||||++.....    ......+..|+. +++.++||||++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~~~   87 (327)
T 3aln_A           12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKEQKQLLMDLDVVMRSSDCPYIVQFY   87 (327)
T ss_dssp             CCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC----HHHHHHHHHHHHHHHSSCCCTTBCCEE
T ss_pred             ChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC----chHHHHHHHHHHHHHHcCCCCcEeeee
Confidence            33444555567999999999999999999998 5899999999864322    122234555555 77888999999999


Q ss_pred             eeecCCCeEEEEEEeccCCCHHHHHH------hcCCChHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEE
Q 010676          397 GTDKDESKLYIFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVK  469 (504)
Q Consensus       397 ~~~~~~~~lyLVmEy~~ggsL~~ll~------~~~l~e~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILLd~~g~VK  469 (504)
                      +++...+.+|+||||+.+ +|.+++.      ...+++..+..++.|++.||.|||++ ||+||||||+||||+.++.+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           88 GALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             EEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEE
T ss_pred             eEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEE
Confidence            999999999999999986 7777765      34689999999999999999999998 999999999999999999999


Q ss_pred             EEecCcccccccCC-cccccCCCccccccccc
Q 010676          470 LADFGLAKATKLND-VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       470 L~DFGLA~~~~~~~-~~s~~GT~~YmAPEVL~  500 (504)
                      |+|||+++...... .....||+.|+|||++.
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~  198 (327)
T 3aln_A          167 LCDFGISGQLVDSIAKTRDAGCRPYMAPERID  198 (327)
T ss_dssp             ECCCSSSCC-----------------------
T ss_pred             EccCCCceecccccccccCCCCccccCceeec
Confidence            99999997654332 23346999999999984

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.95  E-value=2e-28  Score=250.73  Aligned_cols=169  Identities=13%  Similarity=0.086  Sum_probs=125.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHH---HHHhhCCCCceeEEeeee----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYYGTD----  399 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei---~iL~~L~HpnIV~l~~~~----  399 (504)
                      ...|++++.||+|+||.||+|.+ .++..||+|++......  .......+.+|+   .+|+. +||||++++..+    
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~  137 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN--SRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPS  137 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT--HHHHHHHHHHHHHHHHHHHC-----------CBCCCC
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc--cccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeee
Confidence            44699999999999999999997 58999999998764332  233445677774   45555 799988865333    


Q ss_pred             ---cCC-----------------CeEEEEEEeccCCCHHHHHHhc--CCChHHH------HHHHHHHHHHHHHHHHCCce
Q 010676          400 ---KDE-----------------SKLYIFLELVTKGSLLNLYQRY--HLRDSQV------SAYTRQILLGLKYLHDQDVV  451 (504)
Q Consensus       400 ---~~~-----------------~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v------~~i~~QIl~gL~yLHs~gII  451 (504)
                         ...                 ..+||||||++ ++|.+++...  .+.+...      ..++.||+.||.|||++||+
T Consensus       138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv  216 (371)
T 3q60_A          138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV  216 (371)
T ss_dssp             EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence               221                 34899999999 7999998753  3555555      57779999999999999999


Q ss_pred             ecCCCCCcEEEcCCCcEEEEecCcccccccCCcccccCCCcccccccccC
Q 010676          452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       452 HRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      ||||||+||||+.+|.+||+|||+++...... ....+|+.|||||++.+
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-~~~~~t~~y~aPE~~~~  265 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNA  265 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEE-EGGGSCGGGCCHHHHTC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCc-cCccCCcCCcChhhccC
Confidence            99999999999999999999999998654322 24557799999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.95  E-value=2.4e-28  Score=247.03  Aligned_cols=171  Identities=26%  Similarity=0.349  Sum_probs=129.6

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      ....+++|++.+.||+|+||.||+|.+ .++..||||++.......      ....+++..+..++||||+++++++...
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR------NRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC------CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc------HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            445678999999999999999999998 578999999885432221      2345678888889999999999998543


Q ss_pred             C-------eEEEEEEeccCCCHHHHHH-----hcCCChHHHHHHHHHHHHHHHHHH--HCCceecCCCCCcEEEcC-CCc
Q 010676          403 S-------KLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLKYLH--DQDVVHRDIKCANILVDA-NGS  467 (504)
Q Consensus       403 ~-------~lyLVmEy~~ggsL~~ll~-----~~~l~e~~v~~i~~QIl~gL~yLH--s~gIIHRDLKP~NILLd~-~g~  467 (504)
                      .       .+|+||||+.++ |...+.     ...+++..+..++.||+.||.|||  ++||+||||||+||||+. ++.
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred             ccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence            3       389999999975 443332     235888999999999999999999  999999999999999996 899


Q ss_pred             EEEEecCcccccccCC-cccccCCCcccccccccC
Q 010676          468 VKLADFGLAKATKLND-VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       468 VKL~DFGLA~~~~~~~-~~s~~GT~~YmAPEVL~g  501 (504)
                      +||+|||+++...... .....||+.|+|||++.+
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  205 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG  205 (360)
T ss_dssp             EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT
T ss_pred             EEEeeCCCceecCCCCCcccccCCcceeCHHHHcC
Confidence            9999999998655433 345579999999999854

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.95  E-value=6e-28  Score=240.22  Aligned_cols=171  Identities=23%  Similarity=0.427  Sum_probs=142.7

Q ss_pred             ccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC--CCceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~~~~~~~  403 (504)
                      ...++|++++.||+|+||.||++.+.++..||+|++......   ......+.+|+.++..++  |+||+++++++...+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD---NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC---HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc---ccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            345679999999999999999999988999999998654322   334567889999999997  599999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      .+|+||| +.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred             EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence            9999999 567799998876 4589999999999999999999999999999999999996 589999999999865433


Q ss_pred             C----cccccCCCcccccccccC
Q 010676          483 D----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 ~----~~s~~GT~~YmAPEVL~g  501 (504)
                      .    .....||+.|+|||++.+
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~  202 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKD  202 (313)
T ss_dssp             ----------CCGGGCCHHHHTT
T ss_pred             cccccccCCCCCCCcCCHHHHhh
Confidence            2    234469999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.95  E-value=5.9e-28  Score=242.01  Aligned_cols=169  Identities=23%  Similarity=0.309  Sum_probs=140.6

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc-CC-ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc------eeEEee
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD-DG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN------IVQYYG  397 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~-~g-~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------IV~l~~  397 (504)
                      .+.++|++.+.||+|+||.||+|.+. ++ ..||+|++...      ......+.+|+.+++.++|++      ++.+++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------GKYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            35678999999999999999999983 44 78999988532      123356778999998887655      999999


Q ss_pred             eecCCCeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE------------
Q 010676          398 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV------------  462 (504)
Q Consensus       398 ~~~~~~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL------------  462 (504)
                      ++...+.+|+||||+. ++|.+++...   .+++..+..++.||+.||.|||++||+||||||+||||            
T Consensus        90 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           90 WFNFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eeeeCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence            9999999999999995 5666665543   48999999999999999999999999999999999999            


Q ss_pred             -------cCCCcEEEEecCcccccccCCcccccCCCcccccccccCC
Q 010676          463 -------DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       463 -------d~~g~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                             +.++.+||+|||+++..... .....||+.|+|||++.+.
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~  214 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH-HTTIVATRHYRPPEVILEL  214 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC-CCSSCSCGGGCCHHHHTTC
T ss_pred             ccccccccCCCcEEEeecCcccccccc-ccCCcCCCcccCCeeeecC
Confidence                   66889999999999764432 3455799999999998764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.95  E-value=7.3e-28  Score=238.59  Aligned_cols=174  Identities=28%  Similarity=0.408  Sum_probs=132.1

Q ss_pred             cccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       323 ~~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      .+...+++|++++.||+|+||.||+|.+ .++..||||++......   ......+.++..+++.++||||+++++++..
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK---EENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH---HHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc---hHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            4566678999999999999999999998 58999999998753321   2222344455567888899999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      .+.+|+||||+ ++.+..+...  ..+++..+..++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            99999999999 5566666553  4689999999999999999999995 999999999999999999999999999876


Q ss_pred             cccCC-cccccCCCccccccccc
Q 010676          479 TKLND-VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       479 ~~~~~-~~s~~GT~~YmAPEVL~  500 (504)
                      ..... .....||+.|+|||++.
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~  197 (318)
T 2dyl_A          175 LVDDKAKDRSAGCAAYMAPERID  197 (318)
T ss_dssp             ------------CCTTCCHHHHC
T ss_pred             ccCCccccccCCCccccChhhcc
Confidence            54332 33456999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.95  E-value=6.2e-29  Score=246.82  Aligned_cols=172  Identities=24%  Similarity=0.484  Sum_probs=141.5

Q ss_pred             ccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +....++|++++.||+|+||.||+|.+..  .+|+|.+........   ....+.+|+.+++.++||||+++++++....
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNED---QLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCC---CCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHH---HHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            44456789999999999999999998754  599998764322211   1234668999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+.+++|.+++....  +++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            9999999999999999997654  89999999999999999999999999999999999998 78999999999865421


Q ss_pred             -------CCcccccCCCcccccccccC
Q 010676          482 -------NDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       482 -------~~~~s~~GT~~YmAPEVL~g  501 (504)
                             .......||+.|+|||++.+
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~  208 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQ  208 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSC
T ss_pred             ccccccccccccCCCcccccChHHhhh
Confidence                   12233458999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.95  E-value=1.2e-27  Score=256.56  Aligned_cols=169  Identities=24%  Similarity=0.329  Sum_probs=144.2

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-CceeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~~~~~~  403 (504)
                      .+.++|+++++||+|+||.||+|.+ .++..||||++......       ..+.+|+.+++.++| ++|+.+..++...+
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~   76 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGD   76 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence            4567899999999999999999997 68999999987653322       236789999999986 56666777778888


Q ss_pred             eEEEEEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---cCCCcEEEEecCcccc
Q 010676          404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKA  478 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL---d~~g~VKL~DFGLA~~  478 (504)
                      ..||||||+ +++|.+++.  ...+++..++.|+.||+.||.|||++|||||||||+||||   +.++.+||+|||+++.
T Consensus        77 ~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            999999999 889999997  4569999999999999999999999999999999999999   6889999999999986


Q ss_pred             cccCCc---------ccccCCCcccccccccCC
Q 010676          479 TKLNDV---------KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       479 ~~~~~~---------~s~~GT~~YmAPEVL~g~  502 (504)
                      ......         ...+||+.|+|||++.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~  188 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGI  188 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCC
Confidence            543321         255799999999998865

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=5.1e-28  Score=250.07  Aligned_cols=170  Identities=27%  Similarity=0.431  Sum_probs=133.5

Q ss_pred             cceeeeeeecccCceeEEEEEcc--C--CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec-CCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISD--D--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-DES  403 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~--~--g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~-~~~  403 (504)
                      ..|++.++||+|+||.||+|.+.  +  +..||+|.+....    .......+.+|+.++++++||||+++++++. .++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS----CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence            36889999999999999999863  2  3467888765322    2234567889999999999999999999864 456


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+.+++|.+++...  .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            889999999999999999754  478889999999999999999999999999999999999999999999999976533


Q ss_pred             CC------cccccCCCcccccccccCC
Q 010676          482 ND------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~------~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..      .....+|+.|+|||++.++
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~  271 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQ  271 (373)
T ss_dssp             -------------CCGGGSCHHHHHHC
T ss_pred             cccccccccCCCCCcccccChHHhcCC
Confidence            22      1234578899999998654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.95  E-value=2.2e-27  Score=244.24  Aligned_cols=170  Identities=22%  Similarity=0.367  Sum_probs=143.2

Q ss_pred             cccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CC-----ceeEEee
Q 010676          325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HE-----NIVQYYG  397 (504)
Q Consensus       325 ~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----nIV~l~~  397 (504)
                      ..+.++|++.+.||+|+||.||+|.+ .++..||||++...      ......+.+|+.++..++ |+     +|+++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            35678999999999999999999998 57899999988632      223455677888887775 44     4999999


Q ss_pred             eecCCCeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHH--HCCceecCCCCCcEEEc--CCCcEEE
Q 010676          398 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLH--DQDVVHRDIKCANILVD--ANGSVKL  470 (504)
Q Consensus       398 ~~~~~~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLH--s~gIIHRDLKP~NILLd--~~g~VKL  470 (504)
                      ++...+.+|+||||+.+ +|.+++...   .+++..+..++.||+.||.|||  ++||+||||||+||||+  .++.+||
T Consensus       124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence            99999999999999975 899988764   4899999999999999999999  57999999999999995  4788999


Q ss_pred             EecCcccccccCCcccccCCCcccccccccCC
Q 010676          471 ADFGLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       471 ~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      +|||+++..... .....||+.|+|||++.+.
T Consensus       203 ~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~  233 (382)
T 2vx3_A          203 VDFGSSCQLGQR-IYQYIQSRFYRSPEVLLGM  233 (382)
T ss_dssp             CCCTTCEETTCC-CCSSCSCGGGCCHHHHTTC
T ss_pred             EeccCceecccc-cccccCCccccChHHHcCC
Confidence            999999866433 3456799999999998764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.95  E-value=8.1e-28  Score=243.86  Aligned_cols=167  Identities=26%  Similarity=0.331  Sum_probs=141.0

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-----------CCceeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----------HENIVQY  395 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIV~l  395 (504)
                      .++|++++.||+|+||.||+|.+ .++..||||++...      ......+.+|+.+++.++           |+||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            46899999999999999999998 68999999988631      223356778888888876           8999999


Q ss_pred             eeeecCCC----eEEEEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEc----
Q 010676          396 YGTDKDES----KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVD----  463 (504)
Q Consensus       396 ~~~~~~~~----~lyLVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~-gIIHRDLKP~NILLd----  463 (504)
                      ++++...+    .+++||||+ +++|.+++..   ..+++..+..++.||+.||.|||++ ||+||||||+||||+    
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99987654    799999999 7899998875   3489999999999999999999998 999999999999995    


Q ss_pred             --CCCcEEEEecCcccccccCCcccccCCCcccccccccCC
Q 010676          464 --ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       464 --~~g~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                        ..+.+||+|||++...... .....||+.|+|||++.+.
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~  210 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGA  210 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTC
T ss_pred             CcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCC
Confidence              3447999999999765533 3445799999999998765

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.2e-27  Score=263.23  Aligned_cols=169  Identities=26%  Similarity=0.430  Sum_probs=137.9

Q ss_pred             cceeeee-eecccCceeEEEEEcc---CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          329 TYWQKGD-LLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       329 ~~y~i~k-~LG~G~FG~VYka~~~---~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ..+.+.+ .||+|+||.||+|.+.   ++..||||++.....    ......+.+|+.+|++++|||||++++++.. +.
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS----STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            3455555 8999999999999873   567899998864322    1224578899999999999999999999976 56


Q ss_pred             EEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +||||||+.+|+|.+++..  ..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            9999999999999999864  34899999999999999999999999999999999999999999999999999865432


Q ss_pred             Cc-----ccccCCCcccccccccCC
Q 010676          483 DV-----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~-----~s~~GT~~YmAPEVL~g~  502 (504)
                      ..     ....+|+.|||||++.++
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~  514 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFR  514 (613)
T ss_dssp             ------------CCTTSCHHHHHHC
T ss_pred             CceeeeccCCCCccceeCHhhhcCC
Confidence            21     122357899999998643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.95  E-value=2.2e-27  Score=262.28  Aligned_cols=165  Identities=26%  Similarity=0.430  Sum_probs=136.2

Q ss_pred             eeeecccCceeEEEEEc---cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEE
Q 010676          334 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~---~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmE  410 (504)
                      .+.||+|+||.||+|.+   .++..||||+++.....   ......+.+|+.+|+.++|||||++++++.. +.+|||||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E  449 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND---PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME  449 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC---GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEE
Confidence            45899999999999965   35689999988643222   2224678899999999999999999999865 46899999


Q ss_pred             eccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-----c
Q 010676          411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----V  484 (504)
Q Consensus       411 y~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-----~  484 (504)
                      |+.+|+|.+++... .+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++......     .
T Consensus       450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999999998765 48999999999999999999999999999999999999999999999999998654332     2


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....+|+.|+|||++.++
T Consensus       530 ~~~~~t~~y~APE~~~~~  547 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYY  547 (635)
T ss_dssp             -----CGGGSCHHHHHHC
T ss_pred             cCCCCceeeeChhhhcCC
Confidence            233478899999998653

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.94  E-value=1.4e-27  Score=251.01  Aligned_cols=166  Identities=31%  Similarity=0.427  Sum_probs=132.0

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~l  405 (504)
                      +.+.|.+.+.||+|+||+||.+...+|..||||.+....        ...+.+|+.+|..+ +|||||++++++.+.+.+
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   84 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFL   84 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence            345677789999999999987767789999999886321        23467899999876 899999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcCCC--------hHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC------------
Q 010676          406 YIFLELVTKGSLLNLYQRYHLR--------DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN------------  465 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~l~--------e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~------------  465 (504)
                      ||||||+. |+|.+++......        +..+..++.||+.||.|||++||+||||||+||||+.+            
T Consensus        85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence            99999996 5999999765432        22356799999999999999999999999999999754            


Q ss_pred             -CcEEEEecCcccccccCC------cccccCCCcccccccccC
Q 010676          466 -GSVKLADFGLAKATKLND------VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       466 -g~VKL~DFGLA~~~~~~~------~~s~~GT~~YmAPEVL~g  501 (504)
                       +.+||+|||+++......      ....+||+.|||||++.+
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  206 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE  206 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence             489999999998754432      224569999999999865

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.94  E-value=2.9e-27  Score=249.40  Aligned_cols=164  Identities=30%  Similarity=0.410  Sum_probs=133.4

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ..|.+.++||+|+||+||.....+++.||||++.....        ..+.+|+.+|+.+ +|||||++++++.+...+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            46999999999999997655556889999998853221        1245799999998 79999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---C--CcEEEEecCcccccc
Q 010676          408 FLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---N--GSVKLADFGLAKATK  480 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~---~--g~VKL~DFGLA~~~~  480 (504)
                      ||||+.+ +|.+++....  +.+..+..++.||+.||.|||++||+||||||+||||+.   +  ..+||+|||+++...
T Consensus        96 v~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           96 AIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             EEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             EEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            9999975 8999887654  455567899999999999999999999999999999953   2  358899999998654


Q ss_pred             cC-----CcccccCCCcccccccccC
Q 010676          481 LN-----DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~-----~~~s~~GT~~YmAPEVL~g  501 (504)
                      ..     .....+||+.|||||++.+
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~  200 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSE  200 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSC
T ss_pred             CCCcceeeccccCCCcCccChhhhhc
Confidence            32     2334569999999999974

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.94  E-value=1.1e-26  Score=257.69  Aligned_cols=174  Identities=30%  Similarity=0.448  Sum_probs=143.1

Q ss_pred             ccccccceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  399 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~  399 (504)
                      +....++|++++.||+|+||.||+|.+.    .+..||+|.+....    .......+.+|+.+++.++||||+++++++
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  460 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHPHIVKLIGVI  460 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3344578999999999999999999873    34578888765321    233446788999999999999999999998


Q ss_pred             cCCCeEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          400 KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       400 ~~~~~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      . ++.+|+||||+.+|+|.+++...  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            5 46789999999999999999754  48889999999999999999999999999999999999999999999999998


Q ss_pred             ccccCC---cccccCCCcccccccccCC
Q 010676          478 ATKLND---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       478 ~~~~~~---~~s~~GT~~YmAPEVL~g~  502 (504)
                      ......   .....+|+.|||||++.++
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~  567 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFR  567 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHC
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCC
Confidence            654332   1233478899999998643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.93  E-value=6e-26  Score=225.72  Aligned_cols=147  Identities=12%  Similarity=0.015  Sum_probs=130.0

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      +.++|++.+.||+|+||.||+|.+ .+++.||||++......  .......+.+|+.++..++||||+++++++...+.+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL--PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc--CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence            446899999999999999999998 56999999988643322  234456788999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                      |+||||++|++|.++++.. ....++..|+.||+.||.|||++||+||||||+||||+.+|.+||+++|..
T Consensus       107 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~  176 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM  176 (286)
T ss_dssp             EEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred             EEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc
Confidence            9999999999999999654 566678899999999999999999999999999999999999999987754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.93  E-value=1.2e-26  Score=257.95  Aligned_cols=172  Identities=24%  Similarity=0.419  Sum_probs=144.9

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC----
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----  401 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~----  401 (504)
                      ..++|++.+.||+|+||.||+|.+ .+|..||||++....    .......+.+|+.+++.++||||+++++++..    
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL----SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC----CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC----CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence            347899999999999999999998 579999999875321    23345678899999999999999999998765    


Q ss_pred             --CCeEEEEEEeccCCCHHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCc---EEEEe
Q 010676          402 --ESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLAD  472 (504)
Q Consensus       402 --~~~lyLVmEy~~ggsL~~ll~~~----~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~---VKL~D  472 (504)
                        .+.+|+||||+.+++|.+++...    .+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence              67789999999999999999764    4889999999999999999999999999999999999997765   99999


Q ss_pred             cCcccccccCC-cccccCCCcccccccccCC
Q 010676          473 FGLAKATKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       473 FGLA~~~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||++....... .....||+.|+|||++.++
T Consensus       168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~  198 (676)
T 3qa8_A          168 LGYAKELDQGELCTEFVGTLQYLAPELLEQK  198 (676)
T ss_dssp             CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCS
T ss_pred             cccccccccccccccccCCcccCChHHhccC
Confidence            99998765443 3456799999999998764

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=5.7e-27  Score=254.50  Aligned_cols=160  Identities=20%  Similarity=0.216  Sum_probs=123.4

Q ss_pred             eeeeeecccCceeEEEEEccCCceEEEEEEeccccch---hhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       332 ~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      ...++||+|+||.||+|. ..+..+++|.........   ......+++.+|+.+|++++||||+++..++...+..|||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            446789999999999994 456788888765422211   2223356689999999999999999655555566778999


Q ss_pred             EEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-----
Q 010676          409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-----  483 (504)
                      |||+++++|.+++..       +..|+.||+.||.|||++||+||||||+|||++.  .+||+|||+++......     
T Consensus       418 mE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~  488 (540)
T 3en9_A          418 MSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD  488 (540)
T ss_dssp             EECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred             EECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence            999999999999876       5689999999999999999999999999999988  99999999998765432     


Q ss_pred             ----cccccCCCcccccccccC
Q 010676          484 ----VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       484 ----~~s~~GT~~YmAPEVL~g  501 (504)
                          ....+||+.|||||++.+
T Consensus       489 ~~~~~~~~~GT~~y~APEv~~~  510 (540)
T 3en9_A          489 LIVFKKAVLSTHHEKFDEIWER  510 (540)
T ss_dssp             HHHHHHHHHHHCGGGHHHHHHH
T ss_pred             hhhhhhhhcCCCCcCCHHHHHH
Confidence                135579999999999864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.93  E-value=3.9e-25  Score=219.23  Aligned_cols=147  Identities=27%  Similarity=0.382  Sum_probs=127.9

Q ss_pred             ccccceeee-eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHH-hhCCCCceeEEeeeecC-
Q 010676          326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYYGTDKD-  401 (504)
Q Consensus       326 ~~~~~y~i~-k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIV~l~~~~~~-  401 (504)
                      .+.++|.+. ++||+|+||.||+|.+ .++..||+|++...          ..+.+|+.++ +.++||||+++++++.. 
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            456677776 8899999999999998 68899999988531          2356788877 66789999999998876 


Q ss_pred             ---CCeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEe
Q 010676          402 ---ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLAD  472 (504)
Q Consensus       402 ---~~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~---~g~VKL~D  472 (504)
                         ...+|+||||+++++|.+++...   .+++..+..++.||+.||.|||++||+||||||+||||+.   ++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               67899999999999999999765   4899999999999999999999999999999999999998   78999999


Q ss_pred             cCcccccccC
Q 010676          473 FGLAKATKLN  482 (504)
Q Consensus       473 FGLA~~~~~~  482 (504)
                      ||++......
T Consensus       164 fg~a~~~~~~  173 (299)
T 3m2w_A          164 FGFAKETTGE  173 (299)
T ss_dssp             CTTCEECTTC
T ss_pred             cccccccccc
Confidence            9999765433

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.92  E-value=2e-25  Score=233.17  Aligned_cols=167  Identities=20%  Similarity=0.229  Sum_probs=126.0

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-Cce-------------
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENI-------------  392 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pnI-------------  392 (504)
                      ...|.++++||+|+||+||+|.+ .+|..||||++......  .......+.+|+.+++.++| .|+             
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP--PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc--cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34688999999999999999997 68999999988633222  22234668899999999987 221             


Q ss_pred             --eE------EeeeecC-----CCeEEEEEEeccCCCHHHHHH--------hcCCChHHHHHHHHHHHHHHHHHHHCCce
Q 010676          393 --VQ------YYGTDKD-----ESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYLHDQDVV  451 (504)
Q Consensus       393 --V~------l~~~~~~-----~~~lyLVmEy~~ggsL~~ll~--------~~~l~e~~v~~i~~QIl~gL~yLHs~gII  451 (504)
                        +.      ++.++..     ...+|++|+++ +++|.++++        ...+++..+..++.||+.||.|||++|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii  233 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  233 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence              11      1111111     22467777765 568998885        23377778889999999999999999999


Q ss_pred             ecCCCCCcEEEcCCCcEEEEecCcccccccCCcccccCCCcccccccc
Q 010676          452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVC  499 (504)
Q Consensus       452 HRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL  499 (504)
                      ||||||+||||+.++.+||+|||+++..... ....+| +.|||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~  279 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETT  279 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-cccCCC-CceeCchhh
Confidence            9999999999999999999999998765433 445568 999999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=1.5e-24  Score=216.45  Aligned_cols=149  Identities=17%  Similarity=0.131  Sum_probs=118.1

Q ss_pred             ceeeeeeecccCceeEEEEEccCCceEEEEEEeccccch-------------hhHHHHHHHHHHHHHHhhCCCCceeEEe
Q 010676          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS-------------QAKQSISQLEQEIALLSRFEHENIVQYY  396 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~-------------~~~~~~~~~~~Ei~iL~~L~HpnIV~l~  396 (504)
                      .|.+++.||+|+||.||+|.+.+|..||+|.+.......             +.......+.+|+.+++.++  | ++++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            466779999999999999999889999999885422110             01124567889999999998  4 5555


Q ss_pred             eeecCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcc
Q 010676          397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA  476 (504)
Q Consensus       397 ~~~~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA  476 (504)
                      +++.. +.+|+||||++|++|.+ +     .......++.||+.||.|||++||+||||||+||||+ +|.+||+|||+|
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l-----~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a  239 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-V-----RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS  239 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-C-----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred             eEEec-cceEEEEEecCCCcHHH-c-----chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence            54433 56799999999999987 3     2234567999999999999999999999999999999 999999999998


Q ss_pred             cccccCCcccccCCCccccccccc
Q 010676          477 KATKLNDVKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       477 ~~~~~~~~~s~~GT~~YmAPEVL~  500 (504)
                      +           .+..|+|||++.
T Consensus       240 ~-----------~~~~~~a~e~l~  252 (282)
T 1zar_A          240 V-----------EVGEEGWREILE  252 (282)
T ss_dssp             E-----------ETTSTTHHHHHH
T ss_pred             e-----------ECCCCCHHHHHH
Confidence            6           345578888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=5.6e-21  Score=187.56  Aligned_cols=143  Identities=22%  Similarity=0.270  Sum_probs=109.9

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCce--EEEEEEeccccchh-------------------hHHHHHHHHHHHHHHhhC
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFF--FAVKEVSLLDQGSQ-------------------AKQSISQLEQEIALLSRF  387 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~--vAVK~v~~~~~~~~-------------------~~~~~~~~~~Ei~iL~~L  387 (504)
                      .|.+.+.||+|+||.||+|.+ .+|..  ||||++........                   .......+.+|+.+|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478899999999999999998 78988  99998754211100                   112234678999999999


Q ss_pred             CCCce--eEEeeeecCCCeEEEEEEeccC-C----CHHHHHHhcCCChHHHHHHHHHHHHHHHHHH-HCCceecCCCCCc
Q 010676          388 EHENI--VQYYGTDKDESKLYIFLELVTK-G----SLLNLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCAN  459 (504)
Q Consensus       388 ~HpnI--V~l~~~~~~~~~lyLVmEy~~g-g----sL~~ll~~~~l~e~~v~~i~~QIl~gL~yLH-s~gIIHRDLKP~N  459 (504)
                      .|+++  +.++++    +..||||||+.+ |    .|.++...  .++..+..++.||+.+|.||| ++||+||||||.|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            87753  444443    356899999953 3    67665432  235567889999999999999 9999999999999


Q ss_pred             EEEcCCCcEEEEecCcccccc
Q 010676          460 ILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       460 ILLd~~g~VKL~DFGLA~~~~  480 (504)
                      ||++.  .++|+|||+|....
T Consensus       202 ILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             EEESS--SEEECCCTTCEETT
T ss_pred             EEEcC--cEEEEECcccccCC
Confidence            99988  99999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=8.6e-19  Score=183.77  Aligned_cols=140  Identities=15%  Similarity=0.140  Sum_probs=101.4

Q ss_pred             eeeeeeecccCceeEEEEEccCCceEEEEEEeccccc-------------hh----hHHHHHHHHHHHHHHhhCCCCcee
Q 010676          331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-------------SQ----AKQSISQLEQEIALLSRFEHENIV  393 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~-------------~~----~~~~~~~~~~Ei~iL~~L~HpnIV  393 (504)
                      |.++++||+|+||.||+|.+.+|+.||||+++.....             ..    .........+|+..|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            8999999999999999999999999999987532110             00    001111223566666666544332


Q ss_pred             --EEeeeecCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-----
Q 010676          394 --QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-----  466 (504)
Q Consensus       394 --~l~~~~~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-----  466 (504)
                        ..+++    ...+|||||++|+.|..+.     .......++.||+.+|.|||++|||||||||.||||+.+|     
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~-----~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVS-----SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCC-----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhc-----ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence              22222    1237999999998876542     2234567889999999999999999999999999998877     


Q ss_pred             -----cEEEEecCccccc
Q 010676          467 -----SVKLADFGLAKAT  479 (504)
Q Consensus       467 -----~VKL~DFGLA~~~  479 (504)
                           .+.||||+-+...
T Consensus       248 ~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TSEEEEEEECCCTTCEET
T ss_pred             cccccceEEEEeCCcccC
Confidence                 3899999987543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.37  E-value=1.7e-12  Score=125.54  Aligned_cols=143  Identities=13%  Similarity=0.127  Sum_probs=111.9

Q ss_pred             ccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~  404 (504)
                      ..+..|.+...++.|+++.||++... +..+++|.........     ...+.+|+.+++.+. +..+.++++++...+.
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            45567899999999999999999754 6789999875321111     124778999998885 6778889998888889


Q ss_pred             EEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 010676          405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD-------------------------------------  447 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs-------------------------------------  447 (504)
                      .|+||||++|.+|.+.+.    +......++.++..+|..||.                                     
T Consensus        85 ~~lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             eEEEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999999999876531    223345778899999999998                                     


Q ss_pred             ----------------------CCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          448 ----------------------QDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       448 ----------------------~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                                            ..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                  4489999999999998765667999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=5.1e-12  Score=120.57  Aligned_cols=138  Identities=19%  Similarity=0.153  Sum_probs=100.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc--eeEEeeeecCCC
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTDKDES  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~~~~~~~~  403 (504)
                      .....|.+..+.+.|.++.||++...+|..+++|......        ...+.+|+.+++.+.+.+  +.+++.++...+
T Consensus        17 ~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~--------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~   88 (264)
T 1nd4_A           17 ERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--------LNELQDEAARLSWLATTGVPCAAVLDVVTEAG   88 (264)
T ss_dssp             TTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred             HhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc--------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence            3445566655445666799999987778889999865321        134668888888875434  566888888888


Q ss_pred             eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCC----------------------------------
Q 010676          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD----------------------------------  449 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~g----------------------------------  449 (504)
                      ..|+||||++|.+|.  ..  ...   ...++.++...|..||...                                  
T Consensus        89 ~~~~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           89 RDWLLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             CEEEEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             CCEEEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            899999999998874  11  111   2345667777777777643                                  


Q ss_pred             ------------------------ceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          450 ------------------------VVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       450 ------------------------IIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                                              ++|+|++|.|||++.++.+.|+|||.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                    99999999999998776677999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.09  E-value=2.4e-10  Score=116.14  Aligned_cols=140  Identities=13%  Similarity=0.239  Sum_probs=102.0

Q ss_pred             eeeeecccCceeEEEEEccCCceEEEEEEe--ccccchhhHHHHHHHHHHHHHHhhCC--CCceeEEeeeecCC---CeE
Q 010676          333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVS--LLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDE---SKL  405 (504)
Q Consensus       333 i~k~LG~G~FG~VYka~~~~g~~vAVK~v~--~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~~~~~~---~~l  405 (504)
                      ..+.|+.|.++.||++...+ ..+++|...  ...    .......+.+|+.+++.+.  +..+++++.++.+.   +..
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~----~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSK----LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCC----CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence            35678999999999998764 467777543  111    0112245778999998887  45578888887766   458


Q ss_pred             EEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 010676          406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD--------------------------------------  447 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs--------------------------------------  447 (504)
                      |+||||++|..+.+.. ...++......++.+++..|..||.                                      
T Consensus       117 ~~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999999998774311 1236677788889999999999997                                      


Q ss_pred             --------------------CCceecCCCCCcEEEcCCCc--EEEEecCcccc
Q 010676          448 --------------------QDVVHRDIKCANILVDANGS--VKLADFGLAKA  478 (504)
Q Consensus       448 --------------------~gIIHRDLKP~NILLd~~g~--VKL~DFGLA~~  478 (504)
                                          ..++|+|+++.|||++.++.  +.|+||+++..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                35899999999999987753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.63  E-value=7.9e-08  Score=95.37  Aligned_cols=133  Identities=21%  Similarity=0.192  Sum_probs=94.7

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCc--eeEEeeeecCCC---eEEE
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HEN--IVQYYGTDKDES---KLYI  407 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-Hpn--IV~l~~~~~~~~---~lyL  407 (504)
                      .+.|+.|.+..||++.    ..+++|....       ......+.+|..+|+.+. +..  +.+++..+....   ..|+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence            3458999999999873    5688886531       123456888999998773 322  445555544333   3589


Q ss_pred             EEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 010676          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD----------------------------------------  447 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs----------------------------------------  447 (504)
                      ||++++|..|..... ..++..+...++.|+...|..||.                                        
T Consensus        94 vm~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EEECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EEcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999999988764322 346666777777888877777775                                        


Q ss_pred             ------------------CCceecCCCCCcEEEcC--CCcEEEEecCcccc
Q 010676          448 ------------------QDVVHRDIKCANILVDA--NGSVKLADFGLAKA  478 (504)
Q Consensus       448 ------------------~gIIHRDLKP~NILLd~--~g~VKL~DFGLA~~  478 (504)
                                        ..++|+|+++.|||++.  .+.+.|+||+.+..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                              13799999999999998  45678999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.54  E-value=8.4e-07  Score=88.67  Aligned_cols=133  Identities=20%  Similarity=0.149  Sum_probs=87.1

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC---ceeEEeeeec-CCCeEEEEE
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE---NIVQYYGTDK-DESKLYIFL  409 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIV~l~~~~~-~~~~lyLVm  409 (504)
                      .+.++.|....||+.    +..+++|+...       ......+.+|..+|+.+.+.   .+.+++.++. ..+..|+||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS-------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS-------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC-------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence            355788888899998    56788886421       12345688999999988642   3556666653 456688999


Q ss_pred             EeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 010676          410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD------------------------------------------  447 (504)
Q Consensus       410 Ey~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs------------------------------------------  447 (504)
                      +|++|..|....- ..++......++.++...|..||.                                          
T Consensus        93 e~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           93 RKVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             ECCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            9999987765211 112333333333333333333332                                          


Q ss_pred             ------------------CCceecCCCCCcEEEcC---CCc-EEEEecCcccc
Q 010676          448 ------------------QDVVHRDIKCANILVDA---NGS-VKLADFGLAKA  478 (504)
Q Consensus       448 ------------------~gIIHRDLKP~NILLd~---~g~-VKL~DFGLA~~  478 (504)
                                        ..++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                              24699999999999987   455 48999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.49  E-value=2e-06  Score=83.02  Aligned_cols=131  Identities=13%  Similarity=0.162  Sum_probs=88.3

Q ss_pred             ecccCce-eEEEEEcc-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCeEEEEEEecc
Q 010676          337 LGRGSFG-SVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVT  413 (504)
Q Consensus       337 LG~G~FG-~VYka~~~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~lyLVmEy~~  413 (504)
                      +..|..+ .||+.... ++..+++|.....        ....+.+|..+|+.+. +--+.+++.++.+.+..|+|||+++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            3444444 68988764 5667888875421        2345778888888775 3346778888888889999999999


Q ss_pred             CCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 010676          414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---------------------------------------------  448 (504)
Q Consensus       414 ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~---------------------------------------------  448 (504)
                      |.++.+.....   ......+..++...|..||..                                             
T Consensus       104 G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          104 GKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             SEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             CccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            98876654321   111223334444444444421                                             


Q ss_pred             -------------CceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          449 -------------DVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       449 -------------gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                                   .++|+|+++.|||++.++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                         268999999999998877778999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.20  E-value=1.3e-06  Score=88.09  Aligned_cols=83  Identities=4%  Similarity=-0.038  Sum_probs=51.1

Q ss_pred             eeeee-cccCceeEEEEEcc-------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-C--CceeEEeeeecC
Q 010676          333 KGDLL-GRGSFGSVYEGISD-------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-H--ENIVQYYGTDKD  401 (504)
Q Consensus       333 i~k~L-G~G~FG~VYka~~~-------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H--pnIV~l~~~~~~  401 (504)
                      ..+.| +.|....+|+....       ++..+++|...........  ....+.+|+.+++.+. +  -.+.+++.++.+
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~--~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF--PTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS--SCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC--chhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            35678 88888999988654       2667888865321100000  0023556777776664 2  346677776655


Q ss_pred             C---CeEEEEEEeccCCCH
Q 010676          402 E---SKLYIFLELVTKGSL  417 (504)
Q Consensus       402 ~---~~lyLVmEy~~ggsL  417 (504)
                      .   ...|+||||++|..+
T Consensus       102 ~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             STTTSSCEEEEECCCCBCC
T ss_pred             CCccCCceEEEEecCCCCh
Confidence            4   357899999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.15  E-value=1.1e-05  Score=79.96  Aligned_cols=30  Identities=20%  Similarity=0.366  Sum_probs=27.4

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          448 QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       448 ~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888899999999874

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.12  E-value=3.5e-06  Score=86.59  Aligned_cols=80  Identities=14%  Similarity=0.150  Sum_probs=47.5

Q ss_pred             eeeecccCceeEEEEEcc-CCceEEEEEEecccc--chhhHHHHHHHHHHHHHHhhCCC--C-ceeEEeeeecCCCeEEE
Q 010676          334 GDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFEH--E-NIVQYYGTDKDESKLYI  407 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~--~~~~~~~~~~~~~Ei~iL~~L~H--p-nIV~l~~~~~~~~~lyL  407 (504)
                      .+.||.|.++.||++... ++..+++|.......  .........++..|..+|+.+..  + .+.+++.+.  ....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            467999999999999764 567899997642111  00000012345667777776632  3 344566543  334689


Q ss_pred             EEEeccCC
Q 010676          408 FLELVTKG  415 (504)
Q Consensus       408 VmEy~~gg  415 (504)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.77  E-value=5.6e-05  Score=78.52  Aligned_cols=32  Identities=16%  Similarity=0.350  Sum_probs=27.7

Q ss_pred             HHCCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       446 Hs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      +...++|+|+++.|||++.++ ++|+||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            346799999999999998777 99999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.64  E-value=0.00011  Score=73.53  Aligned_cols=31  Identities=35%  Similarity=0.397  Sum_probs=26.9

Q ss_pred             CCceecCCCCCcEEEcCC----CcEEEEecCcccc
Q 010676          448 QDVVHRDIKCANILVDAN----GSVKLADFGLAKA  478 (504)
Q Consensus       448 ~gIIHRDLKP~NILLd~~----g~VKL~DFGLA~~  478 (504)
                      ..++|+|+++.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999874    6899999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.58  E-value=0.00028  Score=71.35  Aligned_cols=75  Identities=17%  Similarity=0.159  Sum_probs=56.6

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC---CCceeEEeeeecCCCeEEEEEE
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIFLE  410 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~~~~~~~lyLVmE  410 (504)
                      .+.|+.|.+..+|+... ++..+++|+....        ....+..|...|+.|.   ...+++++.++...+..|+|||
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            46689999999999876 4567888876521        1345678888887764   3567888888877788999999


Q ss_pred             eccCCCH
Q 010676          411 LVTKGSL  417 (504)
Q Consensus       411 y~~ggsL  417 (504)
                      |++|..+
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9998754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.56  E-value=0.00078  Score=65.96  Aligned_cols=78  Identities=17%  Similarity=0.021  Sum_probs=53.2

Q ss_pred             ceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC---CceeEEeeeecCCCeEE
Q 010676          330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH---ENIVQYYGTDKDESKLY  406 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIV~l~~~~~~~~~ly  406 (504)
                      ...-.+.+|.|..+.||+....+|+.|.+|+........     ...+..|...|+.|..   --+++++.+..    -+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----~~   86 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL-----DGLFRAEALGLDWLGRSFGSPVPQVAGWDD----RT   86 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC-----TTHHHHHHHHHHHHTCSTTCCSCCEEEEET----TE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch-----hhHHHHHHHHHHHHHhhCCCCcceEEeccC----ce
Confidence            345567899999999999999999999999654221111     1235678888877642   23455555432    37


Q ss_pred             EEEEeccCCC
Q 010676          407 IFLELVTKGS  416 (504)
Q Consensus       407 LVmEy~~ggs  416 (504)
                      +||||+.++.
T Consensus        87 lv~e~l~~~~   96 (288)
T 3f7w_A           87 LAMEWVDERP   96 (288)
T ss_dssp             EEEECCCCCC
T ss_pred             EEEEeecccC
Confidence            8999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.50  E-value=0.0003  Score=69.40  Aligned_cols=71  Identities=6%  Similarity=-0.082  Sum_probs=41.9

Q ss_pred             eeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eEEeeeecCCCeEEEEEEec
Q 010676          334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELV  412 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~lyLVmEy~  412 (504)
                      .+.|+.|....+|++     ..+++|+........      ....+|+.+++.+...++ .+++.++.+  .-+++++|+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY------INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C------CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce------eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeec
Confidence            677888999999998     568888764321111      112356666665532122 455655433  347899999


Q ss_pred             -cCCCH
Q 010676          413 -TKGSL  417 (504)
Q Consensus       413 -~ggsL  417 (504)
                       +|..|
T Consensus        90 ~~g~~l   95 (301)
T 3dxq_A           90 AGAQTM   95 (301)
T ss_dssp             TTCEEC
T ss_pred             CCCccC
Confidence             66444

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.30  E-value=0.00084  Score=66.27  Aligned_cols=137  Identities=12%  Similarity=0.053  Sum_probs=74.3

Q ss_pred             eeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc--eeEEeeee------cCCCe
Q 010676          333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTD------KDESK  404 (504)
Q Consensus       333 i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~~~~------~~~~~  404 (504)
                      -.+.|+.|....+|+....+| .+++|......       ....+..|+.++..+...+  +.+++...      ...+.
T Consensus        26 ~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~   97 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR   97 (322)
T ss_dssp             EEEEECC---EEEEEEEESSC-CEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred             EeeccCCCcccceEEEEeCCc-cEEEEEeCCCC-------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence            346678888899999877655 67888775311       0123445666555543111  33333221      12356


Q ss_pred             EEEEEEeccCCCHH-----H------H---HHhc--CC--C------hHHHHHH---------------HHHHHHHHHHH
Q 010676          405 LYIFLELVTKGSLL-----N------L---YQRY--HL--R------DSQVSAY---------------TRQILLGLKYL  445 (504)
Q Consensus       405 lyLVmEy~~ggsL~-----~------l---l~~~--~l--~------e~~v~~i---------------~~QIl~gL~yL  445 (504)
                      .+++|+|++|..+.     .      .   +...  .+  .      .......               ...+...+.+|
T Consensus        98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l  177 (322)
T 2ppq_A           98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL  177 (322)
T ss_dssp             EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence            78999999986431     1      1   1110  11  0      0000000               01133344555


Q ss_pred             HH-------CCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          446 HD-------QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       446 Hs-------~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      +.       .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            42       369999999999999877666899999875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.25  E-value=0.0011  Score=65.73  Aligned_cols=75  Identities=13%  Similarity=0.047  Sum_probs=45.2

Q ss_pred             eeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCC--ceeEEeee-----ecCCCeEEE
Q 010676          335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGT-----DKDESKLYI  407 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~~~-----~~~~~~lyL  407 (504)
                      ..|+ |....||++...+|..+++|.......   .   ...+..|..++..+...  .+++++..     ....+..++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~  104 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA  104 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence            3466 778899998777777899998752211   1   12345566666655311  23444433     112456688


Q ss_pred             EEEeccCCC
Q 010676          408 FLELVTKGS  416 (504)
Q Consensus       408 VmEy~~ggs  416 (504)
                      +|++++|..
T Consensus       105 l~~~i~G~~  113 (328)
T 1zyl_A          105 VFPSVGGRQ  113 (328)
T ss_dssp             EEECCCCEE
T ss_pred             EEEecCCCC
Confidence            999998753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.87  E-value=0.0026  Score=66.63  Aligned_cols=72  Identities=10%  Similarity=-0.013  Sum_probs=46.0

Q ss_pred             eeeeecccCceeEEEEEccC--------CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCC
Q 010676          333 KGDLLGRGSFGSVYEGISDD--------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES  403 (504)
Q Consensus       333 i~k~LG~G~FG~VYka~~~~--------g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~  403 (504)
                      ..+.|+.|-...||++...+        +..+++|+....  ..     ...+.+|+.+++.+. +...+++++.+..  
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~--  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG--  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC--
Confidence            35668888889999997642        467888877321  11     023346777777664 2223566766643  


Q ss_pred             eEEEEEEeccCC
Q 010676          404 KLYIFLELVTKG  415 (504)
Q Consensus       404 ~lyLVmEy~~gg  415 (504)
                        .+||+|++|.
T Consensus       148 --g~v~e~l~G~  157 (429)
T 1nw1_A          148 --GRLEEYIPSR  157 (429)
T ss_dssp             --EEEECCCCEE
T ss_pred             --CEEEEEeCCc
Confidence              3899999864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.83  E-value=0.0018  Score=67.09  Aligned_cols=134  Identities=16%  Similarity=0.129  Sum_probs=77.8

Q ss_pred             eeecccCceeEEEEEcc--------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCeE
Q 010676          335 DLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKL  405 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~--------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~l  405 (504)
                      +.|..|-...+|++...        ++..|++|+.....      .....+.+|..+++.+. +.-..++++++..    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~------~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL------QGVDSLVLESVMFAILAERSLGPQLYGVFPE----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc------chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence            45666777888998764        34678888642211      11234557888887764 3333666776654    


Q ss_pred             EEEEEeccCCCHH--------------HHHH---hcC------C--ChHHHHHHHHHHHH-------------------H
Q 010676          406 YIFLELVTKGSLL--------------NLYQ---RYH------L--RDSQVSAYTRQILL-------------------G  441 (504)
Q Consensus       406 yLVmEy~~ggsL~--------------~ll~---~~~------l--~e~~v~~i~~QIl~-------------------g  441 (504)
                      .+||||++|..|.              ..+.   .-.      .  -+.++..|..++-.                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            2899999985442              1111   111      1  12445555544422                   2


Q ss_pred             HHHHH----H----CCceecCCCCCcEEEcCC----CcEEEEecCcccc
Q 010676          442 LKYLH----D----QDVVHRDIKCANILVDAN----GSVKLADFGLAKA  478 (504)
Q Consensus       442 L~yLH----s----~gIIHRDLKP~NILLd~~----g~VKL~DFGLA~~  478 (504)
                      +..|.    .    ..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33332    2    248999999999999876    7899999998753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.78  E-value=0.0077  Score=60.76  Aligned_cols=31  Identities=26%  Similarity=0.388  Sum_probs=27.3

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          448 QDVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       448 ~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3599999999999999888899999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.75  E-value=0.0022  Score=64.93  Aligned_cols=73  Identities=8%  Similarity=-0.115  Sum_probs=40.4

Q ss_pred             eeeecccCceeEEEEEccC---------CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc-eeEEeeeecCCC
Q 010676          334 GDLLGRGSFGSVYEGISDD---------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES  403 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~---------g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~~~~~~  403 (504)
                      .+.|+.|..-.+|++...+         +..+++|+........      .....|..+++.+...+ +.++++.+.   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~------~~~~~E~~~l~~L~~~g~~P~~~~~~~---  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL------YNTISEFEVYKTMSKYKIAPQLLNTFN---  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT------SCHHHHHHHHHHHHHTTSSCCEEEEET---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce------ecHHHHHHHHHHHHhcCCCCceEEecC---
Confidence            4567878888999987643         2578888654211110      11246666666664222 446665542   


Q ss_pred             eEEEEEEeccCCC
Q 010676          404 KLYIFLELVTKGS  416 (504)
Q Consensus       404 ~lyLVmEy~~ggs  416 (504)
                       -++||+|++|..
T Consensus       109 -~~~v~e~i~G~~  120 (369)
T 3c5i_A          109 -GGRIEEWLYGDP  120 (369)
T ss_dssp             -TEEEEECCCSEE
T ss_pred             -CcEEEEEecCCc
Confidence             278999998753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.58  E-value=0.019  Score=60.96  Aligned_cols=73  Identities=10%  Similarity=-0.025  Sum_probs=45.4

Q ss_pred             eeeecccCceeEEEEEccC-CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-eEEeeeecCCCeEEEEEEe
Q 010676          334 GDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLEL  411 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~-g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~~~~~~~~~lyLVmEy  411 (504)
                      .+.|+.|-...+|++...+ +..+++|+.........      ...+|..++..|...++ .++++++.  +  .+||||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i------dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII------NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS------CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc------CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEe
Confidence            4568888889999998754 57788887642111110      12478888887764433 56777763  2  259999


Q ss_pred             ccCCC
Q 010676          412 VTKGS  416 (504)
Q Consensus       412 ~~ggs  416 (504)
                      ++|..
T Consensus       183 I~G~~  187 (458)
T 2qg7_A          183 MDGYA  187 (458)
T ss_dssp             CCSEE
T ss_pred             eCCcc
Confidence            98743

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.26  E-value=0.045  Score=57.51  Aligned_cols=29  Identities=17%  Similarity=0.462  Sum_probs=25.7

Q ss_pred             CceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          449 DVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       449 gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                      .++|+|+.+.||| +.++.+.|+||..|..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4899999999999 7888999999998753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.50  E-value=0.25  Score=50.88  Aligned_cols=29  Identities=28%  Similarity=0.421  Sum_probs=24.7

Q ss_pred             ceecCCCCCcEEE------cCCCcEEEEecCcccc
Q 010676          450 VVHRDIKCANILV------DANGSVKLADFGLAKA  478 (504)
Q Consensus       450 IIHRDLKP~NILL------d~~g~VKL~DFGLA~~  478 (504)
                      ++|+|+.+.|||+      +.++.++|+||-+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      3467799999998753

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=80.73  E-value=14  Score=41.07  Aligned_cols=25  Identities=32%  Similarity=0.465  Sum_probs=23.1

Q ss_pred             cCCCCCcEEEcCCCcEEEEecCccc
Q 010676          453 RDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       453 RDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      +|=+++||||+.+|++.=+|||++-
T Consensus       551 GDRH~~NILid~tG~v~HIDFG~~f  575 (696)
T 2x6h_A          551 GDRHLDNLLLTTNGKLFHIDFGYIL  575 (696)
T ss_dssp             CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred             CCCCCcceEEeCCCCEEEEeehhhh
Confidence            6999999999999999999999863

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	504
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-46
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-45
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-43
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-41
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-41
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-40
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-38
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-38
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-38
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-37
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-37
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-37
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-36
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-35
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-35
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-35
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-35
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-34
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-34
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-34
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-33
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-33
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-33
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-32
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-30
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-29
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-28
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-19

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (415), Expect = 4e-47
 Identities = 58/193 (30%), Positives = 89/193 (46%), Gaps = 13/193 (6%)

Query: 311 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 369
             E      P   F  +         +G GSFG+VY      +    A+K++S    G Q
Sbjct: 4   VAELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQ 54

Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRD 428
           + +    + +E+  L +  H N +QY G    E   ++ +E     +  L    +  L++
Sbjct: 55  SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 114

Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
            +++A T   L GL YLH  +++HRD+K  NIL+   G VKL DFG A    +    S  
Sbjct: 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPANSFV 172

Query: 489 GTAFWMAPEVCSN 501
           GT +WMAPEV   
Sbjct: 173 GTPYWMAPEVILA 185

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 1e-46
 Identities = 48/173 (27%), Positives = 85/173 (49%), Gaps = 4/173 (2%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++ G  LG+G FG+VY        F  A+K +       +      QL +E+ + S   H
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
            NI++ YG   D +++Y+ LE    G++    Q+     + + + Y  ++   L Y H +
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
            V+HRDIK  N+L+ + G +K+ADFG +     +   +  GT  ++ PE+   
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 178

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 1e-46
 Identities = 55/174 (31%), Positives = 90/174 (51%), Gaps = 10/174 (5%)

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
           +W+    LG G+FG VY+  + +     A K +      +++++ +     EI +L+  +
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCD 67

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLH 446
           H NIV+       E+ L+I +E    G++  +       L +SQ+    +Q L  L YLH
Sbjct: 68  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127

Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEV 498
           D  ++HRD+K  NIL   +G +KLADFG++      +    S  GT +WMAPEV
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 7e-46
 Identities = 50/177 (28%), Positives = 89/177 (50%), Gaps = 10/177 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           W     LG G++G V   ++       AVK V +     +A      +++EI +     H
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 62

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           EN+V++YG  ++ +  Y+FLE  + G L + +     + +     +  Q++ G+ YLH  
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSN 501
            + HRDIK  N+L+D   ++K++DFGLA   + N+    +    GT  ++APE+   
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 3e-45
 Identities = 46/174 (26%), Positives = 86/174 (49%), Gaps = 7/174 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K   LG G+ G V++      G   A K + L           +Q+ +E+ +L     
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNS 63

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
             IV +YG    + ++ I +E +  GSL  + ++   + +  +   +  ++ GL YL ++
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
             ++HRD+K +NILV++ G +KL DFG++     +   S  GT  +M+PE    
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG 177

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 3e-45
 Identities = 61/195 (31%), Positives = 103/195 (52%), Gaps = 18/195 (9%)

Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ 376
           +S +GRF +          +GRGSF +VY+G+ ++     A  E   L      K    +
Sbjct: 4   MSNDGRFLKF------DIEIGRGSFKTVYKGLDTETTVEVAWCE---LQDRKLTKSERQR 54

Query: 377 LEQEIALLSRFEHENIVQYYG----TDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQV 431
            ++E  +L   +H NIV++Y     T K +  + +  EL+T G+L    +R+  ++   +
Sbjct: 55  FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 114

Query: 432 SAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCR 488
            ++ RQIL GL++LH +   ++HRD+KC NI +    GSVK+ D GLA   + +  K+  
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI 174

Query: 489 GTAFWMAPEVCSNPF 503
           GT  +MAPE+    +
Sbjct: 175 GTPEFMAPEMYEEKY 189

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 4e-43
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 12/175 (6%)

Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
              G  +G GSFG+VY+G        AVK   +L+  +   Q +   + E+ +L +  H 
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGDV--AVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQ 448
           NI+ + G      +L I  +     SL +            ++    RQ   G+ YLH +
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVC 499
            ++HRD+K  NI +  + +VK+ DFGLA            +   G+  WMAPEV 
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 8e-43
 Identities = 55/185 (29%), Positives = 94/185 (50%), Gaps = 15/185 (8%)

Query: 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE 378
           P  ++ R        + +G+G+ G+VY  +    G   A+++++L  Q          + 
Sbjct: 18  PKKKYTRF-------EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELII 65

Query: 379 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQI 438
            EI ++   ++ NIV Y  +     +L++ +E +  GSL ++     + + Q++A  R+ 
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC 125

Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAP 496
           L  L++LH   V+HRDIK  NIL+  +GSVKL DFG          K  +  GT +WMAP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 497 EVCSN 501
           EV + 
Sbjct: 186 EVVTR 190

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 5e-42
 Identities = 50/177 (28%), Positives = 91/177 (51%), Gaps = 8/177 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++ G +LG GSF +V           +A+K +    +    +  +  + +E  ++SR +H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDH 67

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
              V+ Y T +D+ KLY  L     G LL   ++     ++    YT +I+  L+YLH +
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVCSN 501
            ++HRD+K  NIL++ +  +++ DFG AK     +K     S  GTA +++PE+ + 
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  149 bits (378), Expect = 2e-41
 Identities = 47/183 (25%), Positives = 90/183 (49%), Gaps = 11/183 (6%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
             +  Y+   + LG G+FG V+  +    G  F  K ++     +        ++ EI++
Sbjct: 25  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISI 79

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLG 441
           +++  H  ++  +   +D+ ++ + LE ++ G L +      Y + +++V  Y RQ   G
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139

Query: 442 LKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEV 498
           LK++H+  +VH DIK  NI+ +     SVK+ DFGLA     +++      TA + APE+
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199

Query: 499 CSN 501
              
Sbjct: 200 VDR 202

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-41
 Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 18/186 (9%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++    +G GS+G   +     DG     KE   LD GS  +     L  E+ LL   +H
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKH 62

Query: 390 ENIVQYY--GTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGL 442
            NIV+YY    D+  + LYI +E    G L ++  +      +L +  V     Q+ L L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 443 KYLHDQD-----VVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMA 495
           K  H +      V+HRD+K AN+ +D   +VKL DFGLA+    +    K+  GT ++M+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 496 PEVCSN 501
           PE  + 
Sbjct: 183 PEQMNR 188

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-40
 Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 11/173 (6%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG G FG V  G     +  A+K +       +   S  +  +E  ++    HE +V
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           Q YG    +  ++I  E +  G LLN     R+  +  Q+    + +   ++YL  +  +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVCSN 501
           HRD+   N LV+  G VK++DFGL++    ++  S    +    W  PEV   
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 47/185 (25%), Positives = 83/185 (44%), Gaps = 11/185 (5%)

Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
           +   ++ ++   + LG G+FG V+       G  FA K V    +          + +EI
Sbjct: 20  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEI 74

Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQIL 439
             +S   H  +V  +   +D++++ +  E ++ G L      +   + + +   Y RQ+ 
Sbjct: 75  QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134

Query: 440 LGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAP 496
            GL ++H+ + VH D+K  NI+     +  +KL DFGL         VK   GTA + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194

Query: 497 EVCSN 501
           EV   
Sbjct: 195 EVAEG 199

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  144 bits (365), Expect = 2e-40
 Identities = 48/180 (26%), Positives = 91/180 (50%), Gaps = 8/180 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 385
           ++  ++LGRG    V   I       +AVK + +   GS + + + +L +    E+ +L 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
           +   H NI+Q   T +  +  ++  +L+ KG L + L ++  L + +     R +L  + 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVCSNP 502
            LH  ++VHRD+K  NIL+D + ++KL DFG +      + ++   GT  ++APE+    
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 4e-39
 Identities = 50/178 (28%), Positives = 78/178 (43%), Gaps = 7/178 (3%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRF- 387
           +Q G LLG G FGSVY GI   D    A+K V            + +++  E+ LL +  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKY 444
                +++     +      + LE       L  +  +R  L++    ++  Q+L  +++
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125

Query: 445 LHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
            H+  V+HRDIK  NIL+D N G +KL DFG     K        GT  +  PE    
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-38
 Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 11/173 (6%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              +G G FG V+ G   +    A+K +       +   S     +E  ++ +  H  +V
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVV 451
           Q YG   +++ + +  E +  G L +  +      +   +      +  G+ YL +  V+
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123

Query: 452 HRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMAPEVCSN 501
           HRD+   N LV  N  +K++DFG+ +     +       +    W +PEV S 
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  141 bits (357), Expect = 2e-38
 Identities = 53/174 (30%), Positives = 90/174 (51%), Gaps = 3/174 (1%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFE 388
           +    ++GRG FG VY     D G  +A+K +       +  ++++  E   ++L+S  +
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
              IV          KL   L+L+  G L  +L Q     ++ +  Y  +I+LGL+++H+
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           + VV+RD+K ANIL+D +G V+++D GLA         +  GT  +MAPEV   
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 179

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-38
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 13/176 (7%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +  + LG G FG V+ G  +     AVK +       Q   S      E  L+ + +H+ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQR 69

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           +V+ Y     E  +YI  E +  GSL   L       L  +++     QI  G+ ++ ++
Sbjct: 70  LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEVCSN 501
           + +HRD++ ANILV    S K+ADFGLA+  + N+    +  +    W APE  + 
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 4e-38
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 13/174 (7%)

Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG G+FG+V +G           AVK   +L   +       +L  E  ++ + ++  IV
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
           +  G  + ES   + +E+   G L   L Q  H++D  +     Q+ +G+KYL + + VH
Sbjct: 72  RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130

Query: 453 RDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFWMAPEVCSN 501
           RD+   N+L+      K++DFGL+KA              +    W APE  + 
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 4e-38
 Identities = 51/175 (29%), Positives = 90/175 (51%), Gaps = 5/175 (2%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    +LG+GSFG V+         FFA+K +   D           + ++  L   +EH
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             +   + T + +  L+  +E +  G L+  +   +    S+ + Y  +I+LGL++LH +
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVCSN 501
            +V+RD+K  NIL+D +G +K+ADFG+ K   L D K  +  GT  ++APE+   
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (351), Expect = 4e-38
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 10/177 (5%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +   D+LG G+F  V            A+K ++        +     +E EIA+L + +H
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK----KALEGKEGSMENEIAVLHKIKH 66

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
            NIV      +    LY+ ++LV+ G L + + ++    +   S    Q+L  +KYLHD 
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVCSN 501
            +VHRD+K  N+L    D +  + ++DFGL+K      V  +  GT  ++APEV + 
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 183

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 9e-38
 Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 15/175 (8%)

Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           LG G+FGSV +G+          A+K +         K    ++ +E  ++ + ++  IV
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
           +  G  + E  L + +E+   G L      +R  +  S V+    Q+ +G+KYL +++ V
Sbjct: 73  RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131

Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVCSN 501
           HRD+   N+L+      K++DFGL+KA   +D       + +    W APE  + 
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 9e-38
 Identities = 50/171 (29%), Positives = 79/171 (46%), Gaps = 4/171 (2%)

Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
           D LG G F +VY+    +     A+K++ L  +            +EI LL    H NI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
                   +S + +  + +     + +      L  S + AY    L GL+YLH   ++H
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123

Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVCSN 501
           RD+K  N+L+D NG +KLADFGLAK+    +        T ++ APE+   
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 4e-37
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
           +    +G+G FG V  G    G   AVK +           +      E +++++  H N
Sbjct: 10  KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKN-------DATAQAFLAEASVMTQLRHSN 61

Query: 392 IVQYYGTD-KDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHD 447
           +VQ  G   +++  LYI  E + KGSL++  +   R  L    +  ++  +   ++YL  
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
            + VHRD+   N+LV  +   K++DFGL K    +   + +    W APE    
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEALRE 174

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (343), Expect = 4e-37
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 17/181 (9%)

Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
             ++G G FG V  G          F A+K +         ++       E +++ +F+H
Sbjct: 31  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDH 86

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHD 447
            N++   G     + + I  E +  GSL +  ++   + +  Q+    R I  G+KYL D
Sbjct: 87  PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA-------TKLNDVKSCRGTAFWMAPEVCS 500
            + VHRD+   NILV++N   K++DFGL++                 +    W APE   
Sbjct: 147 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206

Query: 501 N 501
            
Sbjct: 207 Y 207

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  135 bits (342), Expect = 9e-37
 Identities = 53/173 (30%), Positives = 95/173 (54%), Gaps = 5/173 (2%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +Q    LG GSFG V+   S  +G ++A+K +    +     + +     E  +LS   H
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--EIVVRLKQVEHTNDERLMLSIVTH 63

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 448
             I++ +GT +D  ++++ ++ +  G L +L ++     + V+  Y  ++ L L+YLH +
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           D+++RD+K  NIL+D NG +K+ DFG AK    +   +  GT  ++APEV S 
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYTLCGTPDYIAPEVVST 175

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 1e-36
 Identities = 55/174 (31%), Positives = 83/174 (47%), Gaps = 13/174 (7%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
              LG+G FG V+ G  +     A+K +           S     QE  ++ +  HE +V
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDV 450
           Q Y    +E  +YI  E ++KGSLL+  +     +LR  Q+     QI  G+ Y+   + 
Sbjct: 76  QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEVCSN 501
           VHRD++ ANILV  N   K+ADFGLA+  + N+    +  +    W APE    
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 7e-36
 Identities = 47/180 (26%), Positives = 87/180 (48%), Gaps = 8/180 (4%)

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRF 387
           Y+  G+ LG G F  V +      G  +A K +     + S+   S   +E+E+++L   
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
           +H N++  +   ++++ + + LELV  G L +       L + + + + +QIL G+ YLH
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 447 DQDVVHRDIKCANILVDANGS----VKLADFGLAKATKLNDVKSCR-GTAFWMAPEVCSN 501
              + H D+K  NI++         +K+ DFGLA      +      GT  ++APE+ + 
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 1e-35
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 14/182 (7%)

Query: 331 WQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
            +  + LG GSFG V  G     S      AVK +          +++    +E+  +  
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQPEAMDDFIREVNAMHS 67

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 444
            +H N+++ YG       + +  EL   GSLL+  +++  H     +S Y  Q+  G+ Y
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVC 499
           L  +  +HRD+   N+L+     VK+ DFGL +A   ND      +  +    W APE  
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 500 SN 501
             
Sbjct: 187 KT 188

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-35
 Identities = 39/183 (21%), Positives = 83/183 (45%), Gaps = 12/183 (6%)

Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
           K +   +   + LGRG FG V+  + +     +  K V +             +++EI++
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISI 54

Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLG 441
           L+   H NI+  + + +   +L +  E ++   +        + L + ++ +Y  Q+   
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114

Query: 442 LKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEV 498
           L++LH  ++ H DI+  NI+     + ++K+ +FG A+  K  D  +       + APEV
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174

Query: 499 CSN 501
             +
Sbjct: 175 HQH 177

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 53/186 (28%), Positives = 78/186 (41%), Gaps = 25/186 (13%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
            + +G+G FG V+ G    G   AVK  S  ++ S  +      E EI       HENI+
Sbjct: 8   QESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR------EAEIYQTVMLRHENIL 60

Query: 394 QYYGTDKDE----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--- 446
            +   D  +    ++L++  +    GSL +   RY +    +         GL +LH   
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 447 -----DQDVVHRDIKCANILVDANGSVKLADFGL------AKATKLNDVKSCRGTAFWMA 495
                   + HRD+K  NILV  NG+  +AD GL      A  T         GT  +MA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 496 PEVCSN 501
           PEV  +
Sbjct: 181 PEVLDD 186

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-35
 Identities = 49/203 (24%), Positives = 76/203 (37%), Gaps = 39/203 (19%)

Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G +LG G+FG V          +      AVK +      S+ +     L  E+ ++++ 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA----LMSELKMMTQL 97

Query: 388 E-HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--------------------- 425
             HENIV   G       +Y+  E    G LLN  +                        
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 426 ---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
              L    +  +  Q+  G+++L  +  VHRD+   N+LV     VK+ DFGLA+    +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 483 D----VKSCRGTAFWMAPEVCSN 501
                  + R    WMAPE    
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFE 240

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  130 bits (326), Expect = 7e-35
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 6/173 (3%)

Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
              + +G G++G VY+  ++ G  FA+K++ L  +            +EI++L   +H N
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS---TTIREISILKELKHSN 61

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNL-YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
           IV+ Y     + +L +  E + +     L      L      ++  Q+L G+ Y HD+ V
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVCSN 501
           +HRD+K  N+L++  G +K+ADFGLA+A  +   K      T ++ AP+V   
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (325), Expect = 1e-34
 Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 13/175 (7%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
              LG G +G VYEG+        AVK +       +    + +  +E A++   +H N+
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNL 75

Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQD 449
           VQ  G    E   YI  E +T G+LL+  +   R  +    +     QI   ++YL  ++
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135

Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVCSN 501
            +HRD+   N LV  N  VK+ADFGL++    +   +    +    W APE  + 
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 1e-34
 Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 14/177 (7%)

Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           G  +G G FG V++GI     +     A+K        S  ++      QE   + +F+H
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK----FLQEALTMRQFDH 67

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 447
            +IV+  G    E+ ++I +EL T G L +  Q     L  + +  Y  Q+   L YL  
Sbjct: 68  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVCSN 501
           +  VHRDI   N+LV +N  VKL DFGL++  + +        +    WMAPE  + 
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 3e-34
 Identities = 52/176 (29%), Positives = 90/176 (51%), Gaps = 8/176 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +QK + +G G++G VY+  +   G   A+K++ L    ++ +   S   +EI+LL    H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 447
            NIV+       E+KLY+  E + +     +       +    + +Y  Q+L GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVCSN 501
             V+HRD+K  N+L++  G++KLADFGLA+A    +        T ++ APE+   
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 5e-34
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 6/175 (3%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +    LLG+G+FG V        G ++A+K +    +   AK  ++    E  +L    H
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK--EVIIAKDEVAHTVTESRVLQNTRH 64

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
             +       +   +L   +E    G L   L +     + +   Y  +I+  L+YLH +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVCSN 501
           DVV+RDIK  N+++D +G +K+ DFGL K    +        GT  ++APEV  +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 6e-34
 Identities = 45/182 (24%), Positives = 75/182 (41%), Gaps = 16/182 (8%)

Query: 332 QKGDLLGRGSFGSVYEGISDDG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
            +  ++G G FG VY+G+            A+K +         ++       E  ++ +
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----GYTEKQRVDFLGEAGIMGQ 65

Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKY 444
           F H NI++  G       + I  E +  G+L      +       Q+    R I  G+KY
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVC 499
           L + + VHRD+   NILV++N   K++DFGL++               +    W APE  
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 500 SN 501
           S 
Sbjct: 186 SY 187

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 7e-34
 Identities = 47/181 (25%), Positives = 86/181 (47%), Gaps = 14/181 (7%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           +     +G G++G V       +    A+K++S  +  +  ++      +EI +L RF H
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR----TLREIKILLRFRH 65

Query: 390 ENIVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
           ENI+      +  +    K    +  +    L  L +  HL +  +  +  QIL GLKY+
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-----WMAPEVCS 500
           H  +V+HRD+K +N+L++    +K+ DFGLA+    +   +   T +     + APE+  
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 501 N 501
           N
Sbjct: 186 N 186

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 8e-34
 Identities = 53/198 (26%), Positives = 74/198 (37%), Gaps = 34/198 (17%)

Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
           G  LG G+FG V E        SD     AVK +      S        L  E+ +LS  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP----SAHLTEREALMSELKVLSYL 83

Query: 388 E-HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------LR 427
             H NIV   G         +  E    G LLN  +R                     L 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS- 486
              + +++ Q+  G+ +L  ++ +HRD+   NIL+      K+ DFGLA+  K +     
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 487 ---CRGTAFWMAPEVCSN 501
               R    WMAPE   N
Sbjct: 204 KGNARLPVKWMAPESIFN 221

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 1e-33
 Identities = 47/185 (25%), Positives = 77/185 (41%), Gaps = 23/185 (12%)

Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-F 387
           Y     +LG G  G V +  +      FA+K +          Q   +  +E+ L  R  
Sbjct: 13  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRAS 62

Query: 388 EHENIVQYYGT----DKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILL 440
           +  +IV+              L I +E +  G L +  Q        + + S   + I  
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122

Query: 441 GLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAP 496
            ++YLH  ++ HRD+K  N+L  +   N  +KL DFG AK  T  N + +   T +++AP
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182

Query: 497 EVCSN 501
           EV   
Sbjct: 183 EVLGP 187

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 2e-33
 Identities = 47/194 (24%), Positives = 90/194 (46%), Gaps = 19/194 (9%)

Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
           F   ++ ++K   +G+G+FG V++      G   A+K+V + ++            +EI 
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI---TALREIK 61

Query: 383 LLSRFEHENIVQYYGT--------DKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSA 433
           +L   +HEN+V             ++ +  +Y+  +        L          S++  
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121

Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSC 487
             + +L GL Y+H   ++HRD+K AN+L+  +G +KLADFGLA+A      ++ N   + 
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 488 RGTAFWMAPEVCSN 501
             T ++  PE+   
Sbjct: 182 VVTLWYRPPELLLG 195

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 5e-33
 Identities = 45/191 (23%), Positives = 86/191 (45%), Gaps = 18/191 (9%)

Query: 324 FKRIITY--WQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQ 376
             RI+    ++K  +LG G+FG+VY+G+            A+KE+          ++  +
Sbjct: 2   LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS----PKANKE 57

Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAY 434
           +  E  +++  ++ ++ +  G       + +  +L+  G LL+  + +        +  +
Sbjct: 58  ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 116

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT 490
             QI  G+ YL D+ +VHRD+   N+LV     VK+ DFGLAK     +     +  +  
Sbjct: 117 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 491 AFWMAPEVCSN 501
             WMA E   +
Sbjct: 177 IKWMALESILH 187

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 5e-33
 Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 22/188 (11%)

Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HEN 391
            D++G G+FG V +     DG         + +  S  K        E+ +L +   H N
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPN 72

Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAY 434
           I+   G  +    LY+ +E    G+LL+  ++                   L   Q+  +
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFW 493
              +  G+ YL  +  +HRD+   NILV  N   K+ADFGL++  ++   K   R    W
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192

Query: 494 MAPEVCSN 501
           MA E  + 
Sbjct: 193 MAIESLNY 200

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  125 bits (315), Expect = 6e-33
 Identities = 43/178 (24%), Positives = 75/178 (42%), Gaps = 16/178 (8%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
           +Q    LGRG +  V+E I+  +     VK +              ++++EI +L     
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENLRG 88

Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
             NI+       D       +  E V       LYQ   L D  +  Y  +IL  L Y H
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH 146

Query: 447 DQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVCSNP 502
              ++HRD+K  N+++D  +  ++L D+GLA+        + R  + ++  PE+  + 
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 9e-33
 Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 10/181 (5%)

Query: 331 WQKGDLLGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
           ++    +G G++G V++   + + G F A+K V +         S  +    +  L  FE
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 389 HENIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLG 441
           H N+V+ +          E+KL +  E V +     L +     +    +     Q+L G
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128

Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVCS 500
           L +LH   VVHRD+K  NILV ++G +KLADFGLA+         S   T ++ APEV  
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 188

Query: 501 N 501
            
Sbjct: 189 Q 189

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 9e-33
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 22/211 (10%)

Query: 306 DSSSTTTEPMSNISPN--GRFKRIITYWQKGDLLGRGSFGSVYEGISDD----GFFFAVK 359
           D S+   E +  +     G    I+ +    +++GRG FG VY G   D        AVK
Sbjct: 5   DLSALNPELVQAVQHVVIGPSSLIVHF---NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61

Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDESKLYIFLELVTKGSLL 418
            ++ +         +SQ   E  ++  F H N++   G   + E    + L  +  G L 
Sbjct: 62  SLNRITD----IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117

Query: 419 NLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
           N    + ++     +  +  Q+  G+K+L  +  VHRD+   N ++D   +VK+ADFGLA
Sbjct: 118 NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177

Query: 477 KATKLNDVKS------CRGTAFWMAPEVCSN 501
           +     +  S       +    WMA E    
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (312), Expect = 3e-32
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 12/206 (5%)

Query: 298 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFF 356
            F  + ++D       P  N +   +F RI         LG GSFG V      + G  +
Sbjct: 17  EFLAKAKEDFLKKWETPSQNTAQLDQFDRI-------KTLGTGSFGRVMLVKHKESGNHY 69

Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
           A+K +    Q     + I     E  +L       +V+   + KD S LY+ +E V  G 
Sbjct: 70  AMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127

Query: 417 LLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
           + + L +     +     Y  QI+L  +YLH  D+++RD+K  N+L+D  G +++ DFG 
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187

Query: 476 AKATKLNDVKSCRGTAFWMAPEVCSN 501
           AK  K     +  GT   +APE+  +
Sbjct: 188 AKRVK-GRTWTLCGTPEALAPEIILS 212

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  122 bits (307), Expect = 4e-32
 Identities = 45/208 (21%), Positives = 77/208 (37%), Gaps = 39/208 (18%)

Query: 332 QKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           +    +G G+FG V++  +      +     AVK +        +    +  ++E AL++
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMA 71

Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------- 425
            F++ NIV+  G       + +  E +  G L    +                       
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 426 -----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
                L  ++     RQ+  G+ YL ++  VHRD+   N LV  N  VK+ADFGL++   
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 481 LNDVK----SCRGTAFWMAPEVCSNPFV 504
             D      +      WM PE       
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRY 219

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  121 bits (305), Expect = 7e-32
 Identities = 41/182 (22%), Positives = 75/182 (41%), Gaps = 13/182 (7%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++ G++LG G    V+           AVK +      ++      +  +E    +   H
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAALNH 66

Query: 390 ENIVQYYGTDKDESK----LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
             IV  Y T + E+      YI +E V   +L ++      +   +           L +
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVC 499
            H   ++HRD+K ANI++ A  +VK+ DFG+A+        +    +  GTA +++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 500 SN 501
             
Sbjct: 187 RG 188

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 8e-32
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 11/200 (5%)

Query: 310 TTTEPMSNISPNGRFKRI-ITYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLL 364
           T    +   +  G  +++ I  ++   +LG G++G V+        D G  +A+K +   
Sbjct: 4   TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK- 62

Query: 365 DQGSQAKQSISQLEQEIALLSRFEHE-NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQ 422
               Q  ++      E  +L        +V  +   + E+KL++ L+ +  G L   L Q
Sbjct: 63  ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ 122

Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KAT 479
           R    + +V  Y  +I+L L++LH   +++RDIK  NIL+D+NG V L DFGL+    A 
Sbjct: 123 RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182

Query: 480 KLNDVKSCRGTAFWMAPEVC 499
           +        GT  +MAP++ 
Sbjct: 183 ETERAYDFCGTIEYMAPDIV 202

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-31
 Identities = 48/175 (27%), Positives = 87/175 (49%), Gaps = 7/175 (4%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++K + +G G++G+V++  + +     A+K V L D             +EI LL   +H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKH 60

Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
           +NIV+ +     + KL +  E   +            L    V ++  Q+L GL + H +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVCSN 501
           +V+HRD+K  N+L++ NG +KLA+FGLA+A  +      +   T ++  P+V   
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 3e-31
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 24/207 (11%)

Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 366
           S  TT   +      R + + +Y     ++G GSFG VY+    D G   A+K+V     
Sbjct: 1   SKVTTVVATPGQGPDRPQEV-SY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----- 53

Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGSLLNL 420
                Q      +E+ ++ + +H NIV+        G  KDE  L + L+ V +      
Sbjct: 54  ----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109

Query: 421 YQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-VKLADFGL 475
                 +  L    V  Y  Q+   L Y+H   + HRDIK  N+L+D + + +KL DFG 
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169

Query: 476 AKATKLND-VKSCRGTAFWMAPEVCSN 501
           AK     +   S   + ++ APE+   
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFG 196

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 2e-30
 Identities = 43/189 (22%), Positives = 78/189 (41%), Gaps = 25/189 (13%)

Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
              LG+GSFG VYEG+       +     A+K V+     + + +   +   E +++  F
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEF 80

Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------LRDSQVSAYTR 436
              ++V+  G         + +EL+T+G L +  +                 S++     
Sbjct: 81  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC----RGTAF 492
           +I  G+ YL+    VHRD+   N +V  + +VK+ DFG+ +     D             
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 493 WMAPEVCSN 501
           WM+PE   +
Sbjct: 201 WMSPESLKD 209

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (289), Expect = 1e-29
 Identities = 40/191 (20%), Positives = 68/191 (35%), Gaps = 22/191 (11%)

Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
           R+   ++ G  +G GSFG +Y G     G   A+K   +       K    QL  E  + 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-------KTKHPQLHIESKIY 56

Query: 385 SRFEHEN-IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGL 442
              +    I        +     + +EL+      L  +         V     Q++  +
Sbjct: 57  KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116

Query: 443 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSC---------RGT 490
           +Y+H ++ +HRD+K  N L+        V + DFGLAK  +                 GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 491 AFWMAPEVCSN 501
           A + +      
Sbjct: 177 ARYASINTHLG 187

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 2e-29
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 10/176 (5%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           +    +G G++G+V   +    G   A+K+   L +  Q++    +  +E+ LL    HE
Sbjct: 21  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKK---LYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLL-----NLYQRYHLRDSQVSAYTRQILLGLKYL 445
           N++        +  L  F +       +      L +   L + ++     Q+L GL+Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           H   ++HRD+K  N+ V+ +  +K+ DFGLA+    +++     T ++ APEV  N
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMTGYVVTRWYRAPEVILN 192

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 3e-29
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 10/176 (5%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           Q    +G G++GSV        G   AVK+   L +  Q+     +  +E+ LL   +HE
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 391 NIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
           N++            +E      +  +    L N+ +   L D  V     QIL GLKY+
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137

Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSN 501
           H  D++HRD+K +N+ V+ +  +K+ DFGLA+ T  +++     T ++ APE+  N
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN 192

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  112 bits (282), Expect = 1e-28
 Identities = 37/185 (20%), Positives = 70/185 (37%), Gaps = 24/185 (12%)

Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
           ++ G  +G GSFG ++EG +  +    A+K           +    QL  E         
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-------RSDAPQLRDEYRTYKLLAG 59

Query: 390 -ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
              I   Y   ++     + ++L+       L           V+   +Q+L  ++ +H+
Sbjct: 60  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 448 QDVVHRDIKCANILVDA-----NGSVKLADFGLAKA---------TKLNDVKSCRGTAFW 493
           + +V+RDIK  N L+          + + DFG+ K              + K+  GTA +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 494 MAPEV 498
           M+   
Sbjct: 180 MSINT 184

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 4e-28
 Identities = 43/179 (24%), Positives = 83/179 (46%), Gaps = 13/179 (7%)

Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
           Q    +G G+ G V            A+K+   L +  Q +    +  +E+ L+    H+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKK---LSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 391 NIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
           NI+          T ++   +Y+ +EL+       +         ++S    Q+L G+K+
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE--RMSYLLYQMLCGIKH 134

Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVCSNP 502
           LH   ++HRD+K +NI+V ++ ++K+ DFGLA+    + + +    T ++ APEV    
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 9e-28
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 34/198 (17%)

Query: 334 GDLLGRGSFGSVYEGI--------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
           G  LG G+FG V             +     AVK +         ++ +S L  E+ ++ 
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMK 73

Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLR 427
              +H+NI+   G    +  LY+ +E  +KG+L    Q                    L 
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--- 484
              + +   Q+  G++YL  +  +HRD+   N+LV  +  +K+ADFGLA+     D    
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 485 -KSCRGTAFWMAPEVCSN 501
             + R    WMAPE   +
Sbjct: 194 TTNGRLPVKWMAPEALFD 211

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 3e-27
 Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 31/199 (15%)

Query: 331 WQKGDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
            + G  LGRG+FG V E        +      AVK   +L +G+   +  + + +   L+
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILI 71

Query: 385 SRFEHENIVQYYG-TDKDESKLYIFLELVTKGSLLNLYQRY-----------------HL 426
               H N+V   G   K    L + +E    G+L    +                    L
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 427 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483
               +  Y+ Q+  G+++L  +  +HRD+   NIL+     VK+ DFGLA+    +    
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 484 -VKSCRGTAFWMAPEVCSN 501
                R    WMAPE   +
Sbjct: 192 RKGDARLPLKWMAPETIFD 210

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.8 bits (227), Expect = 4e-22
 Identities = 26/159 (16%), Positives = 52/159 (32%), Gaps = 24/159 (15%)

Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSL-------------LDQGSQAKQSISQLEQE 380
           G L+G G   +V+   S+      VK   +                   +  +I     E
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL 440
              L + +   + + Y  + +     + +EL+    L  +                 IL 
Sbjct: 65  FRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDE------VLDMILE 114

Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
            +   + + +VH D+   N+LV   G + + DF  +   
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEV 152

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 87.4 bits (215), Expect = 2e-19
 Identities = 44/206 (21%), Positives = 77/206 (37%), Gaps = 39/206 (18%)

Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
           + R+            LG G F +V+      +    A+K V         K      E 
Sbjct: 12  DARY-------ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAED 58

Query: 380 EIALLSRFEHENIVQ-------------YYGTDKDESKLYIFLELVTKG----SLLNLYQ 422
           EI LL R    +  +              +   K  + +++ +     G    +L+  Y+
Sbjct: 59  EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE 118

Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANG------SVKLADFGL 475
              +    V   ++Q+LLGL Y+H +  ++H DIK  N+L++          +K+AD G 
Sbjct: 119 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 178

Query: 476 AKATKLNDVKSCRGTAFWMAPEVCSN 501
           A     +   S   T  + +PEV   
Sbjct: 179 ACWYDEHYTNSI-QTREYRSPEVLLG 203

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	504
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.98
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.98
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.98
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.98
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.98
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.98
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.98
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.97
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.97
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.46
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.14
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.73
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.14
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.43
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.39

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=314.32  Aligned_cols=174  Identities=28%  Similarity=0.505  Sum_probs=155.3

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++++.||+|+||+||+|++ .++..||+|++......  .......+.+|+.+++.++|||||++++++.+++.+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE--KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc--ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            57899999999999999999998 57899999988643211  1222456889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc
Q 010676          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~  485 (504)
                      |||||+++|+|.+++.. ..+++..+..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+........
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~  162 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT  162 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence            99999999999998875 46999999999999999999999999999999999999999999999999999877666666


Q ss_pred             cccCCCcccccccccCCC
Q 010676          486 SCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~~  503 (504)
                      ..+||+.|||||++.++.
T Consensus       163 ~~~Gt~~Y~APE~~~~~~  180 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRM  180 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCC
T ss_pred             ccCCCCcccCHHHHcCCC
Confidence            778999999999998764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-39  Score=318.22  Aligned_cols=172  Identities=28%  Similarity=0.541  Sum_probs=150.0

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      ++++|++++.||+|+||+||+|++ .+|+.||||++.....    ....+.+.+|+.+|++++|||||++++++.+++.+
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~   78 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   78 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc----chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence            467899999999999999999998 5799999999865322    22235688999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      ||||||+++|+|.+++.. ..+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...... 
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999999998865 459999999999999999999999999999999999999999999999999998754332 


Q ss_pred             ---cccccCCCcccccccccCC
Q 010676          484 ---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ---~~s~~GT~~YmAPEVL~g~  502 (504)
                         ....+||+.|||||++.++
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~  180 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRR  180 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCS
T ss_pred             cccccceeeCcCccCHhHhcCC
Confidence               3456799999999998764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-38  Score=316.51  Aligned_cols=169  Identities=31%  Similarity=0.558  Sum_probs=152.6

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++++.||+|+||+||+|.+ .+|..||||++.......     .+.+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-----HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence            4689999999999999999998 689999999987543322     2568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--Ccc
Q 010676          408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK  485 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~~~  485 (504)
                      ||||++||+|.+++.+..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....  ...
T Consensus        95 vmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence            999999999999999889999999999999999999999999999999999999999999999999999876433  245


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ..+||+.|||||++.++
T Consensus       175 ~~~gt~~Y~aPE~~~~~  191 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRK  191 (293)
T ss_dssp             CCCSCGGGCCHHHHSSS
T ss_pred             ccccCCCccChhhhcCC
Confidence            56799999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-38  Score=318.71  Aligned_cols=171  Identities=27%  Similarity=0.419  Sum_probs=151.0

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .++|++++.||+|+||+||+|++ .+|..||+|++......    .....+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT----THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH----HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46899999999999999999998 68999999998753221    22356889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      |||||+++|+|.+++.+ ..+++..+..++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.......
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  160 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  160 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc
Confidence            99999999999998865 469999999999999999999997 5999999999999999999999999999987665555


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ...+||+.|||||++.+.
T Consensus       161 ~~~~GT~~Y~APEvl~~~  178 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGT  178 (322)
T ss_dssp             ---CCSSCCCCHHHHHCS
T ss_pred             ccccCCccccCchHHcCC
Confidence            677899999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-37  Score=303.99  Aligned_cols=171  Identities=32%  Similarity=0.577  Sum_probs=149.0

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC----CCe
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESK  404 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~----~~~  404 (504)
                      +|++.+.||+|+||+||+|++ .++..||+|.+......   ....+.+.+|+.+|++++|||||+++++|.+    ...
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            457778899999999999998 57889999988754322   2335678999999999999999999998754    456


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEc-CCCcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~g--IIHRDLKP~NILLd-~~g~VKL~DFGLA~~~~  480 (504)
                      +||||||+++|+|.+++.+. .+++..+..|+.||+.||.|||+++  ||||||||+||||+ .++.+||+|||+|+...
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            89999999999999988764 5999999999999999999999999  99999999999996 58999999999998766


Q ss_pred             cCCcccccCCCcccccccccCCC
Q 010676          481 LNDVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       481 ~~~~~s~~GT~~YmAPEVL~g~~  503 (504)
                      .......+||+.|||||++.+++
T Consensus       167 ~~~~~~~~GT~~Y~aPE~~~~~~  189 (270)
T d1t4ha_         167 ASFAKAVIGTPEFMAPEMYEEKY  189 (270)
T ss_dssp             TTSBEESCSSCCCCCGGGGGTCC
T ss_pred             CCccCCcccCccccCHHHhCCCC
Confidence            66666778999999999998764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-37  Score=309.49  Aligned_cols=174  Identities=28%  Similarity=0.457  Sum_probs=149.8

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      .++|++++.||+|+||+||+|.+ .+|+.||||++.....  ........+.+|+.+|++++|||||+++++|.+++.+|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc--cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            36799999999999999999998 6899999999864221  11223456889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC---
Q 010676          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---  482 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~---  482 (504)
                      |||||+++|+|.+++.. ..+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....   
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            99999999999998765 46999999999999999999999999999999999999999999999999999875432   


Q ss_pred             -CcccccCCCcccccccccCCC
Q 010676          483 -DVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       483 -~~~s~~GT~~YmAPEVL~g~~  503 (504)
                       .....+||+.|||||++.++.
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~  186 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKS  186 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCC
T ss_pred             cccccccCCccccCceeeccCC
Confidence             234567999999999998753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-37  Score=313.25  Aligned_cols=174  Identities=28%  Similarity=0.427  Sum_probs=153.2

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      .+++|++++.||+|+||.||+|++ .+|+.||||++......  .......+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII--AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc--CHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            357899999999999999999998 68999999998643211  122346688999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc--C
Q 010676          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--N  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~--~  482 (504)
                      |+||||++||+|..++... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....  .
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            9999999999999988764 589999999999999999999999999999999999999999999999999986543  2


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....+||+.|||||++.++
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~  180 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDN  180 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSS
T ss_pred             ccccceeCHHHhhhhhccCC
Confidence            34567899999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-37  Score=308.79  Aligned_cols=169  Identities=32%  Similarity=0.527  Sum_probs=149.2

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      +.|++++.||+|+||+||+|++ .++..||||++.....  ......+.+.+|+.+|++++|||||++++++.+.+.+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS--CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc--cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence            4599999999999999999997 6899999999875433  223445778999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHH-hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCccc
Q 010676          408 FLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS  486 (504)
Q Consensus       408 VmEy~~ggsL~~ll~-~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~s  486 (504)
                      |||||.+|+|..++. +..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....  ...
T Consensus        93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--~~~  170 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANS  170 (309)
T ss_dssp             EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCC
T ss_pred             EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--CCc
Confidence            999999999877654 45699999999999999999999999999999999999999999999999999976443  345


Q ss_pred             ccCCCcccccccccC
Q 010676          487 CRGTAFWMAPEVCSN  501 (504)
Q Consensus       487 ~~GT~~YmAPEVL~g  501 (504)
                      .+||+.|||||++.+
T Consensus       171 ~~GT~~Y~APE~~~~  185 (309)
T d1u5ra_         171 FVGTPYWMAPEVILA  185 (309)
T ss_dssp             CCSCGGGCCHHHHTT
T ss_pred             cccCccccCHHHHhc
Confidence            679999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.8e-37  Score=308.88  Aligned_cols=172  Identities=30%  Similarity=0.497  Sum_probs=151.6

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++++.||+|+||+||+|++ .+|+.||||++.....  ......+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            46899999999999999999998 6799999999864221  11223467889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc
Q 010676          407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~  485 (504)
                      +||||+.||+|..++... .+.+..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..... ..
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-~~  159 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TY  159 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-BC
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-cc
Confidence            999999999999888664 5888899999999999999999999999999999999999999999999999876533 44


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ..+||+.|||||++.++
T Consensus       160 ~~~Gt~~Y~APE~l~~~  176 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTK  176 (316)
T ss_dssp             CCCSCTTTCCHHHHTTC
T ss_pred             cccCcccccCHHHHcCC
Confidence            56799999999999875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-37  Score=305.97  Aligned_cols=167  Identities=33%  Similarity=0.587  Sum_probs=147.6

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      +.|++++.||+|+||+||+|.+ .++..||+|++......     ..+.+.+|+.+|++++|||||++++++.+.+.+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-----ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG-----GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH-----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            4699999999999999999998 58999999998753322     23567899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--C
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--~  483 (504)
                      ||||+++|+|.+++.+  ..+++.++..|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.....  .
T Consensus        87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            9999999999998754  34999999999999999999999999999999999999999999999999999764322  2


Q ss_pred             cccccCCCccccccccc
Q 010676          484 VKSCRGTAFWMAPEVCS  500 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~  500 (504)
                      ....+||+.|||||++.
T Consensus       167 ~~~~~Gt~~y~APE~l~  183 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVM  183 (288)
T ss_dssp             HTCCCSCCTTCCHHHHT
T ss_pred             ccccccccccCCHHHHh
Confidence            34567999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-37  Score=303.53  Aligned_cols=172  Identities=31%  Similarity=0.479  Sum_probs=138.8

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC--CCe
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESK  404 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~--~~~  404 (504)
                      .++|++++.||+|+||+||+|++ .+|+.||+|++......   ....+.+.+|+.+|++++|||||++++++.+  ++.
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC---HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC---HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence            36899999999999999999998 67999999998654332   2335678899999999999999999998854  567


Q ss_pred             EEEEEEeccCCCHHHHHHh-----cCCChHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEEcCCCcEEEEecC
Q 010676          405 LYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQD-----VVHRDIKCANILVDANGSVKLADFG  474 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-----~~l~e~~v~~i~~QIl~gL~yLHs~g-----IIHRDLKP~NILLd~~g~VKL~DFG  474 (504)
                      +||||||+++|+|.+++..     ..+++..++.|+.||+.||.|||++|     ||||||||+||||+.+|.+||+|||
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            9999999999999998854     35999999999999999999999876     9999999999999999999999999


Q ss_pred             cccccccCC--cccccCCCcccccccccCC
Q 010676          475 LAKATKLND--VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       475 LA~~~~~~~--~~s~~GT~~YmAPEVL~g~  502 (504)
                      +|+......  ....+||+.|||||++.++
T Consensus       160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~  189 (269)
T d2java1         160 LARILNHDTSFAKAFVGTPYYMSPEQMNRM  189 (269)
T ss_dssp             HHHHC-----------CCCSCCCHHHHTTC
T ss_pred             ceeecccCCCccccCCCCcccCCHHHHcCC
Confidence            998764332  3456799999999999765

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-36  Score=311.59  Aligned_cols=172  Identities=27%  Similarity=0.436  Sum_probs=151.7

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .++++|++++.||+|+||.||+|++ .+|..||||++....     ....+.+.+|+.+|++++|||||++++++.+++.
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   97 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE   97 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4578999999999999999999998 689999999886432     2234678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--CCCcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANGSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd--~~g~VKL~DFGLA~~~~  480 (504)
                      +|||||||+||+|.+++..  ..+++..+..|+.||+.||.|||++|||||||||+||||+  .++.+||+|||+++...
T Consensus        98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            9999999999999998843  4599999999999999999999999999999999999996  46889999999998765


Q ss_pred             cCC-cccccCCCcccccccccCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... ....+||+.|||||++.++
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~  200 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGK  200 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTC
T ss_pred             cccccceecCcccccCHHHHcCC
Confidence            443 4456799999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.8e-37  Score=307.26  Aligned_cols=173  Identities=29%  Similarity=0.448  Sum_probs=136.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.+.|++++.||+|+||+||+|++ .+++.||||++......    .....+.+|+.+|+.++|||||++++++.+++.
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   81 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGH   81 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3456799999999999999999998 57899999998643321    123467899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---CCCcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd---~~g~VKL~DFGLA~~~~  480 (504)
                      +|||||||+||+|.+++... .+++..+..|+.||+.||.|||++|||||||||+|||+.   .++.+||+|||+|+...
T Consensus        82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999999999988654 599999999999999999999999999999999999995   57899999999998765


Q ss_pred             cCC-cccccCCCcccccccccCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... ....+||+.|||||++.++
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~~~  184 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLAQK  184 (307)
T ss_dssp             -----------CTTSCHHHHTTC
T ss_pred             CCCeeeeeeeCccccCcHHHcCC
Confidence            443 4456799999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-36  Score=300.06  Aligned_cols=177  Identities=27%  Similarity=0.488  Sum_probs=153.4

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchh-hHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      +.++|++++.||+|+||+||+|.+ .+|..||||++........ .....+.+.+|+.+|++++|||||+++++|.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            456799999999999999999998 6899999999875432221 11224678899999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC----cEEEEecCccccc
Q 010676          405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKAT  479 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g----~VKL~DFGLA~~~  479 (504)
                      +|||||||++|+|.+++.. ..+++..++.|+.||+.||+|||++||+||||||+|||++.++    .+||+|||+++..
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            9999999999999998865 4699999999999999999999999999999999999998776    5999999999876


Q ss_pred             ccC-CcccccCCCcccccccccCCC
Q 010676          480 KLN-DVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       480 ~~~-~~~s~~GT~~YmAPEVL~g~~  503 (504)
                      ... ......||+.|||||++.++.
T Consensus       168 ~~~~~~~~~~~t~~y~APE~~~~~~  192 (293)
T d1jksa_         168 DFGNEFKNIFGTPEFVAPEIVNYEP  192 (293)
T ss_dssp             TTSCBCSCCCCCGGGCCHHHHTTCC
T ss_pred             CCCccccccCCCCcccCHHHHcCCC
Confidence            543 345567999999999998753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-36  Score=301.09  Aligned_cols=173  Identities=28%  Similarity=0.438  Sum_probs=149.8

Q ss_pred             ccccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE  402 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~  402 (504)
                      |....++|++++.||+|+||+||+|++ .++..||||++.....      ..+++.+|+.+|++++|||||+++++|.+.
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc------hHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            434456899999999999999999998 5788999998753221      135688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                      +.+||||||+++|+|.+++...   .+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+..
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999999999988653   5899999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCc---ccccCCCcccccccccCC
Q 010676          480 KLNDV---KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~~---~s~~GT~~YmAPEVL~g~  502 (504)
                      .....   ....||+.|||||++.++
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~  191 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYN  191 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHC
T ss_pred             CCCCceeeccccccccccChHHHcCC
Confidence            54432   233488999999988654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.5e-36  Score=309.44  Aligned_cols=174  Identities=29%  Similarity=0.402  Sum_probs=149.8

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccch-hhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      +++|+++++||+|+||.||+|++ .+|..||||++....... ..........+++.+++.++|||||+++++|.+.+.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            56899999999999999999998 579999999986422111 1112223334567888888999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCc
Q 010676          406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV  484 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~  484 (504)
                      ||||||++||+|.+++.. ..+++..+..|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.......
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~  162 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  162 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcc
Confidence            999999999999998865 4588999999999999999999999999999999999999999999999999987776666


Q ss_pred             ccccCCCcccccccccC
Q 010676          485 KSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g  501 (504)
                      ...+||+.|||||++.+
T Consensus       163 ~~~~GT~~y~APE~~~~  179 (364)
T d1omwa3         163 HASVGTHGYMAPEVLQK  179 (364)
T ss_dssp             CSCCSCGGGCCHHHHST
T ss_pred             cccccccccchhHHhhc
Confidence            67789999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.7e-36  Score=308.06  Aligned_cols=171  Identities=28%  Similarity=0.481  Sum_probs=151.1

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~l  405 (504)
                      +.++|++++.||+|+||+||+|++ .+|..||||++.....     .....+.+|+.+|++++|||||+++++|.+++.+
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-----LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            457899999999999999999998 6899999999864321     2235678999999999999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--CCCcEEEEecCccccccc
Q 010676          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANGSVKLADFGLAKATKL  481 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd--~~g~VKL~DFGLA~~~~~  481 (504)
                      |||||||+||+|.+++...  .+++.+++.|+.||+.||.|||++|||||||||+||||+  .++.+||+|||+|+....
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            9999999999999877543  589999999999999999999999999999999999998  578999999999987665


Q ss_pred             CC-cccccCCCcccccccccCC
Q 010676          482 ND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      .. .....||+.|||||++.+.
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~  203 (352)
T d1koba_         182 DEIVKVTTATAEFAAPEIVDRE  203 (352)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTC
T ss_pred             CCceeeccCcccccCHHHHcCC
Confidence            44 4456799999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-36  Score=295.28  Aligned_cols=168  Identities=22%  Similarity=0.351  Sum_probs=139.7

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      ++|++++.||+|+||+||+|.+.++..||||++......      .+.+.+|+.++++++|||||++++++..++.+|+|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc------HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            479999999999999999999988889999987542221      24688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC---
Q 010676          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~---  483 (504)
                      |||+++|+|.+++..  ..+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++......   
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999999998865  348889999999999999999999999999999999999999999999999998654332   


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....||+.|||||++.++
T Consensus       159 ~~~~~gt~~y~aPE~l~~~  177 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFS  177 (263)
T ss_dssp             ------CTTSCCHHHHTTC
T ss_pred             ecceecCcccCChHHhcCC
Confidence            2235689999999999865

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-36  Score=307.06  Aligned_cols=173  Identities=28%  Similarity=0.424  Sum_probs=152.4

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++++.||+|+||.||+|.+ .+|+.||||++.....  ......+.+.+|+.+|+.++|||||++++++.+...+|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence            46899999999999999999998 5899999999864221  11223456889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCCcc
Q 010676          407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK  485 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~~~  485 (504)
                      +||||+.+|+|..++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..... ..
T Consensus       118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-~~  196 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TW  196 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BC
T ss_pred             cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-cc
Confidence            99999999999988765 46999999999999999999999999999999999999999999999999999876543 34


Q ss_pred             cccCCCcccccccccCCC
Q 010676          486 SCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~~  503 (504)
                      ..+||+.|||||++.++.
T Consensus       197 ~~~Gt~~Y~APE~~~~~~  214 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKG  214 (350)
T ss_dssp             CCEECGGGCCHHHHTTCC
T ss_pred             cccCccccCCHHHHcCCC
Confidence            567999999999998763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-36  Score=294.46  Aligned_cols=169  Identities=27%  Similarity=0.446  Sum_probs=146.2

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      ..++|++++.||+|+||.||+|...++..||||++......      .+.+.+|+.++++++|||||++++++.+ +.+|
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~------~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~   83 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC------HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence            34689999999999999999999988899999988643221      2468899999999999999999998754 5689


Q ss_pred             EEEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC
Q 010676          407 IFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~  483 (504)
                      |||||+++|+|.+++..   ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence            99999999999987643   248999999999999999999999999999999999999999999999999998765433


Q ss_pred             ---cccccCCCcccccccccCC
Q 010676          484 ---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ---~~s~~GT~~YmAPEVL~g~  502 (504)
                         .....||+.|||||++.++
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~  185 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYG  185 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHC
T ss_pred             cccccccCCcccccChHHHhCC
Confidence               2345689999999998743

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-36  Score=297.08  Aligned_cols=168  Identities=29%  Similarity=0.485  Sum_probs=141.1

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      .++|++++.||+|+||+||+|+...  .||||++.......   ...+.|.+|+.+|++++|||||++++++.. +.+||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTP---QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCT---THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            4678999999999999999998643  59999886543322   335678999999999999999999998754 56899


Q ss_pred             EEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC---
Q 010676          408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---  482 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~---  482 (504)
                      ||||+++|+|.+++..  ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....   
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999999864  34899999999999999999999999999999999999999999999999999765432   


Q ss_pred             -CcccccCCCcccccccccC
Q 010676          483 -DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       483 -~~~s~~GT~~YmAPEVL~g  501 (504)
                       ......||+.|||||++.+
T Consensus       161 ~~~~~~~gt~~y~APE~l~~  180 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRM  180 (276)
T ss_dssp             -----CCCCGGGCCHHHHTT
T ss_pred             ccccccccCcccCCHHHHhc
Confidence             2345679999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.3e-35  Score=291.33  Aligned_cols=174  Identities=26%  Similarity=0.443  Sum_probs=152.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccch----hhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS----QAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~----~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~  401 (504)
                      .++|++++.||+|+||+||+|++ .+|+.||||++.......    ..+.....+.+|+.++++++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            46899999999999999999998 689999999987644332    12333456889999999997 9999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                      ++.+||||||+++|+|.+++.. ..+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            9999999999999999999854 469999999999999999999999999999999999999999999999999998765


Q ss_pred             cC-CcccccCCCcccccccccC
Q 010676          481 LN-DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~-~~~s~~GT~~YmAPEVL~g  501 (504)
                      .. .....+||+.|+|||++.+
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~  183 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIEC  183 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHH
T ss_pred             CCCceeeeeccCCCCCHHHhhc
Confidence            43 3445679999999999853

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-36  Score=297.00  Aligned_cols=169  Identities=30%  Similarity=0.457  Sum_probs=140.7

Q ss_pred             eeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEe
Q 010676          333 KGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (504)
Q Consensus       333 i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy  411 (504)
                      .+++||+|+||+||+|++ .+|+.||||++...............+.+|+.+|+.++|||||++++++.+++.+||||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            468899999999999998 5799999998865433322222345688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--ccccc
Q 010676          412 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCR  488 (504)
Q Consensus       412 ~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~~s~~  488 (504)
                      +.++++..++.. ..+++..+..|++||+.||+|||++||+||||||+|||++.++.+||+|||+++......  ....+
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            999877766654 358999999999999999999999999999999999999999999999999998654432  34567


Q ss_pred             CCCcccccccccC
Q 010676          489 GTAFWMAPEVCSN  501 (504)
Q Consensus       489 GT~~YmAPEVL~g  501 (504)
                      ||+.|||||++.+
T Consensus       162 gt~~y~aPE~~~~  174 (299)
T d1ua2a_         162 VTRWYRAPELLFG  174 (299)
T ss_dssp             CCCTTCCHHHHTT
T ss_pred             cChhhccHHHHcc
Confidence            9999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-35  Score=296.19  Aligned_cols=171  Identities=22%  Similarity=0.381  Sum_probs=150.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      .+.++|++++.||+|+||+||+|.+ .++..||||++.....      ....+.+|+.+|+.++|||||+++++|.+++.
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   75 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT------DQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH------HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            4567899999999999999999998 5899999999864321      12457799999999999999999999999999


Q ss_pred             EEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCC--CcEEEEecCcccccc
Q 010676          405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATK  480 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~--g~VKL~DFGLA~~~~  480 (504)
                      +|||||||+||+|.+++...  .+++.++..|+.||+.||.|||++||+||||||+||||+.+  +.+||+|||+++...
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            99999999999999999754  58999999999999999999999999999999999999854  489999999998765


Q ss_pred             cCC-cccccCCCcccccccccCC
Q 010676          481 LND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       481 ~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... .....||+.|||||++.+.
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~  178 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHD  178 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTC
T ss_pred             cCCcccccccccccccchhccCC
Confidence            443 4456799999999998765

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-35  Score=294.53  Aligned_cols=171  Identities=27%  Similarity=0.462  Sum_probs=135.9

Q ss_pred             ccceeeeeeecccCceeEEEEEcc-CC---ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD-DG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~-~g---~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .++|++.++||+|+||+||+|.+. ++   ..||||.+....    .....+.|.+|+.+|++++|||||++++++.+.+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc----CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            357999999999999999999873 33   357777654321    2334567899999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+++|+|.+++...  .+++.++..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999999988764  489999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc-------ccccCCCcccccccccCC
Q 010676          482 NDV-------KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~~-------~s~~GT~~YmAPEVL~g~  502 (504)
                      ...       ....||+.|||||++.++
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~  208 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYR  208 (299)
T ss_dssp             ---------------CGGGSCHHHHHSC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcC
Confidence            321       123479999999998765

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-35  Score=295.34  Aligned_cols=174  Identities=30%  Similarity=0.499  Sum_probs=148.6

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHh-hCCCCceeEEeeeecCCCeE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS-RFEHENIVQYYGTDKDESKL  405 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~-~L~HpnIV~l~~~~~~~~~l  405 (504)
                      +++|++++.||+|+||+||+|++ .+++.||||++.....  ........+.+|+.++. .++|||||++++++.+++.+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~   78 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   78 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc--cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence            46899999999999999999998 5899999999864221  11122345566766654 68999999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC--
Q 010676          406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~--  482 (504)
                      ||||||+++|+|.+++... .+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....  
T Consensus        79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            9999999999999998654 5999999999999999999999999999999999999999999999999999865432  


Q ss_pred             CcccccCCCcccccccccCCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~~  503 (504)
                      .....+||+.|||||++.++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~  179 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQK  179 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCC
T ss_pred             cccccCCCCCcCCHHHHcCCC
Confidence            344567999999999998753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.1e-35  Score=287.87  Aligned_cols=175  Identities=24%  Similarity=0.338  Sum_probs=144.1

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-  403 (504)
                      .+.++|++.+.||+|+||+||+|++ .+|+.||||++......  .......+.+|+.+|+.++|||||++++++...+ 
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR--DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc--CHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            3557899999999999999999998 68999999998653322  2344567899999999999999999999887643 


Q ss_pred             ---eEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          404 ---KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       404 ---~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                         .+||||||++|++|..++... .+++.++..|+.||+.||.|||++|||||||||+||||+.++.++|+|||++...
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence               489999999999999877554 6999999999999999999999999999999999999999999999999998754


Q ss_pred             ccC-----CcccccCCCcccccccccCC
Q 010676          480 KLN-----DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~-----~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ...     .....+||+.|||||++.++
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~  189 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGD  189 (277)
T ss_dssp             C----------------TTCCHHHHTTC
T ss_pred             ccccccccccccccCcccccCHHHHcCC
Confidence            322     23445799999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=287.19  Aligned_cols=170  Identities=26%  Similarity=0.436  Sum_probs=139.7

Q ss_pred             cceeeeeeecccCceeEEEEEccCC-----ceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g-----~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      +.|++.++||+|+||.||+|.....     ..||||.+.....    ......+.+|+.+|++++|||||++++++.+.+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT----EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC----hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            4688999999999999999987422     4799998854221    223456889999999999999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+.+++|.+++..  ..+++.++..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            99999999999999987765  3589999999999999999999999999999999999999999999999999986543


Q ss_pred             CC-----cccccCCCcccccccccCC
Q 010676          482 ND-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..     .....||+.|||||++.++
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~  188 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYR  188 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSC
T ss_pred             CCccceEeccCCCCccccCHHHHccC
Confidence            32     1234589999999998765

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=284.37  Aligned_cols=168  Identities=25%  Similarity=0.417  Sum_probs=147.7

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      ++|+++++||+|+||+||+|+..++..||||.++.....      ...+.+|+.++.+++|||||++++++.+++.+|+|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC------HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC------HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            478899999999999999999988999999998753322      24688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC---
Q 010676          409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---  483 (504)
Q Consensus       409 mEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~---  483 (504)
                      |||+.+|+|..++..  ..+.+..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......   
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999999988643  458899999999999999999999999999999999999999999999999997654332   


Q ss_pred             cccccCCCcccccccccCC
Q 010676          484 VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 ~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....||+.|||||++.++
T Consensus       158 ~~~~~~t~~y~aPE~~~~~  176 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYS  176 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHC
T ss_pred             ecccCCCCCcCCcHHhcCC
Confidence            2335689999999998754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-35  Score=291.09  Aligned_cols=174  Identities=28%  Similarity=0.405  Sum_probs=147.5

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhh-HHHHHHHHHHHHHHhhCC--CCceeEEeeeecCCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE--HENIVQYYGTDKDES  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~-~~~~~~~~~Ei~iL~~L~--HpnIV~l~~~~~~~~  403 (504)
                      .++|+++++||+|+||+||+|++ .+|..||||++......... .....++.+|+.+|++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            46899999999999999999998 68999999998653221110 011133568999999986  899999999999999


Q ss_pred             eEEEEEEeccC-CCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-CCcEEEEecCcccccc
Q 010676          404 KLYIFLELVTK-GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATK  480 (504)
Q Consensus       404 ~lyLVmEy~~g-gsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~-~g~VKL~DFGLA~~~~  480 (504)
                      .+|+||||+.+ +++.+++.. ..+++.+++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            99999999976 577777654 56999999999999999999999999999999999999985 4799999999998776


Q ss_pred             cCCcccccCCCcccccccccC
Q 010676          481 LNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      .......+||+.|||||++.+
T Consensus       163 ~~~~~~~~GT~~y~aPE~~~~  183 (273)
T d1xwsa_         163 DTVYTDFDGTRVYSPPEWIRY  183 (273)
T ss_dssp             SSCBCCCCSCGGGSCHHHHHH
T ss_pred             cccccccccCCCcCCHHHHcC
Confidence            666667789999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-34  Score=287.20  Aligned_cols=169  Identities=27%  Similarity=0.441  Sum_probs=143.6

Q ss_pred             cceeeeee-ecccCceeEEEEEcc---CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          329 TYWQKGDL-LGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       329 ~~y~i~k~-LG~G~FG~VYka~~~---~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ++|.+.+. ||+|+||+||+|.+.   ++..||||++....    .....+.+.+|+.+|++++|||||++++++.+ +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc----CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            46788885 999999999999763   45689999886432    23345678999999999999999999999865 46


Q ss_pred             EEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +||||||+++|+|.+++..  ..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            8999999999999998754  35999999999999999999999999999999999999999999999999999865433


Q ss_pred             C-----cccccCCCcccccccccCC
Q 010676          483 D-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      .     .....||+.|||||++.++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~  187 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFR  187 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred             ccccccccccccCccccChHHHhCC
Confidence            2     2234689999999998643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-34  Score=288.41  Aligned_cols=172  Identities=30%  Similarity=0.465  Sum_probs=144.7

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY  406 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~ly  406 (504)
                      +++|++++.||+|+||+||+|.+ .+|+.||||++.....   .......+.+|+.+|++++|||||++++++.+.+.+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~   77 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY   77 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence            36899999999999999999998 6899999999864322   1222457889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      +||||+.++.+..+...  ..+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...... 
T Consensus        78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            99999987655444333  459999999999999999999999999999999999999999999999999998654332 


Q ss_pred             -cccccCCCcccccccccCC
Q 010676          484 -VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -~~s~~GT~~YmAPEVL~g~  502 (504)
                       .....||+.|+|||++.+.
T Consensus       158 ~~~~~~gt~~y~apE~~~~~  177 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGC  177 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTC
T ss_pred             cceeecccceeeehhhhccc
Confidence             3445799999999987653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-34  Score=292.43  Aligned_cols=171  Identities=28%  Similarity=0.436  Sum_probs=143.0

Q ss_pred             ccceeeeeeecccCceeEEEEEcc-C-----CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeec
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD-D-----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  400 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~-~-----g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~  400 (504)
                      .++|+++++||+|+||+||+|++. .     ...||+|.+.....    ......+.+|+.+|.++ +|||||++++++.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD----SSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC----HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            468999999999999999999873 2     23688887753221    22345688999999988 8999999999999


Q ss_pred             CCCeEEEEEEeccCCCHHHHHHhc------------------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 010676          401 DESKLYIFLELVTKGSLLNLYQRY------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK  456 (504)
Q Consensus       401 ~~~~lyLVmEy~~ggsL~~ll~~~------------------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLK  456 (504)
                      +.+.+||||||+++|+|.+++...                        .+++..++.|+.||+.||.|||++||||||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK  191 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  191 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence            999999999999999999998653                        37888999999999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEEecCcccccccCCc----ccccCCCcccccccccCC
Q 010676          457 CANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       457 P~NILLd~~g~VKL~DFGLA~~~~~~~~----~s~~GT~~YmAPEVL~g~  502 (504)
                      |+|||++.++.+||+|||+|+.......    ....||+.|||||++.++
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~  241 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG  241 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC
Confidence            9999999999999999999986544332    244589999999988654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-34  Score=285.21  Aligned_cols=164  Identities=26%  Similarity=0.432  Sum_probs=136.6

Q ss_pred             eeecccCceeEEEEEcc---CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEEEEe
Q 010676          335 DLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL  411 (504)
Q Consensus       335 k~LG~G~FG~VYka~~~---~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLVmEy  411 (504)
                      +.||+|+||+||+|.+.   +++.||||++.....   .......+.+|+.+|++++|||||++++++.+ +.+||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC---CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEc
Confidence            57999999999999863   457899998854222   22334678999999999999999999999865 467999999


Q ss_pred             ccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-----cc
Q 010676          412 VTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VK  485 (504)
Q Consensus       412 ~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-----~~  485 (504)
                      +++|+|.+++... .+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++......     ..
T Consensus        89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            9999999998764 59999999999999999999999999999999999999999999999999998654332     22


Q ss_pred             cccCCCcccccccccCC
Q 010676          486 SCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g~  502 (504)
                      ...||+.|||||++.++
T Consensus       169 ~~~gt~~y~APE~l~~~  185 (277)
T d1xbba_         169 HGKWPVKWYAPECINYY  185 (277)
T ss_dssp             --CCCGGGCCHHHHHHC
T ss_pred             ccCCCceecCchhhcCC
Confidence            34689999999998654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-34  Score=291.46  Aligned_cols=167  Identities=27%  Similarity=0.381  Sum_probs=142.6

Q ss_pred             ccccceeee-eeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHh-hCCCCceeEEeeeecC-
Q 010676          326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS-RFEHENIVQYYGTDKD-  401 (504)
Q Consensus       326 ~~~~~y~i~-k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~-~L~HpnIV~l~~~~~~-  401 (504)
                      .++++|++. ++||+|+||+||+|.+ .+++.||||++...          ..+.+|+.++. .++|||||+++++|.+ 
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            456789886 5699999999999998 68999999988531          24568898865 4589999999998864 


Q ss_pred             ---CCeEEEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEe
Q 010676          402 ---ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLAD  472 (504)
Q Consensus       402 ---~~~lyLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~---~g~VKL~D  472 (504)
                         +..+|||||||+||+|.+++...   .+++.+++.|+.||+.||.|||++||+||||||+|||++.   ++.+||+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence               56799999999999999999763   4899999999999999999999999999999999999985   56799999


Q ss_pred             cCcccccccC-CcccccCCCcccccccccCC
Q 010676          473 FGLAKATKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       473 FGLA~~~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||+|+..... .....+||+.|||||++.+.
T Consensus       158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  188 (335)
T d2ozaa1         158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPE  188 (335)
T ss_dssp             CTTCEECCCCCCCCCCSCCCSSCCCCCCCGG
T ss_pred             cceeeeccCCCccccccCCcccCCcHHHcCC
Confidence            9999865443 34566799999999999764

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-34  Score=286.43  Aligned_cols=168  Identities=32%  Similarity=0.462  Sum_probs=140.9

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      .++|++++.||+|+||.||+|++.++..||||++......      .+.|.+|+.++++++|||||++++++.+ +.+|+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~------~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC------HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence            4689999999999999999999988889999988643221      2468899999999999999999999854 56899


Q ss_pred             EEEeccCCCHHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~---~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      ||||+.+|+|..++..   ..+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... 
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            9999999999987753   359999999999999999999999999999999999999999999999999998654332 


Q ss_pred             --cccccCCCcccccccccCC
Q 010676          484 --VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 --~~s~~GT~~YmAPEVL~g~  502 (504)
                        .....||+.|||||++.++
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~  189 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYG  189 (285)
T ss_dssp             -------CCGGGSCHHHHHHC
T ss_pred             eeeccccccccccChHHHhCC
Confidence              2335699999999998654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.7e-34  Score=280.96  Aligned_cols=170  Identities=29%  Similarity=0.456  Sum_probs=146.0

Q ss_pred             cceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF  408 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyLV  408 (504)
                      ++|++++.||+|+||+||+|++.+|+.||||++......   ......+.+|+.+|+.++|||||+++++|...+.+|++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC---hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            689999999999999999999999999999998654322   22235688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--cc
Q 010676          409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK  485 (504)
Q Consensus       409 mEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~~  485 (504)
                      |+|+.++.+..+... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||++.......  ..
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            999998877777663 459999999999999999999999999999999999999999999999999997654332  33


Q ss_pred             cccCCCcccccccccC
Q 010676          486 SCRGTAFWMAPEVCSN  501 (504)
Q Consensus       486 s~~GT~~YmAPEVL~g  501 (504)
                      ...||+.|+|||++.+
T Consensus       159 ~~~~~~~y~~pE~~~~  174 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMG  174 (286)
T ss_dssp             ---CCCTTCCHHHHTT
T ss_pred             eecccchhhhHHHHhC
Confidence            4469999999999865

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-34  Score=286.16  Aligned_cols=169  Identities=27%  Similarity=0.457  Sum_probs=137.2

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCc----eEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~----~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      ++|+++++||+|+||+||+|.+ .+|+    .||+|.+....    .....+.+.+|+.++++++|||||++++++.++ 
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            4699999999999999999987 3554    57777664321    122346788999999999999999999999865 


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      ..+++|||+.+++|.+++...  .+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            578889999999998877653  589999999999999999999999999999999999999999999999999987543


Q ss_pred             CC----cccccCCCcccccccccCC
Q 010676          482 ND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..    .....||+.|||||++.++
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~  188 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHR  188 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHC
T ss_pred             ccccccccccccCccccChHHHhcC
Confidence            32    2234589999999998765

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=285.58  Aligned_cols=170  Identities=25%  Similarity=0.446  Sum_probs=143.4

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC--
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--  403 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~--  403 (504)
                      +.++|++++.||+|+||+||+|++ .+|+.||||++....   ......+.+.+|+.+|+.++|||||+++++|...+  
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh---cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence            457899999999999999999998 679999999886432   22334567889999999999999999999987654  


Q ss_pred             ----eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       404 ----~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                          .+|+||||+ +.+|..+++...+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence                579999999 568888888889999999999999999999999999999999999999999999999999999865


Q ss_pred             ccCCcccccCCCcccccccccC
Q 010676          480 KLNDVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       480 ~~~~~~s~~GT~~YmAPEVL~g  501 (504)
                      ... .....||+.|||||++.+
T Consensus       172 ~~~-~~~~~~t~~y~aPE~~~~  192 (346)
T d1cm8a_         172 DSE-MTGYVVTRWYRAPEVILN  192 (346)
T ss_dssp             CSS-CCSSCSCGGGCCTHHHHT
T ss_pred             CCc-cccccccccccCHHHHcC
Confidence            533 455679999999999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-33  Score=280.74  Aligned_cols=171  Identities=27%  Similarity=0.405  Sum_probs=134.5

Q ss_pred             ccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeec
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK  400 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~  400 (504)
                      .++|++++.||+|+||.||+|.+.      +++.||||.+....    .......+.+|+.++.++ +|+|||.+++++.
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            468999999999999999999862      45789999875322    122345677787777766 6899999999876


Q ss_pred             C-CCeEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 010676          401 D-ESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV  462 (504)
Q Consensus       401 ~-~~~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILL  462 (504)
                      . +..+|+||||+++|+|.+++...                 .+++.++..|+.||+.||.|||++|||||||||+||||
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  167 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence            5 45699999999999999998643                 37889999999999999999999999999999999999


Q ss_pred             cCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          463 DANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       463 d~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      +.++.+||+|||+|+......    .....||+.|||||++.++
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~  211 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR  211 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC
Confidence            999999999999998644322    2345799999999998765

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-33  Score=283.12  Aligned_cols=172  Identities=27%  Similarity=0.470  Sum_probs=143.0

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC-
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-  403 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~-  403 (504)
                      .+..+|++++.||+|+||+||+|++ .+|..||||++....    .....+.+.+|+.+|+.++||||+++++++.... 
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc----ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            3456799999999999999999997 689999999986432    2334467889999999999999999999986543 


Q ss_pred             ---eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccc
Q 010676          404 ---KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK  480 (504)
Q Consensus       404 ---~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~  480 (504)
                         ..+++++|+.+|+|.+++....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++...
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence               23455566778999999998899999999999999999999999999999999999999999999999999997643


Q ss_pred             cC-----CcccccCCCcccccccccC
Q 010676          481 LN-----DVKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       481 ~~-----~~~s~~GT~~YmAPEVL~g  501 (504)
                      ..     .....+||+.|+|||++..
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~  186 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLN  186 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTT
T ss_pred             CCCccceeeccccccceechHHHhhc
Confidence            22     1344569999999999854

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-33  Score=275.77  Aligned_cols=170  Identities=31%  Similarity=0.456  Sum_probs=133.7

Q ss_pred             ccceeeeeeecccCceeEEEEEcc----CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~----~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~  403 (504)
                      .++|++++.||+|+||.||+|++.    .+..||||.+....    .......+.+|+.+|++++|||||++++++. ++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            368999999999999999999873    23467777654221    2334567889999999999999999999985 56


Q ss_pred             eEEEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      .+|+||||+.+|+|.+++...  .+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            799999999999999987543  489999999999999999999999999999999999999999999999999986543


Q ss_pred             CC---cccccCCCcccccccccCC
Q 010676          482 ND---VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       482 ~~---~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..   .....||+.|||||++.++
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~  184 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFR  184 (273)
T ss_dssp             ----------CCGGGCCHHHHHHC
T ss_pred             CcceeccceecCcccchhhHhccC
Confidence            32   2345689999999998754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-33  Score=278.29  Aligned_cols=168  Identities=30%  Similarity=0.424  Sum_probs=140.7

Q ss_pred             ccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCC----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~----  403 (504)
                      .+.|.+.+.||+|+||.||+|+. +|..||||++....      ......+.|+..+.+++|||||++++++.+.+    
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence            45789999999999999999986 68899999885321      11122345666667889999999999987653    


Q ss_pred             eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCcEEEcCCCcEEEEecCc
Q 010676          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD--------QDVVHRDIKCANILVDANGSVKLADFGL  475 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs--------~gIIHRDLKP~NILLd~~g~VKL~DFGL  475 (504)
                      .+|+||||+.+|+|.+++++..+++..+..++.|++.||.|||.        +|||||||||+||||+.++.+||+|||+
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            58999999999999999999999999999999999999999996        5999999999999999999999999999


Q ss_pred             ccccccCC------cccccCCCcccccccccCC
Q 010676          476 AKATKLND------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       476 A~~~~~~~------~~s~~GT~~YmAPEVL~g~  502 (504)
                      ++......      .....||+.|||||++.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  187 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS  187 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTC
T ss_pred             cccccCCCcceeccccceecccCcCChhhcccc
Confidence            98654322      2345699999999998764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-33  Score=279.11  Aligned_cols=171  Identities=26%  Similarity=0.383  Sum_probs=145.9

Q ss_pred             ccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~  401 (504)
                      .++|++++.||+|+||+||+|+..      ++..||||++....    .......+.+|+.+|+.++||||+++++++..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc----ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            467999999999999999999853      56789999875322    23345678999999999999999999999999


Q ss_pred             CCeEEEEEEeccCCCHHHHHHhc-------------------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 010676          402 ESKLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK  456 (504)
Q Consensus       402 ~~~lyLVmEy~~ggsL~~ll~~~-------------------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLK  456 (504)
                      .+.++++|||+.+|+|.+++...                         .+++..+..|+.||+.||+|||+++|||||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            99999999999999999988642                         27888999999999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          457 CANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       457 P~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      |+||||+.++.+||+|||+++......    .....||+.|||||++.+.
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  217 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN  217 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC
Confidence            999999999999999999997643322    2345689999999988754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=7.4e-33  Score=274.66  Aligned_cols=174  Identities=32%  Similarity=0.481  Sum_probs=139.4

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-c-CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhh---CCCCceeEEeeeec
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-D-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENIVQYYGTDK  400 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~-~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~---L~HpnIV~l~~~~~  400 (504)
                      +..++|++++.||+|+||+||+|++ . +++.||||++..........   ..+.+|+.+|+.   ++||||++++++|.
T Consensus         4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~---~~~~~E~~~l~~l~~~~HpnIv~~~~~~~   80 (305)
T d1blxa_           4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCT   80 (305)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH---HHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence            3457899999999999999999997 3 46789999986533222111   224456666554   58999999999874


Q ss_pred             -----CCCeEEEEEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEec
Q 010676          401 -----DESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF  473 (504)
Q Consensus       401 -----~~~~lyLVmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DF  473 (504)
                           ....+|++|||+.++.+.....  ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             ccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecch
Confidence                 3457899999999887654443  345899999999999999999999999999999999999999999999999


Q ss_pred             CcccccccC-CcccccCCCcccccccccCC
Q 010676          474 GLAKATKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       474 GLA~~~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      |+++..... .....+||+.|||||++.+.
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~  190 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQS  190 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTC
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCC
Confidence            998765433 34566799999999998765

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=9.5e-33  Score=276.67  Aligned_cols=177  Identities=29%  Similarity=0.423  Sum_probs=150.6

Q ss_pred             cccccccceeeeeeecccCceeEEEEEc------cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEE
Q 010676          323 RFKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY  395 (504)
Q Consensus       323 ~~~~~~~~y~i~k~LG~G~FG~VYka~~------~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l  395 (504)
                      .+..-.++|+++++||+|+||.||+|+.      .++..||||++.....    ......+.+|+.+++.+ +|||||++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~E~~~~~~l~~HpnIv~~   92 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHMNIVNL   92 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC----HHHHHHHHHHHHHHHhccCCCCEEEE
Confidence            3433457999999999999999999974      4677999998864322    23345788999999998 69999999


Q ss_pred             eeeecCCCeEEEEEEeccCCCHHHHHHhc-------------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 010676          396 YGTDKDESKLYIFLELVTKGSLLNLYQRY-------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK  456 (504)
Q Consensus       396 ~~~~~~~~~lyLVmEy~~ggsL~~ll~~~-------------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLK  456 (504)
                      ++++.+.+.+||||||+++|+|.+++...                   .+++..+..|+.||+.||+|||++||||||||
T Consensus        93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK  172 (311)
T d1t46a_          93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA  172 (311)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence            99999999999999999999999998653                   38889999999999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCCC
Q 010676          457 CANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       457 P~NILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~~  503 (504)
                      |+|||++.++.+||+|||+++......    ....+||+.|||||++.++.
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  223 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV  223 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred             cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence            999999999999999999998654332    23456899999999987543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.98  E-value=8.2e-33  Score=277.69  Aligned_cols=165  Identities=25%  Similarity=0.422  Sum_probs=142.6

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecC--CC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD--ES  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~--~~  403 (504)
                      .++|+++++||+|+||+||+|++ .+|+.||||++....        ..++.+|+.+|+.++ ||||++++++|..  ..
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            46899999999999999999998 689999999886321        245789999999996 9999999999864  46


Q ss_pred             eEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEecCcccccccC
Q 010676          404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLN  482 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-~VKL~DFGLA~~~~~~  482 (504)
                      .+|+||||+.+++|..+.  ..+++..++.++.||+.||.|||++|||||||||+||||+.++ .+||+|||+|+.....
T Consensus       106 ~~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             ceeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            799999999999998764  3599999999999999999999999999999999999998655 6999999999875543


Q ss_pred             -CcccccCCCcccccccccCC
Q 010676          483 -DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 -~~~s~~GT~~YmAPEVL~g~  502 (504)
                       .....+||+.|+|||++.+.
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~  204 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDY  204 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTC
T ss_pred             CcccccccCccccCcccccCC
Confidence             34556799999999998753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.2e-32  Score=268.51  Aligned_cols=171  Identities=29%  Similarity=0.447  Sum_probs=149.9

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCeEEE
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~lyL  407 (504)
                      ++|++++.||+|+||+||+|++ .++..||||+++.....   .....++.+|+.+|+.++||||+++++++.+...+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC---hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence            6899999999999999999998 68899999999754322   2335678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC--c
Q 010676          408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V  484 (504)
Q Consensus       408 VmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~--~  484 (504)
                      ||+++.+++|..++... .+++..+..++.|++.||+|||++|||||||||+||||+.++.+||+|||+++......  .
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence            99999999988877654 58899999999999999999999999999999999999999999999999998754332  3


Q ss_pred             ccccCCCcccccccccCC
Q 010676          485 KSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       485 ~s~~GT~~YmAPEVL~g~  502 (504)
                      ....+++.|+|||++.+.
T Consensus       159 ~~~~~~~~~~~pe~~~~~  176 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGA  176 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTC
T ss_pred             eeeccccchhhhhHhccC
Confidence            344578899999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.2e-32  Score=275.11  Aligned_cols=172  Identities=27%  Similarity=0.444  Sum_probs=140.6

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-----
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-----  401 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-----  401 (504)
                      +++|++++.||+|+||+||+|++ .+|+.||||++.......   .....+.+|+.+|+.++||||+++++++..     
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            57899999999999999999998 689999999876543322   123457799999999999999999998754     


Q ss_pred             ---CCeEEEEEEeccCCCHHHHHHh-cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          402 ---ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       402 ---~~~lyLVmEy~~ggsL~~ll~~-~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                         .+.+|+||||+.++.+..+... ..+.+..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence               4568999999988766654433 458899999999999999999999999999999999999999999999999997


Q ss_pred             ccccC------CcccccCCCcccccccccCC
Q 010676          478 ATKLN------DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       478 ~~~~~------~~~s~~GT~~YmAPEVL~g~  502 (504)
                      .....      .....+||+.|+|||++.+.
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~  196 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE  196 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCC
Confidence            54422      23345799999999998653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=6.5e-33  Score=272.58  Aligned_cols=167  Identities=26%  Similarity=0.430  Sum_probs=136.6

Q ss_pred             cccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-CCeE
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKL  405 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-~~~l  405 (504)
                      -.++|++++.||+|+||.||+|... |..||||+++...       ..+.+.+|+.++++++|||||++++++.+ .+.+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            3568999999999999999999984 7789999875321       12568899999999999999999998854 5678


Q ss_pred             EEEEEeccCCCHHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          406 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~---~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      |+||||+++|+|.+++...   .+++..+..|+.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            9999999999999998653   3899999999999999999999999999999999999999999999999999865433


Q ss_pred             CcccccCCCcccccccccCC
Q 010676          483 DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~~~s~~GT~~YmAPEVL~g~  502 (504)
                       .....+|..|||||++.++
T Consensus       157 -~~~~~~~~~y~aPE~l~~~  175 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREK  175 (262)
T ss_dssp             ------CCTTTSCHHHHHHC
T ss_pred             -CccccccccCCChHHHhCC
Confidence             3345689999999998654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.5e-32  Score=277.68  Aligned_cols=164  Identities=29%  Similarity=0.411  Sum_probs=137.2

Q ss_pred             ceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeec------CC
Q 010676          330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK------DE  402 (504)
Q Consensus       330 ~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~------~~  402 (504)
                      .|+.+++||+|+||+||+|++ .+|+.||||++.....         .+.+|+.+|++++|||||+++++|.      +.
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            699999999999999999998 5799999999864322         1237999999999999999999874      33


Q ss_pred             CeEEEEEEeccCCCHHHHHH----hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC-cEEEEecCccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAK  477 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~----~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g-~VKL~DFGLA~  477 (504)
                      .++||||||++++.+..+..    ...+++.+++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||+++
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence            45899999998765444332    23599999999999999999999999999999999999999775 89999999998


Q ss_pred             ccccC-CcccccCCCcccccccccCC
Q 010676          478 ATKLN-DVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       478 ~~~~~-~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ..... .....+||+.|+|||++.+.
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~  197 (350)
T d1q5ka_         172 QLVRGEPNVSYICSRYYRAPELIFGA  197 (350)
T ss_dssp             ECCTTSCCCSCCSCTTSCCHHHHTTC
T ss_pred             hccCCcccccccccccccChHHhhcc
Confidence            75443 34556799999999987653

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.1e-32  Score=272.78  Aligned_cols=173  Identities=28%  Similarity=0.446  Sum_probs=141.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc--------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEe
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY  396 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~--------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~  396 (504)
                      .-.++|++++.||+|+||.||+|+..        ++..||||++....    .......+.+|+.++.++ +|||||+++
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc----ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence            33578999999999999999999862        23579999775322    223346678888888877 799999999


Q ss_pred             eeecCCCeEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 010676          397 GTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN  459 (504)
Q Consensus       397 ~~~~~~~~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~N  459 (504)
                      ++|.+++.+|+||||+.+|+|.+++...                 .+++.+++.|+.||+.||+|||+++||||||||+|
T Consensus        86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence            9999999999999999999999998643                 37999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEEecCcccccccCC----cccccCCCcccccccccCC
Q 010676          460 ILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       460 ILLd~~g~VKL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~  502 (504)
                      ||++.++.+||+|||+++......    .....||+.|||||++.++
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~  212 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR  212 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC
Confidence            999999999999999998654332    2345689999999998754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-32  Score=274.50  Aligned_cols=171  Identities=27%  Similarity=0.482  Sum_probs=141.4

Q ss_pred             ccceeeeeeecccCceeEEEEEcc-CCc--eEEEEEEeccccchhhHHHHHHHHHHHHHHhhC-CCCceeEEeeeecCCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGISD-DGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES  403 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~~-~g~--~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~~~~~~~  403 (504)
                      .++|+++++||+|+||.||+|++. ++.  .||||.+....    .....+.+.+|+.+|.++ +|||||++++++.+.+
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc----ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            468999999999999999999984 554  46677654322    122345788999999998 6999999999999999


Q ss_pred             eEEEEEEeccCCCHHHHHHhc-----------------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCC
Q 010676          404 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG  466 (504)
Q Consensus       404 ~lyLVmEy~~ggsL~~ll~~~-----------------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g  466 (504)
                      .+|+||||+++|+|.+++...                 .+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            999999999999999998643                 488999999999999999999999999999999999999999


Q ss_pred             cEEEEecCcccccccCC-cccccCCCcccccccccCC
Q 010676          467 SVKLADFGLAKATKLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       467 ~VKL~DFGLA~~~~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      .+||+|||+++...... .....||..|+|||++.++
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~  201 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS  201 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccC
Confidence            99999999997644332 2345699999999998654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.4e-32  Score=273.66  Aligned_cols=174  Identities=25%  Similarity=0.385  Sum_probs=147.5

Q ss_pred             ccccceeeeeeecccCceeEEEEEcc------CCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeee
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD  399 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~~------~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~  399 (504)
                      ...++|++++.||+|+||+||+|.+.      ++..||||++....    .......+.+|+.++++++|||||++++++
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~----~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc----ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            33478999999999999999999863      46789999875322    223345788999999999999999999999


Q ss_pred             cCCCeEEEEEEeccCCCHHHHHHhc-----------CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcE
Q 010676          400 KDESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV  468 (504)
Q Consensus       400 ~~~~~lyLVmEy~~ggsL~~ll~~~-----------~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~V  468 (504)
                      .....+++||||+.+|+|.+++...           .+++..+..|+.||+.||.|||+++|+||||||+||||+.++++
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence            9999999999999999999987542           25788899999999999999999999999999999999999999


Q ss_pred             EEEecCcccccccCC----cccccCCCcccccccccCCC
Q 010676          469 KLADFGLAKATKLND----VKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       469 KL~DFGLA~~~~~~~----~~s~~GT~~YmAPEVL~g~~  503 (504)
                      ||+|||+++......    .....||+.|||||++.++.
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~  211 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV  211 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCC
Confidence            999999998654332    23345899999999987653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.8e-32  Score=276.71  Aligned_cols=173  Identities=29%  Similarity=0.429  Sum_probs=144.3

Q ss_pred             ccccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC---
Q 010676          326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---  401 (504)
Q Consensus       326 ~~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~---  401 (504)
                      .+.++|++++.||+|+||+||+|++ .+|+.||||++.....   ......++.+|+.+|+.++|||||++++++..   
T Consensus        15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~   91 (348)
T d2gfsa1          15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   91 (348)
T ss_dssp             EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence            3457899999999999999999998 6899999998864332   23334678899999999999999999998853   


Q ss_pred             --CCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          402 --ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       402 --~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                        ....+++|+|+.+|+|.+++....+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus        92 ~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          92 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             cccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence              334566777888999999998889999999999999999999999999999999999999999999999999998754


Q ss_pred             ccCCcccccCCCcccccccccCC
Q 010676          480 KLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                      ... .....||+.|+|||++.+.
T Consensus       172 ~~~-~~~~~g~~~y~apE~~~~~  193 (348)
T d2gfsa1         172 DDE-MTGYVATRWYRAPEIMLNW  193 (348)
T ss_dssp             TGG-GSSSCHHHHTSCHHHHTTC
T ss_pred             Ccc-cccccccccccCchhhcCC
Confidence            432 3456699999999987653

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=1.3e-31  Score=266.17  Aligned_cols=168  Identities=23%  Similarity=0.318  Sum_probs=142.6

Q ss_pred             ccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-CceeEEeeeecCCCeE
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESKL  405 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~~~~~~~l  405 (504)
                      -++|++++.||+|+||+||+|++ .+|+.||||++......       ..+.+|+++++.++| +|++.+++++......
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence            45899999999999999999998 57999999987543221       235678889998875 8999999999999999


Q ss_pred             EEEEEeccCCCHHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC-----CCcEEEEecCcccc
Q 010676          406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-----NGSVKLADFGLAKA  478 (504)
Q Consensus       406 yLVmEy~~ggsL~~ll~~~--~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~-----~g~VKL~DFGLA~~  478 (504)
                      |+||||+ +++|.+++...  .++..++..++.|++.||+|||++|||||||||+||||+.     ++.+||+|||+|+.
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            9999999 57898888653  4899999999999999999999999999999999999974     57899999999986


Q ss_pred             cccC---------CcccccCCCcccccccccCCC
Q 010676          479 TKLN---------DVKSCRGTAFWMAPEVCSNPF  503 (504)
Q Consensus       479 ~~~~---------~~~s~~GT~~YmAPEVL~g~~  503 (504)
                      ....         .....+||+.|||||++.++.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~  189 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE  189 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCC
Confidence            5322         123457999999999998763

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.4e-32  Score=267.74  Aligned_cols=171  Identities=27%  Similarity=0.423  Sum_probs=134.5

Q ss_pred             cceeeeeeecccCceeEEEEEc--cC--CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecCCCe
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS--DD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK  404 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~--~~--g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~~~~  404 (504)
                      ++|++.+.||+|+||.||+|..  .+  ...||||++.....  ......+.+.+|+.+|++++|||||++++++.+ ..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~   84 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP   84 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence            5799999999999999999986  22  34789997754322  223445678999999999999999999999976 47


Q ss_pred             EEEEEEeccCCCHHHHHHh--cCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccC
Q 010676          405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN  482 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~~--~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~  482 (504)
                      +|+||||+++|+|.+++..  ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            8999999999999987654  45999999999999999999999999999999999999999999999999999875433


Q ss_pred             C-----cccccCCCcccccccccCC
Q 010676          483 D-----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       483 ~-----~~s~~GT~~YmAPEVL~g~  502 (504)
                      .     .....||..|||||++.+.
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~  189 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTR  189 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHC
T ss_pred             CCcceecCccccCcccCCHHHHhCC
Confidence            2     2234588899999998764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.2e-32  Score=274.73  Aligned_cols=171  Identities=25%  Similarity=0.368  Sum_probs=135.9

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC----
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----  401 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~----  401 (504)
                      +.++|++++.||+|+||+||+|.+ .+|..||||++.....   ......++.+|+.+|++++|||||+++++|..    
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~   91 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL   91 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc
Confidence            457899999999999999999998 5799999999865332   23344678899999999999999999999853    


Q ss_pred             --CCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccc
Q 010676          402 --ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT  479 (504)
Q Consensus       402 --~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~  479 (504)
                        ...+|+||||+.++.+. .+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~~~~~~iv~Ey~~~~l~~-~~-~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          92 EEFQDVYLVMELMDANLCQ-VI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             TTCCEEEEEEECCSEEHHH-HH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             ccCceeEEEEeccchHHHH-hh-hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence              46899999999876554 33 346899999999999999999999999999999999999999999999999998765


Q ss_pred             ccCC-cccccCCCcccccccccCC
Q 010676          480 KLND-VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~-~~s~~GT~~YmAPEVL~g~  502 (504)
                      .... ....+||+.|+|||++.+.
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~l~~~  193 (355)
T d2b1pa1         170 GTSFMMTPYVVTRYYRAPEVILGM  193 (355)
T ss_dssp             -----------CCTTCCHHHHTTC
T ss_pred             ccccccccccccccccChhhhcCC
Confidence            4433 3455799999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.9e-31  Score=266.62  Aligned_cols=167  Identities=28%  Similarity=0.443  Sum_probs=139.5

Q ss_pred             eeeeeecccCceeEEEEEccC----CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCceeEEeeeecC-CCeEE
Q 010676          332 QKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLY  406 (504)
Q Consensus       332 ~i~k~LG~G~FG~VYka~~~~----g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~~~~~-~~~ly  406 (504)
                      +..++||+|+||+||+|.+.+    ...||||.+....    ......++.+|+.+|.+++|||||++++++.. +..+|
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC----CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc----CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            336789999999999998732    2368899875322    23445779999999999999999999998764 56899


Q ss_pred             EEEEeccCCCHHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCcccccccCC-
Q 010676          407 IFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-  483 (504)
Q Consensus       407 LVmEy~~ggsL~~ll~~~~--l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~~~-  483 (504)
                      +||||+.+|+|.+++....  +.+..+..++.|++.||.|||+++|+||||||+||||+.++.+||+|||+++...... 
T Consensus       106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            9999999999999887654  6677889999999999999999999999999999999999999999999998654332 


Q ss_pred             -----cccccCCCcccccccccCC
Q 010676          484 -----VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       484 -----~~s~~GT~~YmAPEVL~g~  502 (504)
                           .....||+.|+|||++.++
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~  209 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQ  209 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHC
T ss_pred             ccceecccccccccccChHHHhcC
Confidence                 2234589999999987643

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.4e-32  Score=272.75  Aligned_cols=173  Identities=28%  Similarity=0.456  Sum_probs=147.0

Q ss_pred             ccceeeeeeecccCceeEEEEEc----cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCC-CceeEEeeeecCC
Q 010676          328 ITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDE  402 (504)
Q Consensus       328 ~~~y~i~k~LG~G~FG~VYka~~----~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~~~~~~  402 (504)
                      +++|++++.||+|+||+||+|..    .+|+.||||++........ ....+.+.+|+.+|++++| |||+++++++.+.
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-hHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence            57899999999999999999986    3588999998854322111 1112456789999999976 8999999999999


Q ss_pred             CeEEEEEEeccCCCHHHHHHhc-CCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccccccc
Q 010676          403 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL  481 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~ll~~~-~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~~~~~  481 (504)
                      ..+|++|||+.+|+|.+++... .+.+..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            9999999999999999988665 588899999999999999999999999999999999999999999999999976543


Q ss_pred             CC---cccccCCCcccccccccC
Q 010676          482 ND---VKSCRGTAFWMAPEVCSN  501 (504)
Q Consensus       482 ~~---~~s~~GT~~YmAPEVL~g  501 (504)
                      ..   .....||+.|+|||++.+
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~  204 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRG  204 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTT
T ss_pred             cccccccccccccccchhHHhhc
Confidence            22   344569999999999865

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=6.3e-31  Score=260.56  Aligned_cols=168  Identities=24%  Similarity=0.337  Sum_probs=137.3

Q ss_pred             cccceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCc-eeEEeeeecCCCe
Q 010676          327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESK  404 (504)
Q Consensus       327 ~~~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~~~~~~~~  404 (504)
                      +-++|++++.||+|+||+||+|++ .+|+.||||++......       .++.+|+.+++.++|+| |+.+.+++.+.+.
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-------HHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence            345799999999999999999998 67999999987653221       23678999999998766 5555667788889


Q ss_pred             EEEEEEeccCCCHHHHHH--hcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcC---CCcEEEEecCccccc
Q 010676          405 LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKAT  479 (504)
Q Consensus       405 lyLVmEy~~ggsL~~ll~--~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~---~g~VKL~DFGLA~~~  479 (504)
                      .|+||||+.+ +|...+.  ...+++..+..++.|++.||+|||++|||||||||+|||++.   +..+||+|||+|+..
T Consensus        78 ~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          78 NVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            9999999965 5655544  345999999999999999999999999999999999999864   457999999999875


Q ss_pred             ccCC---------cccccCCCcccccccccCC
Q 010676          480 KLND---------VKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       480 ~~~~---------~~s~~GT~~YmAPEVL~g~  502 (504)
                      ....         .....||+.|||||++.++
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  188 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGI  188 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCC
Confidence            4322         2345799999999999875

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.93  E-value=1.2e-26  Score=234.07  Aligned_cols=167  Identities=25%  Similarity=0.294  Sum_probs=131.7

Q ss_pred             cceeeeeeecccCceeEEEEEc-cCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-----------CCceeEEe
Q 010676          329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----------HENIVQYY  396 (504)
Q Consensus       329 ~~y~i~k~LG~G~FG~VYka~~-~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIV~l~  396 (504)
                      ++|++++.||+|+||+||+|++ .+|+.||||++....      .....+.+|+.+++.++           |+||++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc------cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            3599999999999999999998 689999999986321      22345677888887765           57899999


Q ss_pred             eeecC--CCeEEEEEEeccCCCHHHH-H---HhcCCChHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEcCCCc--
Q 010676          397 GTDKD--ESKLYIFLELVTKGSLLNL-Y---QRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGS--  467 (504)
Q Consensus       397 ~~~~~--~~~lyLVmEy~~ggsL~~l-l---~~~~l~e~~v~~i~~QIl~gL~yLHs-~gIIHRDLKP~NILLd~~g~--  467 (504)
                      +++..  ....+++|+++..+..... .   ....+.+..++.++.||+.||.|||+ +||+||||||+||||+.++.  
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            88754  4567777777665543322 2   22458889999999999999999998 89999999999999987653  


Q ss_pred             ----EEEEecCcccccccCCcccccCCCcccccccccCC
Q 010676          468 ----VKLADFGLAKATKLNDVKSCRGTAFWMAPEVCSNP  502 (504)
Q Consensus       468 ----VKL~DFGLA~~~~~~~~~s~~GT~~YmAPEVL~g~  502 (504)
                          ++|+|||.+...... ....+||+.|||||++.++
T Consensus       167 ~~~~~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~~~~  204 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGA  204 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTC
T ss_pred             ccceeeEeecccccccccc-cccccccccccChhhcccc
Confidence                999999998765433 3456799999999988754

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=5.8e-24  Score=197.31  Aligned_cols=139  Identities=19%  Similarity=0.210  Sum_probs=110.6

Q ss_pred             eeeeeeecccCceeEEEEEccCCceEEEEEEecccc-------------chhhHHHHHHHHHHHHHHhhCCCCceeEEee
Q 010676          331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ-------------GSQAKQSISQLEQEIALLSRFEHENIVQYYG  397 (504)
Q Consensus       331 y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~-------------~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~  397 (504)
                      +.++++||+|+||+||+|.+.+|+.||||++.....             ............+|+..+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            457899999999999999998999999998653111             0111222344567899999999999999887


Q ss_pred             eecCCCeEEEEEEeccCCCHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          398 TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       398 ~~~~~~~lyLVmEy~~ggsL~~ll~~~~l~e~~v~~i~~QIl~gL~yLHs~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      +..    .+++|||+++..+.      .+....+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|||+|.
T Consensus        82 ~~~----~~lvme~~~~~~~~------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~  150 (191)
T d1zara2          82 WEG----NAVLMELIDAKELY------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSV  150 (191)
T ss_dssp             EET----TEEEEECCCCEEGG------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCE
T ss_pred             ecC----CEEEEEeecccccc------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcc
Confidence            643    37999999986543      35666678899999999999999999999999999999865 48999999987


Q ss_pred             ccc
Q 010676          478 ATK  480 (504)
Q Consensus       478 ~~~  480 (504)
                      ...
T Consensus       151 ~~~  153 (191)
T d1zara2         151 EVG  153 (191)
T ss_dssp             ETT
T ss_pred             cCC
Confidence            654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.46  E-value=3.5e-07  Score=85.59  Aligned_cols=90  Identities=11%  Similarity=0.080  Sum_probs=60.2

Q ss_pred             ccccccceeeeeeecccCceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCC
Q 010676          324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE  402 (504)
Q Consensus       324 ~~~~~~~y~i~k~LG~G~FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~  402 (504)
                      .+.++..|+..+..+.++.+.||+.... +..+.+|.........     ...+.+|..++..+. +--+.+++.++..+
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccc-----hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            4456677887776665666789998654 4456677664322211     123567777776664 33356777777788


Q ss_pred             CeEEEEEEeccCCCHHH
Q 010676          403 SKLYIFLELVTKGSLLN  419 (504)
Q Consensus       403 ~~lyLVmEy~~ggsL~~  419 (504)
                      +..|+||++++|..+..
T Consensus        83 ~~~~lv~~~l~G~~~~~   99 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             TEEEEEEECCSSEEHHH
T ss_pred             CceEEEEEecccccccc
Confidence            89999999999977654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.14  E-value=3.4e-06  Score=78.26  Aligned_cols=134  Identities=19%  Similarity=0.136  Sum_probs=81.2

Q ss_pred             ecccC-ceeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC--CCceeEEeeeecCCCeEEEEEEecc
Q 010676          337 LGRGS-FGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDESKLYIFLELVT  413 (504)
Q Consensus       337 LG~G~-FG~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIV~l~~~~~~~~~lyLVmEy~~  413 (504)
                      +..|. -+.||+....++..+++|.......        ..+..|...|+.+.  .-.+.+++.+..+++..|+||++++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT--------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH--------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            44444 3689999888888899997643221        12456666666553  2236677887788888999999998


Q ss_pred             CCCHHH--------------HHHhcC--------CChHH--HHHHHH--------------------HHHHHHHHHHHC-
Q 010676          414 KGSLLN--------------LYQRYH--------LRDSQ--VSAYTR--------------------QILLGLKYLHDQ-  448 (504)
Q Consensus       414 ggsL~~--------------ll~~~~--------l~e~~--v~~i~~--------------------QIl~gL~yLHs~-  448 (504)
                      |..+..              ++.+-+        +....  ......                    .....+..+... 
T Consensus        90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  169 (255)
T d1nd4a_          90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM  169 (255)
T ss_dssp             SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred             ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence            765421              111100        00000  000000                    112223334332 


Q ss_pred             ------CceecCCCCCcEEEcCCCcEEEEecCcccc
Q 010676          449 ------DVVHRDIKCANILVDANGSVKLADFGLAKA  478 (504)
Q Consensus       449 ------gIIHRDLKP~NILLd~~g~VKL~DFGLA~~  478 (504)
                            .++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                  379999999999998776678999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.73  E-value=3.2e-05  Score=77.70  Aligned_cols=81  Identities=14%  Similarity=0.146  Sum_probs=46.7

Q ss_pred             eeeecccCceeEEEEEcc-CCceEEEEEEecccc--chhhHHHHHHHHHHHHHHhhCC---CCceeEEeeeecCCCeEEE
Q 010676          334 GDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYI  407 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~-~g~~vAVK~v~~~~~--~~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~~~~~~~~~lyL  407 (504)
                      .+.||.|....||++.+. +++.+++|.-.....  .........+...|...|+.+.   ...+++++.+..  ...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence            346899999999999874 467888886532110  0000011123445666665542   234666666543  34578


Q ss_pred             EEEeccCCC
Q 010676          408 FLELVTKGS  416 (504)
Q Consensus       408 VmEy~~ggs  416 (504)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.14  E-value=0.0004  Score=67.36  Aligned_cols=67  Identities=15%  Similarity=0.129  Sum_probs=41.4

Q ss_pred             eeEEEEEccCCceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCCCCce-----eEEe--eeecCCCeEEEEEEeccCC
Q 010676          343 GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-----VQYY--GTDKDESKLYIFLELVTKG  415 (504)
Q Consensus       343 G~VYka~~~~g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-----V~l~--~~~~~~~~lyLVmEy~~gg  415 (504)
                      -.||++...+|..|++|+.....   ..   ..++..|+..+..|...+|     +..-  ..+......+.+++++.|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~---~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER---WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT---SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC---CC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            58999999999999999875321   11   2345567766665542211     1111  1233456788999999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.43  E-value=0.0038  Score=61.74  Aligned_cols=73  Identities=11%  Similarity=0.002  Sum_probs=46.0

Q ss_pred             eeeecccCceeEEEEEccC--------CceEEEEEEeccccchhhHHHHHHHHHHHHHHhhCC-CCceeEEeeeecCCCe
Q 010676          334 GDLLGRGSFGSVYEGISDD--------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK  404 (504)
Q Consensus       334 ~k~LG~G~FG~VYka~~~~--------g~~vAVK~v~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~~~~~~~~  404 (504)
                      ++.|+.|-.=.+|++...+        ...|.+++... ...      .....+|..+++.+. +.-..++++++..   
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~------~idr~~E~~i~~~ls~~gl~Pkll~~~~~---  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET------ESHLVAESVIFTLLSERHLGPKLYGIFSG---  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC------HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch------hhHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence            3568878888999987543        24566665531 111      123457887877765 4334577777754   


Q ss_pred             EEEEEEeccCCCH
Q 010676          405 LYIFLELVTKGSL  417 (504)
Q Consensus       405 lyLVmEy~~ggsL  417 (504)
                       .+||+|++|..|
T Consensus       117 -g~I~efi~g~~l  128 (395)
T d1nw1a_         117 -GRLEEYIPSRPL  128 (395)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -ceEEEEeccccC
Confidence             689999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.39  E-value=0.0036  Score=59.42  Aligned_cols=30  Identities=27%  Similarity=0.318  Sum_probs=27.0

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEEecCccc
Q 010676          448 QDVVHRDIKCANILVDANGSVKLADFGLAK  477 (504)
Q Consensus       448 ~gIIHRDLKP~NILLd~~g~VKL~DFGLA~  477 (504)
                      .|+||+|+.++||+++.+...-|+||+.|.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            379999999999999988777899999875